nanosymposium - Society for Neuroscience

sociEtY FoR NEURosciENcE
Program
Monday
scientific sessions Listings
sessions 308–520
November 14, 2011
washiNgtoN, dc

Information at a Glance
important Phone Numbers
Annual Meeting Headquarters Office — Logistics and Programming
Logistics
Walter E. Washington Convention Center: Room 102, (202) 249-4100
Programming
Walter E. Washington Convention Center: Room 102, (202) 249-4105
Society Executive Lounge
Walter E. Washington Convention Center: Salon F, (202) 249-4075
Annual Meeting Information Booths
Walter E. Washington Convention Center
Grand Lobby, (202) 249-4115
L Street Bridge, (202) 249-4116
L Street Concourse, (202) 249-4117
Press Office
Walter E. Washington Convention Center: Room 204, (202) 249-4080
Exhibit Management
Walter E. Washington Convention Center: Show Office B, (202) 249-4090
First Aid and Hospital Numbers
First Aid Room
Walter E. Washington Convention Center: Hall A, (202) 249-3108; Hall D, (202) 249-3109
George Washington University Hospital
900 23rd Street, NW
Washington, DC 20037
(202) 715-4000
Medics USA Urgent Care Services
1700 17th Street, NW, Suite A
Washington, DC 20008
(202) 483-4400
Key to Poster Floor by Themes
The poster floor begins with Theme A and ends with Theme H. Refer to the poster floor map at the
end of this booklet.
Theme
A Development
B Neural Excitability, Synapses, and Glia: Cellular Mechanisms
C Disorders of the Nervous System
D Sensory and Motor Systems
E Homeostatic and Neuroendocrine Systems
F Cognition and Behavior
G Novel Methods and Technology Development
H History, Teaching, Public Awareness, and Societal Impacts in Neuroscience
NOTE: Theme H Posters will be on display in Hall A beginning at 1 p.m. on Saturday, Nov. 12, and
will remain posted until 5 p.m., Sunday, Nov. 13. One-hour presentation times will occur either
Saturday afternoon or Sunday morning.
Cover Image: Differentiated astrocytes, expressing
glial fibrillary acidic protein (red), migrating
outwards from a neurosphere after treatment of
neural precursors with bone morphogenetic protein
4. Nuclei are stained blue. Transplantation of
such cells is neuroprotective in a mouse model of
tauopathy. Image copyright 2010 Daniel Webber.
David W. Hampton, Daniel J. Webber, Bilada
Bilican, Michel Goedert, Maria Grazia Spillantini,
and Siddharthan Chandran, 2010, The Journal of
Neuroscience, 30: 9973-9983

Monday Highlights
✍ Preregistration Required $ Course Fee � Professional Development ` Networking � Public Outreach
Special Lecture
Rapid Synaptic Actions of Estrogens CME
Catherine S. Woolley, PhD
Northwestern University
8:30 – 9:40 a.m.
Walter E. Washington Convention Center: Hall D
Symposium
Human Cell Reprogramming and Its
Application in Neurological Diseases CME
Chair: Guo-li Ming, MD, PhD
Co-chair: Marius Wernig, MD
8:30 – 11 a.m.
Walter E. Washington Convention Center:
Ballroom B
Symposium
Thalamic Contributions to Basal
Ganglia-Related Behavioral Switching
and Reinforcement CME
Chair: Yoland Smith, PhD
Co-chair: Jim Surmeier, PhD
8:30 – 11 a.m.
Walter E. Washington Convention Center:
Ballroom A
Minisymposium
Neural Phase Coding and
Spike-Field Coherence CME
Chair: Zoltan Nadasdy, PhD
Co-chair: Michael E. Hasselmo, PhD
8:30 – 11 a.m.
Walter E. Washington Convention Center: 207B
Minisymposium
Emerging Roles for Somatostatin-Containing
Cortical Interneurons: Novel Insights
From Transgenic Mice CME
Chair: Ariel Agmon, PhD
8:30 – 11 a.m.
Walter E. Washington Convention Center: 145B
Minisymposium
New Insights on Diverse Neural
Mechanisms Underlying Alcohol
Dependence/Addiction CME
Chair: Changhai Cui, PhD
Co-chair: Antonio Noronha, PhD
8:30 – 11 a.m.
Walter E. Washington Convention Center: 202B
Minisymposium
Large-Scale Automated Histology
in the Pursuit of Connectomes CME
Chair: David Kleinfeld, PhD
Co-chair: Bert Sakmann, PhD
8:30 – 11 a.m.
Walter E. Washington Convention Center:
Ballroom C
Animals in Research Panel
Engaging the Public on Animal Research:
From the Classroom to the Airwaves
9 – 11 a.m.
Walter E. Washington Convention Center: 103
Teaching Neuroscience �
9 a.m. – noon
Walter E. Washington Convention Center: 146C
The Art of Networking �
9 a.m. – noon
Walter E. Washington Convention Center: 146B
David Kopf Lecture on Neuroethics
A Neanderthal Perspective on
Human Origins
Svante Pääbo, PhD
Max Planck Institute for Evolutionary Anthropology
Support contributed by: David Kopf Instruments
10 – 11:10 a.m.
Walter E. Washington Convention Center: Hall D
Special Lecture
Protein Synthesis and
Degradation at Synapses CME
Erin M. Schuman, PhD
Max Planck Institute for Brain Research, Germany
11:30 a.m. – 12:40 p.m.
Walter E. Washington Convention Center: Hall D
Symposium
Beyond the Connectome: Why the Wiring
Diagram Is Not Enough CME
Chair: Vladimir Brezina, PhD
1:30 – 4 p.m.
Walter E. Washington Convention Center:
Ballroom A
Symposium
Genetically Driven Manipulation of Hypothalamic
Circuitry Controlling Behavior CME
Chair: Clifford B. Saper, MD, PhD
1:30 – 4 p.m.
Walter E. Washington Convention Center:
Ballroom B
Minisymposium
Homeostatic Regulation of Synaptic
Strength: New Players, Mechanisms,
and Insights Into Synaptic Scaling CME
Chair: David Stellwagen, PhD
Co-chair: Elva Diaz, PhD
1:30 – 4 p.m.
Walter E. Washington Convention Center:
Ballroom C
Minisymposium
Rapid Estrogen Signaling in the Brain —
Implications for the Fine-Tuning of
Neural Circuitry CME
Chair: Deepak P. Srivastava, PhD
Co-chair: Feng Liu, PhD
1:30 – 4 p.m.
Walter E. Washington Convention Center: 202B
Minisymposium
Melanopsin-Positive Intrinsically
Photosensitive Retinal Ganglion Cells: How
Form Fits Function CME
Chair: Anna Matynia, PhD
Co-chair: Samer Hattar, PhD
1:30 – 4 p.m.
Walter E. Washington Convention Center: 207B
Beyond the Bench: Supporting the Neuroscience
Community Through Leadership,
Outreach, and Accumulated Wisdom �
2 – 5 p.m.
Walter E. Washington Convention Center: 146B
Negotiating a Senior Position �
2 – 5 p.m.
Walter E. Washington Convention Center: 146C
Albert and Ellen Grass Lecture
Optimal Integration of Sensory Evidence:
A Bayesian Journey Through Our
Sixth Sense CME
Dora Angelaki, PhD
Baylor College of Medicine
Support contributed by: The Grass Foundation
3:15 – 4:25 p.m.
Walter E. Washington Convention Center: Hall D
Presidential Special Lecture
Genes, the Environment, and Decisions: How
Fixed Circuits Generate Flexible Behaviors CME
Cornelia I. Bargmann, PhD
Rockefeller University
Support contributed by: MedImmune
5:15 – 6:25 p.m.
Walter E. Washington Convention Center: Hall D
NIH Grant Workshop for Early
Career Investigators* �
6:30 – 9:30 p.m.
Walter E. Washington Convention Center: 103
* Offered by an SfN partner organization
www.sfn.org/am2011 I

Plan to Attend
Tuesday, Nov. 15
Special Lecture
Hippocampal Neurogenesis and Pattern Separation:
Impact on Cognition and Mood CME
Rene Hen, PhD
Columbia University College of Physicians and Surgeons
8:30 – 9:40 a.m.
Walter E. Washington Convention Center: Hall D
Special Lecture
From Single Cells to Neural Lineages Through the
Ages CME
Sally Temple, PhD
New York Neural Stem Cell Institute
11:30 a.m. – 12:40 p.m.
Walter E. Washington Convention Center: Hall D
Special Lecture
The Pluses and Minuses of Optimal Action Selection CME
Howard L. Fields, MD, PhD
University of California, San Francisco
1 – 2:10 p.m.
Walter E. Washington Convention Center: Hall D
History of Neuroscience Lecture
Neurodegenerative Diseases:
The Path to Therapy
Anne B. Young, MD, PhD
Massachusetts General Hospital
Support contributed by: AstraZeneca
2:30 – 3:40 p.m.
Walter E. Washington Convention Center: Hall D
Presidential Special Lecture
The Epigenetic Basis of Common
Human Disease CME
Andrew P. Feinberg, MD, MPH
Johns Hopkins University School of Medicine
Support contributed by: Pfizer Inc.
5:15 – 6:25 p.m.
Walter E. Washington Convention Center: Hall D
II Neuroscience 2011

Chronological List of Monday Sessions
Theme Descriptions
A Development
B Neural Excitability, Synapses, and Glia: Cellular Mechanisms
C Disorders of the Nervous System
D Sensory and Motor Systems
E Homeostatic and Neuroendocrine Systems
F Cognition and Behavior
G Novel Methods and Technology Development
H History, Teaching, Public Awareness, and Societal Impacts
in Neuroscience
All Posters will be presented in the Walter E. Washington Convention Center, Halls A-C. All lecture, symposia, minisymposia, and nanosymposia rooms are in
the Walter E. Washington Convention Center.
Session
Number
Theme Title
Presentation
Type
Poster
Board
Number
Location Session Time
308 E Rapid Synaptic Actions of Estrogens Special Lecture Hall D 8:30 – 9:40 a.m. 1.25
309 D
310 C
311 G
312 D
313 F
Thalamic Contributions to Basal Ganglia-Related
Behavioral Switching and Reinforcement
Human Cell Reprogramming and Its Application in
Neurological Diseases
Large-Scale Automated Histology in the Pursuit
of Connectomes
Emerging Roles for Somatostatin-Containing Cortical
Interneurons: Novel Insights From Transgenic Mice
New Insights on Diverse Neural Mechanisms
Underlying Alcohol Dependence/Addiction
Symposium Ballroom A 8:30 – 11 a.m. 2.5
Symposium Ballroom B 8:30 – 11 a.m. 2.5
Minisymposium Ballroom C 8:30 – 11 a.m. 2.5
Minisymposium 145B 8:30 – 11 a.m. 2.5
Minisymposium 202B 8:30 – 11 a.m. 2.5
314 B Neural Phase-Coding and Spike-Field Coherence Minisymposium 207B 8:30 – 11 a.m. 2.5
315 A Neanderthal Perspective on Human Origins
David Kopf Lecture on
Neuroethics
Hall D 10 – 11:10 a.m.
316 B Protein Synthesis and Degradation at Synapses Special Lecture Hall D 11:30 a.m. – 12:40 p.m. 1.25
317 A
Synaptogenesis: Activity-Dependent Changes in
Connectivity II
Nanosymposium 144A 8 – 10:45 a.m.
318 B Presynaptic Mechanisms I Nanosymposium 150B 8 – 10:30 a.m.
319 C Alzheimer’s Disease: Tau Biochemistry Nanosymposium 140A 8 – 11 a.m.
320 C
Multimodal Neuroimaging Studies of Aging and
Neurodegenerative Disorders
Nanosymposium 143A 8 – 10 a.m.
321 C Parkinson’s Disease: Neuroprotective Mechanisms II Nanosymposium 146A 8 – 10:15 a.m.
322 C
323 C
Multiple Sclerosis: Mechanisms and
Therapeutic Strategies
Nanoparticles as Therapeutic Tools for Diseases
of the Nervous System
Nanosymposium 152A 8 – 11:30 a.m.
Nanosymposium 152B 8 – 10:15 a.m.
324 D Representation of Categories in Extrastriate Cortex Nanosymposium 147B 8 – 11 a.m.
325 E Neural and Molecular Mechanisms of Stress Nanosymposium 147A 8 – 10:15 a.m.
326 F Limbic System Development: Functional Implications Nanosymposium 201 8 – 10:15 a.m.
327 F
Featured Programs
Nanosymposia
Human Memory: Multivariate and
Connectivity Studies
Posters (8 a.m.–noon)
Nanosymposium 206 8 – 10:45 a.m.
328 A Connectome Poster A1-A9 Hall A-C 8 a.m. – noon
329 A Molecular Mechanisms of Neuronal Differentiation Poster A10-A30 Hall A-C 8 a.m. – noon
330 A Neurogenesis and Gliogenesis: Neuron-Glia Interactions Poster A31-A48 Hall A-C 8 a.m. – noon
331 A Postnatal Neurogenesis V Poster A49-B2 Hall A-C 8 a.m. – noon
CME
Hours
www.sfn.org/am2011 III

Session Chronological Theme Title
Presentation
Poster
Number
List of Xxxx Board Sessions
IV Neuroscience 2011
Type
Number
Location Session Time
332 A CNS Synaptogenesis Poster B3-B13 Hall A-C 8 a.m. – noon
333 A Neuromuscular Junction Formation Poster B14-B22 Hall A-C 8 a.m. – noon
334 A Synapse Formation: CNS I Poster B23-B41 Hall A-C 8 a.m. – noon
335 A Motor System Development Poster B42-C1 Hall A-C 8 a.m. – noon
336 B
Nicotinic Acetylcholine Receptors: Pharmacology and
Structure-Function
Poster C2-C23 Hall A-C 8 a.m. – noon
337 B GABA-A Receptor Structure Poster C24-C37 Hall A-C 8 a.m. – noon
338 B GABA-A Receptor Trafficking Poster C38-C50 Hall A-C 8 a.m. – noon
339 B G-Protein-Linked Receptors: Muscarinic Receptors Poster D1-D16 Hall A-C 8 a.m. – noon
340 B Serotonin Receptors Poster D17-D33 Hall A-C 8 a.m. – noon
341 B
G-Protein-Linked Receptors: Peptide and Opioid
Receptors
Poster D34-D61 Hall A-C 8 a.m. – noon
342 B Transporters: Glutamate Poster D62-E15 Hall A-C 8 a.m. – noon
343 B Transporters: Monoamine Poster E16-G3 Hall A-C 8 a.m. – noon
344 B Transporters: Dopamine Poster G4-H11 Hall A-C 8 a.m. – noon
345 B
Modulation of Synaptic Transmission:
Peptides and Amines
Poster H12-K8 Hall A-C 8 a.m. – noon
346 B Modulation of Synaptic Transmission: Amino Acids Poster K9-L9 Hall A-C 8 a.m. – noon
347 B Synaptic Plasticity: Long-Term Depression I Poster L10-N2 Hall A-C 8 a.m. – noon
348 B Synaptic Plasticity: Spike-Timing Dependent Poster N3-O8 Hall A-C 8 a.m. – noon
349 B Neural Oscillators Poster O9-P3 Hall A-C 8 a.m. – noon
350 C APP/Abeta: Animal Models III Poster P4-R11 Hall A-C 8 a.m. – noon
351 C Tau: Animal Models II Poster R12-V5 Hall A-C 8 a.m. – noon
352 C
353 C
Alzheimer’s Disease and Related Dementias:
APP/Abeta/Tau Models
Alzheimer’s Disease and Other Dementias:
Tau Biochemistry and Cell Biology
Poster V6-X8 Hall A-C 8 a.m. – noon
Poster X9-Y17 Hall A-C 8 a.m. – noon
354 C Beta and Gamma Secretase, BACE, and Presenilin I Poster Y18-Z8 Hall A-C 8 a.m. – noon
355 C Parkinson’s Disease: Genetic Determinants Poster Z9-Z17 Hall A-C 8 a.m. – noon
356 C Parkinson’s Disease: Degeneration Models Poster AA2-AA19 Hall A-C 8 a.m. – noon
357 C
Parkinson’s Disease: Models of
Alpha-Synuclein Toxicity
Poster AA20-BB10 Hall A-C 8 a.m. – noon
358 C Huntington’s Disease: Animal Models II Poster BB11-CC11 Hall A-C 8 a.m. – noon
359 C Other Neurodegenerative Disorders II Poster
CC12-
CC30
Hall A-C 8 a.m. – noon
360 C Epilepsy: Human EEG and MRI Poster CC31-DD12 Hall A-C 8 a.m. – noon
361 C Ischemia: Neuroprotection II Poster
DD13-
DD36
Hall A-C 8 a.m. – noon
362 C Ischemia: Cell-Based Therapies and Neurogenesis Poster EE1-FF2 Hall A-C 8 a.m. – noon
363 C Trauma: Neuroprotection Poster FF3-FF32 Hall A-C 8 a.m. – noon
364 C Cell Death: Mitochondria Poster FF33-GG16 Hall A-C 8 a.m. – noon
365 C Oxidative Stress I Poster
366 C Neuroprotection Poster
GG17-
GG35
GG36-
HH15
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
367 C Neuroprotection: New Molecules and Mechanisms Poster HH16-II9 Hall A-C 8 a.m. – noon
368 C
Posters (8 a.m.–noon)
Animal Molecular and Pharmacological Models of
Psychotic Diagnoses
Poster II10-JJ7 Hall A-C 8 a.m. – noon
369 C Mood Disorders: Treatment Studies Poster JJ8-JJ18 Hall A-C 8 a.m. – noon
CME
Hours

Session
Number
Theme Title
Presentation
Type
Poster
Board
Number
Location Session Time
370 C Nicotine Abuse and Addiction: Neural Mechanisms I Poster JJ19-KK5 Hall A-C 8 a.m. – noon
371 C Cocaine Reinforcement and Seeking II Poster KK6-KK35 Hall A-C 8 a.m. – noon
372 C Methamphetamine: Toxicity Poster KK36-LL19 Hall A-C 8 a.m. – noon
373 C Alcohol and Sedative Hypnotics: Neural Mechanisms I Poster LL20-MM2 Hall A-C 8 a.m. – noon
374 D
375 D
376 D
Olfaction: Higher-Order Processing and
Integrative Studies
Olfaction: Animal Behavior and the Neural
Correlates of Behavior
Multisensory Processing: Temporal and
Cognitive Factors
Poster
Poster
MM3-
MM15
MM16-
NN7
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
Poster NN8-NN21 Hall A-C 8 a.m. – noon
377 D Mouse Vision: Functional Organization Poster NN22-OO3 Hall A-C 8 a.m. – noon
378 D Mouse Vision: Response Properties Poster OO4-OO20 Hall A-C 8 a.m. – noon
379 D Eye Movements: Perception and Neural Mechanisms Poster
OO21-
OO36
Hall A-C 8 a.m. – noon
380 D Pain Models: Physiology Poster PP1-QQ2 Hall A-C 8 a.m. – noon
381 D Inflammatory Pain and Sensitization Poster QQ3-QQ25 Hall A-C 8 a.m. – noon
382 D Pain Imaging and Perception I Poster
QQ26-
RR18
Hall A-C 8 a.m. – noon
383 D Pain: Other Analgesics Poster RR19-RR35 Hall A-C 8 a.m. – noon
384 D
385 D
Somatosensory: Local Cortical Circuits
for Whiskers
Stimulus Feature Receptive Fields and
Response Properties
Poster RR36-SS21 Hall A-C 8 a.m. – noon
Poster SS22-TT11 Hall A-C 8 a.m. – noon
386 D Motor Pattern Generation: Connectivity I Poster TT12-UU1 Hall A-C 8 a.m. – noon
387 D Reaching Control: Motor Learning II Poster UU2-UU28 Hall A-C 8 a.m. – noon
388 E Neurohypophyseal Hormones and Neuropeptides Poster UU29-VV4 Hall A-C 8 a.m. – noon
389 E
Prolactin, TIDA Neurons, VTA, Dopamine/Insulin,
Growth Hormone, and Metabolism
390 E Neuroimmunology: Hormonal and Behavioral Effects Poster
Poster VV5-VV22 Hall A-C 8 a.m. – noon
VV23-
VV36
Hall A-C 8 a.m. – noon
391 E Neural Control of Sex Behavior Poster VV37-VV59 Hall A-C 8 a.m. – noon
392 E
Posters (8 a.m.–noon)
Social Behavior: Effects of Genes, Sex,
and Environment
Poster
393 E Renal/Urinary I Poster
394 E Cellular Actions of Stress Poster
395 E Metabolism and Energy Homeostasis I Poster
396 E Circadian Physiology Poster
VV60-
VV77
VV78-
VV94
VV95-
WW20
WW21-
WW40
WW41-
WW58
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
397 E Sleep Neurochemistry and Pharmacology I Poster WW59-XX6 Hall A-C 8 a.m. – noon
398 E Biological Rhythms and Sleep: Functional Imaging Poster XX7-XX24 Hall A-C 8 a.m. – noon
399 F Visual Perception and Imagery Poster
XX25-
XX50
Hall A-C 8 a.m. – noon
400 F Attentional Function Poster XX51-XX65 Hall A-C 8 a.m. – noon
401 F Language: Learning and Second Language Poster
XX66-
XX83
Hall A-C 8 a.m. – noon
402 F Emotion: Disorders and Dysfunctions Poster XX84-YY4 Hall A-C 8 a.m. – noon
403 F Decision-Making and Cognition: Neural Substrates Poster YY5-YY27 Hall A-C 8 a.m. – noon
404 F Executive Function: Learning and Memory Poster YY28-YY50 Hall A-C 8 a.m. – noon
405 F Executive Function: Decision-Making II Poster YY51-YY69 Hall A-C 8 a.m. – noon
CME
Hours
www.sfn.org/am2011 V

Session Chronological Theme Title
Presentation
Poster
Number
List of Xxxx Board Sessions
VI Neuroscience 2011
Type
Number
Location Session Time
406 F Timing and Temporal Processing I Poster YY70-YY88 Hall A-C 8 a.m. – noon
407 F Learning and Memory Systems I Poster YY89-ZZ23 Hall A-C 8 a.m. – noon
408 F Prefrontal and Striatal Anatomy and Function Poster ZZ24-ZZ38 Hall A-C 8 a.m. – noon
409 F
Memory Consolidation and Reconsolidation:
Molecular Mechanisms
Poster ZZ39-ZZ61 Hall A-C 8 a.m. – noon
410 F Hippocampus and Cortex in Behavior Poster ZZ62-ZZ79 Hall A-C 8 a.m. – noon
411 F Learning and Memory: Hippocampus and Aging Poster
412 F Animal Models of Fear, Anxiety, and Pain Poster
413 F Neuroethology: Gene Expression and Neurochemistry Poster
414
415 D
416 E
417 B
418 B
419 D
420
Optimal Integration of Sensory Evidence:
A Bayesian Journey Through Our Sixth Sense
Beyond the Connectome: Why the Wiring Diagram
Is Not Enough
Genetically Driven Manipulation of Hypothalamic
Circuitry Controlling Behavior
Homeostatic Regulation of Synaptic Strength:
New Players, Mechanisms, and Insights Into
Synaptic Scaling
Rapid Estrogen Signaling in the Brain — Implications
for the Fine-Tuning of Neural Circuitry
Melanopsin-Positive Intrinsically Photosensitive
Retinal Ganglion Cells: How Form Fits Function
Genes, the Environment, and Decisions:
How Fixed Circuits Generate Flexible Behaviors
Albert and Ellen Grass
Lecture
ZZ80-
AAA9
AAA10-
AAA27
AAA28-
AAA42
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
Hall A-C 8 a.m. – noon
Hall D 3:15 – 4:25 p.m. 1.25
Symposium Ballroom A 1:30 – 4 p.m. 2.5
Symposium Ballroom B 1:30 – 4 p.m. 2.5
Minisymposium Ballroom C 1:30 – 4 p.m. 2.5
Minisymposium 202B 1:30 – 4 p.m. 2.5
Minisymposium 207B 1:30 – 4 p.m. 2.5
Presidential Special
Lecture
Hall D 5:15 – 6:25 p.m. 1.25
421 A Synapse Formation: CNS II Nanosymposium 144A 1 – 4 p.m.
422 C
Alzheimer’s Disease: Neuroinflammation and
Immune Mechanisms I
Nanosymposium 140A 1 – 4 p.m.
423 C
Posters (1–5 p.m.)
Parkinson’s Disease: Cellular Mechanisms II Nanosymposium 152A 1 – 4 p.m.
424 C Other Neurodegenerative Disorders III Nanosymposium 143A 1 – 4:30 p.m.
425 C Animal Models and Mechanisms I Nanosymposium 145B 1 – 2:45 p.m.
426 C Neuroprotective Agents and Mechanisms Nanosymposium 150B 1 – 2:45 p.m.
427 C Alcohol Reward: Neural Mechanisms Nanosymposium 147B 1 – 3:45 p.m.
428 D Striate Cortex: Functional Organization II Nanosymposium 146A 1 – 3:45 p.m.
429 E Circadian Regulation of Behavior Nanosymposium 147A 1 – 3:30 p.m.
430 F The Social Human Animal Nanosymposium 201 1 – 4 p.m.
431 F Functional Mechanisms of Attention by Animal Nanosymposium 152B 1 – 2:45 p.m.
432 G Cellular Imaging Nanosymposium 206 1 – 2:45 p.m.
433 A Proliferation: Cell Cycle Poster A1-A12 Hall A-C 1 – 5 p.m.
434 A Differentiation of Stem Cells I Poster A13-A36 Hall A-C 1 – 5 p.m.
435 A Stem Cells and Disease Poster A37-A51 Hall A-C 1 – 5 p.m.
436 A Synapse Formation: CNS III Poster A52-A67 Hall A-C 1 – 5 p.m.
437 A
Posters (8 a.m.–noon)
Featured Programs
Nanosymposium
Posters (1–5 p.m.)
Developmental Cell Death: Neurotrophins and Other
Trophic Factors
Poster A68-B11 Hall A-C 1 – 5 p.m.
438 A Regeneration I Poster B12-B36 Hall A-C 1 – 5 p.m.
439 A Regeneration II Poster B37-B58 Hall A-C 1 – 5 p.m.
CME
Hours

Session
Number
Theme Title
Presentation
Type
Poster
Board
Number
Location Session Time
440 A Regeneration III Poster B59-C13 Hall A-C 1 – 5 p.m.
441 A Regeneration IV Poster C14-C29 Hall A-C 1 – 5 p.m.
442 B
443 B
Nicotinic Acetylcholine Receptors:
Regulation and Signaling
Non-NMDA Glutamate Receptors:
Structure and Trafficking I
Poster C31-C48 Hall A-C 1 – 5 p.m.
Poster C49-D14 Hall A-C 1 – 5 p.m.
444 B Transporters: DAT and Amphetamine Poster D15-D25 Hall A-C 1 – 5 p.m.
445 B Presynaptic Mechanisms II Poster D26-D53 Hall A-C 1 – 5 p.m.
446 B Presynaptic Mechanisms III Poster D54-E11 Hall A-C 1 – 5 p.m.
447 B Presynaptic Mechanisms IV Poster E12-E36 Hall A-C 1 – 5 p.m.
448 B Presynaptic Mechanisms: Short-Term Plasticity Poster E37-G8 Hall A-C 1 – 5 p.m.
449 B Synaptic Plasticity: Presynaptic Mechanisms Poster G9-H11 Hall A-C 1 – 5 p.m.
450 B Synaptic Transmission: Regulation by Zinc Poster H12-K6 Hall A-C 1 – 5 p.m.
451 B Oscillations and Synchrony: Unit Studies Poster K7-M5 Hall A-C 1 – 5 p.m.
452 B Dendritic Excitability and Synaptic Integration I Poster M6-N11 Hall A-C 1 – 5 p.m.
453 C
454 C
Physiological Functions and Processing of APP
and APP Metabolites II
Repeat Expansion Diseases:
Non-Huntington’s Disease I
Poster N12-P10 Hall A-C 1 – 5 p.m.
Poster P11-R6 Hall A-C 1 – 5 p.m.
455 C Motor Neuron Disease: Mechanisms IV Poster R7-T7 Hall A-C 1 – 5 p.m.
456 C Epilepsy and Neuronal Networks I Poster T8-V11 Hall A-C 1 – 5 p.m.
457 C Epilepsy and Neuronal Networks II Poster V12-X8 Hall A-C 1 – 5 p.m.
458 C Epilepsy: Human Tissue Poster X9-Y12 Hall A-C 1 – 5 p.m.
459 C Ischemia: Recovery Poster Y13-Y31 Hall A-C 1 – 5 p.m.
460 C Ischemia: Inflammation II Poster Y32-Z14 Hall A-C 1 – 5 p.m.
461 C
Demyelinating Disorders: Molecular and Cellular
Mechanisms I
Poster Z15-Z29 Hall A-C 1 – 5 p.m.
462 C Trauma: Recovery Poster Z30-AA23 Hall A-C 1 – 5 p.m.
463 C Spinal Cord Injury: Molecular Mechanisms Poster
AA24-
AA35
Hall A-C 1 – 5 p.m.
464 C Spinal Cord Injury: Cellular Mechanisms Poster AA36-BB21 Hall A-C 1 – 5 p.m.
465 C Glutamate Toxicity Poster BB22-CC8 Hall A-C 1 – 5 p.m.
466 C NMDA, Kynurenic Acid, and Neurodegeneration Poster CC9-CC31 Hall A-C 1 – 5 p.m.
467 C Human Tissue Studies in Psychotic Disorders Poster
468 C
Genetically Manipulated Animal Models of
Psychotic Diagnoses
CC32-
DD29
Hall A-C 1 – 5 p.m.
Poster DD30-EE18 Hall A-C 1 – 5 p.m.
469 C Alcohol: Behavioral Effects Poster EE19-FF3 Hall A-C 1 – 5 p.m.
470 C Alcohol: Human and Primate Studies Poster FF4-FF16 Hall A-C 1 – 5 p.m.
471 C Cocaine: Neural Mechanisms II Poster FF17-GG8 Hall A-C 1 – 5 p.m.
472 C
Amphetamine, MDMA, and Methylphenidate:
Neural Mechanisms
Poster GG9-GG24 Hall A-C 1 – 5 p.m.
473 C Learning, Memory, Dependence, and Addiction Poster GG25-HH9 Hall A-C 1 – 5 p.m.
474 C Serotonin, Histamine, and Behavior Poster
475 D
Posters (1–5 p.m.)
Olfaction: Cellular and Circuit Mechanisms in
Olfactory Bulb/Antennal Lobe
HH10-
HH27
Hall A-C 1 – 5 p.m.
Poster HH28-II23 Hall A-C 1 – 5 p.m.
476 D Auditory Processing: Pathology and Therapeutics Poster II24-JJ14 Hall A-C 1 – 5 p.m.
477 D Auditory Receptor Cells and Cochlea Poster JJ16-JJ33 Hall A-C 1 – 5 p.m.
CME
Hours
www.sfn.org/am2011 VII

Session Chronological Theme Title
Presentation
Poster
Number
List of Xxxx Board Sessions
478 D
479 D
480 D
VIII Neuroscience 2011
Auditory Processing: Sound Localization and
Binaural Interactions
Auditory Processing: Connectivity, Circuits,
and Neurotransmitters
Auditory Processing: Neural Coding-Experiment
and Theory
Type
Number
Location Session Time
Poster JJ34-KK20 Hall A-C 1 – 5 p.m.
Poster
KK21-
KK30
Hall A-C 1 – 5 p.m.
Poster KK31-LL3 Hall A-C 1 – 5 p.m.
481 D Multisensory Processing: Neural Factors I Poster LL17-LL30 Hall A-C 1 – 5 p.m.
482 D Retinal Circuitry: Synaptic Interactions Poster
483 D Striate Cortex: Neural Coding Poster
484 D
Functional Organization and Circuitry of
Extrastriate Cortex
485 D Visual Processing of Surfaces, Shapes, and Objects Poster
486 D
Visual Processing of Special Objects:
Words, Tools, Bodies, and Scenes
LL31-
MM13
MM14-
NN3
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Poster NN4-NN20 Hall A-C 1 – 5 p.m.
Poster
NN21-
OO10
OO11-
OO30
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
487 D Face Processing in Extrastriate Cortex Poster OO31-PP18 Hall A-C 1 – 5 p.m.
488 D Visual Learning and Categorization Poster PP19-QQ12 Hall A-C 1 – 5 p.m.
489 D Eye Movements: Saccades Poster
QQ13-
QQ29
Hall A-C 1 – 5 p.m.
490 D Eye Movements: Pursuit and Vergence Poster QQ30-RR3 Hall A-C 1 – 5 p.m.
491 D
Vestibular System: Central Physiology
and Anatomy
Poster RR4-RR16 Hall A-C 1 – 5 p.m.
492 D Pain Transduction: Non-TRP Channels Poster RR17-RR27 Hall A-C 1 – 5 p.m.
493 D
Opioid Receptor Pharmacology and
Signaling Mechanisms
Poster RR28-SS4 Hall A-C 1 – 5 p.m.
494 D Visceral Pain-GI Poster SS5-SS24 Hall A-C 1 – 5 p.m.
495 D Somatosensory: Functional Organization Poster SS25-TT16 Hall A-C 1 – 5 p.m.
496 D Thalamocortical Processes Poster TT17-UU1 Hall A-C 1 – 5 p.m.
497 D Motor Pattern Generation: Neuromodulation I Poster UU2-UU17 Hall A-C 1 – 5 p.m.
498 D Posture and Gait: Fatigue and Disease Poster
499 E Hormonal, Genetic, and Epigenetic Factors Poster
500 E
HPG Axis: Hormonal and Epigenetic Regulation
of GnRH Neurons
501 E Steroids: Rapid Effects and Local Synthesis Poster
502 E Hypoxia and Obstructive Sleep Apnea Poster
503 E
Early Life Experience: Maternal Care and
Neonatal Stress
UU18-
UU33
UU34-
VV20
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Poster VV21-VV31 Hall A-C 1 – 5 p.m.
Poster
504 E Stress: Nutrient Intake, Metabolism, and Exercise Poster
505 E Cellular and Molecular Mechanisms Underlying Sleep Poster
506 E Circadian Clock Mechanisms Poster
507 E Brain Blood Flow and the Blood-Brain Barrier Poster
508 F Memory Retrieval Poster
VV32-
VV42
VV43-
VV58
VV59-
VV79
VV80-
WW5
WW6-
WW26
WW27-
WW38
WW39-
WW65
WW66-
XX17
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
Hall A-C 1 – 5 p.m.
509 F Reading Studies Poster XX18-XX41 Hall A-C 1 – 5 p.m.
510 F
Posters (1–5 p.m.)
Human Cognition and Behavior:
Individual Differences
Poster
XX42-
XX69
Hall A-C 1 – 5 p.m.
CME
Hours

Session
Number
511 F
Theme Title
Executive Function: Decision-Making, Impulsivity,
and Risk
Presentation
Type
Poster
Board
Number
Location Session Time
Poster XX70-YY1 Hall A-C 1 – 5 p.m.
512 F Prefrontal and Striatal Molecular and Physiology Poster YY2-YY28 Hall A-C 1 – 5 p.m.
513 F
Medial Temporal Lobe Systems: Molecular and
Cellular Mechanisms
Poster YY29-YY43 Hall A-C 1 – 5 p.m.
514 F Dopamine Mechanisms and Physiology Poster YY44-YY64 Hall A-C 1 – 5 p.m.
515 F
Reward, Attention, and Decision-Making:
Physiological Mechanisms
Poster YY65-YY89 Hall A-C 1 – 5 p.m.
516 F Animal Models of PTSD Poster YY90-ZZ7 Hall A-C 1 – 5 p.m.
517 F Neuroethology: Comparative Sensory Physiology Poster ZZ8-ZZ25 Hall A-C 1 – 5 p.m.
518 G Genomics, Proteomics, and Systems Biology Poster ZZ26-ZZ47 Hall A-C 1 – 5 p.m.
519 G Staining, Tracing, and Imaging Techniques II Poster ZZ48-ZZ77 Hall A-C 1 – 5 p.m.
520 G New Techniques: Microelectrode-Based Approaches Poster
W25
Animals in Research Panel: Engaging the Public on
Animal Research — From the Classroom to
the Airwaves
ZZ78-
AAA18
Hall A-C 1 – 5 p.m.
Workshops/Meetings 103 9 – 11 a.m.
W26 Teaching Neuroscience Workshops/Meetings 146C 9 a.m. – noon
W27 The Art of Networking Workshops/Meetings 146B 9 a.m. – noon
W28
Posters (1–5 p.m.)
Beyond the Bench: Supporting the Neuroscience
Community Through Leadership, Outreach,
and Accumulated Wisdom
Workshops/Meetings 146B 2 – 5 p.m.
W29 Negotiating a Senior Position Workshops/Meetings 146C 2 – 5 p.m.
W30 NIH Grant Workshop for Early Career Investigators* Workshops/Meetings 103 6:30 – 9:30 p.m.
* Offered by an SfN partner organization
Workshops, Meetings & Events
CME
Hours
www.sfn.org/am2011 IX

Monday Workshops, Meetings & Events
✍ Preregistration Required $ Course Fee � Professional Development ` Networking � Public Outreach
Monday, Nov. 14
Animals in Research Panel
Engaging the Public on Animal Research:
From the Classroom to the Airwaves
9 – 11 a.m.
Walter E. Washington Convention Center: 103
Organizer: Sharon Juliano, PhD
Panelists: Susan Adler; Colin Blakemore, PhD;
Elizabeth Burnett; Jon Hamilton
Contact: Paul Libus, plibus@sfn.org
Continued public support for animal research
requires educated citizens who understand science,
and how responsible and regulated animal
research contributes to scientific progress. Too
often, slick animal rights campaigns tell only
one side of the story. What do students and the
broader public hear about animal research, and
how are neuroscientists helping to enhance public
awareness? Join scientists, educators, and media
to discuss how to expand public knowledge about
animal research progress and promise.
Teaching Neuroscience �
9 a.m. – noon
Walter E. Washington Convention Center: 146C
Organizer: Richard Olivo, PhD
Panelists: Joseph Burdo, PhD; Robert
Calin-Jageman, PhD; Bob Rosenberg, PhD;
William Grisham, PhD; Monica Linden, PhD;
Jan Thornton, PhD; Laura Symonds, PhD
Contact: Erum Khan, ekhan@sfn.org
Announcing ERIN, “Educational Resources in
Neuroscience,” the Society’s new NSF-funded
project to create a Web site for listing, reviewing,
and rating teaching resources for higher
education. ERIN’s board of editors will present
highlights in each of their topic areas: Development,
Cellular (Excitability, Synapses, and Glia),
Disorders of the Nervous System, Sensory and
Motor Systems, Homeostatic and Neuroendocrine
Systems, and Cognition and Behavior.
The Art of Networking �
9 a.m. – noon
Walter E. Washington Convention Center: 146B
Organizers: Sherilynn Black, PhD;
Erich Jarvis, PhD
Panelists: Daniel Geschwind, PhD; Heather
Dean, PhD; Olivier Berton, PhD; Ian Maze,
PhD; Anne West, PhD
Contact: Erum Khan, ekhan@sfn.org
Networking can mean different things to each
of us. For some, it means cultivating meaningful
mentor and mentee relationships, while for
others it means learning to effectively foster
scientific collaborations. In a variety of cir-
X Neuroscience 2011
cumstances, networking can be used as a powerful
tool that can dramatically improve your
scientific career. At this workshop, hear how
learning the art of networking has impacted
the careers of several scientists from graduate
school through tenure-track/established positions.
Also hear different networking experiences
from both the male and female scientist
perspective and gain tips on how to maximize
your interactions with others. Finally, gain
valuable insight on how to apply these skills to
real-life events.
Beyond the Bench: Supporting the
Neuroscience Community Through
Leadership, Outreach, and
Accumulated Wisdom �
2 – 5 p.m.
Walter E. Washington Convention Center: 146B
Organizer: Floyd Bloom, MD
Panelists: Floyd Bloom, MD; Kjell Fuxe, MD;
Leslie Tolbert, PhD; Irwin Levitan, PhD;
Story Landis, PhD
Contact: Erum Khan, ekhan@sfn.org
The “silver seers” workshop panel brings
together senior members of the global neuroscience
community to discuss how other senior
members can use their accumulated wisdom
from research and administrative experiences to
strengthen the infrastructure of neuroscience.
These discussions include “science statesmanship”
— engaging in advocacy and public outreach;
building professional contributory skills
outside the laboratory, such as serving on editorial
boards, study sections, and other advisory
roles; contributing directly to SfN activities,
such as serving on committees and in mentoring
and professional development programs;
and successful strategies for transitioning into
and out of leadership roles and alternatives to
active research participation.
Negotiating a Senior Position �
2 – 5 p.m.
Walter E. Washington Convention Center: 146C
Organizer: Gina Poe, PhD
Panelists: Karyn Frick, PhD; Michael Lehman,
PhD; Mark R. Opp, PhD; Joanne E. Berger-
Sweeney, PhD
Contact: Erum Khan, ekhan@sfn.org
For the next steps in your career after your first
academic appointment, you will need to negotiate
beyond lab and office space, start-up funding,
teaching commitments, and faculty mentoring
programs. To ensure your next appointment will
be a success, you should be thinking of professional
development opportunities you can take
advantage of in your current appointment; how
to move an established lab with grants, graduate
students, postdoctorals, and staff; how to buyout
your lab equipment; how to negotiate promotions
contingent with your move (e.g., gaining
tenure or promotion to full professor); and sometimes
how to negotiate additional or supplanting
administrative duties (e.g., director, chair, dean)
and if so, whether and how to downsize your research
effort. Dual career issues become increasingly
complex with advancing career stages of
partners as well. This workshop addresses these
issues and more through the experiences and
wisdom of panelists who have successfully negotiated
spectacular next step and senior positions.
Hear from panelists, ask questions, and employ
their expertise in helping plan your next move up
the ladder in research/academia.
NIH Grant Workshop for Early
Career Investigators* �
6:30 – 9:30 p.m.
Walter E. Washington Convention Center: 103
Organizer: Nancy Pilotte, PhD
Contact: Nancy Pilotte, PhD, npilotte@nih.gov
Calling all predocs, postdocs, new faculty, and
junior faculty. Are you looking for funding for
research training, career development, or your
first research project grant? Do you need a
little advice on how to do that? Then this is the
workshop for you. Program and Review staff
from the National Institute on Drug Abuse
(NIDA), one of the NIH’s 27 Institutes and
Centers, is hosting this informational workshop
as an opportunity for early career investigators
to learn about NIH and the grants
process. Attendance at this workshop should
give you insight as to the most appropriate
funding opportunity for your career stage,
and how to apply for it. This workshop will
focus on mentored awards (F31, F32, K01, K08,
K23, K99) and independent research grants
(R01, R21, R03, DP1) and provide insight into
the review of these applications. Learn how to
contact the Institute and find a program official,
and understand peer review and the role
of Council. There will be brief presentations
and plenty of time to meet directly with NIDA
staff to ask those burning questions.

Monday Socials
6:45 – 8:45 p.m.
Alzheimer’s Disease Social
Social with Brief Presentation
Renaissance Washington, DC: Congressional Hall B
Chairs: Michael P. Murphy, Elizabeth Head
Models, rock stars, politicians… how can
they all make it in Hollywood while scientists
are so woefully represented? Is your lab located
inside a volcano? Do you have your own
iconic catch phrase? This may be your year to
break into film! Guaranteed to be more fun
than writing unfunded grant applications.
Join your fellow neurodegenerative disease
researchers for a night of entertainment and
socializing. Graduate students and postdocs
are especially encouraged to participate.
Behavioral Neuroendocrinology Social
Social with Brief Presentation
Renaissance Washington, DC: Congressional Hall A
Chair: Heather B. Patisaul
Feeling hormonal? Bring down those cortisol
levels by socializing, and otherwise making
merry with old friends and new collaborators at
the annual Society for Behavioral Neuroendocrinology
(SBN) social. SBN is an interdisciplinary
scientific organization dedicated to the study
of hormonal processes and neuroendocrine
systems that regulate behavior. There will be a
festive social gathering along with this year’s presentation
of the Frank A. Beach Award. All are
welcome, especially trainees and new members.
Developmental Neurobiology Social
Purely Social
Renaissance Washington, DC: Renaissance 8 & 9
Chair: Vince Tropepe
Guests: G. Fishell, J. Macklis, F. Miller,
H. Okamoto, C. Schuurmans, S. Temple,
D. Van Der Kooy, C. Houart
Join top researchers in the field for an evening
of relaxed, informal conversations of your
favorite topics in developmental neurobiology.
Meet old friends, make new friends, or discuss
professional opportunities. All are welcome!
Faculty for Undergraduate
Neuroscience Social
Social with Poster Session
Renaissance Washington, DC:
Grand Ballroom Central & North
Chair: Jennifer R. Yates
Guests: S. Dickinson, E. Reynolds
Socialize and exchange ideas with others
interested in undergraduate neuroscience
research and education. Undergraduates
will present posters of their research, and
FUN Student Travel Awards and Educator
of the Year Award will be presented. SOMAS
awardees and their students will be introduced
(www.somasprogram.org). See the
FUN Web site www.funfaculty.org.
Hippocampus Social
Purely Social
Renaissance Washington, DC: Renaissance 4
Chair: Stephen Maren
Guests: G. Buzsaki, L. Davachi, H. Eichenbaum,
M. Fanselow, L. Frank, R. Hen, J. Radulovic
The context is new, and the people may be,
too. But old or new, you will find colleagues
with common interests in mind. Whether
theta and fear or LTP and beer, come
satisfy your yearning to discuss memory
and learning. And if the temporal pole is
your devotion, there will surely be guests
interested in emotion. So venture out and
join us, to relax, unwind, and discuss the
hippocampus. Hope to see you there, and
remember to bring your stories to share!
Ingestive Behavior Social
Purely Social
Renaissance Washington, DC: Renaissance 5
Chair: Robert Ritter
Come and enjoy a drink or light refreshments,
while sharing your interest in the
neural control of ingestion with a very
sociable network of colleagues! Your tastes
in conversation, thirst for the latest news,
and hunger to renew collegial relationships
are sure to be satisfied. The event is intended
to provide scientists and students interested
in the neural controls of food intake, water
intake, and other ingestive behaviors, an
opportunity to discuss their interests and
network. The event also provides an excellent
opportunity for neuroscientists, with interests
in areas tangential to ingestive control, to
meet and talk with a wide cross section of
ingestive neuroscientists.
Music Social
Purely Social
Renaissance Washington, DC: Mount Vernon
Chairs: Richard E. Hartman, William J. Pearce
Guests: R.E. Hartman, W. Pearce,
J. LaManna, D. Tranel
Please join us for an informal evening of music
played by SfN members. All are welcome,
from beginner to accomplished musician,
solo to full band, classical to punk. Although
a piano, drums, amps, and mics will be
provided, musicians are encouraged to bring
their own instruments. Other instruments,
as well as accompaniment, must be arranged
in advance. Join us for a night of psychoacoustic
fun with your colleagues who enjoy
music when not studying the brain.
Neural Control of Autonomic and
Respiratory Function Social
Social with Brief Presentation
Renaissance Washington, DC: Renaissance
Ballroom West A
Chairs: Shaun Morrison,
Donald R. McCrimmon
Come to the Neural Control of Autonomic
and Respiratory Function social to relax,
meet, and mingle with others interested
in the neural regulation of autonomic and
respiratory outflows. It’s also a great chance
for younger scientists to mingle informally
with established investigators. How strong
and/or significant is the central interaction
of these homeostatic systems? Bring a single
slide and express your point of view.
Oculomotor and Vestibular Systems Social:
The View From On High
Social with Brief Presentation
Renaissance Washington, DC: Renaissance 10 & 11
Chair: Paul J. May
Guest: M.E. Goldberg
The highlight of the social will be a presentation
by Michael Goldberg on insights from
his stint as the Society’s President, as seen
from the far side of being in power. Then attendees
can get down to the serious business
of chatting with colleagues.
Pavlovian Society Social
Purely Social
Renaissance Washington, DC: Renaissance 3
Chair: Peter D. Balsam
Guests: T. Gould, F. Helmstetter, P. Holland,
J. Kim
Get together with scientists of all academic
levels (student to emeritus) working at all
levels of analysis (molecules to behavior)
with a shared interest in learning, memory,
and emotion. Bad Pavlovian jokes welcome.
www.sfn.org/am2011 XI

Psychopharmacology Social:
Your Brain on Drugs
Purely Social
Renaissance Washington, DC: Renaissance 2
Chair: Lisa M. Monteggia
Guests: E.J. Nestler, M. Wolf, A. Bonci,
M. Marinelli, J.A. Kauer, D.W. Self, F.S. Lee,
W.A. Carlezon, Y. Hurd, K. Ressler
An informal evening to meet psychopharmacologists
at this purely social event. This is
an opportunity to catch up with friends and
colleagues as well as meet others in the field.
All are welcome.
Vision Social: Intelligence Squared Vision
Lecture with Slides
Renaissance Washington, DC:
Renaissance Ballroom West B
Chairs: Farran Briggs, Greg Horwitz
Guests: D.C. Van Essen, E.M. Callaway,
A. Angelucci, K.D. Miller, J.L. Gallant, R.T. Born
Join us for an evening of lively debate over a
provocative topic in visual neuroscience. Two
groups of expert panelists will argue for and
against a motion and the audience will decide
the winning side.
XII Neuroscience 2011

Monday Satellite Events & Non-SfN Socials
Full descriptions and the latest details on satellite events and socials not sponsored by SfN are available online at www.sfn.org/satellites.
These events also are available in the online Neuroscience Meeting Planner, accessible on-site or at www.sfn.org/nmp.
Title For More Information Time Location Room
Monday, Nov. 14
8th Annual Christopher Reeve
“Hot Topics” in Stem Cell Biology
Advances in Preclinical In Vivo
Brain Imaging
Association for Korean Neuroscientists
Annual Meeting
Behavior. We CARE! American
Psychological Association Social
Brown University Institute for
Brain Science Social
Dartmouth Reception
Drexel University College of
Medicine
g.tec Spike and ECoG Recording
and Analysis Workshop
Inhibitory Synaptic Plasticity and
Neuronal Cl – Regulation
International Behavioral Neuroscience
Society (IBNS) Social
blarraga@sanfordburnham.org 6:30 – 10 p.m. Convention Center 202AB 1
mwaite@visualsonics.com 6:30 – 9:30 p.m. Renaissance Washington, DC Hotel Grand Ballroom South 3
jmchung@utmb.edu 6:30 – 7:30 p.m. Convention Center 146A 3
spanicker@apa.org 6:30 – 8:30 p.m. Grand Hyatt Washington Burnham 2
john_davenport@brown.edu 7 – 9 p.m. Grand Hyatt Washington Wilson 2
joseph.g.oberlander@
dartmouth.edu
6:30 – 8:30 p.m.
Lima Restaurant,
Vetro Lounge,
1401 K Street, NW
pcomey@drexel.edu 6:30 – 8 p.m. Renaissance Washington, DC Hotel 15 2
guger@gtec.at 6:30 – 9:30 p.m. Convention Center 209A 1
m.woodin@utoronto.ca 6:30 – 8:30 p.m. Grand Hyatt Washington McPherson Square 2
ibns@ibnshomepage.org 6:30 – 8 p.m. Grand Hyatt Washington Roosevelt and Cabin John 2
Iranian Neuroscientists Social mohsen.omrani@queensu.ca 6:30 – 8:30 p.m. Renaissance Washington, DC Hotel 6 3
MBL/Grass Foundation Social kshaw@mbl.edu 6:30 – 8 p.m. Grand Hyatt Washington Latrobe 2
Mexican Neuroscientists Social lrocha@cinvestav.mx 6:30 – 8:30 p.m. Grand Hyatt Washington Independence Ballrooms DE 2
Microelectrode and Multielectrode
Recording Techniques
NeuroProbes – Multifunctional
Probe Arrays for Intracortical
Applications
Neuroscience Downunder
Neuroscience in Germany XVIII
Social
Neuroscience in India: Ongoing
Research and Opportunities
NIH’s Doctoral Programs in Neuroscience
with University College
London and Karolinska Institute
NIH Grant Workshop for Early
Career Investigators
Pretzels and Endplates: Motor Neuron
Pathology and the Role of SMN in Motor
Neuron Development
Researchers Who Invent: An
Opportunity to Meet with Small
Businesses that Commercialize
Neurotechnologies
margaret@alascience.com 6:30 – 9 p.m. Convention Center 147A 1
ruther@imtek.de 6:30 – 9:30 p.m. Convention Center 156 2
innovation.washington@dfat.
gov.au
6:30 – 8:30 p.m. The Australian Embassy 2
bernhard.sabel@med.ovgu.de 6:30 – 10 p.m. Grand Hyatt Washington Independence Ballroom B C 2
shubhatole@gmail.com 6:30 – 8:30 p.m. Convention Center 201 2
robert.innis@nih.gov 6:30 – 8 p.m. La Tasca, 722 7th St., NW DC 2
npilotte@nih.gov 6:30 – 9 p.m. Convention Center 103AB 2
lorsonc@missouri.edu 6:30 – 9:30 p.m. Convention Center 150B 2
nwilson@dixongroup.com 6:30 – 8:30 p.m. Grand Hyatt Washington Renwick 2
Serotonin Club Mixer becks@email.chop.edu 6:30 – 8 p.m.
Sleep and Circadian Biology
DataBlitz
Sponsor Category Key: 1: Commercial 2: University/Nonprofit 3: Individual/Group
Fado Irish Pub
and Restaurant,
808 7th Street NW
laposkya@nhlbi.nih.gov 8 – 10 p.m. Convention Center 144 2
Sponsor
Key
www.sfn.org/am2011 XIII
2
3

Title For More Information Time Location Room
Sleep Research Society Club
Hypnos
Social Behavior Paradigms in
Neuroscience
The Behavioral Repertoire of
Zebrafish: A Tool for Neuroscience
Research
UAB Comprehensive Neuroscience
Social
University of Toronto Neuroscience
Program Reception
Washington University in St. Louis
Neuroscience Reception
XIV Neuroscience 2011
ncekosh@srsnet.org 6:30 – 8 p.m. Convention Center 143 3
jthomps@cleversysinc.com 6:30 – 9 p.m. Convention Center 142 3
ychomis@viewpoint.fr 6:30 – 8:30 p.m. Convention Center 152 B 1
mmoran@uab.edu 6:30 – 8:30 p.m. Renaissance Washington, DC Hotel Renaissance Ballroom East 2
michael.fehlings@uhn.on.ca 6:30 – 8:30 p.m. Renaissance Washington, DC Hotel Congressional Hall C 2
jwdubis@npg.wustl.edu 6:30 – 9:30 p.m.
RFD Washington
810 7th Street, NW
Sponsor
Key
2

SPECIAL LECTURE Walter E. Washington Convention Center
308. Rapid Synaptic Actions of Estrogens — CME
Mon. 8:30 AM - 9:40 AM — Hall D
Speaker: C. S. WOOLLEY, Northwestern Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
Complete Session Listing
Estrogens influence brain function through multiple
mechanisms with time courses ranging from minutes to
days. Interest in rapid non-genomic estrogen actions has
resurged recently, in parallel with recognition that estrogens
are produced as neurosteroids in the brains of both males
and females. This lecture covers three converging lines
of research: neural estrogen synthesis, synaptic estrogen
receptors, and acute estrogen modulation of synaptic
function, highlighting recently discovered mechanisms of
rapid estrogen action in the hippocampus and other brain
regions.
SYMPOSIUM Walter E. Washington Convention Center
309. • Thalamic Contributions to Basal Ganglia-Related
Behavioral Switching and Reinforcement — CME
Mon. 8:30 AM - 11:00 AM — Ballroom A
Chair: Y. SMITH
Co-Chair: J. SURMEIER
This symposium highlights the role of the intralaminar
thalamic nuclei in the transmission of salient environmental
stimuli that promote basal ganglia-related behavioral
switching and contribute to reinforcement. The
interdisciplinary expertise of the speakers will set the
stage for a comprehensive discussion of the functional
organization of the thalamostriatal system, and the synaptic
mechanisms whereby this network mediates its effects
through the regulation of striatal activity
8:30 309.01 Introduction.
8:35 309.02 Functional anatomy and synaptic plasticity of the
thalamostriatal systems in normal and parkinsonian states.
Y. SMITH. Emory Univ.
9:10 309.03 Participation of the thalamic CM/PF complex in
response bias, its cancel and behavioral switch. M. KIMURA.
Tamagawa Univ.
9:45 309.04 The role of tecto-thalamostriatal loops in basal
ganglia processes of selection and reinforcement learning. P.
REDGRAVE. Univ. Sheffield.
10:20 309.05 Thalamostriatal gating of cortical signaling by
cholinergic interneurons: A substrate of basal ganglia-related
attentional shifts. D. SURMEIER. Northwestern Univ. Med.
Sch.
10:55 309.06 Closing Remarks.
Monday AM
SYMPOSIUM Walter E. Washington Convention Center
310. Human Cell Reprogramming and Its Application in
Neurological Diseases — CME
Mon. 8:30 AM - 11:00 AM — Ballroom B
Chair: G. MING
Co-Chair: M. WERNIG
The reprogramming of somatic cells to either pluripotent
stem cells or directly to neural cell types has revolutionized
the way of modern biomedical research. The speakers will
share their latest exciting findings in using reprogrammed
human neural cells to model neurological diseases, including
Alzheimer’s disease, Parkinson’s disease, polyglutamine
disease, familial dysautonomia, Rett syndrome and
schizophrenia.
8:30 310.01 Introduction.
8:35 310.02 Stem cells for modeling human neurodegenerative
disease. O. BRUESTLE. Univ. Bonn.
9:00 310.03 Modeling autism spectrum disorders using human
neurons. A. MUOTRI. Univ. of California San Diego.
9:25 310.04 iPSC from schizophrenia patients with a DISC1
mutation. G. MING. Johns Hopkins Univ.
9:50 310.05 Neural induction from pluripotent stem cells and
modeling familial dysautonomia using neural crest derived
from iPSCs. L. STUDER. Sloan Kettering.
10:15 310.06 Novel reprogramming methods and ways to bypass
the pluripotent state by directly converting non-neuronal
somatic cells into functional neurons. M. WERNIG. Stanford
Univ.
10:35 310.07 Closing Remarks.
MINISYMPOSIUM Walter E. Washington Convention Center
311. Large-Scale Automated Histology in the Pursuit of
Connectomes — CME
Mon. 8:30 AM - 11:00 AM — Ballroom C
Chair: D. KLEINFELD
Co-Chair: B. SAKMANN
How does the brain compute? A necessary ingredient
toward answering this question is the attainment of
neuronal wiring diagrams. This task requires an amalgam
of specialized hardware to automatically map neuronal and
neurovascular features as well as software for data analysis
and visualization. Speakers will present the state-of-theart
on the reconstruction of circuits that link brain anatomy
and function at unprecedented levels of detail in terms of
wiring diagrams of neuronal connectivity between identified
cell types and plumbing diagrams of the vasculature that
services brain cells.
8:30 311.01 Introduction.
8:35 311.02 Is Reichardt’s motion detector a myth or reality?
The connectomics perspective. D. B. CHKLOVSKII. HHMI.
Neuroscience 2011 | Monday AM | 1
Mon. AM

8:55 311.03 The specificity of synaptic connections underlying
direction-selectivity in the retina. K. L. BRIGGMAN. MPI
(Winfried Denk Laboratory).
9:15 311.04 Anatomy and in vivo physiology from neuronal
network in visual cortex. D. D. BOCK. Harvard - HMS (R.
Clay Reid Laboratory).
9:35 311.05 The diversity of cortical synaptic connections as
revealed by array tomography. K. D. MICHEVA. Stanford
SoM (Stephen J. Smith Laboratory).
9:55 311.06 Dynamics and control of cortical blood flow in
relation to the angiotome. P. BLINDER. UCSD (David
Kleinfeld Laboratory).
10:15 311.07 The 3-D reconstruction of type-specific neuronal
somata in the neocortex. B. SAKMANN. Max Planck Florida
Inst.
10:35 311.08 Closing Remarks.
MINISYMPOSIUM Walter E. Washington Convention Center
312. Emerging Roles for Somatostatin-Containing
Cortical Interneurons: Novel Insights From
Transgenic Mice — CME
Mon. 8:30 AM - 11:00 AM — 145B
Chair: A. AGMON
Somatostatin-containing (SOM), inhibitory cortical
interneurons have long been thought to play second fiddle
to the better-known “fast spiking” (FS) interneurons. Studies
using SOM-specific mouse lines are now challenging this
perception, revealing how the unique properties of SOM
interneurons, such as their facilitating inputs, distal dendritic
targeting and sensitivity to neuromodulators, allow them
to sculpt cortical activity in a manner distinct from, but
complementary to, FS interneurons.
8:30 312.01 Introduction.
8:35 312.02 State-dependent contribution of SOM interneurons
to cortical dynamics. H. ADESNIK. UCSD.
8:55 312.03 Delayed visual representation by SOM
interneurons. H. TAO. USC Keck Sch. Med.
9:15 312.04 Layer 2/3 SOM cells act as an ON-switch in
mouse somatosensory cortex in vivo. L. J. GENTET. Ecole
Polytechnique Federale de Lausanne.
9:35 312.05 The role of SOM interneurons in regulating sensory
neocortical activity. U. KNOBLICH. Yale Univ.
9:55 312.06 The roles of different subtypes of SOM
interneurons in cortical information processing. H. XU. New
York Univ.
10:15 312.07 Behavioral correlates of SOM and PV interneuron
firing in mouse prefrontal cortex. A. KEPECS. Cold Spring
Harbor Lab.
10:35 312.08 Closing Remarks.
MINISYMPOSIUM Walter E. Washington Convention Center
313. New Insights on Diverse Neural Mechanisms
Underlying Alcohol Dependence/Addiction — CME
Mon. 8:30 AM - 11:00 AM — 202B
Chair: C. CUI
Co-Chair: A. NORONHA
Alcohol dependence/addiction is mediated by complex
neural mechanisms, which involve changes in a variety of
neurotransmitter systems resulting in adaptive changes
in neurocircuits. This minisymposium highlights recent
advances in understanding alcohol addiction from the
perspectives of both reward and stress systems. Speakers
will present studies on metaplasticity, dendritic spines,
optogenetics, and cross-talk of different signaling systems
involved in alcohol dependence/addiction.
8:30 313.01 Introduction.
8:35 313.02 NMDA receptor metaplasticity in the VTA and drug
addiction. H. MORIKAWA. Univ. of Texas at Austin.
8:55 313.03 Parallel changes in synaptic function and structural
in the basal ganglia after chronic ethanol and cocaine
exposure. V. A. ALVAREZ. NIAAA, NIH.
9:15 313.04 Optogenetic deconstruction of brain reward
circuitry. G. STUBER. Univ. of North Carolina at Chapel Hill.
9:35 313.05 mGluR5-mediated signaling within the extended
amygdala circuit is critical for binge alcohol drinking. K. K.
SZUMLINSKI. Univ. of California at Santa Barbara.
9:55 313.06 Binge-like ethanol drinking modulates neuropeptide
stress systems in the extended amygdala. T. KASH. UNC
Sch. of Med.
10:15 313.07 Cellular mechanisms of CRF at the GABAergic
synapses in the central amygdala: Role in ethanol
dependence. M. ROBERTO. The Scripps Res. Inst.
10:35 313.08 Closing Remarks.
MINISYMPOSIUM Walter E. Washington Convention Center
314. Neural Phase Coding and Spike-Field
Coherence — CME
Mon. 8:30 AM - 11:00 AM — 207B
Chair: Z. NADASDY
Co-Chair: M. E. HASSELMO
Phase coding refers to the representation of information
by the phase of action potential firing relative to intrinsic
brain rhythms. This minisymposium covers recent
empirical support for phase coding in sensory cortical
and prefrontal cortical neurons, as well as the emerging
functions of oscillations in controlling information flow in
the hippocampus and in generating entorhinal grid cell
properties. New results provide compelling support for the
role of oscillations in neural coding.
8:30 314.01 Introduction.
8:35 314.02 Mechanisms for phase coding in entorhinal cortex
grid cells. M. E. HASSELMO. Boston Univ.
8:55 314.03 Phase coding of location and novelty by grid cells
and place cells. N. BURGESS. Univ. Col. London.
9:15 314.04 Different frequencies of gamma rhythms in the
hippocampus. L. L. COLGIN. Univ. of Texas at Austin.
2 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:35 314.05 The role of phase of firing and spike times in
encoding naturalistic sensory stimuli. S. PANZERI. Italian
Inst. of Technol.
9:55 314.06 Phase-dependent coding in short-term memory M.
SIEGEL. Univ. of Tübingen.
10:15 314.07 Signatures of spiking neural assemblies in the LFP.
S. A. GRUEN. RIKEN Brain Sci. Inst.
10:35 314.08 Closing Remarks.
DAVID KOPF LECTURE ON NEUROETHICS Walter E.
Washington Convention Center
315. A Neanderthal Perspective on Human Origins
Mon. 10:00 AM - 11:10 AM — Hall D
Speaker: S. PAABO, Max Planck Inst. for Evolutionary
Anthropology, Germany
Support contributed by David Kopf Instruments
Recently produced draft sequences of two extinct human
forms, Neandertals and Denisovans help identify novel
genomic features that appeared recently in present-day
humans, as well as genomic regions likely to have been
affected by positive selection in modern humans since
their divergence from a common ancestor shared with
Neandertals and Denisovans. The lecture will share analysis
of some such candidates, as well as work that focuses on
the evolution FOXP2 in humans, a gene involved in the
development of speech and language.
SPECIAL LECTURE Walter E. Washington Convention Center
316. Protein Synthesis and Degradation at Synapses — CME
Mon. 11:30 AM - 12:40 PM — Hall D
Speaker: E. M. SCHUMAN, Max Planck Inst. for Brain
Research, Germany.
An individual neuron in the brain possesses approximately
10,000 synapses, many located hundreds of microns
away from the cell body, which can process independent
streams of information. During synaptic transmission and
plasticity, remodeling of the local proteome occurs via the
regulated synthesis and degradation of new proteins. This
lecture highlights previous and current studies aimed at
understanding how local protein synthesis and degradation
contribute to synaptic function and plasticity.
NANOSYMPOSIUM
317. Synaptogenesis: Activity-Dependent Changes in
Connectivity II
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, 144A
8:00 317.01 • Postnatal development of GABAA receptormediated
inhibition in primate prefrontal cortex. G.
GONZALEZ-BURGOS*; H. YOSHINO; T. MIYAMAE;
D. E. PAFUNDO; D. C. ROTARU; D. A. LEWIS. Univ. of
Pittsburgh, Nara Med. Univ., Vrije Univ.
8:15 317.02 Neuronal and circuit maturation following neonatal
cerebral hypoxia ischemia. S. RANASINGHE*; A. IEVINS;
V. NGUYEN; G. OR; M. F. WENDLAND; P. S. MCQUILLEN.
UCSF, UCSF.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
8:30 317.03 Hippocampal CA1 pyramidal neurons show
impaired dendritic spine density and morphology only in
presymptomatic Mecp2 mutant mice. C. A. CHAPLEAU*;
G. CALFA; L. POZZO-MILLER. Univ. Alabama Birmingham/
Samford Univ.
8:45 317.04 Cav1.3 calcium channel-deficient mice display
impaired development of a topographic inhibitory
projection within the auditory brainstem. J. J. HIRTZ*; T.
SCHÖNECKER; D. GRIESEMER; E. FRIAUF. Univ. of
Kaiserslautern.
9:00 317.05 Expression of NMDA receptor NR2A, NR2B, and
NR2D subunits in post-metamorphic xenopus tectum. S. B.
UDIN*; R. LIMA. SUNY.
9:15 317.06 Synaptic integration and spike timing in the
developing retinotectal system of Xenopus laevis. J. J. VAN
RHEEDE; B. A. RICHARDS; C. J. AKERMAN*. Univ. of
Oxford.
9:30 317.07 Enhanced synapse maturation in the binocular
vs. monocular retino-collicular map prior to eye opening. M.
FURMAN*; M. C. CRAIR. Yale Univ.
9:45 317.08 Network self-organization explains the distribution
of synaptic efficacies in neocortex. P. ZHENG; J. TRIESCH*;
C. DIMITRAKAKIS. FIAS.
10:00 317.09 Experience-dependent expression of miR132
regulates ocular dominance plasticity. P. TOGNINI*; E.
PUTIGNANO; A. COATTI; T. PIZZORUSSO. Scuola Normale
Superiore, Scuola Normale Superiore, Scuola Normale
Superiore, Inst. Neuroscience, CNR.
10:15 317.10 Targeting of microRNA precursors to dendrites. S.
BICKER*; G. SCHRATT. Univ. of Marburg.
10:30 317.11 Acetylation can regulate synaptogenesis by altering
protein turnover in neurons. K. HSIAO*; D. L. BENSON.
Mount Sinai Sch. of Med.
NANOSYMPOSIUM
318. Presynaptic Mechanisms I
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, 150B
8:00 318.01 Acute delivery of excess synuclein to synapses
causes a massive loss of synaptic vesicles and impairs
vesicle recycling. D. J. BUSCH*; P. A. OLIPHINT; J. R.
MORGAN. Univ. of Texas at Austin, Inst. for Cell and Mol.
Biol., Inst. for Neurosci.
8:15 318.02 Vesicular sterols are essential for synaptic vesicle
recycling. J. S. DASON*; A. J. SMITH; L. MARIN; M. P.
CHARLTON. Univ. Toronto.
8:30 318.03 Refilling rate of synaptic vesicles with glutamate
in the mammalian presynaptic terminal. T. HORI*; T.
TAKAHASHI. Okinawa Inst. of Sci. and Technol., Doshisha
Univ.
8:45 318.04 Vti1a identifies a pool of vesicles that preferentially
recycles at rest and selectively maintains spontaneous
neurotransmission. D. M. RAMIREZ*; M. KHVOTCHEV; E. T.
KAVALALI. Univ. of Texas Southwestern Med. Ctr.
9:00 318.05 Alpha2delta calcium channel subunits control
release probability at central synapses. M. B. HOPPA*; A.
DOLPHIN; T. A. RYAN. Weill Cornell Med. Col., Univ. Col.
London.
Neuroscience 2011 | Monday AM | 3
Mon. AM NANOSYMPOSIUM

NANOSYMPOSIUM
9:15 318.06 The nucleotide exchange factor Hsp110 is
involved in regulating Hsc70:clathrin interactions during
synaptic vesicle endocytosis. E. M. LAFER*; J. JIANG;
P. A. OLIPHINT; A. E. FOLDES; S. JIN; R. SOUSA; J. R.
MORGAN. Univ. Texas Hlth. Sci. Ctr., Univ. of Texas at
Austin.
9:30 318.07 Ca 2+ -influx slows single synaptic vesicle
endocytosis. J. LEITZ*; E. KAVALALI. UT Southwestern
Med. Ctr.
9:45 318.08 PTEN acts as a negative regulator for secretion
through its lipid phosphatase activity. D. RICHARDS*.
Cincinnati Childrens Hosp Med. Ctr.
10:00 318.09 Roles of RIM1 and proteasome in the organization
of the presynaptic active zone. R. FERNÁNDEZ-
BUSNADIEGO; S. ASANO; E. SAKATA; M. ZÜRNER; S.
SCHOCH; W. BAUMEISTER; V. LUCIC*. Max Planck Inst. of
Biochem., Univ. of Bonn.
10:15 318.10 Calcium dynamics and synaptic vesicle exocytosis
at ribbon synapses of mouse and zebrafish retinal bipolar
cells. G. MATTHEWS*; T. VAITHIANATHAN. Stony Brook
Univ.
NANOSYMPOSIUM
319. Alzheimer Disease: Tau Biochemistry
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, 140A
8:00 319.01 Biguanide metformin acts on tau phosphorylation
via mTOR/protein phosphatase 2A (PP2A) signaling.
S. KRAUSS*; E. KICKSTEIN; N. GRIESCHE; D.
RUTSCHOW; R. ZELLER; P. THORNHILL; J. SHARKEY; R.
WILLIAMSON; M. FUCHS; A. KOEHLER; H. GLOSSMANN;
R. SCHNEIDER; C. SUTHERLAND; S. SCHWEIGER. DZNE
/ German Ctr. of Neurodegenerative Dis., MPI mol. Gen.,
DZNE, Univ. Dundee, Univ. Innsbruck.
8:15 319.02 • Tau protein biochemistry in search for toxic tau
species. N. SAHARA*; D. KANG; A. CANNON; M. DETURE;
E. ABDUL-SHUKKUR; C. VOLBRACHT; J. LEWIS. Univ. of
Florida, Univ. of Florida, Mayo Clin., H. Lundbeck A/S.
8:30 319.03 Lysine post-translational modifications and
degradation of aggregated tau in a cell culture model of
tauopathy. S. N. THOMAS*; D. CLARK; K. E. FUNK; Z.
LIAO; J. KURET; A. YANG. Univ. Maryland, Baltimore, Univ.
of Maryland, Ohio State Univ., Univ. of Maryland.
8:45 319.04 Trehalose enhances the degradation of Tau
through the autophagy pathway. U. KRUEGER*; Y. WANG;
S. KUMAR; X. LI; E. MANDELKOW. Max Planck Unit For
Structural Mol. Biology,c/O DESY, DZNE, German Ctr. for
Neurodegenerative Diseases, c/o CAESAR.
9:00 319.05 Cleavage of Tau by calpain in Alzheimer’s disease:
The quest for the toxic 17 kD fragment. Y. WANG*; S.
GARG; T. TIMM; E. MANDELKOW; E. MANDELKOW. Max
Planck Inst., DZNE, German Ctr. for Neurodegenerative
Diseases, c/o CAESAR.
9:15 319.06 � Morphometric analysis of tau-induced dendritic
degeneration in situ. C. AUGUSTIN; G. HALL*. Univ.
Massachusetts Lowell, Univ. Massachusetts Lowell.
9:30 319.07 • Characterization of tau oligomer proteolytic
activity, a novel therapeutic target for Alzheimer’s disease. E.
J. DAVIDOWITZ*; P. LOPEZ; J. G. MOE. OLIGOMERIX, Inc.
4 | Society for Neuroscience
9:45 319.08 MSUT2 is a factor in vunerability to tau
neurotoxicity. C. R. GUTHRIE*; L. GREENUP; J. B.
LEVERENZ; B. C. KRAEMER. VA Puget Sound Hlth. Care
Syst., Univ. of Washington.
10:00 319.09 Tau may exacerbate mitochondrial dysfunction
induced by beta-amyloid or kainic acid. S. M. PRITCHARD*;
R. A. QUINTANILLA; G. V. W. JOHNSON. Univ. of Rochester
Sch. of Med. and Dent., Univ. of Rochester Sch. of Med. and
Dent.
10:15 319.10 Loss of calcium buffering leading to tangle
formation may explain selective vulnerability of basal
forebrain cholinergic neurons in Alzheimer’s disease.
R. SAMAEEKIA; D. RIASCOS; L. GUO*; C. GEULA.
Northwestern University, Feinberg Sch. of Med.,
Northwestern Univ. Med. Sch.
10:30 319.11 • Mechanisms underlying extracellular tau changes
associated with Alzheimer’s disease. C. M. KARCH*; A. T.
JENG; A. M. GOATE. Washington Univ. In St Louis.
10:45 319.12 A novel approach for monitoring Tau aggregation
in regulatable cell models of tauopathy by fluorescenceactivated
cell sorting (FACS). J. BIERNAT*; M. PICKHARDT;
E. MANDELKOW; E. MANDELKOW. Max-Planck-Institute,
DZNE, German Ctr. for Neurodegeneration.
NANOSYMPOSIUM
320. Multimodal Neuroimaging Studies of Aging and
Neurodegenerative Disorders
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, 143A
8:00 320.01 • Fusing data or classifiers: Cross-sectional
Alzheimer’s diagnosis on data from the Alzheimer’s disease
Neuroimaging Initiative. C. G. HABECK*. Columbia Univ.
8:15 320.02 • Retinal nerve fiber thickness as a biomarker in
Alzheimer’s disease. P. A. COOK*; P. S. DHILLON; B. B.
AVANTS; L. J. BALCER; M. GROSSMAN; F. J. SWENSON;
J. C. GEE. Univ. of Pennsylvania, Univ. of Pennsylvania,
Univ. of Pennsylvania, Pfizer Inc.
8:30 320.03 Multivariate analysis strategies of neuroimaging
data in PyMVPA. Y. O. HALCHENKO; M. HANKE; J. V.
HAXBY*. Dartmouth Col.
8:45 320.04 Different spatial scales of categorical phoneme
processing in Broca’s area and the supramarginal gyrus:
Feasible evidence for a posterior-to-anterior gradient in prelexical
speech processing. Y. S. LEE*; R. H. GRANGER;
R. D. S. RAIZADA. Univ. of Pennsylvania, Dartmouth Col.,
Dartmouth Col.
9:00 320.05 • The relationship between cerebrospinal fluid and
neuroimaging biomarkers in neurodegenerative disease. C.
MCMILLAN*; B. AVANTS; D. IRWIN; K. RASCOVSKY; M.
GROSSMAN. Hosp. of the Univ. of Pennsylvania, Univ. of
Pennsylvania.
9:15 320.06 Associated spatial patterns of brain amyloid-β
deposition and atrophy rates in mild cognitive impairment. D.
TOSUN*; N. SCHUFF; M. W. WEINER. San Francisco VA
Med. Ctr.
9:30 320.07 • Increased functional connectivity between
hippocampal subfields in mild cognitive impairment. S.
DAS*; D. KLIOT; L. MANCUSO; S. OROZCO; J. PLUTA; P.
YUSHKEVICH; D. WOLK. Univ. Pennsylvania.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:45 320.08 Signs of time in tauopathy: Integrative longitudinal
analysis techniques. B. AVANTS*; C. MCMILLAN; P. A.
COOK; M. GROSSMAN. Univ. of Pennsylvania.
NANOSYMPOSIUM
321. Parkinson’s Disease: Neuroprotective Mechanisms II
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, 146A
8:00 321.01 Resveratrol-mediated neuroprotection against
lps induced toxicity. K. M. ROSE*; J. E. CAVANAUGH.
Duquesne Univ.
8:15 321.02 Wnt signalling controls synaptic maintenance in
the striatum. S. GALLI; S. E. MILLAR; P. C. SALINAS*. Univ.
Col. London, Univ. of Pennsylvania.
8:30 321.03 Novel function of Regulator of G-protein Signaling
10 in mouse dopaminergic neuron; direct neuroprotective
role of RGS10. J. LEE*; J. CHUNG; M. G. TANSEY. Emory
Univ., Emory Univ.
8:45 321.04 A role of human uncoupling protein 2 (hucp2) in
neuroprotection and energy homeostasis in a Drosophila
Parkinson’s disease model. Y. FRIDELL*; R. ISLAM; L.
YANG; M. SAH; J. KWOK; M. BEAL. Univ. of Connecticut,
Univ. of Florida, Weill Med. Col. of Cornell Univ.
9:00 321.05 Therapeutic potential of Capsaicin in animal model
of Parkinson’s disease. F. ISLAM*; M. M. SAFHI. Jamia
Hamdard, Jazan Univ.
9:15 321.06 Differential regulation of NMDA receptor function by
DJ-1 and PINK1. Q. WAN*; R. HU; M. LIAO. Univ. Nevada
Sch. Med.
9:30 321.07 Polyamidoamine (PAMAM) dendrimer conjugates
of neuroprotective adenosine receptor antagonists. K. A.
JACOBSON*; T. S. KUMAR; F. DEFLORIAN; A. KECSKÉS;
K. PHAN; Z. GAO; D. K. TOSH. NIDDK-NIH.
9:45 321.08 Patients with slower progression of Parkinson’s
disease have high cerebrospinal fluid levels of glial cell
line-derived neurotrophic factor and transforming-growth
factor-β1, and therapeutic efficacy of both factors is
enhanced after co-infusion in experimental Parkinsonism.
E. FERNANDEZ-ESPEJO*; J. M. GARCIA-MORENO; A.
MARTIN-DE-PABLOS; R. GONZALEZ-APARICIO; J. A.
FLORES; C. MENDEZ-LUCENA; J. CHACON. Univ. Sevilla
Fac Med., Neurosci. Clin. Unit, Macarena Hosp., Surgery
Dept., Univ. Sevilla & Anaesthesia Clin. Unit, Macarena
Hosp., Infanta Luisa Hosp.
10:00 321.09 • GPR-139 agonists protect primary mesencephalic
dopaminergic neurons against MPP+ toxicity. G. P. DIETZ*;
K. BAYER ANDERSEN; J. LEANDER JOHANSEN; K. FOG;
G. P. SMITH. H. Lundbeck A/S, Millipore A/S.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
NANOSYMPOSIUM
322. Multiple Sclerosis: Mechanisms and Therapeutic
Strategies
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, 152A
8:00 322.01 Reduction of cd133 positive stem cells circulating
in the peripheral blood of patients with relapsing remitting
multiple sclerosis. A. FINKIELSZTEIN*; A. CZAJKOWSKA-
KAMINSKA; A. BOULLERNE; M. I. GIVOGRI; V. ULLOA;
D. SKIAS; E. A. HARTMAN; R. D. BALABANOV; D.
FEINSTEIN; E. R. BONGARZONE. Univ. of Illinois At
Chicago, Univ. of Illinois At Chicago, Univ. of Illinois At
Chicago, Univ. of Illinois at Chicago, Rush Univ.
8:15 322.02 Members of the TAM receptor tyrosine kinases and
their ligands are implicated in the susceptibility to Multiple
Sclerosis and are upregulated in the peripheral blood of
those with recent onset disease. T. J. KILPATRICK*; G. Z. M.
MA; J. STANKOVICH; J. FIELD; M. D. BINDER. The Univ. of
Melbourne, Florey Neurosci. Inst., The Univ. of Tasmania.
8:30 322.03 Ephrin B3 negatively regulates oligodendrocyte
maturation and CNS remyelination. Y. SYED*; E. HAND; W.
MOBIUS; K. NAVE; M. KOTTER. Univ. of Cambridge, Max
Planck Inst. for Exptl. Medicine,.
8:45 322.04 Defects in homocysteine metabolism play a role in
the pathogenesis of multiple sclerosis. C. J. GROOVER; L.
GARDNER*; M. C. LEVIN. VA Med. Ctr., Univ. of Tennessee
HSC.
9:00 322.05 • Intravenous administration of human multipotent
adult progenitor cells provides functional benefit through
immunomodulation in a mouse model of multiple sclerosis.
S. A. BUSCH; J. A. HAMILTON*; L. BAI; J. RUDESILL; A.
DECHANT; A. E. TING; R. J. DEANS; R. H. MILLER; R. W.
MAYS. Athersys, Inc., Athersys, Inc., Case Western Reserve
Univ.
9:15 322.06 MS disease activity inhibits hepatocyte growth
factor (HGF) production within the CNS - a new putative
mechanism contributing to lack of lesion repair seen in
MS. E. JUN; A. M. MUELLER*; H. CONLON; S. SADIQ.
MSRCNY.
9:30 322.07 Abnormal phosphatase activities mediate lower
phosphorylation of neurofilaments in Krabbe disease. L.
CANTUTI CASTELVETRI*; M. GIVOGRI; R. CHIDAVAENZI;
A. LOPEZ-ROSAS; E. BONGARZONE. Univ. Illinois, Chic,
Univ. Illinois, Chic.
9:45 322.08 Cellular responses of neural stem cells in Theiler’s
Murine Encephalomyelitis Virus model of multiple sclerosis.
A. K. HEBERT*; K. PITUCH; M. I. GIVOGRI; H. LIPTON;
E. R. BONGARZONE. Univ. of Illinois At Chicago, Univ. of
Illinois At Chicago.
10:00 322.09 Ex vivo imaging of calcium dynamics in central
myelinated axons: Role of glutamate excitotoxicity and
calcium stores. W. TEO*; O. GRIESBECK; P. K. STYS.
Univ. of Calgary, Hotchkiss Brain Inst., Max Planck Inst. of
Neurobio.
10:15 322.10 Disruption of NMDA receptors in the
oligodendroglial lineage does not alter susceptibility to
EAE or development of oligodendroglial progenitor cells. F.
GUO*; Y. MAEDA; M. DELGADO; E. MILLS KO; L. MIERS;
D. PLEASURE. UC Davis Sch. Med., Inst. for Pediatric
Regenerative Medicine, Shriners Hosp. for Children,
Northern California.
Neuroscience 2011 | Monday AM | 5
Mon. AM NANOSYMPOSIUM

NANOSYMPOSIUM
10:30 322.11 Low density lipoprotein receptor-related protein-1
mediates myelin phagocytosis and inhibits progression
of experimental autoimmune encephalomyelitis. A.
GAULTIER*; K. AKASSOGLOU; S. R. VANDENBERG; S.
L. GONIAS. UCSD, Gladstone Inst. of Neurolog. Diseases,
Univ. of California, San Francisco.
10:45 322.12 • Diverse pathophysiological outcomes of IgG
binding to aquaporin-4 in astrocytes. S. R. HINSON; M. F.
ROMERO; B. F. G. POPESCU; C. F. LUCCHINETTI; J. P.
FRYER; H. WOLBURG; P. FALLIER-BECKER; S. NOELL;
V. A. LENNON*. Mayo Clin., Mayo Clin., Mayo Clin., Univ. of
Tubingen.
11:00 322.13 Expression of sonic hedgehog targeted genes
in peripheral blood mononuclear cells of patients with
Multiple Sclerosis. A. KAMINSKA-CZAJKOWSKA*; A.
FINKIELSZTEIN; A. BOULLERNE; M. GIVOGRI M.I; L.
CASTELVETRI; D. SKIAS; E. HARTMAN; R. BALABANOV;
D. FEINSTEIN; E. BONGARZONE. Univ. of Illinois At
Chicago, Rush Univ., Univ. of Illinois At Chicago, Univ. of
Illinois At Chicago.
11:15 322.14 • Immune system associated depression and
cognitive impairment in CNS autoimmune diseases: A MRS
brain imaging study of transverse myelitis and multiple
sclerosis. C. C. WATKINS*; J. S. CHENG; H. GUO; J.
BRANDT; D. BONEKAMP; M. G. POMPER; P. B. BARKER;
A. I. KAPLIN. Johns Hopkins Med. Inst., Johns Hopkins Med.
Institutions, Johns Hopkins Med. Institutions, Johns Hopkins
Med. Institutions.
NANOSYMPOSIUM
323. Nanoparticles as Therapeutic Tools for Diseases of the
Nervous System
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, 152B
8:00 323.01 Acute or chronic hypertension exacerbate silica
dust (SiO2 nanoparticles) induced cognitive dysfunction and
brain pathology. H. S. SHARMA*; A. SHARMA; R. PATNAIK;
D. F. MURESANU. Uppsala Univ., Banaras Hindu University,
Inst. of Technol., Univ. of Med. & Pharm.
8:15 323.02 Brain targeting by engineered nanoparticles: In
vivo and in vitro evidences. G. TOSI*; A. GRABRUCKER;
L. BONDIOLI; B. RUOZI; M. ZOLI; A. VILELLA; F. FORNI;
F. RIVASI; M. VANDELLI. Te.far.t.i., Dept. of Pharmaceut.
Sciences, Univ. of Modena and Reg, Stanford Univ., Univ.
of Modena and Reggio Emilia, Univ. of Modena and Reggio
Emilia, Univ. of Modena and Reggio Emilia.
8:30 323.03 Neurotoxicity of Engineered nanoparticles from
metals is dependent on their size and age of the animals. A.
SHARMA*; D. F. MURESANU; R. PATNAIK; H. S. SHARMA.
Uppsala Univ., Univ. of Med. and Pharm., Banaras Hindu
Univrsity, Inst. Technol.
8:45 323.04 � Engineered Nanoparticles from metals
exacerbate aquaporin-4 expression, astrocytic activation,
Blood-brain barrier disruption, edema formation in the
brain following hyperthermia. S. PAUL*; R. PATNAIK;
P. BHATTACHARYA; A. SHARMA; P. K. MENON; H.
S. SHARMA. INSTITUTE OF TECHNOLOGY, BHU,
INSTITUTE OF TECHNOLOGY, Banaras Hindu Univ., Inst.
of Technology, Banaras Hindu Univ., Uppsala Univ. Hosp.,
Uppsala Univ. Hosp.
6 | Society for Neuroscience
9:00 323.05 Nanodrug delivery of neurotrophins potentiates
neuroprotection in methamphetamine neurotoxicity in
normal and diabetic rats. J. V. LAFUENTE*; R. PATNAIK;
A. SHARMA; H. S. SHARMA. Univ. of Basque Country,
Banaras Hindu Univ., Uppsala Univ.
9:15 323.06 Engineered nanoparticles from metals aggravates
neuropathic pain syndrome and exacerbate blood-spinal
cord barrier breakdown, astrocytic activation and neural
injury. L. FENG*; A. SHARMA; H. S. SHARMA. Bethune
Intl. Peace Hosp., Uppsala Univ. Hospital, Anesthesiol. &
Intensive Care Med.
9:30 323.07 Cocaine induced neurotoxicity and behavioral
dysfunction is enhanced by size-dependent cerium oxide
nanoparticles intoxication. R. PATNAIK*; A. SHARMA; H. S.
SHARMA. Banaras Hindu University, Inst. Technol., Uppsala
Univ. Hosp.
9:45 323.08 Nanowired cerebrolysin enhances neuroprotection
in hyperthermia-induced brain damage. D. F. MURESANU*;
R. PATNAIK; A. SHARMA; P. K. MENON; H. S.
SHARMA. ROMANIAN SOCIETY FOR THE STUDY OF
NEUROPROTECTION AND NEUROPLASTICITY, Banaras
Hindu University, Ibst technology, Uppsala Univ. Hospital,
Anesthesiol. & Intensive Care Med.
10:00 323.09 Silicon dioxide nanoparticles induce mitochondriamediated
cell damage in peripheral neural cells. A. R.
JAISWAL; S. LU; A. BHUSHAN; C. K. DANIELS; S. W.
LEUNG; J. C. LAI*. Idaho State Univ.
NANOSYMPOSIUM
324. Representation of Categories in Extrastriate Cortex
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, 147B
8:00 324.01 Behavioral expertise and domain formation as a
consequence of early but not late symbol training. M. S.
LIVINGSTONE*; K. SRIHASAM. Harvard Med. Sch.
8:15 324.02 Category specific domain formation as a
consequence of early but not late symbol training. K.
SRIHASAM*; M. LIVINGSTONE. Harvard Med. Sch.
8:30 324.03 Effects of long-term visual experience on single
neuron responses in the inferior temporal cortex. L.
WOLOSZYN*; D. L. SHEINBERG. Brown Univ.
8:45 324.04 Two critical and functionally distinct time periods
for early face and body perception. D. PITCHER*; B.
DUCHAINE; V. WALSH; N. KANWISHER. NIH/NIMH,
Dartmouth Col., Univ. Col. London, MIT.
9:00 324.05 Distinct roles of parietal and frontal cortices
in visual categorization. S. K. SWAMINATHAN*; D. J.
FREEDMAN. Univ. of Chicago.
9:15 324.06 Neuronal responses in an fMRI-defined faceselective
region in posterior inferotemporal cortex. E. B.
ISSA*; J. DICARLO. McGovern Inst. For Brain Research,
Dept. of Brain and Cognitive Sciences, MIT.
9:30 324.07 • Grasping, Walking, Climbing: Separate visual
processing streams for different classes of actions. R.
ABDOLLAHI; J. JASTORFF; S. MYSORE GOPALRAO*; G.
A. ORBAN. K.U.Leuven Med. Sch., Univ. of Parma.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:45 324.08 • Category representation in macaque anterior
inferotemporal cortex revealed with simultaneous
electrocorticogram and multi-channel unit recording. N.
MIYAKAWA*; K. MAJIMA; H. SAWAHATA; K. KAWASAKI;
N. KOTAKE; T. MATSUO; T. SUZUKI; Y. KAMITANI; I.
HASEGAWA. Niigata Univ. Sch. of Med., NAIST, ATR, JSPS,
Univ. Tokyo, Grad Sch. Med, Univ. Tokyo.
10:00 324.09 Temporal stability of visually selective responses
in intracranial field potentials from the human occipital
and temporal lobes. A. K. BANSAL*; J. M. SINGER; J.
R. MADSEN; G. KREIMAN. Children’s Hosp. of Boston,
Harvard Univ.
10:15 324.10 Object-based attention shifts semantic selectivity
toward an attended object category during natural vision.
T. CUKUR*; S. NISHIMOTO; A. G. HUTH; J. L. GALLANT.
Univ. of California, Univ. of California.
10:30 324.11 Holism without wholes: Insights from a
computational model of face processing mechanisms. C.
TAN*; T. POGGIO. MIT, McGovern Inst. for Brain Res.
10:45 324.12 Anatomical connectivity predicts whole-brain
functional responses to visual categories. D. E. OSHER*; Z.
M. SAYGIN; K. KOLDEWYN; R. SAXE; J. D. E. GABRIELI.
MIT.
NANOSYMPOSIUM
325. Neural and Molecular Mechanisms of Stress
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, 147A
8:00 325.01 Behavioral analysis of mice with embryonal and
adult deletion of the glucocorticoid receptor in serotonergic
neurons. S. WIRTH; T. WEBER; S. KUTSCHERJAWY; M.
VOGT; S. BERGER; G. SCHÜTZ; P. GASS; D. BARTSCH;
S. BERGER*. Central Inst. Mental Hlth., Central Inst. Mental
Hlth., German Cancer Res. Ctr. (DKFZ).
8:15 325.02 � Serotonin 5-HT4 receptors are involved in the
regulation of stress axis. M. PRATLONG*; L. LAURENT;
A. JEAN; G. GASTALDI; C. JUNG; R. PUECH; J.
BOCKAERT; J. BRINGER; G. BERTRAND; V. COMPAN.
IGF, UNIVERSITE DE NIMES, CONTRALCO, IGF, CHU
MONTPELLIER.
8:30 325.03 The effect of prenatal alcohol exposure on stressinduced
alterations in dopamine receptor expression in
female and male rats. K. A. UBAN*; W. L. COMEAU;
F. POURSOLTANI; L. A. E. ELLIS; S. E. LIEBLICH; J.
WEINBERG; L. A. M. GALEA. Univ. of British Columbia,
Univ. of British Columbia.
8:45 325.04 Coordinated regulation of noradrenergic and
serotonergic brain regions by amygdalar neurons. T. A.
RETSON*; E. J. VAN BOCKSTAELE. Thomas Jefferson
Univ.
9:00 325.05 Targeting of amygdalar corticotropin-releasing
factor neurons that project to the locus coeruleus by
noradrenergic afferents. B. A. REYES*; J. RICHARDS; R.
VALENTINO; E. VAN BOCKSTAELE. Thomas Jefferson
Univ., Children’s Hosp. of Philadelphia.
9:15 325.06 Corticosteroid activation of the central amygdala
causes long-term changes in corticotropin-releasing factor
and glucocorticoid receptor expression in the emotion circuit.
L. TRAN*; B. GREENWOOD-VAN MEERVELD. Univ. of
Oklahoma Hlth. Sci. Ctr., Univ. of Oklahoma Hlth. Sci. Ctr.,
VA Med. Ctr.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:30 325.07 Chronic stress alters mu opioid receptor trafficking
in parvalbumin-containing neurons in the female rat
hippocampus. T. A. MILNER*; G. F. MARRONE; T. J.
WILLIAMS; K. C. SCHIERBERL; E. M. WATERS; B. S.
MCEWEN; K. L. GONZALES. Weill Cornell Med. Coll,
Rockefeller Univ.
9:45 325.08 Alterations in stress reactivity and leptin
feeding circuitry in germ free mice. J. A. FOSTER*; C.
VANDERVELDE; K. MCVEY NEUFELD. McMaster Univ.
10:00 325.09 Hippocampal transcriptome associated with stressinduced
analgesia phenotype in mice - Involvement of
neurotensin and GABA receptors genes. A. H. SWIERGIEL*;
A. STANKIEWICZ; G. JUSZCZAK; M. WIECZOREK; P.
LISOWSKI. Dept. Animal Physiology, Univ. of Gdansk,
Inst. Genet. & Animal Breeding, Polish. Acad. Sci., Dept.
Neurophysiology, Univ. Lodz, Inst. Genet. & Animal
Breeding, Polish. Acad. Sci.
NANOSYMPOSIUM
326. Limbic System Development: Functional Implications
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention Center,
201
8:00 326.01 The effect of escalating handling on Morris water
maze performance in young C57bl/6 mice. F. CLAUSEN;
G. FRIDGEIRSDOTTIR; A. ERLANDSSON*; L. HILLERED.
Uppsala Univ., Uppsala Univ.
8:15 326.02 Ontogeny of contextual and cued fear conditioning
in the rat. M. A. BURMAN*; B. E. BOLDUC; S. I. SHIERS.
Univ. of New England, Univ. of New England.
8:30 326.03 Longitudinal development of white matter:
Timing of maturation and effects of sex and behavior.
D. SIMMONDS*; B. LUNA. Univ. of Pittsburgh, Univ. of
Pittsburgh, Univ. of Pittsburgh, Univ. of Pittsburgh.
8:45 326.04 Resting-state neural functional connectivity is
associated with cortisol reactivity to stress in children. M. E.
THOMASON*; I. H. GOTLIB. Wayne State Univ., Stanford
Univ.
9:00 326.05 Altered functional networks in Turner syndrome. S.
L. BRAY*; F. HOEFT; D. S. HONG; B. DUNKIN; A. L. REISS.
Univ. of Calgary, Stanford Univ.
9:15 326.06 Structural connectivity of the developing human
amygdala. Z. M. SAYGIN*; R. MARTIN; D. E. OSHER;
G. REYNOLDS; K. KOLDEWYN; J. D. E. GABRIELI; M.
SHERIDAN. MIT, Labs of Cognitive Neurosci., Children’s
Hosp. Boston, MIT.
9:30 326.07 Towards an OCD Cognitive Endophenotype:
Error-related brain activity in unaffected siblings of children
with obsessive-compulsive disorder. M. CARRASCO*; J.
K. NIENHUIS; S. M. HARBIN; K. D. FITZGERALD; W. J.
GEHRING; G. L. HANNA. Unversity of Michigan, Univ. of
Michigan, Univ. of Michigan.
9:45 326.08 Developmental change in emotional evaluations
and the influence of early-life adversity. N. L. TOTTENHAM*.
UCLA.
10:00 326.09 Medial prefrontal cortical function in pediatric ptsd.
S. C. PERKINS*; C. S. SRIPADA; J. SWAIN; C. MONK; I.
LIBERZON. Univ. and Michigan, Univ. of Michigan, Univ. of
Michigan, Univ. of Michigan.
Neuroscience 2011 | Monday AM | 7
Mon. AM NANOSYMPOSIUM

NANOSYMPOSIUM
NANOSYMPOSIUM
327. Human Memory: Multivariate and Connectivity Studies
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, 206
8:00 327.01 Neural coding of location on a familiar college
campus. L. K. MORGAN*; G. K. AGUIRRE; R. A. EPSTEIN.
Univ. of Pennsylvania.
8:15 327.02 Multi-voxel pattern distinctiveness at encoding
predicts subsequent free recall. L. J. JENKINS*; S. POLYN;
C. RANGANATH. UC Davis, Vanderbilt Univ.
8:30 327.03 Spaced learning improves memory by enhancing
pattern reinstatement. G. XUE*; R. A. POLDRACK; Z. LU;
C. CHEN; J. MUMFORD; Q. DONG. Univ. of Southern
California, Beijing Normal Univ., Univ. of Texas, Austin, Univ.
of California, Irvine.
8:45 327.04 Age-related changes in effective connectivity within
and between the task-positive and task-negative networks
during spatial and temporal context retrieval. D. MAILLET*;
N. RAJAH. McGill Univ.
9:00 327.05 Representations of decision evidence across
perception and memory: An fMRI study. A. M. GORDON*;
R. KIANI; W. T. NEWSOME; A. D. WAGNER. Stanford Univ.,
Stanford Univ., Stanford.
9:15 327.06 Decoding real-world autobiographical retrieval
experiences with fMRI multi-voxel pattern analysis. J.
RISSMAN*; T. CHOW; K. HARDEKOPF; H. T. GREELY; A.
D. WAGNER. UCLA, Stanford Univ., Stanford Univ., Stanford
Univ.
9:30 327.07 Multi-voxel pattern analysis reveals dynamic
tradeoffs between reactivating the past and encoding the
present. B. A. KUHL*; S. D. C. CARTMELL; M. M. CHUN.
Yale Univ.
9:45 327.08 Sources of individual variability in whole brain
activity during recognition memory. M. B. MILLER*; E.
AMINOFF; S. GRAFTON. UC Santa Barbara.
10:00 327.09 High-resolution fMRI reveals distinct encoding
and retrieval states within the hippocampal and midbrain
network. K. D. DUNCAN*; L. DAVACHI. New York Univ.,
New York Univ.
10:15 327.10 Default network connectivity in medial temporal
lobe amnesia. S. M. HAYES*; D. SALAT; M. VERFAELLIE.
Memory Disorders Res. Center, VA Boston Healthcare
Syst., VA Boston Healthcare Syst., Boston Univ. Sch. of
Med., Athinoula A. Martinos Ctr. for Biomed. Imaging, MGH
Radiology.
10:30 327.11 Multi-voxel object representations in the human
medial temporal lobe are shaped by incidental learning of
temporal regularities. A. C. SCHAPIRO*; L. V. KUSTNER; N.
B. TURK-BROWNE. Princeton Univ., Princeton Univ.
8 | Society for Neuroscience
POSTER
328. Connectome
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 A1 328.01 The developing spinal connectome:
Can simple rules govern formation of pioneer spinal motor
networks in Xenopus laevis tadpoles? D. CONTE*; A. K.
AZAD; S. R. SOFFE; R. BORISYUK; A. ROBERTS. Univ. of
Bristol, Univ. of Plymouth.
9:00 A2 328.02 Novel GABAergic inputs to Golgi cells
in the cerebellar granule cell layer. E. FROLA; A. PATRIZI*;
M. SASSOÈ-POGNETTO. Dept Anatomy, Pharmacol. ,
Forensic Med., Children’s Hospital, Boston.
10:00 A3 328.03 Application and evaluation of
automated methods to extract connectivity statements
from neuroscience literature. L. FRENCH*; S. LANE; L.
XU; P. PAVLIDIS. Univ. of British Columbia, Univ. of British
Columbia.
11:00 A4 328.04 � Functional connectivity of amygdala,
hippocampus and parahippocampal gyrus within explicit
memory and emotion. S. WIGMAN*; M. L. ANDERSON.
Franklin & Marshall Col., Franklin & Marshall Col.
8:00 A5 328.05 Knife-edge scanning microscope brain
atlas: A submicrometer-resolution web-based mouse brain
atlas. C. SUNG; J. CHUNG; D. MAYERICH*; J. KWON; D.
MILLER; T. HUFFMAN; J. KEYSER; L. ABBOTT; Y. CHOE.
Texas A&M Univ., Univ. of Illinois, Urbana-Champaign,
Kettering Univ., 3Scan, Texas A&M Univ.
9:00 A6 328.06 An open-source tool for constructing
brain graphs using CoCoMac. R. S. BLUMENFELD*; D.
BLISS; F. PEREZ; M. D’ESPOSITO. UC Berkeley.
10:00 A7 328.07 Data mining techniques for meta-analysis
of neuroimaging studies. C. HAVASI; K. GOLD; M. L.
ANDERSON*. Massachusetts Institite of Technol., Rochester
Inst. of Technol., Franklin & Marshall Col., Univ. of Maryland.
11:00 A8 328.08 iConnectome: An informatics
infrastructure for the processing, visualization, and analysis
for the mouse connectome project. D. LEE; Q. NG; S.
YAMASHITA; A. JOSHI; B. LEE; C. MENA; A. W. TOGA*; H.
DONG. UCLA.
8:00 A9 328.09 Hypothesis generation and reconstruction
of the connectome and cognome from the literature. B.
VOYTEK*; J. B. VOYTEK. Univ. California, Berkeley, Univ. of
California, Berkeley.
POSTER
329. Molecular Mechanisms of Neuronal Differentiation
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 A10 329.01 ADAM10 is involved in cell differentiation
and migration in the developing mouse brain. S. DUAN; Y.
WANG; J. WANG; J. LI*. Zhejiang Univ., affiliated Tongji
Hosp. of Tongji Med. College, Huazhong Univ. of Sci. and
Technol., Zhejiang Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 A11 329.02 Identification of FOXP2-regulated
signaling pathways in human neuronal differentiation. G.
KONOPKA*; G. A. MONTES; G. E. OSBORN; L. CHEN;
H. DONG; F. GAO; E. WEXLER; D. H. GESCHWIND. UT
Southwestern Med. Ctr., UCLA, UCLA, UCLA.
10:00 A12 329.03 A nontelomeric splice variant of TRF2
that is enriched in neurons maintains neuronal traits by
sequestering REST. P. ZHANG*; R. C. POTTS; P. PRECHT;
H. JIANG; Y. LIU; M. J. PAZIN; M. M. MATTSON. Natl.
Institiute on Aging, Natl. Institiute on Aging, Natl. Institiute on
Aging, Natl. Inst. on Aging.
11:00 A13 329.04 DLX transcription factors are necessary
for olfactory bulb interneuron differentiation and migration.
G. B. POTTER*; Y. WANG; E. SHEVCHENKO; T. U. LUU;
M. A. PETRYNIAK; D. H. ROWITCH; J. L. R. RUBENSTEIN.
Oregon Hlth. and Sci. Univ., Univ. of California, San
Francisco, Univ. of California, San Francisco.
8:00 A14 329.05 Heterogeneous ribonucleoproteins
(hnRNP) as brain region-specific regulators of tyrosine
hydroxylase expression. K. BANERJEE; J. W. CAVE; H. D.
BAKER*. Burke Med. Res. Inst.
9:00 A15 329.06 STEF/Tiam2 Thr749 phosphorylation
by PKA is critical for cAMP-induced Rac1 activation and
neurite outgrowth in PC12D cells. A. GOTO*; M. HOSHINO;
M. MATSUDA; T. NAKAMURA. Grad. Sch. of Biostudies,
Kyoto Univ., Natl. Inst. of Neurosci., Res. Inst. for Biol.
Sciences,Tokyo Univ. of Sci.
10:00 A16 329.07 Role of microRNAs in neural
differentiation of human embryonic stem cells. J. LIU*; J.
GITHINJI; J. NOLTA. UC Davis Stem Cell Program.
11:00 A17 329.08 � The effects of perturbing components of
Notch signaling on neurotransmitter phenotype specification
in Xenopus laevis. M. J. MCDONOUGH*; M. S. HARPER; M.
S. SAHA. Col. of William and Mary, Univ. of Colorado.
8:00 A18 329.09 • Ablation of Fmrp in adult neural
stem cells disrupts hippocampus-dependent learning. X.
ZHAO*; W. GUO; A. M. ALLAN; R. ZONG; L. ZHANG; E.
B. JOHNSON; E. G. SCHALLER; A. C. MURTHY; S. L.
GOGGIN; A. EISCH; B. A. OOSTRA; D. L. NELSON; P. JIN.
The Univ. of New Mexico, Baylor Col. of Med., Univ. of Texas
Southwestern Med. Ctr., Erasmus Univ. Med. Ctr., Emory
Univ.
9:00 A19 329.10 BubR1 inhibits neurite outgrowth of
neuroblastoma cells. H. YAMAGATA*; S. UCHIDA; K.
OTSUKI; T. HOBARA; T. SHIBATA; F. HIGUCHI; N. ABE; Y.
WATANABE. Yamaguchi Univ. Sch. of Med.
10:00 A20 329.11 Aberrant expression of thyroid hormoneregulated
genes in rat cerebellum following developmental
exposure to organomercury compounds. A. KHAN; Z.
L. SULKOWSKI; T. CHEN; A. ZAVACKI; E. M. SAJDEL-
SULKOWSKA*. Harvard Med. Sch/BWH.
11:00 A21 329.12 Molecular mechanisms for the morphinesensitive
neurite outgrowth caused by prostaglandin E 2 in
sensory neuron-like ND7/23 cells. T. MAEDA*; K. MITANI; R.
YAMAGATA; F. SEKIGUCHI; A. KAWABATA. Kinki Univ. Sch.
of Pharm. Div. of Pharmacol. and Pathophysiology.
8:00 A22 329.13 Regulating the ceramide
monoglycosylation: Differential roles of sigma-1 receptors in
the synthesis of cerebrosides. T. HAYASHI*; H. SPRONG;
G. VAN MEER; T. SU. Cell. Pathobiology Sec, Integrative
Neurosci Br, IRP, NIDA, NIH, DHHS, Lab. for Zoonoses and
Envrn. Microbiology, Natl. Inst. for Publ. Hlth. and Envrn.
(RIVM), Membrane Enzymology, Bijvoet Ctr. and Inst. of
Biomembranes, Utrecht Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 A23 329.14 The orphan nuclear receptor Nurr1
regulates the expression of the transcription factor Pitx3 thus
promoting dopaminergic differentiation. G. BELLENCHI*; F.
VOLPICELLI; R. DE GREGORIO; C. PERRONE CAPANO;
U. DI PORZIO. Inst. of Genet. and Biophysics “Adriano
Buzzati Traverso”, CNR, Inst. of Genet. and Biophysics.
10:00 A24 329.15 Selective knockout of NeuroD1 in the
retina and pineal gland: Identification and characterization
of potential mediators of photoreceptor degeneration. M. J.
OCHOCINSKA*; E. MUÑOZ; S. VELERI; J. L. WELLER; S.
L. COON; N. POZDEYEV; S. GOEBBELS; P. M. IUVONE;
T. FURUKAWA; K. NAVE; D. C. KLEIN. Eunice Kennedy
Schriver Natl. Inst. of Hlth. and Human Dev., Natl. Inst.
of Hlth., IHEM-CONICET, UNCuyo, ANPCyT, Natl. Eye
Institute, Natl. Inst. of Hlth., Emory Univ. Sch. of Med., Max-
Planck-Institute of Exptl. Med., Osaka Biosci. Inst. and JST,
CREST.
11:00 A25 329.16 � The functional role of the brain finger
protein, Znf179, in neuronal differentiation. P. PAO; S. LIN; J.
T. TSENG; W. CHANG; Y. LEE*. Inst. of Bioinformatics and
Biosignal Transduction, Col. of Biosci. and Biotechnology,
Natl. Cheng Kung Univ., Dept. of Pharmacology, Col. of
Medicine, Natl. Cheng Kung Univ., Grad. Inst. of Med.
Sciences, Col. of Medicine, Taipei Med. Univ., Grad. Inst.
of Neural Regenerative Medicine, Col. of Med. Sci. and
Technology, Taipei Med. Univ.
8:00 A26 329.17 DNA-methyltransferase 1 is a suppressor
of neurogenesis for late-gestational neural stem cells. H.
NOGUCHI*; M. NAMIHIRA; T. TANAKA; T. SANOSAKA;
K. NAKASHIMA. NARA INSTITUTE of SIENCE and
TECHNOLOGY.
9:00 A27 329.18 Insulin’s role in neurofilament transport
and phosphorylation. R. SCHECHTER*; K. E. MILLER.
Oklahoma State Univ. CHS.
10:00 A28 329.19 In vivo targetome analysis reveals new
functions for the proneural transcription factor Atoh1. T. J.
KLISCH*; Y. XI; A. FLORA; L. WANG; W. LI; H. Y. ZOGHBI.
Baylor Col. of Med., Howard Hughes Med. Inst., Jan and
Dan Duncan Neurolog. Res. Inst. at Texas Children’s Hosp.,
Baylor Col. of Med.
11:00 A29 329.20 The correlation between calcium activity
and neurotransmitter phenotype in the developing retina of
Xenopus laevis. E. A. MACMURRAY*; M. S. SAHA. Col. of
William and Mary.
8:00 A30 329.21 Ketamine induces neurotoxicity and
regulates neurogenic and proneural gene expression in
zebrafish. J. KANUNGO*; E. CUEVAS; S. F. ALI; M. G.
PAULE. Natl. Ctr. For Toxicological Research/Food and Drug
Admin.
POSTER
330. Neurogenesis and Gliogenesis: Neuron-Glia
Interactions
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 A31 330.01 Dystroglycan is shed, accumulates
in peripheral nodes of Ranvier with perlecan and agrin,
and contributes to initial sodium channel clustering. C.
COLOMBELLI*; D. ZAMBRONI; M. PALMISANO; S. OCCHI;
S. NICOLE; R. SOININEN; L. WRABETZ; M. L. FELTRI.
San Raffaele Scientific Inst., Inserm, U975; UPMC-Paris 6,
CNRS_UMR7225, Inst. of Biomedicine, Univ. of Oulu.
Neuroscience 2011 | Monday AM | 9
Mon. AM

9:00 A32 330.02 Development of a novel method to purify
and culture rodent astrocytes. L. C. FOO*; N. J. ALLEN;
E. A. BUSHONG; W. CHUNG; L. ZHOU; J. D. CAHOY; R.
DANEMAN; B. A. BARRES; M. H. ELLISMAN. Stanford
Univ., Stanford, Univ. of California San Diego, UCSF.
10:00 A33 330.03 Fgfr1 signaling in astrocytes supports the
postnatal survival of cortical interneurons. K. M. SMITH*; M.
E. MARAGNOLI; P. PHULL; K. M. TRAN; F. VACCARINO.
Yale Univ.
11:00 A34 330.04 Ambient GABA released from Bergmann
glial cells promotes proliferation of cerebellar granule cell
precursors. A. FUKUDA*; T. MORISHIMA; T. KUMADA; C.
TAKAYAMA; S. YOSHIDA. Hamamatsu Univ. Sch. Med.,
Hamamatsu Univ. Sch. Med., Dept Anat, Univ. Ryukyus Fac
Med., Mater Sci, Toyohashi Univ. Tech.
8:00 A35 330.05 Integrins are required for glial and
neuronal development in Drosophila eye. X. XIE*; V. AULD.
Univ. of British Columbia.
9:00 A36 330.06 Relationships between Laminins
receptors and Pmp22 in the peripheral nervous system. Y.
POITELON*; C. COLOMBELLI; S. SACCUCCI; U. SUTER;
L. WRABETZ; M. L. FELTRI. Hunter James Kelly Res.
Institute, Univ. at Buffalo, San Raffaele Scientific Inst., Inst.
of Cell Biology, ETH Zurich.
10:00 A37 330.07 Elucidating Schwann cell and perineurial
glia interactions in the peripheral nervous system. V. T.
SUAREZ*; J. KENNETT; S. KUCENAS. Univ. of Virginia.
11:00 A38 330.08 The role of Nrg1-ErbB signaling in
myelination of adult axons. N. SYED*; H. A. KIM. Rutgers
Univ.
8:00 A39 330.09 Molecular and genetic analysis of Gpr126
in nervous system development. K. R. MONK*. Washington
Univ. Sch. of Med.
9:00 A40 330.10 Maternal immune activation and adverse
developmental outcomes: IL-6 as a key mechanism and
therapeutic target of bioflavonoids. E. C. PARKER-ATHILL*;
H. HOU; D. OBREGON; M. BENGTSON; T. MURPHY; J.
TAN. Rashid Lab. For Developmental Neurobiology, Silver
Child Develop. Ctr., Rothman Ctr. for Neuropsychiatry,
Rashid Lab. For Developmental Neurobiology, Silver Child
Develop. Ctr.
10:00 A41 330.11 Tyro-3, Axl, and Mertk (TAM) receptors
affect adult neurogenesis through regulation of glial immune
responses. R. JI*; Q. LI; Q. LU. Univ. of Louisville, Univ. of
Louisville.
11:00 A42 330.12 Alpha6beta1 and alpha7beta1 integrins
are required for radial axonal sorting during peripheral nerve
development. M. PELLEGATTA*; A. D’URSO; A. NODARI;
D. ZAMBRONI; A. DE ARCANGELIS; E. GEORGES-
LABOUESSE; J. KREIDBERG; U. MAYER; K. MCKEE; P.
YURCHENCO; A. QUATTRINI; L. WRABETZ; M. FELTRI.
Dibit San Raffaele Scientific Institute, Inst. de Génétique
et de Biologie Moléculaire et Cellulaire, Children’s Hosp.
Boston, Univ. of East Anglia, Robert Wood Johnson Med.
Sch.
8:00 A43 330.13 Immune contribution to the valproic acid
model of autism. P. S. AWALE*; W. J. GELDENHUYS; R. T.
CARROLL. Northeast Ohio Med. Univ.
9:00 A44 330.14 Connexin expression and gap junction
mediated coupling by neuroblasts and radial glia in the
early postnatal subventricular zone. J. R. MENEZES*; A. L.
R. XAVIER; C. HEDIN-PEREIRA; C. M. FURTADO; A. S.
FREITAS; M. M. FRÓES. Univ. Federal do Rio de Janeiro,
Univ. Federal do Rio de Janeiro.
10:00 A45 330.15 Astrocyte secreted CHL1 selectively
increases inhibitory axon length and branching in
hippocampal neurons in vitro. J. S. MCGURK*; E. G.
HUGHES; H. ISCHIROPOLOUS; R. J. BALICE-GORDON.
Univ. of Pennsylvania Sch. of Med., Univ. of Pennsylvania
Sch. of Med., Children’s Hosp. of Philadelphia.
11:00 A46 330.16 Astroglial mGluR-dependent regulation
of astroglial morphological maturation during postnatal
development. L. MOREL; H. HIGASHIMORI; T. BEDOR; Y.
YANG*. Tufts Univ. Sch. of Med.
8:00 A47 330.17 • Effects of stress by noise on the
proliferation rate of radial astrocytes and survival of
neuroblasts in the adult subgranular zone. O. GONZALEZ-
PEREZ*; O. E. CHAVEZ; A. GALVEZ-CONTRERAS; L.
E. ALVAREZ; J. GUZMAN-MUNIZ; N. MOY-LOPEZ; Z.
J. AGUIRRE; J. TORRES; S. LUQUIN; R. GONZALEZ-
CASTANEDA. Psicologia/University of Colima, Univ. de
Colima, Univ. de Guadalajara.
9:00 A48 330.18 High level expression of neuronal class
III ß-tubulin in adult canine olfactory ensheathing cells but
not in Schwann cells in vitro. K. WEWETZER*; M. OMAR;
F. HANSMANN; R. KREUTZER; M. KREUTZER; G.
BRANDES; C. PECK; W. BAUMGÄRTNER. Univ. Vet Med.
Hannover, Hannover Med. Sch., Ctr. of Systems Neurosci.
POSTER
331. Postnatal Neurogenesis V
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 A49 331.01 Activity-dependent plasticity in
dopaminergic neurons of the olfactory bulb. A. N. CHAND*;
M. S. GRUBB. King’s Col. London.
9:00 A50 331.02 Neurogenesis in the adult cerebellum
of mice exposed to different periods of environmental
enrichment. D. B. VAZQUEZ SANROMAN*; M. CARBO
GAS; C. SANCHIS SEGURA; J. MANZO; M. MIQUEL. Univ.
Jaume I, Univ. Veracruzana.
10:00 A51 331.03 Social modulation of adult neurogenesis
in the neural network underlying aggressive behavior in
zebrafish. M. TELES; D. A. PETERSON*; R. F. OLIVEIRA.
Unidade de Investigação em Eco-Etologia , ISPA, Lisboa,
Portugal, Champalimaud Neurosci. Programme, Inst.
Gulbenkian de Ciência, Oeiras, Portugal, Rosalind Franklin
Univ. Med. Sci.
11:00 A52 331.04 Growth factor infusion increases BrdUpositive
cells in the denervated medial septum following
192-IgG-saporin lesion. S. S. WINTER; J. R. KÖPPEN;
J. M. STOUT; H. A. CAMERON; D. G. WALLACE*; J. L.
CHEATWOOD. Northern Illinois Univ., Southern Illinois Univ.
Sch. of Med., Natl. Inst. for Mental Hlth.
8:00 A53 331.05 Fate plasticity of GAD65-expressing
neuroblasts of the SVZ in a mouse model of hypoxiainduced
white matter injury observed in preterm infants.
M. RAYMOND*; V. GALLO. Children’s Natl. Med. Ctr., The
George Washington Univ.
9:00 A54 331.06 How does galactic cosmic radiation
alter adult hippocampal neurogenesis? J. A. LEBLANC*; M.
COLE; P. RIVERA; H. SHIH; B. P. C. CHEN; A. J. EISCH.
UT Southwestern Med. Ctr., UT Southwestern Med. Ctr., UT
Southwestern Med. Ctr.
10 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

10:00 A55 331.07 Basolateral amygdala activity and stress
effects on adult hippocampal neurogenesis. E. D. KIRBY*;
M. J. LEONG; W. G. SUN; D. KAUFER. Univ. of California
Berkeley.
11:00 A56 331.08 Systemic angiotensin II and its type I
receptor are essential for running-enhanced neurogenesis
in adult rat hippocampus. T. MUKUDA*; Y. KOYAMA; S.
HAMASAKI; Y. FURUKAWA. Hiroshima Univ.
8:00 A57 331.09 Role of visual activity in regulating
number of neurons in visual circuitry: Creating another
dimension for plasticity? P. K. SHARMA*; H. T. CLINE. The
Scripps Res. Inst.
9:00 A58 331.10 Baclofen treatment decreases the
number of oligodendrocyte progenitor cells in the complete
transection injured neonatal mice spinal cord. Y. QU*; V.
BELEGU; D. GARY; D. BECKER; J. ZHAO; J. MCDONALD.
Kennedy Krieger Inst., Johns Hopkins Univ. Sch. of Med.,
Johns Hopkins Univ. Sch. of Med.
10:00 A59 331.11 Midbrain dopamine neurons associated
with reward processing innervate the neurogenic
subventricular zone. J. B. LENNINGTON*; S. POPE; A.
GOODHEART; L. DROZDOWICZ; S. B. DANIELS; J. D.
SALAMONE; J. C. CONOVER. Univ. of Connecticut, Univ. of
Connecticut.
11:00 A60 331.12 Role of the endocannabinoid system on
adult neurogenesis in the mouse olfactory epithelium. C. R.
HUTCH*; C. C. HEGG. Michigan State Univ., Michigan State
Univ., Michigan State Univ.
8:00 A61 331.13 • Early exposure to general anesthesia
causes significant cognitive impairments that are abolished
by the use of free oxygen scavenger and mitochondrial
protector, EUK-134 and R(+) pramipexole. A. BOSCOLO*;
J. A. STARR; N. LUNARDI; C. ORI; J. P. BENNETT, Jr; V.
JEVTOVIC-TODOROVIC. Univ. of Virginia, Univ. of Padua,
Univ. of Virginia, Univ. of Virginia.
9:00 A62 331.14 • Early exposure to general anesthesia
induced significant up regulation of reactive oxygen species
and lipid peroxidation in neonatal rat brain. J. A. STARR*;
A. BOSCOLO; V. SANCHEZ; M. DIGRUCIO; C. ORI; J. P.
BENNETT, Jr; V. JEVTOVIC-TODOROVIC. Univ. of Virginia,
Univ. of Padua, Univ. of Virginia.
10:00 A63 331.15 Dose-related reduction in neuronal
and doublecortin positive cell number in the hippocampus
following prenatal ethanol exposure in the vervet monkey. M.
W. BURKE; R. M. PALMOUR; H. SLIMANI; M. PTITO; F. R.
ERVIN*. U Montreal, McGill Univ., McGill Univ.
11:00 A64 331.16 Effects of status epilepticus on
neurogenesis and GABA A receptor subunit expression
in the postnatal rat hippocampus. H. B. LAURÉN*; T.
KUKKO-LUKJANOV; S. RUOHONEN; F. R. LÓPEZ-
PICÓN; J. E. VIRTA; J. T. JÄRVELÄ; M. UUSI-OUKARI; I.
E. HOLOPAINEN. Inst. of Biomedicine, Univ. of Turku, Inst.
of Biomedicine, Univ. of Turku, Univ. of Helsinki, Turku PET
Center, Preclinical imaging.
8:00 A65 331.17 BDNF/NFATc4 axis in regulation of adult
hippocampal neurogenesis and spatial memory formation
in physiological conditions and following stroke injury. G.
QUADRATO*; S. ALBER; M. BENEVENTO; C. JACOB; T.
NGUYEN; E. FLORIDDIA; J. MOLKENTIN; S. DI GIOVANNI.
Hertie Inst. for Clin. Brain Research, Univ. of Tuebingen,
Grad. Sch. for Cell. and Mol. Neurosci., Howard Hughes
Med. Institute, Cincinnati Children´s Hosp. Med. Ctr.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 A66 331.18 Estradiol organizes sex differences in
cell proliferation in the dentate gyrus of the hippocampus
in postnatal rats. S. B. BANERJEE*; J. M. BOWERS; J.
WADDELL; M. M. MCCARTHY. Univ. of Maryland Sch. of
Med.
10:00 A67 331.19 The fast acting anti-depressant
desvenlafaxine promotes new granule neuron maturation
in the dentate gyrus of adult rats. A. ASOKAN*; A. BALL;
C. LAIRD; L. HERMER; B. ORMEROD. Unv Florida,
Gainesville.
11:00 A68 331.20 Circulating and central inflammatory
cytokines linked to hippocampal neurogenesis; both modified
by running in aged rats. R. B. SPEISMAN*; A. KUMAR; A.
RANI; T. C. FOSTER; B. K. ORMEROD. Univ. of Florida,
Univ. of Florida.
8:00 B1 331.21 Adult neural progenitor cells influence
cell survival and ensemble activity following oxygen-glucose
deprivation on microelectrode arrays. C. L. STEPHENS*; T.
B. DEMARSE; B. K. ORMEROD. Univ. of Florida.
9:00 B2 331.22 24/7 seizure monitoring in epileptic mice
with fate-mapped hippocampal granule cell progenitors.
M. S. HESTER*; R. PUN; C. FAULKNER; S. DANZER.
Cincinnati Children’s Med. Ctr.
POSTER
332. CNS Synaptogenesis
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 B3 332.01 Nicotinic Acetylcholine receptors
stability at the NMJ deficient in alpha syntrophin in vivo.
I. M. MARTINEZ PEÑA VALENZUELA*; C. MOUSLIM;
M. DE OLIVEIRA; M. E. ADAMS; S. C. FROEHNER; M.
AKAABOUNE. Univ. Michigan, Univ. of Washington.
9:00 B4 332.02 Proper positioning of oligodendrocytes
is required for appropriate synapse formation in the dorsal
spinal cord. J. R. LESLIE*; F. IMAI; K. FUKUHARA;
N. TAKEGAHARA; R. H. FRIEDEL; F. WANG; A.
KUMANOGOH; Y. YOSHIDA. Cincinnati Children’s Hosp.
Med. Ctr., Osaka Univ., Mount Sinai Sch. of Med., Duke
Univ. Med. Ctr.
10:00 B5 332.03 Axonal and synaptic degeneration is
regulated by the Hiw E3 ubiquitin ligase and conditioning
lesion. C. A. COLLINS*; X. XIONG. Univ. of Michigan, Univ.
of Michigan.
11:00 B6 332.04 • After unilateral corticospinal injury
electrical stimulation of the intact motor cortex drives robust
outgrowth of corticofugal terminations and preferentially
targets the impaired side of the spinal cord. J. B. CARMEL*;
L. J. BERROL; J. H. MARTIN. Burke-Cornell Med. Res. Inst.,
City Univ. of New York.
8:00 B7 332.05 The activity-dependent gtpase rem2
regulates dendrite morphology. A. E. GHIRETTI; N. C.
LAU; S. D. VAN HOOSER; S. PARADIS*. Brandeis Univ.,
Brandeis Univ.
9:00 B8 332.06 Role of calcineurin and microglia on
monocular enculeation-induced plasticity. P. TRINDADE*; L.
S. CHAGAS; P. C. LEITE; A. C. F. MELIBEU; R. LINDEN; C.
A. SERFATY. Federal Fluminense Univ., Federal Univ. of Rio
de Janeiro, Federal Fluminense Univ.
Neuroscience 2011 | Monday AM | 11
Mon. AM

10:00 B9 332.07 Dendritic targeting of SALM1 in
hippocampal neurons regulates cell morphology. G. K.
SEABOLD*; P. Y. WANG; R. S. PETRALIA; K. CHANG;
A. ZHOU; Y. WANG; S. L. MILGRAM; R. J. WENTHOLD.
NIDCD/NIH, NHLBI/NIH.
11:00 B10 332.08 The Rac-specific GEF Dock4 controls
dendritic spine formation in hippocampal neurons. S. UEDA*;
M. NEGISHI; H. KATOH. Lab. of Mol. Neurobiology, Grad.
Sch. of Biostudies, Kyoto Univ.
8:00 B11 332.09 Active zone density is conserved during
synaptic growth but impaired in aged mice. J. CHEN*; T.
MIZUSHIGE; H. NISHIMUNE. Univ. of Kansas Med. Ctr.
9:00 B12 332.10 The Intellectual Disability gene CC2D1A
regulates neuronal differentiation and NF-κB signaling. M.
MANZINI*; V. MITSIALIS; D. TISCHFIELD; D. GLEASON; R.
HILL; J. N. PARTLOW; B. BARRY; S. B. LIZARRAGA; M. A.
M. SALIH; C. A. WALSH. CHB - Harvard Med. Sch., CHB -
Harvard Med. Sch., King Saud University, Col. of Med.
10:00 B13 332.11 The role of F-BAR protein Rapostlin/
FBP17 in dendritic spine formation in hippocampal neurons.
Y. WAKITA*; T. KAKIMOTO; H. KATOH; M. NEGISHI. Kyoto
Univ.
POSTER
333. Neuromuscular Junction Formation
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 B14 333.01 • The role of tyrosine phosphatase in the
postsynaptic acetylcholine receptor clustering. Y. S. ZHAO*;
H. B. PENG. Div. of Life Science, The Hong Kong Univ. of
Sci. and Technol.
9:00 B15 333.02 Effects of BDNF and cAMP in inhibiting
the maturation of the neuromuscular junction. W. SONG*; H.
B. PENG. Hong Kong Univ. of Sci. and Technol.
10:00 B16 333.03 Deficiency in plasmalogens affects
muscle innervation and synpase formation. T. SILVA; V.
SOUSA; R. J. A. WANDERS; M. M. SOUSA; P. BRITES*.
Inst. de Biologia Mol. e Celular - Lab. Nerve Regeneration,
Academic Med. Ctr., Inst. de Biologia Mol. e Celular - Lab.
Nerve Regeneration.
11:00 B17 333.04 Role of MuSK-ColQ interactions
in synaptogenesis of the neuromuscular junction.
A. DOBBERTIN; S. SIGOILLOT; F. BOURGEOIS; J.
KARMOUCH; C. LEGAY*. Paris V Univ.
8:00 B18 333.05 The formation of complex acetylcholine
receptor clusters requires MuSK kinase activity and
structural information from the MuSK extracellular domain.
R. HERBST*; S. MAZHAR. Med. Univ. Vienna.
9:00 B19 333.06 Severe congenital myasthenic
syndrome caused by mutations in agrin. M. J. FERNS*; J.
ARREDONDO; M. NGO; D. C. WILLIAMS; C. NAVARRO; R.
A. MASELLI. Univ. California Davis, Univ. California Davis,
Univ. California Davis, Hosp. Meixoeiro.
10:00 B20 333.07 • Regulation of stable nerve-muscle
interaction and synaptogensis at the neuromuscular junction
by PTEN signaling. P. P. LI*; M. MENG; H. B. PENG. Hong
Kong Univ. of Sci. and Technol.
11:00 B21 333.08 Heterogeneity in synaptic vesicle
release at developing neuromuscular synapses of mice
expressing synaptopHluorin. C. R. HAYWORTH*; E. ABER;
R. J. BALICE-GORDON. Univ. of Pennsylvania, Univ. of
Pennnsylvania.
8:00 B22 333.09 Spatial constraints dictate glial territories
at murine neuromuscular junctions. M. S. BRILL*; Y.
ZUO; T. MISGELD. Inst. of Neurosci., Molecular, Cell and
Developmental Biol.
POSTER
334. Synapse Formation: CNS I
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 B23 334.01 NGL-2 regulates the development and
function of specific CA1 glutamatergic synapses. L. A.
DENARDO*; S. OTTO; J. DE WIT; A. GHOSH. UCSD.
9:00 B24 334.02 Mammalian SAD-A/B kinases regulate
presynaptic maturation of diverse classes of nerve terminals.
B. N. LILLEY*; A. KRISHNASWAMY; Z. WANG; A. PAN; E.
FRANK; J. R. SANES. Harvard Univ., Tufts Univ. Sch. of
Med.
10:00 B25 334.03 Differential regulation of neurexin at
glutamatergic and GABAergic synapses in the cerebellar
cortex. G. PREGNO; E. FROLA; A. PATRIZI; M. ARESE; M.
SASSOE-POGNETTO*. Univ. Torino, Harvard Med. Sch.,
Univ. Torino.
11:00 B26 334.04 The immunoglobulin superfamily code for
retinal laminar specificity: Genetic analysis of Sidekick-1 and
2 in mice. M. YAMAGATA*; J. R. SANES. Harvard Univ.
8:00 B27 334.05 The leucine-rich repeat protein FLRT3
regulates the development of hippocampal synapses via
a novel trans-synaptic interaction. M. O’SULLIVAN*; J. DE
WIT; J. SAVAS; S. OTTO; J. YATES, III; A. GHOSH. UCSD,
The Scripps Res. Inst.
9:00 B28 334.06 Role of dact1 in cortical interneuron
morphology and synapse development. A. ARGUELLO*; B.
N. R. CHEYETTE. Univ. of California San Francisco.
10:00 B29 334.07 Elfn1 regulates short-term plasticity at
CA1-oriens interneuron synapses. E. L. SYLWESTRAK*; A.
GHOSH. UCSD, UCSD.
11:00 B30 334.08 Cortactin binding protein 2 regulates
dendritic spine formation through the interaction with
cortactin. Y. CHEN*; Y. HSUEH. Inst. Mol. Biol.
8:00 B31 334.09 • Local synthesis of β-catenin during
synapse formation. A. M. TAYLOR*; H. TAI; E. SCHUMAN.
Unc-Chapel Hill, NCSU, Caltech, Max Planck Inst. for Brain
Res.
9:00 B32 334.10 Leptin regulates transient receptor
potential cation (TrpC) channels in hippocampal neurons
through activation of CaM kinase kinase and CaM Kinase
1. S. M. APPLEYARD*; M. ZHU; M. DHAR; M. A. DAVARE;
T. J. LAMBERT; G. A. WAYMAN. Program In Neuroscience,
VCAPP, Washington State Univ., Oregon Hlth. and Sci. Univ.
10:00 B33 334.11 The role of SRPX2 in synapse formation
and language development. G. SIA*; R. HUGANIR. Johns
Hopkins Univ.
12 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 B34 334.12 Fyn and cdk5 coordinately regulate Dab1
phosphorylation dynamics. J. H. TROTTER*; I. FILONOVA;
H. HOE; G. REBECK; E. J. WEEBER. Byrd Alzheimer’s Ctr.,
USF Hlth. Byrd Alzheimer’s Inst., Georgetown Univ.
8:00 B35 334.13 Elucidating the function of the class 4
semaphorin, Sema4D, in GABAergic synapse formation.
A. R. MOORE*; M. S. KUZIRIAN; I. CHUDOTVOROVA; A.
RAISSI; S. PARADIS. Brandeis Univ.
9:00 B36 334.14 � Cortactin regulates Synaptic Growth.
C. MALDONADO*; B. MARIE. Inst. of Neurobiology, Univ. of
Puerto Rico.
10:00 B37 334.15 Non-cell autonomous competition for
ephrin-B3 and EphB2 sets the synapse density in cortical
neurons. M. HRUSKA*; M. B. DALVA. Univ. of Pennsylvania.
11:00 B38 334.16 Transforming growth factor beta 1
induces excitatory synapses of cerebral cortex neurons. F.
C. GOMES*; J. CARVALHO; V. TORTELLI; J. STIPURSKY;
P. PERDIGÃO; N. CASTRO; R. PANIZZUTTI; L. DINIZ.
Federal Univ. of Rio De Janeiro.
8:00 B39 334.17 Characterization of activity-induced
nucleocytoplasmic translocation of CPEB3 in neurons. H.
CHAO; Y. HUANG*. Academia Sinica/Institute of Biomed.
Sci.
9:00 B40 334.18 Myosin Va localizes a subset of
postsynaptic proteins to dendritic spines and regulates the
maturation of spines. A. YOSHII*; S. PANDIAN; J. ZHAO; B.
VAN ZUNDERT; M. CONSTANTINE-PATON. MIT, Andrés
Bello Univ.
10:00 B41 334.19 The replacement of GluN2B with
GluN2A increases synaptic trafficking of AMPA receptors
in the neonatal mouse brain. S. HAMADA*; I. OGAWA; M.
YAMASAKI; Y. KIYAMA; A. M. WATABE; H. KASSAI; K.
NAKAO; A. AIBA; M. WATANABE; T. MANABE. Inst. of Med.
Science, Univ. of Tokyo, Grad. Sch. of Medicine, Hokkaido
Univ., Jikei Univ. Sch. of Med., PRESTO, JST, Ctr. for
Dis. Biol. and Integrative Medicine, Univ. of Tokyo, Ctr. for
Developmental Biology, RIKEN Kobe.
POSTER
335. Motor System Development
Theme A: Development
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 B42 335.01 Characterization of a novel zebrafish
mutant with peripheral glial defects: Failure to launch (ftl
vu268). J. ECKARDT*; S. KUCENAS. Univ. of Virginia.
9:00 B43 335.02 Genetic dissection of the hindbrain by the
Gal4-UAS system in zebrafish. K. ASAKAWA*; G. ABE; K.
KAWAKAMI. Natl. Inst. of Genet., SOKENDAI.
10:00 B44 335.03 Ionic conductances underpinning
synchronous periodic depolarizations in the developing
zebrafish spinal cord. H. TONG; J. R. MCDEARMID*. Univ.
of Leicester.
11:00 B45 335.04 Phase Relationships in a Computational
Model of Respiratory Rhythm Generation in an in vitro slice.
C. FIETKIEWICZ; K. A. LOPARO; C. G. WILSON*. Case
Western Reserve Univ., Case Western Reserve Univ.
8:00 B46 335.05 Experimental regulation of embryonic
chick limb movements: An optogenetic approach. A. A.
SHARP*; S. FROMHERZ. SIU Sch. Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 B47 335.06 Distribution of corticospinal neurons
innervating the spinal segment of C7 and L4 in adult and
early postnatal period: Retrograde double-labeling studies
with fluorescent beads. T. KAMIYAMA; H. KAMEDA*; N.
MURABE; M. SAKURAI. Teikyo Univ. Sch. of Med.
10:00 B48 335.07 Contralateral migration of oculomotor
neurons is regulated by Slit/Robo signals. B. BJORKE*; C.
SCHLEMMER; G. MASTICK. Dept. of Biol.
11:00 B49 335.08 Mirror forelimb movements produced by
bilateral corticospinal tract in conditional EphA4-Emx1-cre
knockout mice. N. SERRADJ*; K. KULLANDER; J. MARTIN.
CCNY, Uppsala UNiversity.
8:00 B50 335.09 Analysis of cerebellar development and
function in conditional Dicer knockout mice. A. SHIBATA*; M.
BOSCH; A. HAKE; M. PIERCE; G. A. SOUKUP. Creighton
Univ., Creighton Univ.
9:00 B51 335.10 Inhibition of the JNK pathway improves
long-term neurobehavioral outcomes after juvenile traumatic
brain injury. D. O. AJAO*; J. E. KAMPER; A. M. FUKUDA;
V. POP; D. W. SORENSEN; V. B. TOCA; R. E. HARTMAN;
A. OBENAUS; S. ASHWAL; J. BADAUT. Loma Linda Univ.,
Loma Linda Univ., Loma Linda Univ., Loma Linda Univ.,
Loma Linda Univ., Loma Linda Univ.
10:00 B52 335.11 Dueling embryonic respiratory oscillators.
J. A. HAYES; P. RUFFAULT; J. BOUVIER; G. FORTIN*.
CNRS, Inst. de Neurobiologie Alfred Fessard.
11:00 B53 335.12 Specification of spinal motoneurons
by microRNA-9 regulating transcriptional networks. G.
LUXENHOFER; M. HELMBRECHT; J. LANGHOFF; D.
REFOJO; A. B. HUBER*. Helmholtz Zentrum München, Max
Planck Inst. for Psychiatry.
8:00 B54 335.13 Postnatal transition in trophic factor
regulation of neuromuscular transmission in the diaphragm
muscle. L. G. ERMILOV*; D. C. SIECK; W. ZHAN; G. C.
SIECK; C. B. MANTILLA. Col. of Medicine, Mayo Clin., Col.
of Medicine, Mayo Clin.
9:00 B55 335.14 Development of a unique cellular
subcompartment within the striatum containing EphA7
expressing neurons. L. F. KROMER*; A. X. TAI; O. F.
RAHMAN. Georgetown Univ. Med. Ctr., Georgetown Univ.
Med. Ctr., Georgetown Univ.
10:00 B56 335.15 • Supplementation of the maternal diet
with free sialic acid increases neurite growth and white
matter maturation in the offspring. A. E. GARRISON; M. J.
WEISER; J. P. ZIMMER; C. M. BUTT*. DSM-Martek.
11:00 B57 335.16 Cell body position of spinal motor
neurons within the neural tube determined by Islet
transcription factor. H. LEE*. Gwangju Inst. of Sci. and
Technol. (GIST).
8:00 B58 335.17 Characterization of Schwann cellperineurial
glial interactions during development. G. LEWIS*;
V. PATEL; S. KUCENAS. Univ. of Virginia.
9:00 B59 335.18 QTL analysis of neuron number in
the striatum and cerebral cortex in mice. G. D. ROSEN*;
L. KOGANTI; A. J. NEWBURY; E. G. GRIFFIN; N. A.
AZOULAY; M. J. LARIMER. Beth Israel Deaconess Med. Ctr.
10:00 B60 335.19 • Developmental profile of multi-joint
position sense of the upper limb. L. C. PELLAND*; C.
HENDERSON; T. HERTER; S. H. SCOTT. Queen’s Univ.,
Queen’s Univ.
Neuroscience 2011 | Monday AM | 13
Mon. AM

11:00 B61 335.20 Is the mesencephalic locomotor
region necessary for locomotion of newborn opossums
(Monodelphis domestica)? M. AMALRIC*; T. CABANA; J.
PFLIEGER. Univ. De Montréal.
8:00 B62 335.21 Postural control and automaticity in
dyslexic children: Visual information and body sway. J. A.
BARELA*; A. R. VIANA; M. RAZUK. Univ. Cruzeiro Do Sul,
Univ. Estadual Paulista.
9:00 B63 335.22 Structural and functional analysis of
brains of patients with congenital Mirror Movement Disorder.
H. BOYACI*; A. ORS; P. BOYACI; T. OZCELIK; H. UYSAL;
K. DOERSCHNER. Bilkent Univ., Bilecik Univ., Dokuz Eylul
Univ., Bilkent Univ., Akdeniz Univ.
10:00 B64 335.23 Lifespan changes in cortico-striatal
resting state connectivity. C. LEE; J. BO*; Y. KWAK; S.
PELTIER; J. BERNARD; M. BUSCHKUEHL; S. JAEGGI; J.
WIGGINS; J. JONIDES; C. MONK; R. SEIDLER. Eastern
Michigan Univ., Univ. of Michigan.
11:00 C1 335.24 Development and sensory control of
the reach-to-eat movement in human infants between
6-months and 12-months of age: Vision for grasping and
somatosensation for withdrawal. L. R. SACREY*; I. Q.
WHISHAW. Univ. of Lethbridge.
POSTER
336. Nicotinic Acetylcholine Receptors: Pharmacology and
Structure-Function
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 C2 336.01 Identifying propofol binding site(s) in
the Torpedo nicotinic acetylcholine receptor (nAChR). S.
S. JAYAKAR*; W. P. DAILEY; R. G. ECKENHOFF; J. B.
COHEN. Harvard Med. Sch., Univ. of Pennsylvania, Univ. of
Pennsylvania.
9:00 C3 336.02 Non-orthosteric subunit faces are
involved in alpha4beta2 nAChR responses to acetylcholine
and desformylflustrabromine in high and low sensitive
receptor preparations. M. M. WELTZIN*; M. K. SCHULTE.
Univ. of Alaska Fairbanks.
10:00 C4 336.03 The twin drug approach for novel nicotinic
acetylcholine receptor (nAChR) ligands: Synthesis and
structure-affinity relationships. I. TOMASSOLI; C. EIBL; M.
WULF; R. L. PAPKE; M. R. PICCIOTTO; D. GUNDISCH*.
Col. of Pharm. UHH, Dept. of Pharmacol. and Therapeutics,
Col. of Medicine, Univ. of Florida, 3Department of Psychiatry,
Yale Sch. of Medicine, Yale Univ.
11:00 C5 336.04 Ketamine and metabolites induce
nicotinic receptor-mediated 86rb+ flux and nonnicotinic
receptor-mediated [3h]dopamine release from
synaptosomes. R. MOADDEL; G. STAUBER; I. W. WAINER;
L. TOLL*. Natl. Inst. on Aging, SRI Intl.
8:00 C6 336.05 • Differential allosteric modulation of high-
and low-sensitivity forms of the α4β2 nAChR: Evidence for
distinct modulator binding sites. D. B. TIMMERMANN*; M.
GRUNNET; D. PETERS; P. K. AHRING. Neurosearch.
9:00 C7 336.06 An additional ach binding site at the
α4/α4 interface of the (α4β2)2α4 nicotinic acetylcholine
receptor influences agonist sensitivity. S. MAZZAFERRO;
N. BENALLEGUE; A. CARBONE; M. MORONI; I.
BERMUDEZ*. Oxford Brookes Univ., Leibniz-institut fur
Molekulare Pharmakologie and Neurocure Initiative Charite
Universitatsmedizin, Dept. of Pharmacology, Univ. Col.
London.
10:00 C8 336.07 Novel α-conotoxins from cone snail
species from the Americas with varying selectivity profiles for
blocking nAChRs. F. MARI*; M. HEIGHINIAN; A. FRANCO;
M. MEJIA; T. GODENSCHWEGE; N. DALY; K. AKONDI; P.
ALEWOOD; D. CRAIK; S. NAG; D. ADAMS. Florida Atlantic
Univ., IMB - Univ. of Queensland, RMIT Univ.
11:00 C9 336.08 Discovery of nicotinic acetylcholine
receptor ligands in the chemical universe database gdb-13.
S. BERTRAND*; L. C. BLUM; R. VAN DEURSEN; J. BÜRGI;
J. REYMOND; M. MAVER; D. BERTRAND. Hiqscreen, Univ.
of Bern.
8:00 C10 336.09 Probing alpha7 nAChR with the positive
allosteric modulator PNU-120596 provides insights on
single-channel mechanisms. D. K. WILLIAMS*; R. L.
PAPKE. Univ. of Florida.
9:00 C11 336.10 Factors regulating the constitutive
activation of alpha7 nAChR produced with tethered agonist
analogs and PNU-120596. R. L. PAPKE*; C. STOKES; J.
WANG; N. A. HORENSTEIN. Univ. Florida, Univ. Florida.
10:00 C12 336.11 • Comparison of pharmacologic
properties of AZD3480 and AZD1446 on neuronal nicotinic
receptor subtypes. G. VON EULER*; D. BERTRAND; E. C.
JOHNSON. AstraZeneca, CNSP iMED Sci. Södertälje, R&D,
Innovative Medicines, HiQScreen Sàrl, AstraZeneca, Project
Management, CNS Pain Innovative Medicines Unit.
11:00 C13 336.12 Novel negative allosteric modulators
of human α4β2 nicotinic receptors: Pharmacological
characterization, SAR, and binding site localization. T. F.
GONZALEZ-CESTARI*; B. J. HENDERSON; B. YI; M.
L. DALEFIELD; R. E. PAVLOVICZ; D. J. CARPER; R. S.
COLEMAN; C. LI; R. T. BOYD; D. B. MCKAY. Ohio State
Univ., Ohio State Univ., Univ. of North Carolina, Ohio State
Univ., Ohio State Univ.
8:00 C14 336.13 Validation of a novel negative
allosteric site on human α4β2 nicotinic receptors. B.
J. HENDERSON*; R. E. PAVLOVICZ; T. GONZALEZ-
CESTARI; B. YI; C. LI; T. BOYD; D. B. MCKAY. The Ohio
State Univ., The Ohio State Univ., The Ohio State Univ.
9:00 C15 336.14 Novel allosteric modulators of nAChRs:
Discovery, structure-activity relationship studies, and
mechanism of action. B. YI*; T. F. GONZÁLEZ-CESTARI;
B. J. HENDERSON; M. L. DALEFIELD; R. E. PAVLOVICZ;
D. J. CARPER; R. S. COLEMAN; C. LI; R. T. BOYD; D. B.
MCKAY. The Ohio State Univ., The Ohio State Univ., Univ. of
North Carolina, The Ohio State Univ., The Ohio State Univ.
10:00 C16 336.15 Binding sites for galanthamine and
physostigmine in the Torpedo nicotinic acetylcholine receptor
extracellular domain. A. K. HAMOUDA*; J. B. COHEN.
Harvard Med. Sch.
11:00 C17 336.16 • Positional effects on function of
a6/3a4b2b3 nicotinic acetylcholine receptor (nAChR)
function. M. BHAKTA*; L. LUCERO; R. J. LUKAS; I.
BERMUDEZ; P. WHITEAKER. Barrow Neurolog. Inst.,
Oxford Brookes Univ.
14 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 C18 336.17 Construction of cell line heterologously
expressing the a6/3b2b3 nicotinic acetylcholine receptor
(nAChR) subtype. P. WHITEAKER*; L. LUCERO; R. J.
LUKAS; C. HEPLER; J. P. STRACHAN; S. LETCHWORTH.
St. Joseph’s Hosp, Targacept Inc.
9:00 C19 336.18 • Pharmacological fingerprints of
acetylcholine, nicotine and varenicline at neuronal nicotinic
acetylcholine receptor subtypes. S. VALERA; R. S. HURST*;
H. ROLLEMA; D. BERTRAND. HiQscreen, Pfizer Global
R&D, Rollema Biomed. Consulting.
10:00 C20 336.19 • Electrophysiological characterisation
of NS9283, a novel positive allosteric modulator of
alpha4beta2 nicotinic receptors. M. GRUPE*; M. GRUNNET;
J. K. CHRISTENSEN; P. K. AHRING; A. A. JENSEN.
Neurosearch, Univ. of Copenhagen.
11:00 C21 336.20 Behavioural effects of acute and repeated
administration of alpha7 nAChR agonist and positive
allosteric modulators; differential long-term effects. M. EL-
SAYED*; J. MIKKELSEN; M. THOMSEN. Neurobio. Res.
Unit, Copenhagen Univ. Hosp.
8:00 C22 336.21 Spillover of acetylcholine activates highaffinity
extrasynaptic nicotinic receptors at the motoneuron-
Renshaw cell synapse. B. LAMOTTE D’INCAMPS*; E.
KREJCI; P. ASCHER. Univ. Paris Descartes, Univ. Paris
Descartes, Univ. Paris Descartes.
9:00 C23 336.22 Modulation of human α4β2 nAChR
responses to acetylcholine with partial agonists. B.
EATON; J. LIU; H. ZHANG; L. YU; P. WHITEAKER; A. P.
KOZIKOWSKI; R. J. LUKAS*. Barrow Neurol Inst., Univ. of
Illinois at Chicago.
POSTER
337. GABA-A Receptor Structure
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 C24 337.01 Engineering a third functional domain
for a prokaryotic cys-loop receptor. R. GOYAL; A. A.
SALAHUDEEN; M. JANSEN*. TTUHSC, TTUHSC.
9:00 C25 337.02 • Investigating the subunit composition
of δ-containing GABA-A receptors. B. PATEL*; M.
MORTENSEN; T. G. SMART. Univ. Col. London.
10:00 C26 337.03 Two amino acid residues contribute to a
Cation-π Binding Interaction in the Binding Site of an insect
GABA receptor. S. C. LUMMIS*; I. MCGONIGLE; J. A.
ASHBY; D. A. DOUGHERTY. Univ. of Cambridge, CalTech.
11:00 C27 337.04 Assessment of the molecular actions of
carisoprodol on GABAA receptors. M. KUMAR*; M. KUMAR;
C. B. HORNER; G. H. DILLON. UNT Hlth. Sci. Ctr.
8:00 C28 337.05 A conserved phenylalanine residue
is important for GABA binding and efficacy at a synaptic,
but not an extrasynaptic, GABAA receptor subtype. B. G.
NILSSON; J. L. KOZUSKA*; S. M. J. DUNN. Univ. of Alberta.
9:00 C29 337.06 Threonine 244 determines the
pharmacology of S- and R-GABOB at GABA rho1 receptors.
I. YAMAMOTO*; N. GAVANDE; J. CARLAND; D. O’HAGAN;
G. A. R. JOHNSTON; J. R. HANRAHAN; M. CHEBIB. The
Univ. of Sydney, The Univ. of St Andrews.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
10:00 C30 337.07 � Differences in the structure of the
benzodiazepine binding site in different GABA-A receptor
isoforms. B. P. LÜSCHER*; R. BAUR; E. SIGEL. Inst. of
Biochem. and Mol. Medizin.
11:00 C31 337.08 Pharmacological profile of extrasynaptic
α 4 β 2 δ GABA A receptor. L. H. BANG; M. L. JENSEN*; N. R.
MIRZA. Neurosearch A/S, NeuroSearch.
8:00 C32 337.09 X-ray crystal structures, function and
pharmacology of a prokaryote GABA-A receptor. C. ULENS*;
R. SPURNY; J. RAMERSTORFER; K. PRICE; M. BRAMS;
M. ERNST; H. NURY; M. VERHEIJ; P. LEGRAND; D.
BERTRAND; S. BERTRAND; D. DOUGHERTY; I. DE ESCH;
P. CORRINGER; W. SIEGHART; S. LUMMIS. Kuleuven,
KULeuven, Med. Univ. Vienna, Univ. of Cambridge, Pasteur
Inst., Dept. of Medicinal Chem., SOLEIL Synchrotron,
HiQScreen, Caltech.
9:00 C33 337.10 Benzodiazepines modulate GABA-A
receptors by affecting a preactivation step. M. GIELEN*; T.
G. SMART. Univ. Col. London.
10:00 C34 337.11 Are the etomidate sites on GABA A
receptors equivalent? S. A. FORMAN*; G. GUITCHOUNTS;
D. STEWART. Massachusetts Gen. Hosp.
11:00 C35 337.12 Mapping anesthetic induced movements
in the prokaryotic ligand-gated ion channel GLIC. B.
GHOSH*; C. CZAJKOWSKI. Univ. of Wisconsin.
8:00 C36 337.13 Site-directed spin labeling electron
paramagnetic resonance spectroscopy reveals protoninduced
movement of loop 9 in GLIC. C. D. DELLISANTI*; J.
M. RASPANTI; V. A. GRANT; S. M. HANSON; B. GHOSH; C.
S. KLUG; C. CZAJKOWSKI. Univ. of Wisconsin - Madison,
Med. Col. of Wisconsin.
9:00 C37 337.14 A novel polymorphism linked to epilepsy
encoding a missense mutation in the pre-M1 region of α6
subunits alters the gating, but not trafficking, of GABAA
receptors. C. C. HERNANDEZ*; K. N. GURBA; N. HU; R. L.
MACDONALD. Vanderbilt Univ. Med. Ctr.
POSTER
338. GABA-A Receptor Trafficking
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 C38 338.01 Differential regulation of postsynaptic
gephyrin and GABA A receptor clustering by collybistin
isoforms. T. CHIOU*; B. BONHOMME; H. JIN; C. P.
MIRALLES; H. XIAO; Z. FU; R. J. HARVEY; K. HARVEY; S.
VICINI; A. L. DE BLAS. Univ. of Connecticut, Georgetown
Univ. Sch. of Med., The Sch. of Pharm.
9:00 C39 338.02 GABA chaperoning of GABA A receptors
in primary neuronal cultures. N. J. LEIDENHEIMER*; P.
WANG; R. S. ESHAQ. Louisiana State Univ. HSC, Louisiana
State Univ. HSC.
10:00 C40 338.03 Heterozygous loss of the epilepsyassociated
GABA A receptor α1 subunit increases the surface
expression of α3 subunit-containing GABA A receptors.
Z. HUANG; L. DING; C. D. FLANAGAN; R. PATEL; M. J.
GALLAGHER*. Vanderbilt Univ. Med. Sch.
Neuroscience 2011 | Monday AM | 15
Mon. AM

11:00 C41 338.04 Activation of mGluR5 reduces GABA
neurotransmission through PKCε mediated down regulation
of post-synaptic GABA A receptors. Z. QI*; T. MCMAHON; R.
O. MESSING. Ernest Gallo Clin. and Res. Center, Univ. of
California, San Francisco.
8:00 C42 338.05 • C-21191: Deuterated subtype-selective
GABA(A) modulator for spasticity and neuropathic pain. J.
F. LIU*; S. HARBESON; V. UTTAMSINGH; A. J. MORALES;
S. NGUYEN; G. BRIDSON; C. CHENG; L. BRADLEY; A.
ASLANIAN; L. WU; R. TUNG. Concert Pharmaceuticals,
Inc., Novartis Inst. for BioMedical Res.
9:00 C43 338.06 • Deuterated subtype-selective GABA(A)
modulators for cognition enhancement. S. L. HARBESON*;
J. F. LIU; V. UTTAMSINGH; S. NGUYEN; G. BRIDSON; L.
WU. Concert Pharmaceuticals.
10:00 C44 338.07 Ovarian cycle-related changes
in expression and function of extrasynaptic GABA-A
receptors in the hippocampus subfields. D. S. REDDY*; O.
GANGISETTY; X. WU. Texas A&M Hlth. Sci. Ctr.
11:00 C45 338.08 Neuroprotective effects of GABAergic
agents in the rat model of refractory status epilepticus. R.
KURUBA*; D. S. REDDY. Texas A & M Hlth. Sci. Ctr.
8:00 C46 338.09 miR-378 and miR 541 inhibit the
expression of the GABAA receptor alpha 5 subunit. A.
NAKAE*; K. NAKAI; T. TANAKA; Y. ISHIDA; A. MIKAMI; M.
YAMANAKA; S. HAGIHIRA; K. YANO; K. HOSOKAWA; T.
MASHIMO. Osaka Univ. Grad. Sch. of Med.
9:00 C47 338.10 Effects of Diazepam on GABAA receptor
dynamics. G. GOUZER*; C. SPECHT; A. TRILLER. IBENS.
10:00 C48 338.11 Benzodiazepines modulate GABA-A
receptor surface levels and synaptic inhibition. T. C. JACOB*;
G. MICHELS; L. SILAYEVA; J. HAYDON; S. MOSS. Univ. of
Pittsburgh,School of Med., Univ. of Cologne, Tufts Univ. Sch.
of Med.
11:00 C49 338.12 Cell surface expression of GABA A
receptors is controlled by a highly conserved extracellular
region adjacent to the first transmembrane domain of
the receptor subunits. C. HATCHETT; M. ZLOH; A. M.
THOMSON; F. STEPHENSON*; J. N. JOVANOVIC. Sch. of
Pharm. Univ. of London.
8:00 C50 338.13 Disrupting gamma-aminobutyric acid
alpha-2 subunit function models the cognitive symptoms of
schizophrenia. R. M. HINES*; D. J. HINES; T. G. SMART; S.
J. MOSS. Tufts Med., Tufts Med., Univ. Col. London.
POSTER
339. G-Protein-Linked Receptors: Muscarinic Receptors
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 D1 339.01 Phosphorylation of muscarinic receptor 4
by ERK is essential for receptor signaling. M. GUO*; D. JIN;
B. XUE; L. MAO; J. WANG. Univ. of Missouri-Kansas City.
9:00 D2 339.02 Morphine-induced locomotion increases
following viral transfection of M5 muscarinic receptor genes
in the ventromedial hypothalamus of mice. S. S. NAWAZ*;
A. BAHRI; S. A. JOSSELYN; A. RASHID; J. S. YEOMANS.
Univ. of Toronto, Hosp. for Sick Children Res. Inst., Univ. of
Toronto, Univ. of Toronto.
10:00 D3 339.03 • Muscarinic M 1 positive allosteric
modulators as potential target for the treatment of
Alzheimer’s disease and schizophrenia. A. M. BASSO*;
C. KLEIN; M. ZHANG; A. L. RELO; E. A. CRONIN; V. A.
RODERWALD; L. E. RUETER; K. M. WICKE; W. AMBERG;
M. SCHMIDT. Abbott Labs., Abbott GmbH & Co.KG.
11:00 D4 339.04 Localisation and function of muscarinic
receptors in murine tracheal neurons. B. SCHUETZ*; C.
RINGER; G. JOSITSCH; S. WIEGAND; P. HARTMANN; G.
KRASTEVA; C. NASSENSTEIN; J. WESS; E. WEIHE; W.
KUMMER. Philipps Univ., Justus-Liebig-University, Natl. Inst.
of Diabetes, Digestive and Kidney Dis.
8:00 D5 339.05 Modulatory actions of muscarinic agonists
on the intrinsic and synaptic properties of layer iii/iv auditory
cortical neurons. A. M. CRUZ-TORRES*; C. COX. Univ. of
Illinois at Urbana-Champaign.
9:00 D6 339.06 Characterization of M1-selective partial
agonists VU0364572 and VU0357017: Evidence for brain
region-specific electrophysiological and behavioral effects.
G. J. DIGBY*; T. J. UTLEY; W. G. ADAM; D. J. SHEFFLER;
E. J. HERMAN; Z. XIANG; H. C. PLUMBLEY; A. A. DAVIS;
N. E. BYUN; N. M. COLLEEN; J. K. CARRIE; C. W.
LINDSLEY; P. J. CONN. Vanderbilt Univ., Vanderbilt Univ.
10:00 D7 339.07 Muscarinic M2 receptor-positive
interneurons and the absence of cholinergic cells in the
hippocampus of C57BL/6J mice. S. L. STAUTBERG*; J.
BARRERA; A. LOPEZ; N. INOUE; A. A. ALCANTARA. Univ.
of Houston, Univ. of Houston, Univ. of Houston.
11:00 D8 339.08 Muscarinic receptor-induced
afterdepolarization persists despite individual TRPC
subunit deletions in the prefrontal cortex. P. TANAKA*; L.
BIRNBAUMER; R. ANDRADE. Wayne State Univ., Natl. Inst.
of Envrn. Hlth. Sci.
8:00 D9 339.09 • Design and development of M5
muscarinic antagonists for the treatment of drug abuse. W.
S. MESSER*, JR; A. MAHESHWARI; P. S. S. RAO; A. C.
KLEIN. Univ. Toledo, Univ. Toledo.
9:00 D10 339.10 Evaluation of benzyl quinolone
carboxylic acid on phosphorylation of CREB in mouse
brain regions using Alphascreen ® technology and focused
microwave irradiation. K. DE WAEPENAERT*; T. SMETS;
G. VANHOOF; J. ATACK. Janssen Res. and Development,
A Div. of Janssen Pharmaceutica NV, Janssen Res. &
Develop., Janssen Res. & Develop.
10:00 D11 339.11 • Identification and characterization
of a selective agonist and a selective positive allosteric
modulator of the m1 muscarinic acetylcholine receptor. Y.
G. SHANKER*; S. ALTMANN; D. ORTUNO; A. MUNZLI;
R. SCHWANDNER; L. SCHENKEL. Amgen, Amgen Res.
GmbH, Amgen.
11:00 D12 339.12 A C-terminal domain is involved in
the agonist-dependent downregulation of muscarinic M 1
receptors. A. THANGARAJU*; G. W. SAWYER. Oklahoma
State Univ. CHS.
8:00 D13 339.13 Unmasking allosteric modulation of
efficacy and determining agonist affinities for different active
conformations by removing the influence of receptor reserve
on muscarinic responses. E. STAHL; G. ELMSLIE; J.
ELLIS*. Penn State Univ.
9:00 D14 339.14 The unique binding site of the M1
muscarinic receptor selective allosteric potentiator, benzyl
quinolone carboxylic acid. L. MA*; C. KREATSOULAS; M. A.
JACOBSON; J. J. RENGER; W. J. RAY. Merck Res. Labs.,
Merck Res. Labs., Merck Res. Labs.
16 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

10:00 D15 339.15 Elucidation of M 5 -muscarinic receptor
neurophysiology in midbrain dopamine neurons using the
novel allosteric modulator VU0238429. D. J. FOSTER*; T.
M. BRIDGES; Z. XIANG; P. J. CONN. Vanderbilt Ctr. For
Neurosci. Drug Discovery.
11:00 D16 339.16 Structure-function relation of dexras1. A.
THAPLIYAL*; M. THAPLIYAL. Graphic Era Univ., RCU Govt.
PG Col.
POSTER
340. Serotonin Receptors
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 D17 340.01 Anterior-posterior gradient of 5-HT 1A
receptor expression in the human hippocampus. M.
BOLDRINI; Z. DONALDSON; M. J. BAKALIAN*; M.
PASQUALETTI; S. A. KASSIR; A. N. SANTIAGO; B.
SULLIVAN; M. D. UNDERWOOD; R. HEN; J. J. MANN; V.
ARANGO. NY State Psychiatric Inst., Columbia Univ., Univ.
of Florence, NY State Psychiatric Inst., Columbia Univ., NY
State Psychiatric Inst., Univ. of Pisa, NY State Psychiatric
Inst., Oberlin Col., Columbia Univ.
9:00 D18 340.02 • Approaches to the PET imaging of
activated 5-HT1a receptors. I. M. NEWINGTON; R. AHMAD;
H. BETTS; R. DAVIS; D. HISCOCK; J. S. D. KUMAR; J. J.
MANN; R. V. PARSEY*; S. PLANT; E. ROBINS; G. SMITH;
D. WYNN. GE Healthcare, Columbia Univ. Col. of Physicians
and Surgeons, Columbia Univ.
10:00 D19 340.03 Sumoylated 5-HT 1A receptors are located
in the endoplasmic reticulum: Possible role in regulation
of 5-HT 1A receptor maturation. Q. LI*; N. A. MUMA. Univ.
Kansas.
11:00 D20 340.04 Identifying the selective contribution of
5-HT1B autoreceptors to conditioned fear behaviors using
cell type-specific viral-mediated gene transfer. Y. LIU*; J. F.
NEUMAIER. Univ. of Washington.
8:00 D21 340.05 • A PET study with [ 11 C]AZ10419369
to determine5-HT 1B receptor occupancy of zolmitriptan
in healthy male volunteers. K. VARNÄS; A. JUCAITE;
D. J. MCCARTHY*; C. HALLDIN; L. FARDE; S. KANES.
Karolinska Institutet, AstraZeneza LP, AstraZeneza LP,
AstraZeneza LP.
9:00 D22 340.06 5-HT 1B receptors inhibit glutamate release
from primary afferent terminals in rat medullary dorsal horn
neurons. I. CHOI; J. CHO; M. LEE; I. JANG*. Kyungpook
Natl. Univ., Kyungpook Natl. University, Sch. of Med.
10:00 D23 340.07 Differential role of cannabinoid receptors
in the regulation of postsynaptic serotonin 2A (5-HT 2A )
and dopamine 2 (D 2 ) receptors in prefrontal cortex. G. A.
CARRASCO*; J. M. FRANKLIN. Univ. of Kansas.
11:00 D24 340.08 Cannabinoid 2 receptor agonists
upregulate serotonin 2A (5-HT 2A ) receptor activity via MAP
kinase signaling: Role of PKC. J. M. FRANKLIN*; G. A.
CARRASCO. Univ. of Kansas.
8:00 D25 340.09 In vivo assessment of [ 11 C]Cimbi-36 as a
5-HT 2A receptor agonist PET tracer. G. M. KNUDSEN*; W.
MUHAMMED; M. A. SANTINI; M. HANSEN; J. PAINE; M.
PALNER; S. HOLM; J. MADSEN; A. ETTRUP. Righospitalet,
Univ. of Copenhagen, Copenhagen Univ. Hospital,
Rigshospitalet.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 D26 340.10 Alterations of serotonin 2c and 2a
receptors in response to t10 spinal cord transection in
rats. S. DRACHEVA*; S. NAVARRETT; L. COLLIER; C.
CARDOZO. James J. Peters VA Med. Ctr., Mount Sinai Sch.
of Med., James J. Peters VA Med. Ctr., Mount Sinai Sch. of
Med.
10:00 D27 340.11 • Effects of 5-HT 2A/2C receptor on
cytoskeletal dynamics in the dendritic growth cone filopodia
of cortical neurons. A. OHTANI; F. LI; K. SENZAKI; T.
SHIGA*. Univ. of Tsukuba.
11:00 D28 340.12 The serotonin 5-HT5A receptor:
Its electrophysiological effects in prefrontal cortex
and compensatory plasticity in 5-HT5A-/- mice. N. M.
GOODFELLOW*; C. D. C. BAILEY; E. K. LAMBE. Univ.
Toronto, Univ. Toronto, Univ. Toronto.
8:00 D29 340.13 Physical and functional interaction
between human serotonin receptor 6 and Nova-1. H. RHIM*;
S. KIM; L. YOO; E. NOH; K. C. CHUNG; G. H. SON; K. KIM;
G. NAM. Korea Inst. Sci. Tech. (KIST), Yonsei Univ., Seoul
Natl. Univ.
9:00 D30 340.14 � The Role of 5-HT7/G12 signaling
pathway in developmental regulation of morpho- and
synaptogenesis in hippocampal neurons. D. GUSEVA*; F.
KOBE; U. RENNER; E. PONIMASKIN. Hannover Med. Sch.,
Dept. of Neuro- and Sensory Physiology, Univ. of Göttingen,
Ctr. for Mol. Physiol. of the Brain (CMPB), Med. Sch.
Hannover, Inst. of Neurophysiol.
10:00 D31 340.15 The zebrafish serotonin system. H.
SCHNEIDER*; V. MOCK; J. ABARR; J. BEHRENS; R.
EDELEN; B. EDWARDS; J. HOBGOOD; M. POGUE; N.
SINGH. Depauw Univ.
11:00 D32 340.16 Serotonin receptors in differentiated
primary rat brain astrocyte culture. K. K. PARKER*; B. HALL;
K. V. RAMA RAO; A. R. JAYAKUMAR; K. S. PANICKAR;
M. D. NORENBERG. Skaggs Schl Pharmacy,The Univ.
Montana, COBRE Ctr. for Structural and Functional
Neurosci., Univ. of Miami Miller Sch. of Med., U.S. Dept. of
Agr., Univ. of Miami Miller Sch. of Med. and VA Med. Ctr.
8:00 D33 340.17 Evidence for chronically reduced cortical
serotonin in human female recreational Ecstasy (MDMA)
users. R. L. COWAN*; C. R. DI IORIO; T. J. WATKINS; M.
S. DIETRICH; A. CAO; J. U. BLACKFORD; B. ROGERS;
M. S. ANSARI; R. M. BALDWIN; R. LI; R. M. KESSLER;
R. M. SALOMON; M. BENNINGFIELD. Vanderbilt Univ.
Sch. of Med., Vanderbilt Univ. Sch. of Nursing, Vanderbilt
Univ. Sch. of Med., Vanderbilt Univ. Sch. of Med., Inst. for
Neurodegenerative Disorders.
POSTER
341. G-Protein-Linked Receptors: Peptide and Opioid
Receptors
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 D34 341.01 Pituitary adenylate cyclase activating
polypeptide (PACAP) modulates ionotropic glutamatergic
signaling in hippocampal neurons through increased cell
surface expression of NR2B receptors. T. MUSTAFA*; L.
EIDEN. Natl. Inst. of Mental Hlth.
Neuroscience 2011 | Monday AM | 17
Mon. AM

9:00 D35 341.02 • Netupitant inhibition of substance-P
mediated responses in NG108-15 cells is enhanced by
palonosetron. C. ROJAS*; M. STATHIS; S. CANTOREGGI;
C. PIETRA; B. SLUSHER. Johns Hopkins Sch. of Med.,
Helsinn Healthcare SA.
10:00 D36 341.03 Dopamine-galanin receptor heteromers
modulate cholinergic neurotransmission in the rat ventral
hippocampus. N. CAI*; E. MORENO; S. H. VAZ; C.
FERRADA; C. QUIROZ; S. K. BARODIA; K. NADDINE; E.
I. CANELA; P. J. MCCORMICK; C. LLUIS; R. FRANCO; J.
A. RIBEIRO; A. M. SEBASTIÃO; S. FERRÉ*. NIDA/NIH, Ctr.
de Investigación Biomédica en Red sobre Enfermedades
Neurodegenerativas and Dept. of Biochem. and Mol.
Biology, Fac. of Biol., Inst. of Pharmacol. and Neurosciences
Fac. of Med., Krasnow Inst. for Advanced Study.
11:00 D37 341.04 Ultra-low concentrations of orexin A
inhibit depotentiation of synaptic transmission at Schaffer
Collateral-CA1 synapses in mouse hippocampal slices. G.
LU*; L. CHIOU. Col. of Medicine, Natl. Taiwan Univ., Col. of
Medicine, Natl. Taiwan Univ., Col. of Medicine, Natl. Taiwan
Univ.
8:00 D38 341.05 An oxytocin receptor gene polymorphism
found in autistic patients impairs receptor internalization and
signal transduction. W. MA; M. HASHII*; H. HIGASHIDA; S.
YOKOYAMA. Kanazawa Univ. Grad. Sch. of Med.
9:00 D39 341.06 Ca 2+ signals evoked by argininevasopressin
in non-neuronal cells from rat dorsal root
ganglia. T. MORIYA*; T. KAYANO; N. KITAMURA; Y.
HOSAKA; C. VIERO; E. C. TOESCU; G. DAYANITHI; I.
SHIBUYA. Dept. of Vet. Physiology, Fac. of Agriculture,
Tottori Univ., Dept. of Vet. Anatomy, Fac. of Agriculture,
Tottori Univ., Dept. of Cardiology, Wales Heart Res. Institute,
Sch. of Medicine, Cardiff Univ., Dept. of Neuropharm. and
Neurobiology, Sch. of Medicine, Birmingham Univ., Dept. of
Cell. Neurophysiology, Inst. of Exptl. Medicine, Acad. of Sci.
of the Czech Republic.
10:00 D40 341.07 Effects of Vasoactive intestinal peptide on
spontaneous firing rates of mouse suprachiasmatic nucleus.
T. KUDO; C. S. COLWELL*. UCLA.
11:00 D41 341.08 Delayed wound healing in mice
overexpressing opioid growth factor receptor (OGFr). P. J.
MCLAUGHLIN*; C. L. KEIPER; I. S. ZAGON. Penn State
Univ. Coll Med., Penn State Univ. Coll Med.
8:00 D42 341.09 PI3K/Akt responses to oxytocin
stimulation in Caco2BB gut cells. B. Y. KLEIN; H. TAMIR*;
M. G. WELCH. Columbia Univ. Col. of Physicians and
Surgeons, New York State Psychiatric Inst., New York State
Psychiatric Inst.
9:00 D43 341.10 Somatostatin receptor-4 and μ-Opioid
receptor interaction modulates receptor coupling, signaling
and excitatory postsynaptic currents. R. K. SOMVANSHI*; N.
CHAUDHARI; B. YANG; B. R. SASTRY; U. KUMAR. Univ. of
British Columbia, Univ. of British Columbia.
10:00 D44 341.11 Sex dependent heterodimerization of
mu and kappa opioid receptors and its mediation of femalespecific
morphine antinociception. S. CHAKRABARTI*;
N. LIU; A. GINTZLER. SUNY Downstate Med. Ctr., SUNY
Downstate Med. Ctr.
11:00 D45 341.12 Opioid Receptor Like-1 (ORL1)
intracellular trafficking and kinase signaling requires
c-terminal phosphorylation. W. PLANER; L. J. STICKLER;
N. ZHANG; T. PALMER; R. AL-HASANI; M. R. BRUCHAS*.
Washington Univ., Washington Univ. Sch. of Med.
8:00 D46 341.13 The role of G protein-coupled receptor
kinases (GRK) on the nociceptin-mediated desensitization of
NOP opioid receptors in rat stellate ganglion (SG) neurons.
V. RUIZ-VELASCO*; S. MAHMOUD; J. YUN. Penn State
Col. of Med., Penn State Col. of Med.
9:00 D47 341.14 Differential modulation of Ca 2+ channel
currents by μ and κ opioid receptors in dorsal root ganglion
neurons expressing EGFP under control of the Scn10A
promoter. B. HASSAN*; V. RUIZ-VELASCO. Penn State Col.
of Med.
10:00 D48 341.15 Human delta opioid receptors stimulate
AMP-activated protein kinase through coincident signaling
with G q/11 -coupled receptors. M. C. OLIANAS*; S. DEDONI;
P. ONALI. Univ. Cagliari.
11:00 D49 341.16 Towards the elucidation of the Gαβγ
heterotrimer involved in coupling of NOP receptors and Ca 2+
channels in rat stellate ganglion neurons. S. A. MAHMOUD*;
V. RUIZ-VELASCO; J. YUN. Penn State Univ. Col. of Med.,
Penn State Univ. Col. of Med.
8:00 D50 341.17 Modulation of the calcium current in the
vestibular primary afferent neurons by mu-opioid receptor
activation. E. SESEÑA MENDEZ*; E. SOTO; R. VEGA. Inst.
De Fisiologia, Univ. Autonoma De Puebla.
9:00 D51 341.18 Discovery of a novel alkaloid from
Corydalis yanhusuo W.T. Wang with pharmacological
activity at the mu opioid receptor and dopamine receptors.
Y. ZHANG*; C. WANG; G. PARKS; Z. WANG; X. ZHANG;
X. LIANG; O. CIVELLI. UC Irvine, Dalian Inst. of Chem.
Physics, Chinese Acad. of Sci.
10:00 D52 341.19 Differential activity of similar functionally
selective kappa antagonist in a Beta-arrestin recruitment
assay. E. J. BUTALA*; B. GILMOUR; F. I. CARROLL; H.
NAVARRO. RTI Intl., RTI Intl.
11:00 D53 341.20 Mapping and characterizing the 3’
untranslated region of MOR-1A, an alternatively spliced
variant of the mu opioid receptor gene, OPRM1. Z. LU*;
J. XU; G. W. PASTERNAK; Y. PAN. Mem. Sloan-Kettering
Cancer Ctr.
8:00 D54 341.21 Exploring roles of alternatively spliced
variants encoding proteins with single transmembrane
domain of the mu opioid receptor gene, OPRM1, in
modulating full-length mu opioid receptor (MOR-1)
expression and function. J. XU; M. XU; G. C. ROSSI; C.
E. INTURRISI; G. W. PASTERNAK; Y. PAN*. Mem Sloan
Kettering Cancer Ctr., CW Post College, Long Island Univ.,
Weill Cornell Med. Col.
9:00 D55 341.22 • OX2R activation induces transient
ERK phosphorylation and prolonged CREB phosphorylation
through protein kinase C. Y. GUO*; P. FENG. Cleveland VA
Med. Reseaarch Fndn., Case Western Reserve Univ.
10:00 D56 341.23 The mechanism of RGS4 interaction with
Mu opioid receptor and Gi. R. SANTHAPPAN*; T. E. COTE;
A. T. CROWDER. UNIFORMED SERVICES UNIVERSITY.
11:00 D57 341.24 Kappa-opioid receptor inhibition of
calcium oscillations in spinal cord neurons. T. F. MURRAY*;
L. KELAMANGALATH; J. GEORGE; S. DRAVID; J. V.
ALDRICH. Creighton Univ. Sch. Med., Univ. of Kansas.
8:00 D58 341.25 • Novel imaging of nociceptin/orphanin
FQ peptide receptors in brain and whole-body of humans
using a new positron emission tomography radioligand, [ 11 C]
NOP-1A. T. G. LOHITH; S. S. ZOGHBI; C. L. MORSE; V.
N. BARTH; N. A. GOEBL; J. TAUSCHER; V. W. PIKE; R.
B. INNIS*; M. FUJITA. NIH, NIMH, MIB, Eli Lilly & Co., NIH,
NIMH, MIB.
18 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 D59 341.26 Advancing the rhesus monkey model
for opioid research: Discovery of a novel nonsynonomous
variant in the kappa opioid receptor gene. G. M. MILLER*;
B. K. MADRAS; H. N. PANAS; D. M. PLATT; E. J.
VALLENDER. Harvard Med. School/Neprc.
10:00 D60 341.27 G protein receptor kinase 2-mediated
heterologous desensitization, a new mechanism of
mu-opioid receptor regulation by neuropeptide FF 2
receptor. L. MOULEDOUS*; C. FROMENT; A. SAUBION;
S. DAUVILLIER; O. BURLET-SCHILTZ; J. ZAJAC; C.
MOLLEREAU. CNRS; IPBS (Institut de Pharmacologie et de
Biologie Structurale), Univ. de Toulouse (UPS).
11:00 D61 341.28 Ivy and neurogliaform interneurons
are a major target of μ opioid receptor modulation in the
hippocampus. E. I. KROOK-MAGNUSON*; L. LU; S. LEE;
C. VARGA; I. SOLTESZ. Univ. of California, Irvine, Univ. of
California, Irvine.
POSTER
342. Transporters: Glutamate
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 D62 342.01 Phosphoinositide 3-kinases regulate
neuronal xCT expression and system xc- activity via
phosphorylation of eIF2α and regulation of ATF4. J.
LEWERENZ*; P. MAHER. Univ. Med. Ctr. Hamburg-
Eppendorf, Salk Inst. for Biol. Studies.
9:00 D63 342.02 Structural modeling of substrate binding
domains on the xCT subunit of the System xc- cystine/
glutamate exchanger. S. A. PATEL*; J. L. NEWELL; M.
BRADEN; J. M. GERDES; N. R. NATALE; R. J. BRIDGES.
Univ. Montana.
10:00 D64 342.03 Constitutive and regulated trafficking of
the cystine/glutamate exchange transporter, System xc− in
confluent cultured human glioma (U138MG) cells. N. R.
SCHILLER*; L. A. CHASE. Hope Col.
11:00 D65 342.04 � Oxidative stress causes modification
- and decreased function of system x . M. HARTWELL*; L. A.
c
CHASE. Hope Col., Hope Col.
- 8:00 D66 342.05 � Activation of system x trafficking via an
c
Akt-dependent signal transduction pathway. D. SMITH*; A.
HAMILTON; L. GREENE; D. HILL; L. A. CHASE. Hope Col.,
West Ottawa High Sch., Grandville Publ. High Sch., Holland
Publ. High Sch., Hope Col.
9:00 D67 342.06 � Characterization of C-terminal
motifs which may regulate the trafficking of System x c -. A.
GEORGES*; L. A. CHASE. Hope Col., Hope Col.
10:00 D68 342.07 Characterization of anti-nociception effect
of GLT-1 over-expression: Site of action and altered GluR1
trafficking. K. M. ROMAN*; R. L. STEPHENS, Jr. The Ohio
State Univ.
11:00 D69 342.08 Gpr30 regulates glt-1 and glast
expression in primary rat astrocytes. B. GRIFFIN; S.
CHORNYY; S. JAMES; M. SIDORYK; M. ASCHNER; E.
Y. LEE*. Meharry Med. Col., Vanderbilt Univ. Med. Ctr.,
Meharry Med. Col.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
8:00 D70 342.09 Interactions between GLAST, the Na+/
K+ ATPase, and mitochondria: Potential implications
for astroglial glutamate metabolism. D. BAUER*; J. G.
JACKSON; E. N. KRIZMAN-GENDA; M. M. MONTOYA;
C. GERAGOSIAN; M. B. ROBINSON. Children’s Hosp. of
Philadelphia.
9:00 D71 342.10 The contribution of the glutamate
transporter GLT-1 expressed in neurons to synaptosomal
uptake of glutamate. G. T. PETR; N. M. FREDERICK; G.
CORFAS*; C. J. AOKI; P. A. ROSENBERG. Children’s Hosp.
Boston, Children’s Hosp. and Harvard Med. Sch., New York
Univ.
10:00 D72 342.11 Sulfasalazine injection does not
affect mouse behavior in a spontaneous alternation or
rotarod task. E. LANGER*; T. PARK; M. RAGOZZINO; D.
FEATHERSTONE. Univ. of Illinois Chicago.
11:00 E1 342.12 Quantification and localization of the
EAAC1 glutamate transporter in brain. N. C. DANBOLT*;
S. HOLMSETH; Y. DEHNES; Y. H. HUANG; V. FOLLIN-
ARBELET; N. J. GRUTLE; Y. ZHOU; C. PLACHEZ; D. N.
FURNESS; D. E. BERGLES; K. P. LEHRE. Univ. of Oslo,
Johns Hopkins Univ. Sch. of Med., Univ. of Maryland, Sch. of
Med., Keele Univ.
8:00 E2 342.13 EAAC1 protein expression is increased
in the rat hippocampus during water maze learning. A. I.
FRATICELLI*; K. J. THOMPSON. Ponce Sch. of Med., Univ.
of Puerto Rico.
9:00 E3 342.14 Specificity and actions of benzylaspartate
inhibitors of glutamate transport at the Schaffer collateral-
CA1 pyramidal cell synapse. W. SUN; K. M. HOFFMAN; D.
C. HOLLEY; C. S. ESSLINGER; M. P. KAVANAUGH*. Univ.
of Montana.
10:00 E4 342.15 Characterization of glutamate
transporters in the rat locus coeruleus. M. C. MEDRANO;
A. MENDIGUREN*; I. GERRIKAGOITIA; L. MARTINEZ-
MILLAN; J. PINEDA. Univ. Basque Country, Univ. Basque
Country, Univ. Basque Country.
11:00 E5 342.16 A conserved positive charge in TM7 of
glutamate transporters: Critical role in coupling between
substrate transport and anion channel activation. D.
TORRES-SALAZAR*; J. JIANG; S. G. AMARA. Univ. of
Pittsburgh.
8:00 E6 342.17 Amphetamine mediated internalization of
the excitatory amino acid transporter 3. S. M. UNDERHILL*;
D. S. WHEELER; S. G. AMARA. Univ. Pittsburgh, Univ. of
PIttsburgh.
9:00 E7 342.18 Astrocytic PARP-1 regulates glutamate
transporter levels via NF-kB in thiamine deficiency. S. S.
JHALA*; A. S. HAZELL. Univ. of Montreal.
10:00 E8 342.19 Possible connection between TSAinduced
glial cell differentiation and glutamate transporter
gene expression. K. MORITA*; M. ITOH; C. KUNIMI; N.
NISHIBORI; T. SAGARA; S. HER. Shikoku Univ. Sch. Hlth.
Sci., Shikoku Univ. Sch. of Hlth. Sci., Shikoku Junior Col.,
Korea Basic Sci. Institute,.
11:00 E9 342.20 Regulation of glutamate transport by runt
related transcription factor-2 in astrocytes. T. TAKARADA*;
K. FUJIKAWA; Y. YONEDA. Kanazawa Univ.
8:00 E10 342.21 The sodium-driven chloride/bicarbonate
exchanger NDCBE in excitatory presynaptic terminals. A. C.
BURETTE*; R. J. WEINBERG; P. SASSANI; N. ABULADZE;
L. KAO; I. KURTZ. Univ. of North Carolina, UCLA.
Neuroscience 2011 | Monday AM | 19
Mon. AM

9:00 E11 342.22 Bergmann glia plasticity: Glutamatedependent
glast down regulation. L. G. GARCIA*;
Z. MARTÍNEZ-LOZADA; C. HERNÁNDEZ-KELLY;
J. AGUILERA; A. ORTEGA*. CINVESTAV, Inst. de
Neurosciènces i Departament de Bioquímica i Biología Mol.
10:00 E12 342.23 Role of Na,K-ATPase isoforms for
intracellular sodium concentration and rate of glutamate
activated sodium-coupled transport in astrocytes. N. B.
ILLARIONOVA; S. ZELENIN; A. APERIA; E. GUNNARSON*.
Karolinska Institutet.
11:00 E13 342.24 Raloxifene neuroprotection by increased
glutamate transporter expression in astrocytes. S. L.
JAMES*; B. GRIFFIN; S. CHORNYY; L. EUN-SOOK.
Meharry Med. Col.
8:00 E14 342.25 Evaluation of glutamate transporter
EAAT2 translational activators in a mouse model of epilepsy.
Q. KONG*; D. SCHULTE; L. CHANG; G. D. CUNY; M. A.
GLICKSMAN; X. XING; C. G. LIN. The Ohio State University,
Dept. of Neurosci., Brigham & Women’s Hospital, Harvard
Med. Sch.
9:00 E15 342.26 Evaluation of glutamate transporter
EAAT2 translational activators in a mouse model of ALS. C.
G. LIN*; Q. KONG; L. CHANG; B. IBABAO; D. SCHULTE; L.
LAI; Y. LIN; K. TAKAHASHI; G. CUNY; M. GLICKSMAN; X.
XING. Ohio State Univ., Brigham & Women’s Hosp.
POSTER
343. Transporters: Monoamine
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 E16 343.01 Proteomic analysis of an interactome for
ssri-sensitive serotonin transporters. R. YE*; R. BLAKELY.
Vanderbilt Univ. Med. Ctr., Vanderbilt Univ. Med. Ctr.
9:00 E17 343.02 Single-molecule analysis of dopamine
transporter trafficking using ligand-conjugated quantum
dots. O. KOVTUN; I. D. TOMLINSON; D. SAKRIKAR; J. C.
CHANG; R. D. BLAKELY*; S. J. ROSENTHAL. Vanderbilt
Univ., Vanderbilt Univ., Vanderbilt Univ. Sch. Med. Ctr. Molec
Neurosci, Vanderbilt Univ. Sch. Med. Ctr. Molec Neurosci.
10:00 E18 343.03 Accelerated recycling and anomalous
amphetamine regulation of a novel ADHD-associated
dopamine transporter coding variant. D. SAKRIKAR*; M.
S. MAZEI-ROBISON; L. R. MILLER; M. A. MERGY; P. J.
HAMILTON; A. GALLI; M. GILL; R. D. BLAKELY. Vanderbilt
Univ., Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.,
Trinity Col., Vanderbilt Univ.
11:00 E19 343.04 Native immune system regulation of the
brain serotonin transporter. C. ZHU*; K. M. LINDLER; N. L.
BAGANZ; D. SAKRIKAR1; W. A. HEWLETT; E. DENERIS;
R. D. BLAKELY. Vanderbilt Univ., Vanderbilt Univ., Case
Western Reserve Univ., Vanderbilt Univ.
8:00 E20 343.05 A mouse model of ADHD derived from
the human dopamine transporter variant Ala559Val: Initial
characterization. M. A. MERGY*; T. N. JESSEN; J. WRIGHT;
C. S. ORAVEC; P. GRESCH; G. STANWOOD; A. GALLI; R.
D. BLAKELY. Vanderbilt Univ.
9:00 E21 343.06 Who DAT? a forward genetic screen
for presynaptic regulators of dopamine homeostasis. J.
A. HARDAWAY*, III; S. M. WHITAKER; S. R. BAAS; S. L.
HARDIE; D. B. FLAHERTY; R. D. BLAKELY. Vanderbilt
Univ., The Kinkaid Sch., Eckerd Col.
10:00 E22 343.07 Exploring mechanisms of amphetamine
action in intact Drosophila brain. M. S. SONDERS*; Z. Z.
FREYBERG; J. FLORES; A. CHEN; G. HU; H. FEI; B. D.
MCCABE; D. E. KRANTZ; D. SAMES; D. SULZER; J. A.
JAVITCH. Columbia Univ., Columbia Univ., Columbia Univ.,
UCLA, Columbia Univ., Suzhou Inst. of Nano-Tech and
Nano-Bionics, UCLA.
11:00 E23 343.08 Norepinephrine transporter A457P
knockin mouse: A model of a gene variant associated with
comorbid cardiovascular and psychiatric disorders. R. KLAR;
J. K. SHIREY-RICE; J. J. KRUEGER; N. M. WALLACE; M.
APPALSAMY; C. FINNEY; S. LONCE; A. DIEDRICH; D. H.
ROBERTSON; M. K. HAHN*. Vanderbilt Univ. Sch. of Med.,
Vanderbilt Univ. Sch. of Med., Vanderbilt Univ. Sch. of Med.
8:00 E24 343.09 Individual differences in impulsive
action and impulsive choice associated with dopamine and
serotonin transporter function in rat medial prefrontal and
orbitofrontal cortex. M. DARNA*; J. YATES; M. T. BARDO; L.
P. DWOSKIN. Univ. of Kentucky, Univ. of Kentucky.
9:00 E25 343.10 Amphetamine actions rely on the
availability of phosphatidylinositol-4,5-bisphosphate.
F. BUCHMAYER; K. SCHICKER; G. STÜBIGER; P. J.
HAMILTON; T. STEINKELLNER; H. J. MATTHIES; T.
MONTGOMERY; M. WINKLER; J. YANG; M. HOLY; G. F.
ECKER; A. GALLI; V. BOCHKOV; S. BOEHM; H. H. SITTE*.
Med. Univ. Vienna, Vanderbilt Univ., Univ. of Vienna.
10:00 E26 343.11 Acute administration of MDMA and
oral tryptophan supplement induces parallel changes in
serotonin levels in blood and brain tissue. J. M. ELLIOTT*;
S. PATTERSON; A. KIBRIA. De Montfort Univ.
11:00 E27 343.12 Comparison of serotonin transporter
function between human platelets and immortalized
lymphoblastoid cells. M. A. JAVORS*; N. HILL-
KAPTURCZAK; C. MATHIAS; D. RICHARD; P. TIAN; D.
GALINDO; D. DOUGHERTY. Univ. Texas Hlth. Sci. Ctr.,
Univ. of Texas HSC, Univ. of Texas HSC.
8:00 E28 343.13 Development of a real time, spatially
resolved fluorescent assay for vesicular packaging of
monoamines. A. I. BERNSTEIN*; K. A. STOUT; G. W.
MILLER. Emory Univ.
9:00 E29 343.14 A conserved asparagine in the first
transmembrane domain of the human serotonin transporter
is critical for cation selectivity in serotonin transport. B.
FELTS*; N. BURBACH; L. K. HENRY. Univ. of North Dakota
Sch. of Med.
10:00 E30 343.15 Stress-induced increase in serotonin
reuptake is kappa opioid receptor and p38alpha MAPK
mediated and underlies prodepressive and proaddictive
responses. A. G. SCHINDLER*; H. SHANKAR; D. I.
MESSINGER; M. MIYATAKE; R. M. GUSTIN; C. E. HAGAN;
J. F. NEUMAIER; C. CHAVKIN. Univ. of Washington.
11:00 E31 343.16 Linking Akt, monoamine transport
regulation, and mechanisms of abnormal behavior in the
neuronal Rictor null mouse. M. SIUTA*; O. DADALKO;
A. POE; I. REDDY; K. NIESNER; R. VAUGHAN; K.
NISWENDER; H. MATTHIES; A. GALLI. Vanderbilt Univ.,
Vanderbilt Univ., Univ. of North Dakota, Vanderbilt Univ.
20 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 E32 343.17 Ambient pressure ion mobility mass
spectrometry (AP-IMMS) of targeted and global metabolomic
changes following acute administration of cocaine. V. M.
CHIU*; K. A. KAPLAN; P. A. LUKUS; X. ZHANG; W. F.
SIEMS; J. O. SCHENK; H. H. HILL, Jr. Washington State
Univ.
9:00 E33 343.18 Transport activity of human VMAT1
variants. A. M. KHALIFA; A. WATSON-SIRIBOE; W. CHIU;
M. E. NELSON; S. SHUKRY; K. J. FISCHER-STENGER*;
J. K. STEWART. Virginia Commonwealth Univ., Univ. of
Richmond.
10:00 E34 343.19 Examination of phosphorylated tau
and other neurodegenerative markers in different brain
regions of aged serotonin transporter knockout mice. A. R.
BLACKLER*; R. L. FRIED; D. L. MURPHY. Natl. Inst. of
Mental Hlth.
11:00 E35 343.20 Serotonin transporter mediated regulation
of catecholamine release from adrenal chromaffin cells. R. L.
BRINDLEY; M. L. JEWELL; R. D. BLAKELY; K. P. CURRIE*.
Vanderbilt Univ. Sch. of Med., Vanderbilt Univ. Sch. of Med.
8:00 E36 343.21 • Functional in vivo validation of the lowaffinity
allosteric binding site on hSERT for escitalopram
using humanized mice. J. P. JACOBSEN*; P. PLENGE; W.
ROBERTS; A. PHERSON; B. SACHS; Y. DU; X. ZHANG; H.
ZHONG; C. M. SANCHEZ; M. G. CARON. Duke Univ., Univ.
of Copenhagen, Lundbeck USA.
9:00 E37 343.22 Internalization and degradation of the
serotonin transporter (SERT) in rats chronically treated with
fluoxetine. M. RIAD; L. DESCARRIES*. Univ. de Montréal,
Univ. de Montréal.
10:00 E38 343.23 Effects of corticosterone on the
expression of dopamine β-hydroxylase and behavior in rats.
Y. FAN*; P. CHEN; Y. LI; D. NOEL; R. BROWN; M. ZHU.
East Tennessee State Univ.
11:00 F1 343.24 Glucocorticoids induce NET expression
in SK-N-BE(2)M17 cells: Role of the glucocorticoid receptor
and C/EBP-β. M. ZHU*; Q. ZHA; Y. WANG. East Tennessee
State Universit.
8:00 F2 343.25 Decynium-22, an organic cation
transporter 3 blocker, inhibits serotonin uptake in
hippocampus and exerts antidepressant-like effects in mice.
D. M. APPLE*; S. A. CANO; R. E. HORTON; M. VITELA;
W. KOEK; L. C. DAWS. Univ. of Texas Hlth. Sci. Ctr. San
Antonio, Univ. of Texas Hlth. Sci. Ctr. San Antonio.
9:00 G1 343.26 Sert-ainly slower: Reduced sert
expression and function in the flinders sensitive line (fsl) rat
model of depression. W. A. OWENS*; D. AGUILAR; D. H.
OVERSTREET; L. C. DAWS. UT Hlth. Sci. Ctr-SA, Univ. of
North Carolina-Chapel Hill.
10:00 G2 343.27 High-fat and DAT: Implications of a
high-fat diet for the neurochemical and locomotor effects of
cocaine in adolescent and adult rats. R. E. HORTON*; W. A.
OWENS; M. G. BALADI; C. P. FRANCE; L. C. DAWS. UT
Hlth. Sci. Ctr. SA, UT Hlth. Sci. Ctr. SA.
11:00 G3 343.28 TAAR1 signaling links to both cAMP/PKA
and PKC/Ca ++ pathways and differentially regulates DAT and
NET internalization in brain. Z. XIE*; G. M. MILLER. Harvard
Med. School/NEPRC.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
344. Transporters: Dopamine
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 G4 344.01 � Dopamine transporter knock-in mice
expressing a disrupted PDZ-binding motif display D 2 receptor
down-regulation, attenuated cocaine response, and increased
motor endurance. P. HERRSTEDT HANSEN*; G. SØRENSEN;
P. WEIKOP; M. RICKHAG; K. NØRGAARD-STRANDFELT;
G. WÖRTWEIN; D. WOLDBYE; U. GETHER. Lab. of
Neuropsychiatry, Mol. Neuropharm. Group, Protein Lab.
9:00 G5 344.02 Axonal targeting of DAT is independent
of the PDZ-domain protein PICK1 while synaptic distribution
is dependent on PDZ-domain interactions in vivo. M.
RICKHAG*; G. SØRENSEN; K. NØRGAARD-STRANDFELT;
B. ANDRESEN; K. GOTFRYD; E. FÜCHTBAUER; J.
GOMEZA; G. WÖRTWEIN; D. WOLDBYE; U. GETHER.
Mol. Neuropharm Group, Dept. of Neurosci & Pharmacol,
Univ. of Copenhagen, Dept. of Mol. Biology, Aarhus Univ.,
Inst. for Pharmaceut. Biology, Univ. of Bonn, Dept. of
Neurosci. and Pharmacology, Univ. of Copenhagen.
10:00 G6 344.03 Visualization of norepinephrine
transporter in cultured sympathetic neurons by use of a
fluorescent cocaine analogue: Constitutive internalization
and postendocytic sorting. A. VUORENPÄÄ*; J. ERIKSEN;
T. NYGAARD JØRGENSEN; A. NEWMAN; M. SCHEININ;
U. GETHER. Univ. of Copenhagen, Inst. of Biomedicine,
Univ. of Turku, Natl. Inst. on Drug Abuse.
11:00 G7 344.04 • Cellular mechanism underlying the
dopamine D3 receptor regulation on dopamine transporter.
P. CHANG*; J. CHEN. Chang-Gung University/ Grad.
Insititute of Biomed. Sci.
8:00 G8 344.05 Nomifensine has differential effects on
evoked dopamine dynamics in striatal subdomains. I. M.
TAYLOR*; A. C. MICHAEL. Univ. of Pittsburgh.
9:00 G9 344.06 Imaging of dopamine transporter
movement and endocytosis in epitope-tagged dopamine
transporter knock-in mice. A. RAO*; T. L. RICHARDS; D. L.
SIMMONS; N. R. ZAHNISER; A. SORKIN. Univ. of Colorado,
Denver, Univ. of Pittsburgh Sch. of Med.
10:00 G10 344.07 Characterization of the interaction
between the dopamine transporter and DJ-1. B. LUK*; M.
MOHAMMED; F. LIU; F. J. S. LEE. Simon Fraser Univ., Ctr.
for Addiction and Mental Hlth.
11:00 G11 344.08 • Substitution for discriminative
stimulus effect of cocaine requires concurrently attenuated
dopaminergic and adrenergic reuptake activities. H. CHEN*.
Caliper Life Sci.
8:00 G12 344.09 In vivo analysis of sequences required
for synaptic localization of the presynaptic dopamine
transporter. S. BAAS*; J. A. HARDAWAY; S. HARDIE;
S. WHITAKER; R. BLAKELY. Vanderbilt Univ. Med. Ctr.,
Vanderbilt Univ. Med. Ctr., Vanderbilt Univ. Med. Ctr.
9:00 H1 344.10 Maternal separation affects dopamine
transporter function in the Spontaneously Hypertensive
Rat: An in vivo electrochemical study. J. S. WOMERSLEY*;
J. H. HSIEH; L. A. KELLAWAY; G. A. GERHARDT; V. A.
RUSSELL. Univ. of Cape Town, Univ. of Kentucky.
Neuroscience 2011 | Monday AM | 21
Mon. AM

10:00 H2 344.11 • Glucagon-like peptide-1 (GLP-1)
regulates the dopamine transporter in the striatum by a
signaling mechanism mediated by nitric oxide synthase. K.
ERREGER*; A. R. DAVIS; S. D. ROBERTSON; E. E. WATT;
K. A. ROGERS; H. J. G. MATTHIES; C. SAUNDERS; R. A.
VAUGHAN; A. R. WEST; N. H. GREIG; K. D. NISWENDER;
A. GALLI. Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.,
Univ. of North Dakota, Rosalind Franklin Univ., NIA.
11:00 H3 344.12 Membrane insertion and targeting
of the dopamine transporter and dopamine D2 receptor
analyzed by total internal reflection fluorescence
microscopy. T. RAHBEK-CLEMMENSEN*; J. ERIKSEN;
T. N. JØRGENSEN; S. CHRISTENSEN; D. STAMOU;
U. GETHER. Univ. of Copenhagen, Berkeley, Univ. of
California.
8:00 H4 344.13 Membrane potential: A novel regulator
of dopamine transporter trafficking. J. M. SWANT*; H.
KHOSHBOUEI. Meharry Med. Col.
9:00 H5 344.14 Mechanisms of reverse transport by the
dopamine transporter. L. J. WALLACE*. Ohio State Univ.
10:00 H6 344.15 • Computational docking of the
cocaine-like MFZ 2-24 photoaffinity ligand to the dopamine
transporter using RosettaLigand. B. SHARMA; P. AKULA
BALA; R. ACHARYA; J. D. FOSTER; S. NOSKOV; A. H.
NEWMAN; R. VAUGHAN; L. K. HENRY*. Univ. North
Dakota, Univ. North Dakota, Univ. of Calgary, NIH-NIDA.
11:00 H7 344.16 Reciprocal phosphorylation and
palmitoylation of the dopamine transporter regulate transport
capacity. A. E. MORITZ*; J. D. FOSTER; R. A. VAUGHAN.
Univ. N Dakota Sch. Med. & Hlth. Sci.
8:00 H8 344.17 Mapping the attachment site of covalently
bound cocaine analog, [ 125 I]-MFZ-2-24, to the dopamine
transporter. R. ACHARYA*; B. SHARMA; P. AKULA BALA; J.
R. LEVER; M. ZOU; A. H. NEWMAN; J. D. FOSTER; L. K.
HENRY; R. A. VAUGHAN. Univ. N Dakota Sch. Med. & Hlth.
Sci., Univ. N Dakota Sch. Med. & Hlth. Sci., Univ. of Missouri,
Natl. Inst. on Drug Abuse-Intramural Res. Program.
9:00 H9 344.18 Phosphorylation of dopamine transporter
threonine 53 in rat striatal tissue detected using a
phosphospecific antibody. J. D. FOSTER*; A. E. MORITZ; M.
A. SMITH; S. CHALLASIVAKANAKA; K. J. WILEBSKI; B. K.
GORENTLA; R. A. VAUGHAN. Univ. of North Dakota Sch.
Med. & Hlth. Sci.
10:00 H10 344.19 Heterotrimeric G-betagamma subunits
regulates Dopamine Transporter function through direct
interactions. J. GARCIA-OLIVARES*; D. TORRES-
SALAZAR; T. B. BAUST; J. ZHU; S. G. AMARA; G. E.
TORRES. Univ. of Pittsburgh, Univ. of South Carolina.
11:00 H11 344.20 Regulation of dopamine transporter
function by Y335. J. ZHEN; M. E. REITH*. New York Univ.
Schl Med.
POSTER
345. Modulation of Synaptic Transmission: Peptides and
Amines
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 H12 345.01 Chronic cocaine prevents CRF and
Urocortin I-induced depression of GABA B receptor-mediated
synaptic current in the lateral septum. J. LIU*; J. P.
GALLAGHER. Columbia Univ., The Univ. of Texas Med. Br.
9:00 I1 345.02 Selective serotonergic excitation of
callosal-projection pyramidal neurons in the adult mouse
prefrontal cortex. D. AVESAR*; A. T. GULLEDGE. Dartmouth
Med. Sch.
10:00 I2 345.03 Rapid regulation of dopamine release
by endogenous dynorphin and kappa opioid receptors in
nucleus accumbens shell, but not dorsal striatum. J. C.
PATEL*. NYU Sch. of Med.
11:00 I3 345.04 Effects of increasing tyrosine availability
on in vivo dopamine synthesis in the striatum and prefrontal
cortex of the rat. Z. BRODNIK; R. BONGIOVANNI; M. B.
DOUBLE; G. E. JASKIW*. Louis Stokes Cleveland VAMC,
Case Western Reserve Univ.
8:00 I4 345.05 Dopaminergic modulation of excitatory
synaptic transmission in layer II of the lateral entorhinal
cortex. I. GLOVACI*; D. A. CARUANA; C. A. CHAPMAN. Ctr.
For Studies In Behavioral Neurobiology, Concordia Univ.,
Natl. Inst. of Envrn. Hlth. Sci.
9:00 I5 345.06 In vivo, fast-scan cyclic voltammetry
comparison between dopamine and 5-ht synthesis,
packaging, release, uptake and metabolism. P. HASHEMI*;
K. M. WOOD; P. TAKMAKOV; R. LAMA; J. LITTLE; R. M.
WIGHTMAN. UNC at Chapel Hill.
10:00 I6 345.07 Comparison of the membrane
permeability of trace amines to monoamine
neurotransmitters. M. R. SHITUT; B. TOMBERLI; M. D.
BERRY*. Univ. of Saskatchewan, Brandon Univ., Brandon
Univ.
11:00 I7 345.08 Modulation of glutamatergic synaptic
transmission in prefrontal cortex by 5-HT2A receptors. C.
BECAMEL*; A. BARRE; J. BOCKAERT; P. MARIN. Inst. of
Functional Genomic.
8:00 I8 345.09 � Noradrenergic neurons of the A5 region
play a role on hypoxic ventilatory response in unanesthetized
rats. C. L. TAXINI*; K. BÍCEGO; A. TAKAKURA; T.
MOREIRA; L. GARGAGLIONI. Unesp, USP, USP.
9:00 I9 345.10 Spontaneous spiking and synaptic
depression underlie noradrenergic control of feed-forward
inhibition. S. P. KUO*; L. O. TRUSSELL. Oregon Hlth. and
Sci. Univ.
10:00 I10 345.11 Neurotensin induces endocannabinoidmediated
inhibition of glutamate transmission onto ventral
tegmental area dopamine neurons. C. KORTLEVEN*; L.
BRUNEAU; L. TRUDEAU. Univ. de Montreal.
11:00 I11 345.12 Properties of glutamate release from
dopaminergic terminals in the nucleus accumbens. M. F.
ADROVER; J. SHIN*; V. A. ALVAREZ. NIAAA/NIH.
22 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 I12 345.13 � Peptidergic modulation of synaptic
inhibitory transmission in CA1 pyramidal cells and activity
of inhibitory interneurons. V. G. SKREBITSKY*; R. V.
KONDRATENKO; I. S. POVAROV; V. I. DEREVYAGIN. Ctr.
of Neurol.
9:00 J1 345.14 • Atrial natriuretic peptide inhibits
presynaptic neurotransmitter release in the habenulointerpeduncular
pathway. F. HU*; J. REN; M. LUO. Natl. Inst.
of Biol. Sciences, Beijing (NIBS, Beijing).
10:00 J2 345.15 Orexin-A inhibits NMDA receptormediated
excitatory synaptic transmission at hippocampal
mossy fibers: Time-of-day dependence. M. PERIN*; F.
LONGORDO; A. LUTHI. DBCM-UNIL, JCSMR-ANU.
11:00 K1 345.16 A new family of AMPA receptor
associated membrane proteins in vertebrates. W. TANG*; A.
GROSS; P. H. SEEBURG; R. SPRENGEL. Max Planck Inst.
For Med. Res.
8:00 K2 345.17 • � Localization and utilization of
N-acetylaspartylglutamate as a neurotransmitter at the
lizard neuromuscular junction. K. K. WALDER*; S. RYAN; T.
BZDEGA; R. OLSZEWSKI; J. H. NEALE; C. A. LINDGREN.
Grinnell Col., Georgetown Univ.
9:00 K3 345.18 Novel opioid receptor signaling
mechanism changes GABAA receptor function in ventral
tegmental area neurons following stress. E. B. MARGOLIS*;
G. O. HJELMSTAD; J. M. MITCHELL; H. L. FIELDS. Ernest
Gallo Clin. & Resch Ctr., Univ. of California, San Francisco.
10:00 K4 345.19 Subtype-specific activation of
interneurons by oxytocin modulates hippocampal circuitry. S.
F. OWEN*; R. W. TSIEN. Stanford Univ.
11:00 K5 345.20 Pituitary adenylate cyclase-activating
polypeptide (PACAP) potentiates excitatory synaptic
transmission from the basolateral to the central nucleus of
the amygdala. J. CHO*; E. G. MELONI; V. Y. BOLSHAKOV.
McLean Hosp, Harvard Med. Sch.
8:00 K6 345.21 • Neuropeptide y modulates gabaergic
inhibition in the basolateral amygdala via the y 2 receptor.
J. P. MACKAY*; H. B. SILVEIRA; W. F. COLMERS; J. H.
URBAN. Universty of Alberta, Univ. of Alberta, Chicago Med.
School/Rosalind Franklin Univ.
9:00 K7 345.22 Characterization of genetically identified
striatonigral and striatopallidal medium spiny neurons in
primary corticostriatal co-cultures. R. LALCHANDANI*; J. G.
PARTRIDGE; M. J. JANSSEN; S. VICINI. Georgetown Univ.,
Georgetown Univ.
10:00 K8 345.23 The α7 nicotinic acetylcholine receptor
(nAChR) allosteric modulator UCI-40083 differentially
increases dopamine (DA) and norepinephrine (NE)
release in adolescent rat brain. E. CARBONI*; M. IBBA; R.
CADEDDU; D. HOGENKAMP; T. JOHNSTONE; K. W. GEE.
Univ. Cagliari, Univ. California Irvine.
POSTER
346. Modulation of Synaptic Transmission: Amino Acids
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 K9 346.01 • In vitro testing of PH084 as a potential
anticonvulsant agent. S. B. KOMBIAN*; O. A. PHILLIPS.
Kuwait Univ., Kuwait Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 K10 346.02 � Modulation of synaptic transmission
in the nucleus accumbens by the relapse preventing
drug acamprosate. E. PERSSON; J. TERSMEDEN; B.
SÖDERPALM; M. ERICSON*; L. ADERMARK. Neurosci.
and Physiol.
10:00 K11 346.03 Glutamate metabolism in a model
of prenatal restraint stress in rats. E. ADROVER; M. R.
KATUNAR; M. E. PALLARES; C. J. BAIER; K. K. MADSEN;
H. S. WAAGEPETERSEN; A. SCHOUSBOE; M. C.
ANTONELLI*. IQUIFIB, Facultad de Farmacia y Bioquímica-
UBA, Fac. of Pharmaceut. Sci. Univ. of Copenhagen.
11:00 K12 346.04 Synaptic characterization and function
of neurogliaform cells in layer IV of barrel cortex. R.
CHITTAJALLU*; K. A. PELKEY; J. T. R. ISAAC; C. J.
MCBAIN. NIH, Eli Lilly UK.
8:00 L1 346.05 Presynaptic NMDA receptors modulate
glutamate release in the dorsal motor nucleus of the vagus in
normal and diabetic mice. E. C. BACH*; B. N. SMITH. Univ.
of Kentucky.
9:00 L2 346.06 • The slow dissociative and noncompetitive
GlyT1 inhibitors produce the excessive elevation
of CSF glycine concentration and respiratory dysfunction
in mice. T. AOKI*; M. KOTANI; J. KARASAWA; S. CHAKI.
Taisho Pharmaceut. Co., Ltd.
10:00 L3 346.07 Aversive stimuli inhibit mouse dopamine
neurons in the ventral tegmental area by excitation of
local interneurons. K. TAN*; C. YVON; J. DÖHNER; C.
LÜSCHER. Univ. of Geneva, university of Zurich.
11:00 L4 346.08 Microglial activation mediate LPS-induced
excitation of hypothalamic paraventricular nucleus neurons
projecting to rostroventrolateral medulla in rats. T. HAN; H.
LEE; E. KANG; S. LEE; P. RYU*. Seoul Natl. Univ.
8:00 L5 346.09 • Periadolescent facilitation of NMDAdependent
synaptic function in the prefrontal cortex: role
of protein kinase A and NR2B-containing receptors. K.
TSENG*; N. SIMAK; A. CABALLERO; L. HENG. RFUMS/
Chicago Med. Schl.
9:00 L6 346.10 • Diurnal recordings of second-by-second
measurements of tonic and phasic glutamate release in the
prefrontal cortex of awake rats using microelectrode arrays.
C. E. MATTINSON*; J. E. QUINTERO; F. POMERLEAU; P.
HUETTL; G. A. GERHARDT. Univ. of Kentucky.
10:00 L7 346.11 NMDA receptor activation impairs
synaptic GABA A receptor function. M. CHISARI*; C. F.
ZORUMSKI; S. MENNERICK. Washington Univ., Univ. of
Catania, Washington Univ.
11:00 L8 346.12 Gene delivery of the clostridial tetanus
toxin light chain inhibits neural activity in rats. C. R. HANDY*;
C. KRUDY; C. HIRSCHBERG; B. ADADE; E. DONNELLY; D.
O’CONNOR; T. FEDERICI; N. BOULIS. Emory Univ.
8:00 L9 346.13 In utero exposure to cocaine impairs
postnatal synaptic maturation of glutamatergic transmission
in the VTA. C. BELLONE*; M. MAMELI; C. LÜSCHER. Univ.
of Geneva.
Neuroscience 2011 | Monday AM | 23
Mon. AM

POSTER
347. Synaptic Plasticity: Long-Term Depression I
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 L10 347.01 • Identification of thorase interacting
molecular network in vivo. J. ZHANG*; H. KANG; Y. PAI;
S. BYRNE; M. J. KEUSS; L. A. GINOCCHIO; Z. CHI; D. A.
SWING; L. TESSAROLLO; T. M. DAWSON; V. L. DAWSON.
Inst. For Cell Engineering, Johns Hopkins Univ., Johns
Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch. of
Med., Johns Hopkins Univ., Johns Hopkins Univ., Neural
Develop. Section, Natl. Cancer Inst., Johns Hopkins Univ.
Sch. of Med.
9:00 L11 347.02 The JAK/STAT pathway is involved
in synaptic plasticity. C. S. NICOLAS*; S. PEINEAU; Z.
CSABA; M. AMICI; L. HILDEBRANDT; A. FAFOURI; G.
SEATON; S. CHOI; S. SIM; C. BRADLEY; M. ZHUO; B.
KAANG; P. GRESSENS; P. DOURNAUD; S. M. FITZJOHN;
Z. A. BORTOLOTTO; K. CHO; G. L. COLLINGRIDGE. MRC
Ctr. For Synaptic Plasticity, Inserm U676, Dept. of Brain and
Cognitive Sci.
10:00 L12 347.03 Presenilin/gamma-secretase activity
is critical for mGluR-dependent long term depression
at hippocampal CA3-CA1 excitatory synapses. M. J.
GERTNER*; R. S. ZUKIN. Albert Einstein Col. of Med.
11:00 M1 347.04 • Group I metabotropic glutamate
receptors play different roles on synaptic plasticity in the
rat basolateral amygdala. H. LI*; M. JIA; S. SMERIN; L.
ZHANG. Psychiatry/USUHS, U.S.U.H.S.
8:00 M2 347.05 LTD deficit in alpha 7 neuronal nicotinic
receptor (alpha7*) knockout mice is strain dependent. R.
K. FREUND*; S. L. GRAW; K. FLOYD; S. LEONARD; M.
L. DELL’ACQUA. Univ. Colorado, Denver, Univ. Colorado,
Denver, Veterans Affairs Med. Res. Service.
9:00 M3 347.06 Sleep-deprivation induced alterations
in GABA-B and mGlu receptor expression, and LTD of the
EPSP in rat hippocampus. R. TADAVARTY; P. S. RAJPUT;
J. M. WONG; U. KUMAR; B. SASTRY*. The Univ. of British
Columbia, The Univ. of British Columbia, Univ. British
Columbia Fac Med.
10:00 M4 347.07 Structural characterization of PICK1 PDZ
domain-peptide interactions for targeted drug design. M.
A. RATHJE*; S. ERLENDSSON; P. O. HEIDARSSON; M.
ANDERSEN; S. ANDERSEN; A. BACH; K. L. MADSEN; K.
STRØMGAARD; F. M. POULSEN; U. GETHER. Dept. of
Neurosci. and Pharmacol., Univ. of Copenhagen, Univ. of
Copenhagen.
11:00 M5 347.08 Scribble1 controls learning and memory
via an LTD-dependent mechanism. M. HILAL; M. M.
MOREAU; N. PIGUEL; R. RACHEL; S. WARMING; Y.
ADABA; T. PAPOUIN; C. MEDINA; R. ERWIN-COHEN;
L. TESSAROLLO; M. KOEHL; N. G. COPELAND; N. A.
JENKINS; D. N. ABROUS; C. RACCA; S. H. OLIET; M.
MONTCOUQUIOL; N. A. SANS*. INSERM - U862, Natl.
Cancer Institute-Frederick, INSERM, INSERM, Newcastle
Univ.
8:00 M6 347.09 The involvement of SUMOylation in
regulation of long term depression. E. ASHIKAGA; S.
KANTAMNENI; J. M. HENLEY*. Univ. Bristol Med. Sch.
9:00 M7 347.10 Glutamate transporters and metabotropic
glutamate receptors co-modulate LTD at the mossy fiber
hippocampal synapse. F. MATOS-OCASIO*; J. PORTER; K.
J. THOMPSON. Ponce Sch. of Med. and Hlth. Sci.
10:00 M8 347.11 Calcineurin is required for TRPV1mediated
LTD in the hippocampus. T. D. JENSEN*; J. G.
EDWARDS. Brigham Young Univ.
11:00 M9 347.12 Cell-wide long-lasting depression
induced by action potentials firing in the absence of synaptic
activity as a cellular model for memory de-stabilization. O.
BUKALO*; P. R. LEE; R. D. FIELDS. NIH.
8:00 M10 347.13 PI3Kgamma is required for NMDARdependent
long-term depression and behavioral flexibility. H.
LEE*; J. KIM; S. SIM; J. BAEK; N. YU; J. CHOI; S. PARK;
S. AN; S. CHOI; Y. LEE; D. JANG; K. KIM; K. LEE; C. A.
BRADLEY; H. KIM; E. KIM; M. ZHUO; S. KIM; P. H. BACKX;
G. L. COLLINGRIDGE; B. KAANG. Natl. Creative Res.
Initiative Ctr. For Memory, Dept. of Physiol., Dept. of Anat.,
Dept. of Physiol., Dept. of Brain and Cognitive Sci., Natl.
Creative Res. Initiative Ctr. for Synaptogenesis, MRC Ctr. for
Synaptic Plasticity.
9:00 M11 347.14 CaMKII-dependent phosphorylation of
GluK5 increases mobility of KARs and mediates spike-timing
dependent synaptic depression. M. CARTA; P. OPAZO; J.
VERAN; D. CHOQUET; F. COUSSEN; C. MULLE*. IINS,
CNRS, Univ. Bordeaux, CNRS, Univ. Bordeaux.
10:00 M12 347.15 Insulin age-dependently modulates
synaptic transmission and AMPAR trafficking in the rat
hippocampus. S. A. WRIGHTEN*; G. PIROLI; L. REAGAN;
D. MOTT. Univ. South Carolina, Sch. of Med.
11:00 N1 347.16 Opposite dysregulation of synaptic
protein synthesis and plasticity in fragile X syndrome and
Tuberous Sclerosis. E. K. OSTERWEIL*; B. D. AUERBACH;
D. D. KRUEGER; K. REINHOLD; M. F. BEAR. MIT.
8:00 N2 347.17 Altered NMDAR-function during the
labile phase of experience-dependent plasticity in sensory
neocortex. J. A. WEN*; A. L. BARTH. Carnegie Mellon Uni,
Ctr. for the Neural Basis of Cognition.
POSTER
348. Synaptic Plasticity: Spike-Timing Dependent
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 N3 348.01 • Synaptic plasticity responses at different
converging pathways onto individual neurons in mouse
visual cortex. O. M. FITCH*; M. J. FRIEDLANDER. Virginia
Tech. Carilion Res. Inst., Baylor Col. of Med.
9:00 N4 348.02 • Role of internal IP 3 receptors and
ryanodine receptors in synaptic plasticity induction in visual
cortex. D. KALIKULOV*; M. J. FRIEDLANDER. Virginia
Tech. Carilion Res. Inst.
10:00 N5 348.03 GABA operates as a Hebbian/anti-
Hebbian switch for spike-timing-dependent plasticity. E.
FINO*; V. PAILLE; K. DU; T. MORERA HERRERAS; J.
HELLGREN KOTALESKI; L. VENANCE. Columbia Univ.,
Col. de france, Stockholm Brain Institute, Karolinska Inst.
24 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 N6 348.04 � Sub-second induction unveils a switch
from NMDA- to endocannabinoid-LTP. L. VENANCE*; Y.
CUI; V. PAILLE; B. DELORD; S. GENET; H. BERRY. Ctr. For
Interdisciplinary Res. In Biol. (INSERM 1050/CNRS 7241),
Univ. Pierre et Marie Curie, INRIA.
8:00 N7 348.05 Neocortical spike timing-dependent
depression requires astrocyte mediated retrograde signaling.
R. MIN*; T. NEVIAN. Univ. of Berne.
9:00 N8 348.06 Dopamine-dependent STDP at
corticostriatal synapses modulates firing patterns in medium
spiny neurons. D. A. PETERSON*; T. J. SEJNOWSKI. Inst.
for Neural Comput, UCSD, Salk Inst. for Biol. Studies, Inst.
for Neural Computation, UCSD.
10:00 N9 348.07 Induced plasticity of intrinsic excitability
differs between normal and epileptic rats. E. BICHLER; M.
BENVENISTE*. Morehouse Sch. of Med.
11:00 N10 348.08 Axonal locus of induction of t-LTD
demonstrated by compartment-specific photorelease of a
use-dependent NMDA receptor antagonist. A. RODRIGUEZ-
MORENO*; M. M. KOHL; J. E. REEVE; T. R. EATON; H. A.
COLLINS; H. L. ANDERSON; O. PAULSEN. Univ. Pablo de
Olavide, Univ. of Oxford, Univ. of Cambridge.
8:00 N11 348.09 Dopamine D1-type receptors modulate
spike-timing-dependent potentiation at medial perforant pathgranule
cell synapses. K. YANG*; T. ZHANG; J. DANI. Baylor
Col. of Med.
9:00 N12 348.10 Repeated cocaine exposure lowers
the induction threshold and disrupts dopaminergic gating
of associative synaptic plasticity in prefrontal circuitry. H.
RUAN*; T. XU; W. YAO. New England Primate Res. Center,
Harvard Med. Sch.
10:00 O1 348.11 Involvement of brain-derived neurotrophic
factor in Spike Timing-Dependent Plasticity in the CA1 region
of the hippocampus. E. EDELMANN*; V. LESSMANN. Ottovon-Guericke
Univ.
11:00 O2 348.12 Acetylcholine modulation on STDP in
CA1 region of hippocampus. E. SUGISAKI*; Y. FUKUSHIMA;
M. TSUKADA; T. AIHARA. Tamagawa Univ. Grad. Sch. of
Engin., Brain Sci. Institute, Tamagawa Univ., Kawasaki Univ.
of medical welfare.
8:00 O3 348.13 Subthreshold mossy fiber input can
trigger synaptic plasticity between CA3 pyramidal cells. F.
BRANDALISE; U. GERBER*. Univ. of Zurich, Univ. of Zurich.
9:00 O4 348.14 At immature mossy fiber-CA3 synapses,
spike-time dependent depression requires the activation
of CB1 receptors. M. D. CAIATI; S. SIVAKUMARAN; F.
LANORE; C. MULLE; G. MARSICANO; E. CHERUBINI*.
SISSA, Interdisciplinary Inst. for Neuroscience, CNRS UMR
5297, INSERM U862 NeuroCentre Magendie.
10:00 O5 348.15 Problem solving using rewarded STDP.
S. SKORHEIM; P. LONJERS; M. V. BAZHENOV*. Univ.
California, Riverside.
11:00 O6 348.16 Robustness of “memory” to paroxysmal
activity in simulations of model neurons. Y. ZHENG*; G.
BARMASHENKO; T. KIRSCHSTEIN; R. KÖHLING; L.
SCHWABE. Inst. of Computer Sci., Inst. of Physiol.
8:00 O7 348.17 Balancing feed-forward excitation and
inhibition via Hebbian inhibitory synaptic plasticity. Y. LUZ; M.
SHAMIR*. Ben-Gurion Univ.
9:00 O8 348.18 Dynamic filter properties of adaptive spike
timing-dependent plasticity. C. ALBERS; J. T. SCHMIEDT; K.
PAWELZIK*. Univ. Bremen, Univ. Bremen.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
349. Neural Oscillators
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 O9 349.01 Bistability of silence and seizure-like
bursting. W. H. BARNETT*; G. O’BRIEN; G. CYMBALYUK.
Georgia State Univ., Agnes Scott Col., Georgia State Univ.
9:00 O10 349.02 Inhibitory synaptic input locationdependence
of the control of spike timing during thetafrequency
oscillation in hippocampal CA1 pyramidal neuron:
A NEURON model study. S. PARK*; J. KWAG. Korea Univ.
10:00 O11 349.03 Pacemaker rate and depolarization block
in dopamine neurons depend differently upon the density
and spatial distribution of sodium channels. K. R. TUCKER*;
M. A. HUERTAS; J. P. HORN; C. C. CANAVIER; E. S.
LEVITAN. Univ. of Pittsburgh, Louisiana State Univ. Hlth. Sci.
Ctr., Univ. of Pittsburgh.
11:00 O12 349.04 Effects of dopamine on electrical
resonance properties of mouse layer 5 pyramidal neurons.
M. P. THOMAS*; J. ERICKSON. Univ. Northern Colorado,
Univ. of Northern Colorado.
8:00 P1 349.05 A computational conductance-based
model that reproduce theta resonance dynamics in olfactory
amygdala neurons. U. PEREIRA; J. VERA; M. PEZZOLI; J.
BACIGALUPO; M. SANHUEZA*. Univ. de Chile, Biol. Dept
and ICDB Institute, Univ. Chile, Biology, Fac Sci, Univ. Chile.
9:00 P2 349.06 Sub and supra-threshold dynamics
of resonant neurons in the olfactory amygdala. J.
VERA; U. PEREIRA; M. PEZZOLI; R. A. DELGADO*; J.
BACIGALUPO; M. SANHUEZA. Univ. of Chile, Biol. Dept.,
ICDB Institute, Univ. of Chile.
10:00 P3 349.07 Degradation of chondroitin sulfate
proteoglycans in an invertebrate central pattern generator
alters homeostatic maintenance of rhythmic activity. A. E.
HUDSON*; A. A. PRINZ. Biology, Emory Univ., Georgia Inst.
of Technol.
POSTER
350. APP/Abeta: Animal Models III
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 P4 350.01 Amyloid β injections block learning
in the larval zebrafish. P. KETTUNEN*; J. SUNDELL; H.
ZETTERBERG. Inst. of Neurosci. and Physiology, Univ. of
Gothenburg.
9:00 P5 350.02 Assessing the role of amyloidBeta in
Alzheimer’s using the 5XFAD and TgSwDI transgenic
mice. W. XU; M. E. ANDERSON; M. PREVITI; F. XU; J. K.
ROBINSON*; W. E. VAN NOSTRAND. SUNY Stony Book.
10:00 P6 350.03 A diet enriched with grapes alters the
pattern of cortical amyloid beta deposition in a mouse model
of Alzheimer’s disease. N. MISTRY*; V. POP; J. BADAUT; R.
E. HARTMAN. Loma Linda Univ., Loma Linda Univ., Loma
Linda Univ.
Neuroscience 2011 | Monday AM | 25
Mon. AM

11:00 P7 350.04 Roles for heme oxygenase (HO) in
Alzheimer’s disease: A triple transgenic/HO2 knockout
mouse model. T. W. SEDLAK*; E. VERHEYEN; A. V.
SERRITELLA; M. MESSMER; J. HARRISON; M. MATTSON;
S. SNYDER. Johns Hopkins, Quinnipiac Univ., Univ. of
Pennsylvania.
8:00 P8 350.05 Aberrant adult neurogenesis in a novel
rat model of Alzheimer’s disease. K. P. REZAI-ZADEH*; J.
J. BREUNIG; A. RENTSENDORJ; D. GATE; R. M. COHEN;
T. TOWN. Regenerative Med. Institute, Cedars-Sinai Med.
Ctr., Cedars-Sinai Med. Center/UCLA, Regenerative Med.
Institute, Cedars-Sinai Med. Center/UCLA.
9:00 P9 350.06 Amyloid deposition and advanced
age are insufficient to induce progression of disease in
double knock in mouse model of Alzheimer’s disease. G.
H. MALTHANKAR-PHATAK*; Y. LIN; N. GIOVANNONE; R.
SIMAN. Univ. Pennsylvania, Ctr. for Brain Injury and Repair,
Univ. of Pennsylvania.
10:00 P10 350.07 Reductions in 2AG levels and
enhanced coupling of cannabinoid receptors in the
striatum are accompanied by cognitive impairments in the
APPswe/PS1ΔE9 mouse model of Alzheimer’s disease.
N. MAROOF*; M. C. PARDON; D. A. BARRETT; D. A.
KENDALL. Univ. of Nottingham.
11:00 P11 350.08 the investigation of neprilysin methylation
on Alzheimer’s disease mouse. K. CHEN*; C. HU; C.
HSU. Shih Kong Wu Ho-Su Mem. Hosp., Taipei Med. Univ.
Shuang-Ho Hosp., China Med. Univ.
8:00 P12 350.09 The cellular activity of neural stem cells
in the human neurogenic niche in Alzheimer’s disease. A.
CHOU*; J. ROSKAMS. Univ. of British Columbia.
9:00 Q1 350.10 S100 ablation reverses the effects of
mercury and injury on AD pathology. E. A. ROLTSCH*; S.
SCHELLENBURG; J. WELSH; L. ABBOTT; L. HOLCOMB;
D. ZIMMER. Texas A & M Univ., Texas A&M Hlth. Sci. Ctr.,
The Ctr. for Biomolecular Therapeutics, Dept. of Biochem.
and Mol. Biology, Univ. of Maryland Sch. of Med.
10:00 Q2 350.11 Serotonergic blockade prevents
age-related neurodegeneration in C. elegans model of
Alzheimer’s disease. J. T. PIERCE-SHIMOMURA*; A.
CRISP. Univ. Texas, Austin.
11:00 R1 350.12 Identifying partners in the APL-1 pathway
and their implications for APP in Alzheimer’s disease. A.
ALEXANDER; C. LI*. Grad. Center, City Univ. of New York,
City Col. New York.
8:00 R2 350.13 Neuroinflammatory changes over the
disease time course in TgCRND8 mouse model of AD. K.
MA*; H. T. J. MOUNT; J. MCLAURIN. Univ. of Toronto, Univ.
of Toronto.
9:00 R3 350.14 � Strain-dependent neurotoxicity of the
tetracycline transactivator. H. J. HAN*; C. C. ALLEN; C. T.
NEAL; H. A. BORN; M. A. MARIN; M. J. YETMAN; S. P.
RODGERS; C. LJUNGBERG; H. LU; J. L. JANKOWSKY.
Baylor Col. of Med., Rice Univ., Baylor Col. of Med., Texas
Children’s Hosp., Baylor Col. of Med., Baylor Col. of Med.,
Baylor Col. of Med.
10:00 R4 350.15 Rat model of sporadic Alzheimer’s
disease induced by streptozotocin: Cell death, autophagy
and calcium signalling investigation. L. RODRIGUES*; R.
URESHINO; K. OSEKI; C. A. GONÇALVES; S. S. SMAILI.
Federal Univ. of São Paulo, Federal Univ. of Rio Grande do
Sul.
11:00 R5 350.16 IGF-II receptor and lysosomal enzymes
in transgenic mice overexpressing APP in the absence of
NPC1 protein. Y. WANG*; M. MAULIK; B. GHOSHAL; S.
KAR. Univ. of Alberta, Ctr. for Prions and Protein Folding
Disease, Univ. of Alberta, Dept. of Neuroscience, Univ.
of Alberta, Dept. of Psychiatry, Univ. of Alberta, Dept. of
Psychiatry and Dept. of Medicine, Univ. of Alberta.
8:00 R6 350.17 Age- and sex- dependant changes in
general activity, anxiety, motor ability and visuo-spatial
learning and memory in the 5XFAD mouse model of
Alzheimer’s disease. T. P. O’LEARY*; H. M. MANTOLINO;
L. D. HESTERMANN; K. R. STOVER; R. E. BROWN.
Dalhousie Univ.
9:00 R7 350.18 Reduced blood-brain barrier glucose
transport is a multi-factorial injurious stimulus for
acceleration of Alzheimer’s disease-related neurovascular
dysfunction. E. WINKLER*; Y. NISHIDA; R. BELL; J.
SENGILLO; R. DEANE; B. ZLOKOVIC. Univ. of Rochester.
10:00 R8 350.19 A single tyrosine residue in the amyloid
precursor protein (APP) intracellular domain regulates
amyloidogenic APP processing in vivo and is essential
for its function in memory and development. A. P. M.
BARBAGALLO*; R. TAMAYEV; Z. WANG; H. ZHENG; L.
D’ADAMIO. Albert Einstein Col. of Med., Baylor Col. of Med.
11:00 R9 350.20 Small ischemic infarcts increase Aβ
deposition in C57BL/6J mice. T. VAN GROEN*; I. KADISH.
Univ. Alabama-Birmingham.
8:00 R10 350.21 Age-related differences in Alzheimer-type
neuropathology in brains of double and triple transgenic
mice. K. F. MANAYE*; A. DREW; G. XU; Y. SHARMA; B.
ZHI; P. MOUTON; R. S. TURNER. Howard Univ. Col. Med.,
Univ. of South Florida Sch. of Med., Georgetown Univ. Hosp.
9:00 R11 350.22 Chronic administration of simvastatin
does not alter Abeta production/accumulation, but helps
preserve synaptic plasticity in a mouse model of Alzheimer’s
disease. C. P. METAIS; A. MABLY; D. M. WALSH; C. E.
HERRON*, Dr. Univ. Col. Dublin, Univ. Col. Dublin.
POSTER
351. Tau: Animal Models II
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 R12 351.01 Inflammatory processes in the THY-
Tau22 model of AD-like Tau pathology. C. LAURENT*; A.
LEBOUCHER; L. TROQUIER; Y. MONNET; S. BURNOUF;
M. FIGEAC; R. CAILLIEREZ; N. ZOMMER; D. DEMEYER;
M. HAMDANE; S. SCHRAEN-MASCHKE; S. HUNOT; L.
BUEE; D. BLUM. Inserm U837, Inserm/UMPC UMR 975,
UDSL, IMPRT.
9:00 S1 351.02 Overexpression of human tau results
in reduced neurogenesis in the adult mouse brain. Y.
KOMURO*; B. T. LAMB. Lerner Res. Inst. Cleveland Clin.
Fndtn.
10:00 S2 351.03 Repetitive behavior and salience network
dysfunction in a mouse model of frontotemporal dementia.
B. A. WARMUS*; D. R. SEKAR; G. D. SCHELLENBERG; E.
D. ROBERSON. Univ. of Alabama at Birmingham, Univ. of
Alabama at Birmingham, Univ. of Pennsylvania Sch. of Med.
26 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 S3 351.04 • Altered intrinsic properties and
resonance in CA1 pyramidal neurons of a transgenic model
of tauopathy. C. BOOTH*; J. NOWACKI; K. TSANEVA-
ATANASOVA; J. T. BROWN; A. RANDALL. Univ. of Bristol,
Univ. of Bristol.
8:00 S4 351.05 • Age-dependent changes in spatial
novelty preference and locomotor activity in rTg4510 P301L
mice. S. M. LOTARSKI*; P. STOLYAR; K. A. SERPA; M. M.
ZALESKA. Pfizer Global R & D.
9:00 S5 351.06 Effect of long-term exercise in a
transgenic mouse model of Alzheimer’s disease. O. OHIA;
H. POURZARGHAM; M. J. KURZ; Y. LAU; J. ERIKSEN*.
Univ. of Houston, Univ. of Nebraska Med. Ctr.
10:00 S6 351.07 P301S mutant human tau transgenic
mice manifest early symptoms of human tauopathies with
dementia and altered sensorimotor gating. H. TAKEUCHI*;
M. IBA; H. INOUE; M. HIGUCHI; K. TAKAO; K. TSUKITA;
Y. KARATSU; Y. IWAMOTO; T. MIYAKAWA; T. SUHARA;
J. Q. TROJANOWSKI; V. M. -. LEE; R. TAKAHASHI. Dept.
of Neurology, Grad. Sch. of Medicine, Kyoto Univ., Ctr. for
Neurodegenerative Dis. Research, Inst. on Aging and Dept.
of Pathology and Lab. Medicine, Univ. of Pennsylvania Sch.
of Med., Ctr. for iPS Cell Res. and Application (CiRA), Kyoto
Univ., Core Res. for Evolutional Sci. and Technol. (CREST),
Japan Sci. and Technol. Agency, Mol. Imaging Center, Natl.
Inst. of Radiological Sci., Section for Behavior Patterns, Ctr.
for Genet. Analysis of Behavior, Natl. Inst. for Physiological
Sci., Div. of Systems Med. Science, Inst. for Comprehensive
Med. Science, Fujita Hlth. Univ.
11:00 S7 351.08 Calcium dysregulation in a mouse model
of tauopathy (rTg4510). K. J. KOPEIKINA*; R. PITSTICK;
G. CARLSON; B. J. BACKSAI; T. L. SPIRES-JONES; B.
T. HYMAN. Boston Univ. Sch. of Med., MassGeneral Inst.
for Neurodegenerative Dis. at Massachusetts Gen. Hosp.,
McLaughlin Res. Inst., Harvard Med. Sch.
8:00 S8 351.09 Interaction between the ubiquitin
proteasome system, autophagy and progressive tauopathy
in vivo. N. MYEKU*; W. YU; K. E. K. DUFF. Columbia Univ.
9:00 S9 351.10 Chromatin damage threatens
NFT bearing neurons in 3xtg AD mouse model. I. A.
HERNANDEZ MORENO*; M. E. CORNWELL; X. ZHANG;
D. FEDOROV; B. S. MANJUNATH; K. S. KOSIK. UCSB,
UCSB.
10:00 S10 351.11 • Altered intrinsic and synaptic properties
of medial prefrontal cortex pyramidal neurons in a transgenic
mouse model of tauopathy. M. KURIHARA*; A. RANDALL; J.
T. BROWN. Univ. of Bristol.
11:00 S11 351.12 Early synaptic dysfunction in the rtg4510
mouse model of tauopathy. A. B. JORGENSEN*; L. G.
JENSEN; H. S. JENSEN; N. DALBY; C. VOLBRACHT. H.
Lundbeck A/S.
8:00 S12 351.13 � Long-term overexpression of heme
oxygenase 1 promotes tau aggregation in mouse brain
by activating cdk5 pathway. Y. HUI*; D. WANG; X. GAO*.
Harbin Med. Univ.
9:00 T1 351.14 Pathophysiological consequences of dietinduced
obesity in the THY-Tau22 transgenic mouse model
of Alzheimer’s disease-like Tau pathology. A. LEBOUCHER*;
C. LAURENT; F. FERNANDEZ-GOMEZ; S. BURNOUF; L.
TROQUIER; I. BRION; D. DEMEYER; R. CAILLIEREZ; N.
ZOMMER; K. BANTUBUNGI; C. BRETON; B. STAELS; M.
HAMDANE; P. PIGNY; A. MUHR-TAILLEUX; L. BUEE; D.
BLUM. Inserm U837, Inserm U1011, UPRES-EA, USTL.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
10:00 T2 351.15 • The role of TDP-43 in the pathogenesis
in the neurodegenerative disease. K. J. TSAI*; Y. LIU; I.
WANG. Natl. Cheng Kung University, Inst. of Clin. Med.
11:00 T3 351.16 • Preclinical studies using silencing
ofCDK5 in wild type and triple transgenic Alzheimer mice.
J. CASTRO-ALVAREZ; K. S. KOSIK; G. P. CARDONA
GOMEZ*. Univ. of Antioquia, Univ. of California, Univ.
Antioquia.
8:00 T4 351.17 • Neuropil destruction and learning
deficits in adult mice after tau P301L gene transfer. F.
STRIGGOW*; T. G. A. MACK; A. HIRCHE; D. MONTAG; W.
SCHMIDT. German Ctr. for Neurodegenerative Dis. (DZNE),
Translational Ctr. for Regenerative Med. (TRM), Leibniz Inst.
for Neurobio. (LIN).
9:00 T5 351.18 • Examination of nest construction
in rTg4510 mice as a functional outcome indicator for
evaluating potential drugs in Alzheimer’s disease. C. C.
HSU*; C. GONZALES; R. ROOF; Y. CHEN; S. LIANG; K.
PAUMIER; M. ZALESKA. Pfizer, Inc.
10:00 T6 351.19 • Deficits in Arc and Fos expression
in a tauopathy transgenic mouse model. D. M.
BARTEN*; L. YANG; G. W. CADELINA; L. B. DECARR;
S. SANKARANARAYANAN; C. M. CONWAY; M. K.
AHLIJANIAN; C. F. ALBRIGHT. Bristol-Myers Squibb, Bristol-
Myers Squibb.
11:00 T7 351.20 Blue cheese/Alfy affects autophagy
activation and tau toxicity in a Drosophila model of
tauopathy. M. F. BAKHOUM*; G. R. JACKSON. The Univ. Of
Texas Med. Br.
8:00 T8 351.21 Tau-5 antibody injection reduces tau
pathology in middle aged tg4510 mice. S. K. SCHROEDER*;
M. BROWNLOW; M. SELENICA; D. LEE; M. GORDON; D.
MORGAN. Univ. of South Florida, Tampa, Univ. of South
Florida, Tampa, Univ. of South Florida, Tampa.
9:00 U1 351.22 • Neuronal network activity in the limbic
circuitry in tau transgenic (Tg4510) mice. L. SCOTT*; T.
KISS; T. T. KAWABE; B. HARVEY; M. HAJOS. Pfizer.
10:00 U2 351.23 Propagation of tau pathology in a
model of early Alzheimer’s disease. M. POLYDORO*; A.
DE CALIGNON; M. SUÁREZ-CALVET; C. WILLIAM; D. H.
ADAMOWICZ; K. J. KOPEIKINA; R. PITSTICK; K. H. ASHE;
G. A. CARLSON; T. L. SPIRES-JONES; B. T. HYMAN. MGH/
Harvard Med. Sch., Univ. Autònoma de Barcelona., Boston
Univ. Sch. of Med., McLaughlin Res. Inst., Univ. of Minnesota
Med. Sch.
11:00 V1 351.24 Tangle like inclusion induced by
injection of pre-formed tau fibrils into tauopathy transgenic
mice. M. IBA*; J. MCBRIDE; J. GUO; B. ZHANG; J. Q.
TROJANOWSKI; V. M. Y. LEE. Univ. of Pennsylvania.
8:00 V2 351.25 The cycad genotoxin
methylazoxymethanol (MAM) induces brain tissue DNA
damage and accelerates tau pathology in htau mice. G. E.
KISBY*; P. RENSLOW; A. RYAN; M. BEAM; R. WOLTJER.
Western Univ. of Hlth. Sci., Oregon Hlth. & Sci. Univ.,
Oregon Hlth. & Sci. Univ.
9:00 V3 351.26 • Characterisation of the rTg4510
transgenic mouse as an animal model for neuropathology,
cognitive decline and agitation in Alzheimer’s disease. I. E.
DE JONG*; P. JUL; A. I. PARACHIKOVA; L. HELBOE; A. B.
ELVANG; C. VOLBRACHT. H. Lundbeck A/S.
Neuroscience 2011 | Monday AM | 27
Mon. AM

10:00 V4 351.27 Progranulin reduction affects tau
phosphorylation in P301L tau transgenic mice. M.
HOSOKAWA*; T. ARAI; T. NONAKA; M. YAMASHITA;
M. SUZUKAKE; T. MATSUWAKI; M. NISHIHARA; M.
HASEGAWA; H. AKIYAMA. Tokyo Metropolitan Inst. of Med.
Sci., Univ. of Tsukuba, Tokyo Metropolitan Inst. of Med. Sci.,
The Univ. of Tokyo.
11:00 V5 351.28 A neuroanatomical and behavioral
approach to investigate mouse models of neurodegenerative
diseases. A. M. POULOS*; L. GOU; H. HINTIRYAN; B.
ZINGG; X. ZHANG; G. M. COLE; H. DONG. Univ. of
California, Los Angeles,, UCLA.
POSTER
352. Alzheimer Disease and Related Dementias: APP/Abeta/
Tau Models
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 V6 352.01 Assessment of spatial memory in 4- and
15-month old 3×Tg Alzheimer’s mice by Barnes maze using
short versus long training. A. ATTAR*; T. LIU; K. LEI; M.
NEJAD; J. HAYES; G. BITAN. UCLA, UCLA, UCLA.
9:00 V7 352.02 Tau and potassium channel Kv4.2 in
Alzheimer’s disease-related neuronal dysfunction. A. M.
HALL*; S. J. MARKWARDT; L. S. OVERSTREET-WADICHE;
E. D. ROBERSON. Univ. of Alabama at Birmingham, Univ. of
Alabama at Birmingham.
10:00 V8 352.03 • Age-dependent learning deficits
in a chronic rodent model of Alzheimer’s disease. K. S.
MONTGOMERY*; G. EDWARDS, III; J. G. WILSON; D. M.
WILCOCK; C. A. COLTON; J. L. BIZON. Univ. of Florida Col.
of Med., Duke Univ. Med. Ctr.
11:00 V9 352.04 Characterization of myelin pathology
in the hippocampal complex of a transgenic mouse
model of Alzheimer’s disease: A Black-Gold II study. L. C.
SCHMUED*; B. RAYMICK; M. G. PAULE; S. SARKAR. Natl.
Ctr. For Tox Res.
8:00 V10 352.05 Impact of intracellular Aβ amyloid on the
ERK-CREB-CRE pathway in an AD transgenic rat model. L.
PIMENTEL*; S. ALLARD; W. C. LEON; S. DO CARMO; A. C.
CUELLO. McGill Univ., Univ. de Los Andes.
9:00 V11 352.06 The synchrony of CA3-CA1 network
oscillations is decreased in hippocampal slices from aged
mice and at an earlier age in a mouse model of Alzheimer’s
disease. D. J. KANAK*; G. M. ROSE; H. P. ZAVERI; P. R.
PATRYLO. Southern Illinois Sch. of Med., Southern Illinois
Sch. of Med., Southern Illinois Sch. of Med., Yale Univ.
10:00 V12 352.07 The AB25-35 increases heat shock
protein in the hippocampus and decreases the memory
space in a rat model. L. O. HERNANDEZ*; A. DÍAZ;
M. RUBIO; J. GUEVARA; D. LIMON. Laboratorio De
Neurofarmacologia, Instituto Nacional De Neurologia Y
Neurocirugia-Mvs, Universidad Nacional Autonoma De
Mexico.
11:00 W1 352.08 Intraseptal injection of the beta amyloid
peptide 25-35 causes a change in the cholinergic markers
and spatial memory in rats. A. PATRICIO*; A. DÍAZ; D.
JUÁREZ; A. SÁNCHEZ-GONZÁLEZ; J. GUEVARA; J.
AGUILERA; I. D. LIMÓN. Benemerita Univ. Autonoma
De Puebla, Univ. Nacional Autónoma de México, Univ.
Autónoma de Barcelona.
8:00 W2 352.09 Stress-molecule gene expression is
altered during early-stage neuropathology in the 3xTg-
AD mouse model of Alzheimer’s disease. E. K. HEBDA-
BAUER*; A. SUGG; T. A. SIMMONS; S. J. WATSON; H.
AKIL. Univ. Michigan.
9:00 W3 352.10 Testosterone levels in serum and brain
are increased in old male 3xTg-AD mice. C. R. OVERK*;
S. E. PEREZ; C. MA; M. D. TAVES; K. K. SOMA; E. J.
MUFSON. Rush Univ. Med. Ctr., Univ. British Columbia,
Rush Univ. Med. Ctr.
10:00 W4 352.11 Pericytes control Alzheimer’s disease
pathology in a mouse model. B. V. ZLOKOVIC*; E. A.
WINKLER; A. P. SAGARE; R. DEANE; R. D. BELL. Univ.
Rochester, SMD.
11:00 W5 352.12 Pilocarpine-induced epilepsy
accelerates and exacerbates Aβ plaque formation and tau
phosphorylation in 3xTg mice. X. YAN; Y. CAI; J. SHELTON;
H. CAI; G. M. ROSE; P. R. PATRYLO*. SIUC Sch. of Med.,
SIUC, Central South Univ. Xiangya Sch. of Med., SIUC Sch.
of Med., Natl. Institue on Aging, NIH.
8:00 W6 352.13 Overexpression of cellular prion protein
prevents cognitive dysfunction and neurotoxicity induced
by amyloid-β (Aβ 1-40 ) administration in mice. D. RIAL*; T.
PIERMARTIRI; F. S. DUARTE; A. SCHMITZ; A. L. DAFRÉ;
C. I. TASCA; R. WALZ; R. D. S. PREDIGER. Univ. Federal
de Santa Catarina, Univ. Federal de Santa Catarina, Univ.
Federal de Santa Catarina.
9:00 W7 352.14 Tau-dependent cell cycle re-entry of postmitotic
neurons induced by Aβ oligomers, and regulated by
CamKII, fyn and PKA. M. SEWARD; G. S. BLOOM*. Univ. of
Virginia.
10:00 W8 352.15 The role of BDNF in the triple transgenic
Alzheimer’s disease mouse model. J. Z. HONEYWELL*; L.
D. LERCHER; F. M. LAFERLA; C. F. DREYFUS. UMDNJ,
Univ. of California.
11:00 W9 352.16 Beta-amyloid (Aβ) dimers mediate
plaque-associated cytopathology without affecting cognition.
P. LIU*; C. FORSTER; L. KOTILINEK; J. PAULSON; G.
CHEN; D. BENNETT; J. CLEARY; K. ZAHS; S. LESNÉ;
K. ASHE. Univ. of Minnesota, Univ. of Minnesota, Univ. of
Minnesota, Univ. of Minnesota, Rush Univ. Med. Ctr., VA
Med. Ctr.
8:00 W10 352.17 • The novel tetrahydrofuran derivative
ANAVEX2-73 attenuated GSK-3ß activation, Tau
hyperphosphorylation and endogenous Aß1-42 seeding
in a nontransgenic Alzheimer’s disease model in mice. V.
LAHMY*; J. MEUNIER; S. MALMSTRÖM; V. VILLARD; A.
VAMVAKIDES; T. MAURICE. Univ. Montpellier 2 Inserm
U710, AMYLGEN, ANAVEX Life Sci.
9:00 W11 352.18 • Impact of a γ-secretase inhibitor, BMS-
299,897, on Aβ1-42 seeding, oxidative stress and memory
deficits in the Aβ25-35 nontransgenic mouse model of
Alzheimer’s disease. J. MEUNIER*; S. MALMSTRÖM; V.
VILLARD; L. GIVALOIS; T. MAURICE. AMYLGEN, Inserm U.
710, Univ. of Montpellier 2.
10:00 W12 352.19 � Effect of -(-)epicatechin on plasticity,
learning and spatial memory of rats injected with the
AB25-35 fraction into the hippocampal region. I. VAZQUEZ
VILLASEÑOR*; A. DIAZ FONSECA; L. ORTEGA
HERNANDEZ; M. RUBIO OSORNIO; P. AGUILAR ALONSO;
I. LIMON PEREZ DE LEON; J. GUEVARA FONSECA.
Lab. De Neurofarmacoogìa Benemerita Univ. Autonoma
De Puebla, Univ. de las Americas, Puebla, Inst. Nacional
de Neurologia y Neurocirugia, Facultad de Medicina, Univ.
Nacional Autonoma de Mexico.
28 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 X1 352.20 Investigating Alzheimer’s disease using
knock-in mouse models. Q. GUO*; N. JUSTICE; H. LI; H.
ZHENG. Baylor Col. of Med.
8:00 X2 352.21 Inhibition of Sin3A/HDAC activity
suppresses amyloid β-42 accumulation and toxicity through
multiple mechanisms. M. SEKIYA*; K. IIJIMA-ANDO; K.
IIJIMA. Thomas Jefferson Univ.
9:00 X3 352.22 Novel mouse model for sporadic
Alzheimer’s disease. S. KAJA*; P. GARG; P. KOULEN. Univ.
of Missouri - Kansas City, Univ. of Missouri - Kansas City,
Univ. of Missouri - Kansas City.
10:00 X4 352.23 Early development, learning and memory
in the 3xTg-AD mouse model of Alzheimer’s disease. K.
STOVER*; C. BLANEY; D. E. IKPI; R. E. BROWN. Dalhousie
Univ.
11:00 X5 352.24 DAla2-GIP improves memory, synaptic
plasticity and decreases amyloid plaques and inflammation
in APP/PS1 transgenic mice. E. FAIVRE*; C. HOLSCHER.
Ulster Univ.
8:00 X6 352.25 � Impaired cerebral insulin signaling
in a non-human primate model of Alzheimer’s disease.
L. FORNY-GERMANO*; J. BRITO-MOREIRA; J.
CHRISTOPHE-HOUZEL; T. R. BOMFIM; H. KAZI; S. E.
ARNOLD; K. TALBOT; W. L. KLEIN; D. P. MUNOZ; S. T.
FERREIRA; F. G. DE FELICE. Federal Univ. of Rio de
Janeiro, Federal Univ. of Rio de Janeiro, Federal Univ. of Rio
Janeiro, Univ. of Pennsylvania, Northwestern Univ., Queen’s
Univ.
9:00 X7 352.26 Apolipoprotein E, especially
apolipoprotein E4, increases the level of amyloid β peptide
oligomers and its synaptic localization. T. HASHIMOTO*; R.
M. KOFFIE; A. SERRANO-POZO; H. TAI; D. JOYNER; D.
H. THYSSEN; B. J. BACSKAI; M. FINN; D. M. HOLTZMAN;
T. L. SPIRES-JONES; B. T. HYMAN. Massachusetts
Gen. Hosp., Dept. of Neurology, Hope Ctr. for Neurolog.
Disorders.
10:00 X8 352.27 Increase of hippocampal aluminum
is linked to the progression of amyloid pathology in a
triple transgenic mouse model of Alzheimer’s disease. A.
CONSALVO*; D. CIAVARDELLI; V. GATTA; C. ROSSI; C.
DI ILIO; S. L. SENSI. Dept. of Neurosci. and Imaging, Kore
Univ., Ctr. of Excellence on Aging, Univ. of Chieti-Pescara,
Univ. of California Irvine.
POSTER
353. Alzheimer Disease and Other Dementias: Tau
Biochemistry and Cell Biology
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 X9 353.01 Modulation of lipopolysaccharide-induced
tau phosphorylation and kinase activity by corticotropinreleasing
factor receptors. M. A. STAUP*; A. D. ROE; J.
SERRATS; P. E. SAWCHENKO; R. RISSMAN. UCSD, Salk
Inst. for Biol. Studies.
9:00 X10 353.02 A putative role for the prostaglandin
transporter in the pathogenesis of Alzheimer’s disease. H.
HUANG*; Y. CHI; V. L. SCHUSTER; M. E. FIGUEIREDO-
PEREIRA. Hunter Col. of the City Univ. of New York, Albert
Einstein Col. of Med., Hunter College, CUNY.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
10:00 X11 353.03 The effect of Hsp90 inhibition on Tau
aggregation in a cellular model system. A. BUIST*; K.
CALLAERTS; B. F. VASCONCELOS; D. MOECHARS.
Janssen Res. & Develop.
11:00 X12 353.04 Elucidating pathogenesis of neurofibrillary
tangles in a cell model with tau aggregation. J. GUO; V.
LEE*. Univ. Pennsylvania Sch. Med.
8:00 Y1 353.05 A novel mechanism for axonal sorting
of Tau protein: A retrograde barrier at the axon initial
segment. E. MANDELKOW*; X. LI; J. BIERNAT; E.
MANDELKOW. Max-Planck-Institute, DZNE, German Ctr. for
Neurodegenerative Diseases, c/o CAESAR.
9:00 Y2 353.06 Tau pathology in cholesterol accumulating
human APP transgenic mice. M. MAULIK*; B. GHOSHAL; D.
WESTAWAY; S. KAR. Univ. of Alberta, Univ. of Alberta, Univ.
of Alberta, Univ. of Alberta, Univ. of Alberta.
10:00 Y3 353.07 � Association of angiotensin converting
enzyme I/D genotype with Alzheimer’s disease in Indian
patients. S. NIRMAL*; S. VIVEKANANDHAN; S. S.
SHASTRI; M. TRIPATHI; R. SAGAR. All India Inst. of Med.
Sci., All India Inst. of Med. Sci., All India Inst. of Med. Sci., All
India Inst. of Med. Sci., All India Inst. of Med. Sci.
11:00 Y4 353.08 A direct link between mitochondrial
dysfunction and impairment of the ubiquitin/proteasome
pathway in Alzheimer’s neurodegeneration. Q. HUANG*; M.
E. FIGUEIREDO-PEREIRA. Hunter College, City Univ. New
York, Hunter College, CUNY.
8:00 Y5 353.09 � A NH 2 -tau fragment and Ab cooperate
in impairing the oxidative phosphorylation in AD synaptic
mitochondria. G. AMADORO*; V. CORSETTI; A. ATLANTE;
F. FLORENZANO; R. BUSSANI; D. MERCANTI; P.
CALISSANO. Natl. Council of Res., CNR, IRCSS-Santa
Lucia, UCO, European Brain Res. Inst.
9:00 Y6 353.10 • Extracellular tau oligomer trimers
are neurotoxic. H. TIAN; J. G. MOE*; E. DAVIDOWITZ; P.
LOPEZ; M. SIERKS. Arizona State Univ., OLIGOMERIX, Inc.
10:00 Y7 353.11 Subcellular localization and protein
interactions of PTL-1 in Caenorhabditis elegans. K. M.
RALEY-SUSMAN*; C. MCKEE; E. CHOU; J. STURM; N. J.
POKRYWKA. Vassar Col., Vassar Col.
11:00 Y8 353.12 Study of mechanisms underlying tau
transfer between cells. J. W. WU*; E. E. CONGDON; M.
HERMAN; K. E. DUFF. Columbia Univ.
8:00 Y9 353.13 Elevating cAMP with PACAP27 prevents
caspase-mediated tau cleavage rescuing cortical neurons
from the neurotoxic product of inflammation prostaglandin
J2: A new therapeutic approach for Alzheimer’s disease? M.
METCALFE*; M. FIGUEIREDO-PEREIRA. Hunter College,
CUNY.
9:00 Y10 353.14 Regulation of lipid rafts by tau and
β-amyloid: Implications for Alzheimer’s disease. A. F. SILVA*;
G. S. BLOOM. Univ. of Virginia.
10:00 Y11 353.15 Regulation of tau aggregation by lysine
acetylation. P. D. SOHN*; S. MINAMI; X. CONG; B. W.
GIBSON; P. YANG; S. MAEDA; S. MIN; L. ELLERBY; L.
GAN. UCSF, Gladstone Inst. of Neurolog. Diseases, UCSF,
Buck Inst. for Res. on Aging.
11:00 Y12 353.16 Pathological aberrant tau but not
overexpression of normal tau critically increases the
vulnerability of human neurons to oxidative stress leading
to axonal degeneration and neurotoxicity. J. MERTENS*; K.
STÜBER; D. POPPE; J. DOERR; J. LADEWIG; P. KOCH; O.
BRÜSTLE. Univ. of Bonn.
Neuroscience 2011 | Monday AM | 29
Mon. AM

8:00 Y13 353.17 Peptidyl-prolyl isomerase pin1-binding
to cdk5-phosphorylated tau. T. KIMURA*; K. TSUTSUMI;
T. SAITO; K. ISHIGURO; T. UCHIDA; M. HASEGAWA; S.
HISANAGA. Tokyo Metropolitan Univ., Mitsubishi Kagaku
Iustitute of Life Sci., Dept. of Biol., Grad. Sch.of Sci, Tohoku
Univ., Tokyo Inst.Psych.
9:00 Y14 353.18 Lysine methylation of tau protein in
Alzheimer’s disease: Identification of sites and potential
for modification crosstalk. K. E. FUNK*; S. N. THOMAS; Y.
WAN; Z. LIAO; P. DAVIES; J. KURET; A. J. YANG. The Ohio
State Univ., Univ. of Maryland, Albert Einstein Col. of Med.
10:00 Y15 353.19 Antisense to GSK-3beta improves
learning and memory in aged SAMP8 mice. S. A. FARR*;
V. B. KUMAR; M. L. NIEHOFF; J. E. MORLEY. St. Louis
University/VA Med.
11:00 Y16 353.20 • Inhibition of Phosphoprotein
Phosphatase 2A demethylation reduces tau dysfunction. S.
P. BRAITHWAITE*; D. HE; M. VORONKOV; D. C. LO; J. B.
STOCK. Signum Biosci., Duke Univ., Princeton Univ.
8:00 Y17 353.21 GSK3b and cdk5 promote tau proteolysis
and aggregation. S. LEE*; T. B. SHEA. UMass Lowell.
POSTER
354. Beta and Gamma Secretase, BACE, and Presenilin I
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 Y18 354.01 Secreted beta amyloid levels and cell
cycle regulation differentiate Alzheimer’s disease mutations
in presenilin1 but do not correlate with age of disease onset.
U. WOJDA*; E. BIALOPIOTROWICZ; A. SZYBINSKA; J.
KUZNICKI. IIMCB.
9:00 Y19 354.02 PS1Δ8 familial Alzheimer’s mutation
results in motor deficits, region specific cell loss, and a total
loss of all detectable γ-secretase activity. H. BRAUTIGAM*;
D. L. DICKSTEIN; S. GANDY; P. R. HOF; M. E. EHRLICH.
Mount Sinai Sch. of Med., Mount Sinai Sch. of Med., Mount
Sinai Sch. of Med., James J. Peters VA Med. Ctr., Mount
Sinai Sch. of Med.
10:00 Y20 354.03 Lys203 and Lys382 are essential for the
proteasomal degradation of BACE1. Y. ZHANG; R. WANG;
Z. YING; J. ZHAO; R. WANG; Y. DENG; W. SONG; H.
QING*. Beijing Inst. Technol., Univ. of British columbia, Univ.
of British columbia.
11:00 Y21 354.04 γ-secretase modulation properties of
soluble amyloid precursor protein-α. D. DARLINGTON*.
Univ. of South Florida.
8:00 Y22 354.05 Investigating the regional expression of
gamma secretase in the human brain. P. A. LEWIS*, Jr.; M.
RYTEN; D. TRABZUNI; J. HARDY. UCL Inst. of Neurol.
9:00 Y23 354.06 • Vascular factor LPA may contribute to
Alzheimer’s disease. J. SHI*; G. MAO; M. CUI; X. XU. Univ.
of Tennessee.
10:00 Y24 354.07 Chop-induced nf-κb activation increases
bace1 in hippocampal slices treated with the oxysterol
27-hydroxycholesterol. O. GHRIBI*; G. MARWARHA. UND
Med. Sch., Univ. of North dakota.
11:00 Y25 354.08 Characterization of nectin processing
mediated by presenilin-dependent gamma-secretase. S.
T. LIM*; J. KIM; A. DUDAK; A. CHANG; H. J. FEDEROFF.
Georgetown Univ. Med. Ctr.
8:00 Y26 354.09 • Hair follicle mRNA signature finds the
GSI SCH900229 to be Notch sparing in humans. K. Q.
TANIS*; A. A. PODTELEZHNIKOV; J. K. LUNCEFORD;
J. HING; J. CLEMENTS; E. M. FINNEY; A. ALBRIGHT; A.
LOBODA; S. S. BLACKMAN; R. IANNONE; R. MARGOLIN.
Merck, Merck, Merck, Merck, Merck, Merck, Merck, Merck.
9:00 Y27 354.10 The effect of fatty acids on γ-secretase
activity. O. HOLMES*; S. PATURI; W. YE; D. SELKOE; M.
WOLFE. Brigham and Women’s Hospital/Harvard Med. Sch.
10:00 Y28 354.11 Structural analysis of the transmembrane
domain 4 of Presenilin 1 by substituted cysteine accessibility
method. A. TOMINAGA*; S. TAKAGI; T. TOMITA; T.
IWATSUBO. Dept Neuropathol & Neurosci, Univ. Tokyo Grad
Sch. Pharmaceu Sci., Dept Neuropathol, Univ.Tokyo Grad
Sch. Med.
11:00 Y29 354.12 • GSI-1, a presenilin 1 selective
γ-secretase inhibitor with improved side effect profile in
preclinical models. L. ZHANG*; L. A. HYDE; W. WU; D.
BURNETT; M. COHEN-WILLIAMS; R. DEL VECCHIO; N.
JONES; J. LEE; L. SONG; G. TERRACINA; Q. ZHANG;
J. CLADER; W. GREENLEE; A. NOMEIR; M. BERADI; C.
MAHON; R. MARGOLIN; M. HU; E. M. PARKER. Merck
Res. Labs.
8:00 Y30 354.13 • Unable to Attend BACE1 inhibitors:
In vitro-in vivo correlation of Aβ effect in brain. J. JANSON;
S. EKETJÄLL; K. TUNBLAD; F. JEPPSSON; S. BRIEM;
A. RADESÄTER; K. ELIASON; J. FÄLTING*; S. VISSER.
Astrazeneca R&D, AstraZeneca R&D, AstraZeneca R&D,
AstraZeneca R&D.
9:00 Y31 354.14 Familial Alzheimer’s disease-associated
presenilin mutants suppress calcium influx through TRPM7
channels. H. OH; Y. CHUN; S. YOUN; T. KIM; S. CHUNG*.
Sungkyunkwan Univ., Columbia Univ. Med. Ctr.
10:00 Y32 354.15 Age-dependent synaptic dysfunctions
in APPswe;PS1deltaE9 mice. A. MEGILL; P. C. WONG;
H. LEE*. Univ. of Maryland, Johns Hopkins Univ., Johns
Hopkins Sch. of Med.
11:00 Y33 354.16 BACE2 tissue expression and β-amyloid
precursor protein processing in multiple BACE2-targeted
mouse lines. R. W. TERRY*; G. VASSILEVA; W. HU; X.
CHEN; R. DELVECCHIO; L. HYDE; B. G. SALISBURY; E.
PARKER; M. E. KENNEDY. Merck Res. Labs., Merck Res.
Labs., Union County Col.
8:00 Y34 354.17 BACE1 elevation is involved in amyloid
plaque pathogenesis in the triple transgenic model of
Alzheimer’s disease: Profiling an early-onset axonal
accumulation of putative APP β-carboxyl terminal fragments.
X. YAN*; Y. CAI; X. ZHANG; L. N. MACKLIN; H. CAI; X.
LUO; R. G. STRUBLE; G. M. ROSE; P. R. PATRYLO.
Central South Univ., Central South Univ., Harbin Med. Univ.,
Southern Illinois Univ. Sch. of Med., Natl. Inst. on Aging,
Southern Illinois Univ. Sch. of Med., Southern Illinois Univ.
Sch. of Med., Southern Illinois Univ. Sch. of Med.
9:00 Y35 354.18 Presenilin 1 regulates cellular distribution
and neuroprotective function of Trk and EphB receptors.
Z. XUAN*; G. BARTHET; J. DUNYS; J. XU; Z. SHAO; N.
ROBAKIS. Mount Sinai Sch. of Med.
10:00 Y36 354.19 • Gamma-secretase/Notch signaling in
insulin resistance. S. YANG*; D. JO. Sungkyunkwan Univ.
11:00 Z1 354.20 • Adiponectin signaling in Alzheimer’s
disease. S. KIM*; D. JO. Sungkyunkwan Univ.
30 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 Z2 354.21 BACE1 function in the CA3 circuit of
hippocampus. H. WANG*; P. WONG; H. LEE. Univ. of
Maryland, Neurosci. and Cognitive Sci. (NACS) Program,
Univ. of Maryland, Dept. of Pathology, Johns Hopkins Univ.
Sch. of Med., Dept. of Neuroscience, Johns Hopkins Univ.
Sch. of Med.
9:00 Z3 354.22 Implication of the role of ubiquitin
carboxy-terminal hydrolase l1 in Alzheimer’s disease
pathogenesis. M. ZHANG*; Y. DENG; Y. LUO; H. ZOU; F.
CAI; W. SONG. The Univ. of British Columbia.
10:00 Z4 354.23 • Evaluation of phytochemicals regulating
BACE1 expression.. Y. YUN*; J. PARK; Y. LEE; D. JO.
Sungkyunkwan Univ.
11:00 Z5 354.24 Behavioral characterization of BACE-1
knockout mice reveal differences in thermal nociception and
sensory motor gating. R. A. DEL VECCHIO*; M. CALHOUN;
A. LASHOMB; C. MORGAN; L. A. HYDE. Merck Res. Labs,
Merck Res. Labs, Merck Res. Labs.
8:00 Z6 354.25 PICALM impacts the production and
secretion of Aβ42 in cultured cells. Y. MOROHASHI*; K.
KANATSU; T. TOMITA; T. IWATSUBO. Dept Neuropathol
& Neurosci, Univ. Tokyo Grad Sch. Pharmaceu Sci., Univ.
Tokyo Grad Sch. Med.
9:00 Z7 354.26 Analyses of the γ-secretase
complex components. Y. SUN; N. MATSUMURA; M.
MORISHIMA*. Hokkaido Univ, Sch. Pharm Sci.
10:00 Z8 354.27 • Cathepsin B is a major beta-secretase
in wild-type amyloid precursor protein processing. M. S.
KINDY*; J. YU; H. ZHU; G. R. HOOK; V. HOOK. Med. Univ.
South Carolina, Ralph H. Johnson VA Med. Ctr., MUSC,
ALSP, Inc., UCSD.
POSTER
355. Parkinson’s Disease: Genetic Determinants
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 Z9 355.01 Genetic studies of PARK14 and
PARK18 in a Swedish Parkinson cohort. C. T. RAN*; A.
ZETTERGREN; C. FARDELL; A. ANVRET; T. WILLOWS; O.
SYDOW; B. HOLMBERG; H. NISSBRANDT; L. OLSON; D.
GALTER; A. C. BELIN. Dept. of Neuroscience, Karolinska
Institutet, Dept. of Pharmacology, Sahlgrenska academy,
Univ. of Gothenburg, Dept. of Neurology, Karolinska Univ.
Hosp., Dept. of Neurology, Karolinska Univ. Hosp., Dept. of
Clin. Neurosci. and Rehabilitation, Sahlgrenska academy,
Univ. of Gothenburg.
9:00 Z10 355.02 Genetic variation in aldehyde
dehydrogenase 2 is associated with Parkinson´s disease.
C. FARDELL*; A. ZETTERGREN; C. RAN; O. SYDOW;
A. C. BELIN; B. HOLMBERG; H. NISSBRANDT. Dept
Pharmacology, Sahlgrenska Academy, Univ. of Gothenburg,
Karolinska Institutet, Karolinska Univ. Hosp. Solna,
Sahlgrenska academy, Univ. of Gothenburg.
10:00 Z11 355.03 Endogenous Parkin and Ambra1 interact
in neural cells to mediate mitophagy. T. CORNELISSEN; C.
VAN HUMBEECK; H. HOFKENS; W. MANDEMAKERS; K.
GEVAERT; B. DE STROOPER; W. P. VANDENBERGHE*.
K.U. Leuven, VIB, Ghent Univ., VIB, Univ. Hosp. Leuven.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
11:00 Z12 355.04 Dopamine, oxygen and iron homeostasis
might be involved in paraquat neurotoxicity in mice. L. YIN*;
L. LU; B. C. JONES. Neurosci. Grad. Program, Pennsylvania
State Univ., Dept. of Anat. and Neurobiology, Univ. of
Tennessee Col. of Med., Dept. of Biobehavioral Hlth.
8:00 Z13 355.05 Molecular and functional analysis
of zebrafish synucleins. C. MILANESE*; Q. BAI; E. A.
BURTON. Univ. of Pittsburgh.
9:00 Z14 355.06 SRY: A risk factor for Parkinson’s disease
in men? J. LEE*; D. CZECH; C. PRITCHARD; C. L. PARISH;
E. VILAIN; V. R. HARLEY. Prince Henry’s Inst., Florey
Neurosciences Inst., Univ. of California Los Angeles.
10:00 Z15 355.07 LRRK2 mutation affects stability of
protein aggresgates. Y. BANG*; H. CHOI. Chonnam Natl.
Univ.
11:00 Z16 355.08 Analysis of commonly reported LRRK2
mutations in colombian Parkinson’s disease patients. L.
MORALES*; A. DUQUE; J. YUNIS; H. ARBOLEDA; W.
FERNANDEZ; G. ARBOLEDA. Univ. Nacional De Colombia.
8:00 Z17 355.09 Loss of ATP13A2 function promotes
lysosomal deficiency in mammalian cells. B. DEHAY*; M.
THIOLAT; E. DOUDNIKOFF; C. KLEIN; A. RAMIREZ; E.
BEZARD. Inst. of Neurodegenerative Dis., Univ. of Lübeck.
9:00 Z18 355.10 Loss of PINK1 function promotes
autophagy via PP2A inactivation in dopaminergic cells
and a murine model. H. YANG*; Z. QI. Beijing Inst.
For Neuroscience, Capital Med. Univ., Beijing Inst. for
Neuroscience, Capital Med. Univ.
10:00 Z19 355.11 S-Sulfhydration of Parkin enhances
its activity and protective function. M. S. VANDIVER*;
N. SEN; B. PAUL; R. XU; H. S. KO; M. M. GADALLA; S.
KARUPPAGOUNDER; V. DAWSON; T. DAWSON; S. H.
SNYDER. Johns Hopkins Univ. Sch. of Med., Johns Hopkins
Univ. Sch. of Med., Johns Hopkins Univ. Sch. of Med., Johns
Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch. of
Med., Johns Hopkins Univ. Sch. of Med.
11:00 Z20 355.12 Co-expression of LRRK2 and Alpha-
Synuclein exacerbates dopaminergic neuron toxicity. L. LIU-
YESUCEVITZ*; V. GOWDA; S. SAHA; B. WOLOZIN. Boston
Univ. Sch. of Med., Boston Univ. Sch. of Med.
8:00 Z21 355.13 Loss of PLA2G6 (PARK14) expression
causes progressive α-synuclein accumulation and agedependent
dopaminergic terminal dystrophy in mouse brain.
J. WANG*; Z. ZHAO; Z. MA; Z. YUE. Mount Sinai Sch. Med.,
Mount Sinai Sch. Med., Mount Sinai Sch. Med.
9:00 Z22 355.14 The role of parkin in modulating
mitochondrial fission, fusion, transport and mitophagy
in neurons. V. S. VAN LAAR*; N. ROY; S. J. CASSADY;
B. ARNOLD; E. A. BURTON; S. B. BERMAN. Univ. of
Pittsburgh, Univ. of Pittsburgh, Univ. of Pittsburgh.
10:00 Z23 355.15 Parkin regulates pro-apoptotic protein
RTP801 in in vitro and in vivo models of Parkinson’s
disease. J. ROMANÍ; Z. HAO JIN; S. MENDRITZKI; A.
MARÍN NAVARRO; H. LUEBBERT; L. A. GREENE; C.
MALAGELADA GRAU*. Univ. De Barcelona, Columbia Univ.,
Ruhr-University, Univ. De Barcelona.
11:00 Z24 355.16 Age-dependent behavioral changes in the
homozygous A53T alpha synuclein over-expressing model
of Parkinson’ disease. A. W. OAKS*; J. WILLS; A. SIDHU.
Georgetown Univ.
8:00 Z25 355.17 Effects of LRRK2 kinase activity on
dendrites and synapses. B. SEPULVEDA*; R. MESIAS; X.
LI; Z. YUE; D. L. BENSON. Mount Sinai Sch. of Med., Mount
Sinai Sch. of Med.
Neuroscience 2011 | Monday AM | 31
Mon. AM

9:00 Z26 355.18 Genomic instability caused by defects in
nucleotide excision repair perturbs dopaminergic neurons
in the nigrostriatal pathways. S. SEPE*; C. BOMBARDIERI;
S. MORENO; A. TRAFICANTE; G. BATTAGLIA; J.
HOEIJMAKERS; P. MASTROBERARDINO. Univ. of “Roma
Tre”, Erasmus Med. Ctr., I.N.M. Neuromed, Universtity of
Pittsburgh.
10:00 Z27 355.19 The effect of Parkinson’s diseaselinked
mutations (a30p e46k and a53t) on a-synuclein
phosphorylation. M. MBEFO KAMDEM*; K. PALEOLOGOU;
G. YIN; A. OUESLATI; M. FARES; M. ZWECKSTETTER;
H. LASHUEL. Ecole Polytechnique Federale De Lausanne /
BMI, Max Planck Inst. for Biophysical Chem.
11:00 Z28 355.20 LRRK2-interacting proteins regulate
its neurotoxic effects downstream of its kinase/GTPase
activities. H. J. RIDEOUT*; N. ANTONIOU; P. VALKIMADI.
Biomed. Res. Foundation, Acad. of Athens.
8:00 Z29 355.21 Parkinson’s disease-related homozygous
mutations in pink1 cause bioenergetics and mitochondrial
dysfunction.. S. A. ANDRABI*; L. SCARFFE; V. L. DAWSON;
O. ROSS; Z. K. WSZOLEK; B. JASINSKA-MYGA; G.
OPALA; T. M. DAWSON. Johns Hopkins Univ., Johns
Hopkins Univ., Johns Hopkins Univ., Johns Hopkins Univ.,
Mayo Clin., Mayo Clin., Med. Univ. of Silesia.
9:00 Z30 355.22 � A parkinsonian-like motor phenotype
responsive to dopaminergic agonists in LRRK2-G2019S
transgenic mice. M. VOLTA; M. CALCAGNO; C. PARADISO;
F. LONGO; H. MELROSE; M. J. FARRER; M. MORARI*.
Univ. Ferrara, Mayo Clin., Univ. of British Columbia.
10:00 Z31 355.23 Evaluation of the neuroprotective effect
of parkin against α-synuclein-induced neurotoxicity in a rat
model of Parkinson’s disease. G. MERCANTI; G. BAZZU;
G. ROCCHITTA; M. ALVAU; P. SERRA; S. D. SKAPER; M.
DESOLE; P. F. GIUSTI*. Univ. Padova, Univ. of Sassari,
Univ. Padova.
11:00 Z32 355.24 Characterization of LRRK2 function
at the cytoskeleton. M. GARCIA-MIRALLES*; N. FUNK;
K. HAEBIG; F. GILLARDON; J. COOMARASWAMY; M.
C. HERZIG; D. GALTER; M. WOEFLE; M. JUCKER; T.
GASSER; A. B. WEST; S. BISKUP. Hertie Inst. For Clin.
Brain Res. AND DZNE, Inst. of Med. Genet., Boehringer
Ingelheim Pharma GmbH & Co. KG, Hertie Inst. For
Clin. Brain Res. AND DZNE, Karolinska Institutet, Ctr. for
Neurodegeneration and Exptl. Therapeut.
8:00 Z33 355.25 Transgenic mice expressing G2019S
mutant LRRK2 show age-dependent reduction in both
locomotor activity and rotarod performance. Y. HUANG*;
Y. LIANG; F. NUCIFORA; W. W. SMITH; X. WANG; G.
RUDOW; L. TESSAROLO; N. G. COPELAND; N. A.
JENKINS; D. R. BORCHELT; J. C. TRONCOSO; C. A.
ROSS. Johns Hopkins Univ. Sch. of Med., Johns Hopkins
Univ. Sch. of Med., Johns Hopkins Univ. Sch. of Med., Natl.
Cancer Institute, NIH, Inst. for Mol. and Cell Biol., Univ. of
Florida, Johns Hopkins Univ. Sch. of Med.
9:00 Z34 355.26 DJ-1 deficiency induces gender-selective
modulation of behaviour and biogenic amines in male mice.
K. T. HO*; J. K. GRIFFIN; J. YANG; E. LAM; H. T. J. MOUNT.
Univ. of Toronto, Univ. of Toronto, Univ. of Toronto, Univ. of
Toronto.
10:00 Z35 355.27 • Synaptic impairment in the CA1 region
in mice expressing the human A53T substitution mutation
of alpha-synuclein. D. V. VASILYEV*; K. L. PAUMIER; C.
GONZALES; J. DUNLOP; E. J. KAFTAN. Pfizer, Pfizer.
11:00 Z36 355.28 Shading more light on LRRK2 function.
C. RIEKER*; M. HERZIG; P. KRUMOVA; G. ROVELLI; D.
SHIMSHEK; H. VAN DER PUTTEN. Novartis Pharma AG.
8:00 AA1 355.29 Mutation screening of genes linked
to Alzheimer`s disease and frontotemporal dementia in
patients with Parkinson`s disease. E. C. SCHULTE*; B.
MOLLENHAUER; C. TRENKWALDER; J. WINKELMANN.
Technische Univ. München, Helmholtz Zentrum München,
Paracelsus Elena Klinik, Georg-August Univ. Göttingen,
Technische Univ. München.
POSTER
356. Parkinson’s Disease: Degeneration Models
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 AA2 356.01 The neuroprotective effects of PACAP
on prostaglandin J2-induced neurotoxicity in a model of
Parkinson’s disease. K. SHIVERS*; M. FIGUEIREDO-
PEREIRA. Hunter College, CUNY.
9:00 AA3 356.02 Embryonic lethality and dopaminergic
neuron defects in zebrafish with loss of parla and parlb
function. S. NOBLE*; A. ISMAIL; R. S. GODOY; Y. XI; M.
EKKER. Ctr. For Advanced Res. In Envrn. Genomics, Univ.
of Ottawa.
10:00 AA4 356.03 � The effects of manganese toxicity on
motor activity in Drosophila melanogaster. L. R. MCGINNIS;
B. J. KROEKER; S. DIMES; J. J. GOTO*. California State
University, Fresno, California State University, Fresno,
California State University, Fresno.
11:00 AA5 356.04 Drosophila model of Parkinson’s
disease: In search for genetic interactors of Leucine-rich
repeat kinase 2. K. VENDEROVA*; G. KABBACH; P.
MACROGLIESE; E. ABDEL-MESSIH; G. LI; S. ABUAISH; E.
HAQUE; R. SLACK; D. S. PARK. Univ. of the Pacific, Univ. of
Ottawa.
8:00 AA6 356.05 Repression of Nurr1 and altered midbrain
dopaminergic neurons in Id2 null mice. M. C. HAVRDA*;
B. PAOLELLA; N. WARD; K. HOLROYD; J. SULLIVAN; A.
MANTANI; M. ISRAEL. Dartmouth Med. Sch., Weill Cornell
Col. of Med., Yoshida Gen. Hosp.
9:00 AA7 356.06 Generation of a transgenic zebrafish
line expressing green fluorescent protein in dopaminergic
neurons. R. S. GODOY*; Y. XI; M. EKKER. Ctr. for Advanced
Res. In Envrn. Genomics, Univ. of Ottawa.
10:00 AA8 356.07 Decreased concentrations of dopamine
and its metabolites after manganese inhalation. J.
ORDONEZ LIBRADO*; A. GUTIÉRREZ VALDEZ; V. ANAYA-
MARTÍNEZ; E. MONTIEL-FLORES; P. ALEY MEDINA; J.
ESPINOSA VILLANUEVA; M. AVILA COSTA. UNAM, FES
Iztacala UNAM.
11:00 AA9 356.08 Progressive dopaminergic neuronal
death is mediated by Bax-dependent AIF activation in mouse
model of Parkinson’s disease. T. KIM*; B. CHO; I. RHYU; H.
KIM; W. SUN. Col. of Med, Korea Univ.
8:00 AA10 356.09 Transcriptomics of cypermethrinmediated
neurotoxicity in the rat striatum: Role in chemically
induced Parkinson’s disease. M. N. TIWARI*; A. K. SINGH;
O. PRAKASH; M. P. SINGH. Indian Inst. of Toxicology Res.,
Indian Inst. of Toxicology Res., Banaras Hindu Univ.
32 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 AA11 356.10 BmDJ-1 is a key regulator of oxidative
modification in the development of the silkworm, bombyx
mori. H. TABUNOKI*; T. SHIMADA; K. MITA; Y. BANNO; J.
SATOH. Meiji Pharmaceut. Univ., The Univ. of Tokyo, Natl.
Inst. of Agrobiological Sci., Univ. of Kyushu.
10:00 AA12 356.11 Peripheral Adenosine triphosphate (ATP)
and L-methionine (Met) caused Parkinson’s disease-like
behavioral and molecular changes in C57BL mouse exposed
to prenatal and postnatal to MPTP. G. MUTHIAN*; V. R.
MACKEY; L. DENT, MD; T. S. WALTERS; M. SMITH; J.
KING; C. G. CHARLTON. Meharry Med. Col., Meharry Med.
Col.
11:00 AA13 356.12 • Monitoring aggregation of adenoassociated
virus is a critical tool for the development of
AAV mediated α -synuclein overexpression rodent Model
for Parkinson’s disease. S. CHIOU*; R. BRENDZA; K.
CALLAWAY; S. NELSON; M. YU; K. MAKAYED; H. NI;
K. HU; M. LEE; D. FAUSS; R. MOTTER; G. KINNEY;
D. GAMES; T. YEDNOCK; L. MCCONLOGUE. Elan
Pharmaceuticals.
8:00 AA14 356.13 Lipid-perooxidation products of DHA,
major phospholipids composing neural membrane, induce
toxic fibril formation of alpha-synuclein and cell death in
dopamine neurons. W. MARUYAMA*; M. SHAMOTO-
NAGAI; M. NAOI; Y. NOSE-KUROKAWA. Nat’L Ctr.
Geriatric. Gerontol., Gifu Intl. Inst. of Biotech.
9:00 AA15 356.14 Targeting cGMP/phosphodiesterases
pathway restores corticostriatal long-term depression and
alleviates L-DOPA-induced dyskinesia. V. PENDOLINO;
B. PICCONI; V. BAGETTA; V. GHIGLIERI; V. PAILLÉ; M.
DI FILIPPO; S. MARINUCCI; A. TOZZI; C. GIAMPÀ; F. R.
FUSCO; C. SGOBIO; P. CALABRESI*. Fondazione Santa
Lucia, Clinica Neurologica, Univ. Perugia.
10:00 AA16 356.15 Neuropathlogy of task switching in
Parkinson’s disease. E. A. ISHAM*; K. A. RUSSO; M. I.
VENTURA; M. COPARA; K. SIGVARDT; S. MINEYEV; L.
ZHANG; N. MALHADO-CHANG; E. A. DISBROW. Ctr. For
Mind and Brain, UC Davis, Ctr. for Neurosci., UCSF, UC
Davis, UC Davis Med. Ctr., VA Northern California Hlth. Care
Syst.
11:00 AA17 356.16 Movement patterns and motor
performance of dyskinetic Parkinson’s patients and choreic
Huntington’s patients. C. DUVAL*; B. CARTIGNAN; J.
DANEAULT. UQAM, Ctr. de Recherche Inst. Universitaire de
Gériatrie de Montréal, McGill Univ.
8:00 AA18 356.17 Parkin alterations induced by the
neurotoxic product of inflammation prostaglandin J2 in a
cellular model of Parkinson’s disease. H. WANG*; M. E.
FIGUEIREDO-PEREIRA. Hunter College, Biol., Hunter Col.
of CUNY.
9:00 AA19 356.18 Functional loss of Omi enhances
α-synuclein aggregation, mitochondrial dysfunction and
toxicity in yeast. Z. PEI*; Z. LIU; L. CHEN; X. LU; C. GAO.
The First Affiliated Hospital, Sun Yat-Sen Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
357. Parkinson’s Disease: Models of Alpha-Synuclein
Toxicity
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 AA20 357.01 • Nrf2-deficient mice exhibit exacerbate
nigrostriatal neurodegeneration and neuroinflammation
induced by AAV6-α-synuclein. A. CUADRADO*; A. ULUSOY;
N. G. INNAMORATO; A. RABANO; D. KIRIK; I. LASTRES-
BECKER. Univ. Autónoma de Madrid, Dept. de Bioquímica
e Inst. de Investigaciones Biomédicas “Alberto Sols”
Consejo Superior de Investigaciones Científicas-Universidad
Autónoma, Facultad de Medicina, Univ. Autónoma de
Madrid; CIBERNED, Dept. of Exptl. Med. Science,
Brain Repair and Imaging in Neural Systems, Lab. de
Neuropatología, Unidad de Investigación Proyecto Alzheimer
(UIPA), Fundación CIEN,.
9:00 AA21 357.02 Prefibrillar alpha-synuclein mutants
are less neurotoxic in a rat model of Parkinson’s disease.
G. TASCHENBERGER*; M. GARRIDO; M. BÄHR; M.
ZWECKSTETTER; S. KÜGLER. Univ. of Göttingen, Ctr. for
Neurosci. and Cell Biol., Max Planck Inst. for Biophysical
Chem.
10:00 AA22 357.03 • Transgenic rats expressing Parkinson’s
disease genes: Characterization and toxicant sensitivity. J. T.
GREENAMYRE*; T. SEW; V. TAPIAS; L. MONTERO; K. D.
GEGHMAN; C. LI; J. R. CANNON. Univ. of Pittsburgh, Weill
Cornell Med. Col., Mount Sinai Sch. of Med.
11:00 AA23 357.04 PLK2 and PLK3 phosphorylate
α-synuclein at Ser129 in vivo. K. BUCK*; N. LANDECK; A.
ULUSOY; D. KIRIK. BRAINS Unit, Lund Univ., German Ctr.
for Neurodegenerative Dis.
8:00 AA24 357.05 Role of the A53T mutation of alphasynuclein
in dopaminergic neurodegeneration: A new model
of Parkinson’s disease. C. SGOBIO; G. LIU; Y. MATEO;
L. WU; D. M. LOVINGER; H. CAI*. NIH/NINDS, Natl. Inst.
Aging, NIH/NIAAA.
9:00 AA25 357.06 rAAV-mediated shrna knock-down of
alpha-synuclein in the rat substantia nigra results in aberrant
dopamine handling. F. P. MANFREDSSON*; T. KHUNDKAR;
A. C. RISING; R. J. MANDEL. Michigan State Univ., Univ. of
Florida.
10:00 AA26 357.07 • Transcriptome network and pathway
analyses reveal early alterations in dopaminergic
neurons of mice overexpressing human wild-type alphasynuclein
(Thy1-aSyn). F. RICHTER*; F. GOA; N. BOVE;
V. MEDVEDEVA; P. LEE; E. D. KIM; F. MORTAZAVI;
B. MEURERS; G. COPPOLA; D. H. GESCHWIND; E.
MASLIAH; R. PRUSS; M. CHESSELET. UCLA David Geffen
Sch. of Med., UCSD Sch. of Med., Trophos S.A.
11:00 AA27 357.08 Characterization of the phenotypic and
age-dependant changes exhibited by the A53T mouse model
of Parkinson’s disease. K. L. PAUMIER*; C. GONZALES;
P. STOYLAR; S. LOTARSKI; C. HSU; R. ROOF; K. E.
G. RICHTER; Z. BERGER; L. LI; M. MONAGHAN; W. D.
HIRST; M. M. ZALESKA; J. DUNLOP. Pfizer Inc.
8:00 AA28 357.09 Authentically phosphorylated α-synuclein
at Ser129 accelerates neurodegeneration in a rat model of
familial Parkinson’s disease. H. SATO; S. ARAWAKA*; S.
HARA; S. FUKUSHIMA; S. KOYAMA; T. KATO. Yamagata
University, Fac. of Med.
Neuroscience 2011 | Monday AM | 33
Mon. AM

9:00 AA29 357.10 Effects of intravenous immunoglobulin on
pathological conformations of alpha synuclein. L. M. SMITH*;
A. KLAVER; M. COFFEY; D. LOEFFLER. William Beaumont
Hosp. Res. Inst., William Beaumont Hosp. Res. Inst.
10:00 AA30 357.11 Cognitive dysfunction and cholinergic
alterations prior to DA loss in mice over-expressing wild-type
human alpha-synuclein (Thy1-aSyn mice). I. MAGEN*; K.
M. CARDIFF; D. DINH; K. DE LA ROSA; J. KWONG; E.
MASLIAH; M. CHESSELET. UCLA, UCSD.
11:00 AA31 357.12 Regionally specific microglial activation
precedes neuropathology and peripheral immune response
in mice over-expressing wildtype alpha synuclein. M. B.
WATSON*; S. K. LEE; F. RICHTER; E. MASLIAH; M.
CHESSELET. UCLA, UCLA, UCSD.
8:00 AA32 357.13 Progressive synucleinopathy in a novel,
non-genetic rat model of parkinsonism. P. J. YAROWSKY*;
K. A. MCDOWELL; W. SHEN. Univ. Maryland, Sch. of Med.,
Maryland VA Hlth. Care Syst., Univ. of Maryland.
9:00 AA33 357.14 Targeting GATA2 to transcriptionally
ameliorate alpha-synuclein and iron pathologies in
Parkinson’s disease. M. P. HOROWITZ*; J. R. CANNON;
T. J. SEW; L. M. MONTERO; Q. BAI; E. A. BURTON;
J. T. GREENAMYRE. Univ. Pittsburgh, Med. Scientist
Training Program (MSTP), Ctr. for Neurosci. Univ. of
Pittsburgh (CNUP), Dept. of Neurol., Pittsburgh Inst.
for Neurodegenerative Dis., Dept. of Neurol., Dept. of
Microbiology and Mol. Genet., PIttsburgh VA Healthcare
Syst., Med. Scientist Training Program (MSTP).
10:00 AA34 357.15 Ultrasonic vocalizations in mice
overexpressing human wild-type alpha-synuclein. J. N.
BASKEN; L. M. GRANT; F. RICHTER; K. DE LA ROSA; J.
E. MILLER*, Dr.; C. M. FOX; S. A. WHITE; E. MASLIAH;
M. CHESSELET; M. R. CIUCCI. Univ. of Wisconsin, David
Geffen Sch. of Medicine, UCLA, Integrative Biol. & Physiol.,
Natl. Ctr. for Voice and Speech, UCSD Sch. of Med., Reed
Neurolog. Res. Ctr.
11:00 AA35 357.16 The impact of transglutaminase 2
modulation on alpha-synuclein-associated phenotype in vivo.
H. GROSSO*; K. LEE; G. V. JOHNSON; R. M. GRAHAM; E.
MASLIAH; E. JUNN; M. M. MOURADIAN. UMDNJ-Robert
Wood Johnson Med. Sch., Univ. of Rochester, Victor Change
Cardiac Res. Inst., Univ. of California at San Diego.
8:00 AA36 357.17 Tissue-specific elevation of alphasynuclein
spliced transcript levels in Parkinson’s disease
brain tissues and in a transgenic mouse model of human
alpha-synuclein overexpression. J. R. MCLEAN*; P. J.
HALLETT; O. COOPER; M. STANLEY; O. ISACSON.
Harvard Med. Sch.
9:00 BB1 357.18 Biochemical investigation of alpha
synuclein accumulation in an experimental mouse model of
Parkinson’s disease. L. R. MANGIERI*. Univ. of Alabama At
Birmingham.
10:00 BB2 357.19 Brain region specific histopathological
alterations in mice overexpressing wild-type human alphasynuclein
under the Thy1 promoter. C. ZHU*; F. RICHTER;
C. HUTSON; S. SUBRAMANIAM; N. FRANICH; E.
MASLIAH; M. CHESSELET. UCLA, UCSD, UCLA.
11:00 BB3 357.20 Inhibition of prolyl oligopeptidase
disturbs its subcellular colocalization with α-synuclein and
reduces α-synuclein aggregation. T. T. MYÖHÄNEN*; M.
J. HANNULA; R. VAN ELZEN; M. GERARD; P. VAN DER
VEKEN; A. GARCIA-HORSMAN; V. BAEKELANDT; P.
T. MÄNNISTÖ; A. LAMBEIR. Univ. of Helsinki, Univ. of
Antwerp, Katholieke Univ. Leuven-Kortrijk, Univ. of Antwerp,
Katholieke Univ. Leuven.
8:00 BB4 357.21 Characterization of β-synuclein and
α-synuclein Δ70-83 expressing rAAV vectors as controls for
α-synuclein expression in vivo. N. LANDECK*; K. BUCK; D.
KIRIK. BRAINS Unit, Lund Univ.
9:00 BB5 357.22 Impact of phospholipid membranes
on alpha-synuclein self-assembly and neurotoxicity in
Parkinson’s disease. A. M. GRIGGS; K. HEAD; H. ZHANG;
L. STANCIU; J. ROCHET*. Purdue Univ., Purdue Univ.,
Purdue Univ.
10:00 BB6 357.23 Altered phosphorylation of 14-
3-3 proteins in models of Parkinson’s disease. T. A.
YACOUBIAN*; S. R. SLONE. Univ. Alabama Birmingham,
Univ. of Alabama at Birmingham.
11:00 BB7 357.24 • Direct visualization of alpha synuclein
oligomers in rat brain. H. DIMANT; L. V. KALIA; S. K.
KALIA; L. N. KIBUUKA; D. EBRAHIMI-FAKHARI; N. R.
MCFARLAND; P. J. MCLEAN*. Massgeneral Inst. For
Neurodegenerative Dis., Univ. of Florida.
8:00 BB8 357.25 • Novel structure based designed
compound reduces accumulation of toxic alpha-synuclein
and improves deficits in a transgenic murine model of
PD/DLB. D. L. PRICE*; A. D. PAULINO; T. GONZALEZ-
RUELAS; K. UBHI; E. ROCKENSTEIN; I. TSIGELNY; W.
WRASIDLO; H. MOESSLER; E. MASLIAH. Neuropore
Therapies, Inc., UC San Diego, UC San Diego, UC San
Diego.
9:00 BB9 357.26 Alpha-synuclein overexpressing
transgenic mice show peripheral organ pathology and
autonomic deficits. P. HALLETT*; J. R. MCLEAN; A.
KARTUNEN; O. ISACSON. McLean Hospital/Harvard Med.
Sc.
10:00 BB10 357.27 Effect of alpha-synuclein phosphorylation
by Polo-Like Kinase 2 on alpha-synuclein aggregation and
toxicity in vivo. O. ABID*; B. SCHNEIDER; P. AEBISCHER;
H. LASHUEL. EPFL.
POSTER
358. Huntington’s Disease: Animal Models II
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 BB11 358.01 Efficacy of a novel proneurogenic
neuroprotective small molecule, P7C3, in the R6/2
transgenic mouse model of Huntington’s disease. G. L.
BECKER*; M. TANG; S. HUSAIN; C. P. PHILIP; P. J.
HUNTINGTON; A. R. BURKET; S. L. MCKNIGHT; A. A.
PIEPER. Univ. of Texas Southwestern Med. Sch., Univ. of
Texas Southwestern Med. Sch.
9:00 BB12 358.02 Serine 421 is a crucial mediator of
pathology in a mouse model of Huntington’s disease. I.
H. KRATTER*; H. ZAHED KARGARAN; A. ZANDONA;
A. S. TSVETKOV; X. GU; X. W. YANG; E. MASLIAH; S.
FINKBEINER. Gladstone Inst. For Neurolog. Dis., UCSF,
Taube-Koret Ctr. for Huntington’s Dis. Res., UCLA, UCSD,
UCSF.
10:00 BB13 358.03 Selective decrease in the function of
postsynaptic striatal A2A receptors in presymptomatic
stages of a rat model of Huntington’s disease. M. ORRU’; J.
ZANOVELI; X. GUITART*; C. QUIROZ; V. BEAUMONT; S.
FERRE’. NIDA/IRP/DHHS/NIH, UFPR, NIMH / NIH, CHDI
Fndn.
34 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 BB14 358.04 Exercise is not beneficial and may
accelerate symptom onset in a mouse model of Huntington’s
disease. M. C. POTTER*; C. YUAN; C. OTTENRITTER; M.
R. MUGHAL; H. VAN PRAAG. NIA.
8:00 BB15 358.05 Mutant huntingtin protein expression,
gliosis and neurodegeneration in the eye of R6/2 mice.
J. T. PUOLIVALI*; S. RÖNKKÖ; G. KALESNYKAS;
T. HEIKKINEN; O. KONTKANEN; J. YRJÄNHEIKKI.
Cerebricon Ltd/Charle River Labs. Discovery and Imaging
Services, Univ. of Eastern Finland.
9:00 BB16 358.06 The length of the non-pathogenic
polyglutamine (polyQ) stretch in wild type huntingtin can
influence phenotype in an Hdh(140Q/+) knock-in mouse
model for Huntington’s disease. S. ZHENG*; S. O. ZEITLIN.
Univ. Virginia, Univ. Virginia.
10:00 BB17 358.07 Longitudinal genomic profiling of
peripheral blood from a transgenic Huntington’s disease
monkey model. J. KOCERHA*; Y. LIU; A. NEUMAN; T. CHI;
K. LARKIN; A. W. S. CHAN. Emory Univ.
11:00 BB18 358.08 Neuroprotective effect of Licofelone
against 3-nitropropionic acid-induced animal models of
Huntington’s disease in rats. P. KUMAR*; H. KALONIA; A.
KUMAR. ISF Col. of Pharm., Panjab Univ., Panjab Univ.
8:00 BB19 358.09 Transgenic mouse model expressing
mutant huntingtin in synapses. Q. XU*; S. HUANG; S. LI; X.
LI. Emory Univ. Sch. of Med., Tongji Med. Col. of Huazhong
Univ. of Sci. and Technol.
9:00 BB20 358.10 Differential changes in inhibitory inputs
onto striatal medium-sized spiny neurons of the direct and
indirect pathway in the R6/2 mouse model of Huntington’s
disease. S. P. RAO*; V. M. ANDRÉ; C. CEPEDA; M. S.
LEVINE. IDDRC, Semel Inst. for Neurosci. and Human
Behavior, UCLA.
10:00 BB21 358.11 • BDNF mRNA expression in the midbrain
and thalamus in a transgenic mouse model of Huntington’s
disease. P. SAMADI*; J. MAHEUX; V. V. RYMAR; F.
BEAUBIEN; J. CLOUTIER; D. LEVESQUE; A. F. SADIKOT.
Montreal Neurolog. Institute, Mc Gill Univ., Montreal Univ.
11:00 BB22 358.12 Altered GABAergic function in striatal
large cholinergic interneurons in mouse models of
Huntington’s disease. P. R. JOSHI*; C. CEPEDA; M. S.
LEVINE. IDDRC, Semel Inst. for Neurosci. and Human
Behavior, UCLA.
8:00 BB23 358.13 Comparison of backcrossed CAG140KI
and Hdh(CAG)150 knock-in mouse models of Huntington’s
disease: Neuropathological and behavioral analysis. N. R.
FRANICH*; M. A. HICKEY; J. S. STEFFAN; C. ZHU; T. CHU;
R. LERNER; M. CHESSELET. UCLA, Univ. of California
Irvine.
9:00 BB24 358.14 In vivo detection of iron accumulation
in the R6/2 mouse model of Huntington’s disease using
magnetic resonance Carr-Purcell-Meiboom-Gill method with
variable inter-pulse delays. K. LEHTIMÄKI; P. TUUNANEN;
O. M. KONTKANEN*; J. PUOLIVÄLI; O. GRÖHN; L. PARK;
D. HOWLAND; J. YRJÄNHEIKKI; A. NURMI. Cerebricon
Ltd./ Charles River Labs. Discovery Services, Cerebricon
Ltd./ Charles River Labs. Discovery Services, Ltd, AIV
Insititute, Univ. of Eastern Finland, CHDI Foundation. Inc.,
CHDI Foundation. Inc.
10:00 CC1 358.15 Investigating the role of the huntingtin
proline-rich region (PRR) in modulating Huntington’s disease
mouse model pathogenesis. M. NEVEKLOVSKA; J. LIU; S.
O. ZEITLIN*. Univ. Virginia.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
11:00 CC2 358.16 • Cognitive impairment in mice
expressing Poly-Q stretches in striatum. J. KIM*; C. YOOK;
J. SONG; J. HAN. Korea Advanced Inst. of Sci. and Technol.
8:00 CC3 358.17 Reduction of cognitive deficits in the HD
51 CAG rat model of Huntington’s disease with a NMDA
receptor partial agonist, GLYX-13. A. CRANE*; K. D. FINK;
J. ROSSIGNOL; S. A. LOWRANCE; J. J. MATYAS; M. I.
SANDSTROM; J. R. MOSKAL; G. L. DUNBAR. Central
Michigan Univ., Field Neurosciences Inst., Northwestern
Univ.
9:00 CC4 358.18 Striatum specific lactate change in
BACHD model of Huntington’s disease. L. ZACHAROFF; I.
TKAC; C. TANG; P. BOLAN; T. LI; J. M. DUBINSKY*. Univ.
Minnesota, Univ. of Minnesota, Biolead.org Res. Group, LC
Sci.
10:00 CC5 358.19 Immunohistochemical characterization
of Huntington’s disease R6/2 mouse model with special
emphasis on iron accumulation. N. E. VARTIAINEN*; J.
PUOLIVÄLI; A. NURMI; O. KONTKANEN; D. HOWLAND;
L. PARK; J. YRJÄNHEIKKI. Cerebricon Ltd / Charles River
Labs. Discovery Services, CHDI Fndn. Inc., CHDI Fndn. Inc.
11:00 CC6 358.20 Characterization of behavioral changes,
mri brain volumetry and mr spectroscopy in q175 knock in
mouse model of Huntington’s disease. J. M. YRJANHEIKKI*;
J. PUOLIVÄLI; K. LEHTIMÄKI; L. C. PARK; D. HOWLAND;
O. KONTKANEN; T. HEIKKINEN. Cerebricon Ltd/Charles
River Labs. Discovery Services, CHDI Fndn. Inc., CHDI
Fndn. Inc.
8:00 CC7 358.21 A proteasome-targeted scFv fusion
intrabody enhances Huntingtin exon 1 degradation and
phenotypic correction. D. C. BUTLER*; A. SYNDER-
KELLER; A. MESSER. New York State Dept. of Hlth., Univ.
at Albany.
9:00 CC8 358.22 Silencing toxic gene expression in both
in vitro and in vivo models of Huntington’s disease using a
cyclodextrin-based short interfering RNA delivery system.
B. M. D. C. GODINHO*; J. R. OGIER; R. DARCY; C. M.
O’DRISCOLL; J. F. CRYAN. Univ. Col. Cork, Univ. Col. Cork,
Univ. Col. Dublin, Alimentary Pharmabiotic Centre, Univ. Col.
Cork.
10:00 CC9 358.23 • Recombinant Adeno Associated Viral
(AAV) vector delivery of mutant huntingtin as rat model for
in vitro and in vivo studies. C. SCALI*; I. CECCARELLI; R.
REMELLI; D. FRANCESCHINI; L. ROSSINI; G. POLLIO; M.
CAMARRI; I. BIOTTI; A. CAPPELLI; V. MIRAGLIOTTA; P.
FIENGO; A. CARICASOLE; G. GAVIRAGHI. Siena Biotech
SpA.
11:00 CC10 358.24 Long term-memory deficits are
associated with reduced CBP histone acetyltransferase
activity in Huntington´s disease knock in mutant mice. M.
PUIGDELLIVOL; A. GIRALT; O. CARRETON; P. PAOLETTI;
J. VALERO; A. PARRA; C. A. SAURA; J. ALBERCH;
S. GINES-PADROS*. Med. School, Univ. of Barcelona,
Inst. d´Investigacions Biomèdiques August Pi i Sunyer,
CIBERNED, Med. School, Univ. Autonoma de Barcelona,
Inst. de Neurociencies.
8:00 CC11 358.25 Role of Heme-oxigenase-1 in the
quinolinic acid-induced neuronal death. A. L. COLÍN
GONZÁLEZ*; M. OROZCO-IBARRA; M. CHÁNEZ-
CÁRDENAS; D. SILVA-ADAYA; A. SANTAMARIA; J.
PEDRAZA-CHAVERRI; P. MALDONADO. Natl. Inst. of
Neurol. and Neurosurg., Autonomous Natl. Univ. of Mexico.
Neuroscience 2011 | Monday AM | 35
Mon. AM

POSTER
359. Other Neurodegenerative Disorders II
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 CC12 359.01 Structural and functional connectivity of
cerebral palsy patients with the periventricular leukomalacia.
H. PARK*; M. UM; B. PARK. Yonsei Univ. Col. Med., BK21
Project for Med. Science, Yonsei Univ. Col. of Med.
9:00 CC13 359.02 • Potential contribution of ABO blood
group transferase to the risk of developing HTLV-1
associated neurological disease. S. LEE*; Y. SHIN; S.
MAINALI; D. CLARK; E. GOTUZZO; M. C. LEVIN. Univ.
Tennessee, Veterans Affairs Med. Ctr., Univ. Peruana
Cayetano Heredia.
10:00 CC14 359.03 Investigating the oxidative stress
hypothesis of tardive dyskinesia, a role for the antioxidant
curcumin. C. SOOKRAM*; M. TAN; R. MISHRA.
McMasterUniversity.
11:00 CC15 359.04 Property of lysosomal storage disease
in the CNS of lysosome-associated membrane protein-2
deficient mice. A. FURUTA*; K. WADA; Y. UCHIYAMA.
Juntendo Univ. Grad Sch. of Med., Juntendo Univ. Grad Sch.
of Med., NCNP.
8:00 CC16 359.05 • Gray matter demyelination in atypical
multiple sclerosis brains. M. HENDRICKSON*; A. CHANG;
S. STAUGAITIS; K. EASLEY; B. D. TRAPP. Cleveland Clinic/
Kent State Univ., Cleveland Clin., Cleveland Clin.
9:00 CC17 359.06 Fast-scan cyclic voltammetry
measurement of putative adenosine in human essential
tremor patients during Deep Brain Stimulation (DBS) surgery.
S. CHANG*; I. KIM; M. MARSH; D. JANG; S. HWANG; C.
KIMBLE; K. E. BENNET; P. GARRIS; C. BLAHA; K. LEE.
Mayo Clin., Soonchunhyang Univ., Mayo Clin., Illinois State
Univ., Univ. of Memphis.
10:00 CC18 359.07 Anterograde transport deficits precede
retrograde tracing loss in the retinotectal projection of the
DBA/2J mouse. S. D. CRISH*; A. S. DARVESH. NEOUCOM.
11:00 CC19 359.08 Fractal dimension analysis of brain white
matter complexity in amyotrophic lateral sclerosis (ALS)
patients. Z. LIU; V. RAJAGOPALAN; E. P. PIORO*; G. H.
YUE. Cleveland Clin., Cleveland State Univ., Cleveland Clin.,
Cleveland Clin.
8:00 CC20 359.09 Kinetics and subcellular mechanisms
of axon degeneration in zebrafish sensory neurons. K.
O’DONNELL*; A. SAGASTI. UCLA.
9:00 CC21 359.10 Temporal proteasome disruption
results in irreversible protein aggregation in Drosophila. T.
SCHMIDT-GLENEWINKEL*; C. YEH; M. JANSEN; J. GAO;
M. FIGUEIREDO-PEREIRA. Hunter Col. of CUNY, Hunter
Col. and Grad. Ctr. of CUNY.
10:00 CC22 359.11 Cortical grey matter atrophy in ALS
patients with or without cognitive impairment: A voxel based
morphometry study. V. RAJAGOPALAN*; G. H. YUE; E. P.
PIORO. Cleveland Clin., Cleveland Clin., Cleveland Clin.
11:00 CC23 359.12 Characterization of the TMEM106B
protein, implicated in frontotemporal lobar degeneration with
TDP-43 pathology (FTLD-TDP). A. NICHOLSON*; N. FINCH;
A. WOJTAS; M. BAKER; N. RUTHERFORD; B. BOEVE; N.
GRAFF-RADFORD; D. DICKSON; R. RADEMAKERS. Mayo
Clin. Jacksonville, Mayo Clin. Rochester.
8:00 CC24 359.13 Promotion of Neurotrophin-induced
neurite outgrowth by TRPV4 underlies its channelopathy in
spinal motor atrophy. Y. JANG; D. YANG; M. TAK; H. KIM; U.
OH*. Seoul Natl. Univ. Col. Pharm.
9:00 CC25 359.14 • Demyelination of mouse optic chiasm
and nerves induces SVZ-RMS cell expansion and migration.
S. MOZAFARI*; F. POURABDOLHOSSEIN; M. JAVAN; M.
SHERAFAT; J. MIRNAJAFI-ZADEH. L’Institut Du Cerveau
Et De La Moelle Epinière, Tarbiat Modares Univ., Tarbiat
Modares Univ.
10:00 CC26 359.15 The HIV protein, gp120, impairs
oligodendrocyte differentiation and oligodendrocyte-axon
contact. D. GARY*; J. W. MCDONALD; N. HAUGHEY.
Kennedy Krieger Inst., Johns Hopkins Sch. of Med.
11:00 CC27 359.16 Iron deficiency up-regulates dopaminerelated
genes in the ventral midbrain in inbred mice. B. C.
JONES*; L. C. JELLEN; E. L. UNGER; C. J. EARLEY; R. P.
ALLEN; L. LU; R. W. WILLIAMS; X. WANG; S. ROUSSEAU.
Pennsylvania State Univ., Pennsylvania State Univ., The
Johns Hopkins Univ., Univ. of Tennesee Hlth. Sci. Ctr., Univ.
of Toulouse.
8:00 CC28 359.17 Oxidative-stress impairs lysosomal
cathepsin D maturation and activity contributing to
neuropathology in a mouse model of INCL. G. CHANDRA*;
A. SAHA; M. R. MORALLE; Z. ZHANG; C. SARKAR; S.
PENG; A. B. MUKHERJEE. NIH.
9:00 CC29 359.18 Conditional inactivation of notch1 and
notch2 in excitatory pyramidal neurons of the postnatal
mouse forebrain does not cause neurodegeneration. J.
ZHENG*; H. WATANABE; M. WINES-SAMUELSON; J.
SHEN. Brigham and Women’s Hospital, Harvard Med. Sch.
10:00 CC30 359.19 Altered acetylcholine release in brain
regions of dystrophic mice. C. SOUCCAR*; E. D. COLETTA-
YUDICE; F. M. NOGUEIRA; M. T. R. LIMA-LANDMAN; A. J.
LAPA. Univ. Federal de Sao Paulo/EPM.
POSTER
360. Epilepsy: Human EEG and MRI
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 CC31 360.01 Epileptic human lateral amygdala:
Interictal-like network activity. E. SPECKMANN*; S.
GRAEBENITZ; O. KEDO; A. GORJI; H. PANNECK; V.
HANS; N. PALOMERO-GALLAGHER; A. SCHLEICHER; K.
ZILLES; H. PAPE. Univ. Munster, Bethel Epilepsy Ctr., Inst.
of Neuropathology,, Inst. of Neurosci. and Med., C. & O.
Vogt-Institute of Brain Res.
9:00 CC32 360.02 Problem of signal contamination in interhemispheric
dual-sided subdural electrodes. G. NUNE*; J.
WINAWER; A. M. RAUSCHECKER; M. DASTJERDI; B. L.
FOSTER; B. WANDELL; J. PARVIZI. Stanford Univ. - Dept of
Neurol., Stanford, Stanford Univ.
10:00 DD1 360.03 Probing interictal fast ripples (200-
500 Hz) in human epileptic neocortex with subdural
macroelectrodes. J. R. CHO*; E. JOO; S. HONG; S. HONG.
Samsung Med. Ctr., Samsung Med. Ctr.
11:00 DD2 360.04 The study of action of differences of
antiepileptic drugs on the eeg pattern in epileptic patients. I.
O. KHACHIZE*; M. GUGUSHVILI; V. MALOLETNEV. Ctr. of
Life Sci. (beritashvili Inst. of Physiology), Tbilisi, 0160, GE.
36 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 DD3 360.05 Digital analysis of EEGs recorded
during Wada tests. B. TU*; L. HIRSCH; C. BAZIL; M.
HAMBERGER. Columbia Univ., Yale Univ., Columbia Univ.
9:00 DD4 360.06 • Using multi-electrode array recordings
to improve our understanding of ECoG recordings of seizure
activity. C. A. SCHEVON*; S. WEISS; G. MCKHANN, Jr; R.
R. GOODMAN; R. EMERSON; A. TREVELYAN. Columbia
Univ., Columbia Univ., Hosp. for Special Surgery, Univ. of
Newcastle.
10:00 DD5 360.07 • Seizures of mice and men: Sharp
discontinuities in neuronal recruitment patterns during
epileptic propagation. A. J. TREVELYAN*; S. WEISS; G.
MCKHANN, Jr; R. R. GOODMAN; R. G. EMERSON; C. A.
SCHEVON. Univ. of Newcastle, Columbia Univ., Columbia
Univ.
11:00 DD6 360.08 Effective connectivity of normally
functioning and epileptogenic networks in human cortex. A.
KORZENIEWSKA*; M. CERVENKA; C. JOUNY; J. PERILLA;
G. BERGEY; P. FRANASZCZUK; N. CRONE. The Johns
Hopkins Univ. Sch. of Med.
8:00 DD7 360.09 Can Granger Causality measures help
localize seizure onset? B. M. ADHIKARI*; C. EPSTEIN; M.
DHAMALA. Georgia State Univ., Emory Univ. Sch. of Med.,
Georgia State Univ., Georgia State Univ.
9:00 DD8 360.10 Default mode network differences in
epilepsy patients and healthy volunteers using independent
component analysis. R. A. PIZARRO*; V. A. NAIR; R.
HOLDSWORTH; E. TUNNEL; P. RUTECKI; K. SILLAY; B.
MEYERAND; V. PRABHAKARAN. UW Madison.
10:00 DD9 360.11 The human connectome network in
mesial temporal lobe epilepsy. P. CHEN*; J. LEE; H. LIOU;
W. HUANG; K. CHU; Y. SHIH; W. I. TSENG. Advanced
Biomed. MRI Lab, Ctr. For Optoelectronic Biomedicine,
Neurobio. and Cognitive Sci. Center, Natl. Taiwan Univ.,
Inst. of Zoology, Natl. Taiwan Univ., Institue of Statistical
Sciences, Academia Sinica, Grad. Inst. of Pharmacology,
Natl. Taiwan Univ. Col. of Med., Dept. of Neurology, Natl.
Taiwan Univ. Hosp.
11:00 DD10 360.12 Grey matter predicts cognition and
language in toddlers following a prolonged febrile seizure.
M. MARTINOU*; M. YOONG; K. SEUNARINE; R. SCOTT;
M. DE-HAAN. Inst. of Child Health, UCL, Inst. of Child Hlth.,
Inst. pf Child Hlth., Dartmouth Med. Sch., Inst. of Child Hlth.
8:00 DD11 360.13 Correlative structural changes in patients
with juvenile myoclonic epilepsy. Y. SHON*; S. LIM; Y. KIM.
St. Mary’s Hosp., The Catholic Univ. of Korea.
9:00 DD12 360.14 Initial reductions in fractional anisotropy
following prolonged febrile convulsions resolve after 1 year.
M. YOONG*; M. MARTINOS; K. SEUNARINE; R. F. CHIN;
C. A. CLARK; R. C. SCOTT. UCL Inst. of Child Hlth., UCL
Inst. of Child Hlth., UCL Inst. of Child Hlth., UCL Inst. of Child
Hlth., Dartmouth Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
361. Ischemia: Neuroprotection II
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 DD13 361.01 Protective effects of lycium barbarum
polysaccharides on cerebral edema and blood-brain
barrier disruption after ischemic stroke. D. YANG*; S. LI; R.
CHANG; K. SO; D. WONG; A. LO. Eye Institute, Li Ka Shing
Fac. of Medicine, The Univ. of Hong Kong, Dept. of Anatomy,
The Univ. of Hong Kong, Res. Ctr. of Heart, Brain, Hormone
and Healthy Aging, The Univ. of Hong Kong.
9:00 DD14 361.02 Contribution of chaperone-mediated
autophagy to the survival of cells under hypoxic condition.
E. DOHI*; S. TANAKA; T. SEKI; T. ONJI; T. TAKAHASHI;
I. HIDE; M. MATSUMOTO; N. SAKAI. Hiroshima Univ.,
Hiroshima Univ.
10:00 DD15 361.03 Novel protection of lipophilic porphyrins in
subarachnoid hemorrhage. H. SHENG*; M. LU; J. HONG; Z.
WANG; I. BATINIC-HABERLE; D. S. WARNER. Duke Univ.
Med. Ctr., Duke Univ. Medcial Ctr., Duke Univ. Med. Ctr., Duke
Univ. Med. Ctr., Duke Univ. Med. Ctr., Duke Univ. Med. Ceter.
11:00 DD16 361.04 Post-cardiac arrest therapeutic
hypothermia protects cerebellar Purkinje neurons. M. G.
PAINE*; D. CHE; R. W. NEUMAR. Univ. Pennsylvania.
8:00 DD17 361.05 Suppressive effect of orexin-A on the
development of post-ischemic glucose intolerance and
neuronal damage. S. HARADA*; W. FUJITA; S. TOKUYAMA.
Kobe Gakuin Univ.
9:00 DD18 361.06 Coumestrol has neuroprotective effects
before and after global cerebral ischemia in female rats.
C. C. CASTRO*; A. M. ETGEN; A. S. PAGNUSSAT; L.
ORLANDI; C. NETTO; A. M. ETGEN. Univ. Federal Do Rio
Grande Do Sul, Albert Einstein Col. of Med., Univ. Federal
de Ciencias da Saude de Porto Alegre.
10:00 DD19 361.07 Lutein protects against neuronal
damages by its anti-apoptotic, anti-oxidative and antiinflammatory
properties in a mouse model of ischemic
stroke. A. C. LO*; S. LI; T. WOO; D. WONG. Eye Institute,
The Univ. of Hong Kong, Res. Ctr. of Heart, Brain, Hormone
and Healthy Aging, The Univ. of Hong Kong.
11:00 DD20 361.08 Neuroprotective therapy of stroke with
D-4F, a reconstituted fragment of high density lipoprotein,
in type 2 diabetic mice. X. CUI*; M. CHOPP; Y. CUI; C.
ROBERTS; J. CHEN. Henry Ford Hlth. Syst., Oakland Univ.
8:00 DD21 361.09 • BB3, a hepatocyte growth factor mimetic,
causes sustained improvement in outcome from focal brain
ischemia in rats. R. E. CHAPARRO; H. SHENG; D. SMITH;
D. S. WARNER*. Duke Univ. Med. Ctr., Duke Univ. Med. Ctr.,
Angion Biomedica Corp, Duke Univ. Med. Ctr.
9:00 DD22 361.10 Combined antioxidant (S-PBN)hypothermia
treatment, administered immediately post-injury,
is not neuroprotective for striatal medium-spiny neurons
after neonatal rat hypoxia-ischemia: a dose-response and
stereological study. D. E. OORSCHOT*; C. E. HOBBS; B.
KHOURI; E. BARNETT; A. ALWAKEEL; J. LIM. Univ. Otago
Sch. Med. Sci.
10:00 DD23 361.11 Novel protein biological caspase
inhibitors for stroke. N. AKPAN*; B. E. ZACHARIA; A. F.
DUCRUET; S. J. SNIPAS; G. S. SALVESEN; E. CONNOLLY
JR; C. M. TROY. Columbia Univ., Columbia Univ., Burnham
Med. Res. Inst.
Neuroscience 2011 | Monday AM | 37
Mon. AM

11:00 DD24 361.12 Decreased infarct volume in a
rabbit ischemic stroke model following treatment with
dodecafluoropentane emulsion. R. D. SKINNER*; W. C.
CULP; P. K. ROBERSON; S. D. WOODS; J. D. LOWERY;
A. T. BROWN; M. J. BORRELLI. Univ. Arkansas Med. Sci.,
Univ. of Arkansas for Med. Sci., Univ. of Arkansas for Med.
Sci., Univ. of Arkansas for Med. Sci.
8:00 DD25 361.13 Neuroprotective effect of β-cembrene in
brain ischemia in mice. J. HAO*; J. HU; K. EL SAYED. Univ.
of Cincinnati, Univ. of Louisiana.
9:00 DD26 361.14 The role of estrogen in neuroprotection
in mice deficient for the vesicular acetylcholine transporter
subjected to cerebral ischemia in vitro. D. F. GONÇALVES*;
V. PRADO; M. PRADO; G. PEREIRA; A. MASSENSINI.
Federal Univ. of Minas Gerais, Robarts Res. Institute, Univ.
of Western Ontario.
10:00 DD27 361.15 Acute estradiol rescues ischemia-induced
cell death in old rats after long-term hormone withdrawal,
and increases synaptic transmission in aging hippocampus.
T. INAGAKI*; N. KANEKO; H. CHANG; S. ZUKIN; P.
CASTILLO; A. M. ETGEN. Albert Einstein Col. of Med.
11:00 DD28 361.16 Development of a cell-permeable peptide
that acts downstream of nNOS to protect neurons against
excitotoxicity. L. LI*; V. GINET; A. C. TRUTTMAN; M. J.
COURTNEY. A.I. Virtanen Inst. For Mol. Sci., DBCM, Univ.
de Lausanne, Dept. of Pediatrics and Pediatric Surgery,
CHUV.
8:00 DD29 361.17 Cannabinoid-induced neuroprotection
in vitro and in a middle cerebral artery occlusion model.
L. CALTANA; B. HEIMRICH; H. A. BRUSCO*. IBCN
(UBA-CONICET), 2Inst. Anat. and Cell Biology, Ctr. for
Neuroscience, Univ. Freiburg.
9:00 DD30 361.18 Central and peripheral effects of Vitamin
D in a stroke model. R. BALDEN*; F. SOHRABJI. Texas
A&M Hlth. Sci. Ctr.
10:00 DD31 361.19 Acute effects of hypoxia and prolyl
hydroxylase inhibition on synaptic plasticity in the rat
hippocampus. J. J. O’CONNOR*; A. CORCORAN. UCD,
UCD.
11:00 DD32 361.20 � Protection against glutamate toxicity
in HT22 neurons by a novel phosphodiesterase inhibitor. V.
BREEN; J. R. BURDO*. Boston Col.
8:00 DD33 361.21 Identification of proteins regulated by
ferulic acid in focal cerebral ischemic injury - a proteomics
approach. P. KOH*; J. SUNG; J. CHO; C. WON; M. KIM.
Gyeongsang Natl. Univ., Gyeongsang Natl. Univ.
9:00 DD34 361.22 • Combination treatment of pyruvate and
tissue plasminogen activator protects the HT22 cells from in
vitro ischemic stroke. M. RYOU*; G. ROY CHOUDHURY; R.
LIU; R. T. MALLET; S. YANG. Univ. of North Texas Hlth. Sci.
Ctr. At Fort Worth, Univ. of North Texas Hlth. Sci. Ctr. At Fort
Worth.
10:00 DD35 361.23 • Methylene blue enhances mitochondrial
function and probides protection against oxidative stress in a
cellular model of Friedreich’s Ataxia. A. E. YU*; E. POTEET;
M. RYOU; W. LI; Y. WEN; J. W. SIMPKINS; S. YANG.
UNTHSC, Texas Col. of Osteo. Med.
11:00 DD36 361.24 P38 mitogen-activated protein kinase and
astrocyte activation in ischemic stroke. E. C. POTEET*; W.
LI; G. CHOUDHURY; R. LIU; Y. WEN; S. YANG. UNT Hlth.
Sci. Ctr.
POSTER
362. Ischemia: Cell-Based Therapies and Neurogenesis
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 EE1 362.01 Functional recovery and increased
myelination after intra-arterial delivery of human embryonicderived
neural stem cells for treatment of neonatal
hypoxia-ischemia. T. SMITH*; S. ROSENBLUM; N. WANG;
K. WANG; A. AURIAT; S. LAWRENCE; H. VOGEL; R.
GUZMAN. Stanford Univ. Sch. of Med., Stanford Univ. Sch.
of Med.
9:00 EE2 362.02 Ips cell transplantation with whisker
stimulation increases neurogenesis in a neonatal stroke
model. M. J. CHAU*; I. L. MCCULLOUGH; L. WEI. Emory
Univ.
10:00 EE3 362.03 Role of brain-derived neurotrophic factor
on subventricular zone cells recruitment to the ischemic
striatum. S. GRADE*; Y. C. WENG; J. KRIZ; J. O. MALVA;
A. SAGHATELYAN. Ctr. de Recherche Univ. Laval Robbert-
Giffard, Ctr. for Neurosci. and Cell Biology, Univ. of Coimbra,
Ctr. de Recherche du CHUL (CHUQ), Univ. Laval.
11:00 EE4 362.04 Intravenous and intra-arterial
administration of bone marrow mononuclear cells after focal
cerebral ischemia: Is there a difference in the biodistribution
and efficacy? A. DE VASCONCELOS DOS SANTOS*;
P. ROSADO-DE-CASTRO; S. DE SOUZA; J. SILVA; F.
GUBERT; A. BERNARDO; G. DE FREITAS; L. BARBOSA
DA FONSECA; B. GUTFILEN; R. MENDEZ-OTERO. Inst. de
Biofísica Carlos Chagas Filho, Dept. de Radiologia, Hosp.
Universitário Clementino Fraga Filho, Univ. Federal do Rio
de Janeiro.
8:00 EE5 362.05 Human neural stem cells centrally
injected into the rat pup brain migrate and differentiate
similarly to endogenous progenitor cells in an animal model
of neonatal hypoxic-ischemic stroke. C. I. TURENIUS*; B.
TONE; E. Y. SNYDER; A. OBENAUS; S. ASHWAL. Loma
Linda Univ., Sanford-Burnham Inst. for Med. Res. Inst.,
Loma Linda Univ., Loma Linda Univ., Loma Linda Univ.
9:00 EE6 362.06 Nasal mesenchymal stem cell treatment
after neonatal hypoxic-ischemic brain damage improves
motor and cognitive function. V. DONEGA*; C. T. J. VAN
VELTHOVEN; C. H. NIJBOER; M. LAARAKKER; F. VAN
BEL; M. J. H. KAS; A. KAVELAARS; C. J. HEIJNEN. Univ.
Med. Ctr. Utrecht, Univ. Med. Ctr. Utrecht, Univ. Med. Ctr.
Utrecht.
10:00 EE7 362.07 Mesenchymal stem cells engineered to
produce neurotrophic factors stimulate regeneration of the
neonatal hypoxic-ischemic brain. C. T. VAN VELTHOVEN*;
A. KAVELAARS; H. L. D. M. WILLEMEN; C. J. HEIJNEN.
UMC Utrecht, UMC Utrecht.
11:00 EE8 362.08 Preconditioning with IL-6 enhances
survival of transplanted neural stem cells after ischemic
stroke in mice. H. SAKATA*; K. NIIZUMA; J. E. JUNG; P.
NARASIMHAN; T. WAKAI; G. S. KIM; T. TOMINAGA; P. H.
CHAN. Dept. of Neurosurgery, Stanford Univ. Sch. of Med.,
Dept. of Neurosurgery, Tohoku Univ. Grad. Sch. of Med.
8:00 EE9 362.09 Mesenchymal stem cells restore cortical
rewiring after neonatal ischemia. C. T. J. VAN VELTHOVEN;
Y. VAN DE LOOIJ; A. KAVELAARS; J. ZIJLSTRA; F. VAN
BEL; P. S. HUPPI; S. SIZONENKO; C. J. HEIJNEN*. Univ.
Med. Ctr. Utrecht, Univ. of Geneva, Univ. Med. Ctr. Utrecht.
38 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 EE10 362.10 • Valproic acid increases
oligodendrocytes, axons and new neurons after stroke.
X. LIU*; M. CHOPP; H. KASSIS; L. F. JIA; A. HOZESKA-
SOLGOT; R. L. ZHANG; C. CHEN; Z. G. ZHANG. Henry
Ford Hlt Syst, Oakland Univ.
10:00 EE11 362.11 Human nasal olfactory stem cells
home into murine injured hippocampus, one month after
an excitotoxic lesion. S. GIRARD*; K. BARANGER; D.
STEPHAN; A. DEVÈZE; E. NIVET; F. FÉRON; F. ROMAN.
UMR 6149 CNRS Univ. De Provence, UMR 6184 NICN
CNRS Univ. de la Méditerranée, Dept. ORL, Hôpital
Universitaire Nord, AP-HM.
11:00 EE12 362.12 Mesenchymal stem cells primed with
valproate and lithium robustly migrate to infarcted region and
facilitate recovery in a stroke model. L. TSAI*; Z. WANG;
J. MUNASINGHE; Y. LENG; P. LEEDS; D. CHUANG. Natl.
Taiwan Univ. Hosp., NIH, NIH.
8:00 EE13 362.13 Hematopoetic endothelial progenitor cells
enhance motor function and motor map integrity following
cerebral ischemia. J. MOCCO*; A. AFZAL; N. THOMAS; Z.
WARRAICH; J. KLEIM. Univ. of Florida, Arizona State Univ.,
Arizona State Univ.
9:00 EE14 362.14 Systemic post-treatment with cell culture
media after cardiac arrest is therapeutic. N. R. BRANDON;
Y. TAKAHASHI; H. DOU; Y. XU*. Univ. Pittsburgh Sch. Med.,
Texas Tech. Univ. Hlth. Sci. Ctr.
10:00 EE15 362.15 Comparison of effects of human
umbilical cord mesenchymal cells versus umbilical cord
blood mononuclear cells in middle cerebral artery occlusion
model of stroke in rats. N. KARLUPIA*; S. P. CHETTY;
M. NORTON; G. K. STEINBERG. Stanford Univ. Sch. of
Medicine, Stanford Univ., All India Inst. of medical Sci.,
Stanford Univ. Sch. of Med., Stanford Univ. Sch. of Medicine,
Stanford Univ., Stanford Univ. Sch. of Med.
11:00 EE16 362.16 Motor, cognition, and emotional functions
in cerebral hypoxic ischemic damaged neonatal rats
are recovered by paracrine effect of human cord blood
mononuclear cells. S. BAE; T. KONG; H. LEE; K. KIM; M.
CHOPP; J. KANG; H. KIM; M. PARK; J. PARK; Y. SHIN; Y.
LEE; H. HAN; J. MOON*. CHA Univ., Henry Ford Hosp.
8:00 EE17 362.17 Enriched environment synergistically
enhances functional recovery after transplantation of
mesenchymal stem cells in hypoxic-ischemic brain injury. J.
YU; J. SEO; J. KIM; M. LEE; J. LEE; S. CHO*. Brain Korea
21 Project for Med. Science, Yonsei Univ., Yonsei Univ. Col.
of Med., Yonsei Univ. Col. of Med., Res. Inst. of Rehabil.
Med.
9:00 EE18 362.18 Timing of intra-arterial neural stem cell
transplantation after hypoxic-ischemia onset influences cell
survival and differentiation. S. ROSENBLUM*; N. WANG; J.
CHUA; H. BIRK; T. SMITH; R. GUZMAN. Stanford Univ.
10:00 EE19 362.19 Functional engraftment of CHR2expressing
human neural stem cells in experimental model
of stroke. G. STEINBERG; I. GOSHEN; J. KLAUSNER;
C. LEE-MESSER; G. SUN; K. DEISSEROTH; M. DAADI*.
Stanford Univ.
11:00 EE20 362.20 • Extensive neuronal fibers in the white
matter were detected after neural stem cell transplantation
to periventricular leukomalacia model rat. T. MASUDA*; M.
AOYAMA; S. MISUMI; R. NISHIGAKI; K. SAWAMOTO; K.
ASAI; H. HIDA. Nagoya City Unicersity Gradutate Sch. of
Med. Sci., Nagoya City Unicersity Gradutate Sch. of Med.
Sci., Nagoya City Unicersity Gradutate Sch. of Med. Sci.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
8:00 EE21 362.21 Neurovascular signaling systems in poststroke
neurogenesis. A. J. BRUMM*; M. MACHNICKI; G.
COPPOLA; D. GESCHWIND; S. T. CARMICHAEL. Univ. of
California Los Angeles.
9:00 EE22 362.22 • � Stable immortalized neural stem
cell line generated from adult human CNS. J. KIM; Y. SEO;
H. LEE*; I. LIM; S. LEE; S. KIM; K. CHANG; S. KIM. Chung-
Ang Univ. Col. of Med., Div. of neurology, Dept. of Medicine,
Univ. of British Columibia, Chaung -Ang Univ. Col. of Med.,
Natl. Primate Res. Center, KRIBB.
10:00 EE23 362.23 The conditioned medium derived from
human adipose stem cells show in vivo therapeutic effects
against the stroke. Y. CHO*. Seoul Natl. Univ. Col. of Med.
11:00 EE24 362.24 Striatal lesioning-induced neurogenesis in
adult mouse forebrain. H. ZHANG*; E. GUEORGUIEV; J. M.
PARENT. Univ. Michigan.
8:00 EE25 362.25 The therapeutic effects of intravenous
administration of human amniotic mesenchymal stem cells
on cerebral ischemic-reperfusion injury in rats. S. LU*. The
First Affiliated Hosp. of Soochow Univ.
9:00 EE26 362.26 Demonstration of neuroprotective
efficacy of mesenchymal stem cells and identification
of corresponding molecular correlates in an in vitro
neuronal culture oxygen and glucose deprivation model.
S. S. PRASAD*; C. A. LEBLANC-WESTWOOD; M.
NOWAKOWSKA; G. MURADIA; N. AL-ATTAR; M. ROSU-
MYLES. Hlth. Canada.
10:00 EE27 362.27 Neurogenesis in adult rodent models of
stroke. D. K. LEWIS*; H. ZHANG; J. M. PARENT. Univ. of
Michigan Hlth. Syst.
11:00 EE28 362.28 Stroke induces changes of subventricular
zone neurogenic and vascular niche. R. ZHANG*; M.
CHOPP; C. ROBERTS; X. WANG; X. LIU; M. WEI; Z.
ZHANG. Henry Ford Hosp., Henry Ford Hosp.
8:00 FF1 362.29 Characterization of stem cell-like
astrocytes from hypoxic cortex and hippocampus.
M. SIMONINI*; N. SALMASO; B. BI; D. PALEJEV; F.
VACCARINO. Yale Univ.
9:00 FF2 362.30 Reduction of neuroprogenitor cells in
mice impedes functional recovery without increasing stroke
size. C. SUN*; H. SUN; S. WU; T. CHANG; S. G. KERNIE; J.
LIU. Univ. of California, San Francisco, 2nd Affiliated Hosp.
of Zhejiang Univ. Med. Col., San Francisco VA Med. Ctr., 6th
People’s Hosp. of Shanghai Jiao Tong Univ., Univ. of Texas
Southwestern Med. Ctr.
POSTER
363. Trauma: Neuroprotection
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 FF3 363.01 Lithium ameliorates neurodegeneration,
suppresses neuroinflammation, and improves behavioral
performance in a mouse model of traumatic brain injury. F.
YU*; Z. WANG; F. TCHANTCHOU; C. CHIU; Y. ZHANG; D.
CHUANG. NIH, Uniformed Services Univ. of the Hlth. Sci.,
Uniformed Services Univ. of the Hlth. Sci.
9:00 FF4 363.02 • Progranulin suppresses excessive
activation of CD68-positive microglia following traumatic
brain injury in mice. Y. TANAKA*; T. MATSUWAKI; K.
YAMANOUCHI; M. NISHIHARA. Univ. of Tokyo.
Neuroscience 2011 | Monday AM | 39
Mon. AM

10:00 FF5 363.03 • Adenosine 2A receptors exert opposite
effects on brain damage in mild and severe traumatic brain
injury of mice. S. DAI*; X. FU; X. HE; G. LI; Y. ZENG; F. HE.
The Third Military Med. Univ.
11:00 FF6 363.04 Continuous infusion of erythropoietin
has neuroprotective effects on experimental traumatic brain
injury model of rats. T. KADOTA*; T. YASUHARA; K. SATOU;
Y. OKUMA; M. KAMEDA; J. TAYRA; T. HISHIKAWA; Y.
MIYOSHI; K. ONODA; I. DATE. Okayama Univ, Grad Sch.
Med., Japanese Red Cross Okayama Hosp., Shin Komonji
Hosp.
8:00 FF7 363.05 • Simvastatin attenuates axonal injury
and promotes neurite outgrowth after traumatic brain injury.
H. WU*; A. MAHMOOD; C. QU; Y. XIONG; M. CHOPP.
Henry Ford Hosp., Henry Ford Hosp.
9:00 FF8 363.06 Velcade improves functional recovery
by inhibiting the inflammatory response and reducing lesion
volume in rats following traumatic brain injury. C. QU*; M.
ASIM; X. YE; R. NING; H. WU; L. ZHANG; J. CHEN; H.
JIANG; M. CHOPP. Henry Ford Hlth. Syst., Henry Ford Hlth.
Syst.
10:00 FF9 363.07 Selective inhibition of α/β-hydrolase
domain 6 attenuates neurodegeneration, alleviates
blood brain barrier breakdown and improves behavioral
performance in a mouse model of traumatic brain injury. F.
TCHANTCHOU*; Y. ZHANG. Uniformed Services Univ. of
the Hlth. Sci., Uniformed Services Univ. of the Hlth. Sci.
11:00 FF10 363.08 Post-injury administration of a novel CNS
experimental therapeutic in the rodent fluid percussion model
extends the potential range of efficacy to diffuse traumatic
brain injury. A. D. BACHSTETTER*; D. M. WATTERSON; R.
ROWE; J. LIFSHITZ; L. J. VAN ELDIK. Univ. of Kentucky,
Northwestern Univ. Feinberg Sch. of Med., Univ. of Kentucky,
Univ. of Kentucky, Univ. of Kentucky.
8:00 FF11 363.09 Novel neuroprotective strategies for
aberrant neuronal signal transduction in traumatic brain
injury. M. I. TORRES-ALTORO*; K. DAY; R. GOLDEN; F.
LU; K. KANGASNIEMI; M. TAKAHASHI; S. G. KERNIE; J. A.
BIBB. UT Southwestern Med. Ctr.
9:00 FF12 363.10 Calpastatin overexpression in transgenic
mice reduces acute posttraumatic calpain-mediated
cleavage of spectrin and sodium channel protein. K. M.
SCHOCH*; C. R. VON REYN; G. C. TELLING; D. F.
MEANEY; K. E. SAATMAN. Univ. of Kentucky, Univ. of
Pennsylvania, Univ. of Kentucky.
10:00 FF13 363.11 � HSP70-inducer 17-AAG as a potential
therapeutic for traumatic brain injury. N. KIM; M. A. YENARI*.
Univ. California, San Francisco and San Francisco Veterans
Affairs Med. Ctr.
11:00 FF14 363.12 Neurobiology and pathophysiology of tbiinduced
long term disabilities, spacticity, cognitive, balance,
anxiety, and pain related behaviors. F. J. THOMPSON*;
R. NELSON; J. HOU; R. PARMER; K. WILLIAMS; S.
SENNHAUSER; N. NISSIM; P. JAISWAL; J. KEENER; P.
BOSE. Malcom Randall VAMC, Univ. of Florida, Univ. of
Florida, Malcom Randall VAMC, Univ. of Florida.
8:00 FF15 363.13 • Intrathecal baclofen (ITB) treatment
in acute TBI more effectively reduced spasticity than ITB
treatment in sub-chronic TBI. P. K. BOSE*; R. NELSON;
J. HOU; R. PARMER; K. WILLIAMS; N. NISSIM; S.
SENNHAUSER; J. KEENER; P. W. WACNIK; F. J.
THOMPSON. North Florida/South Georgia VAMC, Univ. of
Florida, Univ. of Florida, Medtronic Inc, Univ. of Florida.
9:00 FF16 363.14 RNA Interference against aquaporin 4
improves neurological outcome after juvenile traumatic brain
injury. A. ADAMI*; A. FUKUDA; S. ASHWAL; A. OBENAUS;
J. BADAUT. UC Riverside, Loma Linda Univ., Loma Linda
Univ., Loma Linda Univ., Loma Linda Univ.
10:00 FF17 363.15 Neuroprotective effects of NA-1, a novel
PSD-95 blocker, in a rodent model of penetrating ballistic-like
brain injury. D. A. SHEAR*; X. M. LU; R. PEDERSEN; F. C.
TORTELLA. Walter Reed Army Inst. of Res.
11:00 FF18 363.16 Cyclin D1 knockout mice show
neuroprotection after traumatic brain injury. S. V. KABADI*;
B. A. STOICA; K. R. BYRNES; D. J. LOANE; M. HANSCOM;
R. M. CABATBAT; A. I. FADEN. Univ. of Maryland, Uniformed
Services Univ.
8:00 FF19 363.17 The angiotensin II type I receptor
antagonist, Candesartan, protects against traumatic brain
injury in mice. S. VILLAPOL*; A. YASZEMSKI; E. SANCHEZ-
LEMUS; J. M. SAAVEDRA; A. J. SYMES. Ctr. For Neurosci.
and Regenerative Med., Natl. Inst. of Mental Hlth.
9:00 FF20 363.18 Additive neuroprotection by combined
inhibition of caspase- and AIF-dependent cell death
pathways after controlled cortical impact injury in mice. C.
PIAO*; B. STOICA; D. LOANE; S. LI; M. HANSCOM; R.
CABATBAT; K. BLOMGREN; A. FADEN. Univ. of Maryland,
Baltimore Sch. of Med., Goteborg University, Inst. of
Neurosci. and Physiol.
10:00 FF21 363.19 PEG-PDLLA micelles repair neuronal
membranes and improve axonal function after traumatic
brain injury. X. PING; S. LEE; J. CHENG; X. JIN*. IUPUI,
Purdue Univ.
11:00 FF22 363.20 c-Jun-N-terminal Kinase pathway inhibitor
provides long-term protection from fine motor deficits
following juvenile traumatic brain injury. J. A. BELLONE; D.
AJAO; J. BADAUT; R. E. HARTMAN*. Loma Linda Univ.,
Loma Linda Univ.
8:00 FF23 363.21 Effect of traumatic brain injury and
ceftriaxone treatment on expression of the glutamate
transporter GLT1 in the rat brain. G. S. GOODRICH; A.
Y. KABAKOV*; M. Q. HAMEED; P. A. ROSENBERG; A.
ROTENBERG. Children’s Hospital, Harvard Med. Sch.
9:00 FF24 363.22 Anti-CD11d treatment reduces leukocyte
infiltration and improves functional recovery in rats after
traumatic brain injury. F. BAO; S. R. SHULTZ; J. HEPBURN;
V. OMANA; L. C. WEAVER; D. P. CAIN; A. BROWN*.
Robarts Res. Inst., Univ. of Western Ontario, Univ. of
Western Ontario.
10:00 FF25 363.23 Inhibition of P2X7 improves neurologic
outcomes in a murine model of traumatic brain injury. D.
KIMBLER*; J. SHIELDS; K. DHANDAPANI. Georgia Hlth.
Sci. Univ.
11:00 FF26 363.24 Neuroprotection by Acetyl-L-carnitine
after traumatic brain injury in immature rats. S. SCAFIDI*; J.
RACZ; D. SHI; S. XU; R. GULLAPALLI; M. C. MCKENNA;
G. FISKUM. Univ. Maryland, Univ. Maryland, Univ. Maryland,
Univ. Maryland.
8:00 FF27 363.25 Intranasal neuroprotectants reduce
edema by AQP4 downregulation following traumatic brain
injury. M. H. DIGICAYLIOGLU*; S. SPRAGUE; L. WATTS;
T. EVANS; L. FLETCHER; D. F. JIMENEZ. UTHSCSA,
UTHSCSA.
40 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 FF28 363.26 • Inhibition of the neuronal voltage
gated P/Q calcium channel reduces secondary brain
damage after experimental traumatic brain damage in
mice. N. A. TERPOLILLI*; R. DOLP; A. M. J. M. VAN DEN
MAAGDENBERG; M. D. FERRARI; N. PLESNILA. Univ.
of Munich, Dept. of Neurosurg., Univ. of Munich, Univ. of
Leiden, Univ. of Leiden, Royal Col. of Surgeons in Ireland.
10:00 FF29 363.27 Inhibition of beta adrenergic signaling
after traumatic brain injury improves behavioral performance.
M. CLOND*; M. SINGER; E. J. LEY. Cedars Sinai Med. Ctr.
11:00 FF30 363.28 The Jak-STAT and MAPK-ERK pathways
mediate CNTF-induced magnocellular neuron survival in the
SON. J. M. ASKVIG*; D. Y. LO; L. J. LEIPHON; J. A. WATT.
Univ. of North Dakota.
8:00 FF31 363.29 Pycnogenol®: A natural compound that
thwarts injury cascades after TBI. M. A. ANSARI*; K. N.
ROBERTS; S. W. SCHEFF. Univ. Kentucky.
9:00 FF32 363.30 Edaravone suppressed secondary
neuronal cell damage after traumatic brain injury in
mice. K. MIYAMOTO; H. OHTAKI; K. DOHI; D. SONG; T.
TSUMURAYA; H. NAKANO; K. KIRIYAMA; H. KAGEYAMA*;
T. ARUGA; S. SHIODA. Showa Univ. Sch. of Med., Showa
Univ. Sch. of Med.
POSTER
364. Cell Death: Mitochondria
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 FF33 364.01 Isolation of brain mitochondria from
neonatal mice. X. WANG*; A. LEVERIN; W. HAN; C. ZHU;
B. R. JOHANSSON; E. JACOTOT; V. S. TEN; N. R. SIMS;
H. HAGBERG. Inst. for Neurosci. and Physiology, Univ. of
Gothenburg, Inst. for Biomedicine,, Imperial Col., Columbia
Univ., Sch. of Medicine, Flinders Univ., Sahlgrenska
Academy,University of Gothenburg.
9:00 FF34 364.02 Synaptosomal mitochondria is more
susceptible to calcium overload than nonsynaptosomal
mitochondria. S. CHATTIPAKORN*; C. YARANA; J.
SANIT; N. CHATTIPAKORN. Chiang Mai Univ., Cardiac
Electrophysiology Res. and Training Ctr.
10:00 GG1 364.03 • Evaluation of mitochondrial dysfunction
and oxidative stress in CNS with novel imaging tools. D. W.
BEACHAM*; B. S. MANDAVILLI; L. PIGNATARO; M. YAN;
M. S. JANES. Life Technologies, Invitrogen Corp., Columbia
Univ.
11:00 GG2 364.04 Mitochondrial dysfunction-triggered
autophagy activation and cell death in astrocytes. G. J.
PEREIRA*; N. C. TRESSOLDI; S. S. SMAILI. Federal Univ.
of São Paulo.
8:00 GG3 364.05 RanBP9 promotes apoptosis via a
mitochondria-mediated mechanism. T. LIU*; S. ROH; D.
KANG. Seoul Natl. Univ. Col. of Med., Seoul Natl. Univ. Col.
of Med., UCSD.
9:00 GG4 364.06 The bHLH transcription factor NeuroD6
mediates a nuclear-mitochondrial crosstalk during
neuronal differentiation. M. N. UITTENBOGAARD; A. E.
CHIARAMELLO*. George Washington Univ. Med. Ctr.,
George Washington Univ. Med. Ctr.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
10:00 GG5 364.07 The c-subunit of the F1FO ATP synthase
contains a leak channel that regulates neuronal metabolism
and survival. K. N. ALAVIAN*; E. LAZROVE; P. NABILI; E. A.
JONAS. Yale Univ.
11:00 GG6 364.08 Bcl-xL enhances neuronal metabolic
efficiency through interaction with F1Fo ATP synthase. E.
A. JONAS*; H. LI; P. NABILI; E. LAZROVE; P. J. SMITH; J.
HARDWICK; K. N. ALAVIAN. Yale Univ. Sch. Med., Univ. of
Southampton, John Hopkins Univ.
8:00 GG7 364.09 KCa2.2 channels are located at the inner
mitochondrial membrane - implications for mitoprotection.
A. M. DOLGA*; F. PEROCCHI; N. DOTI; L. MEISSNER;
S. TOBABEN; J. GROHM; H. ZISCHKA; N. PLESNILA; C.
CULMSEE. Philipps-Universität Marburg, Dept. of Systems
Biol. and Med., Royal Col. of Surgeons in Ireland (RCSI),
Inst. of Biostructures and Bioimaging, Inst. of Toxicology.
9:00 GG8 364.10 Magnesium sulfate improves neuronal
bioenergetics following excitotoxic glutamate exposure. P.
CLERC; A. GRIGORE; G. FISKUM; B. M. POLSTER*. Univ.
Maryland Sch. of Med.
10:00 GG9 364.11 The mitochondrial protein prohibitin
(PHB) interacts with respiratory chain complex I and III
in neural cells. P. ZHOU*; L. QIAN; J. ANRATHER; G.
MANFREDI; C. IADECOLA. Weill Med. Coll Cornell Univ.
11:00 GG10 364.12 Effects of chronicle oxidative stress on
mitochondrial function in hippocampus of rats exposed to
ozone. A. E. RODRIGUEZ*; F. MARTINEZ; T. ESPINOSA; S.
RIVAS ARANCIBIA. UNAM, UNAM, UNAM, UNAM.
8:00 GG11 364.13 Melatonin attenuates KA-induced
α-synuclein aggregation and autophagy. M. A. LIN*.
Veterans Gen Hosp Taipei, Natl. Yang-Ming Univ.
9:00 GG12 364.14 Neurite-associated apoptosis: Microfluidic
approach for analysis of intracellular transmission of cell
death information. Y. EDAGAWA*; T. WATANABE; M. FUJII;
K. KAWAII; S. SHOJI. Waseda Univ., Grad. Sch. of Sci.
and Engineering, Waseda Univ., Grad. Sch. of Engineering,
Osaka Univ., Facluty of Sci. and Engineering, Waseda Univ.
10:00 GG13 364.15 • Acetyl-L-carnitine improves in
vitro mitochondrial bioenergetics and function. T.
SUMMAVIELLE*; L. CUNHA; J. BRAVO; S. FERNANDES;
A. MAGALHÃES; Z. BINIENDA; A. VIRMANI. Inst. de Biol
Mol. e Celular, ESTSP-IPP, NCTR/FDA, Sigma-tau S.p.A.
11:00 GG14 364.16 Elucidation of the relationship between
Zn 2+ sequestration within neuronal mitochondria and the
generation of reactive oxygen species. A. D. CLAUSEN*;
J. H. WEISS. Univ. of California, Irvine, Univ. of California,
Irvine.
8:00 GG15 364.17 The regulation of reactive oxygen species
production by permeability transition pore opening in rat
brain mitochondria. N. I. KONONENKO*; O. V. AKOPOVA; L.
I. KOLCHINSKAYA; V. I. NOSAR; M. K. MALYSHEVA; V. F.
SAGACH. Inst. Physiol.
9:00 GG16 364.18 Inhalation anesthetic isoflurane induces
mitochondrial dysfunction. Y. ZHANG; Z. XU; H. WANG; Y.
DONG; R. E. TANZI; Z. XIE*. Massachusetts Gen. Hosp.
and Harvard Med. Sch., Massachusetts Gen. Hosp. and
Harvard Med. Sch.
Neuroscience 2011 | Monday AM | 41
Mon. AM

POSTER
365. Oxidative Stress I
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 GG17 365.01 Inducibility of heat shock proteins
by celastrol and temperature elevation varies with
developmental age of primary cortical cultures. A. M.
CHOW*; D. W. F. TANG; A. HANIF; I. R. BROWN. Univ. of
Toronto Scarborough.
9:00 GG18 365.02 Stress-induced localization of HSP70
proteins to centrosomes (Microtubule Organizing Centers-
MTOCs) in cultured human neuronal cells. S. KHALOUEI*;
A. M. CHOW; I. R. BROWN. Univ. of Toronto Scarborough.
10:00 GG19 365.03 Overexpression of HSP70 is
neuroprotective in in vitro models of neuronal apoptosis.
B. E. SABIRZHANOV*; B. STOICA; M. HANSCOM; A.
I. FADEN. Univ. of Maryland, Univ. of Maryland, Univ. of
Maryland Sch. of Med.
11:00 GG20 365.04 Engineered nanoparticles from metals
alter regional distribution of immunoreactive dynorphin A (1-
13) in normal and heat stressed rat brain. F. J. NYBERG*;
R. PATNAIK; A. SHARMA; H. S. SHARMA. Uppsala Univ.,
Banaras Hindu Univ., Univ. Hospital, Uppsala Univ.
8:00 GG21 365.05 Role of an ER stress response element in
regulating the bidirectional promoter of the mouse CRELD2-
ALG12 gene pair. K. KIUCHI*; K. OH-HASHI; H. KAGA; S.
IKEDA; K. SHAMADA; Y. HIRATA. Dept Biomol Sci, Fac
Engineering, Gifu Univ., Kazusa DNA Res. Inst.
9:00 GG22 365.06 Effect of oxidative stress on foxo,
inflammatory response in hippocampus of rats exposed to
ozone. N. GOMEZ-CRISOSTOMO*; C. GALLEGOS-RIOS;
E. RODRÍGUEZ-MARTÍNEZ; S. RIVAS-ARANCIBIA. UNAM.
10:00 GG23 365.07 • Nuclear receptor interacting protein 1: A
potential governor of stress granule assembly. X. FENG; P.
HO; L. WEI*. Univ. Minnesota.
11:00 GG24 365.08 Cyp2e1 induction and oxidative stress in
cerebellar granule neurons. A. C. VALENCIA*; J. MORÁN;
J. J. ESPINOSA-AGUIRRE. Inst. De Investigaciones
Biomédicas UNAM, Inst. de Fisiología Celular.
8:00 GG25 365.09 Pterostilbene, a resveratrol analog found
in blueberries, enhances calcium buffering in hippocampal
cells and reduces stress signaling in BV-2 mouse microglia.
A. N. CAREY*; D. R. FISHER; S. M. GOMES; A. M.
RIMANDO; D. F. BIELINSKI; B. SHUKITT-HALE. USDA-
ARS Human Nutr. Res. Ctr., USDA ARS Natural Products
Utilization Res. Unit.
9:00 GG26 365.10 • The effects of blueberry and strawberry
combinations in reducing inflammation in BV-2 mouse
microglia. B. SHUKITT-HALE*; D. F. BIELINSKI; S. M.
GOMES; D. R. FISHER. Human Nutrit Res. Ctr. On Aging.
10:00 GG27 365.11 • Walnut extracts reduce
polyubiquitinated protein aggregates in hippocampus and
striatum of aged rats as well as brain cells in culture. D. F.
BIELINSKI*; S. M. POULOSE; B. SHUKITT-HALE. USDA
Human Nutr. Res. Ctr, Tufts Univ.
11:00 GG28 365.12 • Effects of dietary blueberry and
strawberry on behavior associated with inflammation and
microglial activation in the hippocampus and striatum of
aged rats. M. G. MILLER*; A. N. CAREY; B. SHUKITT-
HALE. Tufts Univ., USDA-ARS, HNRCA at Tufts Univ.
8:00 GG29 365.13 Nutraceuticals offer protection from
neuronal apoptosis resulting from nitrosative and oxidative
stress in rat cerebellar granule neurons. J. J. GRAY*;
T. C. SUTCLIFFE; A. N. WINTER; N. A. KELSEY; D. A.
LINSEMAN. Univ. of Denver, Veterans Affairs Med. Ctr.
9:00 GG30 365.14 Factors of inflammation in a model of
stress-induces anhedonia with internal control for stress:
A pharmacological study in mice. J. COSTA-NUNES*; H.
W. M. STEINBUSCH; J. VIGNISSE; A. I. M. SANTOS; T.
STREKALOVA. Ctr. de Biologia Ambiental, Dept. de Biologia
Animal da Faculdade de Ciências da Univ. de Lisboa, Dept.
of Neuroscience, Sch. for Mental Hlth. and Neuroscience,
Maastricht Univ., Bioenergetics and Cerebral Excitability
Unit, Giga-Research, Univ. of Liége, Dept. de Fisiologia da
Faculdade de Ciências Médicas da Univ. Nova de Lisboa.
10:00 GG31 365.15 Antiretroviral drugs induce oxidative
stress and neuronal death in the central nervous system.
C. AKAY*; M. COOPER; A. ODELEYE; M. G. WHITE; S.
CROSS; D. R. COOK; F. M. VASSOLER; P. J. GANNON; A.
M. BUCH; M. PENA; D. LAMORTE; E. S. ANDERSEN; M.
CHRISTOFIDOU-SOLOMIDOU; K. A. LINDL; R. PIERCE; D.
L. KOLSON; K. L. JORDAN-SCIUTTO. Univ. Pennsylvania,
Univ. Pennsylvania, Univ. Pennsylvania.
11:00 GG32 365.16 A role for cell cycle protein E2F1 in HIVinduced
neurotoxicity. J. ZYSKIND*; Y. WANG; C. AKAY; D.
KOLSON; K. JORDAN-SCIUTTO. Univ. of Pennsylvania,
Univ. of Pennsylvania.
8:00 GG33 365.17 • Antiretroviral drugs activate the
neuronal unfolded protein response and alter app processing
in primary neuronal cultures. P. J. GANNON*; C. AKAY;
D. KOLSON, M.D., Ph.D; K. JORDAN-SCIUTTO. Univ. of
Pennsylvania, Univ. of Pennsylvania.
9:00 GG34 365.18 • Restoration of stressor-induced calcium
dysregulation and autophagy function in vitro by polyphenolrich
acai berry extracts. S. M. POULOSE*; D. R. FISHER; D.
F. BIELINSKI; B. SHUKITT-HALE. USDA-ARS, Jean Mayer
Human Nutr. Res. Ctr. On Aging.
10:00 GG35 365.19 Functional roles for E2F1 in the synapse:
Potential mechanisms of synaptic damage in HIV-associated
dementia. J. H. TING*; S. SCHLEIDT; J. WU; Y. WANG; D.
R. MARKS; K. L. JORDAN-SCIUTTO. Univ. of Pennsylvania,
Univ. of Pennsylvania.
POSTER
366. Neuroprotection
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 GG36 366.01 Erythropoietin (EPO) and EPO receptor
expression patterns in neuronal and glial cells of the
adult retina after optic nerve lesion. S. G. WOHL; C. W.
SCHMEER*; L. GUMMLICH; O. W. WITTE; S. ISENMANN.
Hans Berger Dept. of Neurol., Univ. of Witten/Herdecke,
HELIOS Klinikum Wuppertal.
9:00 HH1 366.02 Astrocyte-specific overexpression of
insulin-like growth factor-1 protects hippocampal neurons
following traumatic brain injury in mice. S. KIZHAKKE
MADATHIL*; J. BRELSFOARD; K. SAATMAN. Univ.
Kentucky.
42 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

10:00 HH2 366.03 Extracellular progranulin protects cortical
neurons from toxic insults by activating survival signaling.
J. BRUBAN; J. XU; M. XILOURI; J. SHIOI; Z. SHAO; A.
GEORGAKOPOULOS*; I. PAPAZOGLOU; K. VEKRELLIS;
N. K. ROBAKIS. Mount Sinai Sch. Med., Div. of Basic
Neurosciences, Biomed. Res. Fndn. of the Acad. of Athens.
11:00 HH3 366.04 Apocynin protects the developing
hippocampus against irradiation-induced injury. M. KALM*;
S. MISUMI; K. BLOMGREN. Univ. of Gothenburg.
8:00 HH4 366.05 Mithramycin A protects neurons from
apoptosis via transcriptional inhibition of two BH3-only
proteins: Bim and Dp5/Hrk. Q. HUANG*; B. XIE; M. LI. Dept.
of Pharmacology, Zhongshan Sch. of Medicine, Sun Yat-Sen
Univ.
9:00 HH5 366.06 Desipramine protects neuronal cell death
through heme oxygenase-1 expression. H. LIN*; H. LIN; D.
LU. Natl. Chung Hsing Univ., China Med. Univ.
10:00 HH6 366.07 Neuroprotective effects of endogenous
neural peptide apelin against ischemic stroke. D. CHEN; L.
WEI; Q. KERN; S. YU*. Emory Univ.
11:00 HH7 366.08 Lymphocytes exhibit neuroprotection
in kainate-induced cell death via astrocytic activation
and inhibition of MAP kinase signalling pathways. R.
SHRESTHA*; O. MILLINGTON; J. BREWER; T. J.
BUSHELL. Univ. of Strathclyde, Univ. of Glasgow.
8:00 HH8 366.09 • 4R-cembratrienediol protects against
diisopropylfluorophosphate-induced neurodegeneration with
a long window of therapeutic opportunity. P. FERCHMIN*; J.
M. ALVES; D. PEREZ; B. CUADRADO; M. CARRASCO; J.
M. VELEZ ROMAN; H. A. B. MARTINS; A. C. SEGARRA;
V. A. ETEROVIC. Univ. Central Del Caribe, Univ. Central
Del Caribe, Univ. Central del Caribe, Univ. of Puerto Rico-
Medical Sci. Campus, Univ. C. del Caribe.
9:00 HH9 366.10 APPL1 mediates synaptic NMDA
receptor-dependent neuroprotection. Y. WANG*; S. QIU; J.
WANG; S. WANG; J. LUO. Inst. of Neurobiology, Zhejiang
Univ. Sch. of Med.
10:00 HH10 366.11 Role of cholinergic neurons in
neuroprotection in rats exposed to hypobaric hypoxia. S.
MUTHURAJU*; S. PATI; J. ADBULLAH; G. ILAVAZHAGAN.
UNIVERSITY SAINS MALAYSIA, Defence Inst. of Physiol.
and Allied Sci.
11:00 HH11 366.12 Neurochemical perturbations, and
cognitive and motor dysfunctions in rats following perinatal
lead exposure: Protective effect of calcium supplement. D.
CHAND BASHA*; G. RAJARAMI REDDY. Sri Venkateswara
Univ.
8:00 HH12 366.13 Functional and structural protection of
retinal ganglion cells by N-acylethanolamines in diabetic
retinopathy. P. KOULEN*; R. S. DUNCAN; S. KAJA. Univ. of
MO - Kansas City, Vision Res. Center, Univ. of MO - Kansas
City.
9:00 HH13 366.14 Protective role of omega 3 fatty acid
against metal mixture induced neurodevelopmental damage.
A. RAI*; P. KHARE; S. BANDYOPADHYAY. Indian Institute
Of Toxicology Research, Indian Institute Of Toxicology
Research, Indian Institute Of Toxicology Research.
10:00 HH14 366.15 Pituitary adenylate cyclase-activating
polypeptide counteracts the impaired adult neural stem
cell viability induced by palmitate. S. MANSOURI; H.
ORTSÄTER; O. PINTOR GALLEGO; V. DARSALIA; Å.
SJÖHOLM; C. PATRONE*. Karolinska Institutet, Dept. of
Clin. Sci. and Educ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
11:00 HH15 366.16 Progranulin deficiency promotes
neuroinflammation and neuronal loss in an acute model
of toxin-induced CNS injury. L. H. MARTENS*; J. ZHANG;
P. ZHOU; S. J. BARMADA; S. KAMIYA; S. MIN; Y. ZHOU;
L. GAN; S. FINKBEINER; E. J. HUANG; R. V. FARESE,
Jr. Gladstone Inst., Univ. of California, San Francisco,
Gladstone Inst.
POSTER
367. Neuroprotection: New Molecules and Mechanisms
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 HH16 367.01 • Effects of eribulin, vincristine, paclitaxel,
and ixabepilone on kinesin-driven microtubule gliding. N. E.
LAPOINTE*; L. WILSON; S. C. FEINSTEIN; M. JORDAN.
Univ. of California Santa Barbara, Univ. of California, Santa
Barbara, Univ. of California, Santa Barbara.
9:00 HH17 367.02 Neuroprotective effects of silibinin in
obese diabetic mice. G. SCAPAGNINI*; S. DAVINELLI; D.
ZELLA; N. VICECONTE; F. LA DELIA; G. LI VOLTI. Univ.
Molise, Dept. of Hlth. Sciences, Fac. of Medicine, Univ. of
Molise, Dept. of Biochem. and Mol. Biology, Inst. of Human
Virology - Sch. of Med., Dept. of Heart and Great Vessels,
Dept. of Drug Sciences, Section of Biochemistry, Univ. of
Catania.
10:00 HH18 367.03 SN79 attenuates the neurotoxic effect
of methamphetamine: In vivo and in vitro studies. N.
KAUSHAL*; C. R. MCCURDY; R. R. MATSUMOTO. West
Virginia Univ., Univ. of Mississippi.
11:00 HH19 367.04 � Beneficial effect of a novel TNFalpha
protein synthesis inhibitor in a rat model of chronic
neuroinflammation. T. JOPSON; K. BELARBI; D. TWEEDIE;
C. ARELLANO; W. LUO; N. H. GREIG; S. ROSI*. Univ. of
California San Francisco, Natl. Inst. on Aging, NIH.
8:00 HH20 367.05 • The effect of peripheral neuropeptide
Y receptor 1 antagonism on inflammation and behavior. H.
RUIZ*; S. SANI; N. RUPANI; O. CALDERON; P. PANDAY; S.
D. CROLL. Queens Col., Grad. Ctr. of CUNY, Queens Col.,
Regeneron Pharmaceuticals.
9:00 HH21 367.06 Neuroprotective effects of the methylene
chloride fraction of mBHT, a polyherbal medicine, on middle
cerebral artery occlusion-induced ischemic stroke in rats. T.
OHR*; H. JUNG; K. PARK; Y. PARK; C. -. HAN*. Dongguk
Univ., Oriental Med. R&D Ctr.
10:00 HH22 367.07 Comparison of the effectiveness of
galantamine and pyridostigmine as antidotes against the
toxicity of sarin: Electroencephalographic (EEG) recordings
and Fluoro Jade-B staining. Y. ARACAVA*; G. KULKARNI; E.
F. R. PEREIRA; E. X. ALBUQUERQUE. Univ. Maryland Sch.
Med.
11:00 HH23 367.08 Acetylcholinesterase inhibition by
soman reveals endogenous nicotinic cholinergic modulation
of AMPA EPSCs in guinea pig CA1 stratum radiatum
interneurons. M. ALKONDON*; E. F. R. PEREIRA; Y.
ARACAVA; E. X. ALBUQUERQUE. Univ. Maryland Sch.
Med.
8:00 HH24 367.09 • Neuroprotective effects of dimethyl
fumarate on malonate-induced striatal lesion volume in
sprague-dawley rat brain. C. HUANG; R. H. SCANNEVIN*;
R. HUANG; T. M. ENGBER; K. J. RHODES; H. M. ARNOLD.
Biogen Idec.
Neuroscience 2011 | Monday AM | 43
Mon. AM

9:00 HH25 367.10 Delayed effects of a single exposure to
the organophosphorus pesticide chlorpyrifos on emotional
and cognitive behavior in guinea pigs. J. MAMCZARZ*; L.
GAVRUSHENKO; Y. ARACAVA; E. F. R. PEREIRA; E. X.
ALBUQUERQUE. Univ. of Maryland Sch. Med.
10:00 HH26 367.11 Histone acetylation induced by exposure
to organophosphorus agents in guinea pig brain is prevented
by treatment with galantamine. W. R. RANDALL*; E. F. R.
PEREIRA; M. AKKERMAN; E. X. ALBUQUERQUE. Univ.
Maryland Sch. Med., Univ. of Maryland.
11:00 HH27 367.12 Beneficial effects of αB-crystallin in spinal
cord contusion injury. A. J. KLOPSTEIN*; E. SANTOS-
NOGUEIRA; A. REDENSEK; S. DAVID; X. NAVARRO; R.
LOPEZ-VALÉS. Univ. Autonoma De Barcelona, Res. Inst. of
the McGill Univ. Hlth. Ctr.
8:00 HH28 367.13 Absence of tolerance to the
anticonvulsant and neuroprotective effects of imidazenil
against diisopropyl fluorophosphate-induced seizure and
neuronal damage. B. KADRIU; J. GOCEL; J. LARSON; A.
GUIDOTTI; J. M. DAVIS; M. P. NAMBIAR; J. AUTA*. Univ. of
Illinois At Chicago, Walter Reed Army Inst. of Res.
9:00 HH29 367.14 Neuroprotection afforded by galantamine
in guinea pigs exposed to the organophosphorus
poison soman. G. KULKARNI; E. F. R. PEREIRA; F. L.
MARGOLIS*; E. X. ALBUQUERQUE. Univ. Maryland Sch.
Med., Univ. Maryland Sch. Med.
10:00 HH30 367.15 Effects of methylmercury on the
maintenance of dopamine homeostasis in PC12 cells.
C. T. TIERNAN*; E. A. EDWIN; J. L. GOUDREAU; W. D.
ATCHISON; K. J. LOOKINGLAND. Michigan State Univ.
11:00 HH31 367.16 Secreted phospholipase A2 (sPLA2)
involvement in neurodegeneration: Differential effects of
sPLA2 inhibitor CHEC-9 on neural and immune cells. S.
CHEN*; L. YAO; T. CUNNINGHAM. Drexel Univ,College
Med.
8:00 HH32 367.17 The neuroprotective effect of extract
of Chelidonium majus. A. JALSRAI*; J. LONG; J. LIU; P.
DOHERTY; R. WILLIAMS. Ctr. of Traditional Med., 1Institute
of Mitochondrial Biol. and Medicine, Dept. of Biol. Sci. and
Engineering, The Key Lab. of Biomed. Information Engin. of
Ministry of Education, Xi’an Jiaotong Univ. Sch. of Life Sci.
and Technol., Univ. of Kentucky Col. of Med., The Wolfson
Ctr. for Age-Related Diseases, King’s Col. London, Univ. of
Bath.
9:00 II1 367.18 Effects of low-level nerve agent exposure
and galantamine on acetylcholinesterase activity in vivo. W.
P. FAWCETT; E. F. PEREIRA*; Y. ARACAVA; M. ADLER; E.
X. ALBUQUERQUE. Univ. Maryland Sch. Med., USAMRICD.
10:00 II2 367.19 Effects of remifentanil against septic
shock model. Y. TOMOYASU; S. MAEDA*; H. HIGUCHI;
M. SUDA; M. ISHII; T. MIYAWAKI. Okayama Univ. Hosp.,
Okayama University, Grad. Sch. of Medicine, Dent. and
Pharmaceut. Sci.
11:00 II3 367.20 An unbiased chemical screen
for transcriptional inducers of p21 waf1/cip1 identifies
neuroprotective compounds with anti-tumor activity, including
inhibitors of hypoxia-inducible factor proyl-4-hydroxylases.
T. C. MA*; B. KO; B. LANGLEY; R. R. RATAN. Burke Med.
Res. Inst., Weill Med. Col. of Cornell Univ.
8:00 II4 367.21 Development of therapeutic methods for
rodent model of mps type ii (hunter syndrome) using neural
stem cells secreting iduronate-2-sulfatase (ids). J. AN*.
Seoul Natl. Univ. Col. of Med.
9:00 II5 367.22 Valproic acid induces CDNF and MANF
expression in neural stem cells. W. ALMUTAWAA; N. KANG;
S. BAHNA; Y. PAN; L. P. NILES*. McMaster Univ.
10:00 II6 367.23 Peptide-mediated inhibition of AIF/CypA
interaction: A new strategy for neuroprotection. N. DOTI; C.
REUTHER; L. SCOGNAMIGLIO; J. GHROM; A. DOLGA;
N. PLESNILA*; M. RUVO; C. CULMSEE. Royal Coll. of
Surgeons (RCSI), Inst. of Bioimaging and Biostructures-
CNR, Inst. for Pharmacol. and Clin. Pharm. Univ. of Marburg.
11:00 II7 367.24 • Proteomic approach to the study of
neuroprotection following intranasal deferoxamine. D. B.
RENNER*; J. M. FINE; A. B. CAGAN; J. M. CROW; J. M.
COONER; W. H. FREY II; L. R. HANSON. Regions Hosp.,
Univ. of Minnesota.
8:00 II8 367.25 Histone deacetylase inhibitor
suberoylanilide hydroxamic acid normalizes the levels of
very long chain fatty acids in human skin fibroblasts from
x-adrenoleukodystrophy patients and downregulates the
expression of proinflammatory cytokines in abcd1/2 silenced
mouse astrocytes. J. SINGH; M. KHAN; I. SINGH*. Med.
Univ. South Carolina.
9:00 II9 367.26 Anthocyanins protects against ethanolinduced
neuronal apoptosis via GABA B receptor in prenatal
rat hippocampal neurons. L. HAE YOUNG*; U. IKRAM; M.
KIM. Res. Institue of Natural Sci., Gyeongsang Natl. Univ.
POSTER
368. Animal Molecular and Pharmacological Models of
Psychotic Diagnoses
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 II10 368.01 Low dose locomotor depressant effects
of ketamine. M. BATES*; M. KLUMPH; K. A. TRUJILLO.
California State Univ. San Marcos.
9:00 II11 368.02 Transient inactivation of the developing
ventral hippocampus impairs the mesolimbic regulation of
prefrontal glutamate release and set-shifting performance
in adults. D. M. BORTZ*; J. M. BROOKS; M. SARTER; J. P.
BRUNO. The Ohio State Univ., Unversity of Michigan.
10:00 II12 368.03 Is glutamate release involved in the
behavioral effects of ketamine? C. Y. HELLER; M. L. SMITH;
K. A. TRUJILLO*. California State Univ.
11:00 II13 368.04 Prenatal stress decreases the expression
of group-II metabotropic glutamate receptors in mouse
brain and induces behavior deficits: A potential model
for schizophrenia. F. MATRISCIANO*; P. TUETING; S.
MACCARI; F. NICOLETTI; A. GUIDOTTI. Univ. of Illinois at
Chicago, N. Univ. of Lille, France, Univ. of Rome.
8:00 II14 368.05 Cell-to-cell transmissibility of DISC1
aggregates. V. BADER; P. OTTIS; C. KORTH*. Heinrich
Heine Univ. Dusseldorf.
9:00 II15 368.06 Clozapine-induced locomotor
suppression is mediated by cortical 5-ht2a receptors. C. E.
MCOMISH*; A. LIRA; J. B. HANKS; J. A. GINGRICH. Res.
Fndn. For Mental Hyg., Columbia Univ., Howard Florey Inst.
10:00 II16 368.07 Presynaptic effects of dysbindin mutation:
Are snare complexes involved? A. LAVIN*; S. SAGGU. Med.
Univ. South Carolina.
44 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 II17 368.08 Hippocampal formation expression of the
immediate early gene Arc/Arg3.1 is reduced in dysbindin-1
null protein mice and schizophrenia cases. K. TALBOT*;
W. ONG; M. HO; A. J. SAMOYEDNY; S. E. ARNOLD. Univ.
Pennsylvania, Natl. Univ. of Singapore.
8:00 II18 368.09 Phenotypic effects in adulthood of
repeated psychosocial stress during adolescence in mice
mutant for the schizophrenia risk gene neuregulin-1:
a putative model of gene × environment interaction. L.
DESBONNET; C. O’TUATHAIGH; G. CLARKE; C. O’LEARY;
E. PETIT; N. CLARKE; O. TIGHE; D. LAI; R. HARVEY; J.
CRYAN; T. G. DINAN; J. L. WADDINGTON*. Royal Col. of
Surgeons in Ireland, Univ. Col. Cork, Univ. of New South
Wales, Royal Col. Surgeons in Ireland.
9:00 II19 368.10 Long-term potentiation at hippocampal
output synapses in the MK-801 model of acute psychosis.
J. BEHR*; J. BARTSCH; P. FIDZINSKI. Charité,
Universitätsmedizin Berlin, Charité.
10:00 II20 368.11 DISC1 affects ErbB4 signaling and
interneuron functioning in the mature cortex. S. R.
SESHADRI*; A. SAWA. Johns Hopkins Univ.
11:00 II21 368.12 Knockdown of DISC1 in the mouse
results in alterations in synaptic function in slices of
hippocampal CA3 and striatum in vitro. M. A. ACKLEY*;
M. P. KELLY; B. BATES; L. ZHANG; R. S. HURST; N. J.
BRANDON. Pfizer Global R&D, Pfizer Global R&D.
8:00 II22 368.13 • Low dose subchronic phencyclidine
(PCP) pretreatment potentiates acute PCP-induced
hyperlocomotion in adult rats: A model of schizophrenia? L.
VER DONCK*; H. DUYTSCHAEVER; R. WILLEMS. Janssen
Res. and Development, A Div. of Janssen Pharmaceutica
NV.
9:00 II23 368.14 Electrophysiological and behavioral
analysis of adult shRNA-DISC1 mice and adult DISC1-N
inducible transgenic mice. W. LI*; M. ZHOU; Y. ZHOU; H.
BAO; S. WANG; X. TIAN; A. J. SILVA. Shanghai Jiao Tong
Univ., Wuxi Mental Hlth. Ctr., UCLA, UCLA.
10:00 II24 368.15 Resistance of Egr3-deficient mice to
sedation by clozapine is mediated by the 5HT2A receptor.
A. WILLIAMS; W. M. INGRAM; A. KOZLENKOV; J.
GONZÁLEZ-MAESO; A. L. GALLITANO*. Arizona State
Univ., Univ. of California, Berkeley, Mount Sinai Sch. of
Medicine, , NY 10029, Mount Sinai Sch. of Med., Univ.
Arizona COM PHX.
11:00 II25 368.16 The effects of pregnenolone on
schizophrenia-like behaviors in dopamine transporter
knockout mice. P. WONG*; M. G. CARON; X. ZHANG; W.
C. WETSEL. Neurosci. and Behavioral Disorders Program,
Duke-NUS Grad. Med. Sch., Duke Univ., Duke Univ., Duke
Univ.
8:00 II26 368.17 Executive function deficits and altered
hippocampal synapse morphology in mice lacking Lrrtm1,
a gene associated with schizophrenia. J. ARUGA*; N.
TAKASHIMA; Y. S. ODAKA; K. SAKOORI; T. AKAGI; T.
HASHIKAWA; N. MORIMURA; K. YAMADA. RIKEN BSI,
RIKEN BSI, RIKEN BSI.
9:00 II27 368.18 Acute administration of cotinine to
DBA/2 mice increases conditioning amplitude in the sensory
inhibition model. K. E. STEVENS*; L. ZHENG. Univ. of CO
Anschutz Med. Campus, Veterans Affairs Med. Ctr.
10:00 II28 368.19 Effect of maternal immune activation on
progeny behavior and D3 dopamine receptor function in the
Drd3-EGFP mouse model. E. V. KUZHIKANDATHIL*; Y. LI.
UMDNJ -New Jersey Med. Sch., UMDNJ -New Jersey Med.
Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
11:00 JJ1 368.20 • Conditional deletion of GSK3β in
striatopallidal neurons mimics antipsychotic action. N. URS*;
W. SIESSER; J. JACOBSEN; M. CARON. Duke Univ.
8:00 JJ2 368.21 Modelling the functions of the confirmed
psychosis risk gene ZNF804A. J. EDDY; T. AL-JANABI; T.
HUMBY; L. CARROLL; M. OWEN; M. O’DONOVAN; L. S.
WILKINSON*. Cardiff Univ., Cardiff Univ.
9:00 JJ3 368.22 Recognition memory and hippocampal
function in dysbindin mutant mice. K. H. KARLSGODT*; E.
LUTKENHOFF; S. SPIEGEL; J. JENTSCH. UCLA, UCLA.
10:00 JJ4 368.23 • Developmental profiling of DISC1,
PDE4 and GSK3 in wild-type and Disc1 mutant mice. E.
GRUNEWALD*; C. CLAXTON; Q. WANG; N. J. BRANDON;
D. J. PORTEOUS; J. K. MILLAR. Univ. of Edinburgh, Pfizer.
11:00 JJ5 368.24 Alterations in 5HT 2A receptor function in
an animal model of solvent-induced psychosis. H. CHEN*;
M. LEE; J. HWANG. Tzu Chi Univ., Academia Sinica.
8:00 JJ6 368.25 • Impact of increasing adult hippocampal
neurogenesis on cognition and mood. A. SAHAY*; K. N.
SCOBIE; A. S. HILL; C. M. O’CARROLL; M. A. KHEIRBEK;
N. S. BURGHARDT; A. A. FENTON; A. DRANOVSKY; R.
HEN. Columbia Univ., Ctr. for Regenerative Medicine, Dept.
of Psychiatry, Mass Gen. Hospital, Harvard Med. Sch.,
Mount Sinai Sch. of Med., The Robert F. Furchgott Ctr. for
Neural and Behavioural Science, State Univ. of New York,
Downstate Med. Ctr.
9:00 JJ7 368.26 • Dopamine D2 receptor partial agonists:
Defining the association between intrinsic efficacy and
reinforcing properties in monkeys. D. J. HEAL*; A. C.
MCCREARY; K. B. FREEMAN; W. L. WOOLVERTON.
Renasci Consultancy Ltd, Abbott Healthcare Products BV,
Univ. of Mississippi Med. Ctr.
POSTER
369. Mood Disorders: Treatment Studies
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 JJ8 369.01 Reduction of depressive symptoms
via repeated intravenous ketamine infusions in three
patients with highly treatment-resistant depression. S. M.
SZYMKOWICZ*; R. M. DALE; N. FINNEGAN. Lutheran
Hospital, Cleveland Clin. Fndn.
9:00 JJ9 369.02 Sertraline modulates expression and
activity of GSK3B. H. P. JOAQUIM*; L. L. TALIB; B. S. DINIZ;
W. F. GATTAZ. Lim-27, Psychiatry Inst. HCFMUSP, Lim-27,
Psychiatry Inst. HCFMUSP, Lim-27.
10:00 JJ10 369.03 • Structural brain alterations induced by
repetitive transcranial magnetic stimulation on prefrontal
region possibly associated with its antidepressant effect.
M. NAKAMURA*; Y. NODA; T. SAEKI; E. KAWAMOTO;
H. IWANARI; Y. HIRAYASU. Kinkou Hospital, Kanagawa
Psychiatric Ctr., Yokohama City Univ. Sch. of Med., Univ. of
Tokyo, Grad. Sch. of Med.
11:00 JJ11 369.04 Anterior insula predicts treatment specific
remission in major depression. C. L. MCGRATH*; P. E.
HOLTZHEIMER, III; M. E. KELLY; A. R. FRANCO; B. W.
DUNLOP; W. E. CRAIGHEAD; H. S. MAYBERG. Emory
Univ., Emory Univ., Emory Univ., Emory Univ.
Neuroscience 2011 | Monday AM | 45
Mon. AM

8:00 JJ12 369.05 • Differential slow wave sleep response
to ketamine in major depressive disorder vs. bipolar disorder.
J. H. SELTER; W. C. DUNCAN; D. A. LUCKENBAUGH; G.
CHEN*; C. A. ZARATE. Natl. Inst. of Mental Hlth., Janssen
Pharmaceut. Companies of Johnson & Johnson.
9:00 JJ13 369.06 • Evaluation of effective stimulation
settings for chronic epidural stimulation as a treatment
approach for major depressive disorder. Y. PATHAK*; K.
G. DRIESSLEIN; B. H. KOPELL; P. LAVIOLETTE; C. R.
BUTSON. Marquette Univ., Med. Col. of Wisconsin, Med.
Col. of Wisconsin, Med. Col. of Wisconsin, Med. Col. of
Wisconsin, Marquette Univ.
10:00 JJ14 369.07 The relationship between oxidative stress
and mood disorders in patients with thyroid dysfunction.
L. HERNANDEZ*; G. CAMARGO-HERNANDEZ; A.
CISNEROS-ESPARZA; A. LOPEZ-ALVAREZ; E. G.
CARDONA-MUÑOZ; M. ESCALANTE-PULIDO; R.
ZARAGOZA-GONZALEZ; M. A. RAMIREZ-HERRERA; A.
HERNANDEZ-CHAVEZ; M. HUERTA. CUCS - Univ. De
Guadalajara, Univ. de Colima, CIBO-IMSS, IMSS, Univ. de
Colima.
11:00 JJ15 369.08 • Neural activity in visual processing
areas during WM predicts antidepressant response to
scopolamine. E. L. FRANKEL; W. C. DREVETS*; E.
HOFFMAN; A. SPEER; M. FUREY; C. ZARATE. Natl. Inst.
of Mental Hlth., Laureate Inst. For Brain Res., Univ. of
Maryland, Natl. Inst. of Mental Hlth., Natl. Inst. of Mental
Hlth.
8:00 JJ16 369.09 Hypoactivation of the stress
response circuitry in depression associated with loss of
parasympathetic control of the heart and dysfunction in
the HPG axis: A combined analysis of fMRI and heart
rate variability. L. M. HOLSEN*; J. LEE; S. B. SPAETH;
L. OGDEN; A. KLIBANSKI; S. WHITFIELD-GABRIELI;
J. M. GOLDSTEIN. Brigham & Women’s Hosp., Harvard
Med. Sch., Brigham & Women’s Hosp., Korea Univ.,
Massachusetts Gen. Hosp., Harvard Med. Sch., MIT.
9:00 JJ17 369.10 Gene expression biomarkers for Major
Depressive Disorder before and after ECT treatment. E.
IACOB*; S. C. TADLER; A. R. LIGHT; H. R. WEEKS; R. W.
HUGHEN; K. W. SMITH; A. T. WHITE; L. BUSHNELL; K. C.
LIGHT. Univ. of Utah, Univ. of Utah, Univ. of Utah.
10:00 JJ18 369.11 • Cognitive behavior therapy and its
effects on brain activation in PTSD and MDD. S. E. BRUCE;
C. FALES; C. R. CONWAY; A. DURBIN; W. BROWN; K.
BUCHHOLZ; Y. I. SHELINE*. Univ. of Missouri - St. Louis,
Washington Univ. Sch. of Med., Washington Univ. Sch. of
Med., Univ. of Missouri St. Louis.
POSTER
370. Nicotine Abuse and Addiction: Neural Mechanisms I
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 JJ19 370.01 Withdrawal from chronic nicotine
exposure increases excitability of accumbens cholinergic
interneurons. S. A. LIM*; D. S. MCGEHEE. Univ. of Chicago.
9:00 JJ20 370.02 Locomotor depression in response to
nicotine in agouti mice. M. A. DINGMAN; J. GYEKIS; D. J.
VANDENBERGH*. Penn State Univ., Penn State Univ.
10:00 JJ21 370.03 Nicotine delivery to rodents via lung
alveolar region-targeted aerosol technology produces blood
pharmacokinetics resembling human smoking. X. M. SHAO*;
B. XU; J. LIANG; Y. ZHU; J. L. FELDMAN; X. S. XIE. David
Geffen Sch. Med. at UCLA, UCLA Sch. of Publ. Hlth., David
Geffen Sch. of Med. at UCLA, Afasci Res. Lab.
11:00 JJ22 370.04 Heightened anxiety and hyperalgesia
following abstinence from extended access to nicotine
predicts increased nicotine intake in rats: Mediation by CRF-
CRF1R activity and CREB phosphorylation in the extended
amygdala. A. COHEN*; G. F. KOOB; S. EDWARDS; O.
GEORGE. TSRI, TSRI.
8:00 JJ23 370.05 The α5 nicotinic acetylcholine receptor
subunit and aversive learning. C. D. FOWLER*; P. J.
KENNY. The Scripps Res. Inst.
9:00 JJ24 370.06 Nicotine self-administration differentially
modulates stress-induced neuronal activation in the limbic
stress-integrative pathway. G. YU*; B. M. SHARP. Univ. of
Tennessee Hlth. Sci. Ctr.
10:00 JJ25 370.07 Effects of nicotine administration on
DRD1a and DRD2 gene expressions: Epigenetic changes.
O. GOZEN*; E. KOYLU; L. KANIT; S. POGUN. Ege Univ.
Sch. of Med., Ege Univ.
11:00 JJ26 370.08 Neuroadaptation mechanisms to nicotine
in mesencephalic dopaminergic neurons: Role of dopamine
D3 receptor and nicotinic acetylcholine receptors. G.
COLLO*; L. PLEBANI; L. CAVALLERI; F. BONO; E. MERLO
PICH; M. ZOLI; U. MASKOS; P. SPANO; C. MISSALE. Univ.
of Brescia, Glaxo SmithKline, Univ. of Modena and Reggio
Emilia, Inst. Pasteur.
8:00 JJ27 370.09 Acute low dose nicotine alters enkephalin
and melanin-concentrating hormone expression in
distributed reward- and feeding-related brain areas. A. J.
CARR; G. CHANG; J. R. BARSON; O. KARATAYEV; J.
BAYLAN; S. F. LEIBOWITZ*. Rockefeller Univ.
9:00 JJ28 370.10 Functional study of SNPs located in the
A3A5B4 gene cluster using two different neuroblastoma
cell lines. F. X. GALLEGO*; A. V. FLORA; E. M. FUNK; J. A.
STITZEL; M. A. EHRINGER. Univ. of Colorado.
10:00 JJ29 370.11 Neurons in the pedunculopontine
tegmental nucleus demonstrate differential response
patterns following intra-ventral tegmental area administration
of rewarding or aversive doses of nicotine. H. TAN*; S. R.
LAVIOLETTE. Univ. of Western Ontario.
11:00 JJ30 370.12 Differential amygdala responses to
varenicline and nicotine in acutely-abstinent smokers:
Implications for personalized smoking cessation treatment?
M. T. SUTHERLAND*; A. J. CARROLL; B. SALMERON; T. J.
ROSS; E. A. STEIN. NIDA-IRP.
8:00 JJ31 370.13 A genetic predisposition for high-alcohol
preference contributes to a greater sensitivity to nicotine
in the posterior ventral tegmental area as indicated by
increased dopamine release in the nucleus accumbens shell
of high-alcohol drinking (HAD) rats. G. A. DEEHAN*; S. R.
HAUSER; Z. A. RODD; W. J. MCBRIDE. Indiana Univ.
9:00 JJ32 370.14 � Passive exposure to tobacco smoke
potentiates the locomotor response to nicotine. G. B.
RODRICK*; R. M. BAUZO; A. W. BRUIJNZEEL. Univ. of
Florida, Univ. of Florida.
10:00 JJ33 370.15 Chronic nicotine and acute nicotine
withdrawal does not effect responses to nicotine in brain
areas involved with cognitive processes. J. A. STARK; B.
VAUPEL; H. LU; Y. ZOU; Y. YANG; E. A. STEIN*. Nat’l Inst.
Drug Abuse-IRP.
46 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 JJ34 370.16 Audiovisual feedback of Trier Social
Stress Test in smokers activates insula, anterior cingulate
and right inferior frontal gyrus. B. SALMERON*; K. CACIC;
M. LEE; J. PAPAC; J. JAVERBAUM; D. EPSTEIN; T. ROSS.
NIDA, Univ. of Maryland, Col. Park.
8:00 JJ35 370.17 miRNome analysis of the neuronal
nicotinic acetylcholine receptor gene family. E. M. HOGAN*;
M. D. SCOFIELD; Z. MOU; C. W. JOHNSON; A. R.
TAPPER; P. D. GARDNER. Univ. of Massachusetts Med.
Sch.
9:00 JJ36 370.18 The role of the basal ganglia in disruption
of smoking addiction. N. GAZNICK*; A. MC NUTT; A.
BECHARA; D. TRANEL. Univ. of Iowa, Univ. of Iowa, USC.
10:00 KK1 370.19 Can brain circuitry predict smoking
status? V. PARIYADATH*; E. A. STEIN; T. J. ROSS. Natl.
Inst. On Drug Abuse, Natl. Inst. On Drug Abuse, Natl. Inst. of
Hlth.
11:00 KK2 370.20 Nicotine dependence recruits new CRF
neurons in the ventral tegmental area that mediate aversions
to nicotine withdrawal. T. E. GRIEDER*; H. VARGAS-
PEREZ; E. CRAWFORD; J. FREILING; L. CLARKE; P.
SAWCHENKO; G. F. KOOB; D. VAN DER KOOY; O.
GEORGE. Univ. Toronto, The Scripps Res. Inst., The Salk
Inst.
8:00 KK3 370.21 Sensory modality of smoking cues
modulates neural cue reactivity. Y. YALACHKOV*; J.
KAISER; A. GÖRRES; A. SEEHAUS; M. J. NAUMER.
Goethe Univ. Hosp.
9:00 KK4 370.22 cGMP-dependent protein kinase type
II (PKG-II) signaling in the dorsal striatum is sufficient to
maintain nicotine cue approach in mice. D. SCOTT*; M. LEE;
K. TANIGAKI; J. SCHLOSSMANN; F. HOFMANN; N. HIROI.
Albert Einstein Coll. Med., Albert Einstein Coll. Med., Shiga
Med. Ctr., Univ. Regensburg, TU München, Albert Einstein
Coll. Med.
10:00 KK5 370.23 1’-N-methyl nicotinium potentiates ACh
responsiveness of α7 nicotinic acetylcholine receptors. H.
XING*; Z. LU; W. R. KEM. Univ. Florida.
POSTER
371. Cocaine Reinforcement and Seeking II
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 KK6 371.01 Novel and conditioned stimuli reinstate
extinguished reward-seeking behavior and induce similar
patterns of fos expression. R. M. BASTLE*; P. R. KUFAHL;
M. N. TURK; N. S. PENTKOWSKI; K. J. THIEL; S. M.
WEBER; J. L. NEISEWANDER. Arizona State Univ., Arizona
State Univ.
9:00 KK7 371.02 C57BL/6J mice demonstrate attenuated
cocaine-induced suppression of saccharin intake compared
with DBA/2J mice. C. S. FREET*; P. S. GRIGSON. Penn
State Coll Med.
10:00 KK8 371.03 Chronic food restriction increases
persistence of a cocaine-conditioned place preference. D.
ZHENG*; S. CABEZA DE VACA; K. D. CARR. NYU Sch. of
Med., NYU Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
11:00 KK9 371.04 Environmental enrichment reduces
cocaine seeking and reinstatement and improves long term
memory. E. SUDAI*; O. CROITORU; I. GISPAN; G. YADID.
The Mina & Evarerd Fac. of Life Sciences, Bar-Ilan Univ.,
Bar Ilan Univ.
8:00 KK10 371.05 Trans-generational epigenetic
transmission of a cocaine-resistance phenotype. C.
PIERCE*; S. L. WHITE; P. I. ORTINSKI; G. SADRI-VAKILI;
F. M. VASSOLER. Univ. Pennsylvania Sch. of Med., Harvard
Med. Sch.
9:00 KK11 371.06 Differential reinstatement of cocaine vs.
heroin seeking in rats trained to self-administer both drugs
as a function of the setting of drug taking. C. MONTANARI*;
M. DE LUCA; M. MERINGOLO; L. CONTU; A. BADIANI.
Univ. Roma Sapienza.
10:00 KK12 371.07 Relapse-suppression by cocaine
omission cues. N. SUTO*; R. A. WISE; G. I. ELMER. MPRC,
Dept of Psychiatry, Univ. of Maryland Sch. of Med., Natl. Inst.
on Drug Abuse/ NIH.
11:00 KK13 371.08 Acute cocaine locomotor activity in rats
predicts cue-primed reinstatement of cocaine seeking. D. L.
SIMMONS*; T. L. RICHARDS; B. H. MANDT; C. NG; N. R.
ZAHNISER; R. M. ALLEN. Univ. of Colorado Hlth. Sci. Ctr.,
Univ. of Colorado.
8:00 KK14 371.09 Increasing the speed of intravenous
cocaine delivery leads to the development of drug
consumption patterns characteristic of addiction. E.
MINOGIANIS*; K. BOUAYAD-GERVAIS; A. SAMAHA. Univ.
De Montréal.
9:00 KK15 371.10 Cocaine induced conditioned-placepreference
response in a nonhuman primate. M. BARROS*;
S. CHABRAWI; R. S. MAIOR; C. P. MÜLLER; C. TOMAZ; M.
DE SOUZA SILVA; J. P. HUSTON. Univ. of Brasilia, Univ. of
Brasilia, Univ. of Erlangen-Nuremberg, Univ. of Dusseldorf.
10:00 KK16 371.11 A role for sensitization in reinstatement of
drug-seeking behavior. K. C. SUMMERS; J. D. STEKETEE*.
Univ. Tennessee Hlth. Sci. Ctr.
11:00 KK17 371.12 Social dominance in rats is associated
with novelty preference and cocaine reinforcement. E. R.
JORDAN*; J. E. MURRAY; B. J. EVERITT; T. W. ROBBINS;
J. W. DALLEY. Univ. of Cambridge, Univ. of Cambridge.
8:00 KK18 371.13 Incubation of conditioned reward with
peripheral cocaine actions as the conditioned stimulus. B.
WANG*; R. A. WISE. NIDA-IRP/NIH/DHHS.
9:00 KK19 371.14 Differential persistence of cocaineinduced
conditioned place preferences and aversions after
varying periods of drug abstinence. Z. SU*; J. M. WENZEL;
A. SANTOOSTAROAM; A. ETTENBERG. Univ. California.
10:00 KK20 371.15 Enhancement of cue-induced
reinstatement of cocaine seeking in rat model of
schizophrenia; the neonatal ventral hippocampal lesion
(NVHL). R. KARLSSON*; D. KIRCHER; Y. SHAHAM; P.
O’DONNELL. Univ. of Maryland Sch. of Med., Natl. Inst. of
Drug Abuse.
11:00 KK21 371.16 Reinstatement of cocaine-seeking in rats
with an addiction-prone phenotype. R. P. WATERS*; A. B.
YOUNG; M. W. FELTENSTEIN; R. E. SEE. Med. Univ. of
South Carolina.
8:00 KK22 371.17 Intermittent intravenous cocaine
self-administration in mice: A mouse model of escalated
drug intake? L. CASAL; A. J. ROBERTS; S. HUITRON-
RESENDIZ*. The Scripps Res. Inst.
Neuroscience 2011 | Monday AM | 47
Mon. AM

9:00 KK23 371.18 Self-administration on a progressive
ratio schedule results in high individual variability in the
motivation for cocaine. C. WESTENBROEK*; A. N. PERRY;
J. B. BECKER. Univ. of Michigan, Univ. of Michigan, Univ. of
Michigan, Univ. of Michigan.
10:00 KK24 371.19 • � Cocaine self-administration is
a learned skilled behavior. K. COFFEY*; D. ROOT; D.
BARKER; S. MA; A. FABBRICATORE; M. WEST. Rutgers
Univ.
11:00 KK25 371.20 Differential relation of impulsive choice
and impulsive action with cocaine taking and seeking. N.
BROOS; A. N. M. SCHOFFELMEER; T. J. DE VRIES*; T.
PATTIJ. Neurosci. Campus Amsterdam, VU Univ. medical
center, NCA Vu&Vumc.
8:00 KK26 371.21 Strength of association between two
rodent models of impulsivity and cocaine self-administration.
J. B. RICHARDS*; A. M. GANCARZ; M. A. KAUSCH; L.
J. BEYLEY; D. R. LLOYD; M. A. ROBBLE. Res. Inst. On
Addictions.
9:00 KK27 371.22 Sensory reinforcement as an animal
model of sensation seeking: Strength of association to
cocaine self-administration. A. M. GANCARZ*; M. ROBBLE;
M. KAUSCH; L. BEYLEY; D. LLOYD; E. MAZIOL; J.
RICHARDS. Univ. Buffalo, RIA.
10:00 KK28 371.23 The impact of visual stimulus
reinforcement on cocaine self-administration in rats. M.
ROBBLE*; A. M. GANCARZ; M. KAUSCH; D. LLOYD;
L. BEYLEY; E. MAZIOL; J. B. RICHARDS. Res. Inst. On
Addictions.
11:00 KK29 371.24 Cocaine self-administration using a
two-lever progressive ratio procedure: 1. Measurement
of consummatory responding. B. A. ZIMMER*; D. C. S.
ROBERTS. Wake Forest Univ. Hlth. Sci.
8:00 KK30 371.25 Cocaine self-administration using a
two-lever progressive ratio procedure: 2. Measurement of
appetitive responding. D. C. ROBERTS*; B. A. ZIMMER.
Wake Forest Univ. Hlth. Sci.
9:00 KK31 371.26 Individual variation in the ability of a
classically conditioned cocaine-cue to reinstate cocaine selfadministration
behavior. L. M. YAGER*; T. E. ROBINSON.
Univ. of Michigan.
10:00 KK32 371.27 A cue evokes relapse in the face
of adverse consequences preferentially in rats prone
to attribute incentive salience to reward cues. B. T.
SAUNDERS; T. E. ROBINSON*. Univ. of Michigan, Univ.
Michigan.
11:00 KK33 371.28 • Adolescent onset of cocaine selfadministration
precipitates greater stress-induced
reinstatement. W. WONG*; J. E. MCCUTCHEON; K. A.
FORD; N. E. PAGELS; M. MARINELLI. Rosalind Franklin
Univ. of Med. and Sci.
8:00 KK34 371.29 Ontogeny of cocaine- and
methamphetamine-induced one-trial behavioral sensitization.
O. O. KOZANIAN*; A. GUTIERREZ; A. MOHD-YUSOF; S. A.
MCDOUGALL. California State Univ.
9:00 KK35 371.30 Persistence of one-trial cocaineinduced
conditioned activity in young and adult rats. T.
DER-GHAZARIAN; J. A. PIPKIN; A. GUTIERREZ; S. M.
CARBAJAL; A. M. CORTEZ; S. A. MCDOUGALL*. California
State Univ.
POSTER
372. Methamphetamine: Toxicity
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 KK36 372.01 The serum levels of methylphenidate,
amphetamine or methamphetamine necessary to produce
hyperthermia and neurotoxicity, over an 8 hr exposure during
the awake or waking cycle, are all in the 2 μM range for rat.
J. F. BOWYER*; M. LEVI; J. P. HANIG; D. R. R. DOERGE;
B. L. DIVINE; M. M. VANLANDINGHAM; N. C. TWADDLE.
FDA, FDA, FDA, FDA.
9:00 LL1 372.02 Effect of a single high-dose of
methamphetamine on striatal alpha-synuclein, RAGE,
neurochemical levels and motor coordination in mice. F. C.
PEREIRA*; S. VIANA; S. NUNES; T. CUNHA-OLIVEIRA; A.
S. TRAVASSOS; C. SILVA; A. M. SILVA; A. C. REGO; S. F.
ALI; C. A. FONTES RIBEIRO. IBILI/Fac Med, Coimbra Univ.,
Coimbra Univ., Natl. Ctr. for Toxicological Research, Food
and Drug Admin. (NCTR/FDA), Fac Med/IBILI, Coimbra
Univ.
10:00 LL2 372.03 Nitric oxide mediates methamphetamineinduced
blood-brain barrier dysfunction. T. MARTINS; N.
HUDSON; N. MILHAZES; F. BORGES; A. F. AMBRÓSIO;
A. P. SILVA*; J. GREENWOOD; P. TUROWSKI. Inst.
Pharmacol & Exp Therapeutic, Fac Med, Univ. Coimbra,
IBILI, Fac. Medicine, Univ. Coimbra, Inst. Ophthalmology,
UCL, Inst. Hlth. Sciences-North, Chem. Dep., Fac. Sciences,
Univ. Porto, Ctr. of Ophthalmology and Vision Sciences, Fac.
Medicine, Univ. Coimbra.
11:00 LL3 372.04 The effects of methamphetamine
treatment on the blood brain barrier and cerebral
vasculature. S. M. KOUSIK*; S. M. GRAVES; T. C. NAPIER;
P. M. CARVEY. Rush Univ. Med. Ctr.
8:00 LL4 372.05 The effects of the β1 antagonist,
metoprolol, on methamphetamine-induced changes in core
temperature in the rat. R. L. HARRELL; H. A. SPEAKER; K.
E. SABOL*. Univ. Of Mississippi.
9:00 LL5 372.06 Methamphetamine self-administration in
rats attenuates deficits induced by a subsequent repeated
high-dose methamphetamine treatment. L. M. MCFADDEN;
S. C. ALLEN; J. D. ELLIS; A. J. HOONAKKER; J. W. GIBB;
G. R. HANSON*; A. E. FLECKENSTEIN. Col. Pharm.
10:00 LL6 372.07 Methamphetamine treatment during
development attenuates the serotonergic deficits caused by
subsequent high-dose methamphetamine administration.
J. W. GIBB*; K. WEBB; L. MCFADDEN; A. HOONAKKER;
P. VIEIRA-BROCK; K. STOUT; N. SAWADA; J. ELLIS; S.
ALLEN; S. NIELSEN; M. ALBURGES; D. WILKINS; G.
HANSON; A. FLECKENSTEIN. Univ. Utah.
11:00 LL7 372.08 Methamphetamine-induced persistent
dopaminergic deficits and vesicular monoaminergic
transporter-2 trafficking. M. E. ALBURGES*; G. C.
HADLOCK; K. M. CONRAD; G. R. HANSON; A. E.
FLECKENSTEIN. Univ. of Utah.
8:00 LL8 372.09 Toxic binge methamphetamine injections
caused upregulation of members of the TGF-β family
of trophic factors in the rat striatum. G. BEAUVAIS*; K.
ATWELL; S. JAYANTHI; B. LADENHEIM; I. N. KRASNOVA;
J. L. CADET. DHHS/NIH/NIDA.
48 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 LL9 372.10 • Participation of neuronal pentraxin-1
(NP1) in methamphetamine-induced cell death in the mouse
hippocampus. C. M. QUINTERO*; I. N. KRASNOVA; S.
PONTIS; E. IVANOVA; T. S. SHIPPENBERG; J. L. CADET.
NIDA/NIH/DHHS.
10:00 LL10 372.11 Effects of methamphetamine and mptp
on the retinal dopaminergic system in mice. R. HAMILTON*;
W. TRICKLER; B. ROBINSON; M. PAULE; S. ALI. NCTR.
11:00 LL11 372.12 The systemic toxicity caused by
methamphetamine contributes to neuronal damage. L. E.
HALPIN*; B. K. YAMAMOTO. Univ. of Toledo.
8:00 LL12 372.13 The role of cyclooxygenase in
monoaminergic depletions produced by the serial exposure
to stress and methamphetamine. N. A. NORTHROP*; B.
K. YAMAMOTO. Univ. of Toledo Hlth. Sci. Campus, Boston
Univ. Sch. of Med.
9:00 LL13 372.14 A subregional decrease in serotonin
neurons within the dorsal raphe after serial exposure to
stress and methamphetamine. R. NATARAJAN*; B. K.
YAMAMOTO. Univ. of Toledo.
10:00 LL14 372.15 The time course of monoamine
markers and axonal protein changes in the rat brain
after methamphetamine exposure. F. YANG*; B. K.
YAMAMOTO. The Univ. of Toledo, Col. of Medicine, Dept. of
Neurosciences.
11:00 LL15 372.16 New neuroprotective role of modafinil
against methamphetamine acute toxic effects in mice.
M. RAINERI*; B. GOITIA; I. TARAVINI; V. PESKIN;
S. GIORGERI; F. J. URBANO; V. BISAGNO. Inst. De
Investigaciones Farmacológicas (ININFA), Lab. de Fisiología
y Biología Molecular, Inst. de Fisiología, Biología Mol. y
Neurociencias (IFIBYNE), UBA-CONICET, Catedra de
Quimica Analitica Instrumental, Facultad de Farmacia y
Bioquimica, UBA, Junin 956.
8:00 LL16 372.17 Automated gait analysis in mice after
administration of an acute toxic dose of methamphetamine
and treatment with modafinil. V. BISAGNO*; K. SMITH; F.
J. URBANO; C. E. CUSTER; S. MYAL; A. LOZAMA; T. E.
PRISINZANO; W. E. FANTEGROSSI; M. RANDOLPH; E.
GARCIA-RILL. ININFA-CONICET, Univ. of Arkansas for Med.
Sci., IFIBYNE,CONICET-UBA, Univ. of Kansas.
9:00 LL17 372.18 9-cis retinoic acid protects against
methamphetamine-induced neurotoxicity in nigrostriatal
dopaminergic terminals in male Sprague-Dawley rats. D.
REINER; H. SHEN; L. YIN*; Y. WANG. Natl. Inst. on Drug
Abuse, Luhe Hosp.
10:00 LL18 372.19 Running wheel exercise ameliorates
methamphetamine-induced damage to striatal dopamine
terminals. S. J. O’DELL*; A. J. BALL; B. A. GALVEZ; J. F.
MARSHALL. Univ. of California, Irvine.
11:00 LL19 372.20 Parkin overexpression protects against
methamphetamine neurotoxicity. A. MOSZCZYNSKA*; B. K.
YAMAMOTO; A. YUHAS. Wayne State Univ., Univ. of Toledo
Col. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
373. Alcohol and Sedative Hypnotics: Neural Mechanisms I
Theme C: Disorders of the Nervous System
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 LL20 373.01 The role of the GABAA receptor in the
muscle relaxant Soma. T. M. CARBONARO*; M. B. GATCH;
M. J. FORSTER. Univ. of North Texas Hlth. Sci. Ctr.
9:00 LL21 373.02 Purkinje cells neurodegeneration induced
by midazolam injected from p4 to p9 days-old in mice. M.
MARQUEZ-OROZCO*; M. V. GASCA-RAMÍREZ; G. DE LA
FUENTE-JUÁREZ; A. MÁRQUEZ-OROZCO. Univ. of Mexico
(UNAM).
10:00 LL22 373.03 Swimming behavioral alterations in 24days
old mice induced by midazolam from P6 to P9-days
old. A. MARQUEZ-OROZCO*; J. GUTIERREZ-AMEZCUA;
G. PINEDA-ALDANA; G. DE LA FUENTE-JUÁREZ; M.
MÁRQUEZ-OROZCO. Univ. of Mexico (UNAM).
11:00 LL23 373.04 • Salsolinol stimulates dopamine
neurons in the VTA, role of mu opioid receptors. G. XIE; L.
HIPOLITO; A. POLACHE; L. GRANERO; J. YE*. UMDNJ
New Jersey Med. Sch., Univ. de València, Spain, UMDNJ
New Jersey Med. Sch.
8:00 LL24 373.05 The effect of intra-VTA quinpirole on
the activity of centrally projecting neurons of the Edinger-
Westphal nucleus. S. KAUR*; D. COCKING; A. E.
RYABININ. Oregon Hlth. and Sci. Univ.
9:00 LL25 373.06 Effects of social isolation rearing
on nucleus accumbens dopamine dynamics and
ethanol interactions. J. T. YORGASON*; J. K.
KONSTANTOPOULOS; R. A. ESPAÑA; S. R. JONES. Wake
Forest Sch. of Med., Wake Forest Sch. of Med.
10:00 LL26 373.07 Effects of D2 type autoreceptor
antagonists on ethanol-induced inhibition of dopamine
release in the nucleus accumbens. D. HANSEN*; J. T.
YORGASON; J. D. WILCOX; J. K. KONSTANTOPOULOS;
D. M. HEDGES; S. R. JONES; S. C. STEFFENSEN.
Brigham Young Univ., Wake Forest Sch. of Med.
11:00 LL27 373.08 The hypocretin system modulates
dopamine responses to chronic ethanol exposure. K. N.
HUGGINS*; J. K. KONSTANTOPOULOS; R. A. ESPAÑA; S.
R. JONES. Wake Forest Sch. of Med.
8:00 LL28 373.09 Ethanol disrupts the mechanisms of
induction of long-term potentiation in the mouse nucleus
accumbens. D. MISHRA*; X. ZHANG; K. CHERGUI.
Karolinska Institutet.
9:00 LL29 373.10 Pretreatment of the posterior ventral
tegmental area with nicotine produces sensitization of local
dopamine neurons to the stimulating effects of ethanol. Z.
DING*; S. KATNER; W. TRUITT; E. ENGLEMAN; Z. RODD;
W. MCBRIDE. Indiana Univ. Sch. of Med., Indiana Univ. Sch.
of Med.
10:00 LL30 373.11 Protracted withdrawal from alcohol
impacts excitability and dynamical properties of neurons of
the bed nucleus of stria terminalis. A. SZÜCS*; F. BERTON;
E. CATALDO; P. SANNA; W. FRANCESCONI. UCSD,
Balaton Limnological Res. Inst., The Scripps Res. Inst., Univ.
of Pisa.
11:00 LL31 373.12 • Long-lasting potentiation of
glutamatergic synapses on GABA neurons in the ventral
tegmental area after ethanol exposure. R. S. WILCOX; B. R.
LARSEN; S. C. STEFFENSEN*. Brigham Young Univ.
Neuroscience 2011 | Monday AM | 49
Mon. AM

8:00 LL32 373.13 Chronic Intermittent Ethanol Exposure
disrupts D2-receptor modulation of prefrontal cortical
neurons. S. CENTANNI*; H. TRANTHAM-DAVIDSON; L. J.
CHANDLER. Med. Univ. of South Carolina, Med. Univ. of
South Carolina.
9:00 MM1 373.14 Contrasting effects of chronic
intermittent ethanol treatment on membrane properties and
synaptic transmission in the nucleus accumbens and the
paraventricular nucleus. V. N. MARTY*; I. SPIGELMAN.
UCLA.
10:00 MM2 373.15 Tolerance and withdrawal effects of
zolpidem in mice given chronic zolpidem treatment. S. A.
HELDT*; B. T. WRIGHT; R. A. SMITH. Univ. of Tennessee
Hlth. Sci. Ctr., Christian Brothers Univ.
POSTER
374. Olfaction: Higher-Order Processing and Integrative
Studies
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 MM3 374.01 Cholinergic modulation in olfactory bulb
and cortex. L. B. DE ALMEIDA*; C. LINSTER. Cornell Univ.
9:00 MM4 374.02 Aversive and appetitive conditioning
effects on odor representation and perception in rats. S.
LUO*; M. EINHORN; P. S. DATE; A. N. SCOCO; T. A.
CLELAND. Cornell Univ.
10:00 MM5 374.03 Muscarinic cholinergic regulation of
learning within olfactory bulb. T. A. CLELAND*; J. H.
ZIMERING; B. J. WIE. Cornell Univ.
11:00 MM6 374.04 Decorrelation via local inhibition in
the olfactory bulb glomerular layer. C. LINSTER*; T. A.
CLELAND. Cornell Univ., Cornell Univ.
8:00 MM7 374.05 • A model of statistical learning in the
olfactory bulb. A. SHEELA MOHAN*; T. A. CLELAND.
Cornell Univ., Cornell Univ.
9:00 MM8 374.06 Persistent gamma oscillations in olfactory
bulb slices. S. T. PEACE*; B. C. JOHNSON; A. C. MOLNAR;
T. A. CLELAND. Cornell Univ., Cornell Univ., Cornell Univ.
10:00 MM9 374.07 Role of brain-derived neurotrophic factor
(BDNF) secretion in neurogenesis-dependent olfactory
consolidation. M. TONG*; T. A. CLELAND. Cornell Univ.
11:00 MM10 374.08 Noradrenergic modulation in the olfactory
bulb influences detection and discrimination thresholds at
low odor concentrations. O. ESCANILLA*. Cornell Univ.
8:00 MM11 374.09 Neural activity in the horizontal limb of
the diagonal band of Broca in awake, behaving rats. S.
DEVORE*; N. P. MORRIS; P. BIBAWI; D. M. SMITH; C.
LINSTER. Cornell Univ., Cornell Univ.
9:00 MM12 374.10 A biophysical model of cholinergic
modulation in the olfactory bulb. G. LI*; T. A. CLELAND.
Cornell Univ.
10:00 MM13 374.11 Estradiol modulates odor memory
duration and specificity. T. DILLON*; L. FOX; C. LINSTER.
Cornell Univ.
11:00 MM14 374.12 Investigating the role of serotonin in the
adult mammalian olfactory bulb. M. LEWIS*; C. LINSTER.
Cornell Univ.
8:00 MM15 374.13 Neuropeptide Y-like neuron encodes
innate odor attractiveness in Drosophila. J. BESHEL*; Y.
ZHONG. Cold Spring Harbor Lab.
POSTER
375. Olfaction: Animal Behavior and the Neural Correlates
of Behavior
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 MM16 375.01 Odor objects mediate valence decisions.
N. E. BOWMAN*; J. K. OLOFSSON; J. A. GOTTFRIED.
Northwestern Univ., Stockholm Univ.
9:00 MM17 375.02 Electrocorticography and electrical
stimulation of the human olfactory system. C. ZELANO;
J. ROSENOW; M. MACKEN; S. SCHUELE; J. A.
GOTTFRIED*. Fienberg Sch. of Medicine, Northwestern
Univ., Fienberg Sch. of Medicine, Northwestern Univ.,
Fienberg Sch. of Medicine, Northwestern Univ., Fienberg
Sch. of Medicine, Northwestern Univ., Northwestern Univ.
Feinberg Sch. of Med.
10:00 MM18 375.03 Prefrontal EEG-power induced by
different intensities of a pleasant and an unpleasant odor. G.
R. CHRISTOFFERSEN*; I. VIEMOSE; P. MØLLER. Univ. of
Copenhagen, Univ. of Copenhagen.
11:00 MM19 375.04 Case of catamenially linked resolution
of hypoosmia and hypogeusia. S. YAKOV*; A. HIRSCH;
Y. YAKOV; S. FREELS; A. YAKOVLEV. Smell and Taste
Treatment and Res. Fndn., Univ. of Illinois, Sch. of Publ.
Hlth.
8:00 MM20 375.05 Olfactory brown. N. SOBEL*; T. WEISS;
K. SNITZ; E. SCHNEIDMAN. Weizmann Inst. of Sci.
9:00 MM21 375.06 • Importance of cortical cholinergic
and glutamatergic neurotransmission in olfactory pattern
separation and completion. J. CHAPUIS*; D. A. WILSON.
Nathan Kline Inst. For Psychiatric Research- Emotional Brain
Inst., New York Univ. Sch. of Med.
10:00 MM22 375.07 Ensemble neural recordings in piriform
cortex during odor discrimination task. A. LOVITZ*; R. L.
RENNAKER; A. SLOAN; D. A. WILSON. Univ. of Texas At
Dallas, New York Univ. Sch. of Med.
11:00 MM23 375.08 The effects of stress and norepinephrine
on olfactory memory. L. C. MANELLA*; C. LINSTER. Cornell
Univ.
8:00 MM24 375.09 Psychophysics and neural correlates of
sniff phase discrimination. M. SMEAR*; R. SHUSTERMAN;
T. BOZZA; D. RINBERG. HHMI/ JFRC, HHMI/ JFRC,
Northwestern Univ.
9:00 MM25 375.10 Quick perception of olfactory intensity
cues. A. RESULAJ*; D. RINBERG. Howard Hughes Med.
Institute, Janelia Farm Res. Campus, Univ. of Cambridge.
10:00 MM26 375.11 Fast timescale adaptation reshapes
odor responses in the olfactory bulb of awake mice. Y. B.
SIROTIN*; R. SHUSTERMAN; D. RINBERG. Rockefeller
Univ., Janelia Farm Res. Campus, HHMI.
11:00 MM27 375.12 Odor intensity coding in awake mouse.
R. SHUSTERMAN*; M. C. SMEAR; Y. B. SIROTIN; D.
RINBERG. Janelia Farm Res. Campus, HHMI, Janelia Farm
Res. Campus, HHMI, Rockefeller Univ.
50 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 MM28 375.13 Analysis of the development of the
olfactory system and behaviour in transgenic mice
overexpressing Anosmin-1. D. GARCÍA-GONZÁLEZ*; V.
MURCIA-BELMONTE; P. F. ESTEBAN; I. SÁNCHEZ-VERA;
J. M. GARCÍA-VERDUGO; F. DE CASTRO. Developmental
Neurobio. - Hosp. Nacional De Parapléjicos, Inst. Cavanilles
de Biodiversidad y Biología Evolutiva, Univ. de Valencia,.
9:00 MM29 375.14 Olfactory and taste sensory information
modulate glucose kinetics and sweet preference. T. TSUJI*;
S. TANAKA; S. BAKHSHISHAYAN; T. YAMAMOTO; M.
KOGO. Osaka Police Hosp., Osaka Univ., Kio Univ.
10:00 MM30 375.15 Exposure to amniotic fluid and milk in the
neonatal rat: Role of the endogenous opioid system during
behavioral activation and coordinated action. V. MENDEZ-
GALLARDO*; S. R. ROBINSON. Univ. of Iowa, Idaho State
Univ.
11:00 NN1 375.16 Organization of sensory input is restored
after extensive regeneration in the Olfactory bulb. E.
BLANCO*; P. VALLE-LEIJA; R. DRUCKER-COLIN; R.
VIDALTAMAYO. Inst. De Fidiologia Celular UNAM, Inst. de
Fisiología Celular, Univ. de Monterrey.
8:00 NN2 375.17 Synchronized top-down inputs from
the olfactory cortex during postprandial sleep participate
in the enhanced cell death of adult-born granule cells in
the olfactory bulb. S. KOMANO*; H. MANABE; M. OTA;
I. KUSUMOTO-YOSHIDA; T. YOKOYAMA; K. MORI; M.
YAMAGUCHI. Dept. of Physiology, Grad. Sch. of Medicine,
the Univ. of Tokyo, CREST (JST).
9:00 NN3 375.18 Nickel sulfate inhalation causes deficits
in sense of smell, possibly through irritation signaling via
TRPA1, TRPV1, and NK-1 receptors. T. R. IQBAL*; C. C.
HEGG. Michigan State Univ., Michigan State Univ.
10:00 NN4 375.19 Brain-machine hybrid system to
elucidate adaptability in insects’ odor searching behavior.
R. MINEGISHI*; A. TAKASHIMA; D. KURABAYASHI; R.
KANZAKI. The Univ. of Tokyo, Kyusyu Univ., Tokyo Inst. of
Technol.
11:00 NN5 375.20 Neuronal analysis of a network for
klinotaxis in C. elegans. K. E. MCCORMICK*; S. R.
LOCKERY; S. FAUMONT. Univ. of Oregon.
8:00 NN6 375.21 Translation of olfactory input
into behavioral output in the Drosophila larva. S. A.
MONTAGUE*; D. MATHEW; J. R. CARLSON. Yale Univ.,
Yale Univ.
9:00 NN7 375.22 Hatchlings to adults: Development of
olfactory structure and function in the locust. K. SUN; N.
GUPTA; M. A. STOPFER*. NIH.
POSTER
376. Multisensory Processing: Temporal and Cognitive
Factors
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 NN8 376.01 Changes in the multisensory temporal
binding window with healthy aging. R. A. STEVENSON*;
B. D. MANGUS; J. KRUEGER FISTER; A. J. HEDLEY-
WILLIAMS; R. F. LABADIE; M. T. WALLACE. Vanderbilt
Univ. Med. Ctr., Natl. Ctr. for Childhood Deafness & Family
Communication, Vanderbilt Kennedy Ctr.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 NN9 376.02 The multisensory temporal binding
window: Impact of stimulus location and salience. M. T.
WALLACE*; J. KRUEGER FISTER; Z. P. BARNETT; A. R.
NIDIFFER; R. A. STEVENSON. Vanderbilt Univ.
10:00 NN10 376.03 The timing of static sounds modulates
sensitivity to low-level visual motion. H. KAFALIGONUL*; G.
R. STONER. Salk Inst.
11:00 NN11 376.04 • Decoding humor experiences from brain
activity patterns in the angular gyrus while viewing comedy
TV programs. Y. SAWAHATA*; K. KOMINE; T. MORITA; N.
HIRUMA. NHK (Japan Broadcasting Corporation).
8:00 NN12 376.05 Multisensory integration in cochlear
implant users: Alterations in the temporal binding window. B.
D. MANGUS*; R. A. STEVENSON; J. KRUEGER FISTER;
R. F. LABADIE; M. T. WALLACE. Vanderbilt Univesity,
Vanderbilt Univ.
9:00 NN13 376.06 Neural plasticity associated with learning
noisy audiomotor transformations. A. B. HERMAN*; D.
HARRELL; J. HOUDE; S. S. NAGARAJAN. UCSF, Univ. of
California, San Francisco, Univ. of California, San Francisco.
10:00 NN14 376.07 Operant motor acts modulate perceived
simultaneity of cross-modal events. S. NOVICH*; B.
PARSONS; D. M. EAGLEMAN. Baylor Col. of Med., Rice
Univ.
11:00 NN15 376.08 Pre-attentive processing of frequency
across audition and touch: A high-density electrical mapping
mismatch negativity study. J. S. BUTLER*; J. J. FOXE; I.
C. FIEBLEKORN; M. R. MERCIER; S. MOLHOLM. Albert
Einstein Col. of Med., Weill Cornell Med. Col.
8:00 NN16 376.09 Audiovisual entrainment to pseudospeech
signals. A. E. RHONE*; J. JENKINS, III; W. J.
IDSARDI; J. Z. SIMON; D. POEPPEL. Univ. of Maryland,
Univ. of Maryland, Univ. of Maryland, New York Univ.
9:00 NN17 376.10 � Examining absolute and relative pitch
as automatic processes via auditory-visual Stroop test. M.
EDELSTEIN*; W. DE HEER; F. THEUNISSEN. Univ. of
California, Berkeley.
10:00 NN18 376.11 Multisensory processing in autism
spectrum disorders: High-density electrical mapping of
audiovisual integration in children and adolescents. A.
B. BRANDWEIN; J. FOXE; J. BUTLER; N. RUSSO; T.
ALTSCHULER; H. GOMES; S. MOLHOLM*. Albert Einstein
Col. of Med., City Univ. of New York (CUNY) Grad. Ctr. and
Queens Col., City Univ. of New York (CUNY) Grad. Ctr. and
City Col.
11:00 NN19 376.12 Event-related potentials reflect a
somatosensory-auditory interaction in the context of speech
perception. T. ITO*; V. L. GRACCO; D. J. OSTRY. Haskins
Labors, McGill Univ.
8:00 NN20 376.13 • Directional change of an audiovisual
stimulus affects gamma coherence between parietal cortex
and auditory and visual cortices. T. D. ARD*; F. CARVER; T.
HOLROYD; R. COPPOLA. NIH.
9:00 NN21 376.14 Audio-visual multimodal integration
activity in human brain: An MEG Study. I. NAKAMURA*; Y.
HIRANO; N. OHARA; N. ORIBE; S. HIRANO; T. UENO; T.
ONITSUKA. Kyushu Univ. Neuropsychiatry, Harvard Med.
Sch.
Neuroscience 2011 | Monday AM | 51
Mon. AM

POSTER
377. Mouse Vision: Functional Organization
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 NN22 377.01 Functionally distinct domains within
mouse primary visual cortex. W. JI*; Q. WANG; A.
BURKHALTER. Weiqing Ji, Washington Univ. Med. Sch.,
Allen Inst. for Brain Sci.
9:00 NN23 377.02 Effects of muscarinic receptors on
functional organization of the mouse primary visual cortex.
M. GROLEAU*; M. P. VANNI; J. WESS; C. CASANOVA; E.
VAUCHER. Univ. De Montréal, NIH-NIDDK.
10:00 NN24 377.03 The segregation between binocular and
monocular zones in primary visual cortex is altered in mice
that lack the β3 subunit of the L-type Ca ^2 + channel. C. L.
LANTZ*; E. K. DILGER; W. GUIDO; A. E. MEDINA. Virginia
Commonwealth Univ. Med. Ctr.
11:00 NN25 377.04 Functional imaging reveals a lack of
columnar organization for simple and complex cells in mouse
visual cortex. N. J. PRIEBE*; B. SCHOLL. Univ. Texas,
Austin.
8:00 NN26 377.05 Learn to use L-cone in mice expressing
a human L-cone photopigment. S. ZHANG*; Y. DAN. UC
Berkeley.
9:00 NN27 377.06 The impact of PV neurons on stimulus
selectivity in mouse visual cortex. B. ATALLAH*; M.
SCANZIANI. UCSD, HHMI.
10:00 NN28 377.07 Two distinct subtypes of PV+ inhibitory
interneurons in mouse primary visual cortex. C. A.
RUNYAN*; M. SUR. Picower Inst. For Learning and Memory,
MIT.
11:00 NN29 377.08 • Enhancing specific interneuron activity
improves V1 feature selectivity and visual perception. S.
LEE*; Y. DAN. Univ. of California, Berkeley.
8:00 NN30 377.09 Differential tuning and population
dynamics of excitatory and inhibitory neurons reflect
differences in local intracortical connectivity. S. B. HOFER;
H. KO; B. PICHLER; H. ROS; J. VOGELSTEIN; H. ZENG;
E. LEIN; N. A. LESICA; T. D. MRSIC-FLOGEL*. Univ. Col.
London, Natl. Inst. of Med. Res., Johns Hopkins Univ., Allen
Inst. for Brain Sci., Ear Institute, Univ. Col. London.
9:00 NN31 377.10 Contextual modulation in visual cortex of
anesthetized mice. J. A. HEIMEL*; J. A. M. LORTEIJE; P. R.
ROELFSEMA; C. N. LEVELT. Netherlands Inst. Neurosci,
Netherlands Inst. for Neurosci., Netherlands Inst. for
Neurosci.
10:00 NN32 377.11 Orientation selectivity of clonally
related neurons in mouse visual cortex. G. OHTSUKI; M.
NISHIYAMA; T. MURAKAMI; M. HISTED; K. OHKI*. Kyushu
Univ., Harvard Med. Sch.
11:00 NN33 377.12 Development of direction selectivity
in mouse cortical neurons. N. L. ROCHEFORT*; M.
NARUSHIMA; C. GRIENBERGER; D. N. HILL; A.
KONNERTH. Inst. of Neuroscience, Tech. Univ. Munich.
8:00 NN34 377.13 • Binocular orientation tuning in
the mouse primary visual cortex. X. ZHAO*; J. CANG.
Northwestern Univ.
9:00 NN35 377.14 Transformation of visual sensory
information from cortical layer 4 to layer 2/3: The second
stage of visual cortical processing. P. POLACK; D. CHOW;
J. SHARIM; J. FRIEDMAN; R. GRUVER; S. SMIRNAKIS; P.
GOLSHANI*. UCLA Dept. of Neurol., UCLA Deparment of
Neurobio., UCLA, Baylor Col. of Med.
10:00 NN36 377.15 Layer 6 modulates the gain of visual
processing in upper cortical layers. S. R. OLSEN*; D. S.
BORTONE; H. ADESNIK; M. SCANZIANI. UCSD/HHMI.
11:00 OO1 377.16 Activation of layer 6 directly suppresses
cortical activity via recruitment of local disynaptic inhibition.
D. S. BORTONE*; S. R. OLSEN; H. ADESNIK; M.
SCANZIANI. UC - San Diego.
8:00 OO2 377.17 Targeted in vivo labeling of functionally
identified neurons for cellular and synaptic characterization
in vitro. A. D. LIEN*; M. SCANZIANI. UCSD, HHMI.
9:00 OO3 377.18 Population coding of natural movies
with different spatial frequency content. M. F. IACARUSO;
S. B. HOFER; G. BILLINGS; R. A. SILVER*; T. D. MRSIC-
FLOGEL. Univ. Col. London.
POSTER
378. Mouse Vision: Response Properties
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 OO4 378.01 Circuit analysis of extrastriate cortical
visual processing in the mouse. J. H. MARSHEL*; M. E.
GARRETT; I. NAUHAUS; E. M. CALLAWAY. The Salk Inst.
for Biol. Studies, UCSD.
9:00 OO5 378.02 Stream-specific connections of
mouse visual cortex with the amygdala. Q. WANG; A. H.
BURKHALTER*. Allen Inst. for Brain Sci., Washington Univ.
Med. Sch.
10:00 OO6 378.03 Synaptic properties of connections
between primary and secondary visual cortices in the
mouse. R. DE PASQUALE*.
11:00 OO7 378.04 Laminar distribution of gap junctions in
mouse primary visual cortex. N. HAIDER*; M. CHARY; E.
KAPLAN. Mount Sinai Sch. of Med.
8:00 OO8 378.05 Imaging visually evoked activity in the
primary and high order visual cortices of the mouse using
voltage sensitive dyes reveals simultaneous parallel and
recurrent processing. P. POLACK*; D. CONTRERAS. Univ.
of California - Los Angeles, Univ. of Pennsylvania - Sch. of
Med.
9:00 OO9 378.06 In vivo voltage-sensitive dye imaging
study of inter-areal signal propagation in mouse visual
cortex evoked by electrical stimulation. T. FEHERVARI*; Y.
OKAZAKI; Y. TETSUYA. Osaka Univ.
10:00 OO10 378.07 Circuits for higher vision in the mouse. M.
GARRETT*; J. H. MARSHEL; M. L. NEWTON; I. NAUHAUS;
E. M. CALLAWAY. The Salk Inst. For Biol. Studies, Univ. of
California San Diego.
11:00 OO11 378.08 � Mapping visual areas in alert mice
using optical imaging. D. ROUMIS*; L. GLICKFELD; G.
GOLDEY; A. KERLIN; V. BEREZOVSKII; C. REID; M.
ANDERMANN. Harvard Med. Sch., Northeastern Univ.
52 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 OO12 378.09 The hemodynamic response in visual
cortex of the awake mouse. M. A. PISAURO; T. SATO; M.
CARANDINI; A. BENUCCI*. Univ. Col. London.
9:00 OO13 378.10 Pattern adaptation in mouse primary
visual cortex. N. T. DHRUV*; M. CARANDINI. Univ. Col.
London.
10:00 OO14 378.11 Effect of contrast and locomotion on
spatial integration in mouse visual cortex. A. AYAZ*; M. L.
SCHÖLVINCK; A. B. SALEEM; M. CARANDINI. Univ. Col.
London.
11:00 OO15 378.12 Effect of cortical state on contrast
responses in visual cortex of awake mouse. M. L.
SCHOLVINCK*; A. B. SALEEM; A. AYAZ; M. OKUN; K. D.
HARRIS; M. CARANDINI. Univ. Col. London, Imperial Col.
London.
8:00 OO16 378.13 Active visual processing in behaving
mice. G. B. KELLER*; T. BONHOEFFER; M. HÜBENER.
Max Planck Inst. of Neurobio.
9:00 OO17 378.14 Cortical state dictates the spatiotemporal
spread of evoked activity in mouse visual cortex. B.
HAIDER*; M. HÄUSSER; M. CARANDINI. Univ. Col.
London, Wolfson Inst. for Biomed. Research, Univ. Col.
London.
10:00 OO18 378.15 Responses of mouse primary visual
cortex during virtual navigation. A. B. SALEEM*; A. AYAZ; M.
L. SCHÖLVINCK; K. J. JEFFERY; M. CARANDINI. Univ. Col.
London, Univ. Col. London.
11:00 OO19 378.16 Visual discrimination learning with
variable salience in the mouse. M. TREVINO VILLEGAS*;
T. OVIEDO; S. LI; G. KÖHR; R. J. DE MARCO. Max Planck
Inst.
8:00 OO20 378.17 Higher visual cortical responses mediated
via the superior colliculus in mice. M. TOHMI*; R. MEGURO;
R. HISHIDA; M. NORITA; K. SHIBUKI. Brain Res. Inst,
Niigata Univ., Niigata Univ. Fac. of Med.
POSTER
379. Eye Movements: Perception and Neural Mechanisms
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 OO21 379.01 The influence of eye movements on
contour segregation from a noisy background. A. GILAD*; Y.
PESOA; H. SLOVIN. The Gonda Multidisciplinary Brain Res.
Center, Bar-Ilan Univ.
9:00 OO22 379.02 Saccade planning in the posterior parietal
cortex is suppressed following a reach. M. A. HAGAN*; B.
PESARAN. New York Univ.
10:00 OO23 379.03 Temporo-spatial dynamics of perisaccadic
directional selectivity in areas MT and MST of the macaque
monkey revealed by motion reverse correlation. M.
SARUWATARI*; T. UKA; S. KITAZAWA. Juntendo Univ.
11:00 OO24 379.04 Attention shifts following microsaccades.
S. YUVAL-GREENBERG*; D. J. HEEGER. NYU.
8:00 OO25 379.05 Detection of trans-saccadic target shifts
in human and monkey. W. M. JOINER*; J. CAVANAUGH; E.
J. FITZGIBBON; R. H. WURTZ. Natl. Eye Inst.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 OO26 379.06 Pattern of presaccadic modulation of
visual responses in macaque V4 measured simultaneously
across cortical layers. N. A. STEINMETZ*; T. MOORE.
Stanford Univ.
10:00 OO27 379.07 Random walk analysis of fixational eye
movements during viewing of natural video scenes. J. A.
ROBERTS*; G. WALLIS; M. BREAKSPEAR. Queensland
Inst. of Med. Res., Univ. of Queensland, Royal Brisbane and
Women’s Hosp., The Black Dog Inst., Univ. of New South
Wales.
11:00 OO28 379.08 Oculomotor networks for conjugate
and disconjugate eye movements in the rhesus macaque
monkey. M. K. WARD*; M. S. BOLDING; P. D. GAMLIN.
Univ. Alabama, Birmingham.
8:00 OO29 379.09 Early neurophysiological markers
of target detection during free eye movements. J. E.
KAMIENKOWSKI*; M. J. ISON; R. Q. QUIROGA; M.
SIGMAN. Lab. De Neurociencia Integrativa, Depto. De
Física, Fceyn, UBA, Neuroengineering Lab, Dept. of
Engineering, Univ. of Leicester, Lab. De Neurociencia
Integrativa, Depto. de Física, Fceyn, UBA.
9:00 OO30 379.10 Dynamic temporal modulation in active
vision. A. BARCZAK*; A. FALCHIER; A. MILLS; D. C.
JAVITT; P. LAKATOS; C. E. SCHROEDER. NYU Sch. of
Med., Nathan Kline Inst., NYU Sch. of Med., Columbia Univ.
Col. of Physicians & Surgeons.
10:00 OO31 379.11 Remapping of stimulus location but not
identity across eye movements. J. D. GOLOMB*; M. D.
LESCROART; I. BIEDERMAN; N. KANWISHER. MIT, Univ.
of California, Berkeley, USC.
11:00 OO32 379.12 Influence of eye muscle proprioception
on the updating of spatial representations. M. POLETTI*; M.
RUCCI. Boston Univ., Boston Univ.
8:00 OO33 379.13 Oculomotor networks for conjugate and
disconjugate eye movements in humans. D. GURLER*; M.
S. BOLDING; J. A. DENHOLLANDER; M. K. WARD; P. D.
GAMLIN. Univ. of Alabama At Birmingham, Univ. of Alabama
At Birmingham, Univ. of Alabama At Birmingham.
9:00 OO34 379.14 Seeing blind spots as blank spots:
Implications for understanding phenomenal visual
consciousness. C. WU*. Perception and Cognition Res.
10:00 OO35 379.15 Where cats look during locomotion
with accurate stepping. T. J. RIVERS*; N. A. SHAH; M. G.
SIROTA; I. N. BELOOZEROVA. Barrow Neurolog. Inst.
11:00 OO36 379.16 Limiting the anatomical locus of visual
repetition suppression. S. E. BOEHNKE*; D. J. BERG; L.
ITTI; D. P. MUNOZ. Queen’s Univ., USC, USC.
POSTER
380. Pain Models: Physiology
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 PP1 380.01 An in vitro model to study phenotype
of trophic factor specific sensory neuron terminals and
interaction with keratinocytes. L. PONCE; A. KLUSCH; M.
RINGKAMP; I. SCHÄFER; A. HOLLOSCHI; M. SCHMELZ;
M. HAFNER; M. PETERSEN*. Hochschule Mannheim,
Universitätsklinikum Mannheim, Johns Hopkins Univ.
Neuroscience 2011 | Monday AM | 53
Mon. AM

9:00 PP2 380.02 The interphase of the Formalin test.
M. J. FISCHER*; T. HOFFMANN; A. LEFFLER; P. A.
MCNAUGHTON; P. REEH. Univ. of Cambridge, Univ. of
Erlangen-Nuremberg, Univ. of Hannover.
10:00 PP3 380.03 Visceral pain responses detected by
abdominal electromyography during bladder filling in rats
with lumbosacral ventral root avulsion injury and repair. H. H.
CHANG*; L. HAVTON. Univ. of California at Irvine, Reeve-
Irvine Res. Ctr., Univ. of California at Irvine.
11:00 PP4 380.04 Sumatriptan reverses sensitization of
medullary pain-facilitating neurons in the dural inflammation
model of migraine headache-related pain. M. M.
HEINRICHER*; M. E. MARTENSON. Oregon Hlth. & Sci.
Univ.
8:00 PP5 380.05 Formalin injection dose not increase
contralateral cutaneous blood perfusion under preinflammatory
condition. A. LI*; C. HAGAINS; Y. PENG. Univ.
of Texas At Arlington, Univ. of Texas at Arlington.
9:00 PP6 380.06 Alterations in translational regulation play
a key role in thermal pain sensitivity in mice. R. E. SORGE*;
A. KHOUTORSKY; N. SONENBERG; J. S. MOGIL. McGill
Univ., McGill Univ.
10:00 PP7 380.07 Causal role of reactive oxygen species
in paclitaxel-induced painful peripheral neuropathy. L. A.
GRIFFITHS; M. FIDANBOYLU; S. J. FLATTERS*. King’s
Col. London.
11:00 PP8 380.08 • Unilateral medial meniscus tear
model of OA: Examination of WDR neuronal activity. S. P.
MCGARAUGHTY*; J. XU; K. L. CHU; J. MIKUSA. Abbott
Labs.
8:00 PP9 380.09 • Telemetric recording of ectopic
discharge and EEG in neuropathic rats - its application in
evaluating analgesic and sedative actions of compounds.
F. ZHAO; H. WEI; R. D. JEGGO; D. SPANSWICK*.
NeuroSolutions Ltd.
9:00 PP10 380.10 Effects of DRG exposure to two cell
populations derived from nucleus pulposus on evoked
thalamic neuronal activity. E. M. NILSSON*; K. LARSSON;
B. RYDEVIK; H. BRISBY; I. HAMMAR. Univ. of Gothenburg.
10:00 PP11 380.11 Finite element modeling of the current
transport between cutaneous electrodes. K. S. FRAHM*; C.
DAHL MØRCH; O. K. ANDERSEN. Aalborg Univ.
11:00 PP12 380.12 • Histological and immunohistochemical
characterization and comparison of rat models of
osteoarthritic pain. R. S. BITNER*; Y. LEE; J. BREDERSON;
S. MARKOSYAN; A. NIKKEL; J. MIKUSA; M. F. JARVIS.
Abbott Lab.
8:00 PP13 380.13 Mouse model of touch-evoked itch
(alloknesis). E. E. CARSTENS*; T. AKIYAMA; M. IODI
CARSTENS; F. CEVIKBAS; A. IKOMA; M. STEINHOFF.
Univ. California Davis, Univ. of California, Davis, Univ. of
California, San Francisco.
9:00 PP14 380.14 • A network model of pain processing
in the dorsal horn: Effects of A-fiber input activity on wide
dynamic range projection neuron activity. T. ZHANG*; J. J.
JANIK; W. M. GRILL. Duke Univ., Stryker Corp.
10:00 PP15 380.15 • Brain microdialysis examination of
nociceptive-induced neurotransmitter changes in formalin,
carrageenan, and cfa-stimulated rats. T. A. FEY*; J. B.
WETTER; H. XU; D. F. STOLARIK; M. J. RIESER; M. F.
JARVIS; R. S. BITNER. Abbott Labs.
11:00 PP16 380.16 Increased pain sensitivity after
chronic sleep restriction in mice. A. LATREMOLIERE*;
C. ALEXANDRE; M. YAMAMOTO; R. HERSHER; T.
SCAMMELL; C. WOOLF. Harvard Med. Sch., Children’s
Hosp. Boston, Beth Israel Deaconess Med. Ctr.
8:00 PP17 380.17 Differential effects of chronic neuropathic
and inflammatory pain on sleep patterns in mice. C.
ALEXANDRE*; A. LATREMOLIERE; M. YAMAMOTO; C.
J. WOOLF; T. E. SCAMMELL. Harvard Med. Sch., Harvard
Med. Sch. / FM Kirby Neurobio. Program.
9:00 PP18 380.18 Impact of NTS2 receptor activation on
bone cancer development and pain-related behaviors. G.
ROUSSY*; K. BELLEVILLE; K. KIRBY; N. BEAUDET; K.
WADA; J. MARTINEZ; P. SARRET. Univ. de Sherbrooke,
Natl. Inst. of Neuroscience, Natl. Ctr. of Neurol. and
Psychiatry, Univ. Montpellier 1 et 2.
10:00 PP19 380.19 Role of protein synthesis and degradation
in chronic pain. J. BAEK; H. KO; X. LI; M. ZHUO; B.
KAANG*. Seoul Natl. Univ., Natl. Creative Res. Initiative Ctr.
for Memory, Univ. of Toronto.
11:00 PP20 380.20 A micro-imaging study to correlate bone
cancer pain with tumor growth and bone resorption in the
rat. L. DORE-SAVARD*; L. TREMBLAY; N. BEAUDET;
M. LEPAGE; P. SARRET. Univ. De Sherbrooke, Univ. de
Sherbrooke.
8:00 PP21 380.21 Neuronal hyper-excitability in dorsal
root ganglia induced by intradermal capsaicin injection is
modulated by satellite glial activation. K. GONG*; X. ZOU; Q.
LIN. Univ. of Texas At Arlington.
9:00 PP22 380.22 Natriuretic peptides induce nociceptor
sensitization by upregulating TRPV1 activity/expression. L.
LOO; A. J. SHEPHERD; R. A. LORCA; A. D. MICKLE; Y. M.
USACHEV; D. P. MOHAPATRA*. Univ. of Iowa Carver Col. of
Med.
10:00 PP23 380.23 Activation of neuronal Fc-gamma
receptor I triggers a transient receptor potential-like current
in the rat dorsal root ganglion neurons. L. QU*; P. ZHANG;
C. MA. Yale Univ. Sch. of Med.
11:00 PP24 380.24 Selective block of abnormal spontaneous
activity in inflamed rat sensory ganglia greatly reduces
mechanical pain. W. XIE*; J. A. STRONG; J. ZHANG. Univ.
Cincinnati Coll Med.
8:00 PP25 380.25 Mechanisms involved in estrogen
receptor-mediated, rapid enhancement of bradykinin
responses. M. P. ROWAN*; K. A. BERG; K. M.
HARGREAVES; J. L. ROBERTS; W. P. CLARKE. Univ. of
Texas Hlth. Sci. Ctr., Univ. of Texas Hlth. Sci. Ctr.
9:00 PP26 380.26 Chronic inflammation enhances
excitability and hyperpolarization-activated current (Ih) in C-,
but not Aδ-, fiber nociceptive DRG neurons in rats in vivo. L.
DJOUHRI*; X. WENG. Univ. of Liverpool.
10:00 PP27 380.27 Pulmonary sensory nerve silencing
as a strategy to reduce the neurogenic component of
allergen-induced airway inflammation. C. VON HEHN*;
O. HAWORTH; I. CHIU; B. BEAN; B. LEVY; C. WOOLF.
Harvard Med. Sch., Children’s Hosp. Boston, Brigham and
Women’s Hosp.
11:00 PP28 380.28 Cutaneous sympathetic fibre sprouting
in an animal model of monoarthritis. G. M. LONGO*; M.
OSIKOWICZ; A. RIBEIRO-DA-SILVA. McGill Univ.
8:00 QQ1 380.29 Mechanisms underlying inflammationinduced
increase in evoked Ca 2+ transients in rat dorsal root
ganglion neurons. N. SCHEFF; S. LU; M. S. GOLD*. Univ.
Pittsburgh, Univ. of Maryland.
54 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 QQ2 380.30 Gain of constitutive function is the
defining feature of axonal neuropathies-linked mutant
TRPV4 channels. H. DENG*; F. FECTO; Y. SHI; R. HUDA;
M. MARTINA; T. SIDDIQUE. Northwestern Univ. Feinberg
Sch. of Med., Northwestern Univ. Feinberg Sch. of Med.
POSTER
381. Inflammatory Pain and Sensitization
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 QQ3 381.01 Modification of histone h3 in subsets
of dorsal horn neurons during the development of an
inflammatory pain state. K. K. TOCHIKI*; S. P. HUNT; S. M.
GÉRANTON. Univ. Col. London.
9:00 QQ4 381.02 Characterising spinal changes associated
with chronic pain in collagen induced arthritis. M. A.
MALCANGIO*; J. GRIST; A. AL-KASHI; M. PERRETTI; A.
K. CLARK. Wolfson CARD, The Wolfson Wing, Kings Col.
London, Barts and The London Sch. of Medicine, Queen
Mary Univ. of London.
10:00 QQ5 381.03 Sensitization of TRPV1 receptors
expressed at the central end of C afferents following
inflammation. M. YOSHIMURA*; D. XIE; D. UTA; J.
HACHISUKA; H. FURUE. Kumamoto Hlth. Sci. Univ.,
Kumamoto Hlth. Sci. Univ., Natl. Inst. for Physiological Sci.,
Kyushu Univ.
11:00 QQ6 381.04 • Involvement of AMPA receptor GluR2
and GluR3 subunit C-termini in orofacial inflammatory pain.
M. MIYAMOTO*; Y. TSUBOI; M. SHINODA; K. IWATA. Nihon
Univ. Sch. of Dent., Nihon Univ. Sch. of Dent.
8:00 QQ7 381.05 Microglial/macrophage GRK2 determines
duration of post-inflammatory hyperalgesia by regulating the
M1/M2 balance. H. L. D. M. WILLEMEN; C. J. HEIJNEN;
A. GARZA CARBAJAL; K. W. KELLEY; R. DANTZER; A.
KAVELAARS*. UMC Utrecht, Univ. of Illinois.
9:00 QQ8 381.06 Enhanced GABAergic neuronal activity in
the spinal dorsal horn following complete Freund’s adjuvant
injection is accompanied by apoptotic changes. X. ZOU; K.
GONG; Q. LIN*. Univ. of Texas At Arlington.
10:00 QQ9 381.07 • TNFα receptor R1/R2 dual deficient
mice develop chronic arthritis. L. ZHANG*; F. MA; K. N.
WESTLUND. Univ. Kentucky.
11:00 QQ10 381.08 Changes in epigenetic machinery in
the superficial dorsal horn correlate with the pattern of
gene expression that follows the development of joint
inflammation. S. M. GERANTON*; K. K. TOCHIKI; S. P.
HUNT. Univ. Coll London.
8:00 QQ11 381.09 Microglial Cathepsin S and CX 3 CR 1
contribute to chronic pain in collagen induced arthritis. A.
K. CLARK*; J. GRIST; A. AL-KASHI; M. PERRETTI; M.
MALCANGIO. Kings Col. London, Barts and The London
Sch. of Medicine, Queen Mary Univ. of London.
9:00 QQ12 381.10 Role of TRPV1 and TNF-alpha in
regulating spinal cord synaptic plasticity and long-term
potentiation and inflammatory pain. C. PARK*; N. LU; Z. XU;
T. LIU; R. JI. Brigham & Women’s Hosp. and Harvard Med.
Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
10:00 QQ13 381.11 Mitochondria and plasma membrane
Ca 2+ -ATPase (PMCA) control presynaptic [Ca 2+ ] i clearance in
capsaicin-sensitive sensory neurons. L. P. SHUTOV; M. KIM;
Y. M. USACHEV*. Univ. Iowa.
11:00 QQ14 381.12 Caspase-6 drives inflammatory pain and
central sensitization via TNF-alpha signaling. T. BERTA*;
Z. XU; N. LU; C. PARK; T. LIU; R. JI. Brigham and Women
Hosp. and Harvard Med. Sch.
8:00 QQ15 381.13 • Spinal cord isoforms of PI3 Kinase:
Cellular location and role in nociception. L. S. SORKIN*;
F. J. KOEHRN; I. D. KALCHEVA; D. L. BOYLE; G. S.
FIRESTEIN. Univ. California San Diego.
9:00 QQ16 381.14 The ATP/UTP receptor P2Y2
modulates cutaneous and visceral nociceptor function.
D. C. MOLLIVER*; E. S. SCHWARTZ; T. TAKAHIRO; H.
O. VONGTAU; G. F. GEBHART. Univ. Pittsburgh, Univ.
Pittsburgh, Univ. of Pittsburgh, Univ. of Pittsburgh.
10:00 QQ17 381.15 PKC epsilon phosphorylates and
increases the function of the voltage-gated sodium channel
Na v 1.8. D. F. WU*; T. MCMAHON; D. WANG; J. DADGAR;
J. STECHER; V. N. KHARAZIA; Z. QI; Y. LIANG; S. G.
WAXMAN; S. D. DIB-HAJJ; R. O. MESSING. Ernest Gallo
Clin. and Res. Ctr. At UCSF, Yale Univisity Sch. of Med.
11:00 QQ18 381.16 Intra-accumbal administration of
AP5, NMDA receptor antagonist, attenuates analgesia
induced by cannabinoid receptor agonist (WIN 55,212-2)
microinjected into the basolateral amygdala in tail-flick
test. A. HAGHPARAST*; M. GHALANDARI-SHAMAMI; M.
HASSANPOUR-EZATTI. Neurosci. Res. Center, Shahid
Beheshti Univ. of Med. Sci., Dept. of Biology, Fac. of Basic
Sciences, Shahed Univ.
8:00 QQ19 381.17 The roles of Gr-1 + leukocytes in postincisional
nociceptive sensitization and inflammation. P.
SAHBAIE*; X. LI; X. SHI; Y. QIAO; D. C. YEOMANS; J. D.
CLARK. Stanford Univ., VAPAHCS.
9:00 QQ20 381.18 Novel approach for the treatment of
chronic pain associated with arthritis. M. OSIKOWICZ*; G.
LONGO; A. CUELLO; A. RIBEIRO-DA-SILVA. McGill Univ.
10:00 QQ21 381.19 Activation of monocyte chemoattractant
protein-1and its receptor chemokine (c-c motif) receptor
2 in dorsal root ganglion by paclitaxel. H. ZHANG*; P. M.
DOUGHERTY. UT MD Anderson Cancer Ctr., UT MD
Anderson Cancer Ctr.
11:00 QQ22 381.20 Atopic keratinocytes induce increased
neurite outgrowth in a coculture model of porcine DRG
neurons and human skin cells. D. ROGGENKAMP; S.
FALKNER; F. STÄB; M. PETERSEN; M. SCHMELZ*; G.
NEUFANG. Beiersdorf AG, Univ. Heidelberg.
8:00 QQ23 381.21 JTE-013, a putative selective antagonist
of sphingosine 1-phosphate receptor 2, increases the
excitability of rat sensory neurons independently of the
receptor. C. LI*; W. XIE; J. STRONG; J. ZHANG; G. NICOL.
Indiana Univ. Sch. of Med., Univ. of Cincinnati.
9:00 QQ24 381.22 Expression levels of sphingosine
1-phosphate receptors in single isolated rat sensory
neurons. G. D. NICOL*; C. LI; J. S. KAYS. Indiana Univ. Sch.
Med.
10:00 QQ25 381.23 Agonist or inflammation increases
prostaglandin E2 EP4 receptor externalization in primary
sensory neurons. B. ST-JACQUES; P. CRUZ DUARTE; W.
MA*. McGill Univ., McGill Univ., McGill Univ.
Neuroscience 2011 | Monday AM | 55
Mon. AM

POSTER
382. Pain Imaging and Perception I
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 QQ26 382.01 Imaging the neural correlates of ongoing,
parametrically modulated, mechanical pain in healthy human
subjects using arterial spin labeling. A. R. SEGERDAHL*;
J. XIE; Y. KONG; M. MINETT; E. DUFF; I. TRACEY. Andy
Segerdahl, Univ. of Oxford (FMRIB Centre), FMRIB Ctr.
9:00 QQ27 382.02 Rhythms of the pain - chronic pain
without organic etiology leads to higher oscillations of the
human brain’s resting state. M. NOLL-HUSSONG*; A.
OTTI; A. M. WOHLSCHLAEGER; P. HENNINGSEN; C.
ZIMMER; H. GUENDEL. Clin. for Psychosomatic Med. and
Psychotherapy, Technische Univ. Muenchen, Technische
Univ. Muenchen, Universitaetsklinikum Ulm.
10:00 QQ28 382.03 Long-term yoga practice is associated
with anatomical changes in pain-related brain areas. M.
CEKO*; C. VILLEMURE; V. COTTON; C. BUSHNELL.
McGill Univ.
11:00 QQ29 382.04 An fMRI study on how contextual learning
can modulate pain perception. J. KONG*; K. JENSEN; R.
LOIOTILE; A. CHEETHAM; B. ROSEN; J. SMOLLER; T.
KAPTCHUK; R. GOLLUB. Massachusetts Gen. Hosp.,
MGH/MIT/HMS Athinoula A. Martinos Ctr. for Biomed.
Imaging, Osher research center.
8:00 QQ30 382.05 The experience of pain shapes resting
state regional homogeneity in the brain. A. L. CHEETHAM*;
R. LOIOTILE; R. B. SPAETH; Y. TAN; K. JENSEN; R.
L. GOLLUB; J. KONG. Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp.
9:00 QQ31 382.06 Mental stress of a stroop task leads to
reduced pain during a cold pressure test - a psychophysics
and fMRI study. R. RINGLER*; P. V.D. KEYLEN; K.
DETMAR; R. LOOSE; C. FORSTER. Univ. of Appl. Sci.,
Univ. of Erlangen, Clin. Ctr. of Nuremberg.
10:00 QQ32 382.07 Pain behaviors in patients with chronic
back pain predict their perception of pain in others: An fMRI
study. E. VACHON-PRESSEAU*; M. MARTEL; M. ROY;
M. J. SULLIVAN; P. L. JACKSON; P. RAINVILLE. Univ. de
Montreal, McGill Univ., Columbia Univ., Univ. Laval.
11:00 QQ33 382.08 Decoding an individual’s sensitivity to
pain from the multivariate analysis of EEG data. E. SCHULZ;
A. ZHERDIN; L. TIEMANN; C. PLANT; M. PLONER*.
Technische Univ. München, TU Muenchen.
8:00 QQ34 382.09 The impact of fibromyalgia over brain
functional connectivity: A r-Beta single-subject analysis.
P. MONTOYA*; M. A. MUÑOZ; E. TAGLIAZUCCHI; P.
BALENZUELA; D. FRAIMAN; L. HESS; D. R. CHIALVO.
Univ. of Balearic Islands, Univ. de Buenos Aires, Brain
Imaging Center, Goethe Univ., CONICET, Univ. de San
Andrés, Univ. Nacional de Rosario, Univ. of California at Los
Angeles.
9:00 QQ35 382.10 • Differential magnetoencephalographic
(MEG) cortical response to selective activation of A or C fiber
thermonociceptors. M. I. NEMENOV*; S. NAGARAJAN; A.
FINDLAY; D. C. YEOMANS. Lasmed LLC, Stanford Univ.,
Univ. of California at San Francisco.
10:00 QQ36 382.11 Enhanced excitability to visual stimulation
in area V1 and LGN using fMRI in patients with migraine
with aura. R. DATTA*; J. A. DETRE; G. K. AGUIRRE; B. L.
CUCCHIARA. Univ. of Pennsylvania, Univ. of Pennsylvania.
11:00 RR1 382.12 Mirrors, phantoms and phantom limb
pain: Mechanisms and treatment. H. FLOR*; J. FOELL;
R. BEKRATER-BODMANN; M. DIERS. Dept. of Clin. and
Cognitive Neurosci. / Univ. of Heidelberg.
8:00 RR2 382.13 Spotting pain in the brain - assessing
nociceptive and tactile responses in conscious unrestrained
rats. T. JENSEN*; L. ETEMADI; G. LIND; B. LJUNGQUIST;
F. TSANAKALIS; P. PETERSSON; J. THELIN; M.
GARWICZ; J. SCHOUENBORG. Section For Neuroscience,
Lund Univ.
9:00 RR3 382.14 The awake rat brain’s metabolic response
to formalin injection in the hind paw using small animal
PET. S. J. THOMPSON*; A. ALIAGA; M. MILLECAMPS; L.
A. LOW; P. VACHON; L. S. STONE; B. J. BEDELL; M. C.
BUSHNELL. McGill Univ., McGill Univ., McGill Univ., Univ. de
Montréal, McGill Univ.
10:00 RR4 382.15 • Imaging pain generators in vivo using
positron emission tomography (PET)-labeled sodium
channel toxin derivatives. S. BISWAL; W. PARSONS; A.
HOEHNE; B. SHEN; D. BEHERA; F. CHIN; J. MULCAHY; G.
P. MILJANICH*; D. YEOMANS; J. DU BOIS. Stanford Univ.,
Stanford Univ., Siteone Therapeut., Stanford Univ.
11:00 RR5 382.16 hTNF and BOLD fMRI in mice and man:
Precinical and clinical treatment approaches. A. HESS*; R.
AXMANN; J. RECH; I. WANK; S. KREITZ; O. SPORNS;
G. KOLLIAS; A. DOERFLER; K. BRUNE; G. SCHETT. I.F.
Pharmacol & Toxicol, Dept. of Intrnl. Med. 3, I.f. Pharmacol
& Toxicol, Dept. of Psychological and Brain Sci., Inst. of
Immunol., Div. of Neuroradiology.
8:00 RR6 382.17 • Do psychological traits associated with
eating disorders influence pain sensitivity? K. L. KERR*; S.
PALIT; E. L. TERRY; J. L. RHUDY. Univ. of Tulsa.
9:00 RR7 382.18 Native Americans have reduced pain
sensitivity and reduced temporal summation of spinal
nociception: A pilot study. S. PALIT*; K. L. KERR; B. L.
KUHN; E. L. TERRY; J. L. DELVENTURA; E. J. BARTLEY;
J. O. SHADLOW; J. L. RHUDY. Univ. of Tulsa.
10:00 RR8 382.19 Functional MRI as a new method for
investigating the analgesic activity of crotoxin, a classic
ß-neurotoxin. S. WOLZ; S. KREITZ*; K. ESSER; A. HESS.
Inst. For Pharmacol. and Toxicology, Inst. of Zoology, Univ.
of Vet. Med.
11:00 RR9 382.20 A functional MRI study on the effects of
different anesthetics on pain processing in the rat CNS. T.
MAKAROVA; C. HEINDL-ERDMANN*; A. HESS. Friedrich-
Alexander-University.
8:00 RR10 382.21 Morphological and functional
reorganization of the limbic system predicts transition from
acute to chronic back pain in humans. B. PETRE*; M.
BALIKI; T. J. SCHNITZER; A. V. APKARIAN. Northwestern
Univ.
9:00 RR11 382.22 Brain functional and anatomical changes
in chronic prostatitis/chronic pelvic pain syndrome. M. A.
FARMER*; M. L. CHANDA; E. L. PARKS; M. N. BALIKI; A. V.
APKARIAN; A. J. SCHAEFFER. Northwestern Univ., McGill
Univ., Northwestern Univ., Northwestern Univ.
10:00 RR12 382.23 Effects of short-term duloxetine dosing
on brain processing of pain and emotional pictures in
patients with major depressive disorder. D. BORSOOK*; B.
BRENNAN; L. NUTILE; D. WALLIN; S. SAVA; M. HENRY;
P. RENSHAW; I. ELMAN; L. BECERRA. P.A.I.N. Group,
McLean Hosp.
56 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 RR13 382.24 Biphasic BOLD responses to graded
heat indicate differential encoding of pain intensity in
somatosensory cortex and anterior insula. E. A. MOULTON*;
G. PENDSE; M. GRANT; J. BISHOP; L. BECERRA; D.
BORSOOK. McLean Hosp.
8:00 RR14 382.25 Habenula fMRI activation following
noxious heat stimulation. L. SHELTON*; A. DROSOS; G.
PENDSE; L. BECERRA; D. BORSOOK. Harvard Univ. /
Children’s Hosp. Waltham.
9:00 RR15 382.26 Hyperexcitability of the temporal pole is
related to the migraine attack frequency and is associated
with cortical thickening. N. MALEKI*; L. BECERRA; G.
PENDSE; J. BRAWN; D. BORSOOK. Harvard Med. Sch.
and P.A.I.N. Group, McLean Hosp., Massachusetts Gen.
Hosp. (MGH).
10:00 RR16 382.27 Mechanisms of pain relief following
motor cortex stimulation: An fMRI study. L. JIANG*; Y. JI;
M. KEASER; D. A. SEMINOWICZ; J. D. GREENSPAN; R.
M. MASRI. Univ. of Maryland Dent. Sch., Univ. of Maryland
Dent. Sch., Univ. of Maryland Med. Sch.
11:00 RR17 382.28 Mechanisms of spinal cord injury pain:
A longitudinal magnetic resonance spectroscopy study.
R. MASRI*; S. XU; Y. JI; L. JIANG; R. P. GULLAPALLI.
Univ. Maryland, Univ. of Maryland Sch. of Med., Core for
Translational Res. in Imaging.
8:00 RR18 382.29 Resting state fMRI in a rat model of
spinal cord injury neuropathic pain: A longitudinal study. D.
SEMINOWICZ*; L. JIANG; Y. JI; M. KEASER; R. M. MASRI.
Univ. of Maryland Dent. Sch., Univ. of Maryland Dent. Sch.
POSTER
383. Pain: Other Analgesics
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 RR19 383.01 Riluzole and gabapentinoids enhance
glutamate-induced glutamate release from cultured
astrocytes. M. YOSHIZUMI*; J. C. EISENACH; K.
HAYASHIDA. Wake Forest Univ. Sch. of Med.
9:00 RR20 383.02 A molluscan neuropeptide, APGWamide,
shows the antiallodynic effect in the rat model of diabetic
neuropathy. T. IKEDA*; K. IGAWA; Y. ISHIZUKA; T.
NAKAMURA; R. NAONO; R. TAKEDA; Y. ISHIDA; T.
NISHIMORI. Univ. of Miyazaki, Univ. of Miyazaki, Univ. of
Miyazaki.
10:00 RR21 383.03 Resveratrol inhibits Cdk5 activity through
regulation of p35 expression. E. S. UTRERAS PURATICH*;
A. B. KULKARNI. NIH.
11:00 RR22 383.04 Dissociation of hypoalgesia, ketosis,
and hypoglycemia with two ketogenic diets in the rat. D.
N. RUSKIN*; T. A. C. S. SUTER; J. ALTSCHULER; S. A.
MASINO. Trinity Col.
8:00 RR23 383.05 Specific modulation of spinal GABAergic
analgesia by KCC2 inhibition. M. N. ASIEDU*; G. MEJIA, Jr;
M. K. OSSIPOV; P. T. MALAN; K. KAILA; T. J. PRICE. Univ.
of Arizona, Univ. of Helsinki.
9:00 RR24 383.06 Effect from Motor Cortex Stimulation in
neuropathic pain in experimental animals. J. KIM*; J. KIM; K.
MIN; S. LEE; S. KIM; J. CHANG. Brain Korea 21 Proj Med.
Sci., Yonsei Univ. Col. of Med., Seoul Natl. Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
10:00 RR25 383.07 The effect of the analgesic KMX010 on
rat skin fibroblast cells. H. A. CROSBY*; D. SLOAN; K. E.
MILLER. Oklahoma State Univ. Ctr. For Hlth. Sci., Tulsa
Community Col.
11:00 RR26 383.08 Antinociceptive activity of CC44, a
biotinylated congener of improgan. P. HOERBELT; J. W.
NALWALK; J. G. PHILLIPS; L. B. HOUGH*. Albany Med.
Col., Curragh Chemistries.
8:00 RR27 383.09 ADL6906, a 5-HT 2 serotonin receptor
antagonist and norepinephrine reuptake inhibitor, for the
treatment of pain. B. LE BOURDONNEC*; P. J. LITTLE; C. J.
LABUDA; M. KOBLISH; T. M. GRACZYK; R. N. DEHAVEN;
L. K. LEISTER; G. H. CHU; R. E. DOLLE; B. L. BROGDON;
A. ADEDOYIN; L. M. TECHNER; R. M. MANGANO; R. M.
WOODWARD. Adolor Corp.
9:00 RR28 383.10 • Novel analogs of endomorphins provide
antinociception without spatial and recognition memory
deficits produced by morphine. J. JERNBERG*; X. XHANG;
J. E. ZADINA. Tulane Univ., Tulane Univ. Sch. of Med.,
Tulane Univ. Sch. of Med., SE LA Veterans HCS.
10:00 RR29 383.11 Demethylating drugs have an
antiproliferative and analgesic effect in oral squamous cell
carcinoma. C. T. VIET*; Y. YE; B. L. SCHMIDT. New York
Univ.
11:00 RR30 383.12 � Synergistic interaction between
diacerhein and topiramate locally administered, in the
rat formalin test. A. ZÚÑIGA-ROMERO; K. PONCE-
CHÁVEZ; M. GAUTHEREAU-TORRES; L. F. ORTEGA-
VARELA*. Univ. Michoacana de San Nicolás de Hidalgo,
Univ. Michoacana de San Nicolás de Hidalgo, Escuela De
Enfermería y Salud Publica, Univ. Michoacana De San
Nicolás De.
8:00 RR31 383.13 Molecular signaling pathway of
acupuncture stimulation in mouse skin layer. J. PARK*;
H. PARK; S. JEON; J. PARK; H. LEE; H. LEE; Y. CHAE.
AMSRC, Dept. of Oriental Med. Science, Grad. School,
Col. of Korean Medicine, Kyung Hee Univ., Dept. of Oriental
Medicine, The Grad. Sch. of Dongguk Univ., Asian Med. and
Acupuncture Research, Dept. of Physical Med. and Rehabil.
9:00 RR32 383.14 N-(4-Methoxy-2-nitrophenyl)
hexadecanamide, an analogue of palmitoylethanolamide,
reduces formalin-induced nociception. M. DECIGA-
CAMPOS*; J. E. ROA-CORIA; V. GRANADOS-SOTO.
Escuela Superior De Medicina IPN, CINVESTAV Sede Sur.
10:00 RR33 383.15 Antinociceptive interaction of ethanol
extract of Rhodiola rosea with cianocobalamin or riboflavin
in mice. R. M. MONTIEL-RUIZ*; M. DÉCIGA-CAMPOS.
Escuela Superior De Medicina, IPN.
11:00 RR34 383.16 • Stem cell-based systems biology
approach for developing therapeutics to manage peripheral
pain. G. W. MAGUIRE*; P. FRIEDMAN. Bioregenerative
Sciences, Inc.
8:00 RR35 383.17 Mechanisms of sanshool-induced
numbing in sensory neurons. R. C. LENNERTZ*, III; M.
TSUNOZAKI; D. BAUTISTA; C. L. STUCKY. Med. Col. of
Wisconsin, Univ. of California, Berkeley.
Neuroscience 2011 | Monday AM | 57
Mon. AM

POSTER
384. Somatosensory: Local Cortical Circuits for Whiskers
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 RR36 384.01 Investigating cortico-cortical
interactions in the mouse somatosensory system using
electrophysiological and optogenetic techniques. T.
BUSCHMAN*; J. VOIGTS; J. H. SIEGLE; D. VIERLING-
CLAASSEN; C. I. MOORE. MIT.
9:00 SS1 384.02 Axonal projection patterns of cortical layer
6 inhibitory interneurons with reference to cortical columns in
rat vibrissal cortex. M. ARZT*; B. SAKMANN; H. S. MEYER.
Max Planck Florida Inst.
10:00 SS2 384.03 Spatial attention modulates alpha rhythm
synchrony between prefrontal and somatosensory cortex. M.
D. SACCHET*; Q. WAN; D. L. PRITCHETT; A. K. C. LEE; M.
HÄMÄLÄINEN; C. I. MOORE; S. R. JONES; C. KERR. MIT,
Harvard Med. Sch., Athinoula A. Martinos Ctr. for Biomed.
Imaging.
11:00 SS3 384.04 Inactivating somatostatin-positive cells
reveals a critical role for neocortical inhibition in sensory
adaptation. U. KNOBLICH*; T. C. BROWN; J. A. CARDIN; M.
CARLEN; K. MELETIS; K. DEISSEROTH; H. TANIGUCHI;
Z. HUANG; C. I. MOORE. MIT, Yale Univ., Karolinska
Institutet, Stanford Univ., Cold Spring Harbor Lab.
8:00 SS4 384.05 Systematic examination of oscillations
in SI during a vibrissal motion detection task. D. L.
PRITCHETT*; J. H. SIEGLE; C. I. MOORE. MIT.
9:00 SS5 384.06 The hemo-neural hypothesis: Testing
the impact of controlled hyperemia on sensory evoked
responses in ‘barrel’ neocortex. D. L. VIERLING-
CLAASSEN*; J. A. CARDIN; C. I. MOORE. MIT McGovern
Inst. For Brain Res., Yale Univ. Sch. of Med.
10:00 SS6 384.07 Propagation of neural correlations in
the mouse barrel cortex. G. NATTAR RANGANATHAN*; H.
KOESTER. Ctr. For Learning and Memory, Ctr. For Learning
and Memory.
11:00 SS7 384.08 Effect of a novel focal electrochemical
release technology on barrel cortex sensory information
processing. Z. DU*; G. BI; X. T. CUI. Univ. of Pittsburgh,
Carnegie Mellon Univ., Univ. of Pittsburgh, Univ. of Sci. and
Technol. of China.
8:00 SS8 384.09 Cellular mechanisms for sparse
L4-evoked spiking of L2/3 pyramidal cells in vitro. J.
ELSTROTT*; D. E. FELDMAN. UC Berkeley.
9:00 SS9 384.10 [Unable to Attend] Modulation of whisker
stimulation evoked inhibition in the rat barrel cortex by
repetitive transcranial magnetic stimulation. K. FUNKE*; A.
THIMM. Ruhr-University Bochum, Med. Fac.
10:00 SS10 384.11 • � Dendritic spines over lifespan
development in layer VI barrel cortex neurons. D. ORNER*;
D. E. ORNER; C. CHEN; J. C. BRUMBERG. Queens
College, CUNY, Queens College, CUNY, The Grad. Ctr.
11:00 SS11 384.12 Neuromodulators abolish persistent
network activity and rebalance synaptic inputs in neocortex.
M. FAVERO; G. THOMAS; M. A. CASTRO-ALAMANCOS*.
Drexel Univ. Col. Med.
8:00 SS12 384.13 Asymmetric distribution of synaptic
input in neocortical circuits. Y. TAKASHIMA*; A. L. BARTH.
Carnegie Mellon Univ.
9:00 SS13 384.14 Projections from rat MI whisker cortex
terminate selectively in the septa-aligned columns in SI
barrel cortex. U. KIM*; T. LEE. Pennsylvania State Univ. Coll
Med.
10:00 SS14 384.15 3D reconstruction of cell type-specific
thalamocortical and intracortical circuits in rat barrel cortex.
M. OBERLAENDER*; R. T. NARAYANAN; A. RAMIREZ; L.
BALTRUSCHAT; B. SAKMANN; R. M. BRUNO; C. P. J. DE
KOCK. Max Planck Florida Inst., Ctr. for Neurogenomics and
Cognitive Res. (CNCR), Columbia Univ.
11:00 SS15 384.16 Cell type-specific excitatory synaptic
connections from layer 4 to layer 6A in rat barrel cortex. G.
QI; D. FELDMEYER*. Res. Ctr. Juelich, RWTH Aachen Univ.
8:00 SS16 384.17 The temporal asymmetries of crosslaminar
integration and spike-timing dependent plasticity
segregate learning from signaling in a population of L2/3
neurons. H. J. KOESTER*; G. NATTAR RANGANATHAN.
Univ. Texas-Austin.
9:00 SS17 384.18 Analysis of local microcircuits of layer 2/3
mouse barrel cortex in vitro. M. AVERMANN*; C. TOMM; C.
MATEO; W. GERSTNER; C. C. H. PETERSEN. Friedrich
Miescher Inst. For Biomed. Res., École Polytechnique
Fédérale de Lausanne (EPFL), École Polytechnique
Fédérale de Lausanne, Univ. of California.
10:00 SS18 384.19 • Impact of perineuronal nets on barrel
cortex neurons. P. CHU*; R. ABRAHAM; F. KHAN, BA; J. C.
BRUMBERG. The Grad. Center, CUNY, Queens College,
CUNY, Queens College, CUNY.
11:00 SS19 384.20 Spatial patterns of axonal projections and
synaptic organizations from distinct types of whisker-sensory
neurons inside brainstem barrelettes. K. SAKURAI*; A.
SCOTT; F. WANG. Duke Univ. Med. Ctr.
8:00 SS20 384.21 3D reconstruction and standardization
of the barrel field in rat vibrissal cortex. R. EGGER*; R.
T. NARAYANAN; C. P. J. DE KOCK; B. SAKMANN; M.
OBERLAENDER. Max Planck Florida Inst., VU Univ.
Amsterdam.
9:00 SS21 384.22 Direct patch-clamp recordings from
merkel cells in situ in vibrissal hair follicles of rats. M. CHA*;
J. LING; J. GU. Univ. of Cincinnati.
POSTER
385. Stimulus Feature Receptive Fields and Response
Properties
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 SS22 385.01 Whisking-related discharges in rat
whisker motor cortex. T. GERDJIKOV; F. HAISS; O.
RODRIGUEZ-SIERRA; C. SCHWARZ*. Univ. of Leicester,
Univ. of Zurich, Rutgers Univ., Univ. Tuebingen.
9:00 SS23 385.02 Properties of Vibrissa responsive neurons
in rat Trigeminal Nucleus Caudalis. A. M. CASTRO*; A.
KELLER. Univ. of Maryland Sch. of Med.
10:00 SS24 385.03 Coding of vibrotactile signals by
trigeminal ganglion neurons. A. M. CHAGAS*; B.
SENGUPTA; M. STUETTGEN; C. SCHWARZ. Univ. of
Tuebingen, Univ. of Tuebingen, Univ. of Tuebingen, Univ. of
Cambridge, Ruhr Univ. Bochum.
58 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 SS25 385.04 Opposing catecholamine responses to
tail-pinch in the limbic system. E. BUCHER*; J. PARK; E.
A. BUDYGIN; R. M. WIGHTMAN. UNC Chapel Hill, Wake
Forest Univ.
8:00 SS26 385.05 Spectro-temporal receptive field
properties of neurons in primate somatosensory cortex. M.
A. HARVEY*; A. WEBER; M. D. BEST; S. BENSMAIA. Univ.
of Chicago.
9:00 SS27 385.06 Pre-neuronal texture-whisker
transduction in anaesthetized Rats: A predictive model of
whisker deflections. Y. BOUBENEC; D. E. SHULZ*; G.
DEBRÉGEAS. CNRS, CNRS-ENS.
10:00 SS28 385.07 • Strengthening of thalamocortical
synapses at layer 4 in the adolescent whisker barrel
measured by MRI and electrophysiology. X. YU*; S.
CHUNG; S. WANG; S. DODD; J. WALTERS; J. ISAAC; A.
KORETSKY. NIH, Auburn Univ.
11:00 SS29 385.08 The influence of skin thickness and
hardness on touch and vibratory thresholds across the
human foot sole. N. STRZALKOWSKI*; J. J. TRIANO; L. R.
BENT. Canadian Mem. Chiropractic Col., Univ. of Guelph.
8:00 SS30 385.09 Integration of cutaneous and
proprioceptive inputs in tactile 3D curvature perception.
Y. CHO*; S. KIM; S. S. HSIAO. Mind-Brain Inst. / Johns
Hopkins Univ., Mind-Brain Inst. / Johns Hopkins Univ., Mind-
Brain Inst. / Johns Hopkins Univ.
9:00 SS31 385.10 Adaptation facilitates neuronal response
to subsequent sensory stimulation in the barrel cortex. K.
COHEN-KASHI*; M. JUBRAN; I. LAMPL. Weizmann Inst. of
Sci.
10:00 SS32 385.11 Cooling effects on cutaneous
receptor response to vibration. C. R. LOWREY*; N. D. J.
STRZALKOWSKI; L. BENT. Univ. Guelph.
11:00 TT1 385.12 Somatosensory signaling for flight
control in bats. M. CHADHA*; S. J. STERBING-D’ANGELO;
B. FALK; J. BARCELO; W. XIAN; C. F. MOSS. Univ. of
Maryland, Col. Park, Univ. of Maryland, Univ. of Maryland.
8:00 TT2 385.13 Interaction between proprioceptive and
cutaneous receptive fields in somatosensory cortex. S. KIM;
P. THAKUR; M. GOMEZ-RAMIREZ; S. S. HSIAO*. Johns
Hopkins Univ., Johns Hopkins Univ., The Johns Hopkins
Univ.
9:00 TT3 385.14 Neuromodulators set different
sensory processing modes in rat superior colliculus. T.
BEZDUDNAYA*; M. CASTRO-ALAMANCOS. Drexel Univ.
Col. of Med.
10:00 TT4 385.15 Spatial response properties of rapidlyadapting
mechanoreceptive fibers in the rat glabrous skin.
I. DEVECIOGLU; B. GUCLU*. Bogazici Univ., Namik Kemal
Univ.
11:00 TT5 385.16 Human psychophysics for afferent
brain-machine interfaces. M. R. SCHEID; B. ZAAIMI*; L. E.
MILLER; K. KORDING. Northwestern Univ., Rehabil. Inst. of
Chicago.
8:00 TT6 385.17 Dynamics of the evoked activity in
primary and association somatosensory areas during
sustained tactile hand stimulation in humans. M.
POPESCU*; S. BARLOW; E. POPESCU; L. VENKATESAN;
J. WANG. Hoglund Brain Imaging Ctr., Kansas Univ. Med.
Ctr., The Univ. of Kansas, The Univ. of Kansas.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 TT7 385.18 The functional organization of layer
2-3 in the rat barrel cortex: A 2-photon imaging study. L.
GARION; Y. RUBIN; U. DUBIN; Y. SCHILLER*; R. AZOUZ;
J. SCHILLER. Technion Med. Sch., Ben Gurion Univ.
10:00 TT8 385.19 • Pleasant touch in autism: A role for
c-tactile afferents? F. P. MCGLONE*; R. ACKERLEY; A.
CURRAN; E. HASSAN; M. KAISER. Liverpool John Moores
Univ., Univ. of Gothenburg, Alder Hey Hosp., MARIARC,
Yale Sch. of Med.
11:00 TT9 385.20 Neuronal correlates of whisker
vibration in wild type mice and models of schizophrenia. C.
SCHREINER*; T. BESSAIH; S. SIEGEL; D. FELDMEYER;
D. CONTRERAS; T. ABEL. Univ. of Pennsylvania, RWTH
Aachen Univ., Res. Ctr. Juelich, Univ. of Pennsylvania, Sch.
of Med., Univ. of Pennsylvania, Res. Ctr. Juelich.
8:00 TT10 385.21 • EEG correlates of patterned pneumatic
oral stimulation in preterm infants. S. M. BARLOW*; P.
JEGATHEESAN; B. GOVINDASWAMI; S. WEISS; L.
VENKATESAN; D. SONG. Univ. of Kansas, Univ. of Kansas,
Santa Clara Valley Med. Ctr.
9:00 TT11 385.22 Pectoral fin innervation and sensation
of movement. R. WILLIAMS, IV; N. L. NEUBARTH; M. E.
HALE*. Univ. Chicago.
POSTER
386. Motor Pattern Generation: Connectivity I
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 TT12 386.01 Dopaminergic innervation of the
mesencephalic locomotor region: Descending inputs from
the posterior tuberculum. D. RYCZKO*; F. AUCLAIR; R.
DUBUC. Univ. Montréal, Univ. du Québec à Montréal.
9:00 TT13 386.02 Contribution of intrinsic neuronal
properties to the activity patterns of reticulospinal locomotor
neurons. E. TRILLAUD-DOPPIA*; L. JUVIN; R. DUBUC.
Univ. Montréal, Univ. du Québec à Montréal.
10:00 TT14 386.03 Neurons in the mesencephalic
locomotor region project monosynaptically to neurons in the
respiratory-generating centers. J. GARIEPY*; K. MISSAGHI;
F. AUCLAIR; R. DUBUC. Univ. Montréal, Univ. du Québec à
Montréal.
11:00 TT15 386.04 � Fictive rhythmic motor patterns
generated in tail segments of the adult salamander. V.
CHARRIER; J. S. CABELGUEN*. INSERM.
8:00 TT16 386.05 Fos-like immunoreactivity in the
cerebellum of decerebrate cats during fictive scratching. M.
MARTINEZ*; J. CONTRERAS-GARCÍA; G. GUTIÉRREZ-
OSPINA; E. MANJARREZ; J. QUEVEDO. CINVESTAV-IPN,
Inst. de Investigaciones Biomédicas, UNAM, Benemérita
Univ. Autónoma de Puebla.
9:00 TT17 386.06 Bulbo-cervical propagation of sinusoidal
electrical waves associated with the respiratory central
pattern generator. A. C. PLIEGO*; A. TREJO; J. TAPIA; E.
MANJARREZ. Benemerita Univ. Autonoma de Puebla.
10:00 TT18 386.07 Sinusoidal electrical waves on cervical
and thoracic spinal cord segments during quadrupedal
spontaneous fictive locomotion in decerebrate cats. A.
TREJO*; L. ABYAZOVA; J. A. TAPIA; E. MANJARREZ.
Benemerita Univ. Autonoma de Puebla, Kazan State Med.
Univ.
Neuroscience 2011 | Monday AM | 59
Mon. AM

11:00 TT19 386.08 The obex slow potential and the on-off
and off-on discharge patterns of reticular formation neurons
before the onset of fictive scratching in decerebrate cats. J.
A. TAPIA*; A. TREJO; E. MANJARREZ. Benemerita Univ.
Autonoma De Puebla.
8:00 TT20 386.09 Functional anatomy of respiratory
networks in ventrolateral medulla inferred using time-series
analysis. B. GOUREVITCH; N. M. MELLEN*. CNPF, UMR
CNRS 8195, Univ. Paris-Sud, Univ. Louisville.
9:00 TT21 386.10 Visualizing pre-motor neural circuits of
whisking motor neurons using monosynaptic rabies virus
based trans-synaptic tracing. J. TAKATOH*; B. ARENKIEL;
F. WANG*. Duke Univ. Med. Ctr., Baylor Col. of Med.
10:00 TT22 386.11 • Characterisation of hindbrain trigeminal
interneurons in the swim initiating pathway of young
Xenopus tadpoles. E. BUHL*; S. R. SOFFE; A. ROBERTS.
Univ. of Bristol.
11:00 TT23 386.12 Sinusoidal electrical waves and perievent
firing rates of spinal interneurons during fictive
scratching. C. A. CUELLAR*; P. LINARES; R. DELGADO-
LEZAMA; E. MANJARREZ. Ctr. De Investigación Y De
Estudios Avanzados, Inst. de Fisiología, Benemérita Univ.
Autónoma de Puebla.
8:00 TT24 386.13 Neuronal activity in the isolated
mouse spinal cord during spontaneous deletions in fictive
locomotion: Insights into locomotor CPG organization.
G. ZHONG*; N. SHEVTSOVA,; I. RYBAK; R. HARRIS-
WARRICK. Cornell Univ., cornell university, drexel university,
cornell university.
9:00 TT25 386.14 Recruitment patterns in mouse
commissural interneurons during neural evoked locomotion
as revealed by calcium-imaging. M. HAGGLUND*; O.
KIEHN. Karolinska Inst.
10:00 TT26 386.15 The excitatory EphA4-related population
is involved in coordinating the mammalian locomotor CPG.
L. BORGIUS*; H. NISHIMARU; G. MARGARYAN; B.
ZHENG; T. IWASATO; O. KIEHN. Dept. of Neuroscience,
Karolinska Institutet, Univ. of Tsukuba, Univ. of California
San Diego, Natl. Inst. of Genet.
11:00 TT27 386.16 Locomotor-like activity generated by
a predominantly inhibitory network. A. E. TALPALAR*; T.
ENDO; L. BORGIUS; P. LÖW; J. RYGE; T. S. HNASKO; O.
KIEHN. Dept. Neuroscience, Karolinska Institutet, Univ. of
California San Francisco.
8:00 TT28 386.17 Compensation to the genetic ablation of
P/Q-type calcium channels and the generation of eupnea,
sighs and gasping activity. H. KOCH*; S. ZANELLA; A. WEI;
G. E. ELSEN; R. XUN; C. M. GOMEZ; J. RAMIREZ. Seattle
Childrens Res. Inst., Univ. of Washington, Univ. of Chicago.
9:00 UU1 386.18 Holographic photostimulation of 4-9
neurons triggers inspiratory burst generation in the neural
circuit controlling mammalian respiratory rhythm in vitro. K.
KAM*; J. W. WORRELL; C. VENTALON; V. EMILIANI; J. L.
FELDMAN. UCLA, Neurophysiol. and New Microscopy Lab.,
CNRS UMR8154, INSERM U603, Univ. Paris Descartes.
POSTER
387. Reaching Control: Motor Learning II
Theme D: Sensory and Motor Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 UU2 387.01 Testing predictions of optimal control
models of arm movement. D. A. KISTEMAKER*; J. D.
WONG; P. L. GRIBBLE. Univ. of Western Ontario.
9:00 UU3 387.02 A physiologically plausible learning model
for the sensorimotor system. J. GOODNER*; G. TSIANOS;
Y. LI; G. E. LOEB. USC.
10:00 UU4 387.03 Use-dependent learning is represented
in extrinsic rather than muscle-based coordinates. V. S.
SELVANAYAGAM*; S. RIEK; A. DE RUGY; T. J. CARROLL.
The Univ. of Queensland, Univ. of Malaya.
11:00 UU5 387.04 Early adaptation to novel biomechanics
exploits previous solutions instead of re-optimizing for
muscle redundancy. A. DE RUGY*; G. E. LOEB; T. J.
CARROLL. Univ. Queensland, USC.
8:00 UU6 387.05 Adaptation rates to virtual surgeries are
predicted by their compatibility with muscle synergies. D.
J. BERGER; R. GENTNER; T. EDMUNDS; D. K. PAI; A.
D’AVELLA*. Santa Lucia Fndn., Univ. of British Columbia.
9:00 UU7 387.06 The random-walk nature of motor
planning. R. J. VAN BEERS*; E. BRENNER; J. B. J.
SMEETS. VU Univ. Amsterdam.
10:00 UU8 387.07 Grasping prism adaptation by separate
adaptation of the digits of one hand. W. D. SCHOT*; E.
BRENNER; J. B. J. SMEETS. VU Univ. Amsterdam.
11:00 UU9 387.08 A model for simultaneous opposite
visuomotor adaptation of the digits of the same hand.
J. B. SMEETS*; W. D. SCHOT; E. BRENNER. VU Univ.
Amsterdam.
8:00 UU10 387.09 State-dependence of reach adaptation
following action and movement observation. P. A. WANDA*;
G. LI; K. A. THOROUGHMAN. Washington Univ. StL.
9:00 UU11 387.10 The disadvantage of inflexible neural
tunings in hierarchical neural network models. K. A.
THOROUGHMAN*; R. P. KHAN. Washington Univ.
10:00 UU12 387.11 The advantages of flexible neuronal
tunings and learning rules in models of human motor
adaptation. E. N. MARONGELLI*; K. A. THOROUGHMAN.
Washington Univ., Washington Univ. in St. Louis.
11:00 UU13 387.12 Visuomotor adaptation in Parkinson’s
disease: Differential adaptation to changes in visual extent
and direction. J. A. SEMRAU*; K. A. THOROUGHMAN.
Washington Univ.
8:00 UU14 387.13 The parallel control of motion and contact
forces. M. CASADIO*; F. A. MUSSA-IVALDI. Rehabil. Inst. of
Chicago, Northwestern Univ.
9:00 UU15 387.14 White matter microstructure changes
induced by motor skill learning. X. WANG; M. CASADIO;
K. WEBER; T. B. PARRISH; F. A. MUSSA-IVALDI*.
Northwestern Univ., Rehabil. Instiotute of Chicago,
Northwestern Univ., Northwestern Univ.
10:00 UU16 387.15 Intra- and inter-manual motor skills
transfer influenced by multiple coordinates and visual
presentations. P. PARMAR*; F. C. HUANG; J. L. PATTON.
Rehabil. Inst. of Chicago, Univ. of Illinois at Chicago.
60 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

11:00 UU17 387.16 Reduced dimensionality training and
learning of finger coordination patterns. R. RANGANATHAN;
J. A. WIESER; R. A. SCHEIDT*. Rehabil. Inst. of Chicago,
Marquette Univ.
8:00 UU18 387.17 Motor space encoding in motor learning:
Learning the metrics of space when grasp substitutes
for reach. P. ECCARIUS; T. FOXWORTHY; Y. WANG; R.
SCHEIDT; F. A. MUSSA-IVALDI; K. M. MOSIER*. Indiana
Univ. Sch. of Med., Indiana University-Purdue Univ.
Indianapolis, Marquette Univ., Northwestern Univ.
9:00 UU19 387.18 Phasor analysis for inference of manual
control policy. F. C. HUANG*. Rehabil Inst. of Chicago.
10:00 UU20 387.19 Evidence for the reset of the intended
trajectory in response to error and time in discreet reaching
motions. J. R. HOROWITZ*. Rehab Inst. of Chicago.
11:00 UU21 387.20 Impairment in novel motor skill learning
in a mouse model of traumatic brain injury: Preliminary
results. S. C. SCHWERIN*; M. SHINDELL; E. MASON; S.
L. JULIANO; L. G. COHEN. Uniformed Services Univ., NIH,
Uniformed Services Univ.
8:00 UU22 387.21 Design of individualized motor training
schedules based on predictions of long-term retention. Y. OH*;
V. BARRES; J. LEE; N. SCHWEIGHOFER. USC, USC, USC.
9:00 UU23 387.22 Dysfunctional extrinsic spatial
representations for motor adaptation in Alzheimer’s disease.
D. PRESS*; J. B. BRAYANOV; M. A. SMITH. Beth Israel
Deaconess Med. Ctr., Harvard Univ.
10:00 UU24 387.23 Variance and higher order statistics drive
grip force adaptation. A. M. HADJIOSIF*; M. A. SMITH.
Harvard Univ.
11:00 UU25 387.24 Local generalization in the adaptive
control of reaching arm movements. L. N. GONZALEZ
CASTRO*; H. WU; M. A. SMITH. Harvard Univ. - MIT,
Harvard Univ.
8:00 UU26 387.25 Investigating the role of motor output
variability in human reward-based motor learning. Y. R.
MIYAMOTO*; B. P. OLVECZKY; M. A. SMITH. Harvard Univ.
9:00 UU27 387.26 Patterns of generalization and
interference reveal differential plasticity in forward
and inverse models. H. G. WU*; J. BRAYANOV; L. N.
GONZALEZ CASTRO; M. A. SMITH. Harvard Univ.
10:00 UU28 387.27 Visuomotor transformations elicit
simultaneous learning in two distinct coordinate systems. J.
B. BRAYANOV*; B. PETRESKA; M. A. SMITH. Harvard Univ.
POSTER
388. Neurohypophyseal Hormones and Neuropeptides
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 UU29 388.01 Identification of the cis-elements
regulating cell-specific vasopressin gene expression using
adeno-associated virus-mediated gene delivery of promoter
deletion constructs into the rat supraoptic nucleus in vivo. O.
M. RASHID; Y. D. SALINAS; T. A. PONZIO; R. L. FIELDS; D.
LUBELSKI; H. GAINER*. NIH/NINDS.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 UU30 388.02 Postmortem Di I tracing of
vasopressinergic and of oxytocinergic projections in the
human limbic system. G. F. JIRIKOWSKI*; E. V. SIVUKHINA;
L. PUSCH; J. D. CALDWELL; V. GRINEVICH. Friedrich
Schiller Univ., Friedrich Schiller Univ., FSU Jena, LECOM,
Max-Planck-Institute for Med. Res.
10:00 UU31 388.03 Vasopressinergic and oxytocinergic
magnocellular neurons are activated by sodium free
refeeding after fasting. F. LUCIO-OLIVEIRA*; C. FRANCI.
Sch. of Med. Ribeirão Preto - Univ. of São Paulo.
11:00 UU32 388.04 Glycine transporter-like
immunoreactivities (GlyT1 and GlyT2) in the rat
hypothalamus, with special reference to the magnocellular
neurohypophysial system. A. MARTINEZ; L. GENTIL; M.
MIRANDA; A. M. KHAN*. Univ. of Texas at El Paso.
8:00 UU33 388.05 A SNP in the prairie vole oxytocin
receptor gene exhibits allelic imbalance and predicts
individual variation in oxytocin receptor density in the
nucleus accumbens. L. B. KING*; K. INOUE; L. J. YOUNG.
Emory Univ., Emory Univ.
9:00 UU34 388.06 Effects of ACREB, a dominant negative
inhibitor of CREB, on the expression of c-fos and other
immediate early genes in the rat SON during hyperosmotic
stimulation in vivo. D. LUBELSKI*. Cleveland Clin. Lerner
Col. of Med.
10:00 UU35 388.07 Effects of morphine and cannabinoid
compounds on plasma AVP levels in rats. A. HOSSENI
NAJARKOLAEI*; N. NADERI; M. YOUSEFPOUR; F.
MOTAMEDI. Mahdiyeh Hosp., Neurosci. Res. Center,
Shahid Beheshti Univ. of Med. Sci.
11:00 UU36 388.08 GABA is excitatory in vasopressinergic,
but not oxytocinergic magnocellular neuroendocrine cells.
J. HAAM*; I. R. POPESCU; K. C. HALMOS; J. G. TASKER.
Tulane Univ.
8:00 VV1 388.09 Cannabinoids suppress the effects
of vasotocin by blocking receptor internalization: A novel
mechanism for hormone regulation of behavior. E. J.
CODDINGTON*; E. M. MCEVOY; S. SONNENFELD; E. K.
DOLENCE. Willamette Univ., Univ. of Wyoming.
9:00 VV2 388.10 Are birth and oxytocin epigenetic events?
J. CONNELLY; W. KENKEL; E. ERICKSON; C. CARTER*.
Univ. of Virginia, Univ. Illinois @ Chicago.
10:00 VV3 388.11 PICK1 is involved in dense core vesicle
biogenesis giving rise to compromised peptidergic secretion
and somatic growth in PICK1 deficient flies and mice. K. L.
MADSEN*; B. HOLST; A. M. JANSEN; C. JIN; M. RICKHAG;
V. LUND; G. SØRENSEN; A. N. MADSEN; K. QVORTRUP;
R. HUGANIR; O. KJÆRULFF; U. GETHER. Univ. of
Copenhagen, The Johns Hopkins Univ. Sch. of Med.
11:00 VV4 388.12 • Towards a single-case-based analysis
of neuropeptide expression in Periplaneta americana
antennal lobe neurons. R. PREDEL; D. FUSCA; J.
SCHACHTNER; P. KLOPPENBURG; S. NEUPERT*. Univ. of
Cologne, Univ. of Marburg, Beckman Inst.
Neuroscience 2011 | Monday AM | 61
Mon. AM

POSTER
389. Prolactin, TIDA Neurons, VTA, Dopamine/Insulin,
Growth Hormone, and Metabolism
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 VV5 389.01 Prolactin modulation of rat
tuberoinfundibular dopamine (TIDA) neuron
electrophysiology: A novel mechanism for feedback in
the lactotrophic axis. D. J. LYONS*; A. HELLYSAZ; C.
BROBERGER. Karolinska Inst., Karolinska Inst.
9:00 VV6 389.02 Phenotypic and functional plasticity in
hypothalamic dopamine neurons associated with robust
electrophysiological properties. N. ROMANO; S. H. YIP;
D. J. HODSON; A. GUILLOU; S. PARNAUDEAU; F.
TRONCHE; X. BONNEFONT; S. J. BUNN; D. R. GRATTAN;
P. E. MOLLARD*; A. O. MARTIN. IGF-CNRS_UMR5203/
INSERM_U661, Univ. of Otago, CNRS, UMR7224, INSERM,
U952, Univ. Pierre et Marie Curie.
10:00 VV7 389.03 Acute effects of vasoactive intestinal
polypeptide on prolactin release. A. M. STATHOPOULOS*;
C. V. HELENA; P. A. FLETCHER; R. BERTRAM. Florida
State Univ., Florida State Univ., Florida State Univ.
11:00 VV8 389.04 Effect of gonadectomy on extracellular
prefrontal cortical dopamine and dopamine metabolite levels
in adult male rats following reverse dialysis application of a
GABA-B antagonist. M. LOCKLEAR*; M. F. KRITZER. Stony
Brook Univ.
8:00 VV9 389.05 Interaction between prolactin and
the hypothalamic-pituitary adrenal axis. M. KALYANI*;
K. HASSELFELD; K. LINDAUER; E. MUPHREE; P.
CALLAHAN; J. JANIK. Miami Univ., Miami Univ.
9:00 VV10 389.06 Role of prolactin in the neuroendocrine
response to stress in female mice. S. NAYAR*; T. HURST;
M. FILANOVSKY; E. MURPHREE; J. JANIK; P. CALLAHAN.
Miami Univ., Miami Univ.
10:00 VV11 389.07 Inhibition of progesterone receptor
activity during development increases tyrosine hydroxylase
fiber density in the dentate gyrus. R. KELLER; J. WILLING;
M. J. TETEL*; C. K. WAGNER. Univ. at Albany, Wellesley
Col.
11:00 VV12 389.08 Progesterone receptor is expressed in the
ventral tegmental area during critical periods of mesocortical
dopaminergic pathway development. J. WILLING*; C. K.
WAGNER. Univ. At Albany.
8:00 VV13 389.09 Androgens alter dopamine neuronaldependent
behaviors in male rats with unilateral
6-hydroxydopamine lesions. R. L. CUNNINGHAM*; T.
MACHEDA; E. POTEET; A. GIUFFRIDA; M. SINGH. Univ.
North Texas Hlth. Sci. Ctr., Univ. of Texas Hlth. Sci. Ctr. at
San Antonio.
9:00 VV14 389.10 Estradiol regulation of dopamine kinetics
in the nucleus accumbens core and shell. T. TAVAREZ; M.
KRITZER; D. LEBESGUE*. Albert Einstein Col. Med., Stony
Brook Univ.
10:00 VV15 389.11 � Long term treatment with estradiol in
combination with medroxyprogesterone acetate increases
tyrosine hydroxylase immunoreactive fibers in the medial
prefrontal cortex of aged female Long Evans rats. A. R.
PACKARD; N. C. LOWRY; W. A. KOSS; J. M. JURASKA*.
Univ. of Illinois.
11:00 VV16 389.12 Rosiglitazone improves neuronal
insulin resistance in obese rats induced with high-fat
diets. N. PIPATPIBOON*; W. PRATCHAYASAKUL; N.
CHATTIPAKORN; S. CHATTIPAKORN. Dept. of Physiology,
Fac. of Medicine, Chiangmai Univ., Fac. of Dentistry, Chiang
Mai Univ.
8:00 VV17 389.13 Signaling pathways employed by longterm
treatment of ghrp-6 in bovine somatotrophs cells.
B. DOMINGUEZ MANCERA*; V. SALINAS ZARATE; F.
GRÁCIA HERNÁNDEZ; E. CASTAÑEDA MARTINEZ; J. M.
MARTÍNEZ HERNÁNDEZ; M. BARRIENTOS MORALES; F.
VELAZQUEZ SARMIENTO; A. HERNÁNDEZ BELTRÁN; P.
CERVANTES ACOSTA. Univ. Veracruzana, Dept Fisiología.
9:00 VV18 389.14 Melatonin-induced stimulation of
hypothalamic insulin signaling suppresses hepatic
gluconeogenesis. J. FARIA; A. KINOTE; L. IGNACIO-
SOUZA; T. ARAÚJO; D. FERREIRA; A. BARBOSA; L.
VELLOSO; G. F. ANHE*. State Univ. of Campinas.
10:00 VV19 389.15 The effect of perinatal exposure to the
endocrine disruptor bisphenol-a on metabolism and the
development of diet-induced obesity in adulthood. H. A.
MACKAY*; D. TSIRLIN; S. PATEL; Z. PATTERSON; R.
KHAZALL; A. ABIZAID. Carleton Univ.
11:00 VV20 389.16 Positive and negative regulation of insulin
receptor signaling in adrenal chromaffin cells. T. NEMOTO;
T. YANAGITA; M. MURAKAMI*. Fac. of Med. Univ. of
Miyazaki.
8:00 VV21 389.17 Adiponectin in the brain regulates energy
metabolism. R. WAN*; Z. MIN; M. R. MUGHAL; P. RAPP; M.
P. MATTSON. National Institute On Aging/ National Institutes
Of Health, National Institute On Aging/ National Institutes Of
Health.
9:00 VV22 389.18 Effect of estrogen administration
on insulin receptor function in long term high fat-fed
ovariectomized rats. W. PRATCHAYASAKUL*; N.
CHATTIPAKORN; S. CHATTIPAKORN. Chiang Mai Univ.
POSTER
390. Neuroimmunology: Hormonal and Behavioral Effects
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 VV23 390.01 Immune deficiency influences juvenile
behaviors in mice. K. M. QUARTERMAN*; K. H. COX; E. F.
RISSMAN. Univ. of Virginia, Univ. of Virginia.
9:00 VV24 390.02 • Biochemical, behavioral, and cognitive
consequences of an early-life E. coli infection in BALB/c
mice. J. LIEBLEIN*; D. T. SHEA; A. W. CORONA; M.
BAILEY; S. D. BILBO; J. P. GODBOUT. The Ohio State
Univ., Duke Univ.
10:00 VV25 390.03 Disruption of type I IFN signaling
decreases autoimmune development and kidney damage,
but not anxiety behaviors in lupus-prone mice. J. WANG*; H.
ZHANG. Univ. Missouri-Kansas City.
11:00 VV26 390.04 Binge administration of cocaine alters
distribution of lymphocyte subsets in blood and spleen of
rats - interaction with haloperidol. M. JANKOWSKI*; B.
IGNATOWSKA-JANKOWSKA; W. GLAC; A. H. ŚWIERGIEL.
Univ. of Gdansk, Dept. of Animal Physiol.
62 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 VV27 390.05 Exposure to environmental mold
causes hippocampal inflammation and memory loss. C. F.
HARDING*; K. RYBERG; A. BIEGON; J. DHAWAN; B. ALI;
S. DANNENBERG; K. DENISOVA; M. SANT’ANNA. Hunter
College, CUNY, Brookhaven Natl. Lab.
9:00 VV28 390.06 Co-incubation of 17 beta-estradiol with
splenic lymphocytes: Effects on lymphocyte functions and
modulation by adrenergic receptor agonists. H. PRIYANKA*;
U. SHARMA; V. SHARMA; S. THYAGARAJAN. SRM Univ.
10:00 VV29 390.07 Estrogens regulate inflammatory genes
in the frontal cortex of middle-aged female rats via estrogen
receptor alpha and beta. M. SARVARI*; E. HRABOVSZKY;
I. KALLÓ; N. SOLYMOSI; K. TÓTH; I. LIKÓ; J. SZÉLES;
S. MAHÓ; B. MOLNÁR; Z. LIPOSITS. Inst. Exp Med, Hung
Acad Sci., Pázmány Péter Catholic Univ., Eötvös Loránd
Univ., Semmelweis Univ., Gedeon Richter Plc., Mol Med.
Res. Unit, Hung Acad Sci.
11:00 VV30 390.08 A sensitive period for prostaglandin -
Estradiol mediated signaling in cerebellar development. J. F.
KNUTSON*; M. M. MCCARTHY. Univ. of Maryland, Sch. of
Med.
8:00 VV31 390.09 Does endogenous leptin affect fever and
inflammatory signaling in obese rats? J. POHL*; C. FRATE;
B. WOODSIDE; G. N. LUHESHI. McGill Univ., Concordia
Univ.
9:00 VV32 390.10 Cholinergic signaling modulates
systemic cytokines and subsequent neuroinflammation after
orthopedic surgery. N. TERRANDO*; L. ERIKSSON; J. RYU;
T. YANG; C. MONACO; M. FELDMANN; M. FAGERLUND;
I. CHARO; K. AKASSOGLOU; M. MAZE. UCSF, Karolinska
Institutet, Gladstone Inst. of Neurolog. Dis., Kennedy Inst. of
Rheumatology, Gladstone Inst. of Cardiovasc. Dis.
10:00 VV33 390.11 Capsaicin inhibits the release of cytokines
mediated by Toll-like receptors in salivary glands. K. PARK*;
Y. SHIN*; S. CHOI*; E. NAMKOONG*; S. HWANG*.
11:00 VV34 390.12 In post treatment Lyme disease, coupling
between serum Bb antibodies and specific regional brain
activity is systematically related to psychiatric symptom
severity. J. R. MOELLER*; B. A. FALLON; J. KEILP.
Columbia Univ., New York State Psychiatric Inst.
8:00 VV35 390.13 IFN-alpha effects on basal ganglia
dopamine release: An in vivo microdialysis and
neuroimaging study. J. C. FELGER*; H. L. KIMMEL; C. R.
HERNANDEZ; J. MUN; J. A. NYE; M. M. GOODMAN; D.
F. DRAKE; A. A. FREEMAN; D. B. RYE; L. L. HOWELL; A.
H. MILLER. Emory Univ., Emory Univ., Emory Univ., Emory
Univ., Emory Univ., Emory Univ., Emory Univ., Emory Univ.,
Emory Univ., Emory Univ.
9:00 VV36 390.14 TH1 is more essential than TH2 in the
zebrafish development. Y. CHEN*; M. SUNDVIK; S. ROZOV;
P. PANULA. Univ. of Helsinki.
POSTER
391. Neural Control of Sex Behavior
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 VV37 391.01 Effects of sexual activity on anxietyrelated
behavior: Exploring the potential role of MPOA-PVN
interactions in male rats. J. A. MCHENRY*; T. M. AUBELE;
E. M. HULL. Florida State Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 VV38 391.02 Androgen receptor in purkinje cell:
Influence of gonadal steroids and sexual behavior. M.
PEREZ-POUCHOULEN*; P. SAFT; B. BRUG; C. A. PEREZ;
L. BELTRAN-PARRAZAL; R. TOLEDO; L. I. GARCIA; G. E.
ARANDA-ABREU; M. E. HERNANDEZ; J. MANZO. Univ.
Veracruzana, Univ. Veracruzana.
10:00 VV39 391.03 A role for carbon monoxide signaling in
the MPOA in male rat sexual behavior. C. L. ROBISON*; A.
COLOMBO; E. M. HULL. Florida State.
11:00 VV40 391.04 Gastrin releasing peptide receptor
activation in the spinal cord is required for ejaculation. N.
KOZYREV*; L. M. COOLEN. Univ. of Michigan, Univ. of
Western Ontario.
8:00 VV41 391.05 Estradiol down regulates estrogen
receptor-α in a behaviorally relevant and dose dependent
manner in the arcuate nucleus. M. MAHAVONGTRAKUL*;
S. M. KANJIYA; M. P. GARCIA; P. CHARUKULVANICH; K.
SINCHAK. California State University, Long Beach.
9:00 VV42 391.06 Estradiol attenuates the orphanin FQ/
nociceptin-induced inhibition of proopiomelanocortin
neurons. E. J. WAGNER*; N. TAVITIAN; A. BORGQUIST; K.
SINCHAK. Western Univ. of Hlth. Sci., California State Univ.
Long Beach.
10:00 VV43 391.07 The STX-activated membrane estrogen
receptor regulates female sexual receptivity through
interaction with the metabotropic glutamate receptor. A.
CHRISTENSEN*; P. DEWING; P. MICEVYCH. UCLA.
11:00 VV44 391.08 Progesterone rapidly faciltates sexual
receptivity through deactivation of mu-opioid receptors in the
medial preoptic nucleus of the hypothalamus. B. HUSS*; N.
LONG; L. PONCE; L. GOMEZ; C. A. MOORE; K. SINCHAK.
California State University, Long Beach.
8:00 VV45 391.09 Peripheral nerves mediating the
urethrogenital reflex in urethane-anesthetized, acutely
spinalized, male rats evoked by penile clamping or
retraction. L. MARSON*; T. MASAYUKI; K. THOR; V.
KARICHETI. Urogenix Inc, Astellas pharm Inc.
9:00 VV46 391.10 Analysis of the molecular and neural
mechanism of female mating acceptance depending on
visual information in small fish medaka. T. OKUYAMA*; Y.
SUEHIRO; H. IMADA; A. SHIMADA; H. ABE; M. TANAKA;
K. NARUSE; H. TAKEDA; Y. OKA; T. KUBO; H. TAKEUCHI.
The Univ. of Tokyo, Natl. Inst. for Basic Biol.
10:00 VV47 391.11 The role of the medial preoptic area in
vaginal marking and opposite-sex odor preference in female
Syrian hamsters. L. A. MARTINEZ*; A. PETRULIS. Georgia
State Univ.
11:00 VV48 391.12 Functionally disconnecting the medial
amygdala from the medial preoptic area disrupts copulation
but not opposite-sex odor preference in male Syrian
hamsters. L. E. BEEN*; A. PETRULIS. Georgia State Univ.
8:00 VV49 391.13 Fos response to social odors varies with
odor volatility in male Syrian hamsters. M. BADURA*; A.
PETRULIS. Georgia State Univ.
9:00 VV50 391.14 Activation of GABA B receptor in the
arcuate nucleus of the hypothalamus regulates sexual
receptivity. P. DEWING; K. SINCHAK; A. CHRISTENSEN;
M. BERGER; P. E. MICEVYCH*. David Geffen Schl Med. at
UCLA, Brain Res. Inst., California State Univ.
10:00 VV51 391.15 Ontogeny of progenitor cells in the
preoptic area of the Japanese quail (Coturnix japonica). K.
MOURIEC*; S. BARDET; J. BALTHAZART. Univ. of Liège,
Univ. of Limoges.
Neuroscience 2011 | Monday AM | 63
Mon. AM

11:00 VV52 391.16 Fos expression in catecholaminergic
cell groups following the performance of appetitive and
consummatory sexual behaviors in male and female
Japanese quail. O. IYILIKCI*; J. BALTHAZART; G. F. BALL*.
Johns Hopkins Univ., Univ. of Liege.
8:00 VV53 391.17 Fictive flirting: Investigating a
reproductive pattern generator. K. L. TODD*; J. F. BRATKA;
W. B. KRISTAN; K. FRENCH. Univ. California SD.
9:00 VV54 391.18 Determining the neurohormonal basis of
courtship behavior in a medicinal leech. J. F. BRATKA*; K. L.
TODD; S. SINHA; W. B. KRISTAN; K. FRENCH. UCSD.
10:00 VV55 391.19 How the male brain reacts to conflicting
demands during breeding: Changes in brain activation in
male sticklebacks (gasterosteus aculeatus). M. H. KENT*; A.
M. BELL. Univ. Illinois, Univ. Illinois, Univ. Illinois.
11:00 VV56 391.20 Testosterone regulates the physical
association of nNOS to NMDA receptors in the medial
preoptic area via the scaffolding protein PSD-95. T. S.
GARELICK*; J. M. SWANN. Lehigh Univ., Lehigh Univ.
8:00 VV57 391.21 The role of kisspeptin neurons in the
expression of female sexual behaviors. O. BROCK*; C.
MAYER; U. BOEHM; J. BAKKER. Netherlands Inst. For
Neurosci., Ctr. for Mol. Neurobiology, Inst. for Neural Signal
Transduction, GIGA-Neuroscience.
9:00 VV58 391.22 Segmental synaptic effects and
morphometric analysis of pudendal sensory neurons
supplying the distal glans and urethral orifice in male rats.
S. L. FERRERO*; V. P. DUGAN; R. D. JOHNSON. Univ. of
Florida.
10:00 VV59 391.23 Electrophysiological analyses of reflexes
to bulbospongiosus (BS) and urethral rhabdosphincter (URS)
muscles evoked by stimulation of pudendal afferent fibers
reveals differences in adequate stimulus, patterns of activity,
supraspinal control, and desensitization. V. KARICHETI*; T.
MASAYUKI; L. MARSON; K. THOR. Urogenix, Inc, Astellas
Pharm Inc.
POSTER
392. Social Behavior: Effects of Genes, Sex, and
Environment
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 VV60 392.01 Sexual differentiation of mouse social
recognition. L. M. TEJADA*; E. F. RISSMAN. Univ. Virginia.
9:00 VV61 392.02 DISC1 promotor methylation and mRNA
expression is sexually dimorphic within the developing
Amygdala. H. J. WHITE*; H. M. JESSEN; M. H. KOLODKIN;
C. J. AUGER; A. P. AUGER. Univ. of Wisconsin, Madison.
10:00 VV62 392.03 Developmental ethinyl estradiol, but not
Bisphenol A, treatment increases juvenile play behavior of
Sprague-Dawley rats. S. A. FERGUSON*; C. D. LAW; M. E.
SMITH. Natl. Ctr. Toxicological Res.
11:00 VV63 392.04 � The effect of beta-endorphin on male
mice with sexually receptive and non-receptive females.
L. HASELDEN*; W. STALLINGS; A. MOSER; C. PEAY; J.
GRISEL. Furman Univ.
8:00 VV64 392.05 • Estrogen receptor α -and BDNF
-mediated intracellular signaling in anxiety- and depressionlike
behaviors in postpartum rats. M. FURUTA*; T.
NUMAKAWA; S. CHIBA; M. NINOMIYA; Y. KAJIYAMA; T.
FUNABASHI; T. AKEMA; H. KUNUGI. St. Marianna Univ.,
Natl. Inst. of Neurosci. Natl. Ctr. of Neurol. and Psychiatry.
9:00 VV65 392.06 Early life stress has sexually dimorphic
effects on partner preference formation in prairie voles
(Microtus ochrogaster): Potential moderation by oxytocin
receptors. C. E. BARRETT*; P. FERNANDEZ; A. QUETANT;
L. J. YOUNG. Ctr. For Translational Social Neurosci, Emory
Univ., Yerkes Natl. Primate Ctr., Dept. of Psychiatry and
Behav. Sci.
10:00 VV66 392.07 The effects of naloxone on maintenance
of pair bonding in male and female zebra finches. J.
SCHNELKER*; B. ZATIRKA; M. TOMASZYCKI. Wayne
State Univ.
11:00 VV67 392.08 Sex chromosome gene effects on
juvenile social and anxiety behaviors: Implications for
turner syndrome. K. H. COX*; A. ESCHENROEDER; E. F.
RISSMAN. Univ. of Virginia, Univ. of Virginia.
8:00 VV68 392.09 DNA methyltransferase 3a regulates
promoter methylation and expression of estrogen receptor
α within the developing rat amygdala. M. H. KOLODKIN*;
H. M. JESSEN; M. N. EDELMANN; A. P. AUGER. Univ. of
Wisconsin, Univ. of Wisconsin.
9:00 VV69 392.10 The ovaries are essential for the longterm
effects of peripubertal immune challenge on adult
behavioral responsiveness to ovarian hormones. N. ISMAIL*;
B. RAPPLEYEA; H. M. KING; J. D. BLAUSTEIN. Univ. of
Massachusetts.
10:00 VV70 392.11 MeCP2 disruption within the developing
amygdala leads to dysregulation of DISC1 mRNA levels in
a sex specific manner. H. M. JESSEN*; H. J. WHITE; R.
M. FORBES-LORMAN; C. J. AUGER; A. P. AUGER. Univ.
Wisconsin Madison.
11:00 VV71 392.12 The social environment impacts sex
differences in play fighting. M. J. PAUL*; V. Z. ZHU; J. I.
TERRANOVA; E. K. MURRAY; N. ISMAIL; G. J. DE VRIES.
Univ. of Massachusetts, Amherst, Univ. of Massachusetts,
Amherst, Amherst Col., Univ. of Massachusetts, Amherst.
8:00 VV72 392.13 A reduction in MeCP2 within the
developing amygdala differentially alters gene expression
in male and female rats. R. M. FORBES-LORMAN*; J. J.
RAUTIO; C. J. AUGER; A. P. AUGER. UW-Madison.
9:00 VV73 392.14 Vasopressin infusion into the lateral
septum of adult male rats rescues a progesterone induced
impairment in social discrimination. M. E. BYCHOWSKI*; C.
J. AUGER. Univ. Wisconsin, Univ. Wisconsin.
10:00 VV74 392.15 Epigenetic modifications in the regulation
of maternal experience in mice. D. S. STOLZENBERG*; J.
STEVENS; E. F. RISSMAN. Univ. of Virginia.
11:00 VV75 392.16 Septal vasopressin regulates play-fighting
in male and female juvenile rats: Sex- and context-specific
effects. R. BREDEWOLD; C. J. SMITH; A. H. VEENEMA*.
Boston Col.
8:00 VV76 392.17 Tyrosine hydroxylase- and aromatic
L-amino acid decarboxylase-synthesizing neurons in the
male and female prairie vole brain. E. I. AHMED*; K. V.
NORTHCUTT; J. S. LONSTEIN. Michigan State Univ.,
Mercer Univ.
64 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 VV77 392.18 Role of GPER1 in social behaviors,
anxiety, and memory. D. M. ANCHAN*; D. A. HART; A. A.
GAFUR; E. R. LANDERS; N. VASUDEVAN. Tulane Univ.,
Tulane Univ.
POSTER
393. Renal/Urinary I
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 VV78 393.01 • Circadian variation of urodynamics
and excitability in bladder. R. S. WHITE*; G. HERRERA; A.
L. MEREDITH. Univ. of Maryland Sch. of Med., Catamount
Res. and Develop.
9:00 VV79 393.02 Effects of MTEP on pudendal inhibition
of micturition reflex in cats. J. WANG*; J. LARSON; D.
OGAGAN; G. CHEN; B. SHEN; J. R. ROPPOLO; W. C.
DE GROAT; C. TAI. Univ. Pittsburgh, China Rehabil. Res.
Center, Sch. of Rehabil. Medicine, Capital Med. Univ., Univ.
Pittsburgh.
10:00 VV80 393.03 • Expression and plasticity of corticotropin
releasing factor (CRF) and related peptides/receptors in
urinary bladder during postnatal development in rat. B. M.
GIRARD*; S. MALLEY; M. A. VIZZARD. Univ. Vermont col
Med., Univ. Vermont col Med.
11:00 VV81 393.04 Effects of naloxone on tibial nerve
inhibition of bladder activity in cats. C. TAI*; G. CHEN;
J. LARSON; D. OGAGAN; B. SHEN; J. WANG; J. R.
ROPPOLO; W. C. DE GROAT. Univ. Pittsburgh, China
Rehabil. Res. Center, Sch. of Rehabil. Medicine, Capital
Med. Univ., Univ. Pittsburgh.
8:00 VV82 393.05 • Role of chronic variate stress in bladder
dysfunction in rats. L. MERRILL*; A. PETERSON; S.
MALLEY; B. M. GIRARD; W. FALLS; S. HAMMACK; V. MAY;
M. A. VIZZARD. Univ. of Vermont.
9:00 VV83 393.06 Mechanism of urinary bladder overactivity
induced L-cysteine in neonatal rats. N. ESER; S. L.
DAUGHERTY; C. GOCMEN; J. R. ROPPOLO*; K. B.
KORONOWSKI; J. K. VOLPE; A. M. HOHENADEL; D. E.
ARTIM; W. C. DE GROAT. Univ. Pittsburgh Sch. Med., Univ.
of Cukurova Sch. of Med.
10:00 VV84 393.07 � Carbachol injected into the fourth brain
ventricle (4 th V) evokes pressure changes of the urinary
bladder in female rats. E. M. CAFARCHIO; R. L. ALMEIDA;
C. A. OGIHARA; I. H. SAVIOLLI; E. COLOMBARI; M. A.
SATO*. Fac Med. do ABC.
11:00 VV85 393.08 • TAC-302, a novel neurite outgrowth
enhancer, therapeutically improves lower urinary tact
symptoms in rats with bladder outlet obstruction. S.
YOSHIDA; Y. HAYASHI; F. MORI; T. NISHIHASHI; N.
ORIMOTO; K. MIYOSHI; K. MATSUO; N. YOSHIMURA*.
Taiho Pharmaceut. Co., Ltd., Univ. Pittsburgh Sch. Med.
8:00 VV86 393.09 • Neuroprotection by TAC-302, a novel
neurite outgrowth enhancer, prevents bladder dysfunction
following bladder outlet obstruction in rat. Y. HAYASHI*; S.
KOKUBUN; K. AKIKAWA; H. TSUKIHARA; K. MISYOSHI;
K. MATSUO; O. YAMAGUCHI. Taiho Pharmaceut. Co., Ltd.,
Fukushima Med. Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 VV87 393.10 • Effects of TAC-302, a novel neurite
outgrowth enhancer, on voiding dysfunction in rats with
STZ-induced diabetes. A. HAKOZAKI*; Y. HAYASHI; S.
YOSHIDA; N. ORIMOTO; K. MIYOSHI; K. MATSUO. TAIHO
Pharmaceut. Co.,Ltd., Taiho Pharmaceut. Co., Ltd.
10:00 VV88 393.11 • Detrusor overactivity is reflected by
alterations of muscarinic and P2X receptors in the bladder
from rats with STZ-induced diabetes. T. YOSHIZAWA*;
Y. HAYASHI; S. YOSHIDA; A. YOSHIDA; Y. ITO; S.
YAMADA; S. TAKAHASHI. Nihon Univ. Sch. of Med.,
Taiho Pharmaceut. Co., Ltd., Univ. of Shizuoka, Sch. of
Pharmaceut. Sci.
11:00 VV89 393.12 Electrophysiological response patterns
of urethral sensory afferents and their central excitation/
inhibition of pudendal motoneuron reflexes in male rat and
mouse. J. J. DELCAMBRE*; V. P. DUGAN; S. F. FERRERO;
R. D. JOHNSON. Univ. of Florida Col. of Vet. Med.
8:00 VV90 393.13 Bladder length changes recorded during
cystometry in anesthetized adult female rats: Methods
development. B. K. LAPALLO*; X. Y. CHEN; J. R. WOLPAW;
J. S. CARP. Wadsworth Ctr.
9:00 VV91 393.14 External urethral sphincter muscle activity
and bladder length recorded in freely moving adult female
rats: Methods development. J. S. CARP*; B. K. LAPALLO; X.
Y. CHEN; J. R. WOLPAW. Wadsworth Ctr, NYS Dept Hlth. &
SUNY.
10:00 VV92 393.15 • The effects of autonomic drugs on nonvoiding
contractions in the rat urinary bladder during video
urodynamics. M. O. FRASER*; P. C. DOLBER. Duke Univ.
Med. Ctr., Durham Veterans Affairs Med. Ctr.
11:00 VV93 393.16 Heme oxygenase-1 enhances tubular
recovery from kidney ischemia-reperfusion injury through
activating extracellular signal-regulated kinases 1 and 2 in
mice. H. CHEN*; W. HO; C. TSENG. Dept. of Med. Edu.
& Res., Kaohsiung Veterans Gen. Hosp., Inst. of Clin.
Medicine, Natl. Yang-Ming Univ., Dept. of Nephrology,
Zuoying Armed Forces Gen. Hosp.
8:00 VV94 393.17 Parturition - just another voiding activity
controlled by the emotional motor system? G. HOLSTEGE*;
J. BECKEL; T. A. LOVICK. Univ. Med. Ctr. Groningen, Univ.
of Pennsylvania Sch. of Dent. Med., Univ. of Birmingham.
POSTER
394. Cellular Actions of Stress
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 VV95 394.01 Stress-induced trafficking of mu-opioid
receptors in the rat locus coeruleus. K. VAKHARIA*; S.
WOOD; B. REYES; R. VALENTINO; E. VAN BOCKSTAELE.
Thomas Jefferson Univ., Children’s Hosp. of Philadelphia.
9:00 VV96 394.02 Aquaporin 4 (AQP4) expression is
not affected by chronic social stress in hippocampus and
prefrontal cortex of the male rat. C. ARAYA-CALLIS; G. A.
FLUEGGE*. German Primate Ctr, Leibniz Inst. For Primate
Res.
10:00 WW1 394.03 Stress increases Zn 2+ -induced
neurotoxicity through TRPM7 channel in dopamine neurons.
Y. KIM*; S. CHUNG. Sungkyunkwan Univ.
Neuroscience 2011 | Monday AM | 65
Mon. AM

11:00 WW2 394.04 Uncovering novel therapeutic targets
modulating neuroprotection or susceptibility of neurons
to degeneration upon disease stress stimuli promoting
oxidative stress. K. CHO*; H. YI; M. WEBB; P. A.
FERREIRA. Duke Univ. Med. Ctr.
8:00 WW3 394.05 Arginylation of CRT regulates protein fate
outside the ER. C. LOPEZ SAMBROOKS; V. E. GOITEA; M.
A. CARPIO; M. E. HALLAK*. Fac Ciencias Quimicas.
9:00 WW4 394.06 Stress hormones modulate matrix
metalloproteinases (MMPs) expression in oral cancer cells.
D. BERNABE; B. L. SCHMIDT*; S. OLIVEIRA. Sch. of Dent.,
New York Univ. Col. of Dent.
10:00 WW5 394.07 Expression of mRNA of galanin receptor
subtypes in adenohypophysis of Wistar rats in controls and
after acute restraint stress. V. KLENEROVA*; M. DZUR-
GEJDOSOVA; P. SKOPEK; S. HYNIE. Charles Univ. in
Prague, 1st Fac. of Med.
11:00 WW6 394.08 � Immunohistochemical detection of
galanin receptor subtypes in adenohypophysis of Wistar rats;
effects of acute restraint stress. P. SKOPEK*; S. HYNIE; V.
KLENEROVA. Charles Univ. in Prague, First Fac. of Med.
8:00 WW7 394.09 Nerve growth factor decreases ER
stress-mediated apoptosis through refolding unfolded protein
structure by glucose-regulated protein 78 in PC12 cells. K.
SHIMOKE*; H. SASAYA; H. MARUOKA; K. SUGIHARA;
M. NOBUHARA; T. IKEUCHI. Kanasai Univ., Div. of Natural
Product Chemistry, Inst. of Natural Medicine, Univ. of
Toyama, Technol. Res. Laboratory, KURABO.
9:00 WW8 394.10 Temporal profile of phospho-ERK 1/2
immunoreactivity in the mesolimbocortical stress-responsive
circuit nuclei following acute restraint in male rats. C. O.
OKERE*; M. I. SMITH; I. S. NICHOLS. Clark Atlanta Univ.,
Clark Atlanta Univ.
10:00 WW9 394.11 Mechanisms of rapid dendritic spine loss
in hippocampal pyramidal neurons induced by corticotropinreleasing
hormone. A. L. ANDRES*; Y. CHEN; L. PHAN; Y.
NOAM; L. PHI; T. Z. BARAM. Univ. of California-Irvine, Univ.
of California-Irvine, Univ. of Amsterdam.
11:00 WW10 394.12 The stress neuropeptide CRH destroys
the actin cytoskeleton of dendritic spines via a RhoA
mediated cellular pathway. Y. CHEN*; L. CHEN; J. YANG; L.
PHAN; B. LEE; C. GALL; G. LYNCH; T. BARAM. Univ. Cal
Irvine, Univ. Cal Irvine, Univ. Cal Irvine.
8:00 WW11 394.13 Stress triggered modulation of renin
angiotensin system in adrenal medulla: Implications for
catecholamine biosynthesis. E. L. SABBAN*; A. TILLINGER;
R. NOSTRAMO; A. KUMAR; V. PANDEY; L. SEROVA; S.
MAHARJAN. New York Med. Coll, New York Med. Coll.
9:00 WW12 394.14 Serotonin and oxytocin regulate GR
signalling in fetal hippocampal progenitor cells. K. M.
MUSAELYAN; C. ANACKER; P. A. ZUNSZAIN; E. L.
DEMPSTER; J. MILL; C. PARIANTE*. King’s Col., King’s
Col., King’s Col.
10:00 WW13 394.15 Chronic corticosterone alters the
balance of excitatory and inhibitory neurotransmission in the
hippocampus and amygdala: Relevance to depression. A.
L. LUSSIER*; R. ROMAY-TALLÓN; H. J. CARUNCHO; L.
E. KALYNCHUK. Univ. Saskatchewan, Univ. of Santiago de
Compostela, Univ. of Saskatchewan.
11:00 WW14 394.16 Chronic stress upregulates insulin
dependent glucose transporters differentially in male and
female rats. S. D. KELLY; C. HARRELL; C. BOURKE; C. J.
BARNUM*; G. NEIGH. Emory Univ., Emory Univ. Sch. Med.
8:00 WW15 394.17 PACAP, a potential neuroprotective
agent, for stress-induced adrenergic function. D. WONG*; R.
CLAYCOMB. Harvard Med. School/McLean Hosp.
9:00 WW16 394.18 Epigenetic modifications in genetic
and environmental mouse models of depressive-like
disorder: Reversal by chronic treatment with agomelatine.
R. MASSART; E. STRAGIER; E. PAIZANIS; C. GABRIEL;
E. MOCAER; M. HAMON; L. LANFUMEY*. INSERM 894
Ctr. of Psychiatry and Neurosciences, Univ. de Caen Basse
Normandie, IRIS.
10:00 WW17 394.19 • Stress-induced c-Fos and FosB
expression in the paraventricular and supraoptic nuclei of
the rat hypothalamus. G. DAS*; K. UCHIDA; K. ITOI. Tohoku
Univ., Tohoku Univ.
11:00 WW18 394.20 • � Profile of fatty acids in brain of
rats exposed to extremely low frequency electromagnetic
fields and movement stress. A. FLORES-POBLANO; J.
MARTÍNEZ-SÁMANO; V. INCLAN-RUBIO*; L. VERDUGO-
DÍAZ; M. A. JUÁREZ-OROPEZA; P. V. TORRES-DURÁN.
UNAM, UNAM, UNAM.
8:00 WW19 394.21 Metabotropic glutamate receptor 1 gates
state-dependent plasticity in hypothalamic stress circuitry.
W. INOUE*; D. V. BAIMOUKHAMETOVA; Q. J. PITTMAN;
J. S. BAINS. Hotchkiss Brain Institute, Dept. of Physiol. &
Pharmacology, Univ. O.
9:00 WW20 394.22 Glucocorticoid-associated longterm
depression of hypothalamic gaba synapses. J. I.
WAMSTEEKER*; J. S. BAINS. Hotchkiss Brain Inst.
POSTER
395. Metabolism and Energy Homeostasis I
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 WW21 395.01 Behavioral patterns associated with
chemotherapy-induced emesis: A potential signature for
nausea in musk shrews. C. C. HORN*; S. HENRY; K.
MEYERS; M. S. MAGNUSSON. Univ. of Pittsburgh, Univ.
of Pittsburgh Sch. of Med., Univ. of Pittsburgh Cancer Inst.,
Univ. of Pittsburgh, AgroSup Dijon, Univ. of Iceland.
9:00 WW22 395.02 • Sugar solutions and their impact on
appetite regulation. T. W. CASTONGUAY*; D. COLLEY; B.
JIANG; J. KHURAL. Univ. Maryland.
10:00 WW23 395.03 • Effects of dietary saturated fatty
acids on metabolic profile and electrocorticography. T.
SARTORIUS*; A. JANESSA; C. ROTERMUND; A. PETER;
J. MACHANN; F. SCHICK; H. HAERING; A. M. HENNIGE.
Dept. of Intrnl. Med. 4, Univ. of Tuebingen.
11:00 WW24 395.04 Early-life programming of body weight
regulation and neuroinflammation: Is there a connection? J.
L. BOLTON*; N. C. HUFF; S. H. SMITH; W. M. FOSTER; R.
L. AUTEN; S. D. BILBO. Duke Univ., Duke Univ., Duke Univ.
8:00 WW25 395.05 Characterization of insulin signaling
in steroidogenic factor 1 (SF-1) expressing neurons of
the VMH. S. HESS*; T. KLOECKENER; B. HAMPEL;
M. PAEHLER; A. HUSCH; J. C. BRUENING; P.
KLOPPENBURG. Univ. of Cologne, Biocenter of the Univ.
of Cologne, Cologne Excellence Cluster on Cell. Stress
Responses in Aging-Associated Dis. (CECAD), Ctr. for Mol.
Med. (CMMC), Univ. of Cologne.
66 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 WW26 395.06 Use of an in situ brainstem preparation
to study the emetic-like responses of vomiting (musk shrew)
and non-vomiting species (rats and mice). J. S. KAUS*; K.
MEYERS; C. C. HORN. Biobehavioral Med. In Oncology
Program, Hillman Cancer Ctr., Univ. of Pittsburgh Sch. of
Med., Univ. of Pittsburgh Sch. of Med., Univ. of Pittsburgh.
10:00 WW27 395.07 Deficiency of PTP1B in leptin receptorexpressing
cells leads to decreased body weight and
improved glucose homeostasis. R. TSOU*; D. E. ZIMMER;
B. C. DE JONGHE; K. K. BENCE. Univ. of Pennsylvania.
11:00 WW28 395.08 A subpopulation of ventromedial
hypothalamic glucose sensing neurons express estrogen
receptor alpha (ERα) and are modulated by17β-estradiol.
A. M. SANTIAGO*; J. G. POTIAN; Z. SHENG; L. HAO; D. J.
CLEGG; V. H. ROUTH. New Jersey Med. School-GSBS, UT
Southwestern Med. Ctr.
8:00 WW29 395.09 Ca 2+ activated potassium currents
contribute to high fat diet induced inhibtition of POMC
neurons of the mouse nucleus arcuatus. L. PAEGER*;
A. PIPPOW; S. HESS; M. PAEHLER; M. C. VOGT;
T. KLÖCKENER; C. POUZAT; J. C. BRÜNING; P.
KLOPPENBURG. Biocenter, Ctr. for Mol. Med. (CMMC),
Cologne Excellence Cluster in Aging Associated Dis.
(CECAD), Inst. for Genet., Ctr. for Endocrinology, Diabetes
and Preventive Med. (CEDP), Max Planck Inst. for Neurolog.
Res., UFR biomedicale de l’Universite Paris V.
9:00 WW30 395.10 Glucosensing in parvocellular neurons of
the rat hypothalamic paraventricular nucleus. C. J. PRICE*;
I. MELNICK; W. F. COLMERS. Bogomoletz Inst. of Physiol.,
Univ. of Alberta.
10:00 WW31 395.11 Altered feeding patterns of mice with
smooth-muscle specific knockout of neurotrophin-3 suggest
involvement of vago-vagal gastrointestinal reflexes. J. E.
BIDDINGER*; E. A. FOX. Purdue Univ.
11:00 WW32 395.12 � High fructose corn syrup (HFCS) alters
energy partitioning during development in female rats. T. L.
GARRETT; C. C. WEBRE; H. I’ANSON*. Washington & Lee
Univ.
8:00 WW33 395.13 The satiety effects of glucagon is
mediated by peripheral and central glucagon receptor
agonism. I. YU*; S. WANG; T. GARESKI; D. KUBASIAK;
S. WILL; K. COUGHLAN; G. HEBERT; J. JONES; M.
PERREAULT. Cardiovascular, Metabolic, and Endocrine Dis.
Res. Unit, Pfizer Inc.
9:00 WW34 395.14 5-HT 3 agonists activate catecholamine
neurons in the solitary tract nucleus of the brainstem. B.
L. ROBERTS*; R. CUI; H. ZHAO; X. LI; M. ZHU; S. M.
APPLEYARD. Washington State Univ.
10:00 WW35 395.15 Intracerebroventricular LPS leads to
dephosphorylation of hypothalamic AMPK without altering
hepatic PEPCK expression. D. C. VITORINO; G. A.
SANTOS; E. A. D. R. ROMAN; R. F. MOURA; M. MILANSKI;
L. A. VELLOSO*; M. A. TORSONI. Univ. of Campinas, Univ.
Campinas.
11:00 WW36 395.16 Activation of anorexogenic POMC
neurons during refeeding is independent of brainstem inputs.
G. ZSÉLI; T. FÜZESI; R. M. LECHAN; C. FEKETE*. Inst.
Exptl. Med., Tufts-Medical Ctr.
8:00 WW37 395.17 Insulin increases cytosolic Ca 2+ in vagal
afferent nodose ganglion neurons via insulin receptor
signaling. Y. IWASAKI*; H. NAKABAYASHI; M. KAKEI; T.
YADA. Jichi Med. Univ., Kanazawa Univ., Saitama Med.
Center, Jichi Med. Univ., Jichi Med. Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 WW38 395.18 Central vagal afferent NMDA receptors
may contribute to hindbrain neuron activation and reduced
food intake by cholecystokinin. R. C. RITTER*; C. CAMPOS;
G. HERMANN; R. C. ROGERS. Washington State Univ.,
Pennington Biomed. Res. Inst.
10:00 WW39 395.19 • Chronic effects of caffeine on blood
glucose levels and tolerance on healthy and diabetic rats.
Z. URZÚA; X. TRUJILLO; B. TRUJILLO-HERNÁNDEZ; M.
RÍOS-SILVA; C. ONETTI; M. ORTIZ-MESINA; M. HUERTA-
VIERA*. Univ. De Colima, CUIB, Inst. Mexicano del Seguro
Social.
11:00 WW40 395.20 Hindbrain NMDA receptor activation
mediates CCK-induced increase in hindbrain ERK 1/2
phosphorylation and reduction of food intake. C. A.
CAMPOS*; K. CZAJA; M. COVASA; R. C. RITTER.
Washington State Univ., INRA.
POSTER
396. Circadian Physiology
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 WW41 396.01 Cocaine treatments in vitro modulate the
mouse mammalian circadian clock. R. A. PROSSER*; A. J.
BRAGER; J. D. GLASS. Univ. Tennessee, Kent State Univ.
9:00 WW42 396.02 • A facile assay to probe circadian
rhythm abnormalities in Tg2576 mice. M. MARCONI*; E. K.
SYLVAIN; K. R. BALES. Pfizer.
10:00 WW43 396.03 Larval ethanol exposure alters adult
circadian free-running locomotor rhythm in Drosophila
melanogaster. S. AHMAD*; J. A. SEGGIO; B. POSSIDENTE.
Colby Col., Bridgewater State Univ., Skidmore Col.
11:00 WW44 396.04 Daily rhythms of BDNF production in the
brain of the diurnal grass rat. C. A. MARTIN-FAIREY*; A.
A. NUNEZ; L. SMALE. Michigan State University, Michigan
State University, Michigan State University.
8:00 WW45 396.05 Circadian expression of PrP C and its
ligand in sleep- and wake- promoting brain regions. K. S.
LEE*; B. FERRANTE; F. GOELDNER; T. ALVARENGA; P.
ARAUJO; M. ANDERSEN; S. TUFIK. Univ. Federal De Sao
Paulo, UNIFESP.
9:00 WW46 396.06 Circadian properties of cancer stem cells
in the C6 glioma cell line. V. P. SHARMA; M. E. GEUSZ*.
Bowling Green State Univ., Bowling Green State Univ.
10:00 WW47 396.07 � Obesity reduces light response of
circadian locomotor activity and c-Fos in suprachiasmatic
nucleus in the volcano mouse Neotomodon alstoni. V.
P. CARMONA-ALCOCER; M. MIRANDA-ANAYA*; A.
CARMONA CASTRO. Facultad De Ciencias, UNAM,
Facultad De Ciencias, UNAM, Facutad de Ciencias, UNAM.
11:00 WW48 396.08 Chronic alcohol consumption in mice
disrupts the phase relationship between the liver and
suprachiasmatic nucleus. R. L. JOHNSON; A. N. FILIANO;
T. M. SWAIN; M. E. YOUNG; S. M. BAILEY; K. L. GAMBLE*.
UAB Med. Ctr., UAB Med. Ctr., UAB Med. Ctr.
8:00 WW49 396.09 Glutamatergic neurons in the dorsomedial
hypothalamic nucleus regulate body temperature and
circadian control of activity and sleep. N. VUJOVIC*; K. L.
RAPP; P. M. FULLER; C. B. SAPER. Beth Israel Deaconess
Med. Ctr., Beth Israel Deaconess Med. Ctr.
Neuroscience 2011 | Monday AM | 67
Mon. AM

9:00 WW50 396.10 Circadian characteristics in nonentrained
type of circadian rhythm sleep disorder. S. KITAMURA*;
A. HIDA; M. WATANABE; M. ENOMOTO; Y. KATAYOSE;
K. NOZAKI; S. ARITAKE-OKADA; S. HIGUCHI; Y.
MORIGUCHI; Y. KAMEI; K. MISHIMA. Natl. Ctr. of Neurol.
and Psychiatry.
10:00 WW51 396.11 Lesions targeting leptin-sensitive neurons
in the mediobasal hypothalamus dissociate activity and
temperature circadian rhythms. M. F. WIATER*; H. JANSEN;
M. OOSTROM; A. LI; T. DINH; S. RITTER. Washington State
Univ.
11:00 WW52 396.12 The influence of SCN activity on sleep
and wake across the day. F. MUINDI*; D. COLAS; M.
CARTER; L. DE LECEA; H. HELLER. Stanford Univ.,
Stanford Univ.
8:00 WW53 396.13 Rhythmic expression of CYP450
epoxygenases that regulate vascular tone and cerebral
blood flow. K. A. CARVER*; J. C. BESHARSE; D. R.
HARDER. Med. Col. of Wisconsin, Med. Col. of Wisconsin,
Clement J. Zablocki VA Med. Ctr.
9:00 WW54 396.14 Serotonin impacts on the circadian clock
network. H. E. SIKES RESUEHR*; C. M. CIARLEGLIO; J.
C. AXLEY; E. DENERIS; D. G. MCMAHON. Vanderbilt Univ.,
Brown Univ., Case Western Reserve Univ.
10:00 WW55 396.15 Circadian regulation of arousal-promoting
neurons. C. E. MAHONEY*; E. L. BITTMAN. Univ. of
Massachusetts.
11:00 WW56 396.16 Characterization of ultradian rhythms in
adult male rats through EEG analyses. S. MOFFETT; T. D.
JAMES; J. F. SHOUKRY; M. F. SHOUKRY; D. HONG; J. V.
MARTIN*. Rutgers Univ.
8:00 WW57 396.17 Changes in the neuronal activity in the
celiac-superior mesenteric ganglia and suprachiasmatic
nucleus cells during the estrous cycle of the rat. C. MORAN*;
B. ROBLEDO; L. A. MACHORRO; J. JUÁREZ; J. L.
MORÁN; A. HANDAL; R. DOMÍNGUEZ. Univ. Autonoma de
Puebla, Univ. Nacional Autónoma de México.
9:00 WW58 396.18 The SCN modulates the daily activity of
the ARC; Thermoregulatory implications? M. A. GUZMÁN
RUIZ*; G. ACOSTA GALVÁN; D. HERRERA-MORO CHAO;
R. C. SALGADO DELGADO; N. N. GUERRERO VARGAS;
M. D. BASUALDO SIGALES; C. ESCOBAR BRIONES; R.
BUIJS. Inst. De Investigaciones Biomédicas, Facultad de
Medicina.
POSTER
397. Sleep Neurochemistry and Pharmacology I
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 WW59 397.01 � Effect of repetitive transcranial magnetic
stimulation (rTMS) on nicotine-induced suppression of
P13 auditory evoked potential. S. MYAL*; A. M. HAYAR; R.
BUCHANAN; E. GARCIA-RILL. UAMS Ctr. For Translational
Neurosci., Arkansas State Univ.
9:00 WW60 397.02 Substance P depolarizes sleep-active
cortical neurons and induces EEG synchronization. J. E.
HEISS*; L. DITTRICH; T. CHEN; D. WARRIER; X. PEREZ;
M. QUIK; T. S. KILDUFF. SRI Intl., SRI Intl.
10:00 WW61 397.03 Ultrastructural distribution of mu opioid
receptors in noradrenergic neurons and gabaergic axons
within the locus coeruleus of the cat. M. GARZON*; O. F.
ROBAYO; X. ALVIRA-BOTERO. Fac Med. UAM.
11:00 WW62 397.04 Responses of developing
pedunculopontine neurons to glutamate receptor agonists.
C. SIMON*; A. HAYAR; E. GARCIA-RILL. Univ. of Arkansas
For Med. Sci.
8:00 WW63 397.05 Voltage sensitive dye imaging and
population activity in the pedunculopontine nucleus -
effects of carbachol (CAR). J. R. HYDE*; F. J. URBANO;
E. GARCIA-RILL. Univ. of Arkansas For Med. Sci., Ciudad
Universitaria.
9:00 WW64 397.06 Mechanism behind gamma band activity
in developing parafascicular nucleus. N. KEZUNOVIC*; J.
HYDE; F. J. URBANO; E. GARCIA-RILL. UAMS, Univ. of
Buenos Aires.
10:00 WW65 397.07 � Injection of URB597,
oleoylethanolamide or palmitoylethanolamide into lateral
hypothalamus or into dorsal raphe nuclei increases waking
in rats. C. E. RODRÍGUEZ-SOLÍS*; M. CASTAÑEDA-
SALGADO; G. CARRILLO-KU; M. PALOMERO-RIVERO;
D. MILLÁN-ALDACO; R. DRUCKER-COLÍN; E. MURILLO-
RODRÍGUEZ. Univ. Anahuac Mayab, Univ. Nacional
Autónoma de México.
11:00 WW66 397.08 � Intrahypothalamic administrations
of modafinil after total sleep deprivation block the sleep
rebound in rats.. C. HERNANDEZ*; A. DE LA FUENTE-
ORTEGÓN; E. PACHECO-PANTOJA; D. MILLÁN-ALDACO;
M. PALOMERO-RIVERO; R. HARO; R. DRUCKER-COLÍN;
E. MURILLO-RODRÍGUEZ. Univ. Anáhuac Mayab, Univ.
Nacional Autónoma de México, Univ. Nacional Autónoma de
México.
8:00 WW67 397.09 � Microdialysis perfusion into lateral
hypothalamus of the major non-psychoactive component
of Cannabis sativa, cannabidiol (CBD), blocks the
sleep rebound after total sleep deprivation in rats. T. A.
MADRIGAL-LIZCANO*; L. LÓPEZ-LARA; A. SARRO-
RAMIREZ; D. MILLÁN-ALDACO; M. PALOMERO-RIVERO;
R. DRUCKER-COLÍN; R. MECHOULAM; E. MURILLO-
RODRÍGUEZ. Univ. Anáhuac-Mayab, Univ. Nacional
Autónoma de México, Hebrew Univ. of Jerusalem.
9:00 WW68 397.10 • Awakening properties of newly
discovered highly selective H 3 receptor antagonists in rats.
S. BEESKÉ; D. FRANÇON; W. HURST; Z. GAO; P. AVENET;
G. GRIEBEL*. Sanofi-Aventis, Sanofi-Aventis.
10:00 WW69 397.11 � Intrahypothalamic microdialysis
infusions of cannabidiol enhances waking in rats. M. A.
FREIXES SALMERÓN*; C. C; A. ALONZO PERAZA; M.
PALOMERO-RIVERO; D. MILLÁN-ALDACO; R. DRUCKER-
COLÍN; R. MECHOULAM. Univ. Anáhuac Mayab, Inst. de
Fisiología Celular Univ. Nacional Autónoma de México,
Hebrew Univ.
11:00 WW70 397.12 The role of prostaglandin D 2 in causing
post-ictal sleep following seizures. M. LAZARUS*; M. K.
KAUSHIK; T. MORIYAMA; W. QU; K. ARITAKE; M. A.
RAHMAN; Z. HUANG; O. HAYAISHI; Y. URADE. Osaka
Biosci Inst., Fudan Univ.
8:00 WW71 397.13 � Effects of modafinil on the circadian
component of sleep in rats. A. POOT AKÉ*; A. DE LA
FUENTE-ORTEGÓN; E. PACHECO-PANTOJA; D.
MILLÁN-ALDACO; M. PALOMERO-RIVERO; R. HARO;
R. DRUCKER-COLÍN; E. MURILLO-RODRÍGUEZ. Univ.
Anáhuac Mayab, Univ. Nacional Autónoma de México, Univ.
Nacional Autónoma de México.
68 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 WW72 397.14 Prevention of CO 2 -induced arousal by
pharmacologic manipulation of 5-HT receptors in mice. G.
F. BUCHANAN*; G. B. RICHERSON. Yale Univ., Veteran’s
Affairs Med. Ctr., Univ. of Iowa, Veteran’s Affairs Med. Ctr.
10:00 XX1 397.15 Cholinergic neurons of the basal
forebrain and nitric oxide-mediated regulation of sleep
homeostasis. A. V. KALINCHUK*; T. PORKKA-HEISKANEN;
R. W. MCCARLEY; R. BASHEER. Harvard Med. School-VA
Boston Healthcare Syst., Univ. of Helsinki.
11:00 XX2 397.16 Adenosine and adenosine triphosphate
act directly and indirectly to decrease the excitability of
cholinergic and GABAergic basal forebrain neurons in
the mouse. C. YANG*; S. FRANCIOSI; R. MCCARLEY;
Y. YANAGAWA; R. BASHEER; R. BROWN. VA Boston
Healthcare Syst. and Harvard Med. Sch., Inst. of Human
Physiol. II, Univ. of Milan Med. Sch., Gunma Univ. Grad.
Sch. of Med., Japan Sci. and Technol. Agency, CREST,
Sanbacho, Chiyado-ku,.
8:00 XX3 397.17 Binding studies for GABA A and 5-HT 2C
receptor of traditional medicinal plants: Implications of
treatment for insomnia. H. JOUNG*; E. JUNG; H. LEE; D.
HAHM; I. SHIM. Kyung Hee Univ., Col. of Medicine, The
Catholic Univ. of Korea.
9:00 XX4 397.18 Effects of dynorphin on basal forebrain
cholinergic neurons - whole-cell recordings in mice. L. L.
FERRARI; S. Z. IQBAL; T. E. SCAMMELL; E. ARRIGONI*.
Harvard Med. Sch. and Beth Israel Deaconess MC.
10:00 XX5 397.19 • � REM sleep induced by cholinergic
stimulation of the parabrachial region is blocked by an
antagonist subtype muscarinic receptor in the medial
preoptic area. N. GARCIA-CARDENAS; P. POSADAS-
RODRIGUEZ; E. VAZQUEZ-SALAZAR; J. VELAZQUEZ-
MOCTEZUMA; A. JIMENEZ-ANGUIANO*. Univ. Autónoma
Metropolitana-Iztapalapa, Univ. Autónoma Metropolitana.
11:00 XX6 397.20 Infusion of prolactin into the dorsal raphe
nucleus increases REM sleep. R. B. MACHADO*; M. R.
ROCHA; S. TUFIK; D. SUCHECKI. Univesidade Federal De
São Paulo.
POSTER
398. Biological Rhythms and Sleep: Functional Imaging
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 XX7 398.01 Point process analysis of brain resting
fMRI dynamics reveals scale-free avalanches. D. R.
CHIALVO; E. R. TAGLIAZUCCHI; P. BALENZUELA; D. E.
FRAIMAN*. Conicet, UCLA, Univ. de Buenos Aires, Brain
Imaging Center, Goethe Univ., Univ. San Andres, CONICET.
9:00 XX8 398.02 Neurophysiological mechanisms of
spontaneous fluctuations in blood-oxygenation signals. S.
NAAMAN*; A. BORTEL; V. MOCANU; A. SHMUEL. McGill
University/Montreal Neurolog. Inst.
10:00 XX9 398.03 Investigating inter-trial variability
and temporal order in cortical hemodynamic response
magnitude. L. BOORMAN; M. BRUYNS-HAYLETT; A.
KENNERLEY; S. HARRIS; Y. ZHENG; M. JONES; J.
BERWICK*. Univ. Sheffield.
11:00 XX10 398.04 Altered default-mode network connectivity
in williams syndrome. S. MEDA*; J. R. PRYWELLER; T.
A. THORNTON-WELLS. Vanderbilt Univ., Vanderbilt Univ.,
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
8:00 XX11 398.05 The effect of intellectual ability on
functional brain activation in a neurodevelopmental disorder:
fMRI studies in Williams syndrome. J. R. PRYWELLER*; E.
M. DYKENS; T. A. THORNTON-WELLS. Vanderbilt Univ.,
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.
9:00 XX12 398.06 Neural source of laminar fMRI responses
examined with temporal frequency visual stimuli. C. C. YEN;
H. FUKUDA; S. KIM*. Univ. of Pittsburgh, Univ. of Pittsburgh.
10:00 XX13 398.07 Steady state inter-network connectivity in
Williams syndrome: An ICA-based study. T. A. THORNTON-
WELLS*; J. R. PRYWELLER; S. A. MEDA. Vanderbilt Univ.,
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ., Vanderbilt
Univ.
11:00 XX14 398.08 Electrophysiological basis of resting
state fMRI. M. A. PINSK*; Y. B. SAALMANN; L. WANG; M.
ARCARO; X. LI; S. KASTNER. Princeton Univ., Princeton
Univ.
8:00 XX15 398.09 Gender differences in brain functional
connectivity in response to high-calorie food stimulation
in obese individuals. D. ATALAYER*; L. PUMA; D.
HERNANDEZ; S. PANTAZATOS; C. OCHNER; H.
MCCOUATT; E. CONCEICAO; S. HASHIM; J. HIRSCH; A.
GELIEBTER. Columbia Univ., St. Luke’s Roosevelt Hosp.
9:00 XX16 398.10 Dynamic stability of intrinsic connectivity
networks. M. A. FERGUSON; J. A. NIELSEN; J. S.
ANDERSON*. Univ. of Utah, Univ. of Utah, Univ. of Utah.
10:00 XX17 398.11 Whole brain fcMRI lateralization. J.
NIELSEN*; J. ANDERSON; M. FERGUSON. Univ. of Utah,
Univ. of Utah, Univ. of Utah.
11:00 XX18 398.12 A nonlinear measure of fmri functional
connectivity based on resting bold event triggered
averages (rbeta). D. FRAIMAN; E. R. TAGLIAZUCCHI;
P. BALENZUELA*; M. A. MUÑOZ; P. MONTOYA; D. R.
CHIALVO. CONICET, Univ. de San Andrés, Univ. De Buenos
Aires, Brain Imaging Center, Goethe Univ., Univ. Inst. of Hlth.
Sci. Res. (IUNICS), Univ. of Balearic Islands (UIB),, Univ. of
California at Los Angeles.
8:00 XX19 398.13 Significant variation of resting state
network connectivity across the menstrual cycle of healthy
women. T. J. MEEKER; D. S. VELDHUIJZEN; M. L.
KEASER; R. P. GULLAPALLI; J. D. GREENSPAN*. Univ.
Maryland Dent. Sch., Univ. Med. Ctr. Utrecht, Univ. of
Maryland, Sch. of Med.
9:00 XX20 398.14 • Multi-layer neural network classification
of resting state networks. C. D. HACKER*; T. O. LAUMANN;
N. P. SZRAMA; M. CORBETTA; A. Z. SNYDER; E. C.
LEUTHARDT. Washington Univ. Sch. of Med., Washington
Univ. Sch. of Med., Washington Univ. Sch. of Med.,
Washington Univ. Sch. of Med.
10:00 XX21 398.15 Acute hypoxia causes memory deficits
due to activation of the inflammasome. G. S. CHIU*; D.
CHATTERJEE; D. D. MELING; R. W. JOHNSON; G.
G. FREUND. Univ. of Illinois, Urbana-Champaign, Univ.
of Illinois, Urbana-Champaign, Univ. of Illinois, Urbana-
Champaign, Univ. of Illinois, Urbana-Champaign.
11:00 XX22 398.16 Amplitude and timing of BOLD fMRI are
related to specific LFP frequency bands. U. SCHRIDDE*; C.
MAGRI; Y. MURAYAMA; S. PANZERI; N. K. LOGOTHETIS.
MPI Biol. Cybernetics, Italian Inst. of Technol., Univ. of
Manchester.
Neuroscience 2011 | Monday AM | 69
Mon. AM

8:00 XX23 398.17 Influence of skin blood flow on nearinfrared
spectroscopy signals during a verbal fluency task. T.
TAKAHASHI*; Y. TAKIKAWA; R. KAWAGOE; S. SHIBUYA;
T. IWANO; S. KITAZAWA. Juntendo Univ. Grad Sch. Med.,
Kyorin Univ. Sch. of Med., Natl. Inst. of Advanced Industrial
Sci. and Technol.
9:00 XX24 398.18 Direct measurement of BOLD signal
using multi-echo fMRI clearly separates spontaneous brain
networks from noise. P. KUNDU*; S. INATI; J. W. EVANS; W.
LUH; P. A. BANDETTINI. NIMH.
POSTER
399. Visual Perception and Imagery
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 XX25 399.01 Abstract shape encoding activates the
fusiform face area. S. D. SLOTNICK*. Boston Col.
9:00 XX26 399.02 � The face-identity aftereffect is
independent of expertise level. V. BELL; F. PESTILLI; V. P.
FERRERA*; N. QIAN. Brown Univ., Stanford Univ., Columbia
Univ., Columbia Univesity.
10:00 XX27 399.03 Dynamic changes in the spontaneous
brain activities during eye gaze perception task between the
directly facing subjects. S. IWAKI*. Natl. Inst. of Advanced
Industrial Sci. and Technol. (AIST).
11:00 XX28 399.04 Neural adaptation of faces and Chinese
characters: ERP evidence for different mechanisms. S. FU*;
C. FENG; Y. LUO. Dept. of Psychology, Tsinghua Univ.,
State Key Lab. of Cognitive Neurosci. and Learning, Beijing
Normal Univ.
8:00 XX29 399.05 Repetition antipriming: The effects of
perceptual ambiguity on object recognition. G. KIM; D. YI*.
Yonsei Univ.
9:00 XX30 399.06 Dissociating repetition priming and
adaptation-aftereffect related neural activity in the human
brain. G. KOVÁCS*; D. KAISER; C. WALTHER; S. R.
SCHWEINBERGER. Budapest Univ. Technol. and Econ.
Budapest, Univ.Regensburg, Friedrich-Schiller-University.
10:00 XX31 399.07 Frontal communications underlying
semantic processing in go/no-go conditions: A granger
causality approach. E. SHOKRI KOJORI*; M. BRIER; J. J.
HART; M. KRAUT; D. KRAWCZYK. Washington Univ. in St.
Louis, The Univesrity of Texas at Dallas, The Johns Hopkins
Hosp., The Univ. of Texas at Dallas.
11:00 XX32 399.08 The biological basis of a universal
constraint on color naming: The warm/cool categorization
of colors. Y. XIAO*; C. KAVANAU; L. BERTIN; E. KAPLAN.
Mount Sinai Sch. Med., Bennington Col.
8:00 XX33 399.09 Event related potentials are related to
affective associations on a Stroop-like task. D. W. EVANS*;
S. LAZAR; H. BATCHELDER*; D. BRETON; K. JANOSCO;
J. DAIGNEAULT; J. GERARD; S. BUONOCORE; A.
WEINSTEIN; A. FOSTER; E. PARRILLA. Bucknell Univ.
9:00 XX34 399.10 Variations of the Kanizsa illusion induce
compression and extension effects during perception and
action of eye and hand. C. J. T. JOBST; J. F. DESOUZA*.
York University, Ctr. For Vision Res., Ctr. For Vision Res.
10:00 XX35 399.11 The cogmaster: A controllable ambiguous
impossible perceived motion effect. A. E. HUANG; E. L.
ALTSCHULER*. Robert Wood Johnson Med. Sch., UMDNJ.
11:00 XX36 399.12 Different perceptual-motor processes to
achieve the same task goal?: Examination of visuomotor
performances to a target object inducing a size-illusion
effect. H. KATSUMATA*; K. IMANAKA. Daito-Bunka Univ.,
Tokyo Metropolitan Univ.
8:00 XX37 399.13 Observer generated motion parallax
elicits binocular eye movements in depth. J. R. FREY*; D. L.
RINGACH. UCLA, UCLA.
9:00 XX38 399.14 Dynamic causal modeling of
the network underlying the Müller-Lyer illusion. T.
PLEWAN*; R. WEIDNER; S. B. EICKHOFF; G. R. FINK.
Forschungszentrum Jülich, Forschungszentrum Jülich,
Rheinisch-Westfälische Technische Hochschule Aachen,
Jülich Aachen Res. Alliance, Univ. Hosp. Cologne.
10:00 XX39 399.15 Aftereffect of contrast-defined spatial
offset depends on carrier orientations. K. KOBAYASHI*; I.
MURAKAMI. Dept. of Life Sciences, Univ. of Tokyo.
11:00 XX40 399.16 Visialising cortical compensation
mechanisms using simultaneous TMS-fMRI. N. BIEN*;
R. GOEBEL; A. T. SACK. Dept. of Cognitive Neurosci. -
Maastricht Univ.
8:00 XX41 399.17 • Different perceptual load for hole and
no-hole figures in visual processing. W. ZHU; J. ZHANG;
J. CAI*; Y. MA. Sch. of Information Science, Yunnan Univ.,
Kunming Inst. of Zoology, Chinese Acad. of Sci., Xiamen
Univ., Kunming Inst. Zool.
9:00 XX42 399.18 N1, categories, color, noise -- an erp
study of perceptual categorization. S. LINNERT; D. GYőRI-
DANI; A. ROKSZIN; G. CSIFCSÁK; T. TOMPA*. Eotvos
Lorand Univ., Univ. of Szeged, Med. Univ. of South Carolina.
10:00 XX43 399.19 Characterizing visuospatial skills in
a dorsal/ventral processing framework. A. CLEMENTS-
STEPHENS*; S. MARCHETTE; A. L. SHELTON. Johns
Hopkins Univ.
11:00 XX44 399.20 Summary statistics of edge information
predict categorization of naturalistic images. I. I. GROEN*;
S. GHEBREAB; V. A. F. LAMME; H. S. SCHOLTE. Univ. of
Amsterdam, Univ. of Amsterdam.
8:00 XX45 399.21 Unconscious processing of unattended
features in human visual cortex. T. EMMANOUIL*; P.
BURTON; T. RO. The City Col. and Grad. Ctr. of the City
Univ. of New York, Univ. of Minnesota.
9:00 XX46 399.22 Non-Invasive neurostimulation on
occipital and posterior parietal regions lastingly speeds
up detection of foveally presented peri-threshold visual
stimuli in the human brain. S. ELKIN-FRANKSTON; R.
J. RUSHMORE; A. VALERO CABRE*. Lab. for Cerebral
Dynamics, Plasticity & Rehabil., Lab. Cerebral Dynamics,
Boston Univ. Sch. of Med., Univ. Pierre et Marie Curie, Open
Univ. of Catalonia (UOC).
10:00 XX47 399.23 Stronger misdirection in curved than in
straight motion. S. MARTINEZ-CONDE*; S. L. MACKNIK; R.
APOLLO; S. MARTINEZ-CONDE. Barrow Neurolog. Inst.,
Univ. of Vigo, Barrow Neurolog. Inst., Whizmob Inc.
11:00 XX48 399.24 P300 dependence on the difference
between stimulus and target. R. FRASCA*; T. BRETL. Univ.
of Illinois At Urbana-Champaign.
8:00 XX49 399.25 Evaluation of left/right perfusion
asymmetries on rCBF studies with SPECT: Probable effect
of highly lateralized dominance for spatial awareness. S.
BAMRI; J. SOUCY*. Univ. de Montréal, Montreal Neurolog.
Inst.
70 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 XX50 399.26 • Silicon large-scale models of
neocortical vision. F. BROCCARD; S. JOSHI; T. YU;
J. PARK; C. MAIER; M. ARNOLD; T. SEJNOWSKI; G.
CAUWENBERGHS*. UCSD, UCSD, Salk Inst. for Biol.
Studies.
POSTER
400. Attentional Function
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 XX51 400.01 • Electrocorticography reveals selective
response in the human intraparietal sulcus during arithmetic
processing. M. DASTJERDI*; B. L. FOSTER; J. PARVIZI.
Stnaford Univ.
9:00 XX52 400.02 Gamma “spike” density is a reliable
measure of task related changes in the gamma power. M.
ÖZKER; M. DASTJERDI; V. RANGARAJAN*; J. PARVIZI.
Stanford Univ.
10:00 XX53 400.03 Toward augmenting selective auditory
attention in a “cocktail party” using electrocorticographic
signals (ECoG) in humans. P. BRUNNER*; A. GUNDUZ; A.
L. RITACCIO; M. A. ADAMO; H. BISCHOF; G. SCHALK.
Wadsworth Ctr, NYSDOH, Albany Med. Col., Graz Univ.
of Technol., Washington Univ. Sch. of Med., Rensselaer
Polytechnic Inst., State Univ. of New York at Albany.
11:00 XX54 400.04 • Awareness of epileptic seizures during
continuous video/EEG (VEEG) monitoring. C. C. EZEANI;
K. DETYNIECKI; L. YANG; H. W. LEE; A. LIGHTEN; A.
PIERCE; P. FAROOQUE; M. C. EUGENE; J. CHAABAN; H.
HAMID; R. B. DUCKROW; H. BLUMENFELD*. Yale Univ.
Sch. of Med., Xiangya Hospital, Central South Univ., Ewha
Womans Univ. Sch. of Med., Yale Univ., Yale Univ. Sch. of
Med., Yale Univ. Sch. Med., Yale Univ. Sch. of Med.
8:00 XX55 400.05 Perceptual load affects the competition
between exogenous attention and endogenous attention:
An event-related potential study. Y. WANG*; S. FU; Y. LUO.
Inst. of Psychology CAS, Key Lab. of Mental Health, Inst.
of Psychology, Chinese Acad. of Sci., Dept. of Psychology,
Tsinghua Univ., State Key Lab. of Cognitive Neurosci. and
Learning, Beijing Normal Univ.
9:00 XX56 400.06 Bilingualism is linked to ERP measures
of inhibition. M. FERNANDEZ*; J. TARTAR; D. PADRON; A.
HARNISCH; J. PABLOS; J. ACOSTA; R. CHOCRON. Nova
Southeastern Univ.
10:00 XX57 400.07 ERP markers of attentional target
selection during free visual search with eye movements. R.
WU*; T. SMITH; S. NICHOLAS; M. EIMER. Ctr. For Brain
and Cognitive Development, Birkbeck, Univ. of London,
Birkbeck, Univ. of London.
11:00 XX58 400.08 The delineation of the temporal and
spatial linking of multisensory stimuli via the spreading of
attention. S. E. DONOHUE*; H. H. ZHANG; T. GRENT-
’T’JONG; K. C. ROBERTS; M. G. WOLDORFF. Duke Univ.,
Univ. of Utrecht.
8:00 XX59 400.09 Majority search: Involvement of
attentional functions. D. MICIC*; N. VAN DAM; M. LINN; H.
SHAH; J. FAN. Queens Col., Queens Col., Townsend Harris
High Sch., Mount Sinai Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 XX60 400.10 Caffeine content of energy drinks
enhances executive control in habitual caffeine-consumers.
G. E. GILES; R. B. KANAREK*; C. R. MAHONEY; T. T.
BRUNYÉ. Tufts Univ., Tufts Univ., U.S. Army Natick RDEC.
10:00 XX61 400.11 Emotional inhibition in young adults:
Utility of the face stop signal task (FSST). A. S. POTTER*; S.
DUBE; E. MAZZULLA. Univ. Vermont.
11:00 XX62 400.12 Transcranial direct current stimulation
influences contralateral visual target detection. J. MEDINA*;
J. C. BEAUVAIS; E. HUBER; R. OLINER; H. COSLETT; R.
H. HAMILTON. Univ. of Pennsylvania, Haverford Col.
8:00 XX63 400.13 Elucidating the role of the cerebellum
in rapid visual attention using TMS. C. P. ARASANZ*; W.
R. STAINES; T. A. SCHWEIZER. Univ. of Waterloo, St.
Michael’s Hosp., Univ. of Toronto.
9:00 XX64 400.14 Changes in attention network function
in early Parkinson’s disease. M. WOJTOWICZ; K. GOOD;
D. BALADI; D. LEWIS; L. BURNS; H. ROBERTSON; J. D.
FISK*. Dalhousie Univ.
10:00 XX65 400.15 EEG and fMRI correlates of variable
performance during typical childhood absence seizures.
J. N. GUO*; J. L. GONZALEZ; X. BAI; M. NEGISHI; N.
DANIELSON; X. HAN; E. LOFTFIELD; R. BERMAN; C.
VEGA; M. SPANN; E. NOVOTNY; R. T. CONSTABLE; H.
BLUMENFELD. Yale Univ., Yale Univ., Yale Univ., Yale Univ.,
Yale Univ.
POSTER
401. Language: Learning and Second Language
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 XX66 401.01 Language learning shapes brain
structure: A cortical thickness study of bilingual and
monolingual individuals. D. KLEIN*; K. MOK; K. WATKINS;
J. CHEN. McGill Univ., Univ. of Oxford.
9:00 XX67 401.02 Enhanced prefrontal-basal ganglia
fiber connectivity as neural substrates subserving second
language ability. C. HOSODA*; T. HANAKAWA; M. HONDA.
Natl. center of Neurol. and Psychiatry, PRESTO, JST.
10:00 XX68 401.03 The role of the right cerebellum
during foreign language vocabulary learning enhanced
by the phonological loop: an fMRI study. K. MAKITA*; H.
YOKOKAWA; H. C. TANABE; H. YOSHIDA; M. MURASE;
N. SADATO. Natl. Inst. For Physiological Sci. (NIPS), Dept.
of Physiological Sciences, Sch. of Life Sciences, The Grad.
Univ. for Advanced Studies, Hayama, Kanagawa, Japan,
Kobe Univ. Sch. of Languages and Communication, Osaka
Kyoiku University, Kashiwara, Osaka 582-8582, Japan, Dept.
of Physiological Sciences, Sch. of Life Sciences, The Grad.
Univ. for Advanced Studies, Hayama, Kanagawa, Japan,
Hayama, Japan.
11:00 XX69 401.04 Effects of second language proficiency in
late learners on neural organization for syntactic processing
indexed by ERPs and fMRI. E. PAKULAK*; M. DOW; H.
NEVILLE. Univ. of Oregon.
8:00 XX70 401.05 Neural activation changes by language
proficiency investigated with fMRI and MEG. Q. WEI*;
A. IHARA; T. SOSHI; N. FUJIMAKI; T. HAYAKAWA; H.
UMEHARA. NICT, Teikyo Univ.
Neuroscience 2011 | Monday AM | 71
Mon. AM

9:00 XX71 401.06 An ERP study to examine the influences
of native language in the processing of English noun and
verb phrases in Mandarin-English and Spanish-English
bilinguals. V. JEEVAKUMAR*; D. OGIELA; M. MAGUIRE.
Univ. of Texas At Dallas.
10:00 XX72 401.07 Learning to read a new language shapes
the neural activities associated with reading in the native
language. L. MEI*; G. XUE; Z. LU; Q. DONG; C. CHEN.
Dept. of Psychology and Social Behavior, Univ. of California,
Irvine, Beijing Normal Univ., USC.
11:00 XX73 401.08 Dual language exposure in infancy can
change neural and language processing in the developing
brain an fnirs investigation. L. PETITTO*; K. K. JASINSKA.
Univ. of Toronto.
8:00 XX74 401.09 Sensorimotor plasticity when learning
to produce non-native speech. A. J. SIMMONDS*; R. J. S.
WISE; P. IVERSON; R. LEECH. Imperial Col. London, MRC
Clin. Sci. Ctr., Univ. Col. London, Imperial Col.
9:00 XX75 401.10 • Brief reading experience induced
neurocognitive plasticity in verb bias learning. Z. QI*; S. M.
GARNSEY. Univ. of Illinois, Urbana-Champaign, Univ. of
Illinois, Urbana-Champaign.
10:00 XX76 401.11 The process of learning novel linguistic
constructions revealed by functional neuroimaging. M. A.
JOHNSON*; N. B. TURK-BROWNE; A. E. GOLDBERG.
Princeton Univ.
11:00 XX77 401.12 Neural mechanisms supporting
implicit versus explicit acquisition of grammar in adults. L.
BATTERINK*; H. NEVILLE. Univ. of Oregon.
8:00 XX78 401.13 Associative vocabulary learning:
Development of two paradigms for language (re)-acquisition
of novel action- and object related words. N. FREUNDLIEB*;
V. RIDDER; G. LIUZZI; C. DOBEL; S. ENRIQUEZ-
GEPPERT; A. BAUMGÄRTNER; P. ZWITZERLOOD; C.
GERLOFF; F. HUMMEL. UKE, Psychological Inst. II, Univ. of
Applied Sci. Fresenius.
9:00 XX79 401.14 Enhancing natural language learning in
healthy adults with transcranial direct current stimulation. S.
B. MESSING*; R. H. HAMILTON. Univ. of Pennsylvania.
10:00 XX80 401.15 Dissociating contextual facilitation
mechanisms with multimodal neuroimaging. E. F. LAU*; S.
BURNS; N. DELANEY-BUSCH; K. FANUCCI; E. FIELDS;
A. GRAMFORT; P. HOLCOMB; M. HAMALAINEN; G.
KUPERBERG. Massachusetts Gen. Hosp., Tufts Univ.
11:00 XX81 401.16 � Learned regulation of left supramarginal
gyrus activity: Effects on language skills. A. CARIA*; S. KIM;
S. DE FALCO; M. REA; R. SITARAM; N. BIRBAUMER. Univ.
of Tübingen, Univ. of Trento.
8:00 XX82 401.17 • The involvement of the left motor
cortex in learning of a novel action word lexicon. G. LIUZZI*;
N. FREUNDLIEB; V. RIDDER; J. HOPPE; K. HEISE; M.
ZIMERMAN; C. DOBEL; S. ENRIQUEZ-GEPPERT; C.
GERLOFF; P. PIENIE ZWITSERLOOD; F. HUMMEL. Univ.
Hosp Hamburg, Dept of Neurol., Univ. of Münster, Univ. of
Münster.
9:00 XX83 401.18 Did Flash Memory, a non-linguistic
symbolic stream, play a role in the emergence of language?
D. M. O’MALLEY*. Northeastern Univ.
POSTER
402. Emotion: Disorders and Dysfunctions
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 XX84 402.01 Pseudoseizures, trauma, and
neurological dysfunction: A focus on amygdala activity using
fMRI. K. E. REDWINE*; P. B. WILLIAMS; M. L. SPEZIO;
A. CIOVICA; B. A. HOLSHOUSER; L. D. UBER-ZAK; E. T.
TERRIS; P. J. ZAK. Whittier Col., Claremont Grad. Univ.,
Scripps Col., Loma Linda Univ. Med. Ctr., Loma Linda Univ.
Med. Ctr., Loma Linda Univ. Med. Ctr., Claremont Grad.
Univ.
9:00 XX85 402.02 Socio-emotional dysfunction and its
relationship with neural correlates of emotional processing in
children and adolescents with fragile X syndrome. S. KIM*; J.
BURRIS; F. BASSAL; F. TASSONE; D. HESSL; S. RIVERA.
Univ. of California-Davis, Univ. of California-Davis, Univeirsity
of California-Davis, Univ. of California-Davis.
10:00 XX86 402.03 � Differential response to emotional
valence and animacy among youth with Conduct Disorder
and Callous-Unemotional traits. C. J. ADALIO*; S. WHITE; J.
BLAIR. NIMH.
11:00 XX87 402.04 Is pathological disgust a hallmark of
obsessive-compulsive disorder? Evidence from facial
electromyography. A. E. WHITTON*; J. D. HENRY; J. R.
GRISHAM; P. G. RENDELL. Univ. of New South Wales,
Univ. of Queensland, Australian Catholic Univ.
8:00 XX88 402.05 The neural basis of implicit affective
biases: The effects of induced anxiety. O. J. ROBINSON*;
K. VYTAL; D. CHARNEY; C. OVERSTREET; C. GRILLON.
NIMH.
9:00 XX89 402.06 Emotionally enhanced attention is
preserved in patients with unilateral amygdala damage. M.
MCHUGO*; S. DUKIC; R. PIECH; S. SMITH; B. ABOU-
KHALIL; D. ZALD. Vanderbilt Univ., Vanderbilt Univ., Trinity
Col., Univ. of Winnipeg, Vanderbilt Univ.
10:00 XX90 402.07 Heightened disgust in anorexia nervosa.
K. K. WATSON*; M. L. PLATT; N. L. ZUCKER. Duke Univ.,
Duke Univ. Med. Ctr., Duke Univ. Med. Ctr.
11:00 XX91 402.08 Impoverished prefrontal control of
attention in trait anxiety: The case of sustained attention.
S. FORSTER; A. O. NUNEZ-ELIZALDE; E. CASTLE; S. J.
BISHOP*. UC Berkeley Dept Psychology.
8:00 XX92 402.09 Specificity of the ‘stop’ signal deficiency
in OCD. A. HINDS*; E. Z. WOODY; L. A. SCHMIDT; M. VAN
AMERINGEN; H. SZECHTMAN. McMaster Univ., Univ. of
Waterloo, McMaster Univ.
9:00 YY1 402.10 Anxiety leads to distinct cognitive
disruptions during a spatial n-back task. A. LETKIEWICZ*; N.
ARKIN; K. VYTAL; C. GRILLON. NIH.
10:00 YY2 402.11 • � Emotional processing and
depression symptoms in children: An ERP study. E.
RAMIREZ*; K. MONDE; B. SOLOMON; T. DENNIS. Hunter
Col., Hunter Col.
11:00 YY3 402.12 Alexithymic trait and response inhibition.
E. C. BALEVICH*; M. LENN; N. T. VAN DAM; D. MICIC; J.
FAN. Queens College, City Univ. of New York, Mount Sinai
Sch. of Med., Mount Sinai Sch. of Med.
72 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

8:00 YY4 402.13 • Between-gender cortical thickness
differences in the anterior cingulate cortex. J. B. KING; M.
P. LOPEZ-LARSON; D. A. YURGELUN-TODD*. The Brain
Institute, Univ. of Utah, Univ. of Utah, Dept. of Veteran Affairs
MIRECC VISN 19.
POSTER
403. Decision Making and Cognition: Neural Substrates
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 YY5 403.01 • A way around uncertainty in high-risk
conditions: Use of the PASS option. Y. JUNG*; E. MULLER-
OEHRING; T. SCHULTE; N. M. ZAHR; E. V. SULLIVAN; A.
PFEFFERBAUM. Stanford Univ. Sch. of Med., Yonsei Univ.
Col. of Med., SRI Intl.
9:00 YY6 403.02 Neural correlates of model-based and
model-free learning in a dynamic decision-making task. D.
WORTHY*; M. A. GORLICK; J. MUMFORD; A. BAKKOUR;
R. A. POLDRACK; W. MADDOX. Texas A&M Univ., Univ. of
Texas at Austin.
10:00 YY7 403.03 � A neural mechanism for enhancement
of rapid decisions. Z. LORSCH*; J. HIRSCH. Cornell Univ.,
Columbia Univ.
11:00 YY8 403.04 How women choose across the
menstrual cycle. S. C. LAZZARO*; R. B. RUTLEDGE; D. R.
BURGHART; P. W. GLIMCHER. New York Univ.
8:00 YY9 403.05 Evaluative neural mechanisms and delay
of gratification. J. T. MCGUIRE*; J. W. KABLE. Univ. of
Pennsylvania.
9:00 YY10 403.06 Decoding of covert responses to selfrelated
questions using single-trial electroencephalogram. J.
CHOI*; J. LEE; K. KIM. Yonsei Univ.
10:00 YY11 403.07 The amygdala’s role in representing
motivational relevance and response uncertainty. A.
SHENHAV*; M. BAR; W. B. MENDES; L. F. BARRETT.
Harvard Univ., MGH Martinos Ctr. for Biomed. Imaging,
Harvard Med. Sch., Univ. of California, San Francisco,
Northeastern Univ.
11:00 YY12 403.08 Dissociating neural correlates of forward
planning from model-free choices. K. WUNDERLICH*; P.
DAYAN; R. DOLAN. UCL.
8:00 YY13 403.09 Salience is not always salient: Neither
magnitude nor valence of expected outcome contributes to
the N2/P3 event-related potential complex in a modified Go/
NoGo task. M. D. LOOSE*; S. ARONSON; H. SCOTT; T.
MEHTA; A. WANG; A. AMLIE-WOLF; K. M. WELCH. Oberlin
Col.
9:00 YY14 403.10 Trait impulsivity and cognitive control: an
fMRI study of the stop signal task. O. M. HENDRICK*; S.
HU; C. R. LI. Yale Univ., Yale Univ.
10:00 YY15 403.11 The neural correlates of intention and
action selection in voluntary task switching. E. POLJAC*; N.
YEUNG. Univ. of Oxford.
11:00 YY16 403.12 Neural correlates of cognitive control in
the stop signal task: Application of an accumulator model. S.
HU*; Y. TSENG; A. WINKLER; C. R. LI. Yale Univ., Smith-
Kettlewell Eye Res. Inst.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
8:00 YY17 403.13 Myopia for the future or a positivity bias?
Performance of older adults on two versions of the Iowa
Gambling Task. A. S. BAUER; J. TIMPE; E. EDMONDS; A.
BECHARA; D. TRANEL; N. L. DENBURG*. Univ. of Iowa
Carver Col. of Med., Rush Presbyterian, USC, Univ. Iowa
Col. Med.
9:00 YY18 403.14 Individual variation in value-responsive
cortical topography. N. SENECAL*; J. MCGUIRE; J. KABLE.
Univ. of Pennsylvania.
10:00 YY19 403.15 Decision making, working memory and
executive functions in schizophrenia and bipolar disorder. M.
JARACZ*; A. BORKOWSKA. Clin. Neuropsychology Unit,
Nicolaus Coparnicus University, Torun.
11:00 YY20 403.16 Sleep deprivation increases delay
discounting by altering cognitive control signals. C.
LIBEDINSKY*; A. LING; W. CHEE; M. W. L. CHEE. Duke-
NUS Grad. Med. Sch.
8:00 YY21 403.17 Biased competition for action in human
primary motor cortex during value-based decision making.
M. C. KLEIN-FLÜGGE*; S. BESTMANN. Sobell Dept. of
Motor Neurosci. and Movement Disorders.
9:00 YY22 403.18 Making an effort to win or avoid losing:
Activity in ACC and dorsal striatum when anticipating high
effort. I. T. KURNIAWAN*; M. GUITART-MASIP; P. DAYAN;
R. J. DOLAN. Univ. Col. London, Univ. Col. London, Univ.
Col. London, Univ. Col. London.
10:00 YY23 403.19 Persistency of priors-induced bias in
decision behavior and the fMRI signal. K. A. HANSEN*;
S. F. HILLENBRAND; L. G. UNGERLEIDER. NIH, Univ. of
California.
11:00 YY24 403.20 Bayesian predictions and evaluation in
the anterior cingulate cortex. J. S. IDE*; P. SHENOY; A. YU;
C. R. LI. Univ. Federal de São Paulo (UNIFESP), Univ. of
California at San Diego, Yale Univ.
8:00 YY25 403.21 Activation differences during a rewarded
antisaccade task in abstinent adult smokers and nonsmokers.
C. GEIER*; M. SWEITZER; R. DENLINGER; G.
SPARACINO; E. DONNY. Pennsylvania State Univ., Univ. of
Pittsburgh.
9:00 YY26 403.22 Deterioration of frontal lobe function in
idiopathic normal pressure hydrocephalus. M. KANAI*; S.
SATO; M. OTSUKA; K. ISHIGURO; N. SASAGUCHI. NHO
Takasaki Gen. Med. Ctr.
10:00 YY27 403.23 Convergent evidence of orbitofrontal
cortex grey and white matter dysfunction in adaptive
behavior failure in neurodegenerative diseases. M.
HORNBERGER*; J. GENG; J. R. HODGES. Neurosci. Res.
Australia.
POSTER
404. Executive Function: Learning and Memory
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 YY28 404.01 Consolidation, robustness, and decay
of visual working memory in the macaque monkey. M.
OEMISCH*; E. HEYSELAAR; K. JOHNSTON; M. PARÉ.
Queen’s Univ.
Neuroscience 2011 | Monday AM | 73
Mon. AM

9:00 YY29 404.02 Memory decay in a multiple-item
discrimination task. V. YAKOVLEV*; S. HOCHSTEIN. Life
Sci. Hebrew Univ., Lily Safra Brain Res. Center, Hebrew
Univ.
10:00 YY30 404.03 Fronto-parietal local field potentials
synchronization: Memory maintenance or event-related
expectancy? R. F. SALAZAR*; N. M. DOTSON; C. M. GRAY.
Montana State Univ., Montana State Univ.
11:00 YY31 404.04 Prefrontal neural correlates of cognitive
capacity limitation and its adaptive allocation revealed by a
dual-task paradigm. K. WATANABE*; S. FUNAHASHI. Kyoto
Univ., Kokoro Res. Ctr.
8:00 YY32 404.05 Detrimental effects of the NMDA
antagonist ketamine on visual working memory in the
macaque monkey. E. HEYSELAAR*; K. JOHNSTON; M.
PARÉ. Queen’s Univ., Queen’s Univ.
9:00 YY33 404.06 Neural activity of mushroom body
extrinsic neurons in honeybees walking in a virtual
environment. N. DE CAMP*; S. HANTKE; R. MENZEL. FU
Berlin.
10:00 YY34 404.07 Modeling serial list learning in macaques:
Extending ACQ. B. GASSER*; M. ARBIB. USC, USC.
11:00 YY35 404.08 Fronto-striatal dopamine, d2 receptors
and behavioural flexibility. H. CLARKE*; R. RYGULA; S.
SAWIAK; T. FRYER; G. COCKCROFT; V. FERRARI; F.
AIGBIRHIO; T. W. ROBBINS; A. C. ROBERTS. Univ. of
Cambridge, Univ. of Cambridge, Univ. of Cambridge, Univ. of
Cambridge, Univ. of Cambridge.
8:00 YY36 404.09 Patterns of errors in oculomotor delayedresponse
tasks: A window into working memory role in action
selection. O. HARISH; K. MOCHIZUKI; G. MONGILLO*; D.
HANSEL; S. FUNAHASHI. Neurophysics and Physiol. UMR
8119 CNRS - Paris Descartes Univ., Kokoro Res. Center,
Kyoto Univ.
9:00 YY37 404.10 Chemical and genetic modulation of
memory formation in larval zebrafish. M. A. WOLMAN*; R.
JAIN; L. A. SCHMIDT; L. E. LISS; M. GRANATO. Univ. of
Pennsylvania.
10:00 YY38 404.11 Neural correlates of explicit memory
in the macaque lateral prefrontal cortex. A. TANAKA*; S.
FUNAHASHI. Kyoto Univ., Kyoto Univ.
11:00 YY39 404.12 Mesencephalic afferents to the
hippocampal formation: An anterograde tracing study in
the macaca fascicularis monkey. D. H. MOMBIELA*; M.
MUÑOZ; M. ARROYO-JIMENEZ; E. ARTACHO-PÉRULA; P.
MARCOS; E. LEGIDOS-GARCIA; M. UBERO; J. FUENTES;
M. LAGARTOS; A. GALVEZ; S. CEBADA; M. IÑIGUEZ
DE ONZOÑO; M. RAMOS; A. MOHEDANO-MORIANO;
R. INSAUSTI. Sch. of Medicine.University of Castilla La
Mancha.
8:00 YY40 404.13 Subcortical efferents of the entorhinal
cortex in the fascicularis monkey: I. Basal prosencephalon.
M. UBERO MARTÍNEZ*; A. MOHEDANO-MORIANO; M.
ARROYO-JIMENEZ; M. LEGIDOS-GARCIA; M. MUÑOZ; D.
HERNANDEZ-MOMBIELA; P. PRO-SISTIAGA; P. MARCOS;
E. ARTACHO-PÉRULA; J. GONZALEZ-FUENTES; M.
LAGARTOS-DONATE; S. CEBADA-SANCHEZ; C. RUIZ-
LÓPEZ; M. RAMOS-HERRERA; M. IÑIGUEZ DE ONZOÑO;
A. GÁLVEZ; R. INSAUSTI. Univ. of Castilla-La Mancha.
9:00 YY41 404.14 Functional role of lateral intra-Parietal
area (LIP) in numerosity discrimination. J. PENG*; N.
DEWIND; E. M. BRANNON; M. L. PLATT. Duke Univ.
10:00 YY42 404.15 Repetition priming effects in monkey
cortex: An fMRI study. A. KURNIKOVA*; D. B. T. MCMAHON;
C. ZHU; H. MERKLE; F. YE; D. A. LEOPOLD. Natl. Inst.
of Mental Hlth., Natl. Inst. of Mental Hlth., Natl. Inst. of
Neurolog. Disorders and Stroke.
11:00 YY43 404.16 Attractor biases in spatial working
memory. A. FERDOASH*; C. PAPADIMITRIOU; L. SNYDER.
Washington Univ. In St. Louis, Washington Univ. In St. Louis.
8:00 YY44 404.17 Event-specific enhancement of long-term
object recognition memory via brief electrical stimulation to
the amygdala in rats. D. I. BASS*; K. N. PARTAIN; A. WANG;
J. R. MANNS. Emory Univ., Emory Univ., Emory Univ.
9:00 YY45 404.18 Reduced mastication accelerates
impairment of thehippocampal-dependent spatial learning
ability of SAMP8 mice. M. KAWAHATA*; Y. ONO; A. OHNO;
S. KAWAMOTO; K. KIMOTO; M. ONOZUKA. Kanagawa
Dent. Col., Meiji Univ., Kanagawa Dent. Col.
10:00 YY46 404.19 • An identified circuit in rat postrhinal
cortex encodes some essential information for performing
specific visual shape discriminations, and, during learning,
identified neurons within the circuit contain activated CaMKII,
MAP kinase, and CREB. G. ZHANG; H. CAO; H. ZHAO; L.
KONG; J. O’BRIEN; A. BAUGHNS; M. JAN; E. CHOI; M.
SVESTKA; X. WANG; X. LU; R. G. COOK; A. I. GELLER*.
Harvard Med. Sch., Tufts Univ.
11:00 YY47 404.20 � A four stage reversal learning paradigm:
A new pre-clinical task to compare the efficacy of novel
cognitive enhancers. N. F. IDRIS*; B. GRAYSON; M. K.
HARTE; S. L. MCLEAN; J. C. NEILL. Univ. Bradford.
8:00 YY48 404.21 Episodic-like memory for what-wherewhich
occasion is selectively impaired in the 3xTgAD mouse
model of Alzheimer’s disease. M. J. EACOTT*; K. E. DAVIS;
A. EASTON; J. GIGG. Univ. of Durham, Univ. of Manchester.
9:00 YY49 404.22 Neural patterns in CA1 and CA3 regions
of the hippocampus reflecting specific spatial and nonspatial
features during an object recognition memory task. R. A.
STEFANESCU; J. B. TRIMPER; J. R. MANNS*. Emory
Univ., Emory Univ.
10:00 YY50 404.23 Evidence from capacity limitations
for a dual-model of working memory. J. M. ROSE*; T. J.
BUSCHMAN; V. R. YORGAN; E. K. MILLER. MIT, MIT,
Brown Univ.
POSTER
405. Executive Function: Decision Making II
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 YY51 405.01 Examining the contributions of rodent
medial prefrontal cortex to rapid behavioral adaptation. D. G.
TERVO*; A. VOLLMER; R. BEHNAM; A. KARPOVA. Janelia
Farm Res. Campus.
9:00 YY52 405.02 Commingling of spatial, reward, and
consummatory activity in medial prefrontal cortex. N.
K. HORST*; M. S. CAETANO; M. LAUBACH. Univ. of
Cambridge, Yale Univ. Sch. of Med., John B. Pierce Lab.
74 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

10:00 YY53 405.03 • Lost in transition: Aging-related
changes in executive control by the medial prefrontal
cortex. M. S. CAETANO*; N. K. HORST; K. A. BORDNER;
L. HARENBERG; B. LIU; A. A. SIMEN; A. F. T. ARNSTEN;
M. LAUBACH. The John B. Pierce Lab., Yale Univ. Sch. of
Med., Univ. of Cambridge, Yale Col.
11:00 YY54 405.04 Devaluation of a reinforcer is differentially
processed by discrete subregions of orbital prefrontal
cortex in rhesus monkeys. E. HOWLAND; J. TURCHI; E. A.
MURRAY*. NIH, NIMH.
8:00 YY55 405.05 Dorsal premotor cortex is involved
in switching motor plans. A. PASTOR-BERNIER*; E.
TREMBLAY; P. CISEK. Univ. Montreal.
9:00 YY56 405.06 Reaching for the larger or smaller of two
rewards: How prefrontal cortex and limbic structures underlie
conventional and unconventional task performance. E. R.
XU*; J. D. KRALIK. Dartmouth Col.
10:00 YY57 405.07 The effect of dopamine D1 antagonists
on the development of adaptive decision strategies
during biased decision-making in macaque monkeys. T.
TEICHERT*; V. P. FERRERA. Columbia Univ.
11:00 YY58 405.08 Neuroeconomic studies of decision
making in Drosophila: The rational larva. S. M.
CONSTANTINO*; M. CAVEY; J. BLAU; P. GLIMCHER. New
York Univ., New York Univ., New York Univ.
8:00 YY59 405.09 Amygdala lesions differentially alter
reward encoding in macaque orbital and medial prefrontal
cortex. P. H. RUDEBECK*; A. R. MITZ; R. V. CHACKO; E. A.
MURRAY. Natl. Inst. of Mental Hlth.
9:00 YY60 405.10 Do amygdala lesions in macaques
alter behavioral and emotional responses to expected
reward quantity? R. C. CHACKO; J. W. KAKAREKA; P. H.
RUDEBECK; A. R. MITZ*; R. H. PURSLEY; T. J. POHIDA;
E. A. MURRAY. Natl. Institue of Mental Health, Natl. Inst. of
Hlth., Ctr. for Information Technology, Natl. Inst. of Hlth., NIH.
10:00 YY61 405.11 Orbitofrontal neurons respond to
naturalistic social videos in rhesus macaques. G. K.
ADAMS*; M. L. PLATT. Duke Univ.
11:00 YY62 405.12 Spatio-temporal patterns in the frontoparietal
network encode stimulus information during working
memory. N. M. DOTSON*; R. F. SALAZAR; C. M. GRAY.
Montana State Univ.
8:00 YY63 405.13 Effects of reward and FEF
microstimulation on choice and visually guided saccades
during a free-choice task. B. E. BURROWS*; A. SOLTANI; R.
J. SCHAFER; C. KOCH; T. MOORE. Stanford Univ. Sch. of
Med., Caltech, Virginia Tech. Carilion Res. Inst., McGovern
Institute, MIT, Howard Hughes Med. Inst.
9:00 YY64 405.14 Behavioral control in the primate brain: A
four-level model. J. D. KRALIK*; D. SHI; O. A. EL-SHROA.
Dartmouth Col.
10:00 YY65 405.15 � A quantitative analysis of discounting in
the patch model. E. MAZIOL*; J. RICHARDS; M. KAUSCH;
A. GANCARZ; M. ROEBEL; L. BEYLEY. Res. Inst. On
Addictions.
11:00 YY66 405.16 • Probabilistic decision making in aged
F344 rats. R. J. GILBERT*; M. MITCHELL; N. SIMON; C.
BANUELOS; S. BEAS; B. SETLOW; J. BIZON. The Univ. of
Florida Col. of Med., The Univ. of Pittsburgh.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
8:00 YY67 405.17 • Alterations in resting-state network
activity following complete commissurotomy in macaque
monkeys. P. L. CROXSON*; J. X. O’REILLY; J. SALLET; M.
P. NOONAN; R. B. MARS; P. G. BROWNING; K. L. MILLER;
M. F. RUSHWORTH; M. G. BAXTER. Mount Sinai Sch. of
Med., Univ. of Oxford, Univ. of Oxford.
9:00 YY68 405.18 Rule-based task switching in the anterior
cingulate and prefrontal cortex. E. L. DENOVELLIS*; T.
J. BUSCHMAN; C. DIOGO; D. BULLOCK; E. K. MILLER.
Boston Univ., Ctr. of Excellence for Learning in Education,
Sci. and Technol., MIT, The Picower Inst. for Learning and
Memory.
10:00 YY69 405.19 Effect of fictive reward on rat’s choice
behavior. K. KIM; N. HUH; M. W. JUNG*. Ajou Univ. Sch. of
Med.
POSTER
406. Timing and Temporal Processing I
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 YY70 406.01 WITHDRAWN
9:00 YY71 406.02 Sequence recall in neuronal ensemble in
primary visual cortex. S. XU*; W. JIANG; Y. DAN; M. POO.
Inst. of Neurosci., Helen Wills Inst. of Neurosci., Howard
Hughes Med. Inst.
10:00 YY72 406.03 Theoretical investigation of scalar
property in a striatal-beat frequency model of interval timing.
S. OPRISAN*; C. V. BUHUSI. Col. of Charleston, Med. Univ.
of South Carolina.
11:00 YY73 406.04 Coordinated multineuron activities related
to externally- and internally-initiated movements in rat motor
cortex. R. KIMURA*; Y. SAKAI; A. SAIKI; Y. FUJIWARA-
TSUKAMOTO; Y. ISOMURA. Brain Sci. Institute, Tamagawa
Univ.
8:00 YY74 406.05 Effect of NMDA receptor antagonist MK-
801 on memory formation for duration in rats. T. HATA*;
S. ISHINO; S. YANAI; H. OKAICHI. Doshisha Univ., Kyoto
Univ., Tokyo Metropolitan Geriatric Hosp. and Inst. of
Gerontology.
9:00 YY75 406.06 Development and maintenance of
multidimensional representations of task phases in the
lateral prefrontal cortex of macaques. Y. SAGA; M. IBA; J.
TANJI; E. HOSHI*. Tamagawa Univ. Brain Sci. Inst., Tokyo
Metropolitan Inst. of Med. Sci., Univ. of Pennsylvania,
Tohoku Univ. Brain Sci. Ctr.
10:00 YY76 406.07 Is time interval encoded in odor fear
conditioning? A. MOULY*; K. SHIONOYA; J. BOULANGER-
BERTOLUS; J. AHERS; E. LONDEN; C. HEGOBURU;
T. SULLIVAN-WILSON; B. L. BROWN; V. DOYÈRE; R.
M. SULLIVAN. Ctr. de Recherche en Neurosci. De Lyon,
Emotional Brain Institute, Nathan Kline Institute,, Child &
Adolescent Psychiatry, New York Univ. Sch. of Med., Queens
Col., Neurobio. of Executive Function.
11:00 YY77 406.08 Discrete network states encode
behaviorally relevant information. T. VLADUSICH*; P.
MILLER; B. F. SADACCA; D. B. KATZ. Brandeis Univ.,
Brandeis Univ.
8:00 YY78 406.09 Accuracy of interval timing in monkeys
during a concurrent fixed interval task. M. R. KLEINMAN*; D.
LEE. Yale Univ. Sch. of Med.
Neuroscience 2011 | Monday AM | 75
Mon. AM

9:00 YY79 406.10 An adaptive drift-diffusion model of
interval timing in non-stationary environments. F. RIVEST*;
A. LUZARDO; E. A. LUDVIG. Royal Military Col. of Canada,
Univ. of São Paulo, Princeton Univ.
10:00 YY80 406.11 Area-specific differences in corticofugal
axon diameters and processing speed. S. TOMASI*; R.
CAMINITI; G. M. INNOCENTI. Neurosci. Inst. Cavalieri
Ottolenghi (NICO), Univ. of Turin, Univ. of Rome “La
Sapienza”, Karolinska Institutet.
11:00 YY81 406.12 Interval bisection in streptozotocininduced
diabetic rats. V. ORDUÑA*; E. HONG; A. BOUZAS.
Universidad Nacional Autonoma De Mexico, Cinvestav, Sede
Sur,.
8:00 YY82 406.13 Emotional modulation of time perception
is altered in transgenic animals for Huntington Disease.
A. FAURE; B. L. BROWN; P. LE BLANC; H. NGUYEN; O.
RIESS; S. VON HÖRSTEN; N. EL MASSIOUI; V. DOYERE*.
CNRS-UMR 8195 CNPS, Univ. Paris-Sud, Ctr. de
Neurosciences Paris-Sud, UMR 8195, Dept of Psychology,
Queens Col., Dept. of Med. Genetics, Univ. of Tuebingen,
Exptl. Therapy, Franz Penzoldt Center, Friedrich-Alexander
Univ.
9:00 YY83 406.14 Mesocortical projections and interval
timing. N. S. NARAYANAN*; B. B. LAND; K. DEISSEROTH;
R. J. DILEONE. Yale Univ. Sch. Med., Yale Univ. Sch. Med.,
Stanford Univ.
10:00 YY84 406.15 Dynamic resting-state correlations
in anesthetized macaques. R. HUTCHISON*; T.
WOMELSDORF; J. GATI; R. MENON; S. EVERLING. Univ.
Western Ontario, Univ. of Western Ontario.
11:00 YY85 406.16 Comparison of prefrontal cortex activity in
spatial and temporal discrimination tasks. A. GENOVESIO*;
S. TSUJIMOTO; S. P. WISE. Sapienza Univ., Kobe Univ.,
Olschefskie Inst. for the Neurobio. of Knowledge.
8:00 YY86 406.17 Interval learning in cortical networks in
vitro. A. GOEL*; D. V. BUONOMANO. UCLA.
9:00 YY87 406.18 Cortical and striatal activity during
acquisition of a timed response in behaving rats. J. E.
SWEARINGEN*; M. REYES; C. V. BUHUSI. Med. Univ. of
South Carolina.
10:00 YY88 406.19 Neurophysiological correlates of time
encoding in the amygdalo-prefronto-striatal network. J.
KNIPPENBERG*; M. GRAUPNER; L. DIAZ-MATAIX; J. E.
LEDOUX; V. DOYERE. Ctr. De Neurosciences Paris-Sud,
Cnrs-Umr8195, Univ. Paris-Sud, Ctr. for Neural Science,
New York Univ., Emotional Brain Institute, Nathan S. Kline
Inst. for Psychiatry Res.
POSTER
407. Learning and Memory Systems I
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 YY89 407.01 Theta modulation in postrhinal cortex
during performance on a visual discrimination task. R. D.
BURWELL*; O. J. AHMED; S. C. FURTAK. Brown Univ.
9:00 YY90 407.02 A novel Go/NoGo task to assess
neuronal correlates of visual recognition, short term memory
and decision making in the rat. J. W. HO*; G. T. NESKE; R.
D. BURWELL. Brown Univ., Brown Univ.
10:00 YY91 407.03 Neuronal correlates in the posterior
parietal cortex during performance on a visuospatial
attention task. F. YANG*; R. D. BURWELL. Brown Univ.
11:00 YY92 407.04 The medial prefrontal cortex is critically
involved in modulating memory retrieval: A paradoxical
improvement in performance following prefrontal inactivation.
G. J. PETERS*; D. M. SMITH. Cornell Univ.
8:00 ZZ1 407.05 The role of the hippocampus in selective
memory retrieval: Evidence from a rodent model of retrievalinduced
forgetting. D. M. SMITH*; G. F. EPSTEIN; G. J.
PETERS. Cornell Univ.
9:00 ZZ2 407.06 Switching from learning behavior to
thigmotaxis in water maze by in vivo delivery of antibody
against AMPA receptor GluR1 C-terminus into hippocampal
CA1 neurons via HVJ-E vector. M. SAJI*; D. SHIMIZU; Y.
OKUMURA; M. SAKAMOTO; M. OGATA; K. NODA; H.
AKITA. Kitasato Univ, Sch. Hlth. Sci., Kitasato University,
Grad. Sch. of Med. Sci.
10:00 ZZ3 407.07 Motor, learning and memory impairments
in adult asphyctic rats. P. GALEANO; E. BLANCO CALVO;
J. I. ROMERO; G. E. SARACENO; M. L. AON BERTOLINO;
L. CUENYA; G. V. KAMENETZKY; A. E. MUSTACA; F.
RODRÍGUEZ DE FONSECA; J. MILEI; F. CAPANI*. Inst. Inv.
Cardiológicas Prof. Dr. Alberto C. Taquini, UBA-CONICET,
Lab. de Medicina Regenerativa, Hosp. Carlos Haya,
Fundación IMABIS, Lab. de Psicología Exp. y Aplicada
(PSEA), Inst. de Investigaciones Médicas (IDIM), UBA-
CONICET.
11:00 ZZ4 407.08 Stress induced facilitation of touchscreen
based reversal learning: Modulation by prefrontal BDNF. C.
GRAYBEAL*; A. PLITT; L. M. SAKSIDA; T. J. BUSSEY; A.
HOLMES. Natl. Inst. on Alcohol Abuse and Alcoholism, NIH,
Univ. of Cambridge.
8:00 ZZ5 407.09 The role of α5-subunit containing GABAA
receptors in hippocampal subregions in memory processes.
E. ENGIN*; M. SIGAL; R. KEIST; A. ZELLER; U. RUDOLPH.
Harvard Med. Sch., Inst. of Pharmacol. and Toxicology, Univ.
of Zurich.
9:00 ZZ6 407.10 Hub molecule p75NTR manipulates
homeostatic function linked with recognition memory in
the basal forebrain-prefrontal system. F. YANG*; F. MEI;
G. CARR; F. PAPALEO; C. MCBAIN; D. WEINBERGER;
B. LU. Natl. Inst. of Mental Hlth., Natl. Inst. of Child
Hlth. and Human Develop., The Italian Inst. of Technol.,
GlaxoSmithKline.
10:00 ZZ7 407.11 Object/context specific memory deficits
following medial frontal cortex damage in mice. S. C.
SPANSWICK*; R. H. DYCK. Univ. of Calgary.
11:00 ZZ8 407.12 Voluntary running enhances saturated
free acid metabolism that is essential for spatial learning and
memory: A neurolipidomics approach. N. E. CHORNA*; N.
MONTANO; A. PEREZ; I. J. SANTOS; A. VÀZQUEZ; A. P.
CHORNYY; N. CARBALLEIRA; S. PEÑA DE ORTIZ. Univ.
Puerto Rico, Rio Piedras Campus, Univ. of Puerto Rico, Rio
Piedras Campus, Univ. of Puerto Rico, Rio Piedras Campus,
Univ. of Puerto Rico, Rio Piedras Campus.
8:00 ZZ9 407.13 Early adolescent exposure to high-fat
diets induces spatial learning and memory deficits and
changes in hippocampal spine density. I. VALLADOLID-
ACEBES; A. FOLE; L. MORALES; N. DEL OLMO; M. RUIZ-
GAYO*. Univ. San Pablo - Sch. of Pharm., Univ. San Pablo
- Sch. of Pharm.
9:00 ZZ10 407.14 Cognition in diabetic rats with
pharmacological effects. S. KITO*; A. S. SHINGO. Seisho
Hosp., Okinaka Mem. Inst. for Med. Res.
76 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

10:00 ZZ11 407.15 � FVB mice show learning in tasks with
non-visual cues. S. J. FARLEY*; B. M. MCKAY; C. WEISS; J.
F. DISTERHOFT. Northwestern Univ. Feinberg Sch. of Med.
11:00 ZZ12 407.16 • Emergence of memory consolidation
deficits in middle age is associated with decreased NMDA
receptor synaptic responses at CA3-CA1 hippocampal
synapses. A. KUMAR*; A. RANI; M. GUIDI; T. C. FOSTER.
Univ. Florida.
8:00 ZZ13 407.17 Biomarkers of age-related memory
syndrome: Differentiating between learning and memory
using a spatial discrimination task. M. GUIDI*; A. RANI; G.
PRADO; A. KUMAR; T. C. FOSTER. Univ. of Florida.
9:00 ZZ14 407.18 Lesions of the lateral entorhinal cortex
impair non-spatial latent learning but spare spatial latent
learning in the rat. E. M. STOUFFER*; J. E. KLEIN.
Bloomsburg Univ. of Penn.
10:00 ZZ15 407.19 A spontaneous ability of songbirds to
discriminate syntactic rules in auditory information. K. ABE*;
D. WATANABE. Kyoto Univ., PRESTO, Japan Sci. and
Technol. Agency, Fac. of Medicine, Kyoto Univ., Grad. Sch.
of Biostudies, Kyoto Univ.
11:00 ZZ16 407.20 An investigation of social learning and
its functional neuroanatomy in male Syrian hamsters. W.
YU*; C. CHANG; M. KUO; W. LAI. Dept. of Psychology, Natl.
Taiwan Univ., Neurobio. and Cognitive Sci. Center, Natl.
Taiwan Univ.
8:00 ZZ17 407.21 Virtual reality reveals spatial learning
driven by visual landmarks in rodents. I. YOUNGSTROM*; B.
W. STROWBRIDGE. Case Western Reserve Univ.
9:00 ZZ18 407.22 The effects of the bacterial immune
stimulant lipopolysaccharide (LPS) on the simultaneous
acquisition of anticipatory nausea and conditioned taste
avoidance. C. J. CLOUTIER*; S. K. CROSS-MELLOR; M.
KAVALIERS; K. OSSENKOPP. Univ. of Western Ontario.
10:00 ZZ19 407.23 Gene activation and memory encoding
in neocortex during hippocampus-dependent learning. R. G.
MORRIS*; D. TSE; T. TAKEUCHI; M. KAKEYAMA; Y. KAJII;
H. OKUNO; C. TOYAMA; H. BITO. Univ. Edinburgh, Univ.
Tokyo, Mitsubishi Tanabe Pharma Corp., Univ. Tokyo.
11:00 ZZ20 407.24 The orbitofrontal cortex and variable
histories of reward. J. S. RICEBERG*; M. SHAPIRO. Mount
Sinai Sch. of Med., Mount Sinai Sch. of Med.
8:00 ZZ21 407.25 Functional specialization of identified
interneuron classes in medial prefrontal cortex of behaving
mice. D. KVITSIANI; S. RANADE; B. HANGYA; H.
TANIGUCHI; J. HUANG; A. KEPECS*. Cold Spring Harbor
Lab.
9:00 ZZ22 407.26 The consequences of silencing the
medio-dorsal thalamus on the hippocampal-prefrontal
circuit. P. K. O’NEILL*; S. BOLKAN; S. PARNAUDEAU; C.
KELLENDONK; J. A. GORDON. Columbia Univ., Columbia
Univ., Columbia Univ.
10:00 ZZ23 407.27 The consequences of silencing the
medio-dorsal thalamus on cognition in the mouse. S.
PARNAUDEAU*; S. BOLKAN; P. K. O’NEILL; R. WARD;
J. A. GORDON; P. BALSAM; C. KELLENDONK. Columbia
Univ., New York State Psychiatric Inst., Columbia Univ.,
Barnard College, Columbia Univ., Columbia Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
408. Prefrontal and Striatal Anatomy and Function
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 ZZ24 408.01 Contralateral vs. ipsilateral corticostriatal
projections in primates: Parallel and integrative networks.
J. LEHMAN*; R. CALZAVARA; S. N. HABER. Univ. of
Rochester Sch. of Med. and Dent., Univ. of Bologna.
9:00 ZZ25 408.02 Frontal corticostriatal projections from
deep vs. superficial layers. Y. TANIMURA*; S. N. HABER.
Univ. Rochester.
10:00 ZZ26 408.03 Diabetes-induced prefrontal nissl
substance deficit and the effects of neem-bitter leaf extract
treatment. O. AKINOLA*. Univ. of Ilorin.
11:00 ZZ27 408.04 Comparative study of the source of inputs
to the anterior and posterior aspect of the paraventricular
nucleus of the midline thalamus. S. LI*; G. KIROUAC. Univ.
of Manitoba, Univ. of Manitoba.
8:00 ZZ28 408.05 � Quantification of the four types
of pyramidal neurons contributing to the corticostriatal
projections related to neglect. T. A. SCHMID*; T. S. STIEP;
J. V. CORWIN; R. L. REEP. Univ. of Florida, Univ. of Florida,
Northern Illinois Univ.
9:00 ZZ29 408.06 The prefrontal cortex modulates diurnal
rhythms in cFos immunoreactivity in the mesolimbic reward
system. R. M. BALTAZAR*; I. C. WEBB; L. M. COOLEN; M.
N. LEHMAN. Univ. Western Ontario, Univ. of Michigan, Univ.
of Michigan, Univ. of Western Ontario, Univ. of Michigan.
10:00 ZZ30 408.07 Ultrastructural analysis of membrane
localization of the norepinephrine transporter in the rat
prefrontal cortex following recovery from acute amphetamine
treatment. S. L. ERICKSON*; S. R. SESACK. Univ. of
Pittsburgh.
11:00 ZZ31 408.08 Basolateral amygdala inputs attenuate
responses to other temporal cortical structures in the
prefrontal cortex. H. A. TEJEDA*; T. SHIPPENBERG; P.
O’DONNELL. NIDA IRP, Univ. of Maryland, Baltimore.
8:00 ZZ32 408.09 Neuroarchitecture of social cognition in
parrot brain. S. SRIVASTAVA*; S. SHRVASTAVA. Barkatullah
University Bhopal.
9:00 ZZ33 408.10 • Immunohistological analyses of
noradrenergic markers in prefrontal cortex at mid and
late adolescence. K. L. AGSTER*; A. T. BATES; B. D.
WATERHOUSE; J. MCGAUGHY. Drexel Univ. - Coll Med.,
Univ. of New Hampshire.
10:00 ZZ34 408.11 Organization of monoaminergic and
cholinergic efferent projections to functionally differentiated
sub-regions of the prefrontal cortex. D. J. CHANDLER*; B.
D. WATERHOUSE. Drexel Univ. Col. of Med.
11:00 ZZ35 408.12 Atypical antipsychotics ameliorates
learning impairments of N-methyl-D-aspartate receptor
(NMDAR) antagonism during acquisition of an operant
conditioning task. M. RAPANELLI*; L. R. FRICK; M.
BERNARDEZ; B. S. ZANUTTO. Inst. De Biologia Y Medicina
Exptl.
8:00 ZZ36 408.13 Unraveling the role of serotonin in
reward-directed learning. L. R. FRICK*; M. RAPANELLI; S.
ZANUTTO. IBYME-CONICET, IBYME-CONICET.
Neuroscience 2011 | Monday AM | 77
Mon. AM

9:00 ZZ37 408.14 Non-stationarities in the prefrontal cortex
- ventral tegmental area interaction. C. J. MININNI*; S.
ZANUTTO. Inst. de Biología Y Medicina Exptl. (CONICET),
Inst. de Ingeniería Biomédica, Inst. de Biología y Medicina
Exptl.
10:00 ZZ38 408.15 Noradrenergic networks in the
anesthetized rat: Interaction between the locus
coeruleus and the prefrontal cortex. A. M. M. MIGUELEZ
FERNÁNDEZ; C. J. MININNI; B. S. ZANUTTO*. Inst. de
Biología y Medicina Exptl. (IBYME-CONICET), Univ. Buenos
Aires-CONICET.
POSTER
409. Memory Consolidation and Reconsolidation: Molecular
Mechanisms
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 ZZ39 409.01 Arc protein expression in the insular
cortex after a novel or familiar taste: Dependence on
muscarinic, NMDA and group I mGluRs. L. MENDOZA-
VIVEROS*; F. BERMUDEZ-RATTONI. UNAM. Inst. De
Fisiología Celular, UNAM, Inst. De Fisiología Celular.
9:00 ZZ40 409.02 � The role of Arc (Arg3.1) protein
translation in reconsolidation of contextual memory. C.
CHIA*; J. CZERNIAWSKI; F. REE; T. OTTO. Rutgers Univ.
10:00 ZZ41 409.03 • Differential expression of ARC in
the DG, CA1, and CA3 subfields of dorsal and ventral
hippocampus induced by trace and discriminative contextual
conditioning. T. A. OTTO*; S. SMITH; S. KOGAN; F. REE; J.
CZERNIAWSKI. Rutgers Univ.
11:00 ZZ42 409.04 CaMKIIα protein expression in the
anterior cingulate cortex is modulated by the basolateral
complex of the amygdala. C. M. HOLLOWAY*; J. R.
MCREYNOLDS; I. A. VILLALOBOS; E. E. INYANG; C. K.
MCINTYRE. Univ. Texas, Dallas.
8:00 ZZ43 409.05 Post-training intra-basolateral complex
of the amygdala infusions of clenbuterol enhance memory
for conditioned place preference and increase Arc protein
expression in hippocampal synaptic fractions. J. R.
MCREYNOLDS*; A. WANG; C. K. MCINTYRE. Univ. of
Texas at Dallas.
9:00 ZZ44 409.06 Molecular mechanisms associated with
non-spatial pattern separation. P. BEKINSCHTEIN*; L. M.
SAKSIDA; T. J. BUSSEY. Univ. of Cambridge, Behavioural
and Clin. Neurosci. Inst.
10:00 ZZ45 409.07 A study upon short term and long term
memory mechanisms. M. GIOVANNINI*; D. LANA; F.
CERBAI; P. KIROVA; A. GIANNETTI. Univ., Acad. of Sci.,
IFAC-CNR.
11:00 ZZ46 409.08 Mechanisms underlying consolidation
and reconsolidation of social recognition memory at the
anatomical level. T. TANIMIZU; H. FUKUSHIMA*; Y. ZHANG;
K. KADOMA; E. OKANO; S. KIDA. Tokyo Univ. Agri.
8:00 ZZ47 409.09 Divergent cellular pathways of
hippocampal memory reconsolidation. J. L. LEE*. Univ.
Birmingham.
9:00 ZZ48 409.10 Increasing CRTC (CREB regulated
transcription coactivator) levels in the dorsal hippocampus is
sufficient to induce contextual fear memory and contextual
discrimination. M. J. SEKERES*; P. W. FRANKLAND; S. A.
JOSSELYN. The Hosp Sick Children, Univ. of Toronto, Univ.
of Toronto.
10:00 ZZ49 409.11 The role of S6K1 in consolidation,
reconsolidation and extinction of fear memory. T. N.
HUYNH*; A. KANG; E. SANTINI; E. KLANN. Ctr. for Neural
Science, New York Univ.
11:00 ZZ50 409.12 Erasure of alcohol-related memories
by mTORC1 inhibition: A new frontier for alcohol relapse
prevention? S. BARAK*; Q. YOWELL; J. NEASTA; V.
KHARASIA; P. H. JANAK; D. RON. UCSF - Gallo Res. Ctr.,
UCSF.
8:00 ZZ51 409.13 Systemic inhibition of mTOR kinase
via rapamycin causes a lasting impairment of predator
stress-induced hyperarousal. K. FIFIELD*; M. HEBERT; V.
LINEHAN; G. GILL; R. ADAMEC; J. J. BLUNDELL. Mem.
Univ. of Newfoundland.
9:00 ZZ52 409.14 Hippocampal overexpression of the
phosphodiesterase pde4a5 impairs memory and synaptic
plasticity. R. HAVEKES*; J. H. K. CHOI; G. S. BAILLIE; A.
J. PARK; J. P. DAY; V. M. BRUINENBERG; L. A. GUERCIO;
E. LINTON; H. SCHOCH; J. D. HAWK; S. POPLAWSKI; P.
MEERLO; M. D. HOUSLAY; T. ABEL. Univ. of Pennsylvania,
Univ. of Glasgow, Univ. of Groningen.
10:00 ZZ53 409.15 Circadian regulation of memory retrieval
by transcription factor BMAL1. S. HASEGAWA*; M. OHTA;
K. SAITO; A. NAKAMURA; H. HOSODA; S. KIDA. Tokyo
Univ. of Agr., CREST, JST.
11:00 ZZ54 409.16 Genetic deletion of Gadd45b, a
regulator of active DNA demethylation, enhances
memory consolidation. F. SULTAN*; J. S. TRONT; D. A.
LIEBERMANN; J. D. SWEATT. UAB, Temple Univ.
8:00 ZZ55 409.17 Enhanced fear conditioning and
locomotor sensitization to cocaine in eukaryotic elongation
factor-2 kinase (EF2K) knock-out mice. S. L. WISEMAN*;
J. R. TAYLOR; A. G. RYAZANOV; A. C. NAIRN. Yale Univ.,
UMDNJ-RWJMS.
9:00 ZZ56 409.18 Requirement of p300 in hippocampus
and perirhinal cortex for gene expression and memory
consolidation. M. A. ESTEVEZ*; A. M. M. OLIVEIRA;
K. LACKENBY; B. MAYWEATHER; T. ABEL. Univ.
Pennsylvania.
10:00 ZZ57 409.19 Role of nfκβ activity in an animal model
of post traumatic stress disorder. A. J. BETZ*; J. JOSHI;
E. FANKE; R. ROTOLO; M. REILLY; D. BISSELL; D.
CAMPBELL; S. JAYATILAKA; A. SCALISE; E. KAPUZA; A.
BETZ. Quinnipiac Univ., Quinnipiac Univ.
11:00 ZZ58 409.20 Reconsolidation drives memory out
of the maintenance phase. Y. FORTIS-SANTIAGO*; J. A.
FIGUEROA; E. E. REID; T. YOSHIDA; N. C. BARRY; D. B.
KATZ. Brandeis Univ., Brandeis Univ., Kyushu Univ.
8:00 ZZ59 409.21 Extracellular signal-related kinase
inhibition in the basolateral amygdala, but not the nucleus
accumbens core, following cocaine memory reactivation
impairs subsequent drug context-induced cocaine seeking in
rats. A. M. WELLS*; A. A. ARGUELLO; H. C. LASSETER; X.
XIE; A. M. REITTINGER; A. R. NEWSOME; R. A. FUCHS.
Univ. of North Carolina At Chapel Hill.
78 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

9:00 ZZ60 409.22 Increase of brain-derived neurotrophic
factor in the hippocampus plays a key role in consolidation of
spatial memory in spontaneous place recognition test in rats.
T. OZAWA*; K. YAMADA; Y. ICHITANI. Univ. of Tsukuba.
10:00 ZZ61 409.23 Glucocorticoid administration into the
nucleus accumbens shell enhances memory consolidation of
both conditioned taste aversion and safe taste learning. R.
WICHMANN*; B. ROOZENDAAL. Univ. of Groningen, Univ.
of Groningen.
POSTER
410. Hippocampus and Cortex in Behavior
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 ZZ62 410.01 To eat or not to eat: Hippocampal
involvement in meal onset. Y. OGAWA*; G. P. SMITH; A.
VAZDARJANOVA; M. B. PARENT. Georgia State Univ., Weill
Cornell Med. Col., Georgia Hlth. Sci. Univ., Georgia State
Univ.
9:00 ZZ63 410.02 How are visuospatial and olfactory cues
of different emotional value encoded in the dorsal and
ventral hippocampus? E. G. WANN*; S. STEAD; I. MUZZIO.
Univ. of Pennsylvania Dept. of Psychology, Mayo Clin.
10:00 ZZ64 410.03 Short-term effects of 56Fe irradiation on
cognitive function in C57Bl6/J female and male mice. G. E.
HALEY*; L. YEISER; R. OLSEN; J. RABER. Oregon Hlth.
and Sci. Univ.
11:00 ZZ65 410.04 Local hippocampal norepinephrine
infusion during post-learning memory consolidation unbinds
place fields, disrupts maps and wipes out spatial memory.
A. SERGEEVA*; J. KIM; J. PASTEWSKI; D. DAVIS; M.
KUZNIA; G. POE. Univ. of Michigan.
8:00 ZZ66 410.05 Long-range GABAergic input from the
hippocampus to the medial entorhinal cortex. M. MICHAEL;
S. MELZER; E. FUCHS*; A. CAPUTI; H. MONYER. Med.
Fac. of Heidelberg Univ. and German Cancer Res. Ctr.
(DKFZ.
9:00 ZZ67 410.06 GABAergic long-range projections from
entorhinal cortex to hippocampus. S. MELZER*; A. CAPUTI;
M. ELIAVA; H. MONYER. Med. Fac. of Heidelberg Univ. and
DKFZ.
10:00 ZZ68 410.07 Memory-invariant models of hippocampal
CA3-CA1 population dynamics during delayed nonmatchto-sample
tasks. D. SONG*; R. H. M. CHAN; V. Z.
MARMARELIS; R. E. HAMPSON; S. A. DEADWYLER; T. W.
BERGER. USC, Wake Forest Univ. Hlth. Sci.
11:00 ZZ69 410.08 Facilitation of behavioral performance
in NHPs as a test of a nonlinear model-based neural
prosthesis. R. HAMPSON*; J. L. LONG; J. V. NOTO; B. C.
PARRISH; K. S. HONG; D. SONG; H. M. CHAN; D. SHIN;
V. Z. MARMARELIS; T. W. BERGER; G. A. GERHARDT; S.
A. DEADWYLER. Wake Forest Sch. of Med., USC, Univ. of
Kentucky.
8:00 ZZ70 410.09 Implementation of a neural prosthesis
facilitates normal brain correlates of memory. A. J.
SWEATT*; R. E. HAMPSON; D. SONG; H. M. CHAN; D. C.
COLLINS; M. R. RILEY; C. H. DYSON; N. HIATT; D. SHIN;
V. Z. MARMARELIS; T. W. BERGER; S. A. DEADWYLER.
Wake Forest Sch. of Med., USC.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
9:00 ZZ71 410.10 Effects of high-energy diet on
hippocampal-dependent retention performance and bloodbrain
barrier permeability depend on obesity phenotype in
rats. T. L. DAVIDSON; A. D. MONNOT; A. A. MARTIN; J.
J. HORTON; A. U. NEAL; L. E. JARRARD*; W. ZHENG.
Purdue Univ., Washington & Lee Univ.
10:00 ZZ72 410.11 The direct entorhinal cortex input to the
hippocampus is crucial for temporally associative learning
and memory. J. SUH*; A. J. RIVEST; S. TONEGAWA. MIT,
MIT.
11:00 ZZ73 410.12 � Stroke affects functional connectivity
during spatial tasks. S. WU*; W. LIU; T. CHANG; C.
BURGER; Y. WANG; J. LIU. UCSF and SFVAMC.
8:00 ZZ74 410.13 Are adult-generated hippocampal
neurons important in the establishment of drug/context
association in morphine conditioned place preference? P. D.
RIVERA*; R. K. RAGHAVAN; M. MCGOVERN; S. E. BULIN;
S. G. BIRNBAUM; A. J. EISCH. UT Southwestern Med. Ctr.
9:00 ZZ75 410.14 Imaging hippocampal CA1 cell activity in
awake mice: A network level measurement of correlates of
learning. M. N. MODI*; A. DHAWALE; U. S. BHALLA. NCBS.
10:00 ZZ76 410.15 Interpreting the rodent hippocampal
structural network at the cell-class level using graph theory.
C. L. REES*; D. W. WHEELER; G. A. ASCOLI. Krasnow Inst.
For Advanced Study.
11:00 ZZ77 410.16 Effect of consumption of fluoridated
water guidance on the capacity of space and field ca1
neuronal density in the rat. P. MARIA ISABEL*; S. PRADO-
GONZALEZ; B. ROCHA-PEREZ; M. CRISTINA; C. SORIA-
FREGOZO; A. FERIA-VELASCO. Univ. De Guadalajara,
Univ. De Guadalajara, Dept. of Cell and Mol. Biology,
CUCBA.
8:00 ZZ78 410.17 Differential effects of the
anticholinesterase physostigmine and the adenosine
antagonist caffeine on memory encoding and retrieval in
aged rats: interventions to reduce proactive interference.
N. E. PAUL*; T. K. JACOBSON; S. PALLAY; J. J. FINK;
B. SCHMIDT; J. J. CHROBAK; E. J. MARKUS. Univ. of
Connecticut.
9:00 ZZ79 410.18 Effects of hippocampal arc knockdown
on hippocampal dependent/independent learning. E.
J. MARKUS*; B. SCHMIDT; A. BOOKER; F. CHEN; M.
ARGRAVES; E. SZKUDLAREK; J. J. LOTURCO. Univ.
Connecticut.
POSTER
411. Learning and Memory: Hippocampus and Aging
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 ZZ80 411.01 Expression of voltage-gated potassium
channels in CA1 pyramidal neurons of the dorsal and ventral
hippocampus in mouse models of Alzheimer’s disease. K.
NEUMAN*; D. M. HARTLEY; D. A. NICHOLSON. Rush Univ.
Med. Ctr.
9:00 ZZ81 411.02 Distance-dependent synaptic scaling
in hippocampal CA1 pyramidal neurons along the dorsalventral
axis of aged, memory-impaired and -unimpaired rats.
N. J. CORBETT*; T. F. MUSIAL; M. D. ANTION; C. WEISS;
J. F. DISTERHOFT; D. A. NICHOLSON. Rush Univ. Med.
Ctr., Feinberg Sch. of Medicine, Northwestern Univ.
Neuroscience 2011 | Monday AM | 79
Mon. AM

10:00 ZZ82 411.03 Differences in mossy fiber bouton
complexes of CA3 pyramidal neurons in aged behaviorallycharacterized
rats. E. W. BUSS*; M. L. MEDEIROS; L.
L. NIELSEN; M. D. ANTION; J. F. DISTERHOFT; D. A.
NICHOLSON. Rush Univ. Med. Ctr., Northwestern Univ.
11:00 ZZ83 411.04 Reduction in synapse number in the most
distal dendrites of CA1 pyramidal neurons in mouse models
of Alzheimer’s disease. D. NICHOLSON*; M. L. WOLKE; A.
PRICE. Rush Univ. Med. Ctr., Rush Univ. Med. Ctr.
8:00 ZZ84 411.05 The expression of H-channels in the
proximal and distal dendrites of CA1 pyramidal neurons
in dorsal and ventral hippocampus of mouse models of
Alzheimer’s disease. N. YBARRA*; C. T. TULISIAK; J. F.
DISTERHOFT; D. A. NICHOLSON. Northwestern Univ.,
Rush Univ. Med. Ctr.
9:00 ZZ85 411.06 � Array tomographic analysis of dendrites
and spines from GFP-expressing and dye- injected
hippocampal CA1 pyramidal neurons from young and
aged mice and rats. A. LIU*; M. WOLKE; P. VAZQUEZ-
BORSETTI; T. F. MUSIAL; D. A. NICHOLSON. Northwestern
Univ., Rush Univ. Med. Ctr.
10:00 ZZ86 411.07 Too much of a good thing? High
androstenedione is associated with spatial reference and
working memory impairment in transitionally and surgically
menopausal middle-aged rats. J. I. ACOSTA*; S. E.
MENNENGA; B. W. CAMP; S. R. VILLA; J. E. GERSON;
H. A. BIMONTE-NELSON. Arizona State Univ., Arizona
Alzheimer’s Consortium.
11:00 ZZ87 411.08 Walk this way: Translating the
rodent radial-arm maze to humans. B. W. CAMP*; I. S.
GRUNFELD; E. B. ENGLER-CHIURAZZI; J. I. ACOSTA;
S. E. MENNENGA; B. B. BRADEN; C. W. S. TSANG; M. L.
KINGSTON; L. T. HEWITT; G. A. BREWER; L. C. BAXTER;
M. K. MCBEATH; H. A. BIMONTE-NELSON. Arizona State
Univ., Arizona Alzheimer’s Consortium, Barrow Neurolog.
Inst. at St. Joseph’s Hosp.
8:00 ZZ88 411.09 Neuroprecursor transplantation and
voluntary running reverses age-associated cognitive
decline in the aged rat. J. SIETTE*; F. WESTBROOK; A.
LOWE; K. SIDHU; P. SACHDEV; M. VALENZUELA. Sch. of
Psychology, Univ. of New South Wales, Univ. of New South
Wales, Univ. of New South Wales.
9:00 AAA1 411.10 The GABA-B agonist baclofen
differentially effects fear responding in aged and young adult
mice. P. J. HERNANDEZ*; M. WIMMER; T. ABEL. Univ.
Pennsylvania.
10:00 AAA2 411.11 Evaluation and induction of cognitive
impairment in a non-human primate model of aging. A.
RAHMAN; S. LANGUILLE; F. PIFFERI; O. BLIN; E. IRVING;
Y. LAMBERTY; E. SCHENKER*; P. LESTAGE; F. AUJARD.
UMR CNRS-MNHN 7179, Ctr. d’Investigation Clinique, UMR
6193, GlaxoSmithKline, UCB Pharma, Inst. De Rescherches
Servier, Inst. de Recherches Servier.
11:00 AAA3 411.12 Impaired motor learning and performance
in aged non-human primates. A. E. ZEAMER*; E. DECAMP;
K. CLARK; C. BOUQUIO; J. SCHNEIDER. Thomas
Jefferson Univ.
8:00 AAA4 411.13 Aging-related changes in immediate
early gene expression in rat medial prefrontal cortex. M.
SEHGAL*; J. A. DETERT; A. M. GIRGIS; J. R. MOYER,
Jr. Univ. of Wisconsin-Milwaukee, Univ. of Wisconsin-
Milwaukee.
9:00 AAA5 411.14 Enhanced immune responses in aged
rats may play a role in establishing a sub-population that
is cognitively impaired. M. C. FARSO*; C. MÉNARD; R.
QUIRION. Douglas Mental Hlth. Univ. Institute, McGill Univ.
10:00 AAA6 411.15 Age-related changes in CREB and
pCREB: Formation of stable inhibitory avoidance memory in
old rats does not require CREB activation. K. A. MORRIS*;
P. E. GOLD. Univ. of Illinois at Urbana-Champaign, Univ.
of Illinois at Urbana-Champaign, Univ. of Illinois at Urbana-
Champaign.
11:00 AAA7 411.16 Quantifying behavioral and metabolic
syndrome indices in the F344 rat model of aging on high fat
diet. K. L. ANDERSON; T. PANCANI; L. D. BREWER; E. M.
BLALOCK; N. M. PORTER; O. THIBAULT*. Univ. Kentucky
Med. Ctr.
8:00 AAA8 411.17 Cognitive phenotyping in diversity
outcross mice. M. KOH*; D. BURRUSS; R. MCMAHAN; M.
GALLAGHER. Johns Hopkins Univ.
9:00 AAA9 411.18 Longitudinal structural and basal
metabolic changes in behaviorally characterized aged
female rhesus monkeys. J. L. SHAMY*; B. B. AVANTS; M.
T. ROBERTS; D. J. ROWLAND; R. LARSON; J. GEE; S. R.
CHERRY; P. R. HOF; J. H. MORRISON; M. G. BAXTER;
P. R. RAPP. Mount Sinai Sch. of Med., Natl. Inst. of Aging,
Univ. of Pennsylvania, California Natl. Primate Res. Ctr.,
Univ. of California, Univ. of California.
POSTER
412. Animal Models of Fear, Anxiety, and Pain
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 AAA10 412.01 Altered emotional behavior and fear
learning in Csnk1e mutants. L. ZHOU*; C. OLKER; M.
VITATERNA; A. LOUDON; F. TUREK. Northwestern Univ.,
Univ. of Manchester.
9:00 AAA11 412.02 � High-throughput behavioral
phenotyping of mouse self-grooming behavior. E. J.
KYZAR*; S. GAIKWAD; M. PHAM; J. GREEN; A. ROTH; A.
STEWART; A. KALUEFF. Tulane Univ. Med. Sch.
10:00 AAA12 412.03 Measures of anxiety and amygdala
volumes in elderly female rhesus macaques. G. E. HALEY;
A. MCGUIRE; D. BERTEAU-PAVY; H. F. URBANSKI; J.
RABER*. OHSU.
11:00 AAA13 412.04 Maternal deprivation versus enriched
environment: Fear learning and memory in rats. L. T. RAO*;
D. SAMPATH; P. HEGDE; S. O’MARA; S. CHATTARJI; B. M.
KUTTY. NIMHANS, Inst. of Neurosci., NCBS.
8:00 AAA14 412.05 Fear extinction and renewal result in
activation of anatomically different neuronal populations in
the lateral, but not in the central amygdala. E. A. KNAPSKA*;
M. MACIAS; T. WERKA; M. MIKOSZ; A. NOWAK; J.
JAWORSKI; L. KACZMAREK. Nencki Inst. of Exptl. Biol.
PAS, Intl. Inst. of Mol. and Cell Biol.
9:00 AAA15 412.06 Presynaptic mechanisms underlie
synaptic potentiation in the nociceptive amygdala in
diabetes-linked neuropathic pain. T. OCHIAI; Y. TAKAHASHI;
M. ASATO; A. M. WATABE*; M. OHSAWA; J. KAMEI; F.
KATO. Jikei Univ. Sch. of Med., Hoshi Univ., PRESTO, JST,
Nagoya City Univ.
80 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

10:00 AAA16 412.07 Repeated exposure to panicogenic
stimuli across development on expression of anxiety and
depression-like behaviors in the adult rat. W. A. TRUITT*;
P. L. JOHNSON; S. D. FITZ; S. P. JANASIK; P. E. MINICK;
A. D. DIETRICH; A. MOLOSH; A. SHEKHAR. Indiana
Univ. Sch. Med., Indiana Univ. Sch. Med., Indiana Clin. and
Translational Sci. Inst.
11:00 AAA17 412.08 Chronic exercise exerts anxiolytic-like
effects and promotes active defensive behaviors despite
repeated pharmacological stress. N. R. SCIOLINO*; R. K.
DISHMAN; P. V. HOLMES. Univ. of Georgia, Biomed. and
Hlth. Sci. Inst., Univ. of Georgia.
8:00 AAA18 412.09 Altered maternal, social and anxietylike
behaviors in rat environmental enrichment. J. R.
PRICHARD*; A. D. MARTYNEC; J. M. OLSON. Univ. St.
Thomas.
9:00 AAA19 412.10 Role of the central amygdala in anxietylike
behaviour in a rat model of traumatic peripheral nerve
injury: An anatomical approach. A. NOVEJARQUE*; T.
PHEBY; A. S. C. RICE. Imperial Col. London.
10:00 AAA20 412.11 Postnatal knock-down of serotonin
1a autoreceptors increases adult anxiety levels. Z. R.
DONALDSON*; D. PIEL; L. CALIZO; K. CAMPBELL; S.
G. BECK; F. A. CHAMPAGNE; R. HEN. Columbia Univ.,
Children’s Hosp. of Philadelphia, Columbia Univ., Columbia
Univ.
11:00 AAA21 412.12 Elevation of tph2 mRNA expression
associated with development of a chronic anxiety-like state.
N. C. DONNER*; P. L. JOHNSON; S. D. FITZ; A. SHEKHAR;
C. A. LOWRY. Univ. of Colorado, Indiana Univ. Sch. of Med.
8:00 AAA22 412.13 � Fear-contextual cues inhibit eating in
food-deprived male and female rats. M. KUTHYAR*; C. J.
REPPUCCI; G. D. PETROVICH. Boston Col.
9:00 AAA23 412.14 Prior stress interferes with the anxiolytic
effect of voluntary exercise in C57BL/6J mice. B. D. HARE;
K. C. D’ONFRO; S. E. HAMMACK; W. A. FALLS*. Univ.
Vermont.
10:00 AAA24 412.15 One month of voluntary wheel
running reduces anxiety levels and increases levels of
docosahexaenoic acid (c22:6) (dha) in the cortex of c57/
bl6 male mice. I. J. SANTOS*; J. VELEZ; I. ADAMES; S.
LANDRAU; C. I. RODRIGUEZ; N. CHORNA; A. T. MENDEZ;
S. PEÑA DE ORTIZ. Univ. Puerto Rico, Univ. del Este.
11:00 AAA25 412.16 Chemical lesion in the medial nucleus
of amygdala changed defensive antinociception but not
tonic immobility response in the guinea pigs. E. B. VIEIRA-
RASTELI*; C. R. A. LEITE-PANISSI. Univ. of São Paulo.
8:00 AAA26 412.17 Early life experiences and behavior
are related to adult GR and SERT mRNA expression in
a sex specific manner. C. M. RAGAN*; J. GYEKIS; D. J.
VANDENBERGH; S. A. CAVIGELLI. Pennsyl State Univ.
9:00 AAA27 412.18 Anabolic androgenic steroids and alcohol
abuse: A potentially anxious relationship. M. ONAKOMAIYA*;
L. P. HENDERSON. Dartmouth Med. Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
413. Neuroethology: Gene Expression and Neurochemistry
Theme F: Cognition and Behavior
Mon. 8:00 AM – Walter E. Washington Convention
Center, Hall A-C
8:00 AAA28 413.01 Using the Zebra Finch Expression Brain
Atlas (ZEBrA) to define the molecular organization of the
songbird brain. P. V. LOVELL*; J. CARLETON; A. MCHUGH;
C. V. MELLO. Oregon Hlth. & Sci. Univ.
9:00 AAA29 413.02 Identification of molecular changes
underlying the initial stages of vocal learning in the zebra
finch. M. DESHPANDE*; T. WHITAKER; A. PFENNING; E.
D. JARVIS; T. LINTS. Texas A and M Univ., Duke Univ. Med.
Ctr.
10:00 AAA30 413.03 Profiling miRNA expression repertoire
during song system development in the zebra finch. L. FU;
G. LUO; Z. SHI; X. WANG; X. LI*. Louisiana State Univ. Hlth.
Sci. Ctr., Inst. of Genet. and Developmental Biology, Chinese
Acad.
11:00 AAA31 413.04 A molecular characterization of major cell
types within the song control system and main subdivisions
of the songbird brain. C. V. MELLO*; P. V. LOVELL. Oregon
Hlth. Sci. Univ.
8:00 AAA32 413.05 Transcriptome complexity during song
system development in the zebra finch revealed by deep
sequencing. Z. SHI*; L. SCHAFFER; L. FU; S. HEAD; T.
GAASTERLAND; X. LI. Louisiana State Univ. Hlth. Sci. Ctr.,
The Scripps Res. Inst., Louisiana State University, Hlth. Sci.
Ctr., Univ. of California at San Diego and Scripps Inst. of
Oceanography.
9:00 AAA33 413.06 Statistical parametric mapping of
experience-dependent immediate-early gene expression in
the awake unrestrained zebra finch. F. PIRLEPESOV*; M.
DESHPANDE; T. LINTS. Texas A&M Univ.
10:00 AAA34 413.07 Developmental changes in gene
expression in the oscine song system during the early
post-hatch and song learning periods. C. R. OLSON*; P. V.
LOVELL; C. V. MELLO. OHSU.
11:00 AAA35 413.08 • Song-induced expression pattern of
Arc mRNA in brain of female zebra finch. Y. MARUYAMA*;
S. HASE; K. HOTTA; K. OKA. Oka Lab. Fac. of Sci. and
Technology, KEIO UNIVERSITY.
8:00 AAA36 413.09 Epigenetic gene expression dynamics
induced by singing regulate a critical period of vocal learning.
M. KOBAYASHI; H. HORITA; R. IMAI; C. MORI; W. LIU;
K. WADA*. Hokkaido Univ., Rockfeller Univ., Fuculty of
Science, Hokkaido Univ.
9:00 AAA37 413.10 Melatonin regulation of daily rhythms in
vocal activity of a teleost fish. N. FENG*; D. J. FERGUS; A.
H. BASS. Cornell Univ.
10:00 AAA38 413.11 Dopamine injections to the midbrain
periaqueductal gray rapidly and reversibly inhibit vocal
production in a teleost fish. J. M. KITTELBERGER*; E. K.
HEISLER; A. K. ALLEN. Gettysburg Coll.
11:00 AAA39 413.12 Gene expression analysis of languagerelated
genes in the common marmoset brain. M. KATO*; K.
OKANOYA; S. WATANABE; A. IRIKI. RIKEN Brain Sci. Inst.,
RIKEN Brain Sci. Inst., Ctr. for Advanced Res. on Logic and
Sensibility (CARLS), Keio Univ.
Neuroscience 2011 | Monday AM | 81
Mon. AM

8:00 AAA40 413.13 Effects of social signals on central
monamine levels in spadefoot toads. V. G. RODRIGUEZ
MONCALVO*; S. S. BURMEISTER; K. S. PFENNIG. Univ. of
North Carolina at Chapel Hill, UNC -chapel Hill.
9:00 AAA41 413.14 Electrical activity and regulation of gene
expression in myogenic tissues of a weakly electric fish.
R. GUETH*; V. SHADD-SALAZAR; G. A. UNGUEZ. New
Mexico State Univ.
10:00 AAA42 413.15 Activity-dependent gene expression
in response to spatial learning in the honey bee brain. C.
C. LUTZ*; A. R. HAMILTON; G. E. ROBINSON. Univ. of
Illinois At Urbana-Champaign, Univ. of Illinois at Urbana-
Champaign, Univ. of Illinois at Urbana-Champaign.
82 | Society for Neuroscience • Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

ALBERT AND ELLEN GRASS LECTURE Walter E. Washington
Convention Center
414. Optimal Integration of Sensory Evidence: A Bayesian
Journey Through Our Sixth Sense — CME
Mon. 3:15 PM - 4:25 PM — Hall D
Speaker: D. E. ANGELAKI, Washington Univ. Med. Sch.
Support contributed by The Grass Foundation
As we navigate through the world and interact with our
environment, salient computations ensure spatial orientation
is maintained effortlessly, largely because of our sixth sense,
the vestibular system. Neural circuits use an internal model
of universal physical laws and multisensory integration to
resolve ambiguities inherent in our sensors. Further, cortical
multisensory integration with visual motion cues ensures
improved precision of spatial perception. Both properties are
predicted by Bayesian integration in a framework that our
brain performs optimal statistical inference.
SYMPOSIUM Walter E. Washington Convention Center
415. Beyond the Connectome: Why the Wiring Diagram Is
Not Enough — CME
Mon. 1:30 PM - 4:00 PM — Ballroom A
Chair: V. BREZINA
Great efforts are currently being exerted to map the
“connectome” of the nervous system. But the connectome
is likely to prove a very incomplete determinant of nervous
system function. This symposium highlights some of the
dynamic mechanisms operating in the nervous systemplasticity,
neuromodulation, dynamic reconfiguration, and
non-uniqueness of the connectivity patterns-that will create
substantial challenges in relating a static wiring diagram to
dynamic function.
1:30 415.01 Introduction.
1:35 415.02 Inhibition dictates the sign of plasticity at excitatory
synapses. A. MAFFEI. SUNY Stony Brook.
2:10 415.03 State-dependent modulation and reconfiguration of
the respiratory network: Why connectivity is kept sparsely. J.
RAMIREZ. Univ. of Washington.
2:45 415.04 Signaling and computation in neuromodulator
networks. V. BREZINA. Mount Sinai Sch. of Med.
3:20 415.05 Similar output from networks with different
connectivity. A. PRINZ. Emory Univ.
3:55 415.06 Closing Remarks.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
Monday PM
SYMPOSIUM Walter E. Washington Convention Center
416. Genetically Driven Manipulation of Hypothalamic
Circuitry Controlling Behavior — CME
Mon. 1:30 PM - 4:00 PM — Ballroom B
Chair: C. B. SAPER
The hypothalamus is a complex part of the brain that is
packed with small cell groups that control discrete aspects
of physiology and behavior. However, it has been hard in
the past to manipulate these tiny cell groups selectively in a
way that can dissect their individual contributions to function.
This symposium shares recent work using genetically
targeted approaches to manipulate hypothalamic circuitry
for controlling aggression, sexual behavior, feeding, wakesleep,
and circadian rhythms.
1:30 416.01 Introduction.
1:35 416.02 Genetic dissection of neural circuits controlling
aggression. D. J. ANDERSON. HHMI/CALTECH.
2:00 416.03 Role of arcuate neurons in feeding and body
weight regulation. S. M. STERNSON. Janelia Farm Res.
Campus, HHMI.
2:25 416.04 Hypothalamic circuitry for glucose homeostasis
and energy balance. J. K. ELMQUIST. Univ. of Texas
Southwestern Med. Sch.
2:50 416.05 Role of dorosmedial hypothalamic neurons in
regulating circadian rhythms. C. B. SAPER. Harvard Med.
School, Beth Israel Deaconess Med. Ctr.
3:15 416.06 Hypothalamic sites of leptin action on reproduction.
C. F. ELIAS. Univ. Texas Southwest Med. Ctr.
3:35 416.07 Closing Remarks.
MINISYMPOSIUM Walter E. Washington Convention Center
417. Homeostatic Regulation of Synaptic Strength: New
Players, Mechanisms, and Insights into Synaptic
Scaling — CME
Mon. 1:30 PM - 4:00 PM — Ballroom C
Chair: D. STELLWAGEN
Co-Chair: E. DIAZ
Homeostatic synaptic plasticity mechanisms provide a
means for neural circuits to maintain stable function when
challenged with perturbations such as developmental or
activity dependent changes in synapse number or strength.
Recent work implicates several signaling pathways
in various forms of homeostatic synaptic plasticity in
the mammalian nervous system and the Drosophila
neuromuscular junction (NMJ). This minisymposium
highlights recent discoveries into this fundamental
phenomenon.
1:30 417.01 Introduction.
1:35 417.02 How synapse stability is maintained through Eph/
Ephexin signaling and calcium channels. C. FRANK. Univ. of
Iowa Carver Col. of Med.
1:55 417.03 Dendritic protein synthesis and homeostatic control
of synapse function. M. A. SUTTON. Univ. of Michigan.
2:15 417.04 Mechanisms of TNFalpha-mediated homeostatic
synaptic plasticity. D. STELLWAGEN. McGill Univ. Hlth. Ctr.
Neuroscience 2011 | Monday PM | 83
Mon. PM

2:35 417.05 Homeostatic regulation of inhibitory synaptic
transmission by retinoic acid. F. SARTI. Stanford Univ.
2:55 417.06 Arc-dependent synapse-specific homeostatic
plasticity. J. BÉÏQUE. Univ. of Ottawa.
3:15 417.07 SynDIG1 regulation of excitatory synaptic strength.
E. DIAZ. UC Davis Sch. of Med.
3:35 417.08 Closing Remarks.
MINISYMPOSIUM Walter E. Washington Convention Center
418. Rapid Estrogen Signaling in the Brain – Implications
for the Fine-Tuning of Neural Circuitry — CME
Mon. 1:30 PM - 4:00 PM — 202B
Chair: D. P. SRIVASTAVA
Co-Chair: F. LIU
Estrogens regulate cognition by initiating rapid signaling
cascades, modulating synapse structure, and fine-tuning
neural circuitry. This minisymposium focuses on recent
insight into rapid estrogen signaling in the brain. Speakers
will discuss the synaptic expression of estrogen receptors
and mechanisms that initiate rapid signaling in neurons;
mechanisms of estrogen modulation of neural circuitry in the
cortex and hippocampus; how sex determines the circuitry
utilized to process stressful stimuli; and how estrogen
receptors are promising therapeutic targets.
1:30 418.01 Introduction.
1:35 418.02 Estrogen regulation of estrogen receptor alpha and
beta suggests differential roles in neuronal plasticity. E. M.
WATERS. Rockefeller Univ.
1:55 418.03 Membrane estrogen receptors activate
metabotropic glutamate receptors to affect nervous system
function. P. G. MERMELSTEIN. Univ. of Minnesota.
2:15 418.04 Modulation of cortical neuron connectivity: A
role for estrogen-induced ‘two-step wiring plasticity’. D. P.
SRIVASTAVA. Northwestern Univ.
2:35 418.05 Estrogen and the subsynaptic cytoskeleton:
surprising partners in regulating excitatory transmission. E.
A. KRAMAR. Univ. California.
2:55 418.06 Males and females use different brain circuits to
learn after stressful life experience. T. J. SHORS. Rutgers
Univ.
3:15 418.07 Understanding the impact of activation of ERbeta
in the brain - potential for broad spectrum efficacy across a
range of CNS disorders. F. LIU. Pfizer.
3:35 418.08 Closing Remarks.
84 | Society for Neuroscience
MINISYMPOSIUM Walter E. Washington Convention Center
419. Melanopsin-Positive Intrinsically Photosensitive Retinal
Ganglion Cells: How Form Fits Function — CME
Mon. 1:30 PM - 4:00 PM — 207B
Chair: A. MATYNIA
Co-Chair: S. HATTAR
Melanopsin-containing, intrinsically photosensitive retinal
ganglion cells (ipRGCs) are uniquely positioned to integrate
visual information as they independently detect light and
receive input from rod and cone photoreceptors. This
minisymposium presents cutting-edge research on the
form and function of ipRGCs, from identification of novel
subclasses, unique physiological light responses, and
retinal circuitry to their role in eliciting central responses and
behavioral outcomes.
1:30 419.01 Introduction.
1:35 419.02 Morphology, physiology and synaptic mechanisms
of the melanopsin pathway in the primate. D. M. DACEY.
Univ. Washington.
1:55 419.03 Cellular properties and retinal connectivity of
ipRGCs. T. SCHMIDT. Johns Hopkins Univ.
2:15 419.04 Melanopsin retinal ganglion cells, intrinsic
responses to single photons and steady light. M. H. DO.
Children’s Hosp. Boston and Harvard Med. Sch.
2:35 419.05 Central responses to melanopsin photoreception.
R. LUCAS. The Univ. of Manchester.
2:55 419.06 Light-associated allodynia and ipRGCs: Seeing
photophobia in a different light. A. MATYNIA. UCLA.
3:15 419.07 Diversity and function of ipRGCs. S. HATTAR.
Johns Hopkins Univ.
3:35 419.08 Closing Remarks.
PRESIDENTIAL SPECIAL LECTURE
Walter E. Washington Convention Center
420. Genes, the Environment, and Decisions: How Fixed
Circuits Generate Flexible Behaviors
Mon. 5:15 PM - 6:25 PM — Hall D
Speaker: C. I. BARGMANN, Rockefeller Univ.
Support contributed by MedImmune
How do genes and the environment interact to generate
flexible behaviors? How are behavioral decisions modified
by context and experience? Genetic variation, internal
states, and environmental conditions converge on common
neuronal circuits to regulate behaviors in the nematode
worm C. elegans. Analysis of these circuits shows the
detailed wiring diagram of C. elegans is both incomplete
and ambiguous, because modulatory inputs invisible in the
anatomical wiring change the flow of information.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

NANOSYMPOSIUM
421. Synapse Formation: CNS II
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, 144A
1:00 421.01 Seizure-related gene 6 stabilizes dendritic filopodia
and developing excitatory synapses. J. M. GUNNERSEN*;
N. L. CARRODUS; J. M. BARWOOD; J. MATEOS; P.
SONDEREGGER; M. J. KENNEDY; M. D. EHLERS; S. TAN.
Howard Florey Inst., Univ. of Zurich, Univ. of Zurich, Duke
Univ., Pfizer Global Res. and Develop.
1:15 421.02 PAH particles perturb prenatal process and
phenotypes: Protection from deficits in object discrimination
afforded by dampening of brain-oxidoreductase following in
utero exposure to inhaled benzo(a)pyrene. D. B. HOOD*;
Z. LI; G. CHADALAPAKA; A. RAMESH; M. MAGUIRE; R.
RHOADES; X. DING; M. ASCHNER; S. SAFE. Meharry
Med. Col., Texas A&M Hlth. Sci. Ctr., Meharry Med. Col.,
Meharry Med. Col., Vanderbilt Univ., Wadsworth Ctr.,
Vanderbilt Univ. Sch. of Med., Texas A & M Univ.
1:30 421.03 Netrin-mediated mechanisms of synaptogenesis
and axon arborization. D. A. COLÓN-RAMOS*; A. STAVOE;
J. NELSON. Yale Univ.
1:45 421.04 Circadian rhythm contributes to diurnal
synaptogenesis in vivo. X. DU*; Y. LI; J. DU. Inst. of
Neurosci. and State Key Lab. of Neuroscience, Shanghai
Inst. for Biol. Sciences, Chinese Acad. of Sci.
2:00 421.05 Tlx3 controls the assembly of spinal circuits
necessary for pain and itch sensations. C. A. SARAIVA
LOPES*; Y. XU; Q. MA; C. BIRCHMEIER. Dana Farber
Cancer Inst., Max-Delbrück-Center for Mol. Med. (MDC).
2:15 421.06 From adhesion to cytoskeletal remodeling: A
novel pathway for shaping synapses. L. M. CHEADLE*; T.
BIEDERER. Yale Univ., Yale Univ.
2:30 421.07 SynCAM cis assembly instructs synaptic adhesion.
T. BIEDERER*; M. STAGI; A. I. FOGEL. Yale Univ., Yale
Univ., Natl. Inst. of Neurolog. Disorders and Stroke.
2:45 421.08 Serotonin 1A receptor-mediated synaptogenic
signaling during neonatal hippocampal development. D.
KERR; A. MOGHA; S. R. GUARIGLIA; P. R. DEBATA; M.
RAGHUNATH; G. WEN; P. BANERJEE*. CUNY Grad. Ctr.,
The Col. of Staten Island (CUNY), Inst. for Basic Res. in
Developmental Disabilities, City Univ. New York Staten Isla.
3:00 421.09 Target-derived matricryptins signal through
integrins to induce climbing fiber nerve terminal formation.
M. A. FOX*; J. SU. Virginia Commonwealth Univ., Virginia
Commonwealth Univ.
3:15 421.10 • The developing connectome: High resolution
structural analysis reveals competition among growing
calyces of Held. G. A. SPIROU*; B. K. HOFFPAUIR; M. H.
DEHOFF; T. DEERKINCK; M. H. ELLISMAN. West Virginia
Univ. Sch. Med., Univ. of California at San Diego.
3:30 421.11 GABAA transmission regulates dendritic spine
density in the developing hippocampus. C. SALMON*; E.
JONES; K. MURAI. Ctr. For Res. In Neurosci., McGill.
3:45 421.12 Cbln1-GluD2 signaling induces dynamic structural
changes of parallel fibers at the onset of cerebellar synapse
formation. A. ITO-ISHIDA*; T. MIYAZAKI; E. MIURA; K.
MATSUDA; M. WATANABE; M. YUZAKI; S. OKABE. The
Univ. of Tokyo, Keio Univ., Hokkaido Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
NANOSYMPOSIUM
422. Alzheimer’s Disease: Neuroinflammation and Immune
Mechanisms I
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, 140A
1:00 422.01 Neuroinflammation as an early event and prime
mover in Alzheimer’s disease. T. C. TOWN*; T. MORI;
R. M. COHEN; J. TAN; K. REZAI-ZADEH. Cedars-Sinai
Med. Center/Ucla, Saitama Med. Ctr. and Univ., Dept. of
Psychiatry and Behavioral Neurosciences, Cedars-Sinai
Med. Center/Ucla, Univ. of South Florida Col. of Med.,
Regenerative Med. Inst., Cedars-Sinai Med. Ctr.
1:15 422.02 Intrinsic neuronal innate immunity regulates
caspase-6 activity. V. KAUSHAL*; A. C. LEBLANC. Lady
Davis Inst. For Med. Res., McGill Univ.
1:30 422.03 MK2 deficiency attenuates high fat/high cholesterol
diet-induced amyloidogenesis in a mouse model of
Alzheimer’s disease. N. R. BHAT*; J. HIRSCHHORN; S.
MOHANTY. Med. Univ. South Carolina.
1:45 422.04 RAGE mediates ischemia induced synaptic
depression in amyloid enriched environment. N. ORIGLIA*;
O. ARANCIO; S. YAN; L. DOMENICI. CNR, Columbia Univ.,
Univ. of Kansas, Univ. of L’Aquila.
2:00 422.05 The astrocyte inflammatory response is modulated
by kinins: Possible implications for Alzheimer’s disease. S.
FLEISHER-BERKOVICH*; T. FILIPOVICH-RIMON. Dept. of
Clin. Pharmacol.
2:15 422.06 CX3CR1 deficiency promotes alternative activation
of microglia and β-amyloid degradation in a mouse model of
Alzheimer’s disease. S. LEE*; B. LAMB. Lerner Res. Inst.
2:30 422.07 Complement receptor type 3-deficiency
reduces amyloid β burden in an APP/PS-1 mouse model
of Alzheimer’s disease. H. FU*; B. LIU; J. FROST; T.
MAYADAS; C. LEMERE. Ctr. For Neurologic Diseases,
Brigham & Women’s Hosp., Harvard Med. Sch., Brigham
and Women’s Hosp.
2:45 422.08 • Identification of brain-reactive autoantibodies in
human sera and their potential in diagnosing Alzheimer’s
disease. M. HAN*; E. NAGELE; C. DEMARSHALL; R.
NAGELE. UMDNJ - Stratford, UMDNJ, Durin Technologies,
Inc.
3:00 422.09 Neuronal expression of peptidylarginine deiminase
4 (PAD4) and protein citrullination occurs in response to
cell stress and damage and is linked to Alzheimer’s disease
pathology. N. K. ACHARYA*; M. HAN; M. KOSCIUK; R.
NAGELE; M. D’ANDREA. New Jersey Inst. of Successful
Aging (NJISA), Coriell Inst.
3:15 422.10 • Therapeutic versus neuroinflammatory effects of
passive immunization is dependent on Aβ/amyloid burden
in a transgenic mouse model of Alzheimer’s disease. R. S.
TURNER*; S. MINAMI; E. SIDAHMED; S. AID; M. SHIMOJI;
T. NIIKURA; I. MOCCHETI; W. REBECK; C. DEALWIS;
F. BOSETTI; Y. MATSUOKA; H. HOE. Georgetown Univ.
Med. Ctr., BPMS /NIA/ NIH, Case Western Reserve Univ.,
GlaxoSmithKline.
3:30 422.11 Systemic infections using the Toll-like receptor 3
agonist PolyI:C promote Amyloid-β and Tau pathology in
non-transgenic mice. I. KNUESEL*; A. MADHUSUDAN; J.
DOEHNER; C. IMHOF; A. MANALASTAS; M. HILFIKER; K.
BREU; D. KRSTIC. Univ. of Zurich.
Neuroscience 2011 | Monday PM | 85
Mon. PM
NANOSYMPOSIUM

NANOSYMPOSIUM
3:45 422.12 The effects of allergy on the brain with focus
on inflammatory aspects and Alzheimer’s disease. H.
SARLUS; X. WANG; C. O. HÖGLUND; B. KARSHIKOFF; M.
LEKANDER; M. SCHULTZBERG*; M. OPRICA. Karolinska
Institutet.
NANOSYMPOSIUM
423. Parkinson’s Disease: Cellular Mechanisms II
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, 152A
1:00 423.01 SUMOylation of the neuronal CDK5 activator
protein p35. A. BUECHNER; P. KRUMOVA; K.
ECKERMANN; M. BAEHR*; J. H. WEISHAUPT. Univ.
Goettingen, Novartis Inst. for Biomed. Res.
1:15 423.02 Leucine-rich repeat kinase 1 and 2: A biochemical
comparison. E. GREGGIO*; L. CIVIERO; F. GAO; A.
BEILINA; E. LOBBESTAEL; R. VANCRAENENBROECK;
L. BUBACCO; V. BAEKELANDT; M. R. COOKSON; J.
TAYMANS. Univ. of Padova, KULeuven, Natl. Inst. on Aging.
1:30 423.03 Protein array analysis reveals EGF-R and 14-3-3
as differential interactors of LRRK1 and LRRK2, respectively.
J. TAYMANS*; L. CIVIERO; A. BEILINA; L. REYNIERS; F.
GAO; E. LOBBESTAEL; L. BUBACCO; V. BAEKELANDT;
E. GREGGIO; M. R. COOKSON. Lab. Neurobio. & Gene
Therapy, KULeuven, Dept. of Biol., Lab. of neurogenetics,
Natl. Inst. on Aging, NIH.
1:45 423.04 • LRRK2 is involved in the regulation of
mitochondrial dynamics. X. ZHU*; B. SU; H. FUJIOKA; G.
PERRY; X. WANG. Case Western Reserve Univ., Case
Western Reserve Univ., Univ. of Texas at San Antonio.
2:00 423.05 Synucleins sense and generate curvature. C.
WESTPHAL; S. S. CHANDRA*. Yale Univ., Yale Univ.
2:15 423.06 Oxidation of the cysteine-rich regions of parkin
perturbs its E3 ligase activity and contributes to protein
aggregation. Z. GU*; F. MENG; D. YAO; Y. SHI; J.
KOBAKOFF; W. WU; J. REICHER; Y. MA; B. MOOSMANN;
E. MASLIAH; S. A. LIPTON. Univ. Missouri Sch. Med.,
Sanford-Burnham Med. Res. Inst., Chinese Acad. of Sci.
Beijing Inst. of Genomics, Univ. of California at San Diego
Sch. of Med.
2:30 423.07 The mitochondrial permeability transition pore
regulates neurodegeneration in Parkinson’s disease-linked
mutant alpha-synuclein transgenic mice. L. J. MARTIN*; S.
SEMENKOW; M. WONG. Johns Hopkins Univ. Sch. of Med.
2:45 423.08 � Identification of protein phosphatases
that mediate the phosphorylation status of LRRK2 in
cells. E. LOBBESTAEL*; J. TAYMANS; F. GAO; R.
VANCRAENENBROECK; M. BEULLENS; M. BOLLEN; M.
R. COOKSON; V. BAEKELANDT. Catholic Univ. Leuven,
NIH.
3:00 423.09 A mechanism underlying burst activity in
subthalamic neurons emerging through NMDA activation
and hyperpolarization. S. KUBOTA*; J. RUBIN. Yamagata
University, Grad. Sch. of Sci. and Engin., Univ. of Pittsburgh.
3:15 423.10 Inhibition of Liver X receptors reduces α-Synuclein
and activation of estrogen receptors increases tyrosine
hydroxylase expression levels in human SH-SY5Y
neuroblastoma cells. G. A. MARWARHA*; O. GHRIBI. Univ.
of North Dakota.
86 | Society for Neuroscience
3:30 423.11 L-DOPA accumulation in astrocytic endfeet
surrounding blood vessels. M. Y. INYUSHIN*; A. HUERTAS;
Y. V. KUCHERYAVYKH; L. KUCHERYAVYKH; V. TSYDIK;
P. SANABRIA; M. J. EATON; S. SKATCHKOV; W. D.
WESSINGER; L. V. ROJAS. Univ. Central del Caribe, Univ.of
Arkansas for Med. Sci.
3:45 423.12 NMDA-induced down-regulation of evokeddopamine
release in the mouse striatum is mediated
by GluN2D-containing NMDA receptors in cholinergic
interneurons. X. ZHANG*; K. CHERGUI. Karolinska Inst.
NANOSYMPOSIUM
424. Other Neurodegenerative Disorders III
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, 143A
1:00 424.01 Prongf\ngf inbalance triggers neurodegeneration
in transgenic mice. L. FASULO; S. CAPSONI; C. TIVERON;
F. MALERBA; F. PAOLETTI; S. MARINELLI; N. BERRETTA;
R. NISTICÒ; R. BRANDI; P. CAPELLI; A. DALFINI; S.
D’AGUANNO; F. FLORENZANO; E. FORMAGGIO; F. LA
REGINA; L. PISTILLO; R. SCARDIGLI; S. PICCININ; D.
VIGNONE; A. URBANI; F. PAVONE; A. CATTANEO*. EBRI -
European Brain Res. Inst., Scuola Normale Superiore, CNR,
Fondazione Santa Lucia IRCCS, Univ. di Verona, Univ. of
Rome Tor Vergata.
1:15 424.02 • Neural substrates of executive function deficits
in fragile x-associated tremor/ataxia syndrome. J. YANG*;
S. KHAN; S. CHAN; A. SCHNEIDER; R. NANAKUL; A.
SERITAN; F. TASSONE; R. HAGERMAN; J. M. OLICHNEY.
UC Davis, Univ. of California, Davis, Univ. of California,
Davis, Natl. Taiwan Normal Univ., Univ. of California, Davis,
Univ. of California, Davis, Univ. of California, Davis, Univ. of
California, Davis, Univ. of California, Davis.
1:30 424.03 • Autoimmunity and neurodegeneration: What
is the mechanism that triggers neuronal cell death? J.
DOUGLAS*; C. J. GROOVER; L. A. GARDNER; M. C.
LEVIN. Univ. of Tennessee Hlth. Sci. Ctr., VA Med. Ctr., VA
Med. Ctr.
1:45 424.04 Measuring longitudinal progression in primary
progressive aphasia: Rates of cortical thinning in PPAsignature
regions compared with clinical progression. D.
SAPOLSKY*; K. DOMOTO-REILLY; M. BRICKHOUSE; B.
DICKERSON. Massachusetts Gen. Hosp, Massachusetts
Gen. Hosp., MGH.
2:00 424.05 Maternal intrauterine inflammation results
in persistant microglial activation to a pro-inflmmatory
phenotype in the neonatal rabbit. A. JYOTI*; H. DAI; B.
BALAKRISHNAN; R. ROMERO; D. CHUGANI; S. KANNAN.
Dept. of Pediatrics, Children’s Hosp. of Michigan, Wayne
State Universit, Perinatology Res. Branch, NICHD, NIH,
DHHS, Bethesda, Maryland, Dept. of Radiology, Children’s
Hosp. of Michigan, Wayne State Univ. Sch. of Medicine,.
2:15 424.06 • Targeting Transthyretin for the treatment of
Transthyretin-associated polyneuropathy using antisense
technology. S. GUO*; S. BOOTEN; L. ALVARADO;
A. SIWKOWSKI; M. BENSON; B. MONIA. ISIS
Pharmaceuticals, Indiana Univ. Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

2:30 424.07 AAV2/5-mediated gene therapy synergies with
bone marrow transplantation in the treatment of infantile
neuronal ceroid lipofuscinosis (INCL). S. L. MACAULEY*;
M. S. ROBERTS; A. WONG; A. S. REDDY; J. D. COOPER;
M. S. SANDS. Washington Univ. Sch. of Med., King’s Col.
London.
2:45 424.08 Age-dependent cognitive decline typical of FTLD in
transgenic mice expressing the 25-kDa C-terminal fragment
of TDP-43. S. ODDO*; A. CACCAMO; S. MAJUMDER. UT
Hlth. Sci. Ctr., Univ. of Texas Hlth. Sci. Ctr. at San Antonio.
3:00 424.09 • The impact of aging on retinal gene expression
in a mouse glaucoma model. M. M. WALSH*; A. SAHA; M.
WEBB; P. FERREIRA. Duke Univ., Duke Univ.
3:15 424.10 • Detection of the induction or inhibition of
autophagy in primary neuronal cultures. N. J. DOLMAN*;
D. BEACHAM; K. CHAMBERS; B. MANDAVILLI; R.
BATCHELOR; M. JANES. Mol. Probes/Life Technologies,
Mol. Probes® Labeling and Detection Technologies – Life
Technologies,.
3:30 424.11 HDAC6 inhibitors reverse the phenotype of
transgenic mice recapitulating Charcot-Marie-Tooth
disease. C. D’YDEWALLE; J. KRISHNAN; D. CHIHEB;
P. VAN DAMME; J. IROBI; A. KOZIKOWSKI; P. VANDEN
BERGHE; V. TIMMERMAN; W. ROBBERECHT; L. M. VAN
DEN BOSCH*. Campus Gasthuisberg O/N2, VIB, Univ. of
Antwerpen, VIB, Univ. of Illinois at Chicago.
3:45 424.12 CSF Transferrin is a disease specific diagnostic
test for prion disorders. A. SINGH*; A. BEVERIDGE; N.
SINGH. Case Western Reserve Univ., Case Western
Reserve Univ.
4:00 424.13 Prion protein inhibits kinesin-1 and dynein based
fast axonal transport. G. F. PIGINO*; Y. SONG; G. MORFINI;
J. MA; S. LINDQUIST; L. JUNGBAUER; M. LADU; S.
BRADY. Univ. Illinois-Chicago, Harvard Med. Sch., Univ. of
Illinois, Ohio State Univ., Massachussets Inst. of Technol.
4:15 424.14 PrPSc generated in vivo and in vitro show distinct
differences. N. SINGH*; A. SINGH. Case Western Reserve
Univ.
NANOSYMPOSIUM
425. Animal Models and Mechanisms I
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, 145B
1:00 425.01 A Drosophila neuroligin regulates synaptic growth
and function in response to activity and Phosphoinositide
3 kinase. B. MOZER*; D. SANDSTROM. NHLBI Intramural
Res. Program, Natl. Inst. of Mental Hlth.
1:15 425.02 Conditional deletion of IKBKAP in the peripheral
nervous system: a mouse model for Familial Dysautonomia.
F. LEFCORT*; M. CHAVERRA; L. GEORGE; M. ORR;
A. GRINDELAND; G. A. CARLSON; B. J. HUNNICUTT.
Montana State Univ., McLaughlin Res. Inst., Montana State
Univ. and Oregon Hlth. Sci. Univ.
1:30 425.03 Cns neuronal function in neurofibromatosis-1
is impaired in a camp/pka/rock-dependent manner. J.
A. BROWN*; S. M. GIANINO; D. H. GUTMANN. Neurol.
Washington Univ. Sch. of Med.
1:45 425.04 A histone demethylase, JARID1C, is required for
learning and memory. S. IWASE*; Y. SHI; J. XU. Children’s
Hosp. Boston, Tufts Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 425.05 Transgenic overexpression of Ube3a, modeling
15q11-13 duplication, produces autism-like behavior and
reduced glutamatergic synaptic transmission in mice. S. E.
SMITH*; Y. ZHOU; G. ZHANG; Z. JIN; D. C. STOPPEL; M.
P. ANDERSON. BIDMC.
2:15 425.06 C-fos-based whole-brain analysis of social
behavior-evoked neural activation in mouse models of
autism. Y. KIM*; K. UMADEVI VENKATARAJU; P. OSTEN.
Cold Spring Harbor Lab.
2:30 425.07 � Classification of ultrasonic vocalizations in a
tuberous sclerosis mouse model of autism. A. C. LEGGITT*;
A. LATSHAW; D. YOUNG; L. JAN; Y. JAN; Z. ADAHMAN;
A. K. SCHENK. Univ. of California, San Francisco, Univ. of
San Francisco, Univ. of California, San Francisco, Univ. of
California, Berkeley, Howard Hughes Med. Inst., Randolph Col.
NANOSYMPOSIUM
426. Neuroprotective Agents and Mechanisms
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, 150B
1:00 426.01 Docosahexaenoic acid in combination with aspirin
enhances neuroprotection in the postischemic brain. N. G.
BAZAN; L. KHOUTOROVA*; T. N. EADY; K. D. ATKINS; A.
OBENAUS; L. BELAYEV. LSU, Loma Linda Univ.
1:15 426.02 Identification of a neuroprotective compound to
ameliorate chemotherapy induced peripheral neuropathy. A.
HOKE*; W. CHEN; J. ZHU. Johns Hopkins Univ.
1:30 426.03 Lamotrigine protects CNS neurons from glutamateinduced
excitotoxicity by HDAC inhibition and Bcl-2
induction. Y. LENG*; D. CHUANG. Natl. Inst. Mental Health/
NIH, Natl. Inst. Menatal Health/NIH.
1:45 426.04 L-Ergothioneine, a unique mitochondrial
cytoprotectant. B. D. PAUL*; S. H. SNYDER. Johns Hopkins
Univ. Sch. of Med.
2:00 426.05 CHIP-mediated degradation of hippocampal
estrogen receptor-α and the critical period hypothesis of
estrogen neuroprotection. D. W. BRANN*; D. HAN; R.
WANG; F. YANG; R. VADLAMUDI; Q. ZHANG. Georgia Hlth.
Sci. Univ., Hebei United Univ., Univ. of Texas Hlth. Sci. Ctr.
2:15 426.06 Neuroprotection against traumatic brain injury by a
peptide derived from collapsin response mediator protein 2
(crmp-2). J. M. BRITTAIN*; L. CHEN; T. BRUSTOVETSKY;
X. GAO; S. M. WILSON; N. M. ASHPOLE; A. HUDMON; N.
BRUSTOVETSKY; J. CHEN; R. KHANNA. Indiana Univ.
2:30 426.07 Adeno-associated virus (AAV)-mediated
expression of the mitochondrial protein prohibitin (PHB)
prevents neuronal death in vitro and in vivo. H. KURINAMI*;
L. QIAN; J. ANRATHER; C. IADECOLA; P. ZHOU. Weill
Cornell Med. Col., Weill Cornell Med. Col.
NANOSYMPOSIUM
427. Alcohol Reward: Neural Mechanisms
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, 147B
1:00 427.01 Novel mechanisms mediating memory for alcohol
reward in Drosophila. K. KAUN*; S. YONG; R. AZANCHI; U.
HEBERLEIN. Univ. of California, San Francisco.
Neuroscience 2011 | Monday PM | 87
Mon. PM
NANOSYMPOSIUM

NANOSYMPOSIUM
1:15 427.02 Bidirectional interactions between the circadian
clock and alcohol neurobiology in Drosophila. L. C. LYONS*;
K. VAN DER LINDE. Florida State Univ.
1:30 427.03 Histamine H3 receptors: Alcohol consumption and
alcohol reward in mice. S. NUUTINEN*; M. LINTUNEN; J.
VANHANEN; T. OJALA; S. ROZOV; P. PANULA. Univ. of
Helsinki/,Neuroscience Ctr. and Inst. of Biomedicine, Abo
Akademi Univ.
1:45 427.04 Delta-9-tetrahydrocannabinol decreases alcohol
intake in the Syrian golden hamster. D. GULICK*; E.
TEMPLETON; A. I. GREEN. Dartmouth Med. Sch.
2:00 427.05 Peri-adolescent ethanol (E) drinking enhances
the sensitivity to, and increases the stimulatory effects of,
E microinjected into the posterior ventral tegmental area on
dopamine release in the nucleus accumbens shell in alcoholpreferring
(P) rats. J. E. TOALSTON*; Z. A. RODD; S. M.
OSTER; Z. M. DING; R. L. BELL; J. M. MURPHY; W. J.
MCBRIDE. IUPUI-Purdue Sch. Sci., Indiana Univ. Sch. Med.
2:15 427.06 The effects of gene knockout of the vesicular
monoamine transporter 2 (VMAT2; SLC18A2) and the
dopamine transporter (DAT; SLC3A6) on drinking in the dark
(DID). M. T. PERONA*; F. S. HALL; Z. LIN; G. R. UHL. Natl.
Inst. On Drug Abuse, Natl. Inst. On Drug Abuse, Harvard
Med. Sch., McLean Hosp.
2:30 427.07 Naltrexone modulates distinct stages of ethanolstimulated
dopamine release. J. P. VALENTA*; J. L.
HUNTER; J. K. LEE; A. J. SOHN; S. L. ZANDY; J. M. RENO;
C. J. SCHIER; R. A. MANGIERI; E. C. HOWARD; R. A.
GONZALES. Univ. of Texas At Austin, Univ. of Texas at
Austin.
2:45 427.08 Disturbances in behavior and cortical enkephalin
expression during the anticipation of ethanol access in
high drinking animals. I. MORGANSTERN*; S. LIANG; O.
KARATAYEV; S. F. LEIBOWIITZ. Rockefeller Univ.
3:00 427.09 BDNF as a putative mediator for “binge”-like
prenatal alcohol exposure-associated increase in alcohol
intake and preference in rat pups. Y. L. CHEN*; M. XIE; M.
NIZHNIKOV; F. TAO; S. MILLER; C. HUESTON; Y. CAO;
T. DEAK; N. E. SPEAR. The State Univ. of New York at
Binghamton, The State Univ. of New York at Binghamton.
3:15 427.10 Differential persistence of reinstatement by stimuli
conditioned to ethanol versus conventional reward. P.
PANDEY*; R. MARTIN-FARDON; F. WEISS. The Scripps
Res. Inst.
3:30 427.11 Social enrichment differentially alters alcohol
intake in two different self-administration paradigms. A. K.
STAROSCIAK*; N. E. GRUNBERG. Univ. of Miami Miller
Sch. of Med., Uniformed Services Univ. of the Hlth. Sci.
NANOSYMPOSIUM
428. Striate Cortex: Functional Organization II
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, 146A
1:00 428.01 Identifying biological signatures of occipital
white matter pathways with novel quantitative magnetic
resonance imaging methods. J. YEATMAN*; A. MEZER; B.
A. WANDELL. Stanford Univ., Stanford Univ.
88 | Society for Neuroscience
1:15 428.02 Lateral pulvinar and the salience of
stimulus representation in primary visual cortex. G.
PURUSHOTHAMAN*; K. LI; R. MARION; D. YAMPOLSKY;
Y. JIANG; V. A. CASAGRANDE. Vanderbilt Univ.
1:30 428.03 Receptive field properties estimated by spiking
activity and local field potentials (LFP) in tree shrew primary
visual cortex (V1). J. VEIT*; A. BHATTACHARYYA; R.
KRETZ; G. RAINER. Univ. De Fribourg.
1:45 428.04 A universal retinotopic map of V1 based on surface
anatomy. G. K. AGUIRRE*; N. C. BENSON; O. H. BUTT;
R. DATTA; D. H. BRAINARD. Univ. Pennsylvania, Univ. of
Pennsylvania.
2:00 428.05 A link between the orientation and retinotopic
maps in tree shrew V1. S. PAIK*; D. L. RINGACH. Univ. of
California at Los Angeles, Univ. of California at Los Angeles.
2:15 428.06 Variability of orientation tuning for nearby neurons
in cytochrome oxidase patches versus interpatches in
macaque V1. J. R. ECONOMIDES*; D. L. ADAMS; J. C.
HORTON; L. C. SINCICH. UCSF, UAB.
2:30 428.07 A geometric principle of pinwheel-fracture inverse
correlation predicts organizations of orientation maps from
primates to rodents. Y. MENG*; S. TANAKA; C. POON. MIT,
The Univ. of Electro-Communications.
2:45 428.08 Precise three-dimensional functional microorganization
in neocortical layer V. T. HOSOYA*; H.
MARUOKA; K. KUBOTA; R. KUROKAWA; S. TSURUNO.
RIKEN.
3:00 428.09 Balanced amplification and normalization in a
simple circuit model of visual cortex explain multiple aspects
of attentional modulation. K. D. MILLER*; D. B. RUBIN.
Columbia Univ.
3:15 428.10 Normalization in a simple circuit model of visual
cortex explains stimulus-induced reduction in shared
variability. D. B. RUBIN*; K. D. MILLER. Columbia Univ.
3:30 428.11 A quantitative comparison between geniculate
axons in V1 and pulvinar axons in V2. R. T. MARION*; K. LI;
G. PURUSHOTHAMAN; D. YAMPOLSKY; D. YAMPOLSKY;
Y. JIANG; M. JULIA; V. CASAGRANDE. Vanderbilt Univ.
NANOSYMPOSIUM
429. Circadian Regulation of Behavior
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, 147A
1:00 429.01 SCN formation and maturation: Influence of
transcription factors, retinal innervation, and vip signaling. C.
M. VANDUNK*; P. A. GRAY. Washington Univ. in St. Louis
Sch. of Med.
1:15 429.02 Developmental influences of the suprachiasmatic
nucleus on circadian and ultradian rhythms of sleep and
wakefulness in infant rats. A. J. GALL*; M. S. BLUMBERG.
Univ. Iowa.
1:30 429.03 Sustained activation of GABA A receptors in the
SCN is necessary and sufficient to produce light-induced
phase delays of the circadian clock. D. L. HUMMER*; T. E.
LARKIN; C. A. WALKER; J. R. PAMPLIN, II; D. DHANRAJ;
P. D. DELISSER; J. C. EHLEN; H. E. ALBERS. Morehouse
Col., Ctr. for Behavior Neurosci., Morehouse Sch. of Med.,
Georgia State Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:45 429.04 Dark pulse-induced phase shifts are altered in
the 5-HT1A receptor knockout mouse. V. M. SMITH*; R. T.
JEFFERS; M. C. ANTLE. Univ. of Calgary, Univ. of Calgary,
Univ. of Calgary.
2:00 429.05 Suprachiasmatic nucleus control of brain circadian
rhythmicity in split hamsters. M. RAINBOW*; M. P. BUTLER;
E. RODRIGUEZ; S. LYON; R. SILVER. Columbia Univ.,
Barnard Col., Columbia Univ. Med. Ctr.
2:15 429.06 Circadian regulation of bird song by pineal
melatonin. V. M. CASSONE*; G. WANG; C. E. HARPOLE; A.
K. TRIVEDI. Univ. of Kentucky, Univ. of Kentuck.
2:30 429.07 The impact of age on circadian desynchrony in
the Per2luc mouse. M. E. HARRINGTON*; I. SONG; E.
FEDERYUK; P. MOLYNEUX; G. LALL; S. BIELLO. Smith
Col., Smith Col., Medway Sch. of Pharm., Univ. Glasgow.
2:45 429.08 Disruption of circadian timing by cocaine action in
the mesolimbic reward pathway. A. J. BRAGER*; J. GLASS;
R. A. PROSSER. Kent State Univ., Univ. of Tennessee.
3:00 429.09 Neural correlates of food anticipatory activity in
the ventromedial hypothalamus. M. MERKESTEIN*; G. VAN
DER PLASSE; M. C. M. LUIJENDIJK; M. VAN DER ROEST;
H. G. M. WESTENBERG; A. B. MULDER; R. A. H. ADAN.
Rudolf Magnus Inst. of Neurosci., Rudolf Magnus Inst. of
Neuroscience, Univ. Med. Ctr. Utrecht, Neurosci. Campus
Amsterdam, VU Univ. Med. Ctr.
3:15 429.10 Assessment of individual circadian phenotypes
using biopsy samples. A. HIDA*; S. KITAMURA; M.
WATANABE; M. ENOMOTO; Y. KATAYOSE; S. ARITAKE;
S. HIGUCHI; M. KATO; Y. MORIGUCHI; M. IKEDA; K.
MISHIMA. Natl. Ctr. of Neurol. and Psychiatry, Saitama Med.
Univ.
NANOSYMPOSIUM
430. The Social Human Animal
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, 201
1:00 430.01 The role of the anterior temporal lobes in
processing specific levels of information vs. social
information. L. M. SKIPPER; I. R. OLSON*. Temple Univ.,
Temple Univ.
1:15 430.02 Precuneus and anterior temporal lobe reflect basic
computations required for learning the social attributes of
others. D. A. STANLEY*; A. RANGEL. Caltech.
1:30 430.03 A dyadic fMRI study of direct interactions between
two brains. R. LEE*; W. DAI; J. JONES. Princeton Univ.
1:45 430.04 Positively biased processing of social feedback.
C. W. KORN*; K. PREHN; H. WALTER; H. R. HEEKEREN.
Freie Univ. Berlin, Freie Univ. Berlin, Charité Univ. Med.
Berlin.
2:00 430.05 Reading fiction improves reading minds: The role
of the default network. D. I. TAMIR*; A. B. BRICKER; J. P.
MITCHELL. Harvard Univ., Stanford Univ.
2:15 430.06 Action alters perception: How imitation alters the
neural encoding of race. E. A. REYNOLDS LOSIN*; M.
IACOBONI; M. DAPRETTO. Univ. of California, Univ. of
California.
2:30 430.07 Age-related changes to the neural correlates of
social evaluation. B. S. CASSIDY*; A. H. GUTCHESS.
Brandeis Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:45 430.08 Unconscious finger movement synchronization as
a somatic marker of implicit social interaction. K. YUN*; K.
WATANABE; S. SHIMOJO. Caltech, Univ. of Tokyo.
3:00 430.09 Effect of attractiveness level on frontal theta
responses to social ostracism. J. M. WILLIAMS*; D. KERN.
Illinois Wesleyan Univ.
3:15 430.10 Mirror, mirror, on the wall, how does my brain
recognize me at all? D. BUTLER*; D. BUTLER*; J. B.
MATTINGLEY; R. CUNNINGTON; T. SUDDENDORF.
Level 3 McElwain Building, Univ. of Queensland, Univ. of
Queensland.
3:30 430.11 Imaging first impressions: Distinct neural
processing of verbal and nonverbal social information.
B. KUZMANOVIC*; G. BENTE; D. Y. VON CRAMON; M.
TITTGEMEYER; K. VOGELEY. Univ. Hosp. Cologne, Univ.
of Cologne, Max-Planck Inst. for Neurolog. Res., Res. Ctr.
Juelich.
3:45 430.12 Macro and microprobe x-ray fluorescence
analysis of elemental distribution in Williams Syndrome
neuronal tissue. A. LAM*; E. L. OHAYON; S. M. WEBB; K.
SEMENDEFERI; U. BELLUGI. Salk Inst. For Biol. Studies,
Univ. of California San Diego, Stanford Synchrotron
Radiation Lightsource.
NANOSYMPOSIUM
431. Functional Mechanisms of Attention by Animal
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, 152B
1:00 431.01 Functional neuroimaging of the nonhuman primate
social brain. C. J. MACHADO*; E. BLISS-MOREAU; A. Z.
SNYDER; M. L. PLATT; S. R. CHERRY; D. G. AMARAL.
Univ. of California, Davis, Washington Univ. Sch. of Med.,
Duke Univ., Univ. of California, Davis.
1:15 431.02 Bilateral representation of space in macaque
dorsolateral prefrontal neurons during target selection. T.
LENNERT*; J. C. MARTINEZ-TRUJILLO. McGill Univ.
1:30 431.03 • Contribution of NMDA receptors to attentioninduced
reduction of firing rate variance and noise
correlation in V1. A. THIELE*; J. HERRERO. Newcastle
Univ.
1:45 431.04 Brain state dependent role of attention in
perceptual processing and decision making. N. EMADI; H.
ESTEKY*. IPM Sch. of Cognitive Sci.
2:00 431.05 Attentional modulation of firing rate varies with
burstiness across putative pyramidal neurons in macaque
visual Area V4. E. B. ANDERSON*; J. F. MITCHELL; J. H.
REYNOLDS. Systems Neurobio. Laboratory, Salk Inst. of
Biol. Sci., UCSD.
2:15 431.06 Towards a mechanistic understanding of the role
of gamma oscillations in attention: An avian midbrain model.
S. DEVARAJAN*; E. I. KNUDSEN. Stanford Univ., Stanford
Univ.
2:30 431.07 Neural basis of distracter filtering in the pulvinar. Y.
B. SAALMANN*; X. LI; S. KASTNER. Princeton Univ.
Neuroscience 2011 | Monday PM | 89
Mon. PM
NANOSYMPOSIUM

NANOSYMPOSIUM
NANOSYMPOSIUM
432. Cellular Imaging
Theme G: Novel Methods and Technology Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, 206
1:00 432.01 Multimodality bioluminescence and MRI monitoring
of intraarterially delivered, VLA-4 expressing glial progenitors
for improved targeting to brain lesions. P. WALCZAK*; M.
JANOWSKI; M. GORELIK; C. ENGELS; I. ORUKARI; J.
W. M. BULTE. Johns Hopkins Univ., Johns Hopkins Univ.,
Mossakowski Med. Res. Centre, Polish Acad. of Sci.,
Mossakowski Med. Res. Centre, Polish Acad. of Sci.
1:15 432.02 • Non-invasive, bioluminescent imaging reveals
that CNS allograft tolerance/rejection is highly dependant
on its implantation site. C. ENGELS*; M. JANOWSKI; M.
GORELIK; I. ORUKARI; J. W. M. BULTE; P. WALCZAK.
Johns Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch.
of Med., Johns Hopkins Univ. Sch. of Med., Mossakowski
Med. Res. Ctr., Mossakowski Med. Res. Ctr.
1:30 432.03 • Tissue engineering in the stroke-damaged brain:
Image-guided injection and non-invasive monitoring of
regeneration. M. M. MODO*. King’s Col. London, Inst. of
Psychiatry, Univ. of Pittsburgh.
1:45 432.04 SPECT imaging to study biodistribution of cell
therapies in MCAO rats. J. T. JOLKKONEN*; B. MITKARI;
E. KERKELÄ; J. NYSTEDT; T. HUHTALA; M. KORHONEN.
Univ. of Eastern Finland, The Finnish Red Cross Blood
Service.
2:00 432.05 Clinical application of MR imaging for noninvasive
tracking of SPIO-labeled cells following
intraventricular transplantation in child with global cerebral
ischemia. M. JANOWSKI*; T. KMIEC; E. JURKIEWICZ; T.
KROPIWNICKI; A. HABICH; K. KOTULSKA; E. JELONEK;
A. SARNOWSKA; M. LITWIN; D. BORUCZKOWSKI; B.
LUKOMSKA; J. WALECKI; M. ROSZKOWSKI; S. JOZWIAK;
K. DOMANSKA-JANIK. Mossakowski Med. Res. Ctr.,
Mossakowski Med. Res. Ctr., Children’s Mem. Hlth. Inst.,
Children’s Mem. Hlth. Inst., Children’s Mem. Hlth. Inst.,
Children’s Mem. Hlth. Inst., Children’s Mem. Hlth. Inst.,
Polish Stem Cell Bank, Central Hosp. of the Ministry of
Interior and Admin.
2:15 432.06 Tracking of autologous VSOP-labelled
mesenchymal stem cells in the sheep brain using 3T MRI.
A. Y. DREYER; B. NITZSCHE; C. PÖSEL; V. ZEISIG;
T. VON GEYMÜLLER; M. FINDEISEN; D. LOBSIEN; K.
HOFFMANN; J. BOLTZE*. Fraunhofer Inst. for Cell Therapy
and Immunol., Translational Ctr. for Regenerative Med.,
Univ. of Leipzig, Univ. of Leipzig, Univ. of Leipzig, Fraunhofer
IZI.
2:30 432.07 Neural stem cells tracking with high resolution
rapid scanning X-ray fluorescence imaging. A. M. AURIAT*;
W. ZHENG; H. NICHOL; M. KELLY; R. GUZMAN. Stanford,
Stanford, Wayne State Univ., Univ. of Saskatchewan,
Stanford.
90 | Society for Neuroscience
POSTER
433. Proliferation: Cell Cycle
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 A1 433.01 Heat Shock Factor 1 protects the
developing cerebral cortex from hazardous prenatal
environmental exposures. K. HASHIMOTO-TORII*; M.
TORII; M. JU; M. FUJIMOTO; A. NAKAI; R. EL FATIMY; V.
MEZGER; P. RAKIC. Sch. Med, Yale Univ., Yamaguchi Univ.,
Univ. Paris Diderot, 75013.
2:00 A2 433.02 Casein kinase 1 regulates mitotic entry
and cerebellar granule cell proliferation. N. AYAD*; M. E.
HATTEN; W. R. ROUSH. Univ. of Miami Miller Sch. of Med.,
Scripps Florida, The Rockefeller Univ.
3:00 A3 433.03 Maternal thyroid hormone deficiency
deranges the neocortical neurogenesis by affecting the
ventricular zone progenitor cells. V. MOHAN*; A. PATHAK;
R. A. SINHA; G. RAO; A. PAL; M. M. GODBOLE. Sanjay
Gandhi Post Grad. Inst. of Med. Sci., Vanderbilt Med. Res.
Ctr., Duke-NUS Grad. Med. School,.
4:00 A4 433.04 Lack of cyclin-dependent kinase 2 elicits
alternative mechanisms for oligodendrogenesis in white
matter after perinatal brain injury. B. JABLONSKA*; J.
SCAFIDI; V. GALLO. Children’s Natl. Med. Ctr.
1:00 A5 433.05 • Neural stem cell proliferation generates
acute oxidative stress during adult neurogenesis. N.
M. WALTON*; K. TAJINDA; R. SHIN; S. MIYAKE; C. L.
HEUSNER; J. H. KOGAN; Q. CHEN; K. TAMURA; M.
MATSUMOTO. Astellas Res. Inst. of America LLC, Astellas
Res. Inst. of America LLC.
2:00 A6 433.06 STAT 1 and STAT 2 could be possible
transcription factors for the synthesis of CD15. B.
SCHWARZ-HERZKE*; J. K. MAI. Heinrich-heine-Universitaet
Duesseldorf.
3:00 A7 433.07 PI3K/Akt pathway regulates mitosis
in developing avian retinal progenitors. I. M. ORNELAS*;
L. FRAGEL-MADEIRA; A. L. M. VENTURA. Fluminense
Federal Univ.
4:00 A8 433.08 CNS neurogenesis and cell cycle
regulation by the Lis1-Brap interaction. A. A. LANCTOT;
Y. FENG*. Northwestern Univ., Northwestern Univ. Sch. of
Med.
1:00 A9 433.09 Midkine a regulates cell cycle kinetics
of neurogenosis in the developing retina. J. LUO*; P. F.
HITCHCOCK. Univ. of Michigan.
2:00 A10 433.10 In utero exposure to dioxin causes
neocortical dysgenesis through the actions of p27 Kip1 . T.
MITSUHASHI*; J. YONEMOTO; H. SONE; Y. KOSUGE; K.
KOSAKI; T. TAKAHASHI. Keio Univ, Sch. Med., Natl. Inst. for
Envrn. Studies.
3:00 A11 433.11 Acute immune system activation and
adult neurogenesis in the cricket. H. M. BRYNER*; M. V.
MENDOZA; M. L. SCHMEES, Jr.; K. A. KILLIAN. Miami Univ.
4:00 A12 433.12 Postnatal hippocampal neurogenesis
is deficient in the absence of pituitary adenylate cyclase
activating polypeptide signaling. L. TASCAU*; X. ZHOU; P.
BRABET; J. WASCHEK; E. DICICCO-BLOOM. UMDNJ,
Inserm U583, Semel Institute, D. Geffen Sch. of Medicine,
Univ. of California, Geffen Sch. of Medicine, Univ. of
California, UMDNJ-Robert Wood Johnson Med. Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

POSTER
434. Differentiation of Stem Cells I
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 A13 434.01 Dmrta1, as a downstream gene of Pax6,
is involved in neurogenesis by regulating Neurogenin2
expression in the mammalian cortex. T. KIKKAWA*; M.
TAKAHASHI; Y. KATSUYAMA; N. OSUMI. Tohoku Univ.
Grad. Sch. of Med.
2:00 A14 434.02 The transcription factor p53 fine-tunes
endogenous ROS levels and neurogenesis in embryonic
NPCs. K. FORSBERG; A. WUTTKE; A. WIZENMANN; S. DI
GIOVANNI*. HIH, Univ. of Tuebingen, Inst. ot Anat.
3:00 A15 434.03 A role for galanin in neural progenitor
cells. O. CORDERO LLANA*; D. WYNICK; M. A.
CALDWELL. Univ. of Bristol, Univ. of Bristol.
4:00 A16 434.04 Maturin is a novel protein required for
primary neurogenesis in Xenopus laevis. R. I. MARTINEZ-
DE LUNA*; Y. LYOU; M. E. ZUBER. SUNY Upstate Med.
Univ.
1:00 A17 434.05 Copine1 induces neuronal differentiation
of HiB5 hippocampal progenitor cells. J. PARK*; N. PARK;
J. YOO; Y. HAH; S. HONG; E. HWANG. Gyeongsang Natl.
Univ. Col. Med., Clin. Res. Inst., Korea Inst. of Sci. and
Technol.
2:00 A18 434.06 • GSK3 temporally regulates Neurogenin
2 proneural activity in the neocortex. S. LI*; P. MATTAR; D.
ZINYK; K. SINGH; C. CHATURVEDI; R. DIXIT; C. KOVACH;
J. CHAN; V. WALLACE; Y. MA; J. DILWORTH; M. BRAND;
C. SCHUURMANS. Univ. of Calgary, Univ. of Ottawa,
Northwestern Univ.
3:00 A19 434.07 The role of NfiB in the developing
cerebral cortex. J. BETANCOURT*; B. CHEN. Universtiy of
California, Santa Cruz.
4:00 A20 434.08 Serotonin molecular signaling path to
the fetal neopallium in organotypic culture. J. HERNANDEZ
RODRIGUEZ*; G. MANJARREZ; R. MERCADO; A. BOYZO.
CINVESTAV-IPN, Ctr. Médico Nacional Siglo XXI, IMSS,
Univ. Michoacana de San Nicolás de Hidalgo.
1:00 A21 434.09 � Changes of connexin expression during
the development of the chick optic tectum (gallus gallus). V.
PASCHON*; G. S. V. HIGA; A. H. KIHARA. Univ. Federal Do
ABC, Univ. de São Paulo.
2:00 A22 434.10 Neural stem cells maintain their
stemness through protein kinase C zeta mediated inhibition
of TRIM32. A. HILLJE; M. WORLITZER; E. C. BUNK*; J.
SCHWAMBORN. ZMBE, ZMBE.
3:00 A23 434.11 Efficient generation and developmental
analysis of basal forebrain cholinergic neurons from mouse
embryonic stem cells. S. ISHII*; Y. OKADA; F. MIYA; T.
TSUNODA; T. SHIMAZAKI; H. OKANO. Sch. of Medicine,
Keio Univ., Kanrinmaru Project, Sch. of medicine, Keio Univ.,
Ctr. for Genomic Medicine, RIKEN.
4:00 A24 434.12 Omega-3 fatty acid decreases
inflammation and induces neurogenesis in the hypothalamus
of obese mice. L. F. NASCIMENTO*; J. MORARI; L.
M. IGNÁCIO-SOUZA; D. S. RAZOLLI; C. SOLON; C.
E. NUÑEZ; B. BOMBASSARO; J. C. MORAES; L. A.
VELLOSO. State Univ. of Campinas.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 A25 434.13 Dorsal root ganglia development requires
modulation of Erbb signaling by the scaffold protein Sorbs3.
S. J. MALMQUIST*; A. ABRAMSSON; H. F. MCGRAW;
T. H. LINBO; D. W. RAIBLE. Univ. of Washington, Univ. of
Gothenburg, Oregon Hlth. and Sci. Univ.
2:00 A26 434.14 The expression and analysis of Tbx3
gene in sturgeon Acipenser baerii. C. FAN*; H. ZHANG; J.
SONG. Shanghai Ocean Univ.
3:00 A27 434.15 Expression profiling of Wnt receptors
during directed differentiation of mouse embryonic stem
cells into neurons. N. V. PATEL*; D. C. MENDEZ; K. A.
KOPPITCH; B. L. NOBLE; T. J. ROUTLEDGE. CSU -
Fullerton, CSU - Fullerton.
4:00 A28 434.16 Regulation of KLF4 expression by
microRNAs. K. MEZA SOSA*; O. LÓPEZ; G. PEDRAZA-
ALVA; L. PÉREZ-MARTÍNEZ. Inst. of Biotech.
1:00 A29 434.17 • Intranuclear Fgf receptor signaling
in dopaminergic neuron development: Nuclear FgfR1 and
Nurr1 interaction. O. BARON; S. NARHLA; C. TERRANOVA;
B. FOERTHMANN; E. STACHOWIAK; K. KUHLEMANN; H.
BRINKMANN; A. RATZKA; M. WESEMANN; P. CLAUS; C.
GROTHE*; M. STACHOWIAK. Hannover Med. Sch., Ctr. for
Systems Neurosci., State Univ. of New York, Hannover Med.
Sch.
2:00 A30 434.18 Targeted deletion of Hand2 reveals a
novel enteric neural precursor cell and affects neurogenesis,
neurotransmitter specification and gangliogenesis. M. J.
HOWARD*; J. LEI. Med. Univ. Ohio (renamed the Univ. of
Toledo Healthe Sci., Univ. of Toledo Hlth. Sci.
3:00 A31 434.19 • RhoA inhibitor C3 transferase improves
neurite outgrowth and neuronal differentiation of mouse
neural stem cells. H. GU; S. YU; C. GUTEKUNST; R.
GROSS; L. WEI*. Emory Univ. Sch. of Med., Emory Univ.
Sch. of Med.
4:00 A32 434.20 Persistent expression of activated Notch
signaling in the developing hypothalamus prevents formation
of the developing arcuate nucleus. P. K. AUJLA*; L. T.
RAETZMAN. Univ. of Illinois At Urbana Champaign, Univ. of
Illinois at Urbana Champaign.
1:00 A33 434.21 The Na + -K + -2Cl - cotransporter NKCC1
regulates the proliferation of interneuron progenitors
in the developing telencephalon. A. MAGALHÃES*; C.
PELLEGRINO; C. RIVERA. Univ. of Helsinki, INMED/
INSERM Unit 29.
2:00 A34 434.22 The role of the INFS mechanism in NGF
induced PC12 neuronal differentiation. C. TERRANOVA; Y.
LEE; P. CLAUS; E. K. STACHOWIAK*; J. M. ALETTA; M.
K. STACHOWIAK. SUNY, Buffalo, Hannover Medcial Sch.,
SUNY, Buffalo, CH3 Biosystems LLC.
3:00 A35 434.23 • Characterization of Sox4 and Sox11
in cerebral cortical development. C. CHEN*; X. ZHAO; C.
GILBERT; M. J. DONOGHUE. Georgetown Univ.
4:00 A36 434.24 • Scalable human neural stem
cells produce mature neural model. M. FENNELL*; R.
MALAVARCA; A. CACACE; M. ROACH. Gigacyte, Bristol-
Myers Squibb, Gigacyte.
Neuroscience 2011 | Monday PM | 91
Mon. PM

POSTER
435. Stem Cells and Disease
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 A37 435.01 Organic acid profiling analysis by GC/
MS in cerebral ischemia following human mesenchymal
stem cell transplantation in rats. S. HYUN; J. SHIM; E. JO;
K. CHOI; W. SHIM; M. PAIK; G. LEE*. Ajou Univ., Ajou Univ.
Sch. of Med.
2:00 A38 435.02 [Unable to Attend] Identification of
a drug-resistant slow-cycling population of cells from a
malignant melanoma cell line C8161. E. MASTRANTONI;
S. CHEN; D. MELCHIORRI*. Univ. of Rome, Dept. of Chem.
Biology, Ernest Mario Sch. of Pharmacy, Rutgers Univ.
3:00 A39 435.03 Establishing non-mammalian induced
stem cells: Generating chimeric model organisms.
R. A. ROSSELLO*; C. CHEN; J. HOWARD; U.
HOCHGESCHWENDER; E. JARVIS. Duke Univ., Duke
University, Howard Hughes Med. Inst.
4:00 A40 435.04 Utilizing patient-specific induced
pluripotent stem (iPS) cells to investigate Aβ generation and
oligomerization. C. R. MURATORE*; L. N. BENJAMIN; D.
J. SELKOE; T. L. YOUNG-PEARSE. Harvard Med. Sch.,
Brigham and Women’s Hosp.
1:00 A41 435.05 Transplantation of embryonic stem cellderived
oligodendrocyte progenitors attenuates the chronic
neuropathic pain caused by spinal cord injury. S. LIU*;
Q. LI; F. TAO; V. BELEGU; A. HURTADO; R. JOHNS; J.
MCDONALD. Hugo W. Moser Res. Inst. At Kennedy Krieger,
Inc., Dept. of Neurology, Johns Hopkins Univ. Sch. of Med.,
Dept. of Anesthesiol. and Critical Care Medicine, Johns
Hopkins Univ. Sch. of Med., Dept. of Physical Medicine,
Johns Hopkins Univ. Sch. of Med.
2:00 A42 435.06 Using direct reprogramming of human
fibroblasts to understand the CACNA1C risk association
with bipolar disorder and schizophrenia. T. YOSHIMIZU*; J.
Q. PAN; S. SU; K. SINGH; J. M. MADISON; L. TSAI. MIT,
Broad Inst., Howard Hughes Med. Inst.
3:00 A43 435.07 Differential pattern of neural precursor
marker induction in hiPSCs neuralized with noggin or the
dorsomorphin analogue, DMH1. D. NEELY*; M. J. LITT; A. A.
ABOUD; A. M. TIDBALL; G. G. LI; P. HEDERA; K. C. ESS;
C. C. HONG; A. B. BOWMAN. Vanderbilt Univ. Med. Ctr.,
Res. Medicine, Veterans Admin. TVHS.
4:00 A44 435.08 • Development of an assay to identify
activators of TrkB signaling using human induced pluripotent
stem cell derived neurons. T. A. LANZ*; L. H. KIMMEL; S.
J. ENGLE; A. M. FRIEDRICH; M. L. WEBER; F. M. PRIOR;
J. T. LAZZARO, Jr; I. V. EFREMOV; R. J. KLEIMAN. Pfizer,
Pfizer, Pfizer, Pfizer.
1:00 A45 435.09 Feeder free differentiation of A9 and A10
type dopaminergic neurons from human pluripotent stem
cells using small molecules. O. COOPER*; M. SUNDBERG;
H. BOGETOFTE-THOMASEN; H. SEO; M. DELEIDI; T.
OSBORN; E. PEREZ-TORRES; T. LAWSON; O. ISACSON.
Harvard Med. Sch.
2:00 A46 435.10 The Sonic hedgehog (Shh) signaling
is involoved in amygdala neurogenesis and fear memory
formation. H. HUNG; P. GEAN*. Natl. Cheng-Kung Univ.
3:00 A47 435.11 Generation of iPS cell-derived forebrain
neurons to investigate synaptic connectivity. J. KIM*; M. L.
O’SULLIVAN; M. HWANG; A. GHOSH. UCSD.
92 | Society for Neuroscience
4:00 A48 435.12 Human induced pluripotent stem cell
lines are capable of producing differentiated products of high
purity. K. STAHL; M. A. WEDEMEYER; D. FERGUSON;
G. I. NISTOR; J. HARNESS; H. OKANO; S. YAMANAKA;
R. TORP*; H. S. KEIRSTEAD. Ctr. for Mol. Biol. and
Neuroscience, Univ. of Oslo, Reeve-Irvine Res. Center, Univ.
of California, Irvine, Dept. of Physiology, Keio Univ. Sch. of
Med., Ctr. for iPS cell Res. and Application, Kyoto Univ., Ctr.
For Mol. Biol. and Neurosciene, Univ. of Oslo.
1:00 A49 435.13 Generation of disease-specific Purkinje
cells from human induced pluripotent stem cells. S.
CHINTAWAR*; M. WATTENHOFFER; D. GALL; S. N.
SCHIFFMANN; H. PUCCIO; M. PANDOLFO. Univ. Libre de
Bruxelles, IGBMC Inst., Univ. Libre de Bruxelles.
2:00 A50 435.14 Non-viral reprogramming of mouse
fibroblasts directly into neurons. E. A. FORCE*; J. J.
LOTURCO. Univ. of Connecticut, Univ. of Connecticut.
3:00 A51 435.15 Induced pluripotent stem cell models from
x-linked adrenoleukodystrophy patients. J. LEE*; J. JANG;
Y. HUH; J. KIM; J. YOO; J. LEE; B. LIM; H. KANG; D. KIM*.
Yonsei Univ. Colleage of Med., Yonsei Univ. Col. of Med.,
Dept. of Pediatric Neurol. Severance Children’s Hosp.
POSTER
436. Synapse Formation: CNS III
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 A52 436.01 Dual switching in the pharmacological
nature of the large-scale depolarization wave in the
mouse embryo. Y. MOMOSE-SATO*; T. NAKAMORI; K.
SATO. Kanto Gakuin Univ., Col. Human & Envrn. Studies,
Komazawa Women’s Univ. Fac. of Human Hlth.
2:00 A53 436.02 The incidence of synapse formation
reduces spontaneous transmitter release. F. XU*; W. ZAIDI;
N. I. SYED. Univ. Calgary, Univ. of Calgary.
3:00 A54 436.03 Tetrameric GluRδ2 for cerebellar synapse
formation. S. LEE*; T. UEMURA; T. YOSHIDA; M. MISHINA.
Grad.sch.Of Med. Univ. of Tokyo.
4:00 A55 436.04 Imaging the emergence of synaptic
transmission during synaptogenesis. L. C. ANDREAE*; A.
LOWE; J. BURRONE. King’s Col. London.
1:00 A56 436.05 The role of transmitter-receptor
interaction in synaptogenesis between identified lymnaea
neurons and isolated axons. C. C. LUK*; N. I. SYED. Univ. of
Calgary.
2:00 A57 436.06 Glutamate receptor δ1 preferentially
stimulates inhibitory synapse formation of cortical neurons.
M. YASUMURA*; T. YOSHIDA; S. LEE; T. UEMURA; J. JOO;
M. MISHINA. Grad. Sch. of Med., Univ. of Tokyo.
3:00 A58 436.07 Astrocyte-secreted factors modulate the
developmental distribution of inhibitory synapses in nucleus
laminaris of the avian auditory brainstem. M. J. KORN*; S. J.
KOPPEL; D. MEHTA; S. B. MEHTA; K. S. CRAMER. Univ. of
California, Irvine.
4:00 A59 436.08 Formation of glycinergic synapse in
developing zebrafish embryos. H. HIRATA*. Natl. Inst. of
Genet.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 A60 436.09 Analysis in vitro of receptors that regulate
synapse development. F. WANG*; S. QIU; P. LEVITT.
Neurosci. Grad. Program, Univ. of Southern California, USC,
USC.
2:00 A61 436.10 Identification of an astrocyte-derived
factor that promotes the formation of excitatory synapses
containing GluA1 AMPA glutamate receptors. N. J. ALLEN*;
C. CHAKRABORTY; M. L. HOWE; B. A. BARRES. Stanford
Univ.
3:00 A62 436.11 VCP involved in frontotemporal dementia
interacts with neurofibromatosis protein and regulates
synaptogenesis in rodents. Y. SHIH*; H. WANG; C. CHEN;
H. CHAO; M. LEE; Y. HSUEH. Academia Sinica, Mol. Cell
Biology, Taiwan Intl. Grad. Program, Inst. of Mol. Biology,
Academia Sinica, and Grad. Inst. of Life Sciences, Natl. Def.
Med. Ctr., Dept. of Neurology, Natl. Taiwan Univ. Hosp.
4:00 A63 436.12 Afferent GABAergic transmission
regulates maturation and synaptic integration of newborn
neurons in adult mouse olfactory bulb. M. PALLOTTO;
A. NISSANT; J. FRITSCHY; U. RUDOLPH; M. SASSOÈ-
POGNETTO; P. PANZANELLI*; P. LLEDO. Dept. of
Anatomy, Pharmacology, and Forensic Medicine, Univ.
Turin, Inst. Pasteur, CNRS URA 2182, Natl. Inst. of
Neurosci., Inst. of Pharmacol. and Toxicology, Lab. of Genet.
Neuropharmacology, McLean Hosp. and Harvard Med.
School,.
1:00 A64 436.13 Leptin induces hippocampal
synaptogenesis via CREB-regulated microRNA-132.
M. DHAR*; M. ZHU; S. IMPEY; T. J. LAMBERT; S. M.
APPLEYARD; G. A. WAYMAN. Washington State Univ.,
Oregon Hlth. and Sci. Univ.
2:00 A65 436.14 BDNF promotes synaptogenesis in
hippocampal neurons by a mechanism involving PGC-
1alpha and mitochondrial biogenesis. A. CHENG*; R. WAN;
J. WANG; N. KAMIMURA; T. SON; X. OUYANG; Y. LUO;
M. P. MATTSON. NATIONAL INSTITUTE ON AGING/
NATIONAL INSTITUTES OF HEALTH, Nippon Med. Sch.
3:00 A66 436.15 Development of pre-synaptic sites is
regulated by a brain-enriched microRNA. Z. HU*; M. DIAZ
BUSTEMANTE; Q. GU; Z. LI. NIH.
4:00 A67 436.16 Influence of trans-synaptic adhesion on
pre-synaptic transport vesicles. L. BURY*; S. L. SABO. Case
Western Reserve Univ.
POSTER
437. Developmental Cell Death: Neurotrophins and Other
Trophic Factors
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 A68 437.01 � Neuroprotective effect of pleiotrophin on
dopaminergic neurons: Analysis from receptor expressions.
Y. WATANABE; T. MASUDA; S. MISUMI; Y. SHIMIZU; T.
MATSUNAGA; T. SUZUKI; H. HIDA*. Nagoya City Univ.
Grad Sch. Med. Sci., Nagoya City Univ. Grad. Sch. Pham.
Sci.
2:00 B1 437.02 The association of p75NTR and coreceptors
on the plasma membrane and in endocytic
vesicles. J. YAROTSKY; M. VOLOSIN; W. J. FRIEDMAN*.
Rutgers Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
3:00 B2 437.03 • Survival of RGC mediated by IL-2, but
not by IL-4, is dependent of heparan sulfate expression in
vitro. A. SHOLL-FRANCO*; C. MARRA. Univ. Fed Rio De
Janeiro.
4:00 B3 437.04 Involvement of GPR3 against apoptotic
neuronal cell death during cerebellar development. S.
TANAKA*; T. MIYAGI; E. DOHI; T. SEKI; I. HIDE; Y. SAEKI;
E. CHIOCCA; M. MATSUMOTO; N. SAKAI. Hiroshima Univ.
Sch. of Biomed. Sci., Dept. of Clin. Neurosci. and Therap.,
Hiroshima Univ. Sch. of Biomed. Sci.,, Dardinger Lab. for
Neuro-oncol. amd Neurosci., Dept of Neurol. Surg., The
Ohio State Univ.
1:00 B4 437.05 The molecular intersection between
neuronal apoptosis and axon degeneration. C. L. CUSACK*;
M. DESHMUKH. Univ. of North Carolina Chapel Hill, Univ. of
North Carolina, Univ. of North Carolina.
2:00 B5 437.06 Global analysis of gene expression in
NGF-deprived sympathetic neurons identifies molecular
pathways associated with cell death. J. HAM*; M.
KRISTIANSEN; F. MENGHI; R. HUGHES; M. HUBANK.
UCL Inst. of Child Hlth.
3:00 B6 437.07 Functional interdependence of p75 and
TNFR1a during sympathetic nervous system development.
K. EDAMURA; K. CHAN; D. HEFFNER; C. JANSCH; C.
DAWSON; C. DEPPMANN*. Univ. of Virginia.
4:00 B7 437.08 Neurotrophic signaling in striatal
development. M. BAYDYUK*; Y. XIE; L. TESSAROLLO; B.
XU. Georgetown Univ., NCI.
1:00 B8 437.09 Mechanistic analysis of 5’ RET splice
variants. N. A. GABRESKI*; B. A. PIERCHALA. The Univ. of
Michigan.
2:00 B9 437.10 Inhibition of cdc2 activity by TrkB
maintains tetraploid neurons in a G2-like state. M.
OVEJERO-BENITO; J. M. FRADE*. Cajal Inst. (CSIC).
3:00 B10 437.11 Necrostatin-1 modulates BDNF
expression in the thalamocortical network improving motor
outcomes following neonatal hypoxia-ischemia. R. CHAVEZ-
VALDEZ; L. J. MARTIN; D. W. MACK; S. RAZDAN; D. L.
FLOCK; E. B. GAUDA; F. J. NORTHINGTON*. Texas Tech.
University- HSC, Johns Hopkins University- Sch. of Med.,
Johns Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch.
of Med., Johns Hopkins Univ. Sch. of Med.
4:00 B11 437.12 Nerve growth factor-induced tumor
inhibition involves innervations and maturation of tumor
neovasculature. S. FUKUHARA; S. TAKATORI*; R.
SHIWAKU; M. GODA; N. HASHIKAWA-HOBARA; Y.
ZAMAMI; P. TANGSUCHARIT; H. KAWASAKI. Okayama
Univ., Niigata Univ., Okayama Univ. of Sci.
POSTER
438. Regeneration I
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 B12 438.01 Targeting klfs to enhance retinal ganglion
cell regeneration. A. APARA*; Y. WANG; D. MOORE; J.
GOLDBERG. Univ. of Miami Miller Sch. of Med., Univ. of
Miami, ETH.
Neuroscience 2011 | Monday PM | 93
Mon. PM

2:00 B13 438.02 Decline of Fluoro Ruby (FR) retrograde
transport coincides with conduction deficits through intact
contralateral white matter after lateral hemisection of adult
rat spinal cord. L. SCHNELL*; V. ALESSI; A. S. HUNANYAN;
H. PETROSYAN; J. LEVINE; L. MENDELL; V. ARVANIAN.
Dept. of Neurobio. and Behavior SUNY At Stony Brook,
Northport Veterans Affairs Med. Ctr., Dept. of Neurobio. and
Behavior SUNY at Stony Brook.
3:00 B14 438.03 Stat3 activation stimulates sympathetic
axon regeneration. M. J. PELLEGRINO*; B. A. HABECKER.
Oregon Hlth. & Sci. Univ.
4:00 B15 438.04 Activity-dependent regulation of axonal
and neuronal Arc/Arg3.1 expression in regenerating adult
sensory neurons. V. JEGADEESAN*; J. M. JOHNSTON; R.
ZHAI; C. R. BRAMHAM; T. GORDON; D. W. ZOCHODNE;
B. SINGH; V. M. K. VERGE. Univ. of Saskatchewan, Univ. of
Bergen, Univ. of Alberta, Univ. of Calgary.
1:00 B16 438.05 Impact of peripheral nerve injury and
brief electrical stimulation on the unfolded protein response
in adult sensory neurons. Z. YING*; J. C. D. HASMATALI;
V. MISRA; T. GORDON; D. ZOCHODNE; V. M. K. VERGE.
Univ. of Saskatchewan, Univ. of Saskatchewan, Univ. of
Saskatchewan, Univ. of Alberta, Univ. of Toronto, Univ. of
Calgary.
2:00 B17 438.06 Temporal analysis of the beneficial effects
of brief electrical stimulation on the demyelinated peripheral
nerve. N. A. MCLEAN*; T. GORDON; D. W. ZOCHODNE; V.
M. K. VERGE. Univ. of Saskatchewan, Univ. of Alberta, Univ.
of Calgary.
3:00 B18 438.07 CSPG- dependent Inhibition of
sympathetic axon outgrowth by infarcted myocardium. R.
GARDNER*; B. A. HABECKER. Oregon Hlth. and Sci. Univ.
4:00 B19 438.08 Unilateral removal of the mouse pelvic
ganglion induces regenerative events in the contralateral
ganglion. M. E. KANJE*; M. EKMAN; K. SWÄRD; B.
UVELIUS. Dept. of Biol., Dept. of Exptl. Med. Sci.
1:00 B20 438.09 In vivo testing of candidate genes
to promote neuron-intrinsic growth ability and axon
regeneration in the injured spinal cord. M. G. BLACKMORE*;
K. PARK; Z. WANG; C. B. SHIELDS; Y. P. ZHANG; V. P.
LEMMON; J. L. BIXBY. Univ. of Miami, Marquette Univ.,
Norton Neurosci. Inst.
2:00 B21 438.10 Differential expression of GAPDH in
adult sensory neurons - impact of peripheral nerve injury on
expression. J. R. NADEAU*; J. M. JOHNSTON; Z. YING; V.
M. K. VERGE. Univ. of Saskatchewan.
3:00 B22 438.11 Peripheral nerve injury discharge induces
regeneration-associated gene expression and enhances
the intrinsic ability of injured sensory neurons to extend
neurites. R. ZHAI; L. M. E. PETTERSSON; T. GORDON; N.
TYREMAN; V. M. VERGE*. Univ. Saskatchewan-Cameco
MS/Neurosci Res. Ctr., Univ. of Alberta, Univ. of Toronto.
4:00 B23 438.12 Retinal regulation of regenerationassociated
genes by a monoclonal RGMa antibody in a rat
optic nerve crush model. A. H. MEYER*; B. K. MUELLER.
Abbott.
1:00 B24 438.13 The role of mTOR-signaling in
neuroprotection and axon regeneration in the mature
CNS after inflammatory stimulation. M. LEIBINGER*; A.
ANDREADAKI; D. FISCHER. Exptl. Neurol., Exptl. Neurol.,
Exptl. Neurol.
94 | Society for Neuroscience
2:00 B25 438.14 Reduced neuronal p75NTR expression
induces perineuronal cell proliferation and dramatically
increases connexin-43 expression. J. R. NADEAU;
T. D. WILSON-GERWING*; V. M. K. VERGE. Univ. of
Saskatchewan, Univ. of Saskatchewan.
3:00 B26 438.15 Transcription factor Luman expression
is altered in primary sensory neurons in response to nerve
injury and colocalizes with the axonal transport protein
Importin-beta1. J. C. HASMATALI*; C. S. WILGENBUSCH;
J. A. DE GUZMAN; Z. YING; V. MISRA; V. M. K. VERGE.
Univ. Saskatchewan/CMSNRC, Univ. of Saskatchewan,
Western Col. of Vet. Med., Univ. of Saskatchewan/CMSNRC.
4:00 B27 438.16 Set-β regulation of axon growth in central
nervous system. E. C. TRAKHTENBERG*; Y. WANG;
A. LAPINS; S. YANG; J. L. GOLDBERG. Univ. of Miami,
Bascom Palmer Eye Inst., Univ. of Miami, Univ. of Miami
Miller Sch. of Med.
1:00 B28 438.17 Neural progenitor cell implants in the
lesioned medial longitudinal fascicle of adult cats regulate
synaptic composition of abducens internuclear neurons.
C. J. MORADO-DÍAZ; E. R. MATARREDONA; M. A.
DAVIS-LÓPEZ DE CARRIZOSA; R. R. DE LA CRUZ; A. M.
PASTOR*. Facultad de Biologia / Univ. De Sevilla.
2:00 B29 438.18 Decreased GSK3β activity underlies
the gain of regenerative capacity following conditioning
lesion. M. A. LIZ; H. I. PIMENTEL; A. M. MARQUES; M. L.
SOUSA*. IBMC.
3:00 B30 438.19 HnRNP K, an RNA binding protein, is
required for optic axon regeneration in Xenopus laevis. Y.
LIU; H. YU; B. G. SZARO*. Univ. At Albany, State Univ. of
NY, Sch. of Medicine, Fudan Univ.
4:00 B31 438.20 Neural cell-derived extracellular matrix
enriched biomaterials. F. MENG*; V. HLADY; P. TRESCO.
Univ. of Utah, Bioengineering Dept.
1:00 B32 438.21 Role of cell-axon interaction in specific
motor and sensory regeneration. E. UDINA*; I. ALLODI; L.
CASALS; J. HERNÀNDEZ; K. C. D. ROET; X. NAVARRO.
Univ. Autònoma De Barcelona, Netherlands Inst. for
Neurosci.
2:00 B33 438.22 Aligned polymer nanofibers modified with
peptides for enhancing motor neuron growth. J. M. COREY*;
J. E. GOODMAN; Y. I. NAIM; M. K. LEACH. Univ. Michigan,
GRECC - VA Ann Arbor Healthcare Ctr., Univ. Michigan.
3:00 B34 438.23 Clock gene expression in regenerated
medial prefrontal cortex. B. D. RAKAI*; M. C. ANTLE. Univ.
of Calgary.
4:00 B35 438.24 Expression of Activating Transcription
Factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal
outgrowth after sciatic nerve repair in diabetic BB rats. L. B.
DAHLIN*; L. STENBERG; K. DOLEZAL; M. KANJE. Scania
Hand Ctr. AB, Deptartment of Biol.
1:00 B36 438.25 Loss of merlin function contributes to
Schwann cell responses following peripheral nerve injury.
I. N. AHMAD*; R. GURGEL; J. J. CLARK; H. V. SHAH; M.
HANSEN. Univ. of Iowa, Stanford Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

POSTER
439. Regeneration II
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 B37 439.01 Analysis of the spatiotemporal gene
expression pattern of FABP-7 in the regenerating zebrafish
retina. P. YURCO*; S. KAISER. Le Moyne Col.
2:00 B38 439.02 Non-prenylatable Rac1 and neurite
outgrowth. J. M. REDDY*; D. L. HYNDS. Texas Woman’s
Univ.
3:00 B39 439.03 Glial cell line-derived neurotrophic factor
(GDNF) in nerve-dependence of axolotl limb regeneration.
R. N. CHRISTENSEN*; K. CRANSTON. Coe Col.
4:00 B40 439.04 Developmental mechanisms of cell
autonomy and microenvironment instruction drive tumor cell
engraftment. C. E. BROWN; A. UGARTE; N. KHOSH; M. E.
BARISH*. City of Hope, Beckman Res. Inst., City of Hope,
Beckman Res. Inst.
1:00 B41 439.05 A simplified model to correlate
regeneration specificity with functional outcome. T. M.
BRUSHART*; A. VYAS; A. O’DALY. Johns Hopkins.
2:00 B42 439.06 Brief one hour 20Hz electrical stimulation
(ES) of chronically axotomized peripheral nerve promotes
axon regeneration through freshly denervated distal nerve
stumps. T. GORDON*; V. M. K. VERGE; N. TYREMAN. Univ.
of Alberta, Div. of Plastic Surgery, Hosp. for Sick Children,
Univ. of Saskatchewan.
3:00 B43 439.07 Cutaneous peripheral sensory axon
regeneration requires hydrogen peroxide and Ikk1
independent of its kinase domain. S. RIEGER*; A. SAGASTI.
Univ. of California Los Angeles.
4:00 B44 439.08 Optimizing neural cell replacement using
versatile hydrogel particles. D. JGAMADZE; L. CHU; S.
PAUTOT*. CRT Dresden, Sichuan Univ.
1:00 B45 439.09 Behavioral and anatomical analysis of
the transgenic thy1-gfp rat following peripheral nerve injury.
S. W. KEMP*; P. D. PHUA; T. GORDON; G. H. BORSCHEL.
The Hosp. For Sick Children/University of Toronto.
2:00 B46 439.10 • Comparison of myelination and
formation of nodes of ranvier in the regenerated sciatic
nerve by transplantation of Schwann cells and olfactory
ensheathing cells. C. RADTKE; K. L. LANKFORD*; M.
SASAKI; J. D. KOCSIS. Yale Univ. Sch. of Med., Hannover
Med. Sch.
3:00 B47 439.11 BMP-7 activates gelatinase activity and
alters neuronal morphology in rat primary cortical neurons.
B. K. HARVEY*; D. B. HOWARD; Y. WANG. NIDA - NIH.
4:00 B48 439.12 Signaling pathways in motoneuron
regeneration. A. A. VYAS*; R. SIDDIQUE; T. M. BRUSHART.
Johns Hopkins Sch. Med., Johns Hopkins Sch. Med.
1:00 B49 439.13 Astrocyte and glial restricted precursorderived
biomaterials for regenerative medicine. J. L.
SKOUSEN; P. A. TRESCO*. Univ. Utah.
2:00 B50 439.14 • Multipotent adult progenitor cells
(MultiStem ® ) ameliorate macrophage-mediated axonal
dieback after spinal cord injury. S. A. BUSCH*; J. A.
HAMILTON; K. P. HORN; F. X. CUASCUT; N. LEHMAN;
R. CUTRONE; R. J. DEANS; A. E. TING; R. W. MAYS; J.
SILVER. Athersys, Inc., Case Western Reserve Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
3:00 B51 439.15 Cultured Schwann cells of different age
groups display clear differences in mass spectra profile
and protein expression. A. F. SVENNINGSEN*; M. TRIER-
KJÆR; G. WICHER; M. ANDERSSON. Univ. of Southern
Denmark, Uppsala Univ., Uppsala Univ.
4:00 B52 439.16 Reconstructing the cellular-structurally
organized cortical neuronal tissue in 3D with a multilayered
basal lamina equivalent films. D. M. TAMULY*; S.
VASUDEVAN; Y. KIM. Univ. of Texas At Arlington, Univ. Of
Texas At Arlington.
1:00 B53 439.17 Axonal GAP-43 mRNA shows dual
modes of post-transcriptional regulation in injury conditioned
neurons. S. YOO*; C. J. DONNELLY; D. VUPPALANCHI; N.
I. PERRONE-BIZZOZERO; J. L. TWISS. A.I.duPont Hosp.,
Univ. of Delaware, Indianna Univ., Univ. of New Mexico Hlth.
Sci. Ctr., Drexel Univ.
2:00 B54 439.18 Rac1 inhibition decreases neurite
outgrowth while increasing complexing of IQ-GAP and EB2.
C. P. GUTIERREZ; D. L. HYNDS*. Texas Woman’s Univ.
3:00 B55 439.19 Use of end-to-side repair as a
“babysitting” technique to prevent the deleterious effect of
chronic denervation of Schwann cells (SCs) on peripheral
nerve regeneration. A. LADAK*; T. GORDON; O. A. R.
SULAIMAN. Univ. of Alberta, Univ. of Alberta, Ochsner Spine
Ctr.
4:00 B56 439.20 Calcium-mediated electrical activity
manifests in the regenerating spinal cord and muscle and is
necessary for appropriate tissue regeneration. M. K. TU; L.
N. BORODINSKY*. Univ. California Davis.
1:00 B57 439.21 Nitric oxide synthase (NOS) expression in
normal and regenerating axolotl retina. E. A. DEBSKI*; J. C.
CHILDERS; H. GUO. Univ. of Kentucky, Univ. of Kentucky.
2:00 B58 439.22 Lack of dystrophin affects axon
regeneration in vivo and neurite growth in vitro. M. DE
STEFANO*; L. LOMBARDI; I. LANNI; C. C. HOOGENRAAD;
P. PAGGI. Sapienza Univ. of Roma, Ctr. for Res. in
Neurobio., Erasmus Med. Ctr.
POSTER
440. Regeneration III
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 B59 440.01 Caspase-6 expression accompanies
distal axonopathy during early Wallerian degeneration of
peripheral neurons. C. CHENG; J. VAN MINNEN; J. A.
MARTINEZ; D. W. ZOCHODNE*. Univ. of Calgary, Univ. of
Calgary.
2:00 B60 440.02 Identifying injury signals and regeneration
enhancers in the conditioning lesion model. F. M. MAR*; A.
M. MARQUES; P. BRITES; A. BARBOSA; V. COSTA; M. M.
SOUSA. IBMC - Nerve Regeneration Group, IBMC - Inst. de
Biologia Mol. e Celular.
3:00 B61 440.03 • NgR1 and NgR3 are inhibitory
receptors for chondroitin sulfate proteoglycans. T. L.
DICKENDESHER*; K. T. BALDWIN; Y. A. MIRONOVA; Y.
KORIYAMA; S. J. RAIKER; Y. DUAN; Y. KATAGIRI; C. G.
GEOFFROY; K. L. ASKEW; B. BATES; M. M. ZALESKA; A.
WOOD; B. ZHENG; L. I. BENOWITZ; H. M. GELLER; R. J.
GIGER. Univ. of Michigan, Univ. of Michigan, Harvard Med.
Sch., Univ. of Michigan, NIH, Univ. of California San Diego,
Pfizer Global Res. and Develop.
Neuroscience 2011 | Monday PM | 95
Mon. PM

4:00 B62 440.04 Changes in VEGF in adult sympathetic
and sensory neurons following axotomy of the superior
cervical ganglion. Z. ZHU*; Z. HESP; T. MORRIS; L.
ISAACSON. Miami Univ.
1:00 B63 440.05 Administration of a deoxyribozyme
to XT-1 mRNA into a dorsal hemisection of the adult rat.
B. KOENIG; C. SCHMITZ; J. DOMKE; V. ESTRADA; H.
MUELLER; B. GRIMPE*. Mol.Neurobiol. Lab., Dept. of
Neurol., Univ. of Duesseldorf, Applied Neurobiology, Dept. of
Neurol., Univ. of Duesseldorf.
2:00 B64 440.06 Low dose GM-CSF promotes CNS axon
growth. J. LEGACY; J. K. THEORET; P. D. SMITH*. Carleton
Univ., Inst. of Neurosci.
3:00 C1 440.07 Developmental and regeneration
features of the in vitro reconstructed meso-cortico-limbic
dopaminergic system: Functionality evaluated with the Multi
Electrode Array (MEA) technique. E. DOSSI*; C. HEINE; I.
SERVETTINI; L. COLOMBO; F. GULLO; A. MAFFEZZOLI;
M. ABBRACCHIO; H. FRANKE; P. ILLES; E. WANKE. Univ.
of Milan-Bicocca, Rudolf Boehm Inst. of Pharmacol. and
Toxicology, Univ. of Leipzig, Univ. of Milan.
4:00 C2 440.08 Neurotrophins affect the speed and
number of regenerating retinal ganglion cell axons. G. S.
VEGA MELÉNDEZ*; C. DEL CUETO; R. E. BLANCO. Inst.
of Neurobio., Univ. of Puerto Rico, Med. Sci. Campus.
1:00 C3 440.09 • Promoting sensory axon regeneration
by mimicking conditioning lesion with ATP injection into
sciatic nerves. S. LEE*; D. WU; J. YEH; Y. ZHANG; X.
BO. Barts and The London Sch. of Medicine, Queen Mary
University, Univ. of London, The Royal London Hosp.
2:00 C4 440.10 Axonal regeneration induced by blockade
of glial inhibitors coupled with activation of intrinsic neuronal
growth pathways. X. WANG*; O. HASAN; L. BENOWITZ;
W. CAFFERTY; S. STRITTMATTER. Yale Univ., Children’s
Hospital, Harvard Med. Sch.
3:00 C5 440.11 Transplantation of specific astrocytes
derived from embryonic glial restricted precursors promotes
functional recovery in long term chronic spinal cord injured
rats. J. E. DAVIES; C. J. PROSCHEL; S. M. GREEN;
K. JASPER; M. NOBLE; M. MAYER-PROSCHEL; S. J.
DAVIES*. Univ. of Colorado, Denver, Univ. of Rochester.
4:00 C6 440.12 Visualization of axon tip dynamics in the
larval zebrafish after spinal axotomy. S. SAHA*; D. ROUMIS;
D. O’MALLEY. Northeastern Univ.
1:00 C7 440.13 Gdnf is required for maintenance of
dopamine and striatal neurons in the nigrostriatal system. I.
M. STROMBERG*; M. CHERMENINA; P. SCHOUTEN; G.
ORÄDD; N. NEVALINEN. Umea Univ.
2:00 C8 440.14 Olfactory mucosal cells promote
axonal regeneration in newly three-dimensional assay.
M. ISHIHARA*; K. IWATSUKI; N. MOCHIZUKI-ODA; H.
KISHIMA; Y. ONISHI; M. UMEGAKI; T. YOSHIMINE. Osaka
Univ. Sch. of Medicine, Dept. of Neurosurg.
3:00 C9 440.15 • Anatomical plasticity of dendritic spines
in the adult cerebral cortex is restricted by NgR1. F. V.
AKBIK*; W. C. CAFFERTY; S. M. STRITTMATTER. Yale
Univ., Yale Univ.
4:00 C10 440.16 Targeted neuronal ablation in
the postnatal rodent cortex using diphtheria toxin. V.
PETRENKO; C. QUAIRIAUX; J. Z. KISS*. Univ. Geneva
Med. Sch.
96 | Society for Neuroscience
1:00 C11 440.17 Effects of NGF over-expressing Schwann
cell transplantation on peripheral nerve regeneration. A.
SHAKHBAZAU; J. KAWASOE; R. KUMAR; J. VAN MINNEN;
R. MIDHA*. Univ. Calgary.
2:00 C12 440.18 Limitation of adult CNS axonal growth
by the nogo/ngr1 pathway. W. B. CAFFERTY*; S. M.
STRITTMATTER. Yale Univ.
3:00 C13 440.19 • Electrical stimulation of primary motor
cortex promotes proliferation of oligodendrocyte progenitor
cells in the injury rodent spinal cord. Q. LI*; T. HOUDAYER;
V. BELEGU; J. W. MCDONALD. Kennedy Krieger Inst.,
Johns Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch.
of Med.
POSTER
441. Regeneration IV
Theme A: Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 C14 441.01 Optimized acellular grafts support
functional recovery after cervical spinal cord injury. Z. Z.
KHAING*; W. ALILAIN; H. SHARMA; J. SILVER; C. E.
SCHMIDT. Case Western Reserve Univ., Univ. of Texas at
Austin.
2:00 C15 441.02 BACE1 activity influences peripheral
nerve regeneration and internode distance of myelinated
fibers. M. H. FARAH*; Z. RAMMELKAMP; P. C. WONG; J.
W. GRIFFIN. Johns Hopkins Univ., Johns Hopkins Univ. Sch.
of Med., Johns Hopkins Univ. Sch. of Med.
3:00 C16 441.03 Neutralization of low density lipoprotein
receptor-related protein-1 blocks the inhibitory effects
of myelin on neuronal regeneration. T. L. STILES*; A.
GAULTIER; A. FERNANDEZ-CASTANEDA; S. L. GONIAS.
Univ. Calif San Diego.
4:00 C17 441.04 Extracellular histones: A novel inhibitor of
axonal regeneration in the CNS. M. M. SIDDIQ*; Y. ZORINA;
M. T. FILBIN. Hunter Col., Mt. Sinai Sch. of Med., Hunter
Col.
1:00 C18 441.05 Fezf2 directs the differentiation of
corticofugal neurons from striatal progenitors and early
postmitotic callosal projection neurons. C. ROUAUX; P.
ARLOTTA*. Harvard Univ.
2:00 C19 441.06 Vimentin phosphorylation and integrin
activation in Schwann cells are involved in axonal
regeneration. I. CHANG; K. KWON; M. KIM; U. NAMGUNG*.
Daejeon Univ.
3:00 C20 441.07 Axonal regeneration and spasticity after
combinatorial treatments for spinal cord injury. K. FOUAD; R.
VAVREK; D. J. BENNETT; K. MURRAY; A. KRAJACIC; M. H.
TUSZYNSKI; A. BLESCH*. Univ. of Alberta, Univ. of Alberta,
UCSD, VA Med. Ctr., Univ. California San Diego, Univ. Hosp.
4:00 C21 441.08 Transient changes in BDNF parallel
plasticity observed in the IML following distal preganglionic
axon injury. A. P. COULIBALY*; B. F. WALSH; L. G.
ISAACSON. Miami Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 C22 441.09 • Nicotine accelerates reinnervation
of phenol-injured adrenergic nerves in rat mesenteric
arteries. H. KAWASAKI*; H. FUJIWARA; K. HAGIMORI; N.
HASHIKAWA-HOBARA; Y. ZAMAMI; P. TANGSUCHARIT;
S. TAKATORI. Okayama Univ. Grd.scl.med.dent.pharm.
Sci., Okayama Univ. of Sci., Okayama−Univ. Grd. Sch. Med.
Dent. Pharmac. Sci.
2:00 C23 441.10 Changes in the superior cervical ganglion
following long term loss of preganglionic innnervation. L. G.
ISAACSON*; I. DAMAS; B. WALSH; K. FRANCIS; Z. HESP;
A. COULIBALY. Miami Univ., Miami Univ.
3:00 C24 441.11 SOX11 regulates expression of the
regeneration-associated gene SPRR1A. X. JING*; K. M.
ALBERS. Univ. of Pittsburgh.
4:00 C25 441.12 Spatial regulation of PI3K and GSK3
signaling controls intrinsic axon regeneration ability of adult
sensory neurons. X. SAIJILAFU*; E. HUR; W. XU; F. ZHOU.
Johns Hopkins Med. Sch.
1:00 C26 441.13 Degeneration and regeneration in
zebrafish lateral line axons. R. M. VILLEGAS SILVA*; S.
MARTIN; M. ALLENDE; A. SAGASTI. Univ. De Chile, Univ.
of California Los Angeles.
2:00 C27 441.14 Genetic dissection of axon regeneration
via in vivo electroporation of adult mouse sensory neurons.
F. ZHOU*; S. SAIJILAFU. Johns Hopkins Univ. Sch. Med.
3:00 C28 441.15 Oligodendroglia in CNS axonal
regeneration. E. A. BURTON*; Q. BAI. Univ. Pittsburgh.
4:00 C29 441.16 Reprogramming Müller glia into retinal
neurons with Ascl1. J. POLLAK*; M. S. WILKEN; Y. UEKI;
R. J. TAYLOR; T. A. REH. Univ. of Washington, Univ. of
Washington.
POSTER
442. Nicotinic Acetylcholine Receptors: Regulation and
Signaling
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 C30 442.01 • Mapping of structures in the rat
forebrain activated by the α4β2 nAChR selective agonist
ispronicline. J. JACOBSEN*; H. H. HANSEN; J. D.
MIKKELSEN. Neurobio. Res. Unit, NeuroSearch A/S.
2:00 C31 442.02 Streptozotocin-induced type I diabetes
reduces dopamine turnover via kynurenic acid production in
rat striatum. T. FUKUWATARI*; A. OKUNO; A. FUJIMOTO;
M. SANO; K. SHIBATA. Univ. Shiga Pref., Res. Institute,
NCGG.
3:00 C32 442.03 Abelson family tyrosine kinases regulate
nicotinic acetylcholine receptor function on autonomic
neurons. J. F. MARGIOTTA*; S. S. JAYAKAR. UT Col. of
Med.
4:00 C33 442.04 • Lynx1 balances neuronal activity
through nicotinic acetylcholine receptor modulation.
R. L. PARKER*; D. S. RHEE; E. D. W. MACKEY; S. L.
MCKINNEY; H. A. LESTER; J. M. MIWA. CALTECH.
1:00 C34 442.05 Multiple mechanisms underlie nicotineinduced
upregulation of endogenous acetylcholine receptors
expressed in rat cortical neurons. A. P. GOVIND*; H.
WALSH; W. N. GREEN. Univ. of Chicago, UC Tech.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 C35 442.06 Genistein’s effects on α7 nAChR function
depends upon exposure duration and time course of
expression in Xenopus oocytes. J. FARLEY*; J. ORCZYK;
M. ISLAM; P. SCHWARTZ; C. AMBLER; J. ROSE. Indiana
Univ., Indiana Univ., Duke Univ. Med. Sch.
3:00 C36 442.07 Type I and II positive allosteric
modulators differentially affect agonist-induced upregulation
of alpha7 nicotinic acetylcholine receptors. M. S.
THOMSEN*; J. D. MIKKELSEN. Copenhagen Univ. Hospital,
Rigshospitalet.
4:00 C37 442.08 The role of the chrna7 3’ untranslated
region in basal and induced gene expression. J. LAUGHLIN;
E. L. CROUCH; S. MEXAL; J. A. STITZEL*. Univ. Colorado,
Univ. Colorado.
1:00 C38 442.09 Deletion of neuronal alpha7 nicotinic
ACh receptors alters the temporal expression of NMDAR
subunits and affects cortical synaptic development during
critical periods. H. LIN*; D. R. LYNCH. The Children’s Hosp.
of Philadelphia.
2:00 C39 442.10 Differences in nicotinic receptor subunit
expression in an adolescent animal model of Attention Deficit
Disorder. M. HEFFERNAN*; M. R. IMPROGO; J. KING.
Univ. of Massachusetts Med. Sch., Univ. of Massachusetts
Med. Sch.
3:00 C40 442.11 • The α7 nAChR function in hippocampal
neurons is regulated by the lipid composition of the plasma
membrane. J. COLON-SAEZ*; J. YAKELL. Natl. Inst. Envrn.
Hlth. Sci.
4:00 C41 442.12 Expression and regulation of α4-, α5- and
β2-containing nicotinic receptors in rat cortex throughout
development. B. G. HOEGBERG*; E. LOMAZZO; D. M.
DEGUISTO; P. M. ANDERSON; D. C. PERRY. The George
Washington Univ., Georgetown Univ.
1:00 C42 442.13 A novel link between the alpha 7 nicotinic
receptor and the cytoskeleton mediated through the G
protein pathway. J. NORDMAN*; J. LINDSTROM; S. CLARK;
N. KABBANI. George Mason Univ., Univ. of Pennsylvania,
George Mason Univ.
2:00 C43 442.14 Evidence for additional α7 nicotinic
receptor chaperones in GH4C1 cells after knocking down
rat Ric3 protein. T. KOPERNIAK*; B. GARG; J. BOLTAX; R.
LORING. Northeastern Univ.
3:00 C44 442.15 Cholesterol modulation of nicotinic
acetylcholine receptor endcytosis. V. BORRONI, *F. J.
BARRANTES; Inst. Biochemistry, Bahía Blanca; UNESCO
Chair Molec. Neurobiol. & Biophysics; PIB-UCA-CONICET,
Buenos Aires, Argentina.
4:00 C45 442.16 � Neuregulin 1 is an endogenous
regulator of nicotinic acetylcholine receptors in autonomic
major pelvic ganglion neurons. H. KIM*; C. LEE; B. CHA; K.
WHANG; S. JEONG. Brain Res. Group, Yonsei Univ. Wonju
Col. Med., Brain Res. Group, Yonsei Univ. Wonju Col. Med.,
Brain Res. Group, Yonsei Univ. Wonju Col. Med.
1:00 C46 442.17 Changes in nicotinic receptor
expression and assembly in stable cell lines expressing
α4β2-type nicotinic acetylcholine receptors with high- and
low-incorporation of α5. T. D. MCCLURE-BEGLEY*; J.
LINDSTROM; J. A. STITZEL; M. R. PICCIOTTO. Yale Univ.,
Univ. of Pennsylvania, Univ. of Colorado, Yale Univ.
Neuroscience 2011 | Monday PM | 97
Mon. PM

2:00 C47 442.18 α7-nicotinic acetylcholine receptors are
up-regulated in a transgenic mouse model that expresses
the HIV-1 coat protein gp120. C. M. CAPO-VELEZ*; M.
DELGADO; R. MELENDEZ; J. LASALDE-DOMINICCI. Univ.
Puerto Rico,, Univ. of Puerto Rico, Rio Piedras Campus,
Univ. of Puerto Rico, Med. Sci. Campus.
3:00 C48 442.19 The alpha7 nicotinic acetylcholine
receptor subunit CHRNA7 and its duplicate form
(CHRFAM7A) in the innate immune system’s inflammatory
response: Friends or foes? R. BENFANTE*; V. ALARI; F.
GIORDANO; C. GOTTI; F. CLEMENTI; D. FORNASARI.
CNR - Inst. of Neurosci., Univ. of Milan.
POSTER
443. Non-NMDA Glutamate Receptors: Structure and
Trafficking I
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 C49 443.01 Hippocampal long-term depression
requires PICK1 interaction with ARP2/3. A. P. PATTON; C. L.
WOOD; J. G. HANLEY; J. R. MELLOR*. Univ. Bristol, Univ.
Bristol, Univ. Bristol.
2:00 C50 443.02 Agonist-induced PKC phosphorylation
regulates GluK2 SUMOylation and kainate receptor
endocytosis. F. A. KONOPACKI*; N. JAAFARI; K. A.
WILKINSON; S. E. CHAMBERLAIN; S. KANTAMNENI; J.
R. MELLOR; J. M. HENLEY; D. L. ROCCA. Univ. of Bristol,
Univ. of Bristol, Univ. of Bristol.
3:00 D1 443.03 Regulation of ampa receptors by a
novel membrane-spanning ring-domain containing e3ligase,
rnf167. M. P. LUSSIER*; B. E. HERRING; Y. NASU-
NISHIMURA; A. NEUTZNER; M. KARBOWSKI; R. J.
YOULE; R. A. NICOLL; K. W. ROCHE. NINDS / NIH, Univ. of
California, NINDS / NIH.
4:00 D2 443.04 Characterization of GluA2 AMPA
receptors with dual insertions of yellow and cyan variants
of green fluorescent protein. L. G. ZACHARIASSEN*; A. S.
KRISTENSEN; D. S. PICKERING. Fac. of Phamaceutical
Sciences, Univ. of Copenhagen, Fac. of Pharmaceut.
Sciences, Univ. of Copenhagen.
1:00 D3 443.05 Functional characterization of the AMPA
receptor N-terminal domain. O. CAIS; M. SUKUMARAN;
M. ROSSMANN; A. C. PENN; A. BALIK*; I. H. GREGER.
MRC Lab. of Mol. Biol., Lab. of Cell. and Synaptic
Neurophysiology, NICHD, Univ. de Bordeaux, IINS, UMR
5297.
2:00 D4 443.06 Roles of TARP PDZ binding in synaptic
transmission in vivo. A. SUMIOKA*; T. BROWN; J. KAUER;
S. TOMITA. Yale Univ., Brown Univ.
3:00 D5 443.07 • Neuronal signaling in hypoxia : A
HIF-independent mechanism. E. C. PARK*; P. GHOSE; Z.
SHAO; Q. YE; L. KANG; S. XU; J. POWELL-COFFMAN; C.
RONGO. The Waksman Institute, Rutgers Univ., Iowa State
Univ., Univ. of Michigan.
4:00 D6 443.08 Functional analysis of cys-knot domain of
CKAMP44 in modulating AMPA receptors. L. ZHANG*. Max
Planck Inst. For Med. Res.
98 | Society for Neuroscience
1:00 D7 443.09 BDNF regulation of GluA1 translation and
membrane delivery requires calcium calmodulin-dependent
protein kinase kinase (CaMKK). D. A. FORTIN*; T.
SRIVASTAVA; V. A. DERKACH; S. NYGAARD; P. PIERRE;
T. R. SODERLING. Oregon Hlth. and Sci. Univ., Univ. de la
Méditerranée.
2:00 D8 443.10 Variation in expression of synaptic
GluR2 containing AMPA receptors as a function of dendritic
distance in cerebellar stellate cells. I. A. SAVTCHOUK*; S. J.
LIU. LSU Hlth. Sci. Ctr., Penn State Univ.
3:00 D9 443.11 Crystal structure of the GluK3 kainate
receptor ligand binding domain in complex with glutamate.
R. VENSKUTONYTE*; K. FRYDENVANG; M. GAJHEDE;
D. S. PICKERING; J. S. KASTRUP. Fac. of Pharmaceut.
Sciences, Univ. of Copenhagen, Fac. of Pharmaceut.
Sciences, Univ. of Copenhagen.
4:00 D10 443.12 Dynamics of the AMPA receptor
N-terminal domain detected at the single-molecule level.
H. NEUWEILER; M. SUKUMARAN; M. HOEGH-JENSEN;
C. M. JOHNSTON; I. H. GREGER*. MRC LMB, Univ. of
Wuerzburg, Fac. of Pharmaceut. Sci.
1:00 D11 443.13 � Molecular identification of leech
AMPA receptor. B. BAUMANN; T. L. DAVIS; P. D.
BRODFUEHRER*. Bryn Mawr Col., Bryn Mawr Col.
2:00 D12 443.14 Interaction of the m4 segment with the
other transmembrane helices is required for ampa receptor
biogenesis. C. L. SALUSSOLIA*; L. P. WOLLMUTH. Stony
Brook Univ.
3:00 D13 443.15 Molecular imaging of functional glutamate
receptors in a lipid membrane. J. BARANOVIC*; C. S.
RAMANUJAN; N. KASAI; D. R. MADDEN; K. TORIMITSU; J.
F. RYAN. Univ. of Oxford, NTT Basic Res. Labs., Dartmouth
Med. Sch.
4:00 D14 443.16 PICK1 phosphorylation regulates its
interaction with the Arp2/3 complex. T. A. ROWLES*; K.
MURK; A. BROSIG; J. G. HANLEY. Univ. of Bristol.
POSTER
444. Transporters: DAT and Amphetamine
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 D15 444.01 Studying amphetamine-induced
trafficking and recycling of the dopamine transporter tagged
with extracellular epitopes. W. C. HONG*; E. BLOCK; M. B.
LARSEN; S. G. AMARA. Univ. Pittsburgh.
2:00 D16 444.02 Amphetamine increases glutamatergic
synaptic transmission in substantia nigra compacta (SNc).
M. LI; S. UNDERHILL; S. G. AMARA; S. L. INGRAM*.
Oregon Hlth. & Sci. Univ., Univ. of Pittsburgh, WSU
Vancouver.
3:00 D17 444.03 Methamphetamine-induced excitation
of dopamine neurons. S. Y. BRANCH; M. J. BECKSTEAD*.
UTHSCSA.
4:00 D18 444.04 Dialogue between DA and AMPH as
they travel through the human dopamine transporter. K.
CAMERON; L. J. DE FELICE*. Virginia Commonwealth Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 D19 444.05 D2 receptors regulate amphetamine
induced dopamine efflux through the dopamine transporter.
P. J. HAMILTON; J. JAVITCH; H. J. MATTHIES*; A. GALLI.
Vanderbilt Univ., Columbia Univ.
2:00 D20 444.06 Amphetamine triggers clathrinindependent
internalization of the DAT by activating
Rho family GTPases in a cAMP regulated fashion. D.
S. WHEELER*; S. M. UNDERHILL; G. ROMERO; S. G.
AMARA. Univ. of Pittsburgh, Univ. of Pittsburgh, Univ. of
PIttsburgh, Univ. of PIttsburgh.
3:00 D21 444.07 Phosphorylation of the SNARE protein
Syntaxin 1 by CK2 regulates AMPH-induced dopamine
efflux and behaviors. E. CARTIER*; P. HAMILTON; C.
KARAM; Y. ZHANG; U. GETHER; J. JAVITCH; P. G.
ULERY-REYNOLDS; H. MATTHIES; A. GALLI. Vanderbilt
Univ., Columbia University, Col. of Physician and Surgeons,
Panum Institute, Univerity of Copenhagen, Univ. of Texas,
SW Med. Ctr.
4:00 D22 444.08 • Multiple exposures to AMPH induce
desensitization of the dopaminergic system in living animals.
M. HOSSAIN*; B. D. SAFRATOWICH; L. CARVELLI. Univ. of
North Dakota, Sch. of Med.
1:00 D23 444.09 Amphetamines and dopamine transporter
localization: Lack of evidence for transporter relocalization
after in vivo treatment. C. L. GERMAN*; G. R. HANSON; A.
E. FLECKENSTEIN. Univ. of Utah.
2:00 D24 444.10 Amphetamines activate cytoplasmic
signaling cascades that regulate transporter internalization.
M. P. MILLER; D. S. WHEELER; S. M. UNDERHILL; S. G.
AMARA*. Univ. Pittsburgh Sch. Med., Univ. Pittsburgh Sch.
Med.
3:00 D25 444.11 � Dopamine-mediated effects
of β-phenylethylamine in Caenorhabditis elegans.
R. WICKRAMASEKARA; B. D. SAFRATOWICH; L.
CARVELLI*. Univ. of North Dakota.
POSTER
445. Presynaptic Mechanisms II
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 D26 445.01 Genetic and molecular analysis of
Drosophila COMPLEXIN function in synaptic transmission.
J. IYER; C. J. WAHLMARK; G. A. KUSER-AHNERT; F.
KAWASAKI*. Penn State Univ.
2:00 D27 445.02 Synaptic transmission and
short-term plasticity at the calyx of Held synapse of
complexin I-deficient mice. S. CHANG; K. REIM; H.
TASCHENBERGER*. Max Planck Inst. for Biophysical
Chem., Max Planck Inst. of Exptl. Med.
3:00 D28 445.03 Regulation of the small GTPase RAB-3
at the C. elegans neuromuscular junction. M. I. FELIU-
MOJER*; J. M. KAPLAN. Mass Gen. Hosp., Harvard Med.
Sch., Harvard Med. Sch.
4:00 D29 445.04 How dead are “dead-end” vesicles: An
analysis of inducing the fusion of unreleasable vesicles. S.
HUGO; U. MATTI; D. HOF; J. RETTIG; U. D. BECHERER*.
Univ. Des Saarlandes.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 D30 445.05 ubMunc13-2 has a role in regulating initial
release probability at a central synapse. S. M. YOUNG*,
JR; Z. CHEN. Max Planck Florida Inst., Key Lab. of Mol.
Biophysics, Ministry of Education, and Joint Lab. of Inst. of
Biophysics, Huazhong Univ. of Sci. and Technology,.
2:00 D31 445.06 Analysis of the role of the Munc13-2
and Munc13-3 gene in synaptic transmission and plasticity
at the calyx of Held synapse. Z. CHEN*; B. COOPER; F.
VAROQUEAUX; N. BROSE; S. M. YOUNG, Jr. Res. Group
Mol. Mechanisms of Synaptic Function,Max Planck Florida
Inst., Key Lab. of Mol. Biophysics, Ministry of Education, and
Joint Lab. of Inst. of Biophysics, Huazhong Univ. of Sci. and
Technol., Dept. of Mol. Neurobiology, Max Planck Inst. for
Exptl. Med., DFG Res. Ctr. for Mol. Physiol. of the Brain.
3:00 D32 445.07 SNAP-25 phosphorylation by PKA and
PKC differentially regulates fusion pore closure and dilation.
Y. HSIAO*; N. CHIANG; C. WANG. Natl. Taiwan Univ., Natl.
Taiwan Univ., Natl. Taiwan Univ.
4:00 D33 445.08 Cooperativity between the tandem C2
domains of synaptotagmin 1 in evoked and spontaneous
neurotransmitter release. J. LEE*; Z. GUAN; Y.
AKBERGENOVA; J. T. LITTLETON. MIT.
1:00 D34 445.09 Transcriptomics analysis of the
hippocampus of knock-out mice lacking Cysteine String
Protein-alpha (CSP-alpha), a mouse model of presynaptic
degeneration. L. GOMEZ-SANCHEZ; R. FERNANDEZ-
CHACON*. IBIS, HUVR-CSIC-Univ. Sevilla& Dept Med.
Physiol & Biophysics& CIBERNED.
2:00 D35 445.10 Two distinct vesicle pools for
depolarization-induced exocytosis in somata of dorsal root
ganglion neurons. Z. ZHOU*; T. LIU; S. SHANG; B. LIU; C.
WANG; Y. WANG; W. XIONG; L. ZHENG; C. ZHANG. Inst.
Mol. Med, Peking Univ.
3:00 D36 445.11 A new role for the dynamin gtpase in the
regulation of fusion pore expansion. A. ANANTHARAM*;
M. A. BITTNER; R. L. AIKMAN; E. L. STUENKEL; S. L.
SCHMID; D. AXELROD; R. W. HOLZ. Univ. of Michigan
Med. Sch., Univ. of Michigan Med. Sch., The Scripps Res.
Inst., Univ. of Michigan.
4:00 D37 445.12 Cysteine string protein-alpha maintains
the number of synaptic release sites and dynamindependent
recycling at motor nerve terminals. J. L. ROZAS;
L. GOMEZ-SANCHEZ; P. LINARES-CLEMENTE; M. E.
VAZQUEZ; R. LUJAN*; R. FERNANDEZ-CHACON. IBIS,
HUVR-CSIC-Univ. Sevilla& Dept Med. Physiol & Biophysics&
CIBERNED, Univ. Santiago de Compostela, Univ. Castilla-La
Mancha.
1:00 D38 445.13 Dynamin isoform selective and activity
dependent vesicle recycling in sympathetic neurons. S.
TANIFUJI; M. MORI; S. MOCHIDA*. Tokyo Med. Univ.
2:00 D39 445.14 Dynamin’s roles in the synaptic vesicle
cycle at the presynaptic terminal. A. B. SEYMOUR*; J.
MORGAN; S. ALFORD. Univ. of Illinois At Chicago, Univ. of
Texas at Austin, Univ. of Illinois at Chicago.
3:00 D40 445.15 Two color imaging of synaptic vesicle
recycling and calcium dynamics. H. LI; S. M. FOSS; Y.
DOBRYY; P. KEVIN; A. HIRES; N. S. SHANER; L. C.
OSBORNE4; R. Y. TSIEN; S. M. VOGLMAIER*. Univ.
California San Francisco, Univ. California San Francisco,
Univ. of California San Diego, Univ. of Chicago.
4:00 D41 445.16 Syntaxin 1A single point mutation
compromises synaptic vesicle recycling. A. VASIN*; T.
LITTLETON; M. BYKHOVSKAIA. Univ. Central Del Caribe,
Massachusetts Inst. of Tecnology, Univ. Central del Caribe.
Neuroscience 2011 | Monday PM | 99
Mon. PM

1:00 D42 445.17 Regulation of modes of synaptic vesicle
release in control and diabetic nerve terminals. A. C.
ASHTON*; M. H. PATEL; D. A. BHUVA; T. S. SIHRA. Sch. of
Pharm. and Biomed. Sci., Sch. of Pharm. and Biomed. Sci.
Univ. of Central Lancashire, Dept. of Neuroscience, Physiol.
and Pharmacol. Univ. Col. London.
2:00 D43 445.18 Estimates of vesicle supply rates at
cerebellar mossy fibre synaptic terminals with FRAP and
3D reaction-diffusion simulations. J. S. ROTHMAN*; Z.
NUSSER; L. KOCSIS; E. HERZOG; N. BROSE; A. SILVER.
Univ. Col. London, Inst. of Exptl. Med., Univ. de Strasbourg,
Max Planck Inst. for Exptl. Med.
3:00 D44 445.19 A stranded vesicle pool at the plasma
membrane enhances endocytosis efficiency at nerve
terminals. L. XUE; B. D. MCNEIL; J. XU; X. WU; F. LUO; L.
HE; L. WU*. NINDS.
4:00 D45 445.20 Intersectin1 (Itsn1) mediates Ca 2+ -
dependent replenishment of the readily-releasable pool
of synaptic vesicles at a central synapse. Y. YANG*; A.
SENGAR; J. AITOUBAH; G. GRANDE; S. EGAN; M.
SALTER; L. WANG. The Hosp. For Sick Children, The Hosp.
For Sick.
1:00 D46 445.21 � Mutations in palmitoyl proteinthioesterase
1 alter exocytosis and endocytosis at synapses
in Drosophila larvae. K. GUMPS; E. ABY; A. ROTH; S.
SIGMON; K. D. PARFITT; C. A. KOREY*. Coll Charleston,
Pomona Col.
2:00 D47 445.22 • BDNF enhances spontaneous and
evoked synaptic vesicle recycling exclusively in excitatory
synapses via a common mechanism. Y. SHINODA*;
S. AHMED; J. SCHRADER; B. ALTAş; V. BHARAT; D.
BROCKELT; C. DEAN. European Neurosci. Inst.
3:00 D48 445.23 Axonal and dendritic synaptotagmin
isoforms revealed by a pHluorin-syt functional screen.
C. B. DEAN*; F. M. DUNNING; H. LIU; E. R. CHAPMAN.
European Neurosci. Inst., Univ. of Wisconsin.
4:00 D49 445.24 Highly efficient vesicle use at mature
Schaffer collateral boutons. T. G. OERTNER*; T. ROSE.
Friedrich Miescher Inst.
1:00 D50 445.25 Comparative neurotransmitter profiles
in five dopaminergic cell culture models. A. G. LOPEZ*;
B. L. ROBINSON; S. M. LANTZ; G. D. NEWPORT; M. G.
PAULE; S. F. ALI. Lab. de Histopatología, ENP, UNAM.,
Neurochemistry Lab, Div. of Neurotoxicology, Natl. Ctr.
Toxicological Res/Fda.
2:00 D51 445.26 Presynaptic short-term plasticity in striatal
dopamine transmission. N. PLATT*; S. J. CRAGG. Univ. of
Oxford.
3:00 D52 445.27 Mechanical tension modulates local and
global vesicle dynamics in neurons. W. AHMED*; T. LI; S.
RUBAKHIN; A. CHIBA; J. SWEEDLER; T. SAIF. U. Illinois,
Beckman Inst. for Advanced Sci. and Technol., Univ. of
Miami, U. Illinois.
4:00 D53 445.28 ADF and n-cofilin act cooperatively in
controlling synaptic vesicle exocytosis. A. GÖRLICH*; A. M.
ZIMMERMANN; M. WOLF; M. SASSOÈ-POGNETTO; E.
FRIAUF; W. WITKE; M. B. RUST. Tech. Univ. Kaiserslautern,
Univ. of Turin, Tech. Univ. Kaiserslautern, Univ. of Bonn.
100 | Society for Neuroscience
POSTER
446. Presynaptic Mechanisms III
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 D54 446.01 Ca 2+ channel control of GABA release in
cortical somatostatin-positive interneurons. I. KRUGLIKOV;
E. ROSSIGNOL; G. J. FISHELL*; B. RUDY. New York Univ.
Med. Ctr.
2:00 D55 446.02 CaV2.3 mediate fast synaptic
transmission in hippocampal neurons and compete with
CaV2.1 and CaV2.2 for saturable presynaptic CaV2-binding
sites or “slots”. D. T. POBURKO*; Y. LI; M. R. TADROSS; R.
W. TSIEN. Stanford Univ.
3:00 D56 446.03 P/Q- and N-type calcium channels
cooperate to control neurotransmitter release at the
excitatory and reciprocal inhibitory synapses between
layer 2/3 pyramidal cells and somatostatin-expressing
interneurons of the mouse somatosensory cortex. M.
SESSOLO; R. CONTI; A. MERIGHI*; D. PIETROBON. Univ.
of Padova, Univ. of Turin, Sch. of Vet. Med.
4:00 D57 446.04 A small number of calcium channels
triggers transmitter release from hippocampal synapses. A.
SCIMEMI*; J. S. DIAMOND. NIH/NINDS.
1:00 D58 446.05 � Variability in stimulus-induced
presynaptic active zone calcium entry along the length of
frog motor nerve terminals. N. R. DESTEFINO; Z. S. MACE;
F. LUO; S. D. MERINEY*. Univ. Pittsburgh.
2:00 D59 446.06 Quantitation of single action potentialevoked
calcium signals in CA1 pyramidal neuron presynaptic
terminals. E. Y. HAMID*; S. ALFORD. Univ. Illinois, Chicago.
3:00 D60 446.07 Differential dependence of miniature
IPSC and EPSC frequency on presynaptic Ca 2+ channels
at hippocampal synapses. S. P. GOSWAMI*; P. JONAS; I.
BUCURENCIU. IST Austria, Spemann Grad. Sch. of Biol.
and Medicine, Univ. of Freiburg, Inst. of Physiology, Univ. of
Freiburg.
4:00 D61 446.08 • Control of release probability in
dopamine neurons. P. PAN*; T. A. RYAN. Weill Cornell Med.
Col.
1:00 D62 446.09 Extrasynaptic exocytosis from the axon
of a serotonergic neuron. M. GUERRERO*; C. LEON
PINZON; F. F. DE MIGUEL; C. TRUETA. Inst. Nacional de
Psiquiatría Ramón de la Fuente, Inst. de Fisiología Celular-
Neurociencias, UNAM.
2:00 D63 446.10 Somatic secretion of serotonin is
calcium- and serotonin-dependent. C. LEON PINZON*; P. L.
NOGUEZ; M. G. CERCÓS; C. TRUETA; F. F. DE MIGUEL.
Inst. de Fisiología Celular-Neurociencias, UNAM, Inst.
Nacional de Psiquiatría Ramón de la Fuente.
3:00 D64 446.11 Calcium current cooperativity and
variability of synaptic response: Domain overlap vs domain
sharing. V. V. MATVEEV*; R. BERTRAM; A. SHERMAN.
New Jersey Inst. Tech., Florida State Univ., NIH.
4:00 D65 446.12 Presynaptic plasticity is controlled
by combinatorial phosphorylation of Munc18-1 and its
phosphorylation-dependent degradation. S. K. SCHMITZ*;
C. R. KING; M. VERHAGE; R. F. G. TOONEN. CNCR, VU
Univ. Amsterdam.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 D66 446.13 Packaging and physiological separation
of the RRP and RP of vesicles within various types of
presynaptic terminals. W. WU*; R. COOPER. Univ. of
Kentuky.
2:00 D67 446.14 Exploration of presynaptic synaptic
vesicle attachment proteins by immunoprecipitation. F.
WONG*; E. F. STANLEY. Toronto Western Res. Inst.
3:00 D68 446.15 The role of intracellular protein domains
in Cav2.2 anchoring at the presynaptic transmitter release
site. S. GARDEZI*; Q. LI; A. FARSI; E. F. STANLEY. Toronto
West Rese, Toronto Western Res. Inst.
4:00 D69 446.16 Recovery from short-term depression
in visual cortical inhibitory synapses depends on activity.
S. HUANG*; A. KIRKWOOD. Johns Hopkins Univ., Johns
Hopkins Univ.
1:00 D70 446.17 Septal neuroblastoma (SN56) cell line
expresses a hybrid cholinergic and glutamatergic phenotype.
L. F. PACHECO*; M. VELASQUEZ; J. RODRIGUEZ; B.
ERMOLINSKY; E. GARRIDO-SANABRIA. UTB, Ctr. for
Biomed. Studies.
2:00 D71 446.18 TRPV1 independent mechanisms of
spontaneous and asynchronous glutamate release at
synapses between primary afferents and second-order
neurons in the nucleus of the solitary tract. J. H. PETERS*.
Washington State Univ.
3:00 D72 446.19 Mitochondrial protein Bcl-xL modulates
depression of neurotransmitter release in the hippocampal
synapse. P. ZHANG*; H. LI; E. A. JONAS. Yale Univ. Sch. of
Med.
4:00 E1 446.20 Effects of potassium channels on
presysnaptic action potentials and the afterdepolarization. K.
G. PARADISO*. Rutgers Univ.
1:00 E2 446.21 Presynaptic GluN3A-containing NMDA
receptors promote neurotransmitter release and spike
timing-dependent plasticity in a visual experience-dependent
manner. R. LARSEN*; R. J. CORLEW; R. J. WEINBERG;
B. D. PHILPOT. Univ. of North Carolina, Max Planck Florida
Inst., Univ. of North Carolina.
2:00 E3 446.22 Characterization of voltage-gated calcium
channels in mouse photoreceptors. C. P. GRABNER*. Chad
Grabner, Univ. des Saarlandes.
3:00 E4 446.23 Dynamics of SNARE complex
disassembly and re-assembly, and dispersion of SNAP-25B
and VAMP-2 in hippocampal neurons. V. E. DEGTYAR; R. S.
ZUCKER*. Univ. of California.
4:00 E5 446.24 Functional ryanodine receptors in the
membranes of neurohypophysial secretory granules.
S. ORTIZ-MIRANDA; J. MCNALLY; E. CUSTER; B. M.
SALZBERG*; D. WOODBURY; J. R. LEMOS. U. Mass. Med.
Sch., Univ. Pennsylvania Sch. Med., Brigham Young Univ.
1:00 E6 446.25 MKP3 eliminates depolarization
dependent neurotransmitter release through down regulation
of L-type calcium channel expression. O. V. MORTENSEN*;
M. H. CHOI; A. C. K. FONTANA; S. G. AMARA. Drexel Univ.
Col. of Med., Univ. of Pittsburgh.
2:00 E7 446.26 Molecular dynamics simulation of SNARE
complex unzippering reveals structural elements that may be
critical for fusion clamping. M. BYKHOVSKAIA*; A. JAGOTA;
B. ZHOROV; J. T. LITTLETON. Univ. Central Del Caribe,
Lehigh Univ., McMaster Univ., MIT.
3:00 E8 446.27 Global rises in Ca 2+ cause prolonged
release from GABAergic amacrine cells. E. D. EGGERS*; J.
S. KLEIN. Univ. of Arizona.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 E9 446.28 • Dissecting the signaling pathways
by which anesthetics inhibit the neurotransmitter release
machinery. Z. XIE*; K. MCMILLAN; C. PIKE; B. E.
HERRING; A. P. FOX. Univ. Chicago, Univ. of Chicago.
1:00 E10 446.29 Atmospheric scanning electron
microscopy (asem) realizes direct em-om correlative
immuno-cytochemistry of neurons in solution. C. SATO*; Y.
MARUYAMA; H. NISHIYAMA; S. MANAKA; A. KOHTZ; M.
SUGA; T. EBIHARA. Natl. Inst. of Advanced Industrial Sci.
and Technol. (AIST), JEOL Ltd.
2:00 E11 446.30 Wnt signaling regulates acetylcholine
receptor translocation and synaptic plasticity in the adult
nervous system. M. R. JENSEN*; F. HOERNDLI; P.
BROCKIE; D. MADSEN; A. V. MARICQ. Univ. Utah.
POSTER
447. Presynaptic Mechanisms IV
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 E12 447.01 The role of the presynaptic scaffold
protein Bassoon in synaptic transmission at the mouse
endbulb of Held. A. MENDOZA SCHULZ; N. STRENZKE*; E.
GUNDELFINGER; C. WICHMANN; T. MOSER. InnerEarLab,
Dept. of Otolaryngology and Ctr. for Mol. Physiol. of the
Brain, Univ. Goettingen, Leibniz Inst. for Neurobio. (LIN),
InnerEarLab, Ultrastructure of ribbon synapses Group, Dept.
of Otolaryngology and CMPB, Bernstein Ctr. for Computat.
Neurosci.
2:00 E13 447.02 � VSM-1 is a SNARE interacting
protein that regulates synapse formation. T. J. WHEELER*;
A. EDWARDS; C. FISCHER; M. GRAHAM; K.
GUTHMUELLER; L. SEALS; M. YODER; A. HOLGADO.
Southwestern Oklahoma State Univ.
3:00 E14 447.03 Evidence for a developmental role of
VGLUT2 in dopamine neurons. G. FORTIN*; M. BOURQUE;
J. A. MENDEZ; D. LEO; L. TRUDEAU. Univ. de Montréal.
4:00 E15 447.04 Activity dependent alteration of large
vesicle clusters in mossy fiber terminals. P. TURKO; K. K. E.
GADALLA; K. K. DEV*; S. COBB. Univ. of Glasgow, Tanta
Univ., Trinity Col. Dublin.
1:00 E16 447.05 • Recruitment of resting vesicles into
functionally recycling pools as a mechanism of synaptic
potentiation at hippocampal synapses. J. RATNAYAKA*; V.
MARRA; D. BUSH; J. J. BURDEN; T. BRANCO; K. STARAS.
Univ. of Sussex, UCL, UCL.
2:00 E17 447.06 Effects of presynaptic calcium stores on
short-term synaptic plasticity. S. NADKARNI*; T. BARTOL;
E. ENNEDY; K. HARRIS; C. STEVENS; H. LEVINE; T.
SEJNOWSKI. Salk Inst. For Biol. Studies, Univ. of California
San Diego, Univ. of California San Diego, Univ. of Texas at
Austin.
3:00 E18 447.07 Quantitative ultrastructural analysis
of commissural/associational CA3 synapses in wild type
and FGF22 knock-out mice. T. A. SCHIKORSKI*; L. QU;
D. CRUZ; T. PASAOGLU; L. CUMBA; L. RIVERA. Univ.
Central Del Caribe, Vanderbilt Univ., Univ. del Este, Univ.
Metropolitana.
Neuroscience 2011 | Monday PM | 101
Mon. PM

4:00 E19 447.08 Effect of DREADD receptor activation
in Drosophila motoneurons on synaptic transmission. Z.
R. MAJEED*; R. L. COOPER; C. D. NICHOLS. Univ. of
Kentucky, Dept. of Biol., Louisiana State Univ. Hlth. Sci. Ctr.
1:00 E20 447.09 A Bcl-x L -Drp1 complex regulates synaptic
vesicle membrane dynamics during endocytosis. H. LI*; K.
ALAVIAN; N. MEHTA; A. JONES; P. ZHANG; M. GRAHAM;
C. RAHNER; E. JONAS. Yale Univ., Yale university.
2:00 E21 447.10 Synaptic vesicle-associated proteins,
SV2 and synaptophysin, in sensory and motor fibers of
cutaneous and enteric neurons. B. D. MCADAMS*; G.
WENDELSCHAFER-CRABB; W. R. KENNEDY. Univ.
Minnesota Neurosci Prgm, Univ. Minnesota.
3:00 E22 447.11 Postnatal development of PIP 2 -dependent
vesicle endocytosis at the calyx of Held. K. EGUCHI; S.
NAKANISHI; Z. TAOUFIQ; H. TAKAGI; T. TAKAHASHI*.
Okinawa Inst. Sci. & Technol., Doshisha Univ.
4:00 E23 447.12 The physiological roles of vesicular GABA
transporter (VGAT) in quantal release of GABA. H. MIWA*;
Y. YANAGAWA. JST, CREST, Gunma Univ.
1:00 E24 447.13 Target cell dependency of presynaptic
properties in hippocampal neurons. A. DE JONG*; R. F. G.
TOONEN; M. VERHAGE. VU Univ. Amsterdam.
2:00 E25 447.14 The role of the GIT1 protein in synapse
development and organization. M. S. MONTESINOS*; R.
T. PREMONT; S. M. YOUNG, Jr. Max Planck Florida Inst.,
Duke Univ. Med. Ctr.
3:00 E26 447.15 Altered presynaptic spike properties in
cerebellar basket cells in a mouse model of Episodic Ataxia
type 1. R. BEGUM; D. M. KULLMANN*. Inst. Neurology,
UCL.
4:00 E27 447.16 Dynamic properties of recycling vesicle
pools in native hippocampal tissue examined using
fluorescence and ultrastructural approaches. V. MARRA*; J.
THORPE; T. BRANCO; A. RATNAYAKA; K. STARAS. Univ.
of Sussex, Wolfson Inst. for Biomed. Research, UCL.
1:00 E28 447.17 BAD and BAX control synaptic vesicle
pools by regulating mitochondrial function. S. JIAO*; Z. LI.
Natl. Inst. of Mental Health, NIH.
2:00 E29 447.18 Stabilization of neurotransmitter release
at retinal ribbon synapses by ribbon-specific subtypes
of complexin. T. VAITHIANATHAN*; G. ZANAZZI; G.
MATTHEWS. State Univ. of New York, State Univ. of New
York.
3:00 E30 447.19 Synapsin isoforms distribution in
calretinin-, calbindin D28K- and parvalbumin-positive
interneurons in the hippocampus. A. RAIMONDI; F.
BENFENATI*; R. ANELLI. FONDAZIONE ISTITUTO
ITALIANO DI TECNOLOGIA, Italian Inst. Technol.
4:00 E31 447.20 Synaptophysin translation and
glycosylation are altered in the rat retina by diabetes. T. S.
D’CRUZ*; B. N. WEIBLEY; S. R. KIMBALL; A. J. BARBER.
Penn State Hershey Eye Center, Penn State Col. of Med.,
Penn State Hershey Eye Center, Penn State Col. of Med.
1:00 E32 447.21 EPAC null mutation impairs synaptic
transmission and social interactions. K. QIAN*; Y. SHANG;
X. XU; J. ZHANG; W. TU; Y. LU. LSU.
2:00 E33 447.22 Postsynaptic to presynaptic
communication at hippocampal mossy fiber synapses. N. A.
REBOLA*; M. CARTA; F. LANORE; C. MULLE. CNRS UMR
5297.
102 | Society for Neuroscience
3:00 E34 447.23 Endogenous trans-synaptic transport of
proteins in the rat visual system. L. M. SCHIAPPARELLI*; J.
LI; D. MCCLATCHY; L. LIAO; J. YATES, III; H. T. CLINE. The
Scripps Res. Inst., The Scripps Res. Inst.
4:00 E35 447.24 Mismatched structural and functional
remodeling at the developing calyx of Held-MNTB synapse
following unilateral removal of sound-evoked activity. G.
GRANDE*; Y. YANG; L. WANG. The Hosp. for Sick Children,
Univ. of Toronto.
1:00 E36 447.25 � The sulfur amino acid metabolite
lanthionine ketimine regulates synaptic transmission and
neural structural remodeling, and offers therapeutic potential
for neurodegenerative disease. E. BENDA; T. BAXTER;
T. HARDIN; K. HENSLEY; A. HOLGADO*. Southwestern
Oklahoma State Univ., Univ. of Toledo.
POSTER
448. Presynaptic Mechanisms: Short-Term Plasticity
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 E37 448.01 • Differential frequency-dependent
plasticity of monosynaptic and longer latency reflexes in the
spinal cord is Dopamine D3 receptor- and calcium channeldependent.
B. E. KEELER*; S. CLEMENS. East Carolina
Univ.
2:00 E38 448.02 Computational study of persistent calcium
binding provides insight into short-term synaptic facilitation.
J. MA; L. KELLY; T. PRICE; J. INGRAM; S. MERINEY; M.
DITTRICH*; J. STILES. Carnegie Mellon Univ., Univ. of
Pittsburgh, Carnegie Mellon Univ.
3:00 F1 448.03 Frequency dependence of feed-forward
inhibition in the hippocampus. A. F. BARTLEY*; L. E.
DOBRUNZ. Univ. Alabama, Birmingham, Univ. Alabama,
Birmingham.
4:00 F2 448.04 � Heterosynaptic interaction of the
sprouted crossed entorhinal and septal inputs to the
hippocampus following unilateral entorhinal cortex lesion in
rats. M. A. DE NIEAR; C. C. CRON; M. L. ROBINSON; P. G.
LAKHMANI; J. J. RAMIREZ*. Dept Psychol, Neurosci Prog,
Davidson Col.
1:00 G1 448.05 Ghrelin enhances synaptic transmission
and phosphorylation of NR2B subunits of the NMDA receptor
in the rat hippocampus. M. ISOKAWA*. Univ. Texas-
Brownsville.
2:00 G2 448.06 Short-term plasticity at GABAergic
synapses in the globus pallidus is altered in a rat model
of Parkinson’s disease. C. MIGUELEZ*; S. MORIN; M.
GOILLANDEAU; B. BIOULAC; J. BAUFRETON. Inst. Des
Maladies Neurodégénératives.
3:00 G3 448.07 • Synapsin II and Rab3a interact in the
regulation of short-term plasticity at hippocampal synapses.
P. A. FELICIANO*; M. BYKHOVSKAIA. Univ. Central Del
Caribe.
4:00 G4 448.08 GPR55 modulates transmitter release
and short term plasticity in the hippocampus by initiating
store mediated pre-synaptic Ca 2+ entry. T. P. JENSEN; S.
SYLANTYEV; R. A. ROSS; D. A. RUSAKOV*. UCL Inst. of
Neurol., Univ. of Aberdeen.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 G5 448.09 A study on the possible role of synaptic
vesicles as a Ca 2+ store for Ca 2+ -induced Ca 2+ release
in frog motor nerve terminals. K. NARITA*; N. HIMI; N.
OKABE; E. NAKAMURA; O. MIYAMOTO; T. NAKAGAWA;
T. MURAYAMA; K. KUBA. Kawasaki Med. Sch., Kawasaki
Med. Sch., Kagawa Univ. Fac. Med. Kagawa, Juntendo
Univ., Nagoya Univ. Arts. Sci. Fac. Nutri.
2:00 G6 448.10 Hysteresis of cultured neuronal network
depend on culture age that depends on network maturity. H.
ITO*; S. N. KUDOH. Sch. of Sci. and Tech.,Kwansei Gakuin
Univ.
3:00 G7 448.11 Activity-dependent growth of new
dendritic spines is acutely regulated by the proteasome. A.
M. HAMILTON*; W. OH; H. VEGA-RAMIREZ; G. PATRICK;
K. ZITO. UC Davis Ctr. for Neurosci., UC San Diego.
4:00 G8 448.12 EPSC amplitude noise caused by
fast synaptic depression: A function in robust spike time
coding. W. J. SPAIN*; S. CAVANAUGH; S. J. SLEE; M.
S. KUZNETSOVA; P. C. SCHWINDT; M. H. HIGGS. Univ.
Washington, Univ. Washington, Johns Hopkins Univ.,
Veterans Affairs Puget Sound Hlth. Care Syst., Veterans
Affairs Puget Sound Hlth. Care Syst.
POSTER
449. Synaptic Plasticity: Presynaptic Mechanisms
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 G9 449.01 The role of heterosynaptic plasticity in
achieving stable synaptic distributions. P. LONJERS*; M.
BAZHENOV; M. VOLGUSHEV. UCR, Univ. of Connecticut.
2:00 G10 449.02 Plasticity induced by intracellular
tetanization in Layer 2/3 rat auditory cortex is dependent on
the initial release conditions of the synapse. C. M. LEE*; C.
R. STOELZEL; M. CHISTIAKOVA; M. VOLGUSHEV. Univ. of
Connecticut.
3:00 G11 449.03 Flip-flop memory circuit uses a synaptic
AMPK-dependent positive feedback loop and is switched
by hunger state. Y. YANG*; D. ATASOY; S. M. STERNSON.
Janelia Farm Res. Campus, HHMI.
4:00 G12 449.04 Essential role for transient receptor
potential vanilloid 3 (TRPV3) in synaptic plasticity in the
hippocampus. A. M. CHIRILA*; T. E. BROWN; B. SCHRANK;
J. A. KAUER. Brown Univ., Brown Univ.
1:00 H1 449.05 Cocaine-evoked plasticity in synapses
between D1 receptor- expressing medium spiny neurons and
VTA GABA neurons. C. BOCKLISCH*; C. LÜSCHER. Ctr.
Medicale Universitaire, Univ. of Geneva, Clin. of Neurology,
Univ. Hosp.
2:00 H2 449.06 Maintenance of long-term potentiation
in hippocampal mossy fiber - CA3 pathway requires
optimal balance of matrix metalloproteinase 9 activity.
G. WIERA; T. WOJTOWICZ; K. LEBIDA; D. DRULIS-
FAJDASZ; M. WAWRZYNIAK; P. MICHALUK; P. DZIEGIEL;
L. KACZMAREK; J. W. MOZRZYMAS*. Wroclaw Univ.,
Wroclaw Med. Univ., Nencki Inst. of Exptl. Biol.
3:00 H3 449.07 Nonlinear dynamical model for the
separation and quantification of pre- and post-synaptic
transmission mechanisms. S. ROACH*; U. LU; D. SONG; T.
W. BERGER. USC.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 H4 449.08 • 5-HT4 receptor activation produces
persistent enhancement of hippocampal mossy fibre
transmission in young, old and Aβ overproducing mice. M.
CAMO; J. WITTON; J. T. BROWN; A. D. RANDALL*. Univ. of
Bristol.
1:00 H5 449.09 • Small dense core vesicles may
facilitate presynaptic enlargement while vesicle-free
transition zones may serve to enlarge PSDs following LTP in
mature hippocampus. M. E. BELL*; M. A. CHIRILLO; J. N.
BOURNE; K. M. HARRIS. Univ. of Texas at Austin.
2:00 H6 449.10 The role of NR2D-containing NMDA
receptors in cerebellar synaptic plasticity and learning. C.
DUBOIS*; P. M. LACHAMP; L. SUN; M. MISHINA; S. LIU.
LSUHSC, Penn State Univ., Univ. of Tokyo.
3:00 H7 449.11 Mechanical force is linked to connectivity
of individual neuromuscular synapses in Drosophila. T. LI*;
A. CHIBA. Univ. of Miami.
4:00 H8 449.12 Altered Ca 2+ -dependent short- and longterm
presynaptic plasticity at cerebellar parallel fiber-Purkinje
cell synapses in mice lacking GluD2. M. YAMASHITA*; S.
KAWAGUCHI; T. HIRANO. Dept. of Biophys, Grad. Sch. of
Science,Kyoto Univ.
1:00 H9 449.13 A mossy fiber-mediated GABAergic
LTP onto specific interneurons of CA3. E. J. GALVAN*; R.
GUTIERREZ. CINVESTAV / IPN, Cinvestav.
2:00 H10 449.14 Sonic hedgehog signaling modifies
presynaptic terminal size and ultrastructure in hippocampal
neurons. P. J. YAO; R. S. PETRALIA*; Y. WANG; M. M.
MATTSON. NATIONAL INSTITUTE ON AGING, NIDCD/NIH.
3:00 H11 449.15 Allocation of peptide positive and peptide
negative presynaptic varicosities by a single neuron at
discrete regions of the motor arborization. D. KUEH; J. A.
JELLIES*. Western Michigan Univ., Western Michigan Univ.
POSTER
450. Synaptic Transmission: Regulation by Zinc
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 H12 450.01 Dendritic Zn 2+ rises modulate
mitochondrial function and glutamatergic transmission in
hippocampal neurons. V. FRAZZINI*; S. L. SENSI. Mol.
Neurol. Unit, Dept. of Neurosci. and Imaging, Univ. California
Irvine.
2:00 I1 450.02 � Roles of methallothionein-3 and
vascular endothelial growth factor in mouse models of
choroidal neovasculaization. J. CHOI*; J. HWANG; J. KOH;
Y. YOON. Asan Life Sci. Inst., The Armed Forces Capital
Hosp., Univ. of Ulsan, Col. of Medicine, Dept of Neurol.,
Asan Med. Ctr, Univ. of Ulsan, Col. of Medicine, Dept of
Ophthamology.
3:00 I2 450.03 • pH-dependent intracellular zinc
release in hippocampal neurons exposed to glutamate. L.
KIEDROWSKI*. Univ. Illinois At Chicago.
4:00 I3 450.04 Motoneuronal cell death by zinc released
from G93A SOD-1 expressing astrocytes. J. KIM*; T. KIM;
J. KOH. Univ. Ulsan Col., Univ. Ulsan Col., Asan Hosp. and
Univ. Ulsan Col. Med.
Neuroscience 2011 | Monday PM | 103
Mon. PM

1:00 I4 450.05 Propagation of spreading depolarizations
is limited by the synaptic release and extracellular actions of
Zn 2+ . R. CARTER*; I. AIBA; A. P. CARLSON; C. SHELINE;
C. W. SHUTTLEWORTH. Univ. of New Mexico, Univ. of New
Mexico, LSUHSC.
2:00 I5 450.06 Metallothionein-3 modulates oxidative
stress-induced brain injury through c-Abl activation. S. LEE*;
T. KIM; J. KOH. Univ. Ulsan Col. Med., Neural Injury Res.
Ctr. for the study of CNS zinc, Neural Injury Res. Ctr. for the
study of CNS zinc, Univ. of Ulsan, Col. of Med.
3:00 I6 450.07 Zinc reduction or NAD + restoration
attenuated light-induced death of photoreceptors and RPE
cells. C. T. SHELINE*; S. BAI. LSU Hlth. Sci. Ctr.
4:00 I7 450.08 � Tamoxifen induces autophagy and
cell death in photoreceptor (661w) cell culture. K. CHO*; J.
CHOI; Y. HAN; Y. YOON; J. KOH. Univ. Ulsan Col. Med.,
Univ. of Ulsan, Col. of Medicine, NRL neural injury research
center, Asan Med. Center,University of Ulsan, Dept. of
Ophthalmology, Asan Med. Center, Univ. of Ulsan, Dept. of
Neurol.
1:00 I8 450.09 Synaptically released Zn 2+ triggers
endocannabinoid synthesis and controls synaptic strength.
T. PEREZ-ROSELLO*; F. J. SCHOPFER; S. SALVATORE;
B. A. FREEMAN; M. HERSHFINKEL; E. AIZENMAN;
T. TZOUNOPOULOS. Dept. of Otolaryngology, Univ. of
Pittsburgh, Univ. of Pittsburgh, Ben Gurion Univ., Univ. of
Pittsburgh.
2:00 I9 450.10 Calcium-dependent release of
endogenous zinc from photoreceptor terminals modulates
presynaptic L-type calcium channels. I. ANASTASSOV; R. L.
CHAPPELL*. Hunter Col, CUNY, The Grad. Center, CUNY,
Marine Biol. Lab.
3:00 I10 450.11 Synaptic Zn 2+ acts as a neurotransmitter
signal via the Zn 2+ sensing ZnR/GPR39 receptor to
upregulate KCC2 activity in the hippocampus. M.
HERSHFINKEL*; E. CHORIN; O. VINOGRAD; I.
FLEIDERVISH; I. SEKLER; E. AIZENMAN. Dept. of
Morphology and Zlotowski Ctr. For Neuroscience; Ben
Gurion Univ., Dept. of Physiol. and Zlotowski Ctr. For
Neuroscience; Ben Gurion Univ., Univ. of Pittsburgh Sch. of
Med.
4:00 I11 450.12 � Upregulation of KCC2 activity following
zinc receptor (ZnR/GPR39) activation is SNARE dependent.
R. A. SAADI; K. HE; K. A. HARTNETT; M. HERSHFINKEL;
E. AIZENMAN*. Univ. Pittsburgh Sch. Med., Ben Gurion
Univ.
1:00 I12 450.13 Zinc histochemistry reveals circuit
refinement and is a reliable marker of visual areas in the
developing ferret cortex. R. KHALIL*; L. BRANDT; J. B.
LEVITT. City Col. of New York, Grad. Ctr. CUNY.
2:00 J1 450.14 • Activity-dependent modulation of
synaptic zinc in the primary visual cortex of mice. H. WU*; R.
DYCK. Univ. of Calgary.
3:00 J2 450.15 Structural and functional correlation
between zinc and taurine: their transporters in rat retinal
cells. A. MÁRQUEZ; M. URBINA; L. LIMA*. Inst. Venezolano
de Investigaciones Científicas (IVIC), IVIC, CBB.
4:00 K1 450.16 Zinc activated channel expression in
neurons: Model for metal excitotoxicity. P. A. DAVIES*; S.
M. TRATTNIG; E. COMENENCIA ORTIZ; S. J. MOSS; A. A.
JENSEN. Tufts Univ., Univ. of Copenhagen.
104 | Society for Neuroscience
1:00 K2 450.17 Zinc levels in the 129S1 inbred mouse
strain vary across regions compared to B6 mice, as
determined by synchrotron X-ray fluorescence microscopy.
C. M. GROEBER*; R. TAPPERO; J. KOSCHO; J. M. FLINN.
George Mason Univ., Brookhaven Natl. Lab.
2:00 K3 450.18 � Supplemental zinc alters dendritic
morphology in the dentate gyrus of chronically and
unpredictably stressed rats. C. SIZEMORE; P. KAKALEC;
G. KNAACK; L. D. CHROSNIAK*; J. FLINN. George Mason
Univ., George Mason Univ.
3:00 K4 450.19 Ascertaining the role of zinc in stress and
PTSD: From the blood to the brain. G. L. KNAACK*; C. G.
MCDONALD; S. M. LEV; J. M. FLINN. George Mason Univ.,
Towson Univ.
4:00 K5 450.20 Vesicular zinc promotes presynaptic
and inhibits postsynaptic long term potentiation of the
hippocampal mossy fiber-CA3 synapse. E. PAN*; X. A.
ZHANG; Z. HUANG; S. J. LIPPARD; J. O. MCNAMARA.
Duke Univ. Med. Ctr., MIT.
1:00 K6 450.21 Examining the effects of excess zinc on
anxiety- and depression-like behaviors in a rat model. E.
H. BEECH*; C. EA; E. D. HOLLIDAY; C. SIZEMORE; J. M.
FLINN. George Mason Univ.
POSTER
451. Oscillations and Synchrony: Unit Studies
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 K7 451.01 Changes in neuronal firing and network
interactions in humans during propofol anesthesia. V. S.
WEINER*; L. D. LEWIS; J. DONOGHUE; S. S. CASH;
E. N. ESKANDAR; E. N. BROWN; P. P. PURDON. MIT,
MIT, Massachusetts Gen. Hosp., Massachusetts Gen.
Hosp., Harvard Med. Sch., Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., Harvard-MIT Hlth. Sci. and
Technol., Massachusetts Gen. Hosp.
2:00 K8 451.02 Two distinct modes of phase-amplitude
coupling in human cortical electrical dynamics under
general anesthesia. E. A. MUKAMEL*; K. F. WONG; E. T.
PIERCE; P. G. HARRELL; J. L. WALSH; E. N. BROWN; P. L.
PURDON. Massachusetts Gen. Hosp., Harvard Univ., MIT.
3:00 K9 451.03 EEG over the occipital sites contains
signatures of loss and recovery of consciousness during
general anesthesia. A. CIMENSER*; P. L. PURDON; E.
T. PIERCE; J. L. WALSH; A. F. SALAZAR-GOMEZ; P. G.
HARRELL; C. TAVARES-STOECKEL; K. HABEEB; E. N.
BROWN. Massachusetts Gen. Hosp., Harvard Med. Sch.,
MIT, MIT.
4:00 K10 451.04 Propofol-induced general anesthesia
produces coordinated action potential bursts in human
cortical neurons. L. D. LEWIS*; V. S. WEINER; E. A.
MUKAMEL; J. A. DONOGHUE; S. S. CASH; E. N.
ESKANDAR; E. N. BROWN; P. L. PURDON. MIT, Harvard,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., Harvard-MIT, Harvard Med. Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 K11 451.05 Relationship between excitatory
and inhibitory neuronal activity and local field potentials
during human sleep. N. DEHGHANI*; A. PEYRACHE; E.
ESKANDAR; J. MADSEN; W. ANDERSON; J. DONOGHUE;
E. HALGREN; A. DESTEXHE; S. CASH. Ctr. Natl. De La
Recherche Scientifique (CNRS), Rutgers Univ., MGH,
Harvard, Children’s hospital,Harvard, Brigham and Women’s
Hosp., MGH, Harvard, UCSD.
2:00 K12 451.06 Spatio-temporal dynamics of
neocortical excitation and inhibition during human sleep. A.
PEYRACHE*; N. DEHGHANI; E. ESKANDAR; J. MADSEN;
W. ANDERSON; J. DONOGHUE; E. HALGREN; S. S.
CASH; A. DESTEXHE. Rutgers Univ., Ctr. Natl. De La
Recherche Scientifique (CNRS), MGH, Harvard, Children’s
hospital, Harvard, Brigham and Women’s Hosp., MGH,
Harvard, UCSD.
3:00 L1 451.07 Predictable spiking underlies spatial
patterns of cortical local field potential. W. L. SHEW*; S. YU;
T. BELLAY; D. PLENZ. NIH.
4:00 L2 451.08 Robust and narrow-band inter-areal
coupling in the gamma to beta range is mediated by the
theta rhythm in macaque visual cortex. E. LOWET; M.
ROBERTS; A. HADJIPAPAS; J. VAN DER EERDEN; P.
FRIES; P. DE WEERD*. Maastricht Univ., Radboud Univ.,
Univ. of Nicosia, Ernst Strüngmann Inst. (ESI) in Cooperation
with Max Planck Society.
1:00 L3 451.09 Gamma synchronization and spike timing
dependent plasticity in the cortex. W. FENG*; R. VICENTE;
W. SINGER; D. NIKOLIC. Max Planck Inst. For Brain Res.,
Frankfurt Inst. for Advanced Studies.
2:00 L4 451.10 Revisiting power law in vivo as a function
of the global brain state, using multiple recordings in
anesthetized cat V1. G. HAHN*; C. MONIER; Y. FRÉGNAC.
UNIC-CNRS, UPR CNRS 3293.
3:00 L5 451.11 Activity of mutually interconnected relay
and reticular cells in the thalamus in vivo. L. ACSADY*; K.
D. HARRIS; P. BARTHÓ. Inst. Exp. Med. Hung Acad Sci.,
Imperial Col. London.
4:00 L6 451.12 • Slow global fluctuations in cortical
circuits under urethane anesthesia. D. A. JERCOG*; A.
ROXIN; A. RENART; P. BARTHO; L. HOLLENDER; K.
D. HARRIS; A. COMPTE; J. DE LA ROCHA. IDIBAPS,
Champalimaud Ctr., Hungarian Acad. of Sci., Rutgers Univ.,
Imperial Col.
1:00 L7 451.13 Neurotensin abolishes the slow oscillation
and excites a sub-population of low-threshold-spiking
interneurons in the rat cortex. L. CASE*; C. BROBERGER.
Karolinska Institutet.
2:00 L8 451.14 Cortical slow oscillations during limbic
seizures are associated with hypothalamic seizure activity
and suppressed brainstem firing. J. E. MOTELOW*; A. M.
MISHRA; R. N. S. SACHDEV; B. G. SANGANAHALLI;
A. GUMMADAVELLI; J. A. CROMER; D. J. ENGLOT; F.
HYDER; H. BLUMENFELD. Yale Sch. of Med., Yale Sch. of
Med., Yale Sch. of Med., Univ. of California, San Francisco,
Yale Sch. of Med.
3:00 L9 451.15 Neuronal interactions between
sensory and prefrontal cortex during synchronized and
desynchronized states. E. J. BERMUDEZ CONTRERAS*;
A. GOMEZ PALACIO SCHJETNAN; M. ARIF; L. A. MOLINA;
B. KOLB; A. GRUBER; A. LUCZAK. Canadian Ctr. For
Behavioural Neurosci.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 L10 451.16 Increased inter-hemispheric
synchronization after direct current stimulation during stroke
recovery. A. GÓMEZ PALACIO SCHJETNAN*; D. C. GIDYK;
G. A. METZ; A. LUCZAK. Univ. of Lethbridge.
1:00 L11 451.17 WITHDRAWN
2:00 L12 451.18 Involvement of thalamic nuclei in slow
oscillation in anesthetized mice. M. SHEROZIYA*; I.
TIMOFEEV. Ctr. De Recherche Univ. Laval Robert-Giffard
(CRULRG).
3:00 M1 451.19 Participation of hilar mossy cells in sharp
wave ripple oscillations in vitro. A. V. EGOROV*; M. BOTH;
A. DRAGUHN. Inst. Physiol. and Pathophysiology, Dept.
Neurophysiology, Heidelberg Univ.
4:00 M2 451.20 • Clock-like theta cells in the mouse
hippocampus. L. LIN*; L. ZHANG; X. MA. East China Normal
Univ.
1:00 M3 451.21 Reversible, task-dependent changes in
the coupling of spike timing to distributed LFP patterns. R. T.
CANOLTY*; K. GANGULY; C. F. CADIEU; K. KOEPSELL; J.
M. CARMENA. Univ. California-Berkeley, Univ. of California,
Berkeley, San Francisco VA Med. Ctr., Univ. of California,
San Francisco, Univ. of California, Berkeley, Univ. of
California, Berkeley.
2:00 M4 451.22 An inhibition-stabilized network model for
stimulus-induced gamma in the visual cortex. M. JADI*; T. J.
SEJNOWSKI. Salk Inst.
3:00 M5 451.23 Correlated variability stabilizes persistent
activity in networks of spiking neurons. B. D. DOIRON*; A.
LITWIN-KUMAR; A. POLK. Univ. of Pittsburgh, Carnegie
Mellon Univ.
POSTER
452. Dendritic Excitability and Synaptic Integration I
Theme B: Neural Excitability, Synapses, and Glia:
Cellular Mechanisms
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 M6 452.01 Effect of Spike Rate Adaptation on phase
precession in adaptive Integrate-and-Fire neuron model. M.
KIM; J. KWAG*. Korea Univ.
2:00 M7 452.02 • Fast nicotinic synaptic transmission
in the thalamus. M. BEIERLEIN*; J. J. RENGER; V. N.
UEBELE; Y. SUN. Univ. Texas Med. Sch., Merck Res. Labs.
3:00 M8 452.03 Task channels powerfully control
dendritic spike initiation and propagation in layer 5 pyramidal
neurons. S. R. WILLIAMS*; M. T. HARNETT; J. C. MAGEE.
Queensland Brain Inst., HHMI Janelia Farm Res. Campus.
4:00 M9 452.04 Dendritic integration of synaptic
inputs in stellate cells of the medial entorhinal cortex. G.
TOLEIKYTE*; C. SCHMIDT-HIEBER; T. BRANCO; C. P.
BURGESS; M. HAUSSER. UCL.
1:00 M10 452.05 Integrative properties of CA1 pyramidal
cell dendrites in the dorsal vs. ventral hippocampus:
Differences in action potential backpropagation correlate
to Kv4.2 expression and phosphorylation levels. B. A.
MARCELIN*; J. N. LUGO; A. E. ANDERSON; A. BECKER;
M. ESCLAPEZ; C. BERNARD. INSERM, Baylor Col. of
Med., Univ. of Bonn, INSERM U751.
Neuroscience 2011 | Monday PM | 105
Mon. PM

2:00 M11 452.06 Active dendrites generate and transmit
theta oscillations in model neurons. A. SCHOEN*; A.
SALEHIOMRAN; E. COOK. McGill Univ., McGill Univ.
3:00 M12 452.07 • Multibranch integration on the dendritic
arbor of CA1 pyramidal neurons. S. YANG*; P. RHODES; V.
EMILIANI; C. TANG. Univ. of Maryland Sch. Med., Evolved
Machines, CNRS UMR 8154, INSERM U603, Univ. of Paris
Descartes.
4:00 N1 452.08 Different noise optima for stochastic
resonance for spike timing - and spike rate -based coding.
M. UUSISAARI*; B. GUTKIN; K. M. STIEFEL. Okinawa Inst.
of Sci. and Technol., Ecole Normale Superieure.
1:00 N2 452.09 Role of active dendrites on the dynamic
range of simulated models of retinal ganglion cells. A. C.
ROQUE*; R. PUBLIO. Univ. de Sao Paulo.
2:00 N3 452.10 Modulation of the CA1 pyramidal cell
input-output function by distinct populations of perisomatic-
and dendrite- targeting interneurons. M. LOVETT-BARRON*;
P. LEE; B. V. ZEMELMAN; S. M. STERNSON; J. C. MAGEE;
A. LOSONCZY. Columbia Univ. Med. Ctr., Howard Hughes
Med. Institute, Janelia Farm Res. Campus, Univ. of Texas at
Austin.
3:00 N4 452.11 DPP6 establishes the A-type K+ current
gradient critical for the regulation of dendritic excitability in
CA1 hippocampal neurons. W. SUN; J. K. MAFFIE; L. LIN;
R. S. PETRALIA; B. RUDY; D. A. HOFFMAN*. NIH, Peking
Univ. Hlth. Sci. Ctr., NYU Sch. Med., NIDCD.
4:00 N5 452.12 A crucial role for dendritic sodium spikes
in the induction of LTP at synapses from the perforant
pathway onto distal dendrites of CA1 pyramidal neurons. Y.
KIM*; N. SPRUSTON. Northwestern Univ.
1:00 N6 452.13 Dendritic integration in hippocampal CA3
pyramidal neurons. J. K. MAKARA*; J. C. MAGEE. Janelia
Farm Res. Campus.
2:00 N7 452.14 Initiation, propagation, and modulation of
action potentials in active thalamic interneuron dendrites. A.
E. CASALE*; D. MCCORMICK. Yale Univ., Yale Univ.
3:00 N8 452.15 Voltage-dependent conductances
modulate the amplification and propagation of signals
in nonspiking neurons. S. YANG*; M. VILARCHAO; L.
SZCZUPAK. Univ. of Buenos Aires, Fac De Ciencias
Exactas Y Naturales, Univ. of Buenos Aires,Facultad de
Ciencias Exactas y Naurales, IFYBYNE-CONICET.
4:00 N9 452.16 Action potential evoked calcium signals
in interneurons within the basolateral amygdala. J. M.
POWER*; G. M. FREEMAN; R. SULLIVAN; P. SAH. Univ. of
Queensland.
1:00 N10 452.17 Ionic and synaptic mechanisms regulate
compartmentalization and coincidence-detection in CA1
distal tuft dendrites. A. D. MILSTEIN*; K. C. BITTNER; B.
K. ANDRÁSFALVY; J. C. MAGEE. HHMI Janelia Farm Res.
Campus.
2:00 N11 452.18 Compartment-specific voltage attenuation
across dendritic spine necks. M. T. HARNETT*; J. K.
MAKARA; N. SPRUSTON; J. C. MAGEE. Janelia Farm Res.
Campus, Howard Hughes Med. Inst., Northwestern Univ.
106 | Society for Neuroscience
POSTER
453. Physiological Functions and Processing of APP and
APP Metabolites II
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 N12 453.01 HSV-1-induced APP processing triggers
apoptotic cell death in rat cortical neurons. G. DE CHIARA;
M. MARCOCCI; L. CIVITELLI; R. PIACENTINI; C. RIPOLI;
E. GARACI; C. GRASSI*; A. PALAMARA. Inst. Superiore
di Sanità, Sapienza Univ. of Rome, Med. Sch, UCSC, Tor
Vergata Univ. of Rome, Inst. Pasteur Cenci Bolognetti Fund.
Sapienza Univ., IRCCS S. Raffaele.
2:00 O1 453.02 The effect of inducing mutations within
the amyloid precursor protein gene on the levels of Aβ42 and
Aβ40 using the BacMam expression system. K. WALLACE;
R. NELSON; P. ZAGOURAS*; B. POLAND; K. STUTZMAN-
ENGWALL; W. QIN; K. R. BALES. Pfizer, Pfizer.
3:00 O2 453.03 Nicotine modulates amyloid precursor
protein processing and synaptic plasticity in the rat
retinocollicular pathway. A. C. FARIA-MELIBEU*; R.
GONÇALVES; J. VASQUES; L. LEO; P. TRINDADE;
P. CAMPELLO-COSTA; C. SERFATY. Univ. Federal
Fluminense, UFF.
4:00 O3 453.04 The Vps10p-domain receptor sortilin
interacts with amyloid precursor protein and might affect
its intracellular traffic and processing. C. GUSTAFSEN*;
A. CARLO; P. MADSEN; A. NYKJÆR; T. WILLNOW; C.
MUNCK PETERSEN. MIND, Dept of Med. Biochemistry,
Aarhus Univ., Max-Delbrueck-Center for Mol. Med.
1:00 O4 453.05 Investigating the cytoprotective functions
of endogenous APP family members in stress signaling and
aging. D. KOGEL*; N. RÖHNER; S. CHANG; A. ZYMNY;
F. BAUMKÖTTER; S. KINS; C. BEHL. Frankfurt Univ.
Hosp., Div. of Human Biol. and Human Genet., Inst. for
Pathobiochemistry.
2:00 O5 453.06 Sortilin intracellular domain interacts
with amyloid precursor protein (APP) and modulates APP
anterograde transport and production of amyloid β peptide.
X. ZHOU*. Flinders Univ.
3:00 O6 453.07 Possible involvement of ubiquitin ligase
HRD1 insolubilization in the pathogenesis of Alzheimer’s
disease. R. SAITO*; M. KANEKO; Y. NOMURA; Y. OKUMA.
Chiba Inst. of Sci., Yokohama Col. of Pharm.
4:00 O7 453.08 � APP is phosphorylated by TrkA
and affects NGF/TrkA signaling. C. MATRONE*; A. P. M.
BARBAGALLO; L. R. LA ROSA; D. MERCANTI; M. V.
CHAO; P. CALISSANO; L. D’ADAMIO. Natl. Council of Res.,
Albert Einstein Univ., Skirball Inst., European Brain Res. Inst.
1:00 O8 453.09 The role of multivesicular bodies in
the generation of beta-amyloid in Alzheimer’s disease. J.
EDGAR*; C. E. FUTTER. Univ. Col. London.
2:00 O9 453.10 In vitro identification and in vivo validation
of Amyloid Precursor Protein metabolism regulators. A. J.
SAUNDERS*; D. MARENDA; C. ZHANG; P. KHANDELWAL;
R. CHAKRABORTY. Drexel Univ.
3:00 O10 453.11 A physiological role for the amyloid β
(Aβ) peptide? The effect of Aβ on the Kv channel accessory
subunit, PSD-95.. R. SUMAN*; H. PEARSON. Univ. Of
Leeds.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 O11 453.12 • APP circadian rhythms in the human
CNS. J. A. DOBROWOLSKA*; Y. HUANG; T. KASTEN; W.
SIGURDSON; R. J. BATEMAN. Washington Univ.
1:00 O12 453.13 Molecular insights on the impact of
membrane cholesterol increase on Alzheimer’s disease
development mechanisms by novel fluorescence
microscopies. C. MARQUER; V. DEVAUGES; J. COSSEC;
G. LIOT; S. LÉCART; G. THINAKARAN; F. SAUDOU; C.
DUYCKAERTS; S. LÉVÊQUE-FORT; M. POTIER*. CRICM
CNRS Umr7225, ISMO, CNRS FRE3363, Inst. Curie/CNRS
UMR3306/INSERM U1005, CLUPS, Univ. Paris-Sud 11, The
Univ. of Chicago.
2:00 P1 453.14 Enhanced amyloidogenic processing
of APP in Alcadeinα-deficient mice. T. YAMAMOTO*; N.
GOTOH; Y. SAITO; S. HATA; T. SUZUKI. Hokkaido Univ.
3:00 P2 453.15 Impaired complex I function leads to Aß
generation - the interplay between brain aging and sporadic
Alzheimer’s disease. K. LEUNER*; T. SCHÜTT; C. KURZ;
S. ECKERT; G. ECKERT; W. E. MÜLLER. FAU Erlangen
Nürnberg, Goethe Univ.
4:00 P3 453.16 Amlyoid precursor protein expression is
coordinated with synaptic metaplasticity. Q. ZHANG*; R. M.
LAZARENKO; B. EDBERG; X. GAO. Vanderbilt Univ.
1:00 P4 453.17 Gene expression profiling in amyloid
precursor protein overexpression cells. Y. WU*; Y. LUO; F.
CAI; W. SONG. The Univ. of British Columbia.
2:00 P5 453.18 The renin-angiotensin system modulates
APP and apoE metabolism. R. YAMAUCHI*; K. ZOU;
C. JUNG; M. MICHIKAWA. Natl. Institude For Longevity
Sciences, Natl. Ctr. of Geriatrics and Ger, Iwate Med. Univ.
3:00 P6 453.19 APP knock-out mice display axonal
transport deficits in two distinct anatomical circuits by
manganese-enhanced MRI. J. J. GALLAGHER*; X. W.
ZHANG; G. ZIOMEK; R. E. JACOBS; E. L. BEARER.
Caltech, Univ. of New Mexico.
4:00 P7 453.20 The E693Δ mutation in amyloid precursor
protein impairs Aβ-mediated cholesterol efflux from cells in
vitro. S. NOMURA*; T. UMEDA; T. TOMIYAMA; H. MORI.
Dept. of Neuroscience, Grad. Sch. of Medicine, Osaka City
Univ.
1:00 P8 453.21 A new function for ß-amyloid monomers.
M. GIUFFRIDA; F. TOMASELLO; F. CARACI; G.
PANDINI; S. CHIECHIO; G. BATTAGLIA; P. DE BONA;
G. PAPPALARDO; R. VIGNERI; F. NICOLETTI; E.
RIZZARELLI; A. G. COPANI*. CNR - I.B.B., Univ. of Catania,
Univ. of Catania, Univ. of Catania, I.N.M. Neuromed, Univ. of
Catania, Univ. of Rome “Sapienza”.
2:00 P9 453.22 Reelin fragments differentially affect
APP processing: Implications for Alzheimer’s disease.
A. MADHUSUDAN*; P. VOGEL; S. K. TYAGARAJAN; U.
KONIETZKO; M. HANENBERG; C. GISLER; B. KUNZ; P.
SONDEREGGER; I. KNUESEL. Inst. of Pharmacol. and
Toxicology, Univ. of Zurich, Div. of Psychiatry Research,
Univ. of Zurich, Dept. of Biochemistry, Univ. of Zurich, Inst. of
Mol. Life Sciences, Univ. of Zurich.
3:00 P10 453.23 DISC1 controls production of amyloid-β
(Aβ) by regulating intracellular trafficking of the Aβ
precursor protein (APP) along the secretory, endocytic, and
degradative route. V. MURESAN; Z. MURESAN*. UMDNJ -
New Jersey Med. Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
454. Repeat Expansion Diseases: Non-Huntington’s Disease I
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 P11 454.01 Abnormal dendrite and spine morphology
in pyramidal neurons of primary visual cortex in Fmr1
premutation knock-in mice. R. F. BERMAN*; H. WENZEL;
G. ARQUE; K. D. MURRAY. Univ. California, Davis,
Neurotherapeutic Res. Inst., Neurolog. Surgery, Univ.
California Davis, Univ. California Davis.
2:00 P12 454.02 Lithium and spinocerebellar ataxia type 1:
A metabolomic-transcriptomic approach. P. JAFAR-NEJAD*;
B. PERROUD; J. R. GATCHEL; O. FIEHN; H. T. ORR; R.
KADDURAH-DAOUK; H. Y. ZOGHBI. Baylor Coll Med/ Jan
and Dan Duncan Neurolog. Res. Inst., Univ. of California,
Baylor Col. of Med., Univ. of Minnesota, Duke Univ. Med. Ctr.
3:00 Q1 454.03 Profiling polyglutamine-expanded AR
aggregates in spinal and bulbar muscular atrophy. T. R.
BERGER*; D. E. MERRY. Thomas Jefferson Univ.
4:00 Q2 454.04 Differential regulation of genes by isoform
selective HDAC inhibitors. S. SHARMA; E. SORAGNI; H. L.
PLASTERER; S. KU; A. C. COOPER; V. JACQUES; J. M.
GOTTESFELD; J. R. RUSCHE*. Repligen, The Scripps Res.
Inst.
1:00 R1 454.05 Hippocampal volumes and cognitive
functioning among men with Fragile X-Associated Tremor/
Ataxia Syndrome (FXTAS). R. M. PORTER*; T. BRUNELLE;
D. RUBINSTEIN; Y. DU; M. BROWN; R. BENNETT; J.
GRIGSBY. Univ. of Colorado Denver.
2:00 R2 454.06 The role of serine 16 phosphorylation and
the N/C interaction of the androgen receptor in SBMA. L. J.
COOPER*; C. ORR; C. KESLER; B. PASCHAL; D. MERRY.
Thomas Jefferson Univ., Univ. of Virginia.
3:00 R3 454.07 Acetylation of mutant AR alters liganddependent
properties of the mutant protein. I. PALAZZOLO*;
J. SAVAS; J. R. YATES, III; D. KRAINC. Scripps Res. Inst.,
Harvard Med. Sch.
4:00 R4 454.08 Protein Kinase A is a new modifier of
polyglutamine androgen receptor toxicity. S. PARODI;
A. CONTESTABILE; F. SAMBATARO; I. GOZES; M.
PENNUTO*. Italian Inst. of Technol., Italian Inst. of Technol.,
Tel-Aviv Univ.
1:00 R5 454.09 A mouse model of neurotoxicity induced
by transcripts containing CUG repeats. J. PRUITT*; D.
RUDNICKI; K. PATE; L. TESSAROLLO; D. SWING; J. CHIH;
R. MARGOLIS. Johns Hopkins Univ., Johns Hopkins Univ.,
Natl. Cancer Inst.
2:00 R6 454.10 Androgen receptor antagonist can
prevent disease in the AR97Q mouse model of SBMA. K.
J. RENIER*; G. SOBUE; H. ADACHI; M. KATSUNO; S. M.
BREEDLOVE; C. L. JORDAN. Michigan State Univ., Nagoya
Univ. Grad. Sch. of Med.
Neuroscience 2011 | Monday PM | 107
Mon. PM

POSTER
455. Motor Neuron Disease: Mechanisms IV
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 R7 455.01 The Survival of Motoneuron (SMN)
protein dysregulates Rho-kinase downstream targets.
P. CLAUS*; Y. SCHILL; N. HENSEL; A. NÖLLE; B.
FÖRTHMANN; J. VAN BERGEIJK; C. GROTHE. Hannover
Med. School, Neuroanatomy, Hannover Med. Sch.
2:00 R8 455.02 Electrophysiological properties of adult
motoneurons in ALS: The size hypothesis. K. A. QUINLAN*;
M. MANUEL; M. JIANG; S. M. ELBASIOUNY; S. AHMED;
C. J. HECKMAN. Northwestern Univ., Northwestern Univ.
Feinberg Sch. of Med.
3:00 R9 455.03 Analysis of amyotrophic lateral sclerosis
immunoglobulins interaction with pre-synaptic proteins. L.
GONZALEZ*; M. L. KOTLER; K. J. MULATZ; R. C. REISIN;
T. P. SNUTCH; O. D. UCHITEL. IFIBYNE UBA CONICET,
Facultad de Ciencias Exactas y Naturales, UBA, Michael
Smith Laboratories, Univ. of British Columbia, Servicio de
Neurofisiología, Hosp. Británico.
4:00 R10 455.04 WITHDRAWN
1:00 R11 455.05 The spinal muscular atrophy disease
protein SMN regulates the assembly and transport of
RNA granules in motor neuron axons by interacting with
mRNA-binding proteins. C. FALLINI*; W. ROSSOLL; G. J.
BASSELL. Emory Univ., Emory Univ.
2:00 R12 455.06 Novel genetic determinants of the SMA
phenotype in a model organism. T. AWANO; C. M. LUTZ; U.
MONANI*. Columbia Univ., The Jackson Labs.
3:00 S1 455.07 Altered tenascin-R expression and
perineuronal net morphology in amyotrophic lateral sclerosis
(ALS). M. A. COLLINS; R. P. BOWSER*. Univ. Pittsburgh
Sch. Med.
4:00 S2 455.08 � Pathological axonal transport II:
Binding cooperativity, ATP, and tau. A. M. ORTICELLI*; C. S.
MITCHELL. Georgia Inst. of Technol.
1:00 S3 455.09 The role of transcription factor c-jun in
mutant sod1 mediated amyotrophic lateral sclerosis. M.
MAKWANA*; A. ACOSTA-SALTOS; C. ACOSTA-SALTOS;
E. ROCHA FERREIRA; D. YILMAZ; J. S. DAVIS; A.
GILCHRIST; A. ROCKCLIFFE; C. DA COSTA; A. BEHRENS;
G. RAIVICH. Univ. Col. London, Cancer Res. UK.
2:00 S4 455.10 Troyer syndrome protein spartin
associates with mitochondria via its plan-related senescence
domain and regulates mitochondrial Ca 2+ homeostasis. D. C.
JOSHI*. Stritch Sch. of Med.
3:00 S5 455.11 Change in the astrocytic aquaporin
4 and Kir4.1 potassium channel expression and the
blood-brain barrier compromise in the ALS rat model.
D. B. BATAVELJIC*; L. NIKOLIC; M. MILOSEVIC; N.
TODOROVIC; P. R. ANDJUS. Univ. of Belgrade, Inst. for
Biol. Res. Sinisa Stankovic, Univ. of Belgrade.
4:00 S6 455.12 Decreased leptin improves survival and
energy metabolism in the mutant superoxide dismutase 1
(mSOD1) mouse model of Amyotrophic Lateral Sclerosis. M.
A. LIM*; K. K. BENCE; R. G. KALB. Univ. of Pennsylvania,
Children’s Hosp. of Philadelphia, Univ. of Pennsylvania.
108 | Society for Neuroscience
1:00 S7 455.13 Pathological axonal transport I: Protein
aggregation, molecular motor deregulation and mutation. C.
S. MITCHELL*; R. H. LEE. Georgia Inst. of Technol., Emory
Univ.
2:00 S8 455.14 • Angiogenin is a neuronallyderived
secreted factor that engages astroglia to protect
motoneurons. K. COUGHLAN; M. A. KING; A. SKORUPA; B.
BREEN; C. G. CONCANNON; J. H. PREHN*. Royal Col. of
Surgeons in Ireland, Royal Col. of Surgeons in Ireland.
3:00 S9 455.15 Intracellular inclusions of the RNA binding
protein RBM45 in ALS and FTLD patients. M. A. COLLINS*;
T. KOVALIK; D. RIASCOS; K. KRUPA; K. KRUPA; R.
BOWSER. Univ. of Pittsburgh, Univ. of Pittsburgh.
4:00 S10 455.16 Gene expression in brainstem and
spinal cord motor neurons with differential susceptibility
to amyotrophic lateral sclerosis. J. M. CAPONITI*; M.
FASOLINO; L. NOIMAN; E. GOULD. Princeton Univ., Johns
Hopkins Univ.
1:00 S11 455.17 Genetic and pharmaceutical approaches
to increase cytochrome c oxidase levels and mitochondrial
function in primary neuronal cultures of CCS/G93ASOD1
mice. M. U. SON*; K. PUTTAPARTHI; S. SNEED; Y. WEN;
J. L. ELLIOTT. Univ. Texas S Western Med. Ctr. Dallas,
UNTHSC.
2:00 S12 455.18 Oxidative damage to nucleic acids in
Motor Neuron Disease. K. RICHARDSON; S. B. WHARTON;
P. G. INCE; P. J. SHAW; P. R. HEATH*. Univ. of Sheffield,
Univ. of Sheffield.
3:00 T1 455.19 Degeneration and abnormal turnover
of spinal cord oligodendrocytes in a mouse model of ALS.
S. H. KANG*; M. FUKAYA; I. SRIVASTAVA; S. SINGH; D.
E. BERGLES. Johns Hopkins Univ. Sch. of Med., Kitasato
Univsersity Sch. of Med.
4:00 T2 455.20 Muscle cells as a potential target
of mutant SOD1 toxicity. A. POLETTI*; E. ONESTO; P.
RUSMINI; V. CRIPPA; A. ZITO; M. GALBIATI. Univ. degli
Studi di Milano.
1:00 T3 455.21 Generation of normal and familial
Amyotrophic lateral sclerosis GFAP-GFP human iPSC
reporter lines using zinc-finger nuclease technology. P.
ZHANG*; R. SATTLER; Y. LI; U. BALASUBRAMANIAN; Y.
AYUKAWA; J. ROTHSTEIN. Johns Hopkins Univ. Sch. of
Med., Johns Hopkins Univ. Sch. of Med.
2:00 T4 455.22 � Mutant but not wild type FUS/TLS
translocates and forms inclusion bodies in primary motor
neurons. N. WILMANS; E. BOGAERT; W. SCHEVENEELS;
G. M. BORMANS*; P. VAN DAMME; W. ROBBERECHT; L.
VAN DEN BOSCH. K.U.Leuven, K.U.Leuven.
3:00 T5 455.23 Fused in sarcoma - RNA binding and
regulation of alternative splicing. B. ROGELJ*; J. ULE; C. E.
SHAW. King’s Col. London - Inst. of Psychiatry, MRC Lab. of
Mol. Biol.
4:00 T6 455.24 Effects of sumoylation on aggregation
and toxicity of ALS-linked SOD1 mutants. T. NIIKURA*; Y.
KITA; Y. ABE. Simon Fraser Univ., Keio Univ. Sch. of Med.
1:00 T7 455.25 Intracellular calcium dysregulation in
mutant SOD1 astrocytes. H. KAWAMATA*; G. MANFREDI.
Weill Med. Col. of Cornell Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

POSTER
456. Epilepsy and Neuronal Networks I
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 T8 456.01 Glutamatergic and GABAergic interictal
spikes and their relationship to ictal transition. L. M. UVA*;
S. TAVERNA; M. DE CURTIS. Fondazione Inst. Neurologico
“C. Besta”, Italian Inst. of Technol.
2:00 U1 456.02 Multi-scale neurodynamic latent states of
the epileptic brain. C. STAMOULIS*; B. S. CHANG. Harvard
Med. School, Departments of Neurol. and Radiology,
Harvard Med. School/ Beth Israel Deaconess Med. Ctr.
3:00 U2 456.03 Electrophysiological markers of the
epileptogenic zone identified by computational analysis of
intracranial stereo-EEG recordings performed in patients
with drug-resistant focal epilepsy. V. GNATKOVSKY*; S.
FRANCIONE; G. LO RUSSO; M. DE CURTIS. IRCCS Inst.
Neurologico C. Besta, Niguarda Cà Granda Hosp.
4:00 V1 456.04 Cortical slow-wave networks and altered
consciousness in temporal lobe seizures. L. YANG*; G.
WORRELL; B. BRINKMANN; C. NELSON; B. HE. Univ. of
Minnesota, Mayo Clin.
1:00 V2 456.05 Complementary seizure propagation
and default state patterns revealed by ECoG in the epileptic
human brain. Z. NADASDY*; R. J. BUCHANAN; J. SHEN;
M. R. LEE; D. L. NELSON; D. F. CLARKE. Univ. Med. Ctr.
At Brackenridge, Univ. of Texas at Austin, UT Southwestern,
Seton Family of Hosp.
2:00 V3 456.06 Dynamical mechanisms underlying
generation of epileptic states. G. P. KRISHNAN*; A.
SHILNIKOV; M. BAZHENOV. Univ. of California, Riverside,
Georgia State Univ.
3:00 V4 456.07 Dissecting epileptiform activity in the
mouse hippocampus. G. FILATOV*; G. P. KRISHNAN; M.
BAZHENOV. Univ. of California Riverside.
4:00 V5 456.08 • Spatiotemporal patterns of epileptiform
spikes recorded by a novel high-density flexible
microelectrode array. A. CHAMBERLAIN*; J. VIVENTI;
J. A. BLANCO; B. LITT. Univ. of Pennsylvania, Univ. of
Pennsylvania.
1:00 V6 456.09 Small-world topology in the rat
hippocampal CA1 region is lost following status epilepticus.
A. L. TYLER*; J. M. MAHONEY; G. L. HOLMES; P. LENCK-
SANTINI; R. C. SCOTT. Dartmouth Col., UCL Inst. of Child
Hlth.
2:00 V7 456.10 • Cortical laminar profile of spontaneous
seizures in anesthetized cats. L. B. GRAND*; M. BLAIS-
D’AMOURS; I. TIMOFEEV. Le Ctr. De Recherche Univ.
Laval Robert-Giffard (CRULRG).
3:00 V8 456.11 Abnormally strong striatal feedforward
inhibition is critical for absence epilepsy. T. ARAKAKI; A.
LEBLOIS*; S. CHARPIER; D. HANSEL. CNRS / Univ. René
Descartes, CRICM Inserm / Univ. Pierre et Marie Curie.
4:00 V9 456.12 Spatiotemporal organization and thalamic
modulation of seizures in the mouse medial thalamic-anterior
cingulate slice. W. CHANG*; J. WU; B. VOGT; B. SHYU.
Inst. of Biomed. Science, Academia Sinica, Inst. of Zoology,
Natl. Taiwan Univ., Cingulum NeuroSciences Inst., Inst. of
Biomed. Science, Academia Sinica.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 V10 456.13 Enduring effects of early-life stress on
neuronal firing patterns in thalamic reticular nucleus and
hippocampus: Implications for limbic epilepsy. I. ALI*; M. R.
SALZBERG; N. C. JONES; D. PINAULT; P. O’BRIEN; C.
FRENCH; M. J. MORRIS; T. J. O’BRIEN. Dept. of Medicine,
Univ. of Melbourne, Univ. of Melbourne, Univ. de Strasbourg,
Univ. of New South Wales.
2:00 V11 456.14 Wave propagation failure in the
7dpf larval zebrafish central nervous system. A. T.
SORNBORGER*; L. TAO; T. J. LEWIS; J. D. LAUDERDALE.
Univ. Georgia, Peking Univ., UC Davis, Univ. Georgia.
POSTER
457. Epilepsy and Neuronal Networks II
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 V12 457.01 Rapamycin prevents hyperexcitability of
dentate granule cells during epileptogenesis -a multicellular
calcium imaging study. C. CHO; C. YUE; C. CHO*; H.
TAKANO; D. COULTER. Childrens’ Hosp. of Philadelphia,
Univ. of Pennsylvania.
2:00 W1 457.02 Beta adrenergic receptors modulate
spontaneous spatiotemporal activity patterns, and intercellular
and inter-regional synchrony in hyper-excitable
hippocampal circuits via PKA-dependent regulation of
phosphorylated ERK. A. HAZRA*; R. ROSENBAUM; L.
ABAD; B. BODMANN; S. CAO; K. JOSIC; J. ZIBURKUS.
Univ. of Houston, Univ. of Houston, Univ. of Houston.
3:00 W2 457.03 • Differential effects of kainate-induced
seizure activity on PTEN, mTOR and Arc in hippocampus
of adult and neonatal rats. X. XU*; Y. HSU; L. YU; X. BI;
M. BAUDRY. USC, USC, Children’s Hosp. of Fudan Univ.,
Western Univ. of Hlth. Sci.
4:00 W3 457.04 Functional integration of a GABAergic cell
line into the hippocampus and its consequences in network
activity. A. MÁRQUEZ-RAMOS; M. GIORDANO; F. PENA*.
Inst. de Neurobiología, UNAM.
1:00 W4 457.05 Failure of adaptive self-organized
criticality during epileptic seizure attacks. C. MEISEL*; A.
STORCH; E. BULLMORE; T. GROSS. Max Planck Inst.
for the Physics of Complex Systems, Dept. of Neurology,
Univ. Clin. Carl Gustav Carus, Behavioural & Clin. Neurosci.
Institute, Departments of Exptl. Psychology and Psychiatry.
2:00 W5 457.06 Loss and recovery of perforant pathway
evoked activity during spontaneous seizures in the epileptic
rat. J. G. KEATING*; H. JUUL; M. A. DICHTER. Univ.
Pennsylvania.
3:00 W6 457.07 The role of inhibition in spontaneous
synchronous discharges in a computational CA3 model. W.
B. SWIERCZ*; K. J. STALEY. Massachusetts Gen. Hosp.,
Harvard Med. Sch., Harvard Med. Sch.
4:00 W7 457.08 Characterizing population of cells in
multiple modalities by multi-cellular functional imaging. H.
TAKANO*; F. HSU; C. CHO; D. A. COULTER. Children’s
Hosp. of Philadelphia, Univ. of Pennsylvania.
1:00 W8 457.09 Recurrent excitatory connectivity of
hilar ectopic granule cells in a rat model of temporal lobe
epilepsy: A laser scanning glutamate uncaging study. W.
ZHANG*; J. HUGUENARD; P. BUCKMASTER. Stanford
Univ., Stanford Univ., Stanford Univ.
Neuroscience 2011 | Monday PM | 109
Mon. PM

2:00 W9 457.10 Hippocampal single neuron firing patterns
during the transition to spontaneous seizures in a rat model
of chronic epilepsy. D. GRASSE*; A. MISRA; K. A. MOXON.
Drexel Univ., Drexel Univ. Col. of Med.
3:00 W10 457.11 Decrease in interictal activity precedes
the onset of temporal lobe epilepsy. C. BERNARD*; L.
CHAUVIERE; T. DOUBLET; F. WENDLING; A. GHESTEM;
F. BARTOLOMEI. INSERM U751, INSERM U751, INSERM
U642.
4:00 W11 457.12 Analysis and treatment of network and
behavioral hyperexcitability in an M channel dependent
epilepsy phenotype. S. MARGUET*; Q. LE; A. NEU; F.
MORELLINI; D. ISBRANDT. Exptl. Neuropediatrics.
1:00 W12 457.13 Neuroanatomical correlates of
susceptibility in a model of genetic epilepsy. V. WIMMER*;
M. LI; E. Y. SO; E. L. HILL; S. S. TAN; S. F. BERKOVIC; S.
PETROU. Howard Florey Inst., Howard Florey Inst., Royal
Melbourne Hosp., Epilepsy Res. Ctr.
2:00 X1 457.14 Functional network structure in
epilepsy: Calcium imaging of the dentate gyrus. S. E.
FELDT MULDOON*; I. SOLTESZ; R. COSSART. Univ. of
California, Irvine, Inst. Natl. de la Santé et de la Recherche
Médicale (INSERM) Unité 901, Inst. de Neurobiologie de la
Méditerranée (INMED), Univ. de la Méditerranée, UMR S901
Aix-Marseille 2.
3:00 X2 457.15 Evolution of synchrony across brain
structures during limbic epilepsy. T. SOBAYO*; A. S. FINE;
D. J. MOGUL. Illinois Inst. of Technology, Univ. of Illinois,
Illinois Inst. of Technol.
4:00 X3 457.16 Fimbria loss and its effect on circadian
rhythms in epilepsy. D. A. STANLEY; M. B. PAREKH; P. R.
CARNEY; W. L. DITTO; T. R. MARECI; S. S. TALATHI*.
Arizona State Univ., Univ. of Florida, Univ. of Florida, Univ. of
Florida.
1:00 X4 457.17 Creation of an in vitro epilepsy model
using microtechnology. L. A. CIRINELLI*; L. A. DAVIDSON;
H. C. ZERINGUE. Univ. of Pittsburgh, Carnegie Mellon Univ.
& The Univ. of Pittsburgh.
2:00 X5 457.18 Characterization of the spatial dynamics
of epileptiform events in the cortical malformation of
microgyria. A. BELL*; R. MCQUISTON; K. M. JACOBS.
Virginia Commonwealth Univ., Virginia Commonwealth Univ.
3:00 X6 457.19 Imaging changes in network connectivity
during post-traumatic epileptogenesis in vitro. K. P. LILLIS*;
M. A. KRAMER; G. Q. ZHOU; J. L. RAYMOND; K. J.
STALEY. Massachusetts Gen. Hosp., Boston Univ., Stanford
Univ.
4:00 X7 457.20 Purinergic control of cortical network
hyper-excitability following traumatic brain injury. F. GU; A.
HAZRA; L. C. MATHEW; A. TAYLOR; C. S. ROBERTSON;
C. G. DULLA; J. ZIBURKUS*. Univ. Houston, Baylor Col. of
Med., Tufts Univ., Ben Taub Gen. Hosp.
1:00 X8 457.21 Decreased incidence of fast calcium
waves in networks of reactive astrocytes in the hippocampus
following early life status epilepticus. R. M. SMEAL*; M. N.
ECONOMO; K. P. FLOOD; K. S. WILCOX; J. A. WHITE.
Univ. Utah, Boston Univ., Univ. of Utah, Brain Inst.
110 | Society for Neuroscience
POSTER
458. Epilepsy: Human Tissue
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 X9 458.01 Frontal cortex neuropile in a catastrophic
epilepsy case: Neuronal and Astrocytic abnormalities.
M. AVILA-COSTA; J. ESPINOZA-VILLANUEVA; A.
GUTIERREZ-VALDEZ; P. ALEY-MEDINA; J. MENDOZA-
SANCHEZ; J. BARRAL-CABALLERO; P. GUEVARA-
SALAZAR; E. MONTIEL-FLORES; L. REYNOSO-AVILA;
J. MACHADO-SALAS*. UNAM, INN, TEC, Ctr. Regional
De Daño Cerebral, HAT. Suite 511, 5o. Piso, Torre De
Consultorio.
2:00 X10 458.02 An epileptic seizure leading to changes
in physiological tremor characteristics. A case report. B.
CARIGNAN*; J. DANEAULT; C. DUVAL. UQAM, Ctr. de
Recherche Inst. Universitaire de Gériatrie de Montreal,
McGill, Montreal Neurolog. Inst.
3:00 X11 458.03 APOE genotype governs Alzheimer
neuropathologies in epilepsy. R. MRAK; S. T. GRIFFIN*; S.
BARGER; O. ABOUD; R. JONES; F. BOOP. Univ. of Toledo
Hlth. Sci. Campus, Univ. Ark Med. Sci., Univ. of Tennessee
Hlth. Sci. Ctr.
4:00 X12 458.04 Epileptic human lateral amygdala:
Receptor expression. S. A. GRAEBENITZ*; O. KEDO;
E. SPECKMANN; A. GORJI; H. PANNECK; V. HANS; N.
PALOMERO-GALLAGHER; A. SCHLEICHER; K. ZILLES; H.
PAPE. Universitätsklinikum Münster, Inst. of Neurosci. and
Med., Bethel Epilepsy Ctr., Inst. of Neuropathology Bethel,
C. & O. Vogt-Institute of Brain Res.
1:00 Y1 458.05 Long term culture of human neural
progenitor cells derived from different parts of the adult brain.
A. PAPAZOGLOU*; J. PRUSZAK; J. WESSOLLECK; G.
NIKKHAH. Federal Inst. For Drugs and Med. Devices, Univ.
Hosp. Freiburg, Univ. of Freiburg.
2:00 Y2 458.06 Genome-wide microRNA profiling of
human temporal lobe epilepsy reveals pathology-specific
expression and altered subcellular distribution of microRNAs.
A. A. KAN*; S. VAN ERP; A. A. H. A. DERIJCK; M. DE WIT;
E. V. S. HESSEL; E. O’DUIBHIR; P. C. VAN RIJEN; P. H.
GOSSELAAR; R. J. PASTERKAMP; P. N. E. DE GRAAN.
Rudolf Magnus Inst. of Neurosci., Univ. Med. Ctr. Utrecht.
3:00 Y3 458.07 Evaluation of binding 5-HT1A receptor in
temporal cortex tissue of patients with refractory epilepsy to
antiepileptic drugs. M. CUÉLLAR-HERRERA*; L. ROCHA;
M. ALONSO-VANEGAS; L. CHÁVEZ; J. M. NUÑEZ; F.
VELASCO; A. L. VELASCO. CINVESTAV-IPN, Epilepsy
Clinic, Hosp. Gen. de México, Natl. Inst. of Neurol. and
Neurosurg. ‘‘Manuel Velasco Suarez,’’, Hosp. Gen. de
México.
4:00 Y4 458.08 Cellular morphology and
electrophysiology of cortical pyramidal neurons in tissue
samples from pediatric Rasmussen’s encephalitis. C.
CEPEDA*; V. M. ANDRÉ; J. S. HAUPTMAN; J. Y. CHEN; F.
VLASHI; H. V. VINTERS; G. W. MATHERN; M. S. LEVINE.
IDDRC, Semel Inst. for Neurosci. and Human Behavior,
UCLA, UCLA, UCLA.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 Y5 458.09 Abnormal expression of NSF and
interacting neurotransmitter receptors in the temporal cortex
of patients with epilepsy. C. HEROLD*; H. BIDMON; H. W.
PANNEK; E. SPECKMANN; K. ZILLES. Heinrich-Heine Univ.
Duesseldorf, C.&O.-Vogt Inst. For Brain Res., Epilepsy-
Centre Bethel, Inst. of Physiology, Univ. Münster, Inst. of
Neurosci. and Med. INM-2, Res. Ctr. Jülich.
2:00 Y6 458.10 Potential role of inflammatory pathways
in the epileptogenicity of human tuberous sclerosis complex
cortical lesions. V. RUPPE*; P. DILSIZ; H. WEINER; C.
REISS; J. FRENCH; O. DEVINSKY; D. M. TALOS. New York
Univ. Med. Ctr., New York Univ., New York Univ. Med. Ctr.,
New York Univ. Med. Ctr., New York Univ., New York Univ.,
New York Univ. Med. Ctr.
3:00 Y7 458.11 Morphological abnormalities and
inhibitory synaptic deficits of hyperexcitable circuits in
pediatric cortical malformation. B. S. MARTIN*; A. L. YAUN;
J. S. LIU; W. D. GAILLARD; M. M. HUNTSMAN. Children’s
Natl. Med. Ctr., Georgetown Univ., Children’s Natl. Med. Ctr.,
Children’s Natl. Med. Ctr., Children’s Natl. Med. Ctr.
4:00 Y8 458.12 Electrophysiological properties of fast
spiking interneurons and principal cells in layer II/III differ
between human epileptogenic and normal temporal cortex.
S. HEFFT*; S. STANCHEVA. Univ. of Freiburg-Dep. of
Neurosurg.
1:00 Y9 458.13 Kappa opioid receptor distribution and
g-proteins activation in temporal neocortex of patients with
pharmacoresistant mesial temporal lobe epilepsy. C. L.
FRIAS-SORIA; M. ALONSO-VANEGAS; J. CISNEROS-
FRANCO; C. ZAVALA-TECUAPETLA; L. L. ROCHA*.
CINVESTAV, Inst. Nacional de Neurologia y Neurocirugia.
2:00 Y10 458.14 Pathophysiological mechanisms
underlying hippocampus sclerosis for mesial temporal
lobe epilepsy: Implications of flavoprotein fluorescence
imaging on human brain slices. H. KITAURA*; H. SHIMIZU;
M. OISHI; M. FUKUDA; H. MURAKAMI; H. MASUDA;
S. KAMEYAMA; H. TAKAHASHI; Y. FUJII; K. SHIBUKI;
A. KAKITA. Brain Res. Institute, Univ.Niigata, Brain Res.
Institute, Univ.Niigata, Brain Res. Institute, Univ.Niigata,
Nishi-Niigata Chuo Natl. Hosp., Brain Res. Institute, Niigata
Univ., Brain Res. Institute, Niigata Univ., Brain Res. Institute,
Niigata Univ.
3:00 Y11 458.15 Functional studies of novel variants in
BRAT1 (BRCA1-associated ATM activator 1) and SNIP1
(Smad nuclear interacting protein 1) associated with
autosomal recessive epilepsy phenotypes in neonates and
children. R. N. JINKS*; C. J. FIORENTINI; R. A. WILLERT;
M. H. MAHONEY; C. J. MILLER; K. A. POLITI; K. N.
WORCESTER; C. SOUGNEZ; K. CIBULSKIS; S. GABRIEL;
N. L. RIDER; D. H. MORTON; E. G. PUFFENBERGER; K.
A. STRAUSS. Franklin & Marshall Col., Franklin & Marshall
Col., The Broad Inst., Clin. for Special Children, Lancaster
Gen. Hosp.
4:00 Y12 458.16 Differential gene expression profile
from hippocampal surgical resection tissue in temporal
lobe epilepsy patients.. O. F. MERCADO-GOMEZ*; T.
ALONSO-VÁSQUEZ; L. URIBE-FIGUEROA; L. ROCHA;
A. VELASCO; R. GUEVARA-GUZMÁN. Facultad de
Medicina, Inst. de Nacional de Medicina Genómica, Ctr. de
Investigación de Estudios Avanzados IPN, Hosp. general de
Mexico.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
459. Ischemia: Recovery
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 Y13 459.01 Growth differentiation factor 10 promotes
axonal sprouting in the somatosensory cortex of the mouse
after stroke. S. LI*; S. T. CARMICHAEL. UCLA.
2:00 Y14 459.02 Post-stroke blockade of astrocytic
ephrin-A5 signaling via delivery of an EphA4 receptor decoy
antibody, combined with forced reaching of the stroke
affected limb, results in robust axonal sprouting in pre-motor
and somatosensory cortex. J. J. OVERMAN*; C. NGUYEN;
B. OVERMAN; S. LI; S. CARMICHAEL. UCLA.
3:00 Y15 459.03 Multimodal imaging of cellular
repair processes after experimental focal ischemia.
M. A. RUEGER*; S. MUESKEN; M. WALBERER; K.
SCHNAKENBURG; S. U. JANTZEN; H. BACKES; R. GRAF;
B. NEUMAIER; M. HOEHN; G. R. FINK; M. SCHROETER.
Univ. Cologne, Max-Planck-Institute for Neurolog. Res.
4:00 Y16 459.04 The effects of paretic and non-paretic
forelimb training on behavioral outcome following unilateral
ischemic insult of sensorimotor cortex in C57BL/6 mice. A.
L. KERR*; J. S. VILLAFANA; M. S. PINJALA; T. A. JONES.
Univ. of Texas, Inst. for Neurosci.
1:00 Y17 459.05 • Dietary branched-chain amino
acids failed to improve motor rehabilitation effects in rats
following focal ischemic stroke to sensorimotor cortex. S. K.
NORDQUIST*; D. L. ADKINS; T. A. JONES. Univ. of Texas,
Univ. of Texas.
2:00 Y18 459.06 Differential effects of ipsilesional forelimb
training following focal ischemic lesions of the rostral and
caudal motor cortex in adult rats. S. C. JEFFERSON*; A. N.
SMITH; U. M. YAKUBU; A. L. KERR; T. A. JONES. Univ. of
Texas at Austin, Univ. of Texas at Austin.
3:00 Y19 459.07 Forelimb motor map plasticity induced
by long-term training on a single-seed reaching task in adult
c57bl/6 mice. S. CHENG*; A. L. KERR; K. A. TENNANT; D.
L. ADKINS; N. A. DONLAN; T. A. JONES. Univ. of Texas At
Austin.
4:00 Y20 459.08 Bidirectional plasticity supports motor
learning and post-ischemic functional recovery in the rat
striatum. K. A. KENT*; P. DENG; U. GUNDIMEDA; T. H.
MCNEILL. USC Cell and Neurobio.
1:00 Y21 459.09 Rehabilitative motor training restores
cortical premotor forelimb representation after ischemic
lesion to primary forelimb motor area in rats. M. NISHIBE; E.
T. URBAN, III; S. BARBAY*; R. NUDO. Univ. Kansas Med.
Ctr., Univ. Kansas Med. Ctr., Univ. Kansas Med. Ctr.
2:00 Y22 459.10 • Contralesional lateral cerebellar nucleus
stimulation combined with training in the past matrix task
enhances recovery of function following cerebral ischemia.
A. G. MACHADO*; J. COOPERRIDER; J. GALE; K. BAKER.
Cleveland Clin., Univ. of Minnesota.
3:00 Y23 459.11 Valproate promotes functional recovery
and enhances post-ischemic angiogenesis in a rat model of
ischemic stroke. Z. WANG*; L. TSAI; J. MUNASINGHE; P.
LEEDS; D. CHUANG. Mol. Neurobiol. Section, NIH/NIMH,
Departments of Neurol. and Stroke Center, Natl. Taiwan
Univ. Hosp. and Natl. Taiwan Univ. Col. of Med., Mouse
Imaging Facility, NIH/NINDS.
Neuroscience 2011 | Monday PM | 111
Mon. PM

4:00 Y24 459.12 SOX9 ablation improves recovery in a
mouse model of stroke. X. XU*; J. MAILLOUX; A. SCHEDL;
A. BROWN. Robarts Resch Inst., Univ. of Western Ontario,
Univ. de Nice Sophia Antipolis.
1:00 Y25 459.13 The effects of VNS paired with
rehabilitative motor training on the behavioral recovery
following ischemic brain damage. N. KHODAPARAST*; T.
FAYYAZ; S. AHMED; R. CHEUNG; C. MAY; F. NAQVI; D.
RATRA; M. JAVIDNIA; A. RUIZ; D. CAO; R. RENNAKER;
M. P. KILGARD. Univ. of Texas At Dallas, Univ. of Texas at
Dallas, Univ. of Texas at Dallas.
2:00 Y26 459.14 � Accelerated sensorimotor functional
recovery and neurovascular regeneration after stroke with
chronic citalopram treatment. A. R. ESPINERA*; M. E.
OGLE; L. WEI. Emory Univ.
3:00 Y27 459.15 Infusion of EGF/EPO with behavioural
rehabilitation accelerates motor recovery after stroke. M.
S. JEFFERS*; M. KELLY; A. HOYLES; C. MORSHEAD; M.
SHOICHET; D. CORBETT. Mem. Univ. of Newfoundland,
Univ. of Toronto, Univ. of Toronto, Univ. of Ottawa.
4:00 Y28 459.16 Spatial recognition in the ischemic gerbil:
Effect of object exposure. B. BROX; C. ROBINSON; J.
OLD ELK; J. AZURE; M. BABCOCK*. Montana State Univ.,
Montana State Univ.
1:00 Y29 459.17 Skilled reaching training increases
microtubule-associated protein-2 immunoreactivity in
primary motor cortex and induces upper limb functional
recovery after intracerebral hemorrhage in adult rats. A.
S. PAGNUSSAT*; M. V. SANTOS; R. G. MESTRINER; C.
A. NETTO. Univ. Federal De Ciências Da Saúde De Porto
Alegre, Univ. Federal do Rio Grande do Sul.
2:00 Y30 459.18 New insights into the role of diabetes and
the secondary somatosensory cortex in recovery of function
after ischemic stroke. C. E. BROWN*; D. SWEETNAM; A.
HOLMES; M. WALLE; P. JONES. Univ. of Victoria.
3:00 Y31 459.19 Transcranial direct current stimulation
supports forelimb rehabilitation, aids in recovery of original
movement patterns and improves inter-hemispheric
coherence after stroke in rats. D. C. GIDYK*; A. GOMEZ
PALACIO SCHJETNAN; A. LUCZAK; G. A. METZ. Univ. of
Lethbridge.
POSTER
460. Ischemia: Inflammation II
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 Y32 460.01 TLR3 activation increases the
vulnerability of the neonatal brain to hypoxia-ischemia.
L. STRIDH*; X. WANG; R. CHAVEZ-VALDEZ; F. J.
NORTHINGTON; C. MALLARD. Neurosci. and Physiol.,
Johns Hopkins Univ. Sch. of Med.
2:00 Y33 460.02 Expression of TWEAK, TRAIL and
osteoprotegrin in neonatal hypoxia-ischemia. A. KICHEV;
C. I. ROUSSET; C. THORNTON; P. GRESSENS; C.
MALLARD; R. REYNOLDS; H. HAGBERG*. Ctr. for the
Developing Brain, Inserm U676, Perinatal Ctr., Wolfson
Neurosci. Labs.
112 | Society for Neuroscience
3:00 Y34 460.03 Is AMP-activated kinase (AMPK)
beneficial or detrimental after perinatal HI? C. I. ROUSSET*;
F. LEIPER; C. THORNTON; P. GRESSENS; D. CARLING;
H. HAGBERG. Ctr. For the Developing Brain, Cell. Stress
Group, Inserm U676, Perinatal Centre, Dpt Obstetrics and
Gynecology.
4:00 Y35 460.04 Implicating mitochondrial p53 in
perinatal brain injury. C. THORNTON*; C. I. ROUSSET;
C. J. HEIJNEN; A. KAVELAARS; P. GRESSENS; H. E. G.
HAGBERG. Ctr. For the Developing Brain, Univ. Med. Ctr.
Utrecht.
1:00 Y36 460.05 Immuno-modulatory peptides are
protective after neonatal brain injury. K. SÄVMAN*;
H. BOULOURI; K. L. BROWN; R. E. HANCOCK; H.
HAGBERG; C. MALLARD. The Queen Silvia Children´S
Hosp., Dept of Neurosci. and Physiology, Univ. of
Gothenburg, Dept of Rheumatology and Inflammation
Research, Univ. of Gothenburg, Dept of Microbiology and
Immunology, Univ. of Brittish Columbia.
2:00 Z1 460.06 Microglial response to sustained
exposure to hydrogen peroxide. P. PATHIPATI*; D. M.
FERRIERO. Univ. of California San Francisco.
3:00 Z2 460.07 Hypoxia-ischemia increases annexin-A2
expression in neonatal rat brain. G. BRENNAN; K. A.
HAJJAR; J. M. PERLMAN; S. J. VANNUCCI*. Weill Cornell
Med. Col., Weill Cornell Med. Col.
4:00 Z3 460.08 Detrimental role of gamma-delta T
cells via IL-17 signaling in stroke. M. P. GELDERBLOM*;
F. LEYPOLDT; E. ORTHEY; C. GERLOFF; T. KORN; E.
TOLOSA; T. MAGNUS. Univ. Hosp. Hamburg, Univ. Hosp.
Hamburg, Klinikum Rechts der Isar, Technische Univ.
München, Univ. Hosp. Hamburg.
1:00 Z4 460.09 • Post-ischemic inflammatory responses
sustain demyelinating pathology in endothelin-1 induced
white matter stroke model. J. CHOI*; J. KIM; Y. KANG; B.
KIM. Brain Dis. Res. Center, Med. Sci. Inst., Ajou Univ. Sch.
of Med.
2:00 Z5 460.10 The effect of post-treatment of PARP
inhibitor, INO-1001 on glial activation and neuronal death
after transient focal cerebral ischemia. S. WON*; S. SUH; R.
A. SWANSON. UCSF and SFVAMC, Hallym Univ.
3:00 Z6 460.11 Galectin-3 modulates microglia
phenotype under in vitro inflammatory conditions. W.
WANG*; H. BOLOURI; K. BROWN; A. CARLSSON; H.
HAGBERG; C. MALLARD; K. SÄVMAN. Gothenburg Univ.,
Dept of Rheumatology.
4:00 Z7 460.12 • Lack of anti-inflammatory properties
when hypothermia does not protect. M. HOKARI; X. TANG*;
Z. ZHENG; M. YENARI. UCSF & SF VAMC, Stanford Univ.
Sch. of Med.
1:00 Z8 460.13 Compound K protects cerebral ischemic
brain injury via inhibition of microglial activation. H. KIM*; J.
PARK; J. JUNG; J. A. SHIN; E. PARK. Ewha Womans Univ.
Med. Sch., Ewha Womans Univ. Med. Sch.
2:00 Z9 460.14 Quantitative assessment of microglia
morphological changes in models of ischemic stroke. H. W.
MORRISON; J. A. FILOSA*. Georgia Hlth. Sci. Univ.
3:00 Z10 460.15 Type-1 Interferon signalling plays a
deleterious role in the outcome after stroke. P. J. CRACK*;
C. E. DOWNES; J. M. TAYLOR; C. H. Y. WONG; M.
ZHANG; P. L. GUIO-AGULAIR; R. ATES; A. MANSELL; P. J.
HERTZOG. Univ. of Melbourne, Monash Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 Z11 460.16 Role of sodium/hydrogen exchanger
isoform 1 in microglial activation and proinflammatory
responses in ischemic brains. Y. SHI*; V. CHANANA; J. J.
WATTERS; P. FERRAZZANO; D. SUN. Univ. of Wisconsin-
Madison, Univ. of Wisconsin-Madison, Univ. of Pittsburgh,
Univ. of Wisconsin-Madison, Univ. of Wisconsin-Madison,
Univ. of Wisconsin-Madison.
1:00 Z12 460.17 Spatiotemporal localization of CD200 and
its receptor in the developing C57BL/6 mice brain following
Hypoxia/Ischemia injury. K. SHRIVASTAVA*; G. LLOVERA;
L. ACARIN. Inst. of Neurosciences. Univ. Autonoma
Barcelona.
2:00 Z13 460.18 • Effects of a semi-purified soy protein
diet on skilled ladder rung walking and neuroinflammatory
markers after stroke in rats. J. L. CHEATWOOD*; A. N.
KNAPP; A. R. SIERMAN; J. AN; D. N. BUTTEIGER; J. R.
KÖPPEN; D. G. WALLACE; W. J. BANZ. SIU Sch. Med.,
Solae, LLC, Northern Illinois Univ., Southern Illinois Univ.
3:00 Z14 460.19 NG2-positive cells and NG2 extracellular
protein constitute demarcation of focal cerebral infarction
in rats. H. L. CLAUS; M. WALBERER; S. M. MUESKEN; B.
EMIG; M. A. RUEGER; G. R. FINK; M. SCHROETER*. Dept.
of Neurology, Univ. Hosp. Cologne, Max-Planck-Institute for
Neurolog. Res., Res. Ctr. Juelich.
POSTER
461. Demyelinating Disorders: Molecular and Cellular
Mechanisms I
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 Z15 461.01 Aberrant activation of mTOR promotes
Schwann cell dedifferentiation. S. HAGERTY*; P. MAUREL;
K. NAVE; J. SALZER. New York Univ. Langone Med. Ctr.,
Rutgers, Max Planck Inst. of Exptl. Med.
2:00 Z16 461.02 • Inhibition of Nogo signaling potentiates
SVZ cells mobilization in response to mouse optic chiasm
demyelination. F. POURABDOLHOSSEIN*; M. JAVAN;
B. DEMENEIX; S. MIRNAJAFIZADEH; S. MOZAFARI; S.
DEHGHAN; A. BARON VAN-EVERCOOREN. Section 5.031,
5th Floor, ICM Building, 47 Bd De L’Hôpital, Tarbiat Modares
Univ., Muséum Natl. d’Histoire Naturelle.
3:00 Z17 461.03 Cyclooxygenase-2 and prostanoids are
associated with excitotoxic death of oligodendrocytes in
culture. N. G. CARLSON*; M. A. ROJAS; J. REDD; B. WOOD;
M. JENSEN; J. W. ROSE. Univ. Utah, VA Salt Lake Hlth. Care
Syst., Univ. Utah, VA Salt Lake City Hlth. Care Syst.
4:00 Z18 461.04 Primary oligodendrocyte death does
not elicit anti-CNS immunity. G. LOCATELLI*; T. BUCH;
S. WOERTGE; B. INGOLD-HEPPNER; F. FROMMER;
B. SOBOTTKA; C. BUEHLMANN; I. BECHMANN; F.
HEPPNER; A. WAISMAN; B. BECHER. Univ. Zuerich, Tech.
Univ. Muenich, Universitätsmedizin der Johanne Gutenberg
Univ., Charité –Universitätsmedizin Berlin, Univ. of Leipzig.
1:00 Z19 461.05 • Thymosin beta 4 (Tβ4) mediates
oligodendrocyte differentiation by activation of the p38 MAPK
signaling pathway. M. SANTRA; D. MORRIS*; S. SANTRA;
Z. ZHANG; M. CHOPP. Henry Ford Hlth. Systems, Henry
Ford Hlth. Systems.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 Z20 461.06 Kainic acid receptors in experimental
autoimmune encephalomyelitis. M. IMBESI*; A.
CONTRACTOR; G. T. SWANSON. Northwestern Univ.,
Northwestern Univ.
3:00 Z21 461.07 Alterations in Olig1 and MBP in Vanishing
White Matter disease in protein and mRNA level. A.
TAKANOHASHI*; A. VANDERVER. Children’s Natl. Med. Ctr.
4:00 Z22 461.08 The anti-aging protein Klotho enhances
oligodendrocyte maturation and myelination. C. R.
ABRAHAM*; J. A. SLOANE; N. AYTAN; L. GIANNARIS; G.
KING; M. KURO-O; C. CHEN. Boston Univ. Med. Sch., Beth
Istrael Deaconess Med. Ctr., Boston VA Med. Ctr., Boston
Univ. Sch. Med., Univ. Texas Southwestern Med. Ctr.,
Boston Univer Sch. Med.
1:00 Z23 461.09 Delivery of BMP4 and Noggin to
the demyelinated mouse brain modulates numbers of
oligodendrocytes and astrocytes during recovery. J. SABO;
T. AUMANN; D. MERLO; T. KILPATRICK; H. S. CATE*. Ctr.
For Neuroscience, Univ. of Melbourne, Florey Neurosci. Inst.
2:00 Z24 461.10 Ex vivo spinal cord slice culture model of
neuromyelitis optica for study of pathogenic mechanisms. H.
ZHANG*; J. L. BENNETT; A. S. VERKMAN. UCSF, Univ. of
Colorado Denver Sch. of Med.
3:00 Z25 461.11 Role of Slit1 and Robo2 in an animal
model of demyelination. G. SPIGONI; C. DEBOUX; B.
NAIT-OUMESMAR*; A. CHEDOTAL; A. BARON VAN
EVERCOOREN. Cr-Icm, Inserm-Univ. Pierre & Marie Curie,
Umr-S975, CNRS UMR 7225, Dept. de Développement,
Inst. de la Vision, Inserm UMRS 592.
4:00 Z26 461.12 Astrogliosis characterzation throughout
acute and chronic demyelination in mice. N. E. HIBBITS*;
J. YOSHINO; R. PANNU; R. C. ARMSTRONG. USUHS,
Colgate Univ., USUHS.
1:00 Z27 461.13 Loss of mature oligodendrocytes
associated with vascular and cognitive impairment in
hypertensive white matter damage. F. Y. JALAL*; Y. YANG;
J. F. THOMPSON; A. C. LOPEZ; G. A. ROSENBERG. UNM.
2:00 Z28 461.14 NG2+ progenitor response in focal
white matter stroke: The origin and fate of oligodendrocyte
progenitors. E. G. SOZMEN*; S. T. CARMICHAEL. David
Geffen Sch. of Med. at UCLA.
3:00 Z29 461.15 Proteoglycan NG2 knock-out mice are
protected from EAE. G. FERRARA; S. MORANDO; F.
GIROLAMO; M. PRINCIPATO; M. ERREDE; S. CASAZZA;
D. VIRGINTINO; R. FURLAN; R. PERRIS; C. BENDOTTI*;
A. UCCELLI. Dept. Neuroscience, Mario Negri Insitute for
Pharmacol. Res., Dept. of Neurosciences, Ophthalmology
and Genetics, Univ. of Genoa, Dept. of Human Anat. and
Histology, Univ. Med. Sch., Neuroimmunology Unit, San
Raffaele Hosp., 5Centre for Mol. and Translational Oncology,
Univ. of Parma, Inst. Di Ricerche Farmacologiche.
Neuroscience 2011 | Monday PM | 113
Mon. PM

POSTER
462. Trauma: Recovery
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 Z30 462.01 The liver X receptor agonist GW3965
improves cognitive deficits and prevents elevated amyloid
beta levels in wild-type mice following mild repetitive
closed head injury. D. R. NAMJOSHI*; G. MARTIN; S.
STUKAS; J. DONKIN; J. FAN; A. WILKINSON; J. CHAN; C.
WELLINGTON. The Univ. of British Columbia.
2:00 Z31 462.02 • Delayed erythropoietin treatment
improves cognitive outcome associated with enhanced
neurogenesis after traumatic brain injury in adult rats. Y.
ZHANG*; Y. XIONG; A. MAHMOOD; Y. MENG; C. QU; M.
CHOPP. Henry Ford Hosp., Henry Ford Hosp., Oakland
Univ.
3:00 Z32 462.03 • Therapeutic effects of delayed
treatment of traumatic brain injury with recombinant human
erythropoietin in rats: A dose response study. Y. MENG*;
Y. XIONG; A. MAHMOOD; Y. ZHANG; C. QU; M. CHOPP.
Henry Ford Hlth. Syst., Henry Ford Hlth. Syst., Oakland Univ.
4:00 Z33 462.04 Erythropoietin promotes long-term
functional recovery associated with neurovascular
remodeling following traumatic brain injury in rats. Y.
XIONG*; R. NING; A. MAHMOOD; Y. ZHANG; Y. MENG; C.
QU; M. CHOPP. Henry Ford Hlth. Syst., Henry Ford Helath
Syst., Oakland Univerisity.
1:00 Z34 462.05 BBG-treatment facilitates regeneration
after optic nerve injury in the adult rat. M. OHLSSON*;
M. RIDDERSTRÖM; B. BELLANDER; L. BRUNDIN; M.
SVENSSON. Karolinska Institutet.
2:00 Z35 462.06 Functional and structural plasticity in
amputees: Reorganization in somatosensory and motor
cortices varies with adaptive strategies for limb use. T. R.
MAKIN*; J. SCHOLZ; A. O. CRAMER; D. HENDERSON
SLATER; I. TRACEY; H. JOHANSEN-BERG. Univ. of
Oxford, Hosp. for Sick Children, Nuffield Orthopaedic Ctr.
3:00 Z36 462.07 Elucidating the role of 5-HT 1A and 5-HT 7
receptors on 8-OH-DPAT-induced behavioral recovery after
traumatic brain injury. J. TAY*; N. K. YELLESWARAPU; W.
M. FRYER; J. P. CHENG; M. A. SHAH; A. E. KLINE. Univ. of
Pittsburgh, Univ. of Pittsburgh.
4:00 AA1 462.08 The therapeutic efficacy of the atypical
antipsychotic aripiprazole after experimental traumatic
brain injury. T. I. PHELPS*; R. L. MCALOON; N. K.
YELLESWARAPU; A. N. GARCIA; M. A. SHAH; J. P.
CHENG; A. E. KLINE. Univ. of Pittsburgh Safar Ctr., Arizona
State Univ., Univ. of Pittsburgh.
1:00 AA2 462.09 Temporal effects of environmental
enrichment-mediated functional improvement after
experimental traumatic brain injury. A. M. MATTER; L. M.
CURATOLO; K. A. FOLWEILER; J. P. CHENG*; A. E. KLINE.
Univ. of Pittsburgh, Univ. of Pittsburgh.
2:00 AA3 462.10 Reassessment of the potential benefits of
environmental enrichment in female rats after experimental
traumatic brain injury. C. M. MONACO; V. V. MATTIOLA;
K. A. FOLWEILER; J. K. TAY; N. K. YELLESWARAPU; L.
M. CURATOLO; A. M. MATTER; Y. T. OLUGBADE; J. P.
CHENG; A. E. KLINE*. Univ. of Pittsburgh, Univ. Pittsburgh.
114 | Society for Neuroscience
3:00 AA4 462.11 Mice lacking in an enzyme involved in
chondroitin sulfate synthesis shows better recovery from
spinal cord injury. K. TAKEUCHI*; S. ONAGA HIGA; C.
KUDO; Y. WATANABE; M. IGARASHI. Niigata Univ., Ctr.
Trans-deciplinary Res. Progr, Niigata Univ.
4:00 AA5 462.12 Brain trauma reduces plasticity in brain
and spinal cord: Therapeutic potential of DHA dietary
supplementation. Z. YING*; A. WU; F. GOMEZ-PINILLA.
UCLA, UCLA.
1:00 AA6 462.13 Effects of dietary n-3 fatty acid content on
sensorimotor outcomes in a rat model of juvenile traumatic
brain injury. K. L. RUSSELL*; N. E. J. BERMAN; B. LEVANT.
Univ. of Kansas Med. Ctr., Univ. of Kansas Med. Ctr., Univ. of
Kansas Med. Ctr.
2:00 AA7 462.14 Neuroimaging of therapy induced
recovery: A longitudinal fMRI study using an MRI-compatible
manipulandum (MaRIA). N. ESTÉVEZ*; V. KLAMROTH-
MARGANSKA; M. HEPP-REYMOND; M. VILLIGER;
L. MICHELS; C. HOLLNAGEL; N. YU; R. RIENER;
S. KOLLIAS. Inst. of Neuroradiology, Univ. Hosp. of
Zurich, Sensory-Motor Systems Lab, ETH Zurich, Inst. of
Neuroinformatics, Univ. of Zurich and ETH Zurich, Inst. for
Biomechanics, ETH Zurich.
3:00 AA8 462.15 Effect of intraperitoneal paroxetine in a
rat model of posttraumatic stress disorder. D. STIDD*; J.
LANGEVIN; J. FELLOUS. Univ. of Arizona, Southern Arizona
VA Hlth. Care Syst., Univ. of Arizona.
4:00 AA9 462.16 SDF-1α encapsulated in alginate induces
migration of neural stem/progenitor cells in vitro and in vivo
following traumatic brain injury. D. SUN*; C. EVANS; W.
REID; A. ROLFE; S. JHA; D. SIMPSON; R. COLELLO. Med.
Coll Virg Commonwealth Univ.
1:00 AA10 462.17 Osteopontin upregulation during the
acute phases of reactive synaptogenesis is transcriptionally
regulated. J. L. CHAN*; L. L. PHILLIPS. Virginia
Commonwealth Univ.
2:00 AA11 462.18 Modulation of Wnt3a pathway by
mesenchymal stem cell treatment in traumatic brain injury:
Implications in neurogenesis and regeneration. Y. ZHAO*; T.
MENGE; K. WATAHA; P. LETOURNEAU; P. DASH; S. PATI.
Univ. of Texas Hlth. Sci. Ctr. at Houston, Univ. of Texas Hlth.
Sci. Ctr. at Houston.
3:00 AA12 462.19 Social isolation prior to controlled cortical
impact impairs motor/sensory and cognitive functions. K.
J. BRYAN; S. G. SOEHNLEN; R. G. RIECHERS, II; S.
L. BALL*. Louis Stokes Cleveland VAMC, Case Western
Reserve Univ., Cleveland State Univ., Cleveland Clin. Lerner
Colleg of Med. at CWRU.
4:00 AA13 462.20 Adaptive neocortical responses to
traumatic brain injury (TBI) in the mouse. D. P. CROCKETT*;
Y. S. SUTHAR; I. D. DOSHI; M. R. RASIN. UMDNJ-Robert
Wood Johnson Med. Sch.
1:00 AA14 462.21 Neural stem cell counteracts traumatic
injury-induced axonal degeneration via modulating α-smooth
muscle actin. P. WU*; E. WANG; J. GAO; T. DUNN; M.
PARSLEY; S. HAIDACHER; D. DEWITT; D. PROUGH; L.
DENNER. UTMB, Sichuan Univ., UTMB, UTMB.
2:00 AA15 462.22 Changes in cAMP levels correlate with
LTP deficits in aged TBI animals. D. J. ADAIKKALASAMY*;
C. FURONES; Y. KANG; C. M. ATKINS. Univ. of Miami Miller
Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 AA16 462.23 Conditional SOX9 ablation reduces
chondroitin sulfate proteoglycan expression and improves
motor function following spinal cord injury. W. M.
MCKILLOP*; A. PNIAK; A. SCHEDL; A. BROWN. Robarts
Res. Inst., Univ. of Western Ontario, Univ. de Nice Sophia
Antipolis.
4:00 AA17 462.24 Anti-calmodulin compounds inhibit Sox9
function and decrease scar-associated gene expression in
cultured rat astrocytes. T. HRYCIW*; M. DRAGAN; W. M.
MCKILLOP; A. BROWN. Robarts Res. Inst., Univ. of Western
Ontario.
1:00 AA18 462.25 Minocycline and N-acetylcysteine
promote remyelination after traumatic brain injury. P. J.
BERGOLD*; M. HABER; N. GRINKINA; R. J. GRILL; S. A.
ORSI; P. DASH; S. G. ABDEL-BAKI. SUNY-Downstate Med.
Cen., SUNY-Downstate Med. Cen., Univ. of Texas Hlth. Sci.
Ctr., Univ. of Texas Hlth. Sci. Ctr., BioSignal Group.
2:00 AA19 462.26 The initial beneficial effects conferred by
nicotinamide treatment may be offset by aging: The results
from a longitudinal assessment of frontal injury. C. VONDER
HAAR*; K. M. MARTENS; J. S. WARD; M. R. HOANE.
Southern Illinois University-Carbondale.
3:00 AA20 462.27 Characterization of functional recovery
and dendritic plasticy after traumatic brain injury and
anti-nogo-a immunotherapy. S. G. NAWARA*; S. TSAI;
K. M. PODRAZA; V. A. HUSAK; G. L. KARTJE; C. M.
PAPADOPOULOS. Loyola Univ. Chicago Stritch Sch. of
Med., Res. Service, Hines VA Hosp., Loyola Univ. Chicago
Stritch Sch. of Med.
4:00 AA21 462.28 � Sex differences in a rat model of post
traumatic stress disorder. K. EDELMAN VOGELSANG*;
R. P. LAHOOD; N. CORRAL-FRIAS; E. D. FRENCH; J.
FELLOUS. Univ. of Arizona, Univ. of Arizona, Univ. of
Arizona, Univ. of Arizona.
1:00 AA22 462.29 TGF-β and BMP-2 induce a scar
like phenotype in rat brain meningeal fibroblasts. A. M.
CAMPBELL; T. T. LOGAN; A. J. SYMES*. USUHS.
2:00 AA23 462.30 Effect of P2X7 receptor blockade
on functional outcome after traumatic brain injury. I. C.
VAAGENES*; S. TSAI; V. A. HUSAK; A. A. ELERBY; G. L.
KARTJE. Loyola Univ. Chicago, Hines VA Hosp., Univ. of
Illinois at Chicago, Loyola Univ. Chicago.
POSTER
463. Spinal Cord Injury: Molecular Mechanisms
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 AA24 463.01 Experimental contusion spinal cord injury
induces long-term increase of mTOR activity. J. S. KJELL*;
S. CODELUPPI; K. PERNOLD; A. JOSEPHSON; M. B.
ABRAMS. Karolinska Institutet, Karolinska Inst.
2:00 AA25 463.02 Large-scale quantitative
phosphoproteomics analysis of Chondroitin sulfate
proteoglycan signaling mechanisms in primary neurons
using iTRAQ. P. YU*; G. WANG; Y. KATAGIRI; H. M.
GELLER. Developmental Neurobio. Section, NHLBI, NIH,
Proteomics Core Facility, NHLBI, NIH.
3:00 AA26 463.03 Spinal cord injury induces change of
microRNA expression in rat brainstem. C. WANG; C. YANG;
S. TZENG*. Natl. Cheng Kung Univ., Natl. Hlth. Res. Inst.,
Natl. Cheng Kung Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 AA27 463.04 Changes in the transcriptome after
complete spinal cord transection in the developing opossum
are age dependent. J. S. TRUETTNER*; M. J. WAKEFIELD;
H. LINDSAY; K. M. DZIEGIELEWSKA; W. D. DIETRICH; C.
J. EK; S. A. LIDDELOW; B. J. WHEATON; N. M. NOOR; N.
R. SAUNDERS. Univ. Miami Miller Sch. of Med., Walter &
Eliza Hall Inst., Univ. of Melbourne.
1:00 AA28 463.05 Endoplasmic reticulum stress response in
the rat contusive spinal cord injury model. D. MATSUYAMA*;
M. WATANABE; K. SUYAMA; M. KUROIWA; J. MOCHIDA.
Tokai Univ.
2:00 AA29 463.06 Internal circadian clock genes expression
in rat spinal cord. J. A. GONZALEZ-BARRIOS*; A. B.
LÓPEZ-MORENO; D. MARTÍNEZ-FONG; B. A. LEÓN-
CHÁVEZ. Hosp Regional Octubre, ISSSTE, CINVESTAV,
Facultad de Ciencias Qumícas, BUAP.
3:00 AA30 463.07 Angiopoietin 2 and spinal cord injury. O.
NESIC*; J. DURHAM-LEE; Y. WU. UTMB, UTMB.
4:00 AA31 463.08 Measures of lipid peroxide formation
after chronic spinal cord injury. S. N. HASSLER*; B. S.
KAPHALIA; C. E. HULSEBOSCH; D. NAUDURI. UTMB,
UTMB.
1:00 AA32 463.09 Primary afferent sprouting after spinal
cord injury correlates with sensory abnormalities and
changes in glycogen synthase kinase-3β activity. S. K.
BAREISS*; K. HERNANDEZ; T. LEE; B. WHITFIELD; K. L.
BREWER. East Carolina Univ., East Carolina Univ.
2:00 AA33 463.10 MicroRNA miR-133b is required for
functional recovery in lesioned adult zebrafish and is
downregulated after spinal cord injury in the rat. K. M.
GIBBS*; Y. YU; J. DAVILA; N. CAMPBELL; S. SUNG; T. I.
TODOROVA; S. OTSUKA; H. E. SABAAWY; M. GRUMET;
R. P. HART; M. SCHACHNER. Rutgers/ W.M. Keck Ctr. For
Collaborative Neurosci., The Cancer Inst. of New Jersey.
3:00 AA34 463.11 Adaptive cortical responses to spinal cord
injury in the mouse in vivo. A. DUBEY*; K. THOMPSON; V.
L. DIBONA; M. R. RASIN; D. P. CROCKETT. Umdnj-Robert
Wood Johnson Med. Sch.
4:00 AA35 463.12 Changes in angiogenic proteins after
acute spinal cord injury in rats. M. T. NG*; J. H. T. LEE; A. T.
STAMMERS; S. TIGCHELAAR; F. STREIJGER; C. K. LAM;
B. K. KWON. ICORD, Univ. of British Columbia, Univ. of
British Columbia.
POSTER
464. Spinal Cord Injury: Cellular Mechanisms
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 AA36 464.01 PDGF and EGF receptor inhibition
downregulates mTOR activity in primary cultures of adult rat
spinal cord astrocytes. S. CODELUPPI*; G. WIGERBLAD;
M. ABRAMS; J. KJELL; L. OLSON. Karolinska Institutet,
Karolinska Institutet, Karolinska Institutet.
2:00 BB1 464.02 Effect of ketamine on neural progenitor
cell differentiation and astrocyte morphology in vitro. U.
SHANMUGALINGAM*; M. COYLE; X. CAO; E. C. TSAI.
Ottawa Hosp. Res. Inst., Univ. of Ottawa, Univ. of Ottawa.
Neuroscience 2011 | Monday PM | 115
Mon. PM

3:00 BB2 464.03 Aligned biomaterial substrates mitigate
astrocyte activity. J. M. ZUIDEMA*; N. W. ZACCOR; A.
HURTADO; A. A. MONGIN; R. J. GILBERT. Rensselaer
Polytechnic Inst., Kennedy Krieger Inst., Johns Hopins Univ.,
Albany Med. Col.
4:00 BB3 464.04 Astrocytic connexins contribute to
secondary expansion of traumatic spinal cord injury. T.
TAKANO*; C. HUANG; X. HAN; X. LI; E. LAM; W. PENG; N.
LOU; A. TORRES; G. TIAN; M. V. L. BENNETT; J. GARRE;
M. NEDERGAARD. Univ. Rochester, Albert Einstein Col. of
Med.
1:00 BB4 464.05 STAT3 signaling in mechanical traumareactive
astrocytes regulates the scar forming process and
expression of specific proteins. I. B. WANNER*; B. SONG; A.
B. FERNANDEZ; Z. GRAY-THOMPSON; G. CZERWIENIEC;
J. A. LOO; M. V. SOFRONIEW. UCLA, UCLA, UCLA.
2:00 BB5 464.06 � γ-synuclein modulation of astrocyte
reactivity following spinal cord injury. C. O. DAVIS; D.
WENDELL; V. OHANNA; C. REMENAPP; A. HURTADO; N.
MARSH-ARMSTRONG*. Kennedy Krieger Inst., The Johns
Hopkins Univ., Kennedy Krieger Inst., The Johns Hopkins
Sch. of Med., Johns Hopkins Univ. Sch. Med., The Johns
Hopkins Sch. of Med.
3:00 BB6 464.07 Excitotoxic spinal cord injury induces
pathological changes in peripheral nerves both at and below
the level of injury. K. L. BREWER*; E. DUGAN; S. BLEVINS;
B. WHITFIELD. Brody Sch. Med. East Carolina Univ., East
Carolina Univ.
4:00 BB7 464.08 Characterization of the vascular damage
and disruption to the blood-spinal cord barrier following
traumatic spinal cord injury. S. A. FIGLEY*; J. T. WILCOX; M.
G. FEHLINGS. Univ. of Toronto, Univ. Hlth. Network, Toronto
Western Res. Inst.
1:00 BB8 464.09 Detection of spontaneous autonomic
dysreflexia in a mouse model of spinal cord injury. Y.
ZHANG*; Z. GUAN; K. HUANG; P. G. POPOVICH. The Ohio
State Univ., The Ohio State Univ.
2:00 BB9 464.10 Characterization of distinct astrocyte
subpopulations generated from glial restricted progenitors.
C. HAAS*; T. YAMAGAMI; J. F. BONNER; B. NEUHUBER; I.
FISCHER. Drexel Univ. Col. of Med.
3:00 BB10 464.11 Understanding ethidium bromide (EB)
demyelination in the adult mouse ventrolateral funiculus
(VLF). N. J. KUYPERS*; M. TRAN; G. ENZMANN; W.
DEVRIES; D. MAGNUSON; S. WHITTEMORE. Kentucky
Spinal Cord Injury Res. Ctr., Univ. of Louisville.
4:00 BB11 464.12 Salubrinal improves functional recovery
after SCI by targeting the ER stress response pathway. S. S.
OHRI*; M. HETMAN; S. R. WHITTEMORE. Univ. Louisville,
Univ. of Louisville.
1:00 BB12 464.13 Histone deacetylase inhibition-mediated
cytotoxicity of oligodendrocyte precursor cells. T. A.
DINCMAN*; J. E. BEARE; S. S. OHRI; V. GALLO; M.
HETMAN; S. R. WHITTEMORE. Univ. Louisville, Univ. of
Louisville, Univ. of Louisville, Children’s Natl. Med. Ctr., Univ.
of Louisville.
2:00 BB13 464.14 Regulation of ependymal stem cell
responses to traumatic and demyelinating lesions of the
adult mouse spinal cord. S. BEAUDOIN; L. HAMILTON;
C. DUGAS; A. AUMONT; I. PINEAU; S. LACROIX; K. J.
FERNANDES*. Univ. De Montréal, Univ. Laval.
116 | Society for Neuroscience
3:00 BB14 464.15 Characterization of adult ependymal cells
after spinal cord injury. H. M. SABELSTRÖM*; F. BARNABÉ-
HEIDER; J. FRISÉN. Karolinska Institutet, Karolinska
Institutet, Karolinska Inst.
4:00 BB15 464.16 The role of intraspinal hemorrhage in
cellular responses to spinal cord injury. F. R. SAHINKAYA*;
A. T. LASH; D. M. MCTIGUE. Ohio State Univ.
1:00 BB16 464.17 NG2 progenitor cells in the lesion core
after spinal cord injury play a role in regeneration failure by
entrapping dystrophic axons. A. FILOUS*; S. A. BUSCH;
K. P. HORN; L. X. BAI; R. H. MILLER; J. SILVER. Case
Western Reserve Univ.
2:00 BB17 464.18 The extension of neurites of neural
progenitors is not inhibited by chondroitin sulfate
proteoglycans in an in vitro model system of the glial scar.
G. GALLO*; A. KETSCHEK; C. HAAS; I. FISCHER. Drexel
Univ. Col. of Med.
3:00 BB18 464.19 Cell survival or cell death: differential
vulnerability of long descending and thoracic propriospinal
neurons to low thoracic axotomy in the adult rat. A. C.
CONTA STEENCKEN*; I. SMIRNOV; D. J. STELZNER.
SUNY Upstate Med. Univ., SUNY Upstate Med. Univ., SUNY
Upstate Med. Univ.
4:00 BB19 464.20 Relationship between angiogenesis,
vascular integrity, and functional improvements after spinal
cord injury in mice. J. C. HSU*; J. LO; T. KO. Natl. Cheng-
Kung Univ. Col. of Med., Sch. of Medicine, Taipei Med. Univ.
1:00 BB20 464.21 Identification of the laterality of RVLM
projections involved in the recovery of baroreflex regulation
in spinally-injured rats using pseudo-rabies virus. M. R.
ZAHNER*; D. G. CASTILLO; L. P. SCHRAMM. Johns
Hopkins.
2:00 BB21 464.22 CD47 knockout mice exhibit improved
functional hindlimb recovery from contusive spinal cord
injury. S. A. MYERS*; W. DEVRIES; K. ANDRES; M.
GRUENTHAL; R. BENTON; T. HAGG; S. WHITTEMORE.
Univ. Louisville, university of louisville.
POSTER
465. Glutamate Toxicity
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 BB22 465.01 Time, sex and region-dependent
neuroinflammation in cortex and hippocampus of mice with
Experimental Autoimmune Encephalomyelitis (EAE). Y.
DERI*; J. CHAPMAN; A. BIEGON. Tel Aviv Univ., Sheba
Med. Ctr., Sheba Med. Ctr., Brookhaven Natl. Labs.
2:00 BB23 465.02 Activation of glutamate receptors
restores cognitive performance and LTP in a mouse
model of neuroinflammation. S. LIRAZ ZALTSMAN*; A.
ALEXANDROVICH; R. YAKA; E. SHOHAMI; A. BIEGON.
The Hebrew Univ., Sheba Med. Ctr., The Hebrew university,
Brookhaven Natl. Lab.
3:00 BB24 465.03 Regional neuroinflammation measured
by TSPO autoradiography in Alzheimer’s disease brains
postmortem. E. KRAVITZ*; A. BIEGON. Sheba Med. Ctr., Tel
Aviv Univ., Sheba Med. Ctr., Brookhaven Natl. lab.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 CC1 465.04 • Treatment with doxorubicin affects
glutamate neurotransmission in the prefrontal cortex
and hippocampus. G. A. GERHARDT*; T. NOEL; P.
JUNGSUWADEE; D. K. ST. CLAIR; M. VORE; T. C.
THOMAS. Univ. Kentucky Med. Ctr., Univ. Kentucky Med.
Ctr., Univ. Kentucky Med. Ctr.
1:00 CC2 465.05 Non-NMDA receptor involvement
in hormetic mechanisms activated by the inhibition of
the Na+/K+ ATPase. M. T. FERNÁNDEZ-SÁNCHEZ; A.
PÉREZ-GÓMEZ; D. CABRERA-GARCÍA; A. M. MARINI; A.
NOVELLI*. Univ. Oviedo, Inst. of Biotech., Univ. Oviedo, Inst.
of Biotech., Uniformed Services Univ. of the Hlth. Sci.
2:00 CC3 465.06 Time-dependent effects of
lipopolysaccharide-induced chronic neuroinflammation upon
glutamate transporter expression as well as extracellular
glutamate levels and clearance measured second-bysecond
in the rat hippocampus. H. M. BROTHERS*; Å.
KONRADSSON-GEUKEN; I. BARDOU; D. M. BORTZ; C. R.
GASH; J. P. BRUNO; G. L. WENK. The Ohio State Univesity,
Karolinska Institutet.
3:00 CC4 465.07 Energy substrates protect against
endogenous glutamate-mediated neuronal damage in awake
rats. C. NETZAHUALCOYOTZI*; R. TAPIA. Univ. Nacional
Autónoma De México.
4:00 CC5 465.08 Air pollution alters glutamate receptor
function. D. A. DAVIS*; G. AKOPIAN; J. P. WALSH; M. A.
RENTELN; Z. NING; C. SIOUTAS; T. E. MORGAN; C. E.
FINCH. USC, USC, USC.
1:00 CC6 465.09 7,8-dihydroxyflavone provides
neuroprotection against glutamate-induced toxicity in HT-
22 cells via its antioxidant activity. X. XU*; J. CHEN; B.
CHUA; C. LIU. Inst. of Neuroscience, Soochow Univ., East
Tennessee State Univ.
2:00 CC7 465.10 Mitochondria-targeted protein kinase
A stabilizes Ca 2+ homeostasis in hippocampal neurons
exposed to toxic concentrations of glutamate. P. R.
HOULIHAN*; A. DICKEY; R. MERRILL; S. STRACK; Y. M.
USACHEV. Univ. of Iowa.
3:00 CC8 465.11 Changes in neuroimmunological markers
in response to N-Methyl-D-Aspartate (NMDA) receptor
activity. S. BURSZTAJN*; F. Y. FONG; S. A. BERMAN.
Dartmouth Med. Sch., Dartmouth Col., Univ. of Central
Florida Col. of Med.
POSTER
466. NMDA, Kynurenic Acid, and Neurodegeneration
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 CC9 466.01 Generation and initial characterization
of homozygous and heterozygous kynurenine
3-monooxygenase knockout mice. F. GIORGINI*; S.
HUANG; K. V. SATHYASAIKUMAR; F. M. NOTARANGELO;
M. THOMAS; E. K. STACHOWSKI; R. SCHWARCZ; P.
J. MUCHOWSKI. Univ. of Leicester, Gladstone Inst. of
Neurolog. Disease, Univ. of California, Taube-Koret Ctr.
for Huntington’s Dis. Res. and The Hellman Family Fndn.
Program in Alzheimer’s Dis. Res., Univ. of Maryland Sch. of
Med., Univ. of California.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 CC10 466.02 Effects of immune stimulation on
central and peripheral kynurenine pathway metabolism
in indoleamine-2,3-dioxygenase-deficient mice. P. B.
LARKIN*; K. V. SATHYASAIKUMAR; F. M. NOTARANGELO;
M. THOMAS; K. HORNING; R. SCHWARCZ; P. J.
MUCHOWSKI. Univ. of California, San Francisco, Gladstone
Inst. of Neurolog. Dis., Maryland Psychiatric Res. Center,
Univ. of Maryland Sch. of Med., Univ. of California, San
Francisco.
3:00 CC11 466.03 Kynurenine 3-monooxygenase activity
is increased in the brains of tryptophan-2,3-dioxygenasedeficient
mice. K. V. SATHYASAIKUMAR*; P. B. LARKIN;
F. M. NOTARANGELO; M. THOMAS; K. HORNING; H.
FUNAKOSHI; T. NAKAMURA; R. SCHWARCZ; P. J.
MUCHOWSKI. MPRC,Univ Maryland Sch. Med., Univ. of
California, Gladstone Inst. of Neurolog. Dis., Osaka Univ.,
Dept. of Microbiology and Immunology, Osaka Univ., Osaka
Univ., Dept. of Biochem. and Biophysics and Dept. of Neurol.
4:00 CC12 466.04 High-throughput assessment of cellular
manganese (Mn) status identifies novel mechanisms
underlying Mn transport deficit in a striatal cell and rodent
models of Huntington’s disease. G. F. KWAKYE*; O. A.
KABOBEL; A. B. BOWMAN. Vanderbilt Univ., Vanderbilt
Univ.
1:00 CC13 466.05 � Kynurenic acid as a potential
endogenous scavenger: Assays in non-biological systems
and an in vivo microdialysis study. T. BLANCO AYALA*; R.
LUGO-HUITRÓN; P. UGALDE MÚÑIZ; D. SILVA-ADAYA; E.
GARCÍA; V. PÉREZ-DE LA CRUZ; A. SANTAMARÍA DEL
ÁNGEL. Inst. Nacional de Neurología y Neurocirugía, Inst.
Nacional de Neurología y Neurocirugía.
2:00 CC14 466.06 L- and D-kynurenine as precursors of
kynurenic acid through ONOO- in synthetic systems and in
vitro conditions. R. LUGO*; T. BLANCO-AYALA; P. UGALDE-
MUÑIZ; I. SERRATOS-ÁLVAREZ; E. ORTIZ-ISLAS; M. A.
GARCÍA-SÁNCHEZ; A. SANTAMARÍA; V. PÉREZ-DE LA
CRUZ. Inst. Nacional De Neurología Y Neurocirugía, Manuel
Velasco Suarez, Univ. Autónoma Metropolitana, Unidad
Iztapalapa.
3:00 CC15 466.07 Phytoestrogens aid in mitigating HIV-1 tat
mediated synaptodendritic injury in long-term hippocampal
cell cultures. S. J. BERTRAND*; M. V. AKSENOVA; M. Y.
AKSENOV; V. ESPENSEN-STURGES; C. F. MACTUTUS;
R. M. BOOZE. Univ. of South Carolina.
4:00 CC16 466.08 Morphine and HIV-1 Tat-induced
synaptodendritic injury: Increases in intracellular calcium and
attenuation by NMDAR & AMPAR blockade in the striatum.
S. FITTING*; S. ZOU; P. E. KNAPP; K. F. HAUSER.
Virginia Commonwealth Univ. - MCV Campus, Virginia
Commonwealth Univ. - MCV Campus.
1:00 CC17 466.09 NMDA-type glutamate receptors mediate
hypoglycemia-induced white matter injury. X. YANG; M. A.
HAMNER; Z. YE; S. CHEN; B. R. RANSOM*. Ruijin Hosp.,
Univ. of Washington, Univ. Washington Sch. Med.
2:00 CC18 466.10 � NMDA receptors and optic nerve injury.
T. R. HURIA*, SR.
3:00 CC19 466.11 Opioid and HIV associated
neurodegeneration: Possible regulation by the P2X4
receptor in primary mouse striatal cells. M. E. SORRELL*; S.
ZOU; P. E. KNAPP; K. F. HAUSER. Virginia Commonwealth
Univ., Virginia Commonwealth Univ.
4:00 CC20 466.12 HIV-1 Tat and morphine mediate
interactive neurodegeneration through CCR5: The role of
glia. E. M. PODHAIZER*; Y. ZHANG; P. E. KNAPP; K. F.
HAUSER. Virginia Commonwealth Univ.
Neuroscience 2011 | Monday PM | 117
Mon. PM

1:00 CC21 466.13 Regulation of intracellular Ca 2+ signal
by ouabain under NMDA-induced excitotoxic stress. D. A.
SIBAROV; A. E. BOLSHAKOV; P. A. ABUSHIK; I. I. KRIVOI;
S. M. ANTONOV*. Sechenov Inst. of Evolutionary Physiol.
and Biochem., Saint-Petersburg State Univ.
2:00 CC22 466.14 Genistein and diadzein exert antiapoptotic
actions in HIV-1 Tat exposed primary neuronal
cultures. R. M. BOOZE*; S. ADAMS; M. AKSENOVA; M.
AKSENOV; C. MACTUTUS. Univ. South Carolina.
3:00 CC23 466.15 HIV-1 Tat and opiate reduce neural
progenitor cells: Does this lead to gender-specific behavioral
effects? Y. HAHN*; E. M. PODHAIZER; S. P. FARRIS; P.
VO; S. FITTING; M. F. MILES; K. F. HAUSER; P. E. KNAPP.
Virginia Commonwealth Universi, Virginia Commonwealth
Universi.
4:00 CC24 466.16 The involvement of glutamatergic and
dopaminergic signaling in the mechanism of the concurrent
methamphetamine and HIV-1 Tat neurotoxicity. M. Y.
AKSENOV; M. AKSENOVA*; C. F. MACTUTUS; R. M.
BOOZE. Univ. of South Carolina.
1:00 CC25 466.17 HIV-1 proteins Tat and GP120 affect
the viability and differentiation of oligodendroglia. S. ZOU*;
S. FITTING; J. L. DUPREE; K. F. HAUSER; P. E. KNAPP.
Virginia Commonwealth Univ., Virginia Commonwealth Univ.
2:00 CC26 466.18 Opioid-gp120 interactive
neuropathogenesis in HIV-1. K. L. SAMANO*; P. E. KNAPP;
K. F. HAUSER. Virginia Commonwealth Univ., Virginia
Commonwealth Univ., Virginia Commonwealth Univ.
3:00 CC27 466.19 • Recombinant HIV-1 Tat 1-86 induces
surface localization of dopamine transporter and
downregulation of vesicular monoamine transporter-2
function in rat striatal synaptosomes. N. M. MIDDE*; A. M.
GOMEZ; J. ZHU. Univ. of South Carolina.
4:00 CC28 466.20 Sublethal pathology and apoptotic death
induced by HIV-1SF162 and morphine in cultured striatal
neurons. R. R. MASVEKAR; S. ZOU; N. EL-HAGE; K. F.
HAUSER; P. E. KNAPP*. Virginia Commonwealth Univ.
1:00 CC29 466.21 The kynurenine pathway mediates
depressive and anxiety-like behavior following peripheral
immune challenge. J. C. O’CONNOR*; A. SALAZAR; J. M.
PARROTT; L. REDUS. UTHSCSA.
2:00 CC30 466.22 Hypoxia-induced activation of N-methyl
D-aspartate receptors causes retinal ganglion cell death in
the neonatal retina. S. VISWANATHAN*; C. KAUR; E. A.
LING; W. S. FOULDS; C. D. LUU. Natl. Univ. of Singapore,
Singapore Eye Res. Inst., Ctr. for Eye Res. Australia.
3:00 CC31 466.23 � Altered KYNA levels after exposure
to pro-oxidants in rat brain homogenates. P. E. UGALDE
MUÑIZ*; T. BLANCO AYALA; R. LUGO HUITRÓN; M.
TORRES; A. SANTAMARIA DEL ANGEL; P. CARRILLO
MORA; V. PÉREZ DE LACRUZ. Inst. Nacional De
Neurología y Neurocirugía, Manuel Velasco, Inst. Nacional
De Neurología y Neurocirugía, Manuel Velasco.
118 | Society for Neuroscience
POSTER
467. Human Tissue Studies in Psychotic Disorders
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 CC32 467.01 Epigenetic modifications in the
human prefrontal cortex of patients with schizophrenia.
S. NUMATA*; T. M. HYDE; T. YE; R. TAO; X. GUITART -
NAVARRO; M. WININGER; D. R. WEINBERGER; J. E.
KLEINMAN; B. K. LIPSKA. The Univ. of Tokushima Grad.
Sch., NIMH.
2:00 DD1 467.02 Perineuronal net abnormalities in the
prefrontal cortex in schizophrenia. S. MAUNEY; S. S. KIM*;
H. PANTAZOPOULOS; S. BERRETTA; T. WOO. McLean
Hosp.
3:00 DD2 467.03 Matching human hippocampal LTP
tissue markers in schizophrenia with parallel animal model
characateristics: NPAS3 knockout mouse. M. YANAGI*; B.
W. POTTS; A. A. PIEPER; S. GHOSE; C. A. TAMMINGA. UT
Southwestern Med. Ctr.
4:00 DD3 467.04 Gene expression profiling of
oligodendrocytes in dorsolateral prefrontal cortex in bipolar
disorder and schizophrenia. C. Y. PIETERSEN*; S. A.
MAUNEY; R. J. ROONEY; R. W. MCCARLEY; T. W. WOO.
McLean Hosp., Harvard Med. Sch., Genome Explorations
Inc., Veterans Affairs Boston Healthcare Syst., Beth Israel
Deaconess Med. Ctr.
1:00 DD4 467.05 • Postnatal developmental trajectories
of axon initial segment innervation in monkey dorsolateral
prefrontal cortex. G. D. HOFTMAN*; K. N. FISH; D. A.
LEWIS. Univ. of Pittsburgh, Univ. of Pittsburgh.
2:00 DD5 467.06 DNA methyltransferase-1 (DNMT1)
and methyl CpG -binding domain protein-2 (MBD2) show
increased binding to specific promoters in prefrontal cortices
of schizophrenia (SZ) and bipolar disorder (BP) patients. D.
R. GRAYSON*; E. DONG; A. GUIDOTTI. Univ. of Illinois At
Chicago.
3:00 DD6 467.07 mGluR5 activity is attenuated in the
dorsolateral prefrontal cortex of patients with schizophrenia.
M. L. MACDONALD; A. BANERJEE; K. BORGMANN-
WINTER; A. STUCKY; H. WANG; C. HAHN*. Univ. of
Pennsylvania, Univ. of Pennsylvania, Univ. of Pennsylvania
amd Children’s hospital of Philadelphia, City Univ. of New
york Med. Sch., Univ. Pennsylvania Sch. Med.
4:00 DD7 467.08 Gene expression throughout human
development in single cell populations in the prefrontal
cortex. N. SHASKAN; T. WOO*. McLean Hosp. and Harvard
Med. Sch.
1:00 DD8 467.09 Disruption of the Duo/Rac1/PAK
molecular pathway may underlie synaptic dysfunction in
schizophrenia. M. D. RUBIO*; V. HAROUTUNIAN; J. H.
MEADOR-WOODRUFF. Univ. of Alabama At Birmingham,
Mount Sinai.
2:00 DD9 467.10 • The effects of a mGluR2/3 agonist on
expression of AMPA receptors in the prefrontal neurons and
in a MK-801 model of schizophrenia. M. WANG*. Drexel
Univ. Col. of Med.
3:00 DD10 467.11 RPTPz/phosphacan abnormalities in the
amygdala of subjects diagnosed with bipolar disorder. R.
MISRA; S. BERRETTA*; H. PANTAZOPOULOS. McLean
Hosp., Harvard Med. Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 DD11 467.12 • Increased expression of Kalirin-9
in the auditory cortex of schizophrenia subjects and its
role in dendritic pathology. A. J. DEO*; M. CAHILL; S. LI;
I. GOLDSZER; R. HENTELEFF; J. VANLEEUWEN; I.
RAFALOVICH; R. GAO; E. K. STACHOWSKI; A. SAMPSON;
P. PENZES; D. A. LEWIS; R. A. SWEET. Translational
Neurosci. Program, Dept.of Psychiatry, U.of Pittsburgh
SOM, Univ. of Pittsburgh Sch. of Med., Northwestern
Univ. Feinberg Sch. of Med., Univ. of Pittsburgh, Univ. of
Pittsburgh, U. of Pitt. SOM, VA Pittsburgh Healthcare Syst.
1:00 DD12 467.13 Expression profiles of TARP proteins
in subcellular fractions from postmortem human brain in
schizophrenia. J. B. DRUMMOND*; D. SHAN; A. PINNER; J.
TUCHOLSKI; V. HAROUTUNIAN; R. E. MCCULLUMSMITH;
J. H. MEADOR-WOODRUFF. Univ. Alabama, Birmingham,
Bronx VA Med. Ctr.
2:00 DD13 467.14 S-palmitoylation of PSD-95 in the
frontal cortex in schizophrenia. J. TUCHOLSKI*; V.
HAROUTUNIAN; J. H. MEADOR-WOODRUFF. Univ.
Alabama-Birmingham, Mount Sinai Sch. of Med., Univ.
Alabama-Birmingham.
3:00 DD14 467.15 • Reduced mRNA levels for KCNS3
potassium channel α-subunit in parvalbumin-containing
neurons in the prefrontal cortex of subjects with
schizophrenia. D. D. GEORGIEV*; Y. MINABE; D. A. LEWIS;
T. HASHIMOTO. Kanazawa Univ. Grad. Sch. of Med. Sci.,
Univ. of Pittsburgh, Univ. of Pittsburgh.
4:00 DD15 467.16 • Deficits in transcriptional regulators of
cortical interneuron subpopulations in schizophrenia. D. W.
VOLK*; T. MATSUBARA; T. HASHIMOTO; E. J. SENGUPTA;
D. A. LEWIS. Univ. of Pittsburgh, Kanazawa Univ., Univ. of
Pittsburgh.
1:00 DD16 467.17 Glycosylation of the GluR2 AMPA
receptor subunit in frontal cortex in schizophrenia. A.
L. PINNER; J. TUCHOLSKI; V. HAROUTUNIAN; J. H.
MEADOR-WOODRUFF*. Univ. Alabama at Birmingham,
Mount Sinai Sch. of Med.
2:00 DD17 467.18 NMDA receptor hypofunction
is associated with decreased src Kinase activity in
schizophrenia. A. BANERJEE*; M. L. MACDONALD; A.
STUCKY; K. BORGMANN-WINTER; H. WANG; C. HAHN.
Univ. Pennsylvania, Univ. Pennsylvania, The City Univ. of
New York Med. Sch., Univ. of Pennsylvania and Children’s
Hosp. of Philadelphia.
3:00 DD18 467.19 Ankyrin 3: A node for the disconnectivity
syndrome in schizophrenia? P. ROUSSOS; P. KATSEL; K.
L. DAVIS; P. BITSIOS; S. G. GIAKOUMAKI; J. JOGIA; K.
ROZSNYAI; D. COLLIER; S. FRANGOU; L. J. SIEVER; V.
HAROUTUNIAN*. Mount Sinai Sch. of Med., Univ. of Crete,
Inst. of Psychiatry, Neurobio. Labs.
4:00 DD19 467.20 Molecular signatures of pyramidal and
parvalbiumin-containing neurons in the human superior
temporal cortex: Deviation in schizophrenia. S. KIM; C.
PIETERSEN; E. PASSERI*; M. LIM; R. ROONEY; J. CHEN;
R. STEPHENS; R. MCCARLEY; K. SONNTAG; T. WOO.
McLean Hosp., Harvard Med. Sch., Genome Explorations
Inc, Advanced Biomed. Computing Ctr., Veterans Affairs
Boston Healthcare Syst., Beth Israel Deaconess Med. Ctr.
1:00 DD20 467.21 Using lcm-qpcr to study cell specific
patterns of gene expression in cortex and thalamus in
schizophrenia. M. S. SIMMONS*; S. D. YATES; G. G.
NELSON; P. M. WALLER; S. O. HYDE; V. HAROUTUNIAN;
R. E. MCCULLUMSMITH; J. H. MEADOR-WOODRUFF.
UAB, Mt. Sinai Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 DD21 467.22 Gender-specific differences in the
expression of GABA receptor genes occur in the anterior
cingulate cortex in schizophrenia. M. S. SODHI*; D. J.
MOUNT; J. BOSTROM; N. HANSEN; V. HAROUTUNIAN;
J. MEADOR-WOODRUFF. Univ. of Illinois At Chicago, UAB,
Mount Sinai Sch. of Med.
3:00 DD22 467.23 • Developmental trajectories of molecular
transcripts regulating GABA inputs to pyramidal cells in
monkey prefrontal cortex. D. DATTA*; D. ARION; D. A.
LEWIS. Univ. of Pittsburgh, Univ. of Pittsburgh, Univ. of
Pittsburgh.
4:00 DD23 467.24 • Marked deficit of GAD67 protein levels
in parvalbumin-containing axon terminals in the prefrontal
cortex of subjects with schizophrenia. A. A. CURLEY*; K. N.
FISH; D. A. LEWIS. Univ. Pittsburgh, Univ. of Pittsburgh.
1:00 DD24 467.25 Prefrontal cortical and hippocampal
expression of dlg4 (psd-95) transcripts in schizophrenia and
affective disorders and association with genetic variance. E.
N. NEWBURN*; T. M. HYDE; T. YE; C. LI; R. TAO; L. WANG;
A. DEEP-SOBOSLAY; L. B. BIGELOW; R. E. STRAUB; R.
VAKKALANKA; M. M. HERMAN; D. R. WEINBERGER; J. E.
KLEINMAN; B. K. LIPSKA. Natl. Inst. of Hlth.
2:00 DD25 467.26 A post mortem brain study of Neuregulin
1 cleavage in pre frontal cortex and hippocampus. K.
MARBALLI*; D. CRUZ; P. THOMPSON; C. WALSS-BASS.
UTHSCSA, UTHSCSA, UTHSCSA.
3:00 DD26 467.27 Kynurenine pathway in the prefrontal
cortex of subjects with mood disorders. D. A. CRUZ*; D.
OLUKOTUN; P. THOMPSON. UTHSCSA.
4:00 DD27 467.28 Kynurenic acid associated with psychotic
features and Plasticity-Related Gene 5 (PRG-5) in bipolar
disorder. S. K. OLSSON*; C. SELLGREN; G. ENGBERG;
A. GRANKVIST; P. LICHTENSTEIN; S. ERHARDT; M.
LANDÉN. Karolinska Institutet, Karolinska Institutet, Univ. of
Gothenburg.
1:00 DD28 467.29 Defects of subcellular glutamate
transporter localization in schizophrenia. R. E.
MCCULLUMSMITH*; D. SHAN; J. HAMMOND; V.
HAROUTUNIAN; J. MEADOR-WOODRUFF. Univ. Alabama-
Birmingham, Mount Sinai Sch. of Med.
2:00 DD29 467.30 Abnormal g protein-coupled receptor
kinase (grk) expression in schizophrenia. A. FUNK*; V.
HAROUTUNIAN; R. MCCULLUMSMITH; J. MEADOR-
WOODRUFF. UAB, Mount Sinai Sch. of Med., UAB, UAB.
POSTER
468. Genetically Manipulated Animal Models of Psychotic
Diagnoses
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 DD30 468.01 Mood stabilizers selectively regulate the
cholecystokinin gene in a mouse model of mania. R. AREY*;
S. SPENCER; S. GHOSE; C. TAMMINGA; C. MCCLUNG.
UT Southwestern Med. Ctr.
2:00 DD31 468.02 Redox dysregulation affects proliferation,
differentiation of oligodendrocyte progenitors and myelination
: Relevance for schizophrenia. A. MONIN; M. KLAEY; C.
BUTTICAZ; J. CABUNGCAL; P. STEULLET*; K. DO. Ctr. For
Psychiatric Neurosciences.
Neuroscience 2011 | Monday PM | 119
Mon. PM

3:00 DD32 468.03 Study of a genetic animal model
of dopamine- and serotonin-associated disorders. C.
BRODSKI*; M. JUKIC; O. NOVIKOV; O. MAYSELESS; A.
AVIN. Ben Gurion Univ. of Negev.
4:00 DD33 468.04 • The effects of pramipexole on locomotor
activity in D3 mutant mice. N. M. RICHTAND*; W. CHANG;
R. AHLBRAND; N. R. SWERDLOW. Univ. Cincinnati
Col. Med., Cincinnati Veterans Affairs Med. Ctr., Univ. of
California San Diego Sch. of Med.
1:00 DD34 468.05 Towards DISC1 functions in astrocytes. J.
NOMURA*; T. MA; S. ABAZYAN; B. ABAZYAN; G. KANNAN;
C. YANG; A. SAWA; S. SNYDER; M. PLETNIKOV. Johns
Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch. of
Med., Johns Hopkins Univ. Sch. of Med.
2:00 DD35 468.06 Postnatal NMDA receptor deletion in
corticolimbic GABAergic interneurons significantly attenuates
gamma oscillation in the adult mouse brain. K. NAKAO*; K.
NAKAZAWA. NIH.
3:00 DD36 468.07 The deficiency of AKT1 results in the
reduction of hippocampus-related cognitive performance and
hippocampal neuromorphology in mice. Y. CHEN*; Y. CHEN;
W. LAI. Natl. Taiwan Univ., Neurobio. and Cognitive Sci.
Center, Natl. Taiwan Univ.
4:00 EE1 468.08 Assessments of behavioral flexibility,
goal-directed action, and reward hedonics in a mouse model
of schizophrenia. M. GALLAGHER*; A. W. JOHNSON; D. R.
SMITH; H. JAARO-PELED; A. SAWA. Johns Hopkins Univ.,
The Johns Hopkins Univ. Sch. of Med.
1:00 EE2 468.09 • Hyperactivity of the chakragati
mouse model of aspects of schizophrenia is sensitive to
both dopaminergic and non-dopaminergic psychoactive
compounds. G. S. DAWE*; R. ALBERT; H. SOO; C. LAI; A.
K. RATTY. Natl. Univ. Singapore, Cerca Insights Sdn Bhd,
Chakra Biotech Pte Ltd.
2:00 EE3 468.10 Novel transgenic rat overexpressing
human full length DISC1 as a model for protein aggregation
in chronic mental disease. S. V. TROßBACH*; M. PUM; J. P.
HUSTON; C. KORTH. Med. Sch. Dusseldorf, Heinrich-Heine
Univ.
3:00 EE4 468.11 • Altered dopamine receptor and
dopamine transporter gene expression in the striatum and
frontal cortex of neurotensin null mice. L. C. GUILLORY*;
H. QU; J. WANG; C. H. BOURKE; C. B. NEMEROFF; B.
KINKEAD. Emory Univ., Univ. of Miami.
4:00 EE5 468.12 Evaluation of attentional functions in
AKT1 mouse model of schizophrenia using the five-choice
serial reaction time task. Y. CHEN*; Y. CHEN; Y. CHEN; W.
LAI. Dept. of Psychology, Natl. Taiwan Univ., Neurobio. and
Cognitive Sci. Center, Natl. Taiwan Univ.
1:00 EE6 468.13 Proteomics analysis of new animal
models of bipolar disorder. H. AGETA*; A. TAKASAKI; K.
INOKUCHI; K. TSUCHIDA. Fujita Hlth. Univ., Fujita Hlth.
Univ., Gifu Univ. of Med. Sci., Univ. of Toyama.
2:00 EE7 468.14 Electrophysiological and behavioral
comparison of mice harboring a complete vs. targeted
mutation of the ErbB4 receptor. D. VULLHORST*; A.
SHAMIR; O. KWON; I. KARAVANOVA; A. BUONANNO.
NICHD, NIH, Dept. of Life Science, Pohang Univ. of Sci. &
Technol. (POSTECH).
3:00 EE8 468.15 Blunted behavioral effects of NMDA
receptor antagonists in dysbindin-1 mutant sandy mice. S.
BHARDWAJ*; Z. ZENG; W. ZHENG; L. K. SRIVASTAVA.
Douglas Mental Hlth. Univ. Inst., Sun-Yat Sen Univ.
120 | Society for Neuroscience
4:00 EE9 468.16 Hippocampal plasticity is altered in an
animal model of NMDA receptor hypofunction, the serine
racemase knockout mouse. D. T. BALU*; A. TRUONG;
J. CORRADI; A. CACACE; J. T. COYLE. McLean Hosp. /
Harvard Univ., Bristol-Myers Squibb Res. and Develop.,
McLean Hosp.
1:00 EE10 468.17 Disrupted-in-Schizophrenia-1 (DISC1)
stabilizes serine racemase (SRR) and modulates D-serine
levels in the brain. T. MA*; J. NOMURA; S. ABAZYAN; B.
ABAZYAN; A. SAWA; S. SNYDER; M. PLETNIKOV. Johns
Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch. of
Med., Johns Hopkins Univ. Sch. of Med., Johns Hopkins
Univ. Sch. of Med.
2:00 EE11 468.18 Aberrant assembly and function of a
hippocampal circuit in Disc1 mutant mice. M. KVAJO*;
H. MCKELLAR; L. J. DREW; A. LEPAGNOL-BESTEL; L.
XIAO; R. J. LEVY; R. BLAZESKI; P. A. ARGUELLO; C.
O. LACEFIELD; C. A. MASON; M. SIMONNEAU; J. M.
O’DONNELL; A. B. MACDERMOTT; M. KARAYIORGOU; J.
A. GOGOS. Columbia Univ., Columbia Univ., West Virginia
Univ. Hlth. Sci. Ctr., INSERM U675, IFR02, Faculté de
Médecine Xavier Bichat, Univ. Paris Diderot-Paris 7.
3:00 EE12 468.19 Role of VTA dopamine firing rates and
morphology in the regulation of anxiety related behavior
in the ClockΔ19 mouse model of mania. L. F. COQUE*; S.
MUKHERJEE; J. CAO; S. M. SPENCER; M. MARVIN; E.
FALCÓN; M. M. SIDOR; S. G. BIRNBAUM; A. PETTERSEN;
R. L. NEVE; E. A. GORDON; A. R. OZBURN; M. S.
GOLDBERG; M. HAN; D. C. COOPER; C. A. MCCLUNG.
UT Southwestern, Univ. of British Columbia, Univ. of
Colorado at Boulder, UT Southwestern, Univ. of Pittsburgh,
MIT, Mount Sinai Med. Ctr.
4:00 EE13 468.20 Behavioral assessment of auditory
functions relevant to schizophrenia in adolescent C57Bl/6
mice. C. E. MOYER*; E. THIELS; R. A. SWEET. Univ.
Pittsburgh, Univ. Pittsburgh, Univ. Pittsburgh, MIRECC, VA
Healthcare Syst.
1:00 EE14 468.21 Lack of schizophrenia-like phenotype in
cortical excitatory neuron-NMDA receptor knockout mice. G.
ROMPALA*; S. ZHANG; K. NAKAO; S. KOLATA; Z. JIANG;
K. NAKAZAWA. NIMH.
2:00 EE15 468.22 Dysbindin-1 mutant mice implicate
reduced parvalbumin-cell mediated inhibition as a final
common disease mechanism in schizophrenia. G. C.
CARLSON*; K. TALBOT; T. B. HALENE; M. J. GANDAL; H.
A. KAZI; L. SCHLOSSER; R. E. GUR; S. E. ARNOLD; S. J.
SIEGEL. Univ. of Pennsylvania, SOM.
3:00 EE16 468.23 Behavioral phenotype of mice that
develop with haploinsufficiency of the netrin-1 receptor
unc5c. M. L. AUGER; C. FLORES*. McGill Univ., McGill
Univ.
4:00 EE17 468.24 Combined effect of pubertal cuprizone
treatment and FABP7 deficiency on phenotypic changes
in adulthood. N. HIROTA*; S. KIMOTO; K. YAMAMURO;
T. NAGASHIMA; T. YAMAUCHI; H. YOSHINO; M.
SADAMATSU; T. KISHIMOTO. Nara Med. Univ.
1:00 EE18 468.25 Plasticity and behavior in a mouse
harboring a targeted mutation of the erbb4 receptor in
dopaminergic neurons. E. LEIVA-SALCEDO*; A. SHAMIR; I.
KARAVANOV; D. VULLHORST; A. BUONANNO. NIH.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

POSTER
469. Alcohol: Behavioral Effects
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 EE19 469.01 � Effects of cigarette smoke and/
or ethanol exposure during adolescence on locomotor
activity. C. C. CAVINA*; A. MANHÃES; C. FILGUEIRAS;
M. GUTHIERREZ; V. NAIFF; A. RIBEIRO-CARVALHO; Y.
ABREU-VILLAÇA. Univ. Do Estado Do Rio De Janeiro,
UERJ.
2:00 EE20 469.02 Behavioral profiling before and after
adolescent ethanol intake in rats subjected to different
early-life conditions. S. PALM; L. DAOURA; E. ROMAN;
I. M. NYLANDER*. Dept Pharmaceut. Biosciences,
Neuropharmacology, Addiction & Behaviour.
3:00 EE21 469.03 The effects of caffeine on ethanol’s
motivational effects in adolescent mice. S. D. DICKINSON*;
E. M. VREEDE; L. M. BAHLS. St. Olaf Col., St. Olaf Col., St.
Olaf Col.
4:00 EE22 469.04 • � Different profiles of ethanolinduced
sensitization are associated with altered 5-HT
mRNA expression. A. L. ANDRADE*; K. P. ABRAHAO; F. O.
GOELDNER; V. D’ALMEIDA; M. O. SOUZA-FORMIGONI.
Univ. Federal De São Paulo, Univ. Federal De São Paulo.
1:00 EE23 469.05 Aripiprazole, an atypical antipsychotic,
prevents the acute effects of ethanol in mice. T. VIANA*;
A. SANTOS ALMEIDA; N. PEREIRA; D. PEIXOTO; D. C.
AGUIAR; F. A. MOREIRA. Univ. of Minas Gerais.
2:00 EE24 469.06 Alcohol self-administration inhibits the
expression of partner preference in a sex-specific manner in
prairie voles. A. M. ANACKER*; T. H. AHERN; L. J. YOUNG;
A. E. RYABININ. Oregon Hlth. & Sci. Univ., Quinnipiac Univ.,
Yerkes Natl. Primate Res. Center, Emory Univ.
3:00 EE25 469.07 Altered responses to ethanol in NMDAR
NR1 (F639A) knock-in mice. C. R. DEN HARTOG; J. T.
BECKLEY; C. T. SMOTHERS; G. E. HOMANICS; J. J.
WOODWARD*. Med. Univ. of South Carolina, Univ. of
Pittsburgh.
4:00 EE26 469.08 Effects of trigeminal desensitization on
chemosensory responding to ethanol and basic tastants in
heterogeneous Wistar rats. J. J. OLNEY*; E. V. DRIVER; S.
M. BRASSER. San Diego State Univ.
1:00 EE27 469.09 � Dopamine’s role in ethanol induced
behavioral disinhibition. E. SALDES*; J. LIM; K. HAN. Univ.
of Texas At El Paso.
2:00 EE28 469.10 The enhancement of pavlovian
conditioned alcohol-seeking by an alcohol-associated
context in rats. J. MENDOZA*; C. TARDIF; N. CHAUDHRI.
Concordia Univ.
3:00 FF1 469.11 Post-stress alcohol treatment alleviates
stress induced impairment in memory in male rats. J. L.
GOMEZ*; M. LEWIS; M. FRANKFURT; P. SERRANO; V.
LUINE. Hunter Col., The Grad. Ctr. of CUNY, Hofstra Univ.
4:00 FF2 469.12 Effects of acute ethanol on memory
encoding, retrieval, and the theta rhythm. K. S. EDWARDS*;
J. N. GAINES; D. TASK; B. GIVENS. The Ohio State Univ.
1:00 FF3 469.13 Ethanol disrupts reversal learning
and neuron excitability in the orbitofrontal cortex. K. A.
BADANICH*; J. J. WOODWARD. Med. Univ. of South
Carolina, Med. Univ. of South Carolina.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
470. Alcohol: Human and Primate Studies
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 FF4 470.01 Gender differences in activation of
fronto-parietal circuitry during Stroop interference among
chronic alcoholics. S. M. M. RUIZ*; K. MARINKOVIC; K.
S. SAWYER; S. LEHAR; M. M. VALMAS; T. URBAN; G.
J. HARRIS; M. OSCAR-BERMAN. Grad. Program for
Neuroscience, Boston Univ., VA Boston Healthcare Syst.,
UC San Diego, Ph.D. Program in Behavioral Neuroscience,
Boston Univ. Sch. of Med., Boston Univ. Sch. of Med.,
Massachusetts Gen. Hosp., Athinoula A. Martinos Ctr. for
Biomed. Imaging, Harvard Med. Sch.
2:00 FF5 470.02 Rest- and task-related functional
connectivity in alcoholism. E. M. MULLER-OEHRING*; E. V.
SULLIVAN; A. PFEFFERBAUM; T. SCHULTE. Stanford Univ.
Sch. of Med., SRI Intl.
3:00 FF6 470.03 Effects of memantine on event-related
oscillations in subjects with and without family histories of
alcoholism. R. JIANTONIO; B. NARAYANAN; M. STEVENS;
J. KRYSTAL; P. SKUDLARSKI*; G. PEARLSON. Hartford
Hosp. / IOL, Yale Univ. Sch. of Med.
4:00 FF7 470.04 Brain activation, alcohol cues, and
craving. M. M. VALMAS*; F. D. TIBAYAN; S. M. M. RUIZ; K.
S. SAWYER; G. J. HARRIS; M. OSCAR-BERMAN. Boston
Univ. Sch. of Med., VA Boston Healthcare Syst., Boston
Univ., Boston Univ. Sch. of Med., Massachusetts Gen.
Hosp., Harvard Med. Sch., Athinoula A. Martinos Ctr. for
Biomed. Imaging.
1:00 FF8 470.05 Alcohol effects on bias to salient alcohol
related stimuli and inhibitory control; brain mechanisms. K.
NIKOLAOU; H. D. CRITCHLEY; T. DUKA*. Univ. of Sussex,
Clin. Imaging Sci. Ctr., Brighton and Sussex Med. Sch.
2:00 FF9 470.06 Brain morphometry and drinking history
in alcoholic men and women. K. S. SAWYER*; M. OSCAR-
BERMAN; N. MAKRIS; G. M. PAPADIMITRIOU; J. KAISER;
S. M. M. RUIZ; M. M. VALMAS; G. J. HARRIS. Ph.D.
Program In Behavioral Neuroscience, Boston Univ. Sch.
of Med., VA Boston Healthcare Syst., Boston Univ. Sch.
of Med., Athinoula A. Martinos Ctr. for Biomed. Imaging,
Massachusetts Gen. Hosp., Boston Univ., Massachusetts
Gen. Hosp., Harvard Med. Sch.
3:00 FF10 470.07 A primate tissue resource for conducting
alcohol research. J. B. DAUNAIS*; E. J. BAKER; A.
T. DAVENPORT; N. SOLTAU; S. W. GONZALES; B.
FERGUSON; S. E. HEMBY; D. P. FRIEDMAN; K. A. GRANT.
Wake Forest Univ. Sch. of Med., Baylor Univ., Oregon Natl.
Primate Res. Center, Oregon Hlth. and Sci. Univ.
4:00 FF11 470.08 Effects of family history on alcohol
consumption and adverse consequences in college
freshmen. J. SISANTE*; B. NARAYANAN; R. ROSEN;
R. JIANTONIO; C. FALLAHI; R. WOOD; C. AUSTAD; H.
TENNEN; S. RASKIN; G. PEARLSON. Olin Neuropsychiatric
Res. Ctr., Olin Neuropsychiatric Researc center, Inst. of
Living, Olin Neuropsychiatric Res. Center, Inst. of Living,
Olin Neuropsychiatry Res. Center, Inst. of Living, Central
Connecticut State Univ., Univ. of Connecticut Sch. of Med.,
Trinity Col., Yale Univ. Sch. of Med.
Neuroscience 2011 | Monday PM | 121
Mon. PM

1:00 FF12 470.09 Risk taking measure sensitive to family
history of alcoholism. R. I. ROSEN; D. C. GLAHN*; M.
K. GINLEY; C. S. AUSTAD; H. TENNEN; S. A. RASKIN;
C. FALLAHI; R. M. WOOD; G. D. PEARLSON. Olin
Neuropsychiatry Res. Ctr., Yale Univ. Sch. of Med., Central
Connecticut State Univ., Univ. of Connecticut Sch. of Med.,
Trinity Col.
2:00 FF13 470.10 The effects of alcohol on cognitive
functioning in college students. S. A. RASKIN*; S. ISAAC;
N. CAGGIANO; K. FOSTER; L. NOVAK; R. ROSEN;
H. TENNEN; C. AUSTAD; C. FALLAHI; R. WOOD; G.
PEARLSON. Trinity Col., Olin Neuropsychiatry Res. Ctr.,
Univ. of Connecticut, Central Connecticut State Univ.
3:00 FF14 470.11 Physiological constituents of coping
mechanisms: Relation to problematic drinking and academic
performance. S. WEMM*; A. FANEAN; A. BAKER; D.
MANDICH; E. BLOUGH; S. MEWALDT; M. BARDI. Marshall
Univ.
4:00 FF15 470.12 Prevalence of depressive symptoms
and suicidal behavior in alcoholics from the southeast
Mexico. H. A. RUBIO-ZAPATA*; E. A. AGUILAR-MENA;
D. F. ESTRELLA-CASTILLO; M. L. PINTO-LORÍA. UADY,
Autonomous Univ. of Yucatán, Autonomous Univ. of Yucatán.
1:00 FF16 470.13 Chronic ethanol alters GABAA and
GABAB gene expression the monkey cerebellum. E.
DOLSON*; S. E. HEMBY; B. A. MCCOOL; K. A. GRANT; D.
P. FRIEDMAN. WFU Sch. of Med., Oregon Hlth. and Sci.
Univ.
POSTER
471. Cocaine: Neural Mechanisms II
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 FF17 471.01 � Error monitoring in current and former
cocaine users. B. C. CASTELLUCCIO*; S. A. MEDA; C. E.
MUSKA; M. C. STEVENS; G. D. PEARLSON. Trinity Col.,
Olin Neuropsychiatry Res. Ctr., Vanderbilt Univ., Yale Univ.
2:00 FF18 471.02 Can wavelet coherence analysis
capture a fronto-amygdalar “contra-phase” relationship
during attempted inhibition of cocaine craving? S. LAM; J.
SUH; Y. LI; Z. WANG; C. P. O’BRIEN*; J. F. MAGLAND; A.
CHILDRESS. Univ. of Pennsylvania, Univ. of Pennsylvania.
3:00 FF19 471.03 Can baclofen impact the “invisible” brain
vulnerability associated with rapid cocaine relapse? A. R.
CHILDRESS*; J. J. SUH; R. N. EHRMAN; Y. LI; Z. WANG;
A. V. HOLE; T. R. FRANKLIN; M. GOLDMAN; R. SZUCS-
REED; J. F. MAGLAND; C. W. TJOA; D. D. LANGLEBEN; C.
P. O’BRIEN. Univ. Pennsylvania Sch. Med.
4:00 FF20 471.04 Trait well being is associated with
increased gray matter volume and reward processing in
the reward and default networks: Relevance to cocaine
addiction. P. A. WOICIK*; J. BUSTAMANTE; N. ALIA-KLEIN;
D. TOMASI; M. PARVAZ; T. MALONEY; A. KONOVA; G.
WANG; F. TELANG; N. D. VOLKOW; R. Z. GOLDSTEIN.
Brookhaven Natl. Lab., Natl. Inst. on Drug Abuse.
1:00 FF21 471.05 Altered expression of α1 subunits of the
GABAA receptor long-term cocaine self-administration by
rhesus monkeys. N. M. SHINDAY*; S. V. WESTMORELAND;
W. YAO; J. K. ROWLETT. New England Primate Res.
Center-Harvard Med. Sch.
122 | Society for Neuroscience
2:00 FF22 471.06 • Acute stress unmasks neurochemical
changes in the mPFC reflecting certainty of cocaine
expectations. V. I. CHEFER*; R. HENRIKSSON; T.
SHIPPENBERG. NIDA/NIH.
3:00 FF23 471.07 Altered function of cortico-striatal
systems after cocaine self-administration. P. GAO; J. H. W.
LIMPENS; S. SPIJKER; L. W. M. VAN KERKHOF; L. J. M. J.
VANDERSCHUREN; P. VOORN*. Vrije Univ. Med. Ctr., Univ.
Med. Ctr. Utrecht, VU Univ., Utrecht University, Fac. of Vet.
Med.
4:00 FF24 471.08 Is compulsive drug seeking associated
with dysfunction of the prefrontal cortex? J. H. W. LIMPENS;
R. DAMSTEEGT; E. H. S. SCHUT; G. M. RAMAKERS*;
L. J. M. J. VANDERSCHUREN. Rudolf Magnus Instute of
Neuroscience, UMC Utrecht, Dept. of Animals in Sci. and
Society, Div. of Behavioural Neuroscience, Fac. of Vet.
Medicine, Utrecht Univ.
1:00 FF25 471.09 Noradrenergic β-receptor activation in the
prelimbic medial prefrontal cortex is necessary for retrieval
of a cocaine-induced conditioned place preference. J. M.
OTIS*; K. B. DASHEW; D. MUELLER. Univ. Wisconsin-
Milwaukee.
2:00 FF26 471.10 Extinction of cocaine seeking reduces
elevated bFGF expression and is enhanced by neutralizing
bFGF in the medial prefrontal cortex. R. C. TWINING*; E.
M. DONCHECK; S. A. RUDER; M. HAFENBREIDEL; J. R.
SCHNEIDER; D. MUELLER. Univ. of Wisconsin - Milwaukee.
3:00 FF27 471.11 NMDA and beta-adrenergic receptors are
necessary for extinction of cocaine seeking. D. MUELLER*;
M. HAFENBREIDEL; R. C. TWINING; J. R. SCHNEIDER.
Univ. of Wisconsin Milwaukee.
4:00 FF28 471.12 Acute cocaine affects inhibitory activity in
prefrontal cortex: Optogenetic studies and pharmacological
investigation. T. TOMPA; J. DILGEN; D. SAGGU*; A. LAVIN.
MUSC, Roland Eotvos Univ.
1:00 FF29 471.13 Effect of intra-prefrontal cortical infusion
of brain-derived neurotrophic factor on cocaine seekinginduced
Arc mRNA induction. N. T. COLEMAN*; W. SUN; J.
F. MCGINTY. Med. Univ. of South Carolina.
2:00 FF30 471.14 A single intra-dorsomedial prefrontal
BDNF infusion attenuates cocaine self-administrationinduced
phospho-Ser9 synapsin in the nucleus accumbens.
W. SUN*; S. A. EISENSTEIN; J. F. MCGINTY. Med. Univ. of
South Carolina.
3:00 FF31 471.15 Effect of contingent or non-contingent
cocaine self-administration on BDNF expression in the
rat brain. F. FUMAGALLI; A. ORRÙ; L. CAFFINO; A. DI
CLEMENTE; F. MORO; C. CASSINA; M. A. RIVA; L.
CERVO*. Univ. of Milan, Mario Negri Inst.
4:00 FF32 471.16 Serotonergic mechanisms within the
orbitofrontal cortex regulate cocaine seeking behaviour. B. J.
EVERITT*; D. ECONOMIDOU. Univ. Cambridge.
1:00 FF33 471.17 Stimulation of serotonin 2C receptors in
the mPFC attenuates cocaine-induced hyperlocomotion and
alters Fos expression in brain regions containing dopamine
neurons. L. A. POCKROS*; N. S. PENTKOWSKI; S. M.
WEBER; J. L. NEISEWANDER. Arizona State Univ., Arizona
State Univ.
2:00 FF34 471.18 Modulation of adenylyl cyclase in media
prefrontal cortex effects on cocaine-induced sensitization.
K. LIU*; J. STEKETEE. Univ. of Tennessee Hlth. Sci. Ctr.,
Capital Inst. of Physical Educ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 GG1 471.19 � Acute cocaine exposure modulates
gabaergic function in mice cerebral cortex. I. GRIGÓRIO;
M. CARVALHO; N. PECINALLI; R. C. KUBRUSLY*. Univ.
Federal Fluminense.
4:00 GG2 471.20 Cocaine “binge” administration alters
inhibitory networks in somatosensory cortical slices from
mice. F. J. URBANO*; J. R. HYDE; W. E. FANTEGROSSI;
V. BISAGNO; E. GARCIA-RILL. IFIBYNE-CONICET, Ctr.
for Translational Neurosci., Assistant Professor, Dept.
of Pharmacol. & Toxicology, ININFA-CONICET, Ctr. for
Translational Neurosci. (Director).
1:00 GG3 471.21 Microinjection of ghrelin into the nucleus
accumbens enhances the increase of cocaine-induced
locomotion. N. HONG; S. SHIN; W. KIM; J. KIM*. Yonsei
Univ. Coll Med, Dept Physiol., Brain Korea 21 Project for
Med. Sci.
2:00 GG4 471.22 δ-containing GABA A receptors are
increased in the nucleus accumbens in female rats following
cocaine sensitization. S. S. POPP*; N. SIEGAL; D. DOW-
EDWARDS. SUNY Downstate Med. Ctr.
3:00 GG5 471.23 SSRIs potentiate methylphenidateinduced
gene regulation in the striatum: transcription factors
(zif 268, c-fos) vs. neuropeptides (substance P, dynorphin).
V. VAN WAES; B. CARR; J. BEVERLEY; H. STEINER*.
RFUMS/Chicago Med. Sch.
4:00 GG6 471.24 • Neurodegeneration of the lateral
habenula efferent fibers after intensive cocaine selfadministration.
Y. DIKSHTEIN*; E. LAX; A. FRIEDMAN;
L. ABRAHAM; G. YADID. The Mina&Evarerd Fac. of
Life Sciences, Bar-Ilan Univ., 2Leslie Susan Gonda
(Goldschmied) Multidisciplinary Brain Res. Ctr., The
Mina&Evarerd Fac. of Life Sciences, Leslie Susan Gonda
(Goldschmied) Multidisciplinary Brain Res. Center, Bar-Ilan
Univ.
1:00 GG7 471.25 Ventral pallidal firing patterns
during cocaine self-administration. D. H. ROOT*; A. T.
FABBRICATORE; S. MA; D. J. BARKER; A. P. PAWLAK; M.
O. WEST. Rutgers, The State Univ. of New Jersey.
2:00 GG8 471.26 β3-containing nicotinic receptors regulate
the psychomotor stimulant and reinforcing properties of
cocaine. L. M. TUESTA; P. M. JOHNSON; C. D. FOWLER;
P. J. KENNY*. The Scripps Res. Inst. - Florida.
POSTER
472. Amphetamine, MDMA, and Methylphenidate: Neural
Mechanisms
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 GG9 472.01 Subregional differences in the
mechanism of amphetamine action in the rat striatum. A. J.
AVELAR*; P. A. GARRIS. Illinois State Univ.
2:00 GG10 472.02 The in vivo effects of amphetamine
on vesicular dopamine release vary markedly with striatal
subregion and stimulation parameters. D. P. COVEY*; P. A.
GARRIS. Illinois State Univ.
3:00 GG11 472.03 Amphetamine-induced alterations in
dopamine neurotransmission in relation to behavior. D.
P. DABERKOW*; S. A. KRANIOTIS; K. D. BUNNER; M.
DOELLMAN; P. A. GARRIS. Eastern Washington Univ.,
Illinois State Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 GG12 472.04 D 1 -D 2 dopamine receptor heteromers
contribute to the expression of amphetamine-induced
locomotor sensitization. K. R. RODVELT*; D. LI; P. VEZINA.
Univ. of Chicago.
1:00 GG13 472.05 Repeated amphetamine exposure
sensitizes dopaminergic inhibition of basolateral amygdala
neural activity. M. TSE*; S. B. FLORESCO. Univ. British
Columbia, Univ. of British Columbia.
2:00 GG14 472.06 Co-administration of a low dose of
baclofen and a positive allosteric modulator prevents the
development of AMPH-induced locomotor sensitization.
L. N. CEDILLO ZAVALETA*; A. SANDOVAL-SÁNCHEZ;
J. JIMENEZ; J. ACOSTA; F. MIRANDA. FACULTAD DE
ESTUDIOS SUPERIORES IZTACALA, FACULTAD DE
ESTUDIOS SUPERIORES IZTACALA.
3:00 GG15 472.07 Interaction between NMDA and
metabotropic glutamate 5 receptors in rat ventral tegmental
area. Effect of repeated amphetamine treatment. C.
FERRADA; J. ABARCA; M. E. ANDRÉS; K. GYSLING*.
Pontificia Univ. Católica De Chile.
4:00 GG16 472.08 Influence of chronic amphetamine
treatment on serotonin reuptake mechanisms in the rat
ventral hippocampus. J. L. BARR*; J. L. SCHOLL; C. A.
LOWRY; K. J. RENNER; G. L. FORSTER. The Univ. of
South Dakota, Univ. of Colorado-Boulder, The Univ. of South
Dakota.
1:00 GG17 472.09 Acute effects of MDMA and
methamphetamine treatment on expression of GAD mRNA
in adult rat forebrain. T. L. KYSER; A. M. HEMMERLE; K.
E. EASLEY; S. N. SCHMELTZER; J. W. DICKERSON; K.
H. LUNDGREN; T. L. SCHAEFER; M. T. WILLIAMS; C. V.
VORHEES; K. B. SEROOGY*. Univ. Cincinnati, Vanderbilt
Univ., Cincinnati Children’s Res. Fndn.
2:00 GG18 472.10 Effects of repeated adolescent coadministration
of MDMA and THC on subsequent measures
of temperature, depressive-like behavior, and memory in
male and female Sprague-Dawley rats. E. Y. SHEN*; N. S.
NNAMANI; R. KULATHILA; J. S. MEYER. UMass, Univ. of
Massachusetts Amherst, Univ. of Massachusetts Amherst.
3:00 GG19 472.11 Synthesis and neurotoxicity profile
of 2,4,5-trihydroxymethamphetamine (THMA) and its
6-(N-actetylcystein-S-yl) conjugate. M. MUELLER*;
A. NEUDÖRFFER; C. MARTINEZ; A. MECHAN; U. D.
MCCANN; G. A. RICAURTE; M. LARGERON. Johns
Hopkins Sch. of Med., Univ. Paris Descartes, Johns Hopkins
Sch. of Med.
4:00 GG20 472.12 Single oral doses of
3,4-methylendioxymethamphetamine (MDMA, Ecstasy)
produce lasting effects on brain serotonin neurons in
non-human primates: Relationship to plasma MDMA and
metabolite concentrations. M. MUELLER; J. YUAN; G.
HATZIDIMITRIOU; U. D. MCCANN; G. A. RICAURTE*.
Johns Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch.
of Med., Johns Hopkins Univ.
1:00 GG21 472.13 Effect of stress on serotonin neurons of
3,4-Methylenedioxymethamphetamine (MDMA, ‘ecstasy’)
treated mice. W. L. BONKALE*; K. A. YOUNG; C. R.
YOUNG; J. R. WELSH. Texas A & M Univ. Syst. HSC,
Neuropsychiatry Res. Program, Central Texas VA HCS/
Texas A&M Univ. Syst. HSC, Dept of Vet. Integrative
Biosciences, Col. of Vet. Med. and Biomed. Sciences, Texas
A & M Univ.
Neuroscience 2011 | Monday PM | 123
Mon. PM

2:00 GG22 472.14 Designer methcathinone analogs target
dopamine and serotonin transporters in rat brain. M. H.
BAUMANN*; J. S. PARTILLA; M. A. AYESTAS, Jr; R. B.
ROTHMAN; N. V. COZZI. IRP, NIDA, NIH, DHHS, Univ. of
Wisconsin Sch. of Med. and Publ. Hlth., Univ. of Wisconsin
Sch. of Med. and Publ. Hlth.
3:00 GG23 472.15 GABA system changes in
methylphenidate sensitized female rats. L. FREESE*; E.
MÜLLER; M. SOUZA; N. COUTO-PEREIRA; M. FERIGOLO;
H. M. T. BARROS. Univ. Federal De Ciências Da Saúde De
Porto Alegre - UFCSPA.
4:00 GG24 472.16 Nucleus accumbens neuronal activity in
freely behaving rats is modulated following acute and chronic
methylphenidate administration. S. L. CHONG; N. DAFNY*.
Univ. Texas Med. Sch.
POSTER
473. Learning, Memory, Dependence, and Addiction
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 GG25 473.01 Epac activation in the rat basolateral
amygdala impairs memory reconsolidation of cues
associated with cocaine self-administration. X. WAN; P.
OLAUSSON*; A. C. NAIRN; M. TORREGROSSA; J. R.
TAYLOR. Yale Univ.
2:00 GG26 473.02 The impact of growth hormone on
adverse effects caused by anabolic androgenic steroids in
male rats. A. GRÖNBLADH*; J. JOHANSSON; F. NYBERG;
M. HALLBERG. Uppsala University, Dept Pharmaceut.
Biosci.
3:00 GG27 473.03 The effects of repeated amphetamine
exposure during adolescence or young adulthood on working
memory in adult rats. L. K. SHERRILL*; B. SEELEY; A.
MCCLORY; M. KANG; A. SHARMA; J. M. GULLEY. Univ.
of Illinois, Urbana-Champaign, Univ. of Illinois at Urbana-
Champaign.
4:00 GG28 473.04 Combined effects of THC and caffeine
on working memory in rats. L. V. PANLILIO; S. FERRE;
S. YASAR; E. B. THORNDIKE; C. W. SCHINDLER*; S.
R. GOLDBERG. DHHS/NIH/NIDA Intramural Res., Johns
Hopkins Univ. Sch. of Med.
1:00 GG29 473.05 Systemic administration of NCS-382
reverses deficits in contextual fear conditioning induced by
gamma-hydroxybutyric acid in adolescent female rats. K.
ISHIWARI*; R. SIRCAR. The Feinstein Inst. for Med. Res.
2:00 GG30 473.06 Learning extinction of alcoholic beer
self-administration is associated with increased pMAPK
expression in orbitofrontal prefrontal cortex and lateral
amygdala. N. J. MARCHANT*; S. COLE; G. P. MCNALLY.
Natl. Inst. On Drug Abuse, Univ. of New South Wales.
3:00 GG31 473.07 Sign tracking of ethanol in rats: Effects
of strain, environmental enrichment, and immune system
activation. M. VIGORITO*; J. D. CASACHAHUA; C. E.
MICHAELS; A. M. RIVERA; N. ANASTASIDES; S. L.
CHANG. Seton Hall Univ., Seton Hall Univ., Seton Hall Univ.
4:00 GG32 473.08 TAAR1 expression and miRNA responses
to methamphetamine in the hippocampus. L. M. OGAWA*;
E. J. VALLENDER; K. A. SULLIVAN; L. J. LYNCH; H. N.
PANAS; G. M. MILLER. Harvard Med. School/Neprc.
124 | Society for Neuroscience
1:00 GG33 473.09 A mouse model of the Gateway
Hypothesis: Nicotine and Cocaine. B. DRISALDI; Y. HUANG;
E. A. GRIFFIN; D. POLLAK; S. XU; D. YIN; C. SCHAFFRAN;
D. B. KANDEL; E. R. KANDEL; A. LEVINE*. Columbia Univ.,
Columbia Univ., Med. Univ. of Vienna, Howard Hughes Med.
Inst.
2:00 GG34 473.10 Cocaine-induced circadian anticipatory
episodes are detectable with both motivational and nonmotivational
behavioral measures in mice. A. G. GILLMAN*;
M. SIDOR; J. KUMAR; A. KETCHERSIDE; E. FALCON;
A. OZBURN; C. MCCLUNG. Univ. of Pittsburgh Med. Ctr.,
Univ. of Texas Southwestern Med. Ctr., Univ. of Texas
Southwestern Med. Ctr.
3:00 GG35 473.11 Behavioral and biochemical effects of
long term GHB treatment in male rats. J. JOHANSSON*;
A. GRÖNBLADH; F. NYBERG; M. HALLBERG. Uppsala
University, Inst. Pharmaceut. Bioscienses.
4:00 GG36 473.12 Repeated exposure to THC, the
primary psychoactive constituent of marijuana, disrupts
the consolidation of extinction learning in mice. L. E.
WISE*; J. M. WIEBELHAUS; A. H. LICHTMAN. Virginia
Commonwealth Univ.
1:00 HH1 473.13 Repeated amphetamine exposure in
adolescent and young adult rats and its effects on attentional
set-shifting in adulthood. E. R. VENHEIM*; N. M. KOFSKY;
J. M. GULLEY. Univ. Illinois Urbana-Champaign, Univ. Illinois
Urbana-Champaign.
2:00 HH2 473.14 Sex- and age-dependent differences in
reward processing in adolescent and adult rats trained in a
Pavlovian approach paradigm. L. M. ROBERTSON*; A. J.
WALDMAN; R. R. MARREDDY; S. H. SHAH; J. M. GULLEY.
Univ. of Illinois - Urbana Champaign, Univ. of Illinois - Urbana
Champaign.
3:00 HH3 473.15 PPAR Gamma as a therapeutic target in
cocaine abuse. W. R. MILLER*; J. RODRIGUEZ-RIVERA; S.
STUTZ; R. FOX; K. CUNNINGHAM; K. DINELEY. UTMB.
4:00 HH4 473.16 NR2B-specific NMDA receptor antagonist
ifenprodil interferes with the reconsolidation of cocainecue
memories. Y. ALAGHBAND*; A. J. KHALAJ; J. F.
MARSHALL. Univ. of California, Irvine.
1:00 HH5 473.17 L-type voltage-gated calcium channels in
the ventral tegmental area regulate acquisition and extinction
of cocaine-induced place conditioning. M. DEGOULET*;
K. AHN; H. MORIKAWA. Waggoner Ctr. For Alcohol and
Addiction Res., Univ. of Texas, Univ. of Bristish Columbia.
2:00 HH6 473.18 Working memory deficits and associated
changes in dopamine transporters after a binge regimen of
methamphetamine in rats. I. A. MENDEZ*; J. F. MARSHALL.
Univ. of California.
3:00 HH7 473.19 � Ability of different conditioning
procedures to cause cue-induced hyperactivity. J. M.
WACHTEL; T. A. PAINE*. Oberlin Col.
4:00 HH8 473.20 The conditioned locomotor response to a
cocaine-paired context is not susceptible to reinstatement or
spontaneous recovery after brief or extended withdrawal. S.
A. JOHNSON*; S. SEDIQZADAH; S. ERB. Univ. of Toronto.
1:00 HH9 473.21 Effect of acute amphetamine on synaptic
transmission in prefrontal cortical neurons in slices from
rats previously exposed to amphetamine in adolescence or
young adulthood. J. M. GULLEY*; K. PAUL; E. R. VENHEIM;
C. L. COX. Univ. Illinois, Urbana-Champaign, Neurosci.
Prog., Univ. Illinois, Urbana-Champaign, Pharmacol.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

POSTER
474. Serotonin, Histamine, and Behavior
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 HH10 474.01 Synergistic antiemetic interactions
between serotonergic 5-HT 3 and tachykininergic NK 1 -
receptor antagonists. N. A. DARMANI*; S. CHEBOLU; B.
AMOS; T. ALKAM. Coll Osteo. Med. Pacific, Western Univ.
Hlth. Sci.
2:00 HH11 474.02 Isoliquiritigenin, a licorice flavonoid,
inhibits methamphetamine-induced hyperlocomotion but
not stereotypical behavior or conditioned place preference
in mice. N. KITANAKA*; J. KITANAKA; K. TANAKA; N.
NISHIYAMA; M. TAKEMURA. Hyogo Col. Med., Hyogo Univ.
Hlth. Sci.
3:00 HH12 474.03 Activation of 5-HT1 A receptors in the
dorsomedial hypothalamus (DMH) suppresses locomotor
responses to various stimuli. D. V. ZARETSKY*; M. V.
ZARETSKAIA; L. BELLMAN; P. J. DURANT; J. A. DIMICCO;
D. E. RUSYNIAK. Indiana Univ. Sch. of Med., Indiana Univ.
Sch. of Med.
4:00 HH13 474.04 Dissociation of the anxiogenic and
serotonergic effects of acute fluoxetine treatment in
adolescent rats. A. E. ARRANT*; C. M. KUHN. Duke Univ.
1:00 HH14 474.05 Involvement of 5-HT 2A , 5-HT 2B and
5-HT 2C receptors in the development and maintenance
of long-term secondary allodynia and hyperalgesia
induced by formalin in the rat. C. CERVANTES-DURÁN*;
P. BARRAGÁN-IGLESIAS; J. B. PINEDA-FARIAS; M.
BRAVO-HERNÁNDEZ; V. GRANADOS-SOTO. Dept. de
Farmacobiología, Cinvestav, Sede Sur, Escuela Superior de
Medicina del Inst. Politécnico Nacional.
2:00 HH15 474.06 Decreased anxiety, increased aggression
and depression-like behavior in mice lacking brain serotonin.
V. MOSIENKO*; B. BERT; D. BEIS; H. FINK; M. BADER;
N. ALENINA. Max-Delbrueck Cneter For Mol. Med., Inst. of
Pharmacol. and Toxicology, Free Univ. Berlin.
3:00 HH16 474.07 Genetic removal of serotonin synthesis
in amygdala-projecting neurons reduces fear but not
anxiety-like behaviors. R. A. MCDEVITT*; M. S. CLARK; R.
PALMITER. NIH / NIDA, Univ. of Washington.
4:00 HH17 474.08 Histamine H 3 receptor agonists decrease
hypothalamic histamine levels and increase stereotypical
biting in mice challenged with methamphetamine. J.
KITANAKA*; N. KITANAKA; F. S. HALL; G. R. UHL; M.
TAKEMURA. Hyogo Col. Med., NIDA-IRP, NIH/DHHS.
1:00 HH18 474.09 Evaluation of anxiolytic and
antidepressant effects of eltoprazine in rats. I. V.
BELOZERTSEVA*; O. DRAVOLINA; L. MUS; A.
GRAVIUS; W. DANYSZ. Pavlov State Med. Univ., Merz
Pharmaceuticals.
2:00 HH19 474.10 Behavioural outcomes of male
and female mice perinatally exposed to fluoxetine. V.
KIRYANOVA*; B. B. MCALLISTER; R. H. DYCK. Univ. of
Calgary, Univ. of Clagary.
3:00 HH20 474.11 Role of serotonin in the therapeutic
effects of subthalamic nucleus deep brain stimulation in
a rat model of tardive dyskinesia. M. C. CREED*; P. J.
FLETCHER; J. N. NOBREGA. Ctr. For Addiction and Mental
Hlth., Univ. of Toronto, Ctr. for Addiction and Mental Hlth.,
Univ. of Toronto, Univ. of Toronto.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 HH21 474.12 Serotonin-related genes and stressful
life events contribute to aggression. C. CHEN*; Y. WANG;
J. LI; Q. DONG. State Key Lab. of Cognitive Neurosci. and
Learning.
1:00 HH22 474.13 Role of 5-HT3 receptors on development
and maintenance of secondary mechanical allodynia
and hyperalgesia. M. BRAVO HERNANDEZ*; P. LÓPEZ-
SÁNCHEZ; P. BARRAGÁN-IGLESIAS; C. CERVANTES-
DURÁN; J. B. PINEDA-FARÍAS; V. GRANADOS-SOTO.
Escuela Superior De Medicina Del Inst. Politecnico Nacional,
Cinvestav, Sede Sur.
2:00 HH23 474.14 Juvenile administration of concomitant
methylphenidate and fluoxetine alters behavioral reactivity
to reward- and mood-related stimuli and disrupts ventral
tegmental area gene expression in adulthood. K. N.
WRIGHT*; B. L. WARREN; L. F. ALCANTARA; S. D.
IÑIGUEZ; C. A. BOLAÑOS-GUZMÁN. Florida State Univ.
3:00 HH24 474.15 • Escitalopram’s effects in the tail
suspension test mediated by the allosteric site on the
serotonin transporter. K. E. MURRAY*; K. J. RESSLER; M.
J. OWENS. Emory Univ.
4:00 HH25 474.16 Increased 5-HT4 receptors in the
nucleus accumbens predisposes 5-HT1B knock-out to
self-impose food refusal. V. COMPAN*; L. LAURENT; A.
JEAN; O. ARIBO; Y. CHARNAY; J. BOCKAERT. Nimes
University/CNRS/INSERM, Inst. de Génomique Fonctionelle,
Contralco, HUG.
1:00 HH26 474.17 � Inhibition of the constitutive activity of
serotonin 4 receptors in the nucleus accumbens produced
binge eating. L. LAURENT*; A. JEAN; M. PRATLONG; R.
MARTIN; V. COMPAN. Inst. De Génomique Fonctionnelle,
Contralco, Univesité de Nïmes, Roche Biosci.
2:00 HH27 474.18 Phenylalkylamine hallucinogens increase
locomotor activity in mice by activating the 5-HT2A receptor.
A. L. HALBERSTADT*; S. B. POWELL; M. A. GEYER.
UCSD.
POSTER
475. Olfaction: Cellular and Circuit Mechanisms in Olfactory
Bulb/Antennal Lobe
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 HH28 475.01 TRPM5, a transduction channel
expressed in olfactory neurons sensing semiochemicals,
is found in a subset of OSNs that project to glomeruli
innervated by mitral cells projecting to medial amygdala. J.
A. THOMPSON*; S. ROLEN; T. E. FINGER; D. RESTREPO.
Univ. of Colorado Denver Anschutz Med. Campus.
2:00 HH29 475.02 Sensory training rehabilitates olfactory
function despite persistent pathophysiology after acute
intranasal cadmium exposure. J. P. MCGANN*; L.
A. CZARNECKI; T. RUBINSTEIN; D. J. TURKEL; J.
POTTACKAL; M. C. ROSENTHAL; A. H. MOBERLY.
Rutgers, The State Univ. of New Jersey.
3:00 HH30 475.03 Olfactory dysfunction during systemic
autoimmune disease. M. KAPADIA*; M. STANOJCIC; A.
EARLS; S. PULAPAKA; J. LEE; J. FOSTER; B. SAKIC.
McMaster Univ., River Oaks Chiropractic And Wellness
Ctr., McMaster Univ., Brain-Body Institute, St. Joseph’s
Healthcare.
Neuroscience 2011 | Monday PM | 125
Mon. PM

4:00 HH31 475.04 GDNF signaling in olfactory system
development. C. A. MARKS*; L. BELLUSCIO; C. F. IBANEZ.
Karolinska Institute/Division of Mol. Neurobiology/Dept. of
Neurosci., NIH, Karolinska Inst.
1:00 HH32 475.05 Vanadium inhalation, olfaction and
neurogenesis. R. S. JIMENEZ-MARTINEZ*, SR; L. COLÍN-
BARENQUE; C. VEGA; A. ARENAS; P. BIZARRO; A.
ZEPEDA; F. PASOS; T. FORTOUL VAN DER GOES. Univ.
Nacional Autonoma De Mexico, FES Iztacala. UNAM.
2:00 II1 475.06 Timing of neurogenesis is a determinant
of olfactory circuitry. F. IMAMURA*; A. E. AYOUB; P. RAKIC;
C. A. GREER. Yale Univ,Sch Med., Yale Univ,Sch Med., Yale
Univ,Sch Med.
3:00 II2 475.07 Adult-born interneurons are necessary
for intrabulbar map refinement. D. M. CUMMINGS*; J. S.
SNYDER; H. A. CAMERON; L. BELLUSCIO. NINDS, Natl.
Inst. of Mental Hlth.
4:00 II3 475.08 Activity dependence of the
interglomerular circuit. C. PLACHEZ*; S. PARRISH-
AUNGST; E. KIYOKAGE; S. LIU; M. T. SHIPLEY; A. C.
PUCHE. Univ. Maryland.
1:00 II4 475.09 Resting presynaptic membrane potential
affects the strength of olfactory mitral-mitral cell synapsis. A.
FEKETE*; J. JOHNSTON; K. R. DELANEY. MTA KOKI, Med.
Res. Council Lab. of Mol. Biol., Univ. of Victoria.
2:00 II5 475.10 Mitral cell spike synchrony modulated
by dendrodendritic synapse location. T. S. MCTAVISH*; M.
MIGLIORE; G. M. SHEPHERD; M. L. HINES. Yale Univ.
Sch. of Med., Inst. of Biophysics, Natl. Res. Council, Yale
Univ.
3:00 II6 475.11 Projection neurons contribute to interglomeruli
crosstalk in Drosophila antennal lobes. K. WANG*;
Y. GUO; Y. WANG; Z. WANG. Inst. of Neuroscience,
Chinese Acad. of Sci.
4:00 II7 475.12 Selective optical activation of a
genetically identified olfactory glomerulus as a tool to
study the glomerular unit response. O. R. BRAUBACH*; T.
BOZZA; L. B. COHEN; R. HOMMA. Yale Univ. Sch. of Med.,
Marine Biol. Lab., Korea Inst. of Sci. and Technol. (KIST),
Northwestern Univ., HHMI Janelia Farm.
1:00 II8 475.13 Functional connectivity and integration in
the mitral cell - granule cell network of the olfactory bulb. J.
T. DAVIE*; A. T. SCHAEFER. Max Plank Inst. for Med. Res.
2:00 II9 475.14 Intraglomerular feed-forward inhibition
of olfactory bulb mitral cells. M. NAJAC; S. CHARPAK; D.
DESAINTJAN*. INSERM U603, CNRS UMR 8154, Univ.
Paris Descartes.
3:00 II10 475.15 GABA-induced calcium transients in
juxtaglomerular neurons of the mouse olfactory bulb. P.
PARSA*; R. D’SOUZA; S. VIJAYARAGHAVAN. Univ. of
Colorado, Sch. of Med.
4:00 II11 475.16 Combined computational-experimental
characterization of the roles of two excitatory glomerular
microcircuits in shaping dynamic responses to olfactory
input. W. E. SHERWOOD*; R. M. CAREY; M. WACHOWIAK.
Boston Univ., Boston Univ., Univ. of Utah.
1:00 II12 475.17 Impact of tonic inhibition on synaptic
integration in olfactory bulb granule cells. C. LABARRERA*;
K. ANGELO. Univ. of Copenhagen.
2:00 II13 475.18 Timing-dependent suppression of mitral
cell output by inter-glomerular lateral inhibition targeted on
external tufted cells. J. D. WHITESELL*; N. E. SCHOPPA.
Univ. of Colorado Anschutz Med. Campus.
126 | Society for Neuroscience
3:00 II14 475.19 Photostimulation of short axon cells
reveals widespread inhibition in the mouse olfactory bulb. F.
MARBACH*; D. ALBEANU. Cold Spring Harbor Lab.
4:00 II15 475.20 Are L-type calcium channels activated
downstream of NMDA receptors during odor preference
learning in the neonate rat? D. JEROME*; Q. YUAN. Div. of
Biomed. Sci.
1:00 II16 475.21 Anesthetic regimes differentially modulate
the spontaneous and odor-induced temporal dynamics
in the mouse olfactory bulb. C. MARTIN*; R. CHERY; M.
BENDAHMANE; H. GURDEN. CNRS.
2:00 II17 475.22 Regulation of juxtaglomerular neuronal
activity by cannabinoid receptors in the main olfactory bulb.
Z. WANG; L. SUN; T. HEINBOCKEL*. Howard Univ. Coll
Med.
3:00 II18 475.23 Modulation of rat olfactory bulb
inhibitory circuits by serotonin. L. J. SCHMIDT*; B. W.
STROWBRIDGE. Case Western Reserve Univ.
4:00 II19 475.24 Locus coeruleus activation causes longterm
suppression of spontaneous and odor-driven firing in
granule cells of the MOB. H. S. DEMMER*; S. D. SHEA.
Cold Spring Harbor Lab.
1:00 II20 475.25 Changes in serotonin and dopamine
concentrations affect olfaction and withdrawal in terrestrial
snail. P. M. BALABAN*; M. V. ROSHCHIN. Inst. Higher
Nervous Activity & Neurophysiol. RAS.
2:00 II21 475.26 Dopamine-gabaergic cotransmission from
short-axon to external tufted cells activates an inhibitoryexcitatory
switch. S. LIU; Z. SHAO; A. PUCHE; M. T.
SHIPLEY*. Univ. Maryland Sch. Med.
3:00 II22 475.27 Serotonin modulates the population
profile of olfactory bulb external tufted cells. S. LIU*; J.
L. AUNGST; A. PUCHE; M. T. SHIPLEY. Univ. Maryland,
Baltimore, FDA, Univ. Maryland, Baltimore.
4:00 II23 475.28 Cholinergic modulation of neuronal
circuits in the mouse olfactory bulb. M. ROTHERMEL*; R.
M. CAREY; M. WACHOWIAK. Univ. of Utah, Sch. of Med.,
Boston Univ.
POSTER
476. Auditory Processing: Pathology and Therapeutics
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 II24 476.01 • Enhanced protein expression of Na-K-
Cl cotransporter (NKCC1) by aldosterone is a putative factor
in regulation of age-related hearing loss. B. DING; R. D.
FRISINA; X. ZHU; Y. SAKAI; M. HARVEY; D. FRISINA*, SR;
B. SOKOLOWSKI; J. P. WALTON. Univ. of South Florida,
Univ. of South Florida, Univ. of South Florida.
2:00 II25 476.02 Age-related changes in GABAARs in the
medial geniculate body. B. D. RICHARDSON*; L. L. LING; V.
V. UTESHEV; D. M. CASPARY. Southern Illinois Unveristy -
Sch. of Med.
3:00 II26 476.03 • Serum aldosterone levels decrease
in old mice with age-related hearing loss. X. ZHU; J. P.
WALTON; B. DING; B. PETERSON; R. D. FRISINA*. Univ. of
South Florida, Univ. of South Florida, Univ. Rochester Med.
Sch.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 II27 476.04 Limbic markers of tinnitus reflect tinnitus
characteristics, not reaction to tinnitus. A. M. LEAVER*; A.
SEYDELL-GREENWALD; T. TURESKY; S. MORGAN; H. J.
KIM; J. P. RAUSCHECKER. Georgetown Univ. Med. Ctr.
1:00 II28 476.05 Cortical processing of musical stimuli
differs between hearing impaired professional musicians and
industrial workers. E. EMMERICH*; M. ENGELMANN; R.
HUONKER; F. RICHTER. Friedrich Schiller Univ. Jena, Univ.
Hosp. Jena, Univ. Hosp. Jena.
2:00 JJ1 476.06 Age-related differences in sequential
stream segregation using natural speech stimuli. S. A.
HUTKA*; C. ALAIN. Rotman Res. Inst.
3:00 JJ2 476.07 • The basal ganglia in perceptual timing:
Timing performance in Multiple System Atrophy. T. E. COPE;
M. GRUBE; D. J. BURN; T. D. GRIFFITHS*. Newcastle
Univ., Newcastle Univ. Med. Sch., Newcastle Univ.
4:00 JJ3 476.08 Cortical processing of FM sweeps in a
mouse model of presbycusis. K. A. RAZAK*; M. TRUJILLO;
M. CARRASCO-REYES; H. M. DEL CAMPO. Univ.
California, Riverside, Univ. California, Univ. California.
1:00 JJ4 476.09 Increased left primary auditory cortex
activity in patients with schizophrenia with auditory
hallucinations while listening to reversed English words. T.
IKUTA*; A. K. MALHOTRA; P. DEROSSE; P. GRUNER; P. R.
SZESZKO. The Zucker Hillside Hosp., The Feinstein Inst. for
Med. Res.
2:00 JJ5 476.10 Quantitative comparisons of
auditory evoked field from lesion-side and normal
ear each of acoustic schwannoma patient using
magnatoencephalography. D. LEE*; B. KIM; Y. LEE;
J. CHANG. Yonsei Univ. Coll. of Med., Brain Korea 21
Project for Med. Science, Yonsei Univ., Med. Res. Center,
Yonsei Univ. Hlth. Syst., Brain and Cognition Measurement
Laboratory, Korea Res. Inst. of Standards and Sci. (KRISS),
Dept. of Neurosurgery, Yonsei Univ. Colllege of Med.
3:00 JJ6 476.11 Abnormal lateralized auditory function in
stuttering : A magnetoencephalographic study. Y. KIKUCHI*;
K. OGATA; T. OKAMOTO; T. UMESAKI; S. KOMUNE; S.
TOBIMATSU. Kyushu Univ.
4:00 JJ7 476.12 Effects of salicylate-induced tinnitus
on sound-evoked and spontaneous activity across layers
of the primary auditory cortex of anesthetized rats. D.
STOLZBERG*; B. L. ALLMAN; R. J. SALVI. Univ. At Buffalo,
the State Univ. of New York.
1:00 JJ8 476.13 Hearing-impairment in adult ferrets
induces partial crossmodal conversion of core auditory
cortex. L. KENISTON*; B. L. ALLMAN; M. A. MEREDITH.
Virginia Commonwealth Univ., State Univ. of New York at
Buffalo.
2:00 JJ9 476.14 • Sensory “gating out” and sensory
“gating in” following chemotherapy: A pilot study of auditory
evoked potentials. R. BIBI*; T. A. AHLES; J. C. MOSES; A.
SARVI; R. D. MELARA. The Grad. Center, CUNY, Mem.
Sloan-Kettering Cancer Ctr., The City Col. of New York,
CUNY.
3:00 JJ10 476.15 The effects of neonatal conductive
hearing loss on neuronal morphology and development
of perineuronal nets in the rat auditory brainstem. R. J.
KULESZA*, JR; J. RAY; A. MYERS. Lake Erie Col. of Osteo.
Med., Lake Erie Col. of Osteo. Med., West Virginia Univ.
4:00 JJ11 476.16 Neural deficits in auditory temporal
processing in auditory thalamus of ectopic BXSB/MpJ mice.
J. F. LINDEN*; L. A. ANDERSON. Univ. Col. London, Univ.
Col. London.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 JJ12 476.17 Comparison between single neuron
responses to cochlear implant and acoustic stimulation
in auditory cortex of awake primate. L. A. JOHNSON*;
C. C. DELLA SANTINA; X. WANG. Dept Biomed Eng,
Johns Hopkins Univ., Dept of Otolaryngology-Head & Neck
Surgery, Johns Hopkins Univ.
2:00 JJ13 476.18 Effect of Phencyclidine (PCP) on the
entrainment of auditory cortex to click trains in the Monkey.
A. Y. FALCHIER*; P. LAKATOS; D. C. JAVITT; C. E.
SCHROEDER. Nathan Kline inst, Columbia Univ. Col. of
Physicians & Surgeons.
3:00 JJ14 476.19 Zic2 knock down mice show the higher
response to auditory stimulus and size reduction of DCoN. Y.
MATSUMOTO*; N. TAKASHIMA; Y. NOZAKI; C. NISHIOKA;
M. KUDOH; J. ARUGA. Brain Sci. Institute(bsi), RIKEN,
Brain Sci. Institute(bsi), RIKEN, Teikyo Univ. Sch. of Med.
POSTER
477. Auditory Receptor Cells and Cochlea
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 JJ16 477.01 � A MARCM based screen for mutations
affecting mechanosensation in Drosophila. T. C. O’BRIEN; S.
M. WEBSTER*. Col. of the Holy Cross.
2:00 JJ17 477.02 Proliferation is required for regeneration
of mechanosensory hair cells in the zebrafish lateral line. S.
M. MACKENZIE*; D. W. RAIBLE. Univ. of Washington.
3:00 JJ18 477.03 Acid sensing ionic channel currents
in spiral ganglion neurons of the mouse. A. GONZALEZ
GARRIDO*; R. VEGA; E. SOTO. Univ. Autonoma De
Puebla.
4:00 JJ19 477.04 Identification of deafness genes in
two xenopus species is facilitated by illumina-solexa next
gen sequencing (ngs). D. RAMIREZ-GORDILLO*; J. VAN
VELKINBURGH; T. POWERS; C. TRUJILLO-PROVENCIO;
F. SCHILKEY; E. SERRANO. New Mexico State Univ., van
Velkinburgh Initiative for Collaboratory BioMedical Res.
(VICBR), Natl. Ctr. for Genome Resources (NCGR).
1:00 JJ20 477.05 Disruption of oncomodulin in outer
hair cells alters efferent innervation in the cochlea. D. D.
SIMMONS*; E. S. WONG; K. S. CHOI; A. J. HORNAK; K. K.
OHLEMILLER. UCLA, Washington Univ. Sch. of Med.
2:00 JJ21 477.06 Bilateral cannulation of guinea pigs for
ototoxicity studies allows evaluation of potential sympathetic
cochleolabrynthitis of a known ototoxic agent, neomycin. R.
L. TAPP*; M. M. ABERNATHY; J. D. YODER; A. A. KOCH;
D. V. GAUVIN; T. J. BAIRD. MPI Res.
3:00 JJ22 477.07 Ciliary tether cells morphologically and
functionally differentiate into the first hair cells in zebrafish
inner ear. M. TANIMOTO*; Y. OTA; M. INOUE; Y. ODA.
Nagoya Univ.
4:00 JJ23 477.08 Trolox prevents cisplatin-induced
hearing loss by attenuating cochlear nitroxidative stress. S.
JAMESDANIEL*; D. COLING; S. HINDUJA; D. DING; R.
SALVI. Univ. At Buffalo.
Neuroscience 2011 | Monday PM | 127
Mon. PM

1:00 JJ24 477.09 The oxidative stress in acoustic trauma:
A potential protective role of Q-ter. D. TROIANI*; S. L.
M. ERAMO; R. ROLESI; L. PETROSINI; A. FETONI; P.
DE BARTOLO. FISIOLOGIA Facoltà Di Medicina Univ.
Cattolica, Otolaryngology Facoltà di Medicina, Psicologia,
Otolaryngology Facoltà di Medicina.
2:00 JJ25 477.10 Dynamic in vivo outer hair cell length
changes measured with low coherence interferometry. A.
L. NUTTALL*; D. ZHA; F. CHEN; S. RAMAMOORTHY; N.
CHOUDHURY; A. FRIDBERGER. Oregon Hlth. Sci. Univ.,
Oregon Hlth. & Sci. Univ., Xijing Hospital, Fourth Military
Med. Univ., Oregon Hlth. & Sci. Univ., Karolinska Institutet.
3:00 JJ26 477.11 Lateral line architecture and function in
larval zebrafish. J. C. LIAO*; M. HAEHNEL. Whitney Lab.
For Marine Bioscience/University of Florida.
4:00 JJ27 477.12 Kanamycin middle ear toxicity: A novel
semi-quantitative histopathological method for evaluating
the middle ear structures following acute intra-aural
administration. M. M. ABERNATHY; R. L. TAPP; P. I. COLE;
J. D. YODER; N. A. BAXTER; D. V. GAUVIN*; T. J. BAIRD.
MPI Res. Inc., MPI Res. Inc., MPI Res. Inc., MPI Res. Inc.
1:00 JJ28 477.13 The expression and vesicular localization
of mouse Trpml3 in multiple sensory organs. N. REMIS*;
A. CASTIGLIONI; E. FLORES; J. GARCÍA-AÑOVEROS.
Northwestern Univ., Northwestern Univ., Northwestern Univ.,
Northwestern Univ., Northwestern Univ.
2:00 JJ29 477.14 Sex differences in auditory brainstem
responses of budgerigars, with and without masking noise.
I. C. NOIROT*; R. J. DOOLING. Univ. of Liege, Univ. of
Maryland.
3:00 JJ30 477.15 The developmental acquisition of a FAST,
calcium regulated, vesicle supply allows sustained high rate
of exocytosis in auditory hair cells. S. LEVIC*; Y. BOULEAU;
D. DULON. Equipe Neurophysiologie de la Synapse
Auditive, Unité Mixte de Recherche, Inserm U587 et Univ.
Victor Segalen, Inst. des Neurosciences de Bordeaux, Ctr.
Hospitalier Universitaire Pellegrin,.
4:00 JJ31 477.16 Synaptic heterogeneity of hair cell ribbon
synapses. T. WANG; A. B. WONG; M. A. RUTHERFORD;
T. FRANK; K. REUTER; S. KÜGLER; T. MOSER*. Univ.
Goettingen Med. Sch., Univ. of Goettingen.
1:00 JJ32 477.17 A computational model of nerve impulses
generated in the spiral ganglion cell radial afferents in response
to stochastic quantal release from inner hair cell ribbon
synapses. H. SUN*; B. WALMSLEY. Australian Natl. Univ.
2:00 JJ33 477.18 Cochlear processing in biosonar:
Modeling sound transduction and the cochlear microphonic
in echolocating bats. J. M. KNOWLES; J. E. GAUDETTE;
J. R. BARCHI; S. S. HOROWITZ; A. M. SIMMONS; J. A.
SIMMONS*. Brown Univ., Brown Univ., Brown Univ.
POSTER
478. Auditory Processing: Sound Localization and Binaural
Interactions
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 JJ34 478.01 • A stereological three-dimensional
reconstruction of the human cochlear nuclear complex. S.
SHARMA; T. C. NAG; D. BHARDWAJ; A. THAKAR; T. ROY*.
All India Inst. of Med. Sci., All India Inst. of Med. Sci., All
India Inst. Med. Sci., All India Inst. Med. Sci.
128 | Society for Neuroscience
2:00 JJ35 478.02 Spatial localization of stimuli in early
auditory processing is based on both head-related and non
head-related coordinate systems. E. SCHECHTMAN; L. Y.
DEOUELL*. The Hebrew Univ. of Jerusalem.
3:00 JJ36 478.03 The organization of the hindbrain auditory
nuclei of turtles follows the sauropsid pattern. K. L. WILLIS*;
C. A. MCCORMICK; C. E. CARR. Univ. Maryland, Oberlin
Col.
4:00 KK1 478.04 Sensitivity for sound-movement
direction in the macaque auditory cortex. C. C. POIRIER*;
S. BAUMANN; C. I. PETKOV; A. REES; A. THIELE; T. D.
GRIFFITHS. Bio-Imaging Lab., Inst. of Neurosci.
1:00 KK2 478.05 Pinna ridges modulate secondary
sidelobes in a model bat ear over a characteristic
echolocation frequency range. G. E. PERRIN*; R. MÜLLER;
F. W. GRASSO. The BioMimetic and Cognitive Robotics Lab,
Brooklyn Col., Virginia Tech., Sch. of Physics, Shandong
Univ.
2:00 KK3 478.06 Functional magnetic resonance imaging
of binaural cues in human auditory cortex: Non-monotonic
response tuning to interaural level difference. G. STECKER*;
S. A. MCLAUGHLIN. Univ. Washington.
3:00 KK4 478.07 Evidence for low-frequency sound
localization in the American alligator. H. S. BIERMAN*; C.
E. CARR; C. BRANDT; B. A. YOUNG; J. CHRISTENSEN-
DALSGAARD. Univ. of Maryland, Col. Park, Univ. of
Maryland, Col. Park, Univ. of Southern Denmark, Univ. of
Massachusetts Lowell.
4:00 KK5 478.08 Acoustic basis of sound localization
behavior in the laboratory mouse. S. J. SLEE; A. M.
LAUER*; B. J. MAY. Johns Hopkins Univ., Johns Hopkins
Univ.
1:00 KK6 478.09 Coincidence analysis of the effect of
cochlear disparities on temporal responses to pure tones. P.
X. JORIS*; S. KARINO. KU Leuven.
2:00 KK7 478.10 Temporary unilateral conductive hearing
loss alters the coding of the interaural level difference cue
to source location in adult animals. J. L. THORNTON*; K.
KOKA; H. G. JONES; D. J. TOLLIN. Univ. of Colorado Sch.
of Med.
3:00 KK8 478.11 Structure and functional roles of bilateral
inhibitory circuits projecting to medial superior olive of cats.
J. M. THOMPSON*; P. B. BROWN; R. J. MILLECCHIA; G. A.
SPIROU. WVU Sch. of Med., WVU Sch. of Med.
4:00 KK9 478.12 Processing of timing and level information
by model auditory neurons is improved by gradients of
potassium channel expression. L. K. KACZMAREK*. Yale
Univ. Sch. Med.
1:00 KK10 478.13 Factors accounting for variation in
the degree of contralateral preference in human auditory
cortical processing of binaural cues: A functional magnetic
resonance imaging study. S. A. MCLAUGHLIN*; G. C.
STECKER. Univ. of Washington.
2:00 KK11 478.14 Pharmacological evidence of a
functionally segregated pathway from the lateral superior
olive to the inferior colliculus. N. T. GREENE*; K. A. DAVIS.
The Univ. of Rochester.
3:00 KK12 478.15 Neural mechanisms of binaural masking
release. H. GILBERT*; C. LANTING; K. KRUMBHOLZ. MRC
Inst. of Hearing Res.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 KK13 478.16 � Mapping ITD in nucleus laminaris of
the barn owl. S. SHAH; T. MCCOLGAN; G. ASHIDA; S.
BRILL; H. WAGNER*; C. CARR. Univ. of Maryland, Inst. Fur
Zoologie.
1:00 KK14 478.17 • Heterogeneity of intrinsic membrane
properties in the avian superior olivary nucleus. M. J.
FISCHL*; R. M. BURGER. Lehigh Univ.
2:00 KK15 478.18 A selective impairment of auditory
perception of motion direction in peripheral space: A
case study. L. THALER; J. PACIOCCO; M. DALEY; D.
W. PURCELL; G. D. LESNIAK; M. A. GOODALE; J. C.
CULHAM*. Univ. of Western Ontario, Univ. of Western
Ontario, Univ. of Western Ontario.
3:00 KK16 478.19 Slow GABAergic transmission in auditory
coincidence detection neurons. Z. TANG; Y. LU*. Northeast
Ohio Med. Univ.
4:00 KK17 478.20 Linear and nonlinear spectral processing
underlying auditory spatial tuning in nontonopic regions of
the inferior colliculus. S. J. SLEE*; E. D. YOUNG. Johns
Hopkins Univ.
1:00 KK18 478.21 Synaptic inputs to inferior colliculus (IC)
neurons underlying coding of interaural level differences in
mouse. M. ONO; D. L. OLIVER*. Univ. of Connecticut Hlth.
Ctr.
2:00 KK19 478.22 An interaural level difference code
for discriminating sound position. N. C. HIGGINS*; D. A.
STORACE; M. A. ESCABI; H. L. READ. Univ. of Connecticut,
Univ. of Connecticut.
3:00 KK20 478.23 Transformation between monaural
and binaural brainstem inputs and target inferior colliculus
neurons reveals tradeoffs for spectrotemporal resolution. M.
A. ESCABI*; C. CHEN; H. READ. Univ. Connecticut, Univ. of
Connecticut, Univ. of Connecticut.
POSTER
479. Auditory Processing: Connectivity, Circuits, and
Neurotransmitters
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 KK21 479.01 Calretinin and NeuN
immunohistochemistry in the avian cochlear nucleus
angularis. A. WILLIAMS; K. M. MACLEOD*. Univ. Maryland.
2:00 KK22 479.02 Golgi-architecture of the subcortical
auditory structures in the Mongolian gerbil. E. BUDINGER*;
H. SCHEICH; J. MYLIUS. Leibniz Inst. for Neurobio.
Magdeburg, Leibniz Inst. for Neurobio. Magdeburg, Leibniz
Inst. for Neurobio. Magdeburg.
3:00 KK23 479.03 GABAergic projections from the inferior
colliculus to the thalamus in guinea pigs: An anterograde
study. J. G. MELLOTT*; B. R. SCHOFIELD. NEOUCOM.
4:00 KK24 479.04 The superior paraolivary nucleus projects
to the medial division of the medial geniculate body. D.
M. SLOAN*; A. S. BERREBI; E. SALDANA. West Virginia
Universiy, West Virginia Sch. of Med., Univ. of Salamanca.
1:00 KK25 479.05 Pathways for auditory cortical effects on
the contralateral central nucleus of the inferior colliculus. K.
T. NAKAMOTO*; B. R. SCHOFIELD. N.E. Ohio Univ. Coll. of
Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 KK26 479.06 Environmental noise determines the
effect of a selective serotonin receptor antagonist on sensory
processing. P. CURTIN*; T. PREUSS. City Univ. of New
York, Hunter Col., City Univ. of New York, City Univ. of New
York, Hunter Col.
3:00 KK27 479.07 Subcortical connections of the
supratemporal plane and rostral superior temporal gyrus in
macaque monkeys. B. H. SCOTT; P. A. LECCESE; K. S.
SALEEM*; M. MISHKIN; R. C. SAUNDERS. Natl. Inst. of
Mental Hlth. (NIMH/NIH).
4:00 KK28 479.08 Circuitry analysis of the gerbil’s central
nucleus of the Inferior Colliculus. L. YASSIN*; F. FELMY.
Ludwig Maximilians Univ.
1:00 KK29 479.09 Synaptic inputs to large tectothalamic
projection neurons of the mouse inferior colliculus. H. A. P.
GEIS; J. G. G. BORST*, Prof. Erasmus MC.
2:00 KK30 479.10 Gene expression differences for
glutamatergic pathways to primary and ventral auditory
cortical fields. D. A. STORACE*; J. A. CHIKAR; N. C.
HIGGINS; D. L. OLIVER; H. L. READ. Univ. of Connecticut,
Univ. of Connecticut Hlth. Ctr., Univ. of Connecticut.
POSTER
480. Auditory Processing: Neural Coding-Experiment and
Theory
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 KK31 480.01 Using optimal experimental design for
capturing parameters of neural networks in the inferior
colliculus of the common marmosets. W. TAM*; E. DEKEL;
C. DIMATTINA; E. D. YOUNG; K. ZHANG. Johns Hopkins
Univ., Case Western Reserve Univ.
2:00 KK32 480.02 State-dependent interactions in auditory
thalamocortical network. S. SAKATA*. SIPBS, Univ. of
Strathclyde.
3:00 KK33 480.03 Mutual information and stimulus-specific
information changes during development in rat primary
auditory cortex. M. N. INSANALLY*; B. F. ALBANNA; H.
KIM; H. KOVER; M. DEWEESE; S. BAO. Univ. of California,
Berkeley, Univ. of California, Berkeley, Univ. of California,
Berkeley.
4:00 KK34 480.04 A computational proof of concept for how
slow rhythms could serve as internal reference frames for
decoding firing patterns in sensory cortices. C. KAYSER*;
N. K. LOGOTHETIS; S. PANZERI. Max Planck Inst. Biol
Cybernetics, Univ. of Manchester, Italian Inst. of Technol.
1:00 KK35 480.05 In vivo electrophysiology of the cochlear
nuclear complex in the echolocating bat, eptesicus fuscus.
J. R. BARCHI*; J. M. KNOWLES; S. S. HOROWITZ; A. M.
SIMMONS; J. A. SIMMONS. Brown Univ.
2:00 KK36 480.06 Stimulus encoding in temporal firing
patterns relative to population-derived stimulus onset times.
R. BRASSELET*; S. PANZERI; N. LOGOTHETIS; C.
KAYSER. Max-Planck Inst. For Biol. Cybernetics, Italian Inst.
of Technol.
3:00 LL1 480.07 Decoding temporal stimulus structure
from single-trial population responses in auditory cortex. S.
V. DAVID*; B. ENGLITZ; J. B. FRITZ; S. A. SHAMMA. Univ.
of Maryland.
Neuroscience 2011 | Monday PM | 129
Mon. PM

4:00 LL2 480.08 Large-scale simultaneous recordings of
auditory-cortex using a multiplexed, high-density, surface
electrode array. J. VIVENTI*; D. KIM; N. HIGGINS; A. S. K.
LIU; B. LITT; H. L. READ; J. A. ROGERS; M. A. ESCABI; Y.
E. COHEN. Univ. of Pennsylvania, Univ. of Illinois at Urbana-
Champaign, Univ. of Connecticut, Univ. of Pennsylvania,
Univ. of Connecticut, Univ. of Pennsylvania.
1:00 LL3 480.09 Modulation of slow oscillations to the
sound coding in auditory thalamus. L. GAO*. Hongkong
Polytechnic Univ.
2:00 LL4 480.10 Population codes in the auditory cortex
predict perceptual discrimination behavior in mice. B.
BATHELLIER; S. RUMPEL*. Res. Inst. of Mol. Pathology.
3:00 LL5 480.11 Multiplexed and robust representations
of sound features in auditory cortex. K. M. WALKER*; J. K.
BIZLEY; J. W. H. SCHNUPP; A. J. KING. Univ. of Oxford.
4:00 LL6 480.12 Laminar population analysis of
multielectrode recordings from rat primary auditory cortex.
E. S. NORHEIM; F. D. SZYMANSKI; K. H. PETTERSEN;
U. G. INDAHL; A. M. DALE; J. W. H. SCHNUPP; G. T.
EINEVOLL*. Norwegian Univ. Life Sci., Italian Inst. of
Technol., Univ. of Oxford, Univ. of California.
1:00 LL7 480.13 Predicting neural responses in
auditory thalamus and cortex. J. Y. SHIH*; K. YUAN; C. E.
SCHREINER. UCSF, UC Berkeley, UCSF.
2:00 LL8 480.14 Developmental plasticity shapes auditory
processing to efficiently code the acoustic environment.
P. HULLETT*; C. E. SCHREINER. Univ. of California, San
Francisco, Univ. of California, San Francisco.
3:00 LL9 480.15 State versus stimulus dependent
coherent activity in primary auditory cortex. D. Y.
TAKAHASHI*; C. CHANDRASEKARAN; H. K. TURESSON;
A. A. GHAZANFAR. Princeton Univ., Princeton Univ.,
Princeton Univ.
4:00 LL10 480.16 Dynamic faces speed up vocal
processing in the auditory cortex of behaving monkeys. C.
CHANDRASEKARAN*; L. LEMUS; A. A. GHAZANFAR.
Princeton Univ., Princeton Univ., Princeton Univ.
1:00 LL11 480.17 Inclusion or exclusion: Encoding
concurrent acoustic events in auditory cortex. Y. ZHOU*; X.
WANG. Johns Hopkins Univ.
2:00 LL12 480.18 Coding of stimulus identity at early stages
in the processing stream for auditory object identity. E.
SMITH*; S. KELLIS; B. GREGER. Univ. of Utah.
3:00 LL13 480.19 Increased population coding performance
by neural decorrelation following rapid plasticity in the
auditory cortex. S. BANDYOPADHYAY; D. E. WINKOWSKI*;
S. A. SHAMMA; P. O. KANOLD. Univ. Maryland.
4:00 LL14 480.20 Harmonic preference in the lateral belt of
rhesus monkey auditory cortex. Y. KIKUCHI*; B. HORWITZ;
M. MISHKIN; J. RAUSCHECKER. Newcastle Univ.,
Georgetown Univ., NIDCD, NIMH.
1:00 LL15 480.21 Population representation of shepard
tones in the auditory cortex of the awake ferret. B. ENGLITZ;
P. YIN; S. AKRAM; S. V. DAVID; C. CHAMBERS; D.
A. DEPIREUX; J. B. FRITZ; D. PRESSNITZER; S. A.
SHAMMA*. Univ. of Maryland, Ecole normale supérieure.
2:00 LL16 480.22 Local receptive field variability in
cat primary auditory cortex. C. A. ATENCIO*; C. E.
SCHREINER. UCSF.
130 | Society for Neuroscience
POSTER
481. Multisensory Processing: Neural Factors I
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 LL17 481.01 Convergent multiple sensory connectivity
of ferret rostral posterior parietal cortex. M. MEREDITH*;
T. M. FIORE; W. A. FOXWORTHY. Virginia Commonwealth
Univ.
2:00 LL18 481.02 • Dendritic spine density differs in
multisensory versus primary sensory cortex. H. R. CLEMO*;
M. A. MEREDITH. Virginia Commonwealth Univ.
3:00 LL19 481.03 Bimodal and unisensory cortical neurons
are differentially sensitive to sensory experience. W. A.
FOXWORTHY*; L. P. KENISTON; M. A. MEREDITH. Virginia
Commonwealth Univ.
4:00 LL20 481.04 The influence of different postnatal
experiences on the integrative capabilities in the SC:
A computational study. C. CUPPINI*; M. URSINO; E.
MAGOSSO; B. A. ROWLAND; B. E. STEIN. Univ. Bologna,
Wake Forest Univ. Sch. of Med.
1:00 LL21 481.05 Rearing animals in omnidirectional
sound disrupts the maturation of multisensory integration in
superior colliculus neurons. J. XU*; L. YU; T. R. STANFORD;
B. A. ROWLAND; B. E. STEIN. Wake Forest Univ. Sch. of
Med.
2:00 LL22 481.06 An active cortex is necessary for the
experience-induced acquisition of multisensory integration in
the adult superior colliculus. L. YU*; B. A. ROWLAND; B. E.
STEIN. Wake Forest Univ. Sch. of Med.
3:00 LL23 481.07 Multisensory integration: Speeded
physiological responses exceed previous estimates. B. A.
ROWLAND*; T. J. PERRAULT, Jr.; T. R. STANFORD; B. E.
STEIN. Wake Forest Univ. Sch. of Med.
4:00 LL24 481.08 Response variability and its role in
multisensory processing. D. GHOSE*; D. K. SARKO; M. T.
WALLACE. Vanderbilt Univ., Vanderbilt Univ.
1:00 LL25 481.09 Neurochemical profile of thalamocortical
projections to the AES in cats. J. KRUEGER*; L. A. DE
LA MOTHE; W. H. LEE; T. A. HACKETT; M. T. WALLACE.
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.
2:00 LL26 481.10 Changes in neuronal response variability
of cortical multisensory processing following visual
deprivation. D. K. SARKO*; M. C. FISTER; D. GHOSE; M.
T. WALLACE. Vanderbilt Univ., Vanderbilt Univ., Vanderbilt
Univ.
3:00 LL27 481.11 Ventromedial medullary cholinergic
neurons target sensory afferent areas. R. L. STORNETTA*;
C. J. MACON; M. B. COATES; P. G. GUYENET. Univ.
Virginia.
4:00 LL28 481.12 • Novel in vitro slice preparation for the
study of medullary controlled sensory motor and autonomic
networks. J. S. NASSE*; S. P. TRAVERS; J. B. TRAVERS.
Ohio State Univ.
1:00 LL29 481.13 A comparison of sources of input to
four populations of lumbar spinocerebellar tract neurons in
the cat. S. SHAKYA SHRESTHA*; B. A. BANNATYNE; E.
JANKOWSKA; I. HAMMAR; E. NILSSON; M. WATANABE;
D. J. MAXWELL. Univ. of Glasgow, Univ. of Gothenburg,
Hokkaido Univ. Sch. of Med.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

2:00 LL30 481.14 Differential effects of the antidepressant
mirtazapine on amphetamine- and dizocilpine-induced PPI
deficits. J. A. LARRAURI*; H. SEXTON; E. D. LEVIN. Duke
Unviersity.
POSTER
482. Retinal Circuitry: Synaptic Interactions
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 LL31 482.01 In vivo characterization of retinal waves
in zebrafish. R. ZHANG*; J. DU. Inst. of Neurosci. and State
Key Lab. of Neurosci.
2:00 LL32 482.02 Extracellular pH dynamics of retinal
horizontal cells examined using electrochemical and
fluorometric methods. J. JACOBY*; S. ALFORD; M.
KREITZER; H. QIAN; R. P. MALCHOW. Univ. of Illinois at
Chicago, Indiana Wesleyan Univ., Natl. Eye Inst., Univ. of
Illinois at Chicago.
3:00 MM1 482.03 Generation of a connexin57-Cre
transgenic mouse to selectively target retinal horizontal
cells. A. A. HIRANO*; J. BOULTER; L. PÉREZ DE SEVILLA
MÜLLER; X. LIU; S. BARNES; N. C. BRECHA. UCLA Sch.
of Med., UCLA Sch. of Med., Dalhousie Univ., VAGLAHS,
UCLA Sch. of Med.
4:00 MM2 482.04 Involvement of Gbeta5/R7RGS proteins
in mammalian vision. C. J. CHEN*; H. SHIM; Y. CHEN; C.
WANG; F. CHEN; J. YANG; R. A. FISHER. VCU Biochem.
and Mol. Biol., Univ. of Iowa.
1:00 MM3 482.05 Genetic targeting and physiological
features of VGLUT3+ amacrine cells. R. P. SEAL*; W. N.
GRIMES; N. OESCH; R. H. EDWARDS; J. S. DIAMOND.
Univ. of Pittsburgh, NINDS, Univ. of California, San
Francisco.
2:00 MM4 482.06 Direction-dependent EPSP summation
and modulation of spike timing by subthreshold synaptic
input in retinal ganglion cells. S. Y. ABBAS*; E. J. YANG; D.
L. PETTIT. Albert Einstein Col. Med.
3:00 MM5 482.07 Receptive field properties of mouse
retinal ganglion cells shaped by inhibition originated from
inner plexiform layer. J. Y. HUANG; S. DI MARCO*; D. A.
PROTTI. Univ. of Sydney, Univ. of Sydney, Univ. of Sydney.
4:00 MM6 482.08 Selectivity of epiretinal stimulation of
retinal ganglion cells can be controlled by pulse width. S.
PANGRATZ-FUEHRER*; N. NAIK; D. PALANKER. Stanford
Univ. Med. Sch., Stanford Univ.
1:00 MM7 482.09 • Cannabinoid modulation of inputs to
retinal ganglion cells. T. P. MIDDLETON; D. A. PROTTI*.
Univ. of Sydney, Bosch Inst.
2:00 MM8 482.10 The diverse array of retinal ganglion
cell types in high acuity regions of the pigeon retina.
A. QUERUBIN*; B. O’BRIEN; K. BUMSTED O’BRIEN.
Australian Natl. Univ., Res. Sch. of Biol.
3:00 MM9 482.11 Changes in guinea pig retinal ganglion
cell spiking after application of somatostatin and the
somatostatin receptor sub-type 4 agonist L-803,087.
J. KING*; S. FARRELL; N. C. BRECHA; S. BARNES*.
Dalhousie Univ., UCLA, VAGLAHS, Jules Stein Eye Institute,
UCLA.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 MM10 482.12 Electrical activation of inner retinal
neurons. M. A. CAMERON; G. J. SUANING; N. H. LOVELL;
J. W. MORLEY*. Univ. of Western Sydney, Univ. of New
South Wales, Univ. of Western Sydney.
1:00 MM11 482.13 � Calcium-dependent regulation of H+
flux from isolated retinal horizontal cells. E. NAYLOR; J.
JACOBY; L. MONTGOMERY; H. QIAN; R. P. MALCHOW;
M. A. KREITZER*. Indiana Wesleyan Univ., Univ. of Illinois at
Chicago, Natl. Eye Inst., Univ. of Illinois at Chicago.
2:00 MM12 482.14 Rat retinal ganglion cells express
neuropeptide y and npy y1, y2, y4 and y5 receptors. A. F.
AMBROSIO*; F. ELVAS; J. F. MARTINS; D. BRUDZEWSKY;
A. R. SANTIAGO. Ctr. For Neurosci. and Cell Biol., IBILI,
Fac. of Medicine, Univ. of Coimbra, AIBILI.
3:00 MM13 482.15 Immunohistochemical localization of
histamine receptor subtypes in suncus and gerbil retinal
ganglion cells.. H. IMADA; K. SAKAI; E. MIYACHI*. Fujita
Hlth. Univ. Sch. Med., Fujita Hlth. Univ. Sch. Hlth. Sci.
POSTER
483. Striate Cortex: Neural Coding
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 MM14 483.01 Temporal structure of V1 population
responses to stimuli of different contrasts. S. ERISKEN; S.
KATZNER; F. FRANZEN; L. BUSSE*. Univ. of Tuebingen,
Bernstein Ctr. for Computat. Neurosci.
2:00 MM15 483.02 The dynamics of local field potential in
monkey primary visual cortex under naturalistic stimulation is
well captured by a model network of excitatory and inhibitory
integrate-and-fire neurons. F. BARBIERI*; A. MAZZONI; N.
LOGOTHETIS; S. PANZERI; N. BRUNEL. ISI Fndn., IIT,
Max Planck Inst. for Biol. Cybernetics, CNRS - Univ. Paris
Descartes.
3:00 MM16 483.03 Choice-related LFP changes in the
monkey V1 during discrimination of spatiotemporal sequence
of oriented stimuli. T. YOON; C. LEE*. Seoul Natl. Univ.,
Seoul Natl. Univ.
4:00 MM17 483.04 Propagation of “network belief” in cat
V1 revealed by apparent motion. M. PANANCEAU*; P. V.
CARELLI; F. GÉRARD-MERCIER; E. YAVUZ; C. MONIER;
Y. FRÉGNAC. UNIC - CNRS, Physics Department, UFPE,
UNIC-CNRS, UPR 3293.
1:00 MM18 483.05 Identification of novel natural images from
LFP signals in V1 predicted by a Gabor wavelet pyramid
model. M. SEYEDHOSSEINI; S. SHUSHRUTH; T. DAVIS; B.
GREGER; A. ANGELUCCI*; T. TASDIZEN. Univ. Utah, Univ.
Utah, Univ. Utah.
2:00 MM19 483.06 Lateral interactions in V1 population
responses to collinear and orthogonal contour elements. M.
M. MICHEL*; E. SEIDEMANN; W. S. GEISLER. The Univ. of
Texas.
3:00 MM20 483.07 Orientation-dependent spread of cortical
responses in primate primary visual cortex. Y. Y. CHEN*; E.
SEIDEMANN. Univ. of Texas at Austin.
4:00 MM21 483.08 Emergence of optimal decoding of
population codes through STDP. S. HABENSCHUSS*; H.
PUHR; W. MAASS. Graz Univ. of Technol.
Neuroscience 2011 | Monday PM | 131
Mon. PM

1:00 MM22 483.09 Neural mechanism of flash lag illusion.
M. SUBRAMANIYAN*; A. S. ECKER; P. BERENS; A.
HOENSELAAR; A. S. TOLIAS. Baylor Col. of Med., Max
Planck Inst. for Biol. Cybernetics, Caltech.
2:00 MM23 483.10 Neurons in primary visual cortex encode
naturalistic visual information using multiple temporal scales.
S. PANZERI*; A. MAZZONI; C. KAYSER; Y. MURAYAMA;
R. QUIAN QUIROGA; J. MARTINEZ; N. K. LOGOTHETIS.
ISTITUTO ITALIANO DI TECNOLOGIA, Max Planck Inst. for
Biol. Cybernetics, Univ. of Leicester, Univ. of Manchester.
3:00 MM24 483.11 LFP signals evoked by natural image
stimulation of the far-surround of V1 neurons carry contrastindependent,
image-specific information. S. SHUSHRUTH*;
T. S. DAVIS; T. TASDIZEN; J. M. ICHIDA; P. HOUSE; B.
GREGER; A. ANGELUCCI. Univ. Utah, Univ. Utah, Univ.
Utah, Univ. Utah.
4:00 MM25 483.12 Improved visual performance is
associated with increased LFP power in area v1. M.
JANSEN*; X. LI; R. LASHGARI; Y. BERESHPOLOVA; H. A.
SWADLOW; J. ALONSO. SUNY Col. of Optometry, Univ. of
Connecticut.
1:00 MM26 483.13 Visual orientation and directional
selectivity through thalamic synchrony. S. T. KELLY; G. B.
STANLEY*; J. JIN; Y. WANG; G. DESBORDES; Q. WANG;
M. J. BLACK; J. ALONSO. Georgia Inst. Technol. & Emory
Univ., SUNY, Boston Univ., Max Planck.
2:00 MM27 483.14 What does V1 really care about,
frequencies or features? R. FARIVAR-MOHSENI*; S.
CLAVAGNIER; B. C. HANSEN; R. HESS. MGH Martinos Ctr.
& Harvard Med. Sch., McGill Univ., Colgate Univ.
3:00 MM28 483.15 Mutual inhibition as a mechanism for
normalization. J. SEELY*; C. C. CHOW. NIH.
4:00 MM29 483.16 Beta/gamma oscillations increase
neural complexity. P. WANG*; B. LIMA; W. SINGER; S.
NEUENSCHWANDER; D. NIKOLIć. Max-Plank Inst. For
Brain Res., Johann Wolfgang Goethe Univ., Columbia Univ.,
Univ. Federal do Rio Grande do Norte.
1:00 MM30 483.17 Dynamics of binocular disparity tuning
explained by a neural network model with recurrent
interactions. J. M. SAMONDS*; B. R. POTETZ; C. W.
TYLER; T. LEE. Carnegie Mellon Univ., Kansas Univ., The
Smith-Kettlewell Eye Res. Inst.
2:00 NN1 483.18 Estimating shared firing rate fluctuations
in neural populations. B. M. YU*; A. KOHN; M. A. SMITH.
Carnegie Mellon Univ., Albert Einstein Col. of Med., Univ. of
Pittsburgh.
3:00 NN2 483.19 The role of correlated neuronal activity in
relaying signals through a feedforward corticocortical circuit.
A. ZANDVAKILI*; A. KOHN. Albert Einstein Col. of Med.
4:00 NN3 483.20 Responses to defined visual stimuli by
optic glomerular interneurons in Drosophila melanogaster.
L. MU*; K. ITO; N. J. STRAUSFELD. Univ. Arizona, Univ. of
Tokyo.
132 | Society for Neuroscience
POSTER
484. Functional Organization and Circuitry of Extrastriate
Cortex
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 NN4 484.01 Differences in spike waveform adaptation
between broad and narrow spiking neurons in Area V4 of the
awake macaque. J. F. MITCHELL*; E. B. ANDERSON; J. H.
REYNOLDS. Salk Inst.
2:00 NN5 484.02 Macaque visual area V4 is a single
visual area: Evidence from foveal regions. R. H. FAN*; H.
TANIGAWA; B. R. LUSTIG; A. W. ROE. Vanderbilt Univ.,
Niigata University, Sch. of Med., Vanderbilt Univ.
3:00 NN6 484.03 A motion direction map in macaque V4. P.
LI*; M. CHEN; C. HAN; S. ZHU; H. XU; A. W. ROE; H. D. LU.
Inst. of Neuroscience, Chinese Acad. of Sci., Vanderbilt Univ.
4:00 NN7 484.04 Short-term receptive field plasticity
in cortical area V4 of the alert macaque monkey. P.
MINEAULT*; T. P. ZANOS; J. A. MONTEON; C. C. PACK.
Montreal Neurolog. Inst.
1:00 NN8 484.05 Rapid reorganization of functional
connectivity in macaque cortical area v4. T. P. ZANOS*;
P. J. MINEAULT; J. A. MONTEON; C. C. PACK. Montreal
Neurolog. Inst.
2:00 NN9 484.06 • Mapping the temporal frequency
dependence of functional networks using frequencytagging
with fMRI-EEG. J. O. GARCIA*; E. A. HECKER; R.
SRINIVASAN. UC Irvine.
3:00 NN10 484.07 Multisensory processing in the
posteromedial suprasylvian visual area (PMLS) and
posterior suprasylvian visual areas PS/20b in the ferret
(Mustela putorius). R. E. BITTENCOURT-NAVARRETE;
B. L. ALLMAN*; L. P. KENISTON; M. A. MEREDITH. Inst.
de Biofísica Carlos Chagas Filho, Univ. Federal do Rio
de Janeiro, State Univ. of New York At Buffalo, Virginia
Commonwealth Univ.
4:00 NN11 484.08 Optical intrinsic signal imaging from
macaque inferotemporal cortex reveals functional structures
in different spatial scales. T. SATO*; M. TANIFUJI. RIKEN
BSI.
1:00 NN12 484.09 Parametric adaptation for size change
in object selective cortex. C. RACEY*; T. ANDREWS; A.
MORLAND; T. HARTLEY. Dept. of Psychology, Univ. of York.
2:00 NN13 484.10 Characterizing the topography of
category-selectivity in human ventral temporal cortex at
high field and high resolution. D. J. KRAVITZ*; S. INATI; S.
MARRETT; C. I. BAKER. NIH, Natl. Inst. of Mental Hlth.,
Natl. Inst. of Mental Hlth.
3:00 NN14 484.11 Behavioral and fMRI correlation patterns
upon repeated viewings of natural movies in the macaque.
B. E. RUSS*; D. A. LEOPOLD. NIMH/NIH.
4:00 NN15 484.12 Topographic organization of higher order
visual areas in the macaque monkey. T. JANSSENS; W.
VANDUFFEL*. Katholieke Univ. Leuven, Harvard Med. Sch.,
Martinos Ctr. for Biomed. Imaging, MGH.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

1:00 NN16 484.13 Low frequency local field potentials
in the inferior convexity of the macaque prefrontal cortex
convey visual information during anesthesia. B. CROCKER;
V. KAPOOR; S. PANZERI; N. K. LOGOTHETIS; F.
PANAGIOTAROPOULOS*. Max Planck Inst. for Biol.
Cybernetics, Italian Inst. of Technol., Univ. of Manchester,
Univ. of Manchester, Max Planck Inst.
2:00 NN17 484.14 Quantitative topographic correlation
between myelo-architecture and cyto-architecture in the
fusiform gyrus of the human brain. N. M. SCHENKER*; C. G.
SHEH; H. BARTSCH; J. ANNESE. UC San Diego, UC San
Diego.
3:00 NN18 484.15 White matter connectivity of the human
superior temporal sulcus using diffusion imaging. J. A.
PYLES*; T. D. VERSTYNEN; W. SCHNEIDER; M. J. TARR.
Carnegie Mellon Univ., Univ. of Pittsburgh.
4:00 NN19 484.16 Organization of multisynaptic top-down
pathways from frontal cortex to visual areas MT and V4 in
macaques. T. NINOMIYA*; H. SAWAMURA; K. INOUE; M.
TAKADA. Kyoto Univ., Tokyo Metropolitan Inst. for Neurosci.,
The Univ. of Tokyo.
1:00 NN20 484.17 • Connections to the extrastriate area
V5/MT from MST in the rhesus macaque. B. AHMED*; P. M.
CORDERY; A. J. PARKER; D. MCLELLAND; W. BAIR; K.
KRUG. Univ. of Oxford.
POSTER
485. Visual Processing of Surfaces, Shapes, and Objects
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 NN21 485.01 Neural encoding of three-dimensional
object orientation. A. ROSENBERG*; N. J. COWAN; D. E.
ANGELAKI. Washington Univ., Johns Hopkins Univ.
2:00 NN22 485.02 A topological model for three-dimensional
spatial orientation. N. J. COWAN*; A. ROSENBERG; D. E.
ANGELAKI. Johns Hopkins Univ., Washington Univ.
3:00 NN23 485.03 Single neuron and LFP responses to
subjective shapes in area V4. M. A. COX*; M. C. SCHMID;
A. J. PETERS; R. C. SAUNDERS; D. A. LEOPOLD; A.
MAIER. Natl. Inst. of Mental Hlth., Ernst Strüngmann Inst.,
UCSD, Natl. Inst. of Mental Hlth.
4:00 NN24 485.04 Position-specific heterogeneity of
orientation pooling in curvature-tuned neurons of macaque
area V4. A. S. NANDY*; T. O. SHARPEE; J. H. REYNOLDS;
J. F. MITCHELL. Salk Inst., Salk Inst.
1:00 NN25 485.05 Neural representation of sequential
stages in object perception. D. SASIKUMAR; V.
STUPHORN*; C. E. CONNOR. Johns Hopkins Univ., Johns
Hopkins Univ.
2:00 NN26 485.06 3D view tuning in macaque
inferotemporal cortex. C. HUNG; C. E. CONNOR*. Johns
Hopkins Univ., Johns Hopkins Univ.
3:00 NN27 485.07 Re-examining spectral receptive fields
and shape selectivity in area V4. T. D. OLESKIW; A.
PASUPATHY; W. BAIR*. Univ. of Washington.
4:00 NN28 485.08 Selectivity for contour shape as a function
of size and position within V4 receptive fields. Y. EL-
SHAMAYLEH*; A. PASUPATHY. Univ. of Washington.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 NN29 485.09 � The Lincoln illusion: Evidence for
coarse-to-fine coding in monkey inferotemporal cortex. J. F.
KALKUS; A. P. SRIPATI; C. R. OLSON*. Univ. of Pittsburgh,
Indian Inst. of Sci., Carnegie Mellon Univ.
2:00 NN30 485.10 Making images familiar sharpens
response dynamics in monkey inferotemporal cortex. T.
MEYER*; C. R. OLSON. CNBC, Carnegie Mellon Univ.
3:00 NN31 485.11 The effect of phase-shift motion on
object-selective responses in the inferior temporal cortex:
A case study of multi-electrode recording from an awake
monkey. R. HAYASHI*. AIST, JST.
4:00 NN32 485.12 The interaction between 2D and 3D
image components in cortical response. C. CHEN*. Natl.
Taiwan Univ.
1:00 NN33 485.13 Contralateral preference and categorical
preference in visual object processing areas. Y. SUNG*;
U. CHOI; S. CHOI; Y. KIM; Z. CHO; S. OGAWA. Kansei
Fukushi Res. Institute, Tohoku Fukushi Univ., Neurosci. Res.
Institute, Gachon Univ. of Med. and Sci.
2:00 NN34 485.14 A common neural representation of object
categories in fusiform, not LOC. R. XU*; Z. ZHEN. Tsinghua
Univ., State Key Lab. of Cognitive Neurosci. and Learning,
Beijing Normal Univ.
3:00 NN35 485.15 Response enhancement and suppression
act together to encode cognitive context in perirhinal cortex
during object search. M. PAGAN*; L. S. URBAN; M. P.
WOHL; N. C. RUST. Univ. of Pennsylvania.
4:00 NN36 485.16 Cortical regions activated by surface
gloss in the macaque visual cortex localized using fMRI.
G. OKAZAWA*; N. GODA; H. KOMATSU. Natl. Inst. for
Physiological Sci., The Grad. Univ. for Advanced Studies
(SOKENDAI), Japan Society for the Promotion of Sci.
1:00 OO1 485.17 Neural selectivity and representation of
gloss in the monkey inferior temporal cortex. A. NISHIO*; N.
GODA; H. KOMATSU. Natl. Inst. For Physiological Sci., The
Grad. Univ. for Advanced Studies (SOKENDAI).
2:00 OO2 485.18 Relationship between neuronal activities
in the macaque inferior temporal cortex and perceptual
gloss space. H. KOMATSU*; A. NISHIO; N. GODA. Natl.
Inst. Physiol Sci., The Grad. Univ. for Advanced Studies
(SOKENDAI).
3:00 OO3 485.19 Consistency of visual response properties
of cells in awake and anesthetized macaque inferior
temporal cortex. N. KATSUMATA*; N. MIYAKAWA; M.
TANIFUJI. RIKEN Brain Sci. Inst., Niigata Univ.
4:00 OO4 485.20 The contributions of visual cortices to the
feature binding. T. CHIANG*; C. KAO; C. CHEN; J. CHEN;
K. LIANG; C. HSIEH; Y. HUANG. Natl. Chung Cheng Univ.,
Natl. Taiwan Univ., Natl. Taiwan Univ.
1:00 OO5 485.21 Decoding object identity and location
from the ventral and dorsal streams using functional
magnetic resonance imaging and multi-voxel pattern
analysis. D. M. MCCORRY*; E. A. HUSSEY; B. L.
FALCONE; W. D. MILLER; J. C. THOMPSON. George
Mason Univ., George Mason Univ.
2:00 OO6 485.22 Functional convergence of form and
position information in object-selective visual cortex. S. P.
MACEVOY*; Z. YANG. Boston Col., Boston Col.
Neuroscience 2011 | Monday PM | 133
Mon. PM

3:00 OO7 485.23 Characterizing responses of translationinvariant
neurons to natural stimuli: Maximally informative
invariant dimensions. R. J. ROWEKAMP; T. O. SHARPEE*;
M. EICKENBERG; M. KOUH. The Salk Inst. for Biol. Studies,
The Salk Inst. For Biol. Studies, Ecole Normale Supérieure
de Cachan, Drew Univ.
4:00 OO8 485.24 A hierarchical model of peripheral vision.
L. ISIK*; J. Z. LEIBO; S. LEE; J. MUTCH; T. POGGIO. MIT,
MIT.
1:00 OO9 485.25 Phenomenology and stochastic model of
emergent recognition of objects hidden in degraded images.
T. MURATA*; T. SHIMOKAWA; M. TANIFUJI; T. HAMADA; T.
YANAGIDA. Natl. Inst. Info Comm Tech., RIKEN, Brain Sci.
Inst., Grad. Sch. Front. Biosci., Osaka Univ.
2:00 OO10 485.26 Stimulus repetition changes
synchronization of neural responses within macaque inferior
temporal cortex. D. KALIUKHOVICH*; R. VOGELS. Catholic
Univ. of Leuven, Katholieke Univ. Leuven.
POSTER
486. Visual Processing of Special Objects: Words, Tools,
Bodies, and Scenes
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 OO11 486.01 Position-sensitivity in the VWFA
measured using fMRI pattern-classification and intracranial
recordings in humans. A. M. RAUSCHECKER*; R. F.
BOWEN; J. PARVIZI; B. A. WANDELL. Stanford Univ.,
Stanford Univ., Stanford Univ.
2:00 OO12 486.02 Ventral occipito-temporal circuits for
word form recognition elucidated using subdural electrode
recordings in humans. J. PARVIZI*; B. WANDELL; A.
RAUSCHECKER. Stanford Univ., Stanford Univ., Stanford
Univ.
3:00 OO13 486.03 A visual number form area in the inferior
temporal cortex. J. SHUM*; M. DASTJERDI; B. L. FOSTER;
J. PARVIZI. Stanford Univ.
4:00 OO14 486.04 Evidence that orthography, not phonology
determines selectivity in the occipitotemporal cortex. L. S.
GLEZER*; X. JIANG; M. RIESENHUBER. Georgetown Univ.
1:00 OO15 486.05 Contextualizing words. E. M. AMINOFF*;
D. CLEWETT; S. FREEMAN; S. T. GRAFTON; M. B.
MILLER. Univ. of California, Santa Barbara.
2:00 OO16 486.06 Tool-specific information in the human
intraparietal sulcus. R. E. MRUCZEK*; I. VON LOGA; S.
SHARIAT TORBAGHAN; S. KASTNER. Princeton Univ.,
Princeton Univ., Princeton Univ.
3:00 OO17 486.07 Semantic relationships in the toolselective
network revealed by formal concept analysis. R.
ADAM*; D. ENDRES; M. A. GIESE; U. NOPPENEY. Max
Planck Inst. for Biol. Cybernetics, Univ. Clin. Tuebingen
and Hertie Inst. for Clin. Brain Res. and Ctr. for Integrative
Neurosci.
4:00 OO18 486.08 Body-selective single cell responses in
the macaque middle superior temporal sulcus body patch
defined by fMRI. I. D. POPIVANOV*; J. JASTORFF; W.
VANDUFFEL; R. VOGELS. KU Leuven, MGH Martinos Ctr.,
Harvard Med. Sch.
134 | Society for Neuroscience
1:00 OO19 486.09 Psychophysiological responses to
acupuncture needle stimulation during modification of body
ownerships induced by the Rubber Hand Illusion. Y. CHAE*;
D. CHANG; Y. KIM; H. LEE. Kyung Hee Univ., Korea Univ.,
Kyung Hee Univ., Kyung Hee Univ.
2:00 OO20 486.10 Integration of form and motion cues
for the processing of biological actions in the monkey
STS. J. JASTORFF*; I. D. POPIVANOV; R. VOGELS; W.
VANDUFFEL; G. A. ORBAN. KU Leuven, Med. Sch., MGH
Martinos Ctr., Harvard Med. Sch., Univ. di Parma.
3:00 OO21 486.11 Competition between biological and
tool motion during overlapping, but not spatially separated
presentation. K. A. SIEMBIEDA; A. SAFFORD; J. C.
THOMPSON*. George Mason Univ., George Mason Univ.,
George Mason Univ.
4:00 OO22 486.12 Biological motion in the first, second, and
third order motion scheme. S. THEUSNER; M. H. E. DE
LUSSANET; M. LAPPE*. Inst. of Psychology.
1:00 OO23 486.13 Dynamic causal modeling of the
attentional modulation of neural responses to biological
motion. A. SAFFORD*; K. A. SIEMBIEDA; J. C.
THOMPSON. George Mason Univ., George Mason Univ.,
George Mason Univ.
2:00 OO24 486.14 The human extrastriate body area:
Selective body responses in human MT/V5 proper. S.
FERRI; H. KOLSTER; J. JASTORFF; G. A. ORBAN*. Univ.
di Parma, Katholieke Univ. Leuven.
3:00 OO25 486.15 The role of transverse occipital sulcus in
scene perception and its relationship to object individuation
in inferior intraparietal sulcus. K. BETTENCOURT*; J. CANT;
Y. XU. Harvard Univ.
4:00 OO26 486.16 A hierarchical model of perspectiveinvariant
scene identification. E. Y. KO*; J. Z. LEIBO; T.
POGGIO. MIT.
1:00 OO27 486.17 Responses of the macaque
occipitotemporal place area to systematically varied scene
stimuli. X. CHENG*; S. KORNBLITH; D. Y. TSAO. Caltech, MIT.
2:00 OO28 486.18 Electrophysiological recordings and
combined fMRI and microstimulation in the macaque
occipitotemporal place area. S. KORNBLITH*; X. CHENG;
D. Y. TSAO. MIT, Caltech.
3:00 OO29 486.19 Identifying patterns of neural activity
during visual category processing in young and old adults
with Multi-Block Barycentric Discriminant Analysis. J. R.
RIECK; D. F. BEATON; A. KRISHNAN; H. ABDI; D. C.
PARK*. Ctr. for Vital Longevity, Univ. of Texas at Dallas, Univ.
of Texas At Dallas.
4:00 OO30 486.20 A new multi-factor framework for
parcellating regions in human high-level visual cortex. K. S.
WEINER*; K. GRILL-SPECTOR. Stanford Univ.
POSTER
487. Face Processing in Extrastriate Cortex
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 OO31 487.01 Face-, place- and object-selective
regions differ in the relative influence of stimulus class
preference and eccentricity. N. WITTHOFT*; G. GOLARAI;
M. NGUYEN; A. LIBERMAN; K. GRILL-SPECTOR. Stanford
Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

2:00 OO32 487.02 Representation of Face Familiarity in AM.
S. MOELLER*; D. Y. TSAO. Caltech.
3:00 OO33 487.03 Representation of faces defined
by moving dots in the macaque monkey. Y. LIN*; N.
SCHWEERS; S. SHIMOJO; D. Y. TSAO. Caltech.
4:00 OO34 487.04 TMS to the occipital face area affects
recognition but not categorization of faces. C. R. MULLIN*;
L. SOLOMON-HARRIS; J. K. E. STEEVES. York Univ., York
Univ.
1:00 OO35 487.05 Heterogeneous response distribution in
face-selective areas to lateralized visual stimulus: A 7T fMRI
study. U. CHOI; Y. SUNG; S. CHOI; Y. KIM; S. OGAWA*; Z.
CHO. Neurosci. research institute, Gachon Univ. of Med. and
Sci., Touhoku Fukushi Univ.
2:00 OO36 487.06 Representation of multiple stimuli by
face selective neurons in the macaque temporal lobe. A. F.
EBIHARA*; D. Y. TSAO; W. A. FREIWALD. The Rockefeller
Univ., Caltech.
3:00 PP1 487.07 Holistic face processing in the human
brain: Evidence for perceptual and decisional sources of
the composite face effect. R. J. VON DER HEIDE*; M. J.
WENGER; J. L. BITTNER; D. FITOUSI. Temple Univ., Univ.
of Oklahoma, Indiana Univ., Duke NUS.
4:00 PP2 487.08 Nonlinear interactions among face parts
in facial-expression adaptation. H. XU*; P. LIU; N. QIAN.
Nanyang Technological Univ., Columbia Univ.
1:00 PP3 487.09 Neural representations of personally
familiar and unfamiliar faces in the anterior inferior temporal
cortex of monkeys. S. EIFUKU*; W. C. DE SOUZA; R.
NAKATA; T. ONO; R. TAMURA. Univ. Toyama, Grad Sch.
Med. Pharm Sci.
2:00 PP4 487.10 Is the monkey middle face patch a
module for face detection? P. L. APARICIO*; J. J. DICARLO.
MIT.
3:00 PP5 487.11 Decoding face gender information from
ECoG is fast and distributed when face is in low spatial
frequency profile. Z. LIU*; R. WU. Inst. Biophysics, CAS.
4:00 PP6 487.12 Hierarchical organization of faceselective
regions in macaque cortex as revealed by fMRI
and pharmacological deactivation. N. LIU*; K. B. JONES;
F. HADJ-BOUZIANE; J. N. TURCHI; R. B. H. TOOTELL;
L. G. UNGERLEIDER. Natl. Inst. of Mental Health, Natl.
Inst. of Hlth., Natl. Inst. of Mental Health, Natl. Inst. of Hlth.,
Massachusetts Gen. Hospital, Harvard Med. Sch.
1:00 PP7 487.13 Exploring face space in the human brain.
X. GAO*; H. R. WILSON. York Univ.
2:00 PP8 487.14 Dynamic faces: fMRI reveals timeline
specific responses to facial expression changes. M. REINL*;
A. BARTELS. Ctr. For Integrative Neurosci., Max Planck Inst.
for Biol. Cybernetics.
3:00 PP9 487.15 How macaques view familiar and
unfamiliar faces: The importance of internal features and
ears. T. K. LEONARD*; G. BLUMENTHAL; K. L. HOFFMAN.
York Univ.
4:00 PP10 487.16 Comparison of human face and object
responsive visual areas mapped by spin-echo and gradientecho
fMRI. T. T. TANSKANEN*; R. A. WAGGONER; K.
UENO; K. TANAKA; K. CHENG. RIKEN Brain Sci. Inst.,
RIKEN Brain Sci. Inst.
1:00 PP11 487.17 Implicit learning of face prototypes
defined by geometric information. H. R. WILSON*; C. OR; F.
WILKINSON. York Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 PP12 487.18 Person knowledge affects face
representations in ventral temporal cortex. S. C. VEROSKY*;
N. B. TURK-BROWNE; A. TODOROV. Princeton Univ.
3:00 PP13 487.19 Selective recovery from blindness
resulting from post-traumatic cerebral blindness. A. B.
MORLAND*; A. GOUWS; E. H. SILSON; J. RODGERS; H.
BASELER; A. W. YOUNG; T. J. ANDREWS; S. HICKMAN.
Univ. of York, Univ. of York, Royal Hallamshire Hosp.
4:00 PP14 487.20 The representation of dynamic facial
expressions in the monkey frontal lobe. Q. ZHU*; K.
NELISSEN; G. ORBAN; W. VANDUFFEL. Lab. For Neuro-
and Psychofysiology, K.U. Leuven, Massachusetts Gen.
Hospital, Harvard Med. Sch.
1:00 PP15 487.21 Neural basis of categorical processing for
human facial expressions. H. YANG*; B. GUO; M. MENG.
Dartmouth Col., Chongqing Univ.
2:00 PP16 487.22 Evidence for modulation of FFA’s
responses by the age of face stimuli in children. G.
GOLARAI*; A. LIBERMAN; K. GRILL-SPECTOR. Stanford
Univ.
3:00 PP17 487.23 Does image contrast modulate brain
activity in the fusiform face area and parahippocampal
place area? B. GUO*; H. YANG; M. MENG. Dartmouth Col.,
Chongqing Univ., Dartmouth Col.
4:00 PP18 487.24 A computational model reveals that
the face domain of macaque inferotemporal cortex (IT)
represents multiple visual features. T. OWAKI*; M. VIDAL-
NAQUET; T. SATO; H. CATEAU; S. ULLMAN; M. TANIFUJI.
TOYOTA CENTRAL R&D LABS., INC., RIKEN BTCC,
RIKEN BSI, Weizmann Inst.
POSTER
488. Visual Learning and Categorization
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 PP19 488.01 Cognitive control signals in perceptual
decision making. M. C. STUTTGEN*; D. LENGERSDORF;
O. GUNTURKUN. Ruhr-Universität Bochum.
2:00 PP20 488.02 Deep generative model of the where-what
pathways in the primate visual cortex. Z. JI; G. T. KENYON*;
S. BRUMBY; L. M. A. BETTENCOURT; J. S. GEORGE. Los
Alamos Natl. Lab., Los Alamos Natl. Lab., Los Alamos Natl.
Lab., Los Alamos Natl. Lab.
3:00 PP21 488.03 Perceptual learning transfers to untrained
retinal locations after double training: A piggybacking effect.
C. YU*; R. WANG; J. ZHANG; D. LEVI; S. KLEIN. Beijing
Normal Univ., UC Berkeley.
4:00 PP22 488.04 Flexible context-dependent behavior
requires synaptic plasticity of feedback projections from
decision neurons. T. A. ENGEL*; X. WANG. Yale Univ.
1:00 PP23 488.05 Interactions between spatial and
non-spatial encoding in parietal cortex during visual
categorization. C. A. RISHEL*; G. HUANG; D. J.
FREEDMAN. Univ. of Chicago.
2:00 PP24 488.06 Effects of resting state on network
processing during perceptual learning. S. L. EAGLEMAN*; V.
DRAGOI. Neurobio. and Anat., Univ. of Texas-Houston Med.
Sch.
Neuroscience 2011 | Monday PM | 135
Mon. PM

3:00 PP25 488.07 Neural correlates of perceptual learning
of contrasts discrimination in macaque area V1 and V4. M.
SANAYEI*; X. CHEN; A. THIELE. Inst. of Neurosci.
4:00 PP26 488.08 Synchronous activity in areas V1 and
V4 during a delayed match to sample task. M. HU*; A. R.
ANDREI; V. DRAGOI. Univ. Texas-Houston, Med. Sch.
1:00 PP27 488.09 Classic visual discrimination deficits in
rhesus monkeys with intact visual perceptual categorization
following bilateral removals of anterior inferior temporal
cortex. N. MATSUMOTO*; R. C. SAUNDERS; B. J.
RICHMOND. AIST, NIH.
2:00 PP28 488.10 � Coarse object similarity accounts for
rapid visual categorization. K. MOHAN; A. P. SRIPATI*.
Indian Inst. of Sci. Educ. and Res., Indian Inst. of Sci.
3:00 QQ1 488.11 Dynamics of feedback-driven visual
learning in MEG. Y. XU*; C. D’LAURO; J. PYLES; R. E.
KASS; M. J. TARR. Carnegie Mellon Univ., Carnegie Mellon
Univ., Carnegie Mellon Univ., Carnegie Mellon Univ.
4:00 QQ2 488.12 Video game training improves vision in
adults with bilateral deprivation amblyopia. T. L. LEWIS*; D.
MAURER; S. T. JEON. McMaster Univ., The Hosp. for Sick
Children.
1:00 QQ3 488.13 Inhibitory modulation to non-target
stimulus disrupts visual perceptual learning of target stimulus
: A fMRI study. Y. YOTSUMOTO*. Keio Univ., KEIO-RIKEN
Res. Ctr. for Human Cognition.
2:00 QQ4 488.14 A statistical model of scene
categorization. Z. YANG*. Georgia Hlth. Sci. Univ.
3:00 QQ5 488.15 Practicing coarse orientation
discrimination improves orientation signals in a macaque
cortical sensory area. H. ZIVARI ADAB*; R. VOGELS. Lab.
Voor Neuro- En Psychofysiologie, K.U.Leuven Med. Sch.
4:00 QQ6 488.16 Lightweight liquid crystal-goggles for
pigeons. T. OTTO; Q. XIAO; B. OTTO; O. GUNTURKUN*.
Ruhr-Universitat Bochum.
1:00 QQ7 488.17 Direction selectivity in primate parietal
cortex during visual motion matching. A. SARMA*; D. J.
FREEDMAN. Univ. of Chicago.
2:00 QQ8 488.18 Mathematical formalism describing neural
activity patterns used by the brain for categorization and
object identification. B. HORWITZ*. NIDCD, NIH.
3:00 QQ9 488.19 Comparing the representation of novel
and familiar stimuli in prefrontal and inferior temporal
cortices. J. L. MCKEE*; S. L. THOMAS; D. J. FREEDMAN.
Univ. of Chicago, Univ. of Chicago.
4:00 QQ10 488.20 Linear and non-linear visual short-term
memory decay in rhesus monkeys. J. H. WITTIG*, Jr.; B. J.
RICHMOND. NIMH.
1:00 QQ11 488.21 Day to day stability of visual responses
in monkey inferotemporal cortex. O. A. AFUWAPE*; D.
B. T. MCMAHON; I. V. BONDAR; D. A. LEOPOLD. Natl.
Inst. of Mental Hlth., Inst. of Higher Nervous Activity and
Neurophysiol.
2:00 QQ12 488.22 • Rapid learning in visual cortical
networks. Y. WANG*; V. DRAGOI. UT medical school at
Houston.
136 | Society for Neuroscience
POSTER
489. Eye Movements: Saccades
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 QQ13 489.01 Tricking the brain into high gear -
behavioral and neural readout of motor preparation. N. J.
GANDHI*; U. K. JAGADISAN. Univ. of Pittsburgh, Univ. of
Pittsburgh.
2:00 QQ14 489.02 A long-memory model of motor learning:
Control of predictive-saccade amplitudes. A. L. WONG*;
M. SHELHAMER. Johns Hopkins Univ. Sch. Med., Johns
Hopkins Univ. Sch. Med.
3:00 QQ15 489.03 Express saccades in the macaque
evoked by s-cone visual stimuli. N. J. HALL*; C. L. COLBY.
Univ. Pittsburgh.
4:00 QQ16 489.04 Mediation of ocular flutter in guinea
pigs by acetylcholine receptor desensitization following
nerve agent exposure. P. WILLIAMS*; K. FINNERAN; R. R.
RITACCO; C. J. HILMAS, MD/PhD. USAMRICD.
1:00 QQ17 489.05 Superior colliculus activity related to
saccade and reach target selection. R. M. MCPEEK*; J.
SONG. SUNY Optometry, Brown Univ.
2:00 QQ18 489.06 A dynamic characterization of
microsaccades and their control during 3-dimensional
viewing. M. VAN HORN*; K. CULLEN. McGill Univ., McGill
Univ.
3:00 QQ19 489.07 Are targets tracked across saccades by
a cross-correlation mechanism? J. P. HERMAN; A. CONTI;
J. WALLMAN*. City Coll, City Univ. New York, Ludwig-
Maximilians-Universitaet.
4:00 QQ20 489.08 Rate of reward determines human
saccade velocities. T. REPPERT*; A. HAITH; R.
SHADMEHR. Johns Hopkins Univ.
1:00 QQ21 489.09 Tracking eye position noninvasively:
Comparison of scleral search coil and infrared optical
tracking techniques recorded simultaneously. D. MAMMO*;
D. L. KIMMEL; W. T. NEWSOME. Stanford Univ.
2:00 QQ22 489.10 Shared velocity feedback for saccades
and smooth pursuit: A control system explanation for eye
movement abnormalities in SCA3. A. Z. ZIVOTOFSKY*; A.
CASPI; L. GANTZ; C. GORDON. Bar Ilan Univ., Shamoon
Col. of Engin., Bar Ilan Univ., Meir Med. Ctr., Tel Aviv Univ.
3:00 QQ23 489.11 Express saccade without V1. M.
YOSHIDA*; T. ISA. Natl. Inst. Physiol Sci., Grad. Univ. Adv.
Stud.
4:00 QQ24 489.12 Measurements of saccadic eye
movement representations in human superior colliculus
using fMRI. S. KATYAL*; E. LUTHER; D. RESS. The Univ. of
Texas At Austin.
1:00 QQ25 489.13 Visual and motor components of local
field potential responses in macaque superior colliculus. J.
CHURAN*; D. GUITTON; C. C. PACK. McGill Univ.
2:00 QQ26 489.14 A foveally-shifted representation of space
prior to microsaccades. Z. M. HAFED*; A. ZAIDI. Werner
Reichardt Ctr. For Integrative Neurosci.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 QQ27 489.15 Visual and motor receptive fields in the
superior colliculus during head-unrestrained gaze shifts. M.
SADEH*; H. WANG; G. P. KEITH; J. D. CRAWFORD. Ctr. for
Vision Research, York Univ., Dept. of Kinesiology and Hlth.
Science, York Univ., Neurosci. Grad. Diploma Program,York
Universiy, Canadian Action and Perception Network,
Dept. of Psychology, York Univ., Neurosci. Grad. Diploma
Program,York Univ.
4:00 QQ28 489.16 A mathematical model for the generation
of fixational eye movements and microsaccades. R.
ENGBERT*; P. SINN; K. MERGENTHALER; A. PIKOVSKY.
Univ. of Potsdam, Tech. Univ. of Berlin, Univ. of Potsdam.
1:00 QQ29 489.17 Re-referencing of saccadic eye
movements and modifications of spatial properties at and
around the PRL in people with AMD. S. T. L. CHUNG*; J.
BERNARD; G. KUMAR; A. S. NANDY; B. S. TJAN. Univ. of
California, Berkeley, The Salk Inst., USC.
POSTER
490. Eye Movements: Pursuit and Vergence
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 QQ30 490.01 Flocculus target neurons are specifically
tuned to eye acceleration during smooth pursuit. M.
JOSHUA*; S. G. LISBERGER. UCSF.
2:00 QQ31 490.02 A winner-take-all model of decision-rule
interpretation by the supplementary eye field. S. RAY*; S. J.
HEINEN. The Smith-Kettlewell Eye Res. Inst.
3:00 QQ32 490.03 Women with PMS show unilateral bias
in horizontal smooth pursuit eye movements during their
late luteal (low estradiol) menstrual cycle phase. M. F.
WESNER*; M. A. RICHARDS. Lakehead Univ.
4:00 QQ33 490.04 Influence of smooth pursuit adaptation on
visual sensitivity of neurons in cortical area MSTI. S. ONO*;
M. J. MUSTARI. Univ. of Washington.
1:00 QQ34 490.05 • Responsiveness of neurons in area V4
during smooth pursuit eye movements. J. HUESERS*; A.
KAMINIARZ; F. BREMMER. Neurophysics Dept.
2:00 QQ35 490.06 Saccades induced by target masking
during two-dimensional predictive visual tracking. J.
MARUTA*; J. GHAJAR. Brain Trauma Fndn., Weill Cornell
Med. Col.
3:00 QQ36 490.07 Anticipatory eye velocity is diminished
with a large random-dot pursuit stimulus. S. J. HEINEN*; Z.
JIN; S. N. J. WATAMANIUK. Smith-Kettlewell Eye Res. Inst.,
Univ. of Electronic Sci. and Technol. of China, Wright State
Univ.
4:00 RR1 490.08 Predictive pursuit eye movements
are degraded with frontotemporal lobar degeneration. S.
COPPE*; J. ORBAN DE XIVRY; D. YUKSEL; A. IVANOIU;
P. LEFEVRE. Univ. catholique de Louvain, ICTEAM,
Univ. catholique de Louvain, Inst. of Neuroscience, Univ.
catholique de Louvain, Ophthalmology Department,
Cliniques Universitaires Saint-Luc, Dept. of Neurology,
Cliniques Universitaires Saint-Luc.
1:00 RR2 490.09 A dynamical model of midbrain vergence
cells. L. C. CORTHELL; K. P. SCHULTZ; C. BUSETTINI*.
Univ. Alabama Birmingham.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 RR3 490.10 Birth-onset vs delayed-onset infantile
strabismus in macaque monkeys: Fusional vergence and
stereopsis. L. TYCHSEN; P. E. FOELLER*; D. BRADLEY.
Washington Univ. Sch. Med., Yerkes Regional Primate Res.
Ctr.
POSTER
491. Vestibular System: Central Physiology and Anatomy
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 RR4 491.01 Neural variability eliminates phaselocking
and enables linear rate coding by vestibular nuclei
neurons in vivo. A. D. SCHNEIDER*; M. J. CHACRON; K. E.
CULLEN. McGill Univ.
2:00 RR5 491.02 Central projections of vestibular lagena
otolith afferents in pigeons. Z. H. MRIDHA*; V. KHORYEVIN;
J. D. DICKMAN. Washington Univ., Bogomolets Inst. of
Physiol.
3:00 RR6 491.03 Visualization of vestibular neurons
activated by sinusoidal galvanic vestibular stimulation. G.
P. MARTINELLI*; B. COHEN; V. L. FRIEDRICH, Jr.; G. R.
HOLSTEIN. Mount Sinai Med. Ctr., Mount Sinai Sch. Med.
4:00 RR7 491.04 Modeling vestibular control of vaso-vagal
responses (VVR). T. RAPHAN*; Y. XIANG; M. KUNIN; D.
OGORODNIKOV; B. COHEN; G. P. MARTINELLI; S. B.
YAKUSHIN. Brooklyn Col. of the City Univ. of New York, Mt.
Sinai Sch. of Med.
1:00 RR8 491.05 Visualization of neurotransmitters and
modulators in vestibular neurons activated by sinusoidal
galvanic vestibular stimulation. G. R. HOLSTEIN*; B.
COHEN; V. L. FRIEDRICH, Jr.; G. P. MARTINELLI. Mount
Sinai Sch. Med., Mount Sinai Sch. Med.
2:00 RR9 491.06 Expression of a neuronal migratory
protein in unipolar brush cells of the adult rat dorsal cochlear
nucleus, paraflocculus, and flocculus. N. A. PAOLONE*; S.
MANOHAR; S. H. HAYES; J. S. BAIZER; R. J. SALVI. Univ.
at Buffalo.
3:00 RR10 491.07 Changes in presynaptic and postsynaptic
GABAB receptors in vestibular nuclei neurons during early
vestibular compensation. M. SHAO; R. REDDAWAY; J. C.
HIRSCH; K. D. PEUSNER*. George Washington Univ. Med.
Ctr., George Washington Univ. Med. Ctr.
4:00 RR11 491.08 Learning in the neural circuit that
underlies the cancellation of vestibular reafference: Evidence
for a rapid updating of internal models in the vestibular
cerebellum. J. X. BROOKS*; J. CARRIOT; K. E. CULLEN.
McGill Univ.
1:00 RR12 491.09 • Subthreshold galvanic vestibular
stimulation modulates ongoing human brain rhythms. D. J.
KIM*; V. YOGENDRAKUMAR; J. CHIANG; E. TY; Z. WANG;
M. M. K. OISHI; M. J. MCKEOWN. Univ. of British Columbia,
Univ. of British Columbia, Univ. of British Columbia.
2:00 RR13 491.10 Firing rates of head direction cells are
different between when moving and when motionless. M. E.
SHINDER*; J. S. TAUBE. Dartmouth, Dartmouth.
3:00 RR14 491.11 Vestibulomotor pathways in the cervical
spinal cord investigated with calcium imaging in the neonatal
mouse. F. M. LAMBERT*; N. KASUMACIC; M. PERREAULT;
J. GLOVER. Dpt of Physiology, Inst. of Basic Med. Sciences,
Univ. of Oslo.
Neuroscience 2011 | Monday PM | 137
Mon. PM

4:00 RR15 491.12 VO neurons selectively encode passive
movements during complex stimuli. J. CARRIOT*; J. X.
BROOKS; M. JAMALI; K. E. CULLEN. McGill Univ.
1:00 RR16 491.13 Organization of vestibulo-parabrachioamygdaloid
connections in rats. C. D. BALABAN*; W. GAO.
Univ. Pittsburgh.
POSTER
492. Pain Transduction: Non-TRP Channels
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 RR17 492.01 Inhibiton of acid-sensing ion channel 1b
by zinc. X. CHU*; Q. JIANG; C. J. PAPASIAN; J. WANG;
Z. XIONG. Univ. Missouri-Kansas City, Morehouse Sch. of
Med.
2:00 RR18 492.02 Modus operandi of calcium-activated
chloride channel TMEM16A in nociceptive sensory
neurones. X. L. JIN; H. ZHANG; N. GAMPER*. Univ. Leeds,
Hebei Med. Univ., Univ. Leeds.
3:00 RR19 492.03 Anoctamin1 acts as a polymodal sensor
in nociceptive neurons. H. CHO*; H. CHUN; Y. YANG; J.
LEE; S. BACK; H. NA; U. OH. Seoul national Univ. Col. of
Pharm., Sensory Res. Ctr., Grad. Sch. of Convergence Sci.
and Technol., Korea Univ., 1Sensory Res. Ctr.
4:00 RR20 492.04 Blockade of action potential propagation
by GABA(A) receptor activation in rat dorsal root ganglion
neurons. J. YAGI*; Y. KOBAYASHI; E. W. MCCLESKEY; N.
HIRAI. Kyorin Univ. Sch. Med., Natl. Def. Med. Col., Howard
Hughes Med. Inst.
1:00 RR21 492.05 Tissue-selective knockout of
NMDA receptors in nociceptive afferents abolishes
peripheral sensitization to NMDA receptor agonists. J. A.
MCROBERTS*; S. JAGANNATHAN; H. S. ENNES; J. C. G.
MARVIZON; E. A. MAYER; M. FANSELOW; J. N. WOOD; B.
VISSEL. David Geffen Sch. Med. UCLA, David Geffen Sch.
Med. UCLA, Univ. Col. London, Garvan Inst. Med. Res.
2:00 RR22 492.06 TRESK is a mechanosensitive channel
in mammalian sensory neurons. G. CALLEJO; X. GASULL*.
Univ. Barcelona, Med. Sch.
3:00 RR23 492.07 Blockade of P2X 3 /P2X 2/3 receptors
attenuates spontaneous and evoked activity of spinal
neurons in inflamed rats. J. XU*; K. L. CHU; M. F. JARVIS;
S. MCGARAUGHTY. Abbott Labs.
4:00 RR24 492.08 Sensitization of T-type calcium channels
by prostaglandin E2 via the EP4 receptor/cyclic AMP/
protein kinase A pathway: A possible mechanism for
mechanical hyperalgesia. D. KANAOKA*; F. SEKIGUCHI;
M. NAKAGAWA; Y. AOKI; Y. NISHIMOTO; S. YOSHIDA; M.
MATSUNAMI; A. KAWABATA. Kinki Univ. Sch. of Pharm.
Divison of Pharmacol. & Pathophysiology, Kinki Univ. Sch. of
Sci. and Engineering, Dept. of Life Sci.
1:00 RR25 492.09 Hypoalgesic behaviors and calcium
channel currents in dorsal root ganglion neurons of P/Q-type
voltage-gated calcium channel mutant mouse, rolling mouse
Nagoya. N. KITAMURA*; N. FUKUMOTO; Y. OBAMA; K.
NIIMI; E. TAKAHASHI; C. ITAKURA; I. SHIBUYA. Dept.
of Vet. Physiology, Fac. of Agriculture, Tottori Univ., Res.
Resources Center, RIKEN Brain Sci. Inst.
138 | Society for Neuroscience
2:00 RR26 492.10 Inhibition of voltage-gated Na+ currents
in sensory neurons by the sea anemone toxin APETx2. M.
BLANCHARD*; L. D. RASH; S. KELLENBERGER. Univ. of
Lausanne, The Univ. of Queensland.
3:00 RR27 492.11 Neuroprotective role of ASIC2a during
acidosis and ischemia. I. DAOU*; A. ASE; P. SEGUELA.
Montreal Neurolog. Institute, McGill Univ.
POSTER
493. Opioid Receptor Pharmacology and Signaling
Mechanisms
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 RR28 493.01 Mu and kappa opioid receptor activation
required for changes in SDF1/CXCR4 signaling in opioidinduced
hypernociception. N. M. WILSON*; M. S. RIPSCH;
F. A. WHITE. Loyola Univ. of Chicago, Indiana Univ. Sch. of
Med.
2:00 RR29 493.02 Increased functional expression of
TLR4 following repeated morphine treatment contributes to
opioid-induced hyperalgesia. M. R. DUE*; N. M. WILSON;
P. F. FELDMAN; M. S. RIPSCH; S. CHAVEZ; H. YIN; F. A.
WHITE. Indiana Univ. Sch. of Med., Loyola Univ. of Chicago,
Univ. of Colorado at Boulder.
3:00 RR30 493.03 � C-Jun N-terminal kinase contributes
to the expression of morphine tolerance following repeated
microinjections into the periaqueductal gray of the rat. R. A.
HASEMAN; S. L. INGRAM; M. M. MORGAN*. Washington
State Univ.
4:00 RR31 493.04 Involvement of the cannabinoid system in
the peripheral and spinal antinociceptive effects of morphine.
J. DESROCHES*; J. BOUCHARD; L. GENDRON; P.
BEAULIEU. Univ. de Montreal, Univ. de Montreal, Univ. de
Sherbrooke, Univ. de Montreal.
1:00 RR32 493.05 Activation of spinal Mu and Delta opioid
receptors potently inhibits substance P release induced by
peripheral noxious stimuli. H. BEAUDRY*; D. DUBOIS; L.
GENDRON. Univ. Sherbrooke, Inst. de pharmacologie de
Sherbrooke.
2:00 RR33 493.06 Selective kappa opioid receptor
antagonists induce long-term suppression of ERK 1/2
MAP kinase signaling in kappa opioid receptor transfected
HEK293 cells. M. R. HOOT*; K. RASAKHAM; J. P.
MCLAUGHLIN. Torrey Pines Inst. For Mol. Studies, Temple
Univ.
3:00 RR34 493.07 Opioids inhibit action potentials in rat
dorsal root ganglion neurons without μ-opioid receptor
activation. K. MIZUTA*; T. FUJITA; C. JIANG; H. YUE; M.
INOUE; L. YANG; S. UEMURA; H. KAWASAKI; T. YASAKA;
E. KUMAMOTO. Dept. of Physiology, Fac. of Medicine, Saga
Univ., JSPS Res. Fellow.
4:00 RR35 493.08 Delta opioid receptor (DOR) and kappa
opioid receptor (KOR) heteromer signaling in peripheral
sensory neurons. B. A. MCGUIRE; W. P. CLARKE; K. A.
BERG*. Univ. Texas Hlth. Sci. Ctr.
1:00 RR36 493.09 Sex-related differences in antinociception
produced by a mixed-action κ opioid agonist, pentazocine,
in the rat. D. L. ROBINSON*, JR; S. NAG; S. S. MOKHA.
Meharry Med. Col.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

2:00 SS1 493.10 Antinociceptive effects of
docosahexaenoic acid via activation of the opioidergic
systems. T. NISHINAKA; K. MATUMOTO; K. NAKAMOTO;
A. AMBO; M. MANKURA; S. TOKUYAMA*. Kobe Gakuin
Univ. Library Yakugaku, Tohoku Pharmaceut. Univ., Ikeda
Tohka Industries Co., Ltd.
3:00 SS2 493.11 Characterization of novel enkephalin
analogs as delta opioid receptor agonists. K. ROCHON*;
A. PROTEAU-GAGNE; P. BOURASSA; G. LANGLOIS; J.
NADON; Y. DORY; L. GENDRON. Univ. De Sherbrooke,
Univ. De Sherbrooke.
4:00 SS3 493.12 Prolonged treatment with the inverse
agonist, naloxone, produces functional competence of mu
and delta opioid receptors in peripheral sensory neurons. K.
A. BERG; L. C. SCARLOTA; W. P. CLARKE*. Univ. Texas
Hlth. Sci. Ctr.
1:00 SS4 493.13 Time course of inflammatory mediatorinduced
functional competence of delta opioid receptors
(DOR) in peripheral sensory neurons. L. C. SCARLOTA*; K.
A. BERG; W. P. CLARKE. Univ. of Texas Hlth. Sci. Ctr.
POSTER
494. Visceral Pain-GI
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 SS5 494.01 P2X receptors activate spinal cord
microglia in rats with chronic visceral hypersensitivity. J.
WANG*; C. SAAB; E. D. AL-CHAER. Univ. Arkansas for
Med. Sci., Rhode Island Hosp.
2:00 SS6 494.02 A role for TRPV4 in colon inflammationinduced
visceral hypersensitivity. M. R. WATTS*; C. GU; J. L.
WATTS; E. D. AL-CHAER. Univ. of Arkansas For Med. Sci.
3:00 SS7 494.03 Minocycline alters neuronal plasticity in
rats with colon inflammation. J. L. WATTS*; K. YADLAPALLI;
A. M. HAYAR; E. D. AL-CHAER. Univ. of Arkansas For Med.
Sci.
4:00 SS8 494.04 • Effect of estrogen receptor beta
activation on the response of dorsal horn neurons to
colorectal distention. D. CAO; Y. JI; B. TANG; R. J. TRAUB*.
Univ. Maryland Dent. Sch.
1:00 SS9 494.05 • Changes in glutamate recycling in
lumbar DRGs in a rat model of stress-induced visceral
hyperalgesia. S. BRADESI*; H. ENNES; V. GOLOVATSCKA;
E. MAYER. UCLA Ctr. for Neurobio. of stress.
2:00 SS10 494.06 TRPV1 and P2X3 are important
mediators of mechanotransduction and sensitization in
colorectal primary afferents. M. E. KIYATKIN*; B. FENG; G.
F. GEBHART. Univ. of Pittsburgh, Sch. of Med.
3:00 SS11 494.07 Intracolonic hypertonicity with mild acidity
sensitizes mechanically-insensitive visceral afferents and
induces persistent colorectal hypersensitivity in the mouse.
J. LA*; B. FENG; E. S. SCHWARTZ; G. F. GEBHART. Ctr.
For Pain Research, Univ. Pittsburgh.
4:00 SS12 494.08 Role of alpha7 nicotinic acetylcholine
receptor in a murine dextran sulfate sodium-induced colitis
model. S. ALSHARARI*; H. AKBARALI; I. DAMAJ. VCU.
1:00 SS13 494.09 Reactive gliosis in colitis. B. W.
LEBLANC*; N. CHAI; E. D. AL-CHAER; C. SAAB. Rhode
Island Hosp., Univ. of Arkansas For Med. Sci., Alpert Med.
Sch. at Brown Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 SS14 494.10 Gut microbiota are essential for
visceral nociception in male mice. M. TRAMULLAS*; P.
FITZGERALD; F. SHANAHAN; T. G. DINNAN; J. F. CRYAN.
Alimentary Pharmabiotic Ctr., Sch. of Pharm., Dept. of
Psychiatry, Dept. of Pharmacol. & Therapeut.
3:00 SS15 494.11 • Characterization of the effects
of different drug classes in normal and intracolonic
hypersensitized rats in the colorectal distension model. L.
YANG*; J. KENNEDY; D. MORROW. Eli Lilly and company.
4:00 SS16 494.12 Cathepsin s is activated during colitis
and causes visceral hyperalgesia by a protease-activated
receptor 2-dependent mechanism in mice. F. CATTARUZZA;
V. LYO; E. JONES; D. PHAM; J. HAWKINS; K. KIRKWOOD;
M. BOGYO; N. W. BUNNETT*. UCSF, UCSF, Stanford Univ.
Sch. of Med., UCSF.
1:00 SS17 494.13 Vitamin D receptor expression is highly
correlated with TRPV1 in sensory neurons innervating the
distal colon. A. N. PIERCE; B. R. HASSAN; J. M. RYALS; J.
A. CHRISTIANSON*. Univ. of Kansas Med. Ctr.
2:00 SS18 494.14 Gene expression of inflammatory
biomarkers in ibs differs in male and female patients. A. Y.
DEL VALLE-PINERO*; B. L. MAJORS; A. C. MARTINO; N.
S. PATEL; W. A. HENDERSON. NIH.
3:00 SS19 494.15 • Effect of spinal hyperpolarizationactivated,cyclic
nucleotide-gated cation channel subunit 1
and 2 ion channels on rats with chronic viseral pain. C. LIN*;
D. LU. Fujian Med. Univ., Fujian Med. Univ.
4:00 SS20 494.16 Rat pericardium contains vesicular
glutamate transporter, glutaminase, aspartate
aminotransferase immunoreactive nerve fibers. T. WANG*;
R. D. FOREMAN; K. E. MILLER. Oklahoma State Univ. Ctr.
For Hlth. Sci., Univ. of Oklahoma Hlth. Sci. Ctr.
1:00 SS21 494.17 Functional brain activation during retrieval
of visceral pain-conditioned passive avoidance in the rat. D.
P. HOLSCHNEIDER*; Z. WANG; R. D. PANG; J. I. MAAREK;
S. BRADESI; E. A. MAYER. USC, VA GLA Healthcare Syst.,
USC, USC, USC, Univ. of California.
2:00 SS22 494.18 Visceral hypersensitivity following
unpredictable early life trauma persists throughout life in a
rodent model. A. S. CHALONER*; B. GREENWOOD-VAN
MEERVELD. Univ. of Oklahoma Hlth. Sci. Ctr., Oklahoma
City Veterans Affairs Med. Ctr., Univ. of Oklahoma Hlth. Sci.
Ctr., Univ. of Oklahoma Hlth. Sci. Ctr.
3:00 SS23 494.19 Synergistic antagonism of TRPV1 and
TRPA1 reduces afferent excitability and inflammation in the
progression of chronic pancreatitis. E. S. SCHWARTZ*; J.
LA; B. M. DAVIS; K. M. ALBERS; G. F. GEBHART. Univ. of
Pittsburgh, Univ. of Pittsburgh.
4:00 SS24 494.20 GRM2 KO rats do not develop
mechanical hypersensitive in an alcohol- and high fat dietinduced
model of pancreatitis. S. L. MCILWRATH*; K. N.
WESTLUND. Univ. of Kentucky.
Neuroscience 2011 | Monday PM | 139
Mon. PM

POSTER
495. Somatosensory: Functional Organization
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 SS25 495.01 Comparative morphometric analysis of
cortico-cortical ipsilateral and callosal axonal terminals from
the primary somatosensory area (S1) of rats. C. P. BAHIA*;
A. DE SÁ; V. C. CORREIA; W. GOMES-LEAL; A. PEREIRA
JR. Univ. Federal Do Pará, Univ. Federal Do Pará, Inst.
Internacional de Neurociências.
2:00 SS26 495.02 Discrimination of electrical stimulation
in the primate somatosensory cortex. C. K. PIERCE*; S. I.
HELMS TILLERY. Arizona State Univ., Arizona State Univ.
3:00 SS27 495.03 An fMRI video animation time-course
analysis of brain regions activated during self-stimulation
to orgasm in women. B. R. KOMISARUK*; N. WISE; E.
FRANGOS; W. BIRBANO; K. ALLEN. Rutgers, The State
Univ. of New Jersey.
4:00 SS28 495.04 Estimating the number of neurons and
temporal scale of integration in somatosensory perception.
A. WOHRER*; R. ROMO; C. MACHENS. ENS, Lab. de
Neurosciences Cognitives, Inst. of Cell. Physiol. of the Natl.
Autonomous Univ. of Mexico (UNAM).
1:00 SS29 495.05 Thermal navigation in larval zebrafish.
D. ROBSON*; J. M. LI; F. ENGERT; A. F. SCHIER. Harvard
Univ.
2:00 SS30 495.06 Genetic dissection of the circuits
underlying active modulation of tactile exploration. S.
PAPAIOANNOU; S. AUER; I. IBANEZ-TALLON; P.
KRIEGER*. Karolinska Inst., Max-Delbrück-Center for Mol.
Med.
3:00 SS31 495.07 Comparison of acute stimulation
selectivity of transverse and longitudinal intrafascicular
electrodes in pigs. A. KUNDU*; K. R. HARREBY; M.
KURSTJENS; T. BORETIUS; T. STIEGLITZ; K. YOSHIDA;
W. JENSEN. Aalborg Univ., Albert-Ludwigs Univ., Indiana
University-Purdue Univ. Indianapolis.
4:00 SS32 495.08 Sub-sensory mechanical noise input to
ankle tendons improves movement detection. R. PAXTON*;
B. L. TRACY; A. M. GROSSMAN; A. A. AMIN; J. L. UPHOFF;
S. K. ANAST. Colorado State Univ.
1:00 TT1 495.09 Late EEG potentials evoked by pleasant
tactile stimulation of human hairy skin from preferential
activation of unmyelinated tactile (CT) afferents. R.
ACKERLEY*; E. ERIKSSON; J. WESSBERG. Univ. of
Gothenburg.
2:00 TT2 495.10 • Characterizing the neural response to
sensory stimuli in the human brain and spinal cord using
fMRI. R. BOSMA*; P. STROMAN. Queen’s Univ.
3:00 TT3 495.11 Between hemisphere correlation analysis
along motor strip reveals minimal symmetry in hand area.
P. GUILLOD; S. INATI; P. BANDETTINI*. NIMH/NIH/DHHS,
NIMH-NIH.
4:00 TT4 495.12 Stability and plasticity of cortical
representations during learning. D. HUBER*; S. PERON; D.
GUTNISKY; L. TIAN; L. LOOGER; K. SVOBODA. Janelia
Farm Res. Campus, Howard Hughes Med. Inst.
140 | Society for Neuroscience
1:00 TT5 495.13 Influence of direct inputs from motor
cortex on neuronal excitability and sensory processing
in primary somatosensory cortex. E. ZAGHA*; R. N.
SACHDEV; M. J. MCGINLEY; D. A. MCCORMICK. Yale Sch.
of Med.
2:00 TT6 495.14 Chronic imaging of cortical sensory
maps using a genetically encoded calcium indicator. M.
MINDERER; W. LIU; S. KÜGLER; F. HELMCHEN; D. J.
MARGOLIS*. Univ. Zurich, Univ. Med. Göttingen.
3:00 TT7 495.15 Flow cytometry and molecular
characterization of mouse primary sensory neurons. I. M.
CHIU*; C. VON HEHN; E. JACOBS; N. BARTENEVA; T.
MANIATIS; C. J. WOOLF. Children’s Hosp., Harvard Med.
Sch., Columbia Univ. Med. Ctr.
4:00 TT8 495.16 Differences in inhibitory neurons across
rat’s primary sensory areas: Morphological variability as
revealed by morphometry. M. A. FREIRE*; J. FABER; C. W.
PICANCO-DINIZ; J. G. FRANCA; A. PEREIRA. Edmond
and Lily Safra Intl. Inst. of Neurosci. of Natal, Univ. Potiguar,
Fndn. Nanosciences and Clinatec/LETI/CEA, Federal Univ.
of Para, Federal Univ. of Rio de Janeiro, Federal Univ. of Rio
Grande do Norte.
1:00 TT9 495.17 Single-unit responses in somatosensory
cortex to precision grip of textured surfaces. S. N. NAUFEL*;
V. J. SANTOS; S. HELMS TILLERY. Arizona State Univ.,
Arizona State Univ., Arizona State Univ.
2:00 TT10 495.18 Frequency-dependant brain activity
during somatosensory stimulation in α-chloralose
anesthetized rats: A comparison using quantitative
2-deoxyglucose autoradiography and functional magnetic
resonance imaging. D. CASH*; C. SIMMONS; A. C.
EASTON; D. J. LYTHGOE; A. DIXON; S. C. R. WILLIAMS;
M. M. BERNANOS. King’s Col. London, King’s Col. London.
3:00 TT11 495.19 Primary motor cortex excitability is
modulated by tactile adaptation in primary somatosensory
cortex. L. TAMÈ; F. PAVANI; C. BRAUN; R. SALEMME; A.
FARNE*; K. REILLY. INSERM U1028, CNRS UMR5292,
Lyon 1 Univ., Ctr. for Mind/Brain Sciences, Univ. of Trento,
MEG-Zentrum, Univ. Tübingen, INSERM 1028, CNRS 5292,
Ucbl1.
4:00 TT12 495.20 How does the spontaneous cortical
activity change with training on a reward task? R. N.
SACHDEV*; M. WOLFEL; Y. YU; M. J. MCGINLEY; D.
MCCORMICK. Yale Univ. Sch. of Med., Yale Univ. Sch. of
Med.
1:00 TT13 495.21 Intrinsic signal optical imaging following
electrical microstimulation reveals specific intracortical
circuitry within somatosensory cortex. A. BROCK*; R.
M. FRIEDMAN; R. H. FAN; A. W. ROE. Vanderbilt Univ.,
Vanderbilt Univ.
2:00 TT14 495.22 Neural computation via neural geometry:
A place code for inter-whisker timing in the barrel cortex?
S. P. WILSON*; J. A. BEDNAR; T. J. PRESCOTT; B.
MITCHINSON. Univ. of Sheffield, Univ. of Edibnurgh.
3:00 TT15 495.23 Evaluation of the stimulation selectivity
of transverse intrafascicular multichannel electrodes in
the chronic Göttingen mini-pig - preliminary results. K. R.
HARREBY*; A. KUNDU; T. BORETIUS; T. STIEGLITZ; K.
YOSHIDA; W. JENSEN. Aalborg Univ., Albert-Ludwigs Univ.,
Indiana University-Purdue Univ. Indianapolis.
4:00 TT16 495.24 Basal forebrain activity during a
tactile discrimination task. E. E. THOMSON*; J. LOU; A.
MCDONOUGH; M. NICOLELIS. Duke Univ., Duke Univ.,
Duke Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

POSTER
496. Thalamocortical Processes
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 TT17 496.01 Long-range excitatory circuits in vibrissal
motor cortex. B. M. HOOKS*; T. MAO; D. KUSEFOGLU;
G. M. G. SHEPHERD; K. SVOBODA. HHMI, Northwestern
Univ. Feinberg Sch. of Med., Oregon Hlth. and Sci. Univ.
2:00 TT18 496.02 Enhanced genetically-encoded probes for
voltage imaging. T. KNOPFEL*; A. PERRON; H. MUTOH; Y.
IWAMOTO; W. AKEMANN. Brain Sci. Inst, RIKEN.
3:00 TT19 496.03 Optogenetic investigation of
glutamatergic inputs and GABAergic outputs of thalamic
reticular nucleus neurons. T. ZOLNIK*; B. W. CONNORS.
Brown Univ.
4:00 TT20 496.04 Comparison of fMRI BOLD responses
and c-fos activations by electrical stimulation of the
ventroposterior complex and medial thalamus of the rat. P.
YANG*; J. CHEN; Y. CHEN; R. CHEN; C. YEN. Natl. Taiwan
Univ., Natl. Yang-Ming Univ., Natl. Taiwan Univ., Natl. Taiwan
Univ.
1:00 TT21 496.05 Cellular and network mechanisms
underlying sensory evoked gamma oscillations. T.
BESSAIH*; M. J. HIGLEY; D. CONTRERAS. Univ. of
Pennsylvania, Sch. of Med., Yale university.
2:00 TT22 496.06 Thalamocortical connections onto
neurons in infragranular cortical layers in vivo. C. M.
CONSTANTINOPLE; R. M. BRUNO*. Columbia Univ.
3:00 TT23 496.07 Properties of the thalamic projection
from the posterior medial nucleus to primary and secondary
somatosensory cortices in the mouse. I. PETROF*; A. N.
VIAENE; S. M. SHERMAN. Univ. Chicago.
4:00 TT24 496.08 Self-generated vibrissa motion and touch
are differentially represented throughout ventral posterior
medial thalamus in awake, head-fixed rats. J. D. MOORE*;
M. DESCHENES; D. KLEINFELD. Univ. California San
Diego, Laval Unisity, Univ. of California San Diego.
1:00 TT25 496.09 Modeling the spatiotemporal local-field
potential footprint of unitary thalamocortical inputs to sensory
cortex. E. HAGEN*; J. C. FOSSUM; K. H. PETTERSEN; J.
M. ALONSO; H. A. SWADLOW; G. T. EINEVOLL. Norwegian
Univ. of Life Sciences, UMB, SUNY Col. of Optometry, Univ.
of Connecticut.
2:00 TT26 496.10 Active dendritic processing in layer-4
neurons of the rat barrel cortex. M. LAVZIN; S. RAPOPORT;
L. GARION; J. SCHILLER*. Technion.
3:00 TT27 496.11 Diversity of thalamocortical short-term
plasticity elicited by complex stimulation. F. J. MARTINI*;
M. DÍAZ-QUESADA; I. BUREAU; M. MARAVALL. Inst. de
Neurociencias de Alicante (UMH-CSIC), INSERM, U901
Inst. de Neurobiologie de la Méditerranée.
4:00 TT28 496.12 Basal activity of the paraventricular
nucleus during electrical stimulation of a mammary nerve
from rats at different reproductive stages. M. A. LARA
GARCIA*; O. LARA GARCIA; A. TOVAR; A. CORTÉS-SOL;
M. ALVARADO; P. PACHECO. Univ. Veracruzana, Univ.
Veracruzana, Univ. Nacional Autónoma de México.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 UU1 496.13 The role of thalamus and thalamocortical
coupling in brain arousal from hypoxic-ischemic injury. D.
WU*; W. XIONG; R. GEOCADIN; N. V. THAKOR. Johns
Hopkins Univ., Johns Hopkins Univ. Sch. of Med., Johns
Hopkins Univ. Sch. of Med.
POSTER
497. Motor Pattern Generation: Neuromodulation I
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 UU2 497.01 Influence of spinal cord injury induced
serotonin transporter reduction on serotonin responsiveness
in V2a interneurons. A. HUSCH*; R. M. HARRIS-WARRICK.
Cornell Univ.
2:00 UU3 497.02 Immunohistochemical quantification
of serotonergic receptors and calcium channels in the
sublesional mouse spinal cord after spinal cord injury. G.
VAN PATTEN*; R. M. HARRIS-WARRICK. Cornell Univ.
3:00 UU4 497.03 Differences in serotonin responsiveness
in mouse spinal V2a interneurons using perforated patch
and whole cell recording techniques. S. DIETZ*; A. HUSCH;
R. M. HARRIS-WARRICK. Cornell Univ.
4:00 UU5 497.04 Contribution of astrocyte to rhythmic
neuronal firing in the masticatory CPG. P. C. MORQUETTE*;
D. VERDIER; I. ARSENAULT; A. PHILIPPE; R. ROBITAILLE;
A. KOLTA. Univ. De Montreal.
1:00 UU6 497.05 Nitric oxide regulation of spontaneous
locomotor rhythm generation in the isolated nervous system
of Xenopus laevis tadpoles. K. T. SILLAR*; N. W. SCOTT; S.
P. CURRIE. Univ. St Andrews.
2:00 UU7 497.06 Endogenous neuropeptide facilitates INap
pacemakers and acts on low respiratory frequency. A. DOI*;
J. M. RAMIREZ. Children’s Res. Inst., Univ. Washington.
3:00 UU8 497.07 � Cellular effects of caffeine on
mammalian locomotor function. M. S. RIVERA-OLIVER;
L. R. MARRERO-CORDERO; M. E. DIAZ-RIOS*.
Interamerican Univ., Univ. of Puerto Rico-Rio Piedras, Univ.
Puerto Rico.
4:00 UU9 497.08 Dopamine exerts activation dependent
modulation of spinal locomotor circuits in the mouse. J. M.
HUMPHREYS*; P. J. WHELAN. Hotchkiss Brain Inst.
1:00 UU10 497.09 The dopaminergic diencephalospinal tract
mediates the developmental switch in the locomotor pattern
of larval zebrafish. A. M. LAMBERT*; J. L. BONKOWSKY; M.
A. MASINO. Univ. of Minnesota- Twin Cities, Univ. of Utah.
2:00 UU11 497.10 Prenatal exposure to fluoxetine reduces
the expression of KCC2 and increases spontaneous activity
in lumbar spinal networks in mice. A. STIL; L. VINAY; J.
VIEMARI*. CNRS.
3:00 UU12 497.11 A modulatory role for the NMDA receptor
glycine binding site during fictive locomotion in Xenopus
laevis larvae. E. R. BJORNFORS; H. ZHANG*; K. T.
SILLAR. Univ. of St. Andrews.
4:00 UU13 497.12 Serotonin preferentially depresses
presynaptic inhibition of contralateral primary afferents
in the isolated rat spinal cord. I. A. SPEIGEL*; J.
SHRECKENGOST; S. HOCHMAN. Emory Univ., Emory
Univ.
Neuroscience 2011 | Monday PM | 141
Mon. PM

1:00 UU14 497.13 Segment-specific dopamine metamodulation
of the monosynaptic stretch reflex in the spinal
cord. T. L. JOHNSON*; S. CLEMENS. East Carolina Univ.
Brody Sch. of Med.
2:00 UU15 497.14 Modulation of neck muscle activities
during cortically induced rhythmic jaw movements by
stimulation of the medial vestibular nucleus in rats. Y.
SATOH*; E. YAJIMA; Y. NAGAMINE; K. ISHIZUKA; T.
MURAKAMI. The Nippon Dent. Univ., The Nippon Dent.
Univ.
3:00 UU16 497.15 Chronic and acute intermitted hypoxia
differentially alters the responsiveness of the respiratory
network to neuromodulators under in vitro and in vivo
condition. J. RAMIREZ*; A. DOI; S. ZANELLA; F. P. ELSEN;
H. KOCH; A. GARCIA, III. Univ. Washington, Seattle
Childrens Res. Inst., Univ. Paul Cezanne.
4:00 UU17 497.16 Substance P reduces calcium current
in lamprey spinal motor neurons and interneurons. C. T.
PEREZ*; R. H. HILL; S. GRILLNER. Karolinska Inst.
POSTER
498. Posture and Gait: Fatigue and Disease
Theme D: Sensory and Motor Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 UU18 498.01 Difference in gait variability caused
by peripheral arterial disease persist after accounting
for the effect of reduced blood flow. S. A. MYERS*; J. M.
JOHANNING; I. I. PIPINOS; N. STERGIOU. Univ. Nebraska,
Omaha, Univ. of Nebraska Med. Ctr., Veterans Affairs Med.
Ctr. of Nebraska and Western Iowa, Univ. of Nebraska Med.
Ctr.
2:00 UU19 498.02 Effects of static and dynamic ankle
fatiguing exercises on postural control. E. J. BISSON*; A.
REMAUD; S. BOYAS; Y. LAJOIE; M. BILODEAU. Univ. of
Ottawa, Élisabeth Bruyère Res. Inst., Univ. of Ottawa.
3:00 UU20 498.03 Fatigue and cognitive dysfunction
following chemotherapy in early breast cancer patients. V.
SIEMIONOW*; H. C. MOORE; K. KISIEL-SAJEWICZ; A.
WYANT; G. H. YUE. The Cleveland Clin., The Cleveland
Clin., Univ. Sch. of Physical Educ.
4:00 UU21 498.04 Effects of plantar flexor muscle fatigue
on postural control and the associated attentional demand
during a postural tracking task. A. REMAUD*; C. THUONG-
CONG; M. BILODEAU. Elisabeth Bruyere Res. Inst., Univ. of
Ottawa, Univ. of Ottawa.
1:00 UU22 498.05 Postural sway and lower limb joint angle
changes associated with ankle plantarflexors fatigue. M.
HAJJ; M. BILODEAU; S. BOYAS*. Univ. of Ottawa, Univ. of
Ottawa, Élisabeth Bruyère Res. Inst.
2:00 UU23 498.06 Brain activation in patients with cancerrelated
fatigue is abnormal during prolonged motor task. Y.
FANG*; S. ROELLE; G. YUE. Lerner Res. Inst., Cleveland
Clin., Univ. of Toledo.
3:00 UU24 498.07 Effects of 3d cable-driven robotic one
session training on overground walking in children with
cerebral palsy. M. WU*; J. M. LANDRY; D. GAEBLER-
SPIRA; Y. ZHANG. Northwestern Univ., Rehabil. Inst. of
Chicago.
142 | Society for Neuroscience
4:00 UU25 498.08 Effect of fatigue recovery of trunk
extensor muscles on postural control. R. A. DA SILVA JR*;
R. B. PARREIRA; L. RABELLO; D. C. TEIXEIRA; E. J.
BISSON; M. BILODEAU. Univ. Norte Do Paraná (UNOPAR),
Univ. Estadual de Londrina, Univ. Norte do Paraná, Univ.
Estadual de Londrina, Univ. of Ottawa, Univ. of Ottawa.
1:00 UU26 498.09 Predictors of ultimate gait impairment
in sci subjects being trained with a robotic gait orthosis
(lokomat). M. M. MIRBAGHERI*; X. NIU; C. PATEL; D.
VAROQUI. Northwestern Univ., Rehab Inst. Chicago.
2:00 UU27 498.10 The effects of a robotic-assisted
locomotor (lokomat) training on impaired voluntary
movement of lower extremity in spinal cord injury. D.
VAROQUI*; C. PATEL; X. NIU; M. MIRBAGHERI. Rehab
Inst. Chicago, Northwestern Univ.
3:00 UU28 498.11 The effect of benzodiazepine use
on postural control in physically independent elderly. D.
R. FERREIRA*; J. P. M. SANTOS; M. C. BOER; V. A.
COELHO; D. C. SANTOS; V. S. PROBST; R. A. DA SILVA;
K. B. P. FERNANDES. Univ. Norte do Paraná - UNOPAR,
Univ. Norte do Paraná – UNOPAR, Univ. Norte do Paraná –
UNOPAR, Univ. Estadual de Londrina.
4:00 UU29 498.12 • � Impact of trunk muscle fatigue
on postural control in young adults and older subjects. R.
B. PARREIRA*; M. C. BOER; L. RABELLO; A. W. GIL;
D. C. TEIXEIRA; E. J. BISSON; M. BILODEAU; R. A. DA
SILVA JR. Univ. Norte do paraná, Univ. Norte do Paraná,
Univ. Norte do Paraná, Univ. Estadual de Londrina, Univ.
of Ottawa, Univ. of Ottawa, Univ. Norte do Paraná, Univ.
Estadual de Londrina.
1:00 UU30 498.13 • Influence of ankle plantarflexor
fatiguing exercise intensity on postural control. S. BOYAS;
A. REMAUD; E. RIVERS; M. BILODEAU*. Univ. of Ottawa,
Élisabeth Bruyère Res. Inst., Univ. of Ottawa.
2:00 UU31 498.14 • Instrumented measures detect mobilityspecific
changes after different exercise intervention better
than clinical scales. L. KING; M. MANCINI; A. SALARIAN; K.
PRIEST; J. G. NUTT; F. B. HORAK*. OHSU.
3:00 UU32 498.15 Acute kinematic and physiologic changes
during walking pre and post radiofrequency denervation of
the zygapophysial joint. J. ROPER*; E. L. STEGEMOLLER;
D. J. KENNEDY; C. J. HASS. Univ. of Florida.
4:00 UU33 498.16 Differential joint activation post clinical
medication change in Parkinson’s disease. F. RAHIMI*; C.
BEE; M. JOG; A. SOUTH; J. DANEAULT; R. EDWARDS;
M. SPEECHLEY; P. BOISSY; M. JOG; C. DUVAL. London
Hlth. Sci. Centre, Univ. of Western Ontario, Univ. de Quebec
a Montreal, Univ. of Victoria, Univ. of Western Ontario, Univ.
de Sherbrooke, Univ. of Western Ontario, Univ. de Quebec a
Montreal.
POSTER
499. Hormonal, Genetic, and Epigenetic Factors
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 UU34 499.01 Sexual differentiation of the neurokinin B
system in the human infundibular nucleus: Developmental
and hormonal aspects. M. TAZIAUX*; D. F. SWAAB; J.
BAKKER. Netherlands Inst. For Neurosci., Netherlands Inst.
for Neurosci.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

2:00 UU35 499.02 Astrocytes are sexually dimorphic
for number but not arbor complexity in the juvenile
medial posterodorsal amygdala. R. T. JOHNSON*; M.
BREEDLOVE; C. L. JORDAN. Michigan State Univ.
3:00 UU36 499.03 Biometrical genetic analysis of digit
ratio in male and female mice. D. B. MCQUADE*; B.
POSSIDENTE; E. STANSKY; P. SHEEHAN; N. SAHAGIAN.
Skidmore Col.
4:00 VV1 499.04 Ontogeny of androgen receptor
expression in SNB motoneurons and their perineal target
muscles in male mice. M. R. SMITH*; D. K. HAMSON; J. E.
POORT; C. L. JORDAN; S. M. BREEDLOVE. Michigan State
Univ.
1:00 VV2 499.05 Identification of novel sexually dimorphic
genes in the developing mouse cortex and hippocampus.
C. ARMOSKUS; C. DONOVAN; H. TSAI*. California State
University, Long Beach.
2:00 VV3 499.06 Progesterone receptor and sex
differences in serotinergic innervation of the medial
preoptic nucleus. D. LALITSASIVIMOL; L. A. BECK; J.
JACOBSKIND; J. WILLING; C. K. WAGNER*. Univ. Albany,
Univ. Colorado, Denver, Univ. Albany.
3:00 VV4 499.07 Estradiol-induced phosphorilation of
cofilin cascade and the establishment of the male-phenotype
of the sexually dimorphic nucleus of the rat preoptic area.
Y. WADA-KIYAMA; C. SUZUKI; T. HAMADA; R. KIYAMA;
Y. SAKUMA*. Nippon Med. Sch., Natl. Inst. of Advanced
Industrial Sci. and Technol.
4:00 VV5 499.08 Neural sex differences before and after
gonadal differentiation: Hormones versus sex chromosomes.
J. T. WOLSTENHOLME*; S. BEKIRANOV; E. F. RISSMAN.
Univ. of Virginia.
1:00 VV6 499.09 Participation of sex chromosome
complement in the dimorphic expression of embryonic
brain aromatase. C. D. CISTERNAS*; X. E. CAEIRO; F.
R. MIR; M. J. SCERBO; L. M. GARCÍA-SEGURA; M. J.
CAMBIASSO. Inst. de Investigación Médica Mercedes y
Martín Ferreyra. INIMEC-CONICET, Inst. Cajal, CSIC.
2:00 VV7 499.10 Knockdown of Foxp2 in newborn rat
pups alters ultrasonic vocalizations, maternal retrieval and
social play. M. BOWERS*; M. R. PÉREZ-POUCHOULÉN;
M. M. MCCARTHY. Univ. of Maryland, Baltimore, Univ.
Veracruzana.
3:00 VV8 499.11 Do microglia mediate sexual
differentiation of the preoptic area and behavior? K. M.
LENZ*; B. M. NUGENT; M. M. MCCARTHY. Univ. of
Maryland Sch. of Med.
4:00 VV9 499.12 The default female brain requires active
repression of masculinization via epigenetic mechanisms. B.
M. NUGENT*; M. M. MCCARTHY. Univ. of Maryland, Sch. of
Med., Univ. of Maryland, Sch. of Med.
1:00 VV10 499.13 The role of epigenetic mechanisms in
the sexual differentiation of AVPV/PeN Kiss1 neurons. S. J.
SEMAAN*; S. DHAMIJA; J. KIM; A. S. KAUFFMAN. UC San
Diego.
2:00 VV11 499.14 Genome-wide epigenetic profiling of
H3K4me3 histone modifications in the BNST / MPOA
of adult male and female mice. N. G. FORGER*; T. H.
AHERN; C. CONNER; G. J. DE VRIES; J. STRAUBHAAR;
S. AKBARIAN. Univ. of Massachusetts, Quinnipiac Univ.,
Univ. of Massachusetts, Univ. of Massachusetts, Univ. of
Massachusetts.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
3:00 VV12 499.15 Sex differences in oxytocin innervation of
the hindbrain. G. J. DE VRIES*; B. J. CHEN; B. D. ROOD;
N. ISMAIL. Univ. Massachusetts, Univ. Massachusetts,
Children’s Hosp. of Philadelphia.
4:00 VV13 499.16 A striking sex difference in estrogen
receptor alpha immunoreactivity in the mouse BNSTp due
to suppression by testicular steroids. D. A. KELLY*; M. M.
VARNUM; N. G. FORGER. Univ. of Massachusetts, Univ. of
Massachusetts.
1:00 VV14 499.17 Exposure to 2,3,7,8-tetrachlorodibenzop-dioxin
(TCDD) induces expression of CUG RNA binding
protein 2 (CUGBP2) and downstream genes important for
dendritic outgrowth and synaptogenesis in the developing
anteroventral periventricular nucleus (AVPV). J. DEL PINO;
S. L. PETERSEN*. Univ. of Massachusetts Amherst.
2:00 VV15 499.18 Neonatal Bisphenol A exposure alters
the sexually dimorphic expression of ERα ERβ and Kiss1
in the postnatal rat hypothalamus. J. CAO; S. M. LEYRER;
K. MCCAFFREY; M. RADFORD; H. B. PATISAUL*. North
Carolina State Univ.
3:00 VV16 499.19 Neonatal BPA exposure disrupts the
sexually dimorphic ontogeny of kisspeptin and RFRP-3
projections to GnRH neurons in the peripubertal female rat
hypothalamus. S. M. LOSA; K. L. TODD; K. MCCAFFREY;
L. T. JOYNER; J. L. LUBISCHER*; H. B. PATISAUL. North
Carolina State Univ., North Carolina State Univ.
4:00 VV17 499.20 Excess prenatal testosterone increases
androgen receptor expression in the female sheep brain.
M. CERNEA*; T. LEE; G. CHENG; V. PADMANABHAN;
M. LEHMAN; L. COOLEN. Univ. of Michogan, The Univ.
of Michigan, The Univ. of Western Ontario, The Univ. of
Michigan, Univ. Of Michigan, Univ. of Michigan.
1:00 VV18 499.21 � Influence of ERβ selective agonism
during the neonatal period on the sexual differentiation of
the rat hypothalamic-pituitary-gonadal (HPG) axis. K. L.
TODD; S. M. LOSA; J. A. MICKENS; K. MCCAFFREY; R. M.
GROSSFELD*; H. B. PATISAUL. North Carolina State Univ.
2:00 VV19 499.22 Critical period for estrogen-dependent
dendritic growth in a sexually dimorphic neuromuscular
system coincides with presence of estrogen receptor in the
target musculature. L. M. RUDOLPH*; D. R. SENGELAUB.
Indiana Univ.
3:00 VV20 499.23 Epigenetic effects and behavioral
consequences of low-dose in utero bisphenol A exposure.
M. KUNDAKOVIC*; K. GUDSNUK; F. P. PERERA; R. L.
MILLER; F. A. CHAMPAGNE. Columbia Univ., Columbia
Univ.
POSTER
500. HPG Axis: Hormonal and Epigenetic Regulation of
GnRH Neurons
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 VV21 500.01 • Deciphering the role of histone
deacetylases in GnRH neuronal development. S. SALIAN-
MEHTA; M. XU; T. HORN; T. MCKINSEY; M. E. WIERMAN*.
Univ. of Colorado Denver- Anschutz Med. Campus, Univ. of
Colorado Denver- Anschutz Med. Campus, Univ. of Colorado
Denver- Anshutz Med. Campus,VAMC.
Neuroscience 2011 | Monday PM | 143
Mon. PM

2:00 VV22 500.02 Sex differences in circadian control of
GnRH and GnIH in the split hamster. J. R. PAMPLIN*; M.
P. BUTLER; R. SILVER. Columbia Univ., Barnard Col.,
Columbia Univ.
3:00 VV23 500.03 Patterns of DNA (CpG) methylation of the
GnRH gene may expose different regions of genomic activity
across puberty in the male rhesus monkey hypothalamus.
J. R. KURIAN; J. A. KAPKE; E. TERASAWA*. Univ. of
Wisconsin-Madison, Univ. Wisconsin.
4:00 VV24 500.04 Effects of ovarian steroids on daily
variation of gonadotropin-releasing hormone mRNA
expression in the preoptic area of ovariectomized rats. C. M.
LEITE*; E. T. UCHOA; J. ANTUNES-RODRIGUES; L. L. K.
ELIAS; J. A. ANSELMO-FRANCI. Univ. of Sao Paulo, Univ.
of Sao Paulo.
1:00 VV25 500.05 The role of CREB in estrogen negative
feedback on GnRH neurons. A. KWAKOWSKY*; A. E.
HERBISON; I. M. ABRAHAM. Univ. of Otago.
2:00 VV26 500.06 Isotype selective estrogen receptor
agonists differentially modulate the complement C5a
receptor agonist-evoked calcium influx in gonadotropin
releasing-hormone producing GT1-7 neurons. I. FARKAS; M.
SÁRVÁRI; M. ALLER; N. OKADA; H. OKADA; Z. LIPOSITS*.
Inst. of Exptl. Medicine, Hungarian Acad., Nagoya City Univ.,
Choju Med. Inst.
3:00 VV27 500.07 Progesterone may directly inhibit GnRH-
1 neuronal activity via progesterone receptor membrane
component 1. N. M. BASHOUR*; S. WRAY. NIH/NINDS.
4:00 VV28 500.08 Role of intracellular and extracellular
sources of calcium in the rapid estrogen action in
primate GnRH neurons. B. P. KENEALY*; K. L. KEEN;
E. TERASAWA. Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison.
1:00 VV29 500.09 • Semaphorin 7A expression in
tanycytes is regulated by sex-steroid hormones and controls
gonadotropin-releasing hormone-1 (GnRH-1) cell plasticity.
J. PARKASH*; A. LOYENS; S. GALLET; E. BALLAND; F.
PRALONG; J. PASTERCAMP; V. PREVOT; P. GIACOBINI.
INSERM, Univ. Hosp. and Fac. of Biol. and Medicine, 1011
Lausanne, Rudolf Magnus Inst. of Neuroscience, Univ. Med.
Ctr.
2:00 VV30 500.10 Generation of kiss1-EGFP transgenic
medaka and neuroanatomical analysis of Kiss1 neuron
network using GFP-immunohistochemistry. S. KANDA*; H.
SHIMADA; Y. AKAZOME; K. OKUBO; Y. OKA. Dept Biol Sci,
Grad Sch. Sci, Univ. Tokyo, Grad Sch. Agr. Life Sci, Univ.
Tokyo.
3:00 VV31 500.11 Anatomical distribution of sex steroid
hormone receptors in the brain of medaka. B. ZEMPO*; S.
KANDA; K. OKUBO; Y. AKAZOME; Y. OKA. Dept Biol Sci,
Grad Sch. Sci, Univ. Tokyo, Dept Aqua Biosci, Grad Sch.
Agricult Life Sci, Univ. Tokyo.
POSTER
501. Steroids: Rapid Effects and Local Synthesis
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 VV32 501.01 A calcium requirement for rapid
glucocorticoid dependent modulation of glutamate release in
the supraoptic nucleus. C. C. HARRIS*; J. TASKER. Tulane
Univ.
144 | Society for Neuroscience
2:00 VV33 501.02 Rapid regulation by glutamate of
aromatase activity. T. D. CHARLIER*; G. F. BALL; J.
BALTHAZART. Univ. Liege, Johns Hopkins Univ.
3:00 VV34 501.03 Synaptosomal aromatase is more
rapidly inhibited by calcium dependent phosphorylations
than microsomal aromatase in the zebra finch brain. C.
A. CORNIL*; C. H. LEUNG; E. R. PLETCHER; K. C.
NARANJO; C. J. SALDANHA. Univ. Liege, Lehigh Univ.
4:00 VV35 501.04 Local inhibition of constitutive,
presynaptic aromatase in the passerine hippocampus
decreases acquisition of spatial memory. D. J. BAILEY*; C.
J. SALDANHA. St. Norbert Col., Lehigh Univ.
1:00 VV36 501.05 Rapid effects of estrogen on signaling
pathways & ERα in murine hypothalamic cells. J.
RAINVILLE*; A. Z. TUMEN; T. E. GURLEY; N. VASUDEVAN.
Tulane Univ., Tulane Univ.
2:00 VV37 501.06 Expression of GPR30/GPER, a
membrane estrogen receptor, in the visual system of
seasonally breeding male goldfish. L. A. MANGIAMELE*; N.
J. CURTIS; T. E. JOHNSON; R. R. THOMPSON. Bowdoin
Col.
3:00 VV38 501.07 Expression of the plasma-membrane
associated G-protein coupled receptor, GPR30, in the
goldfish, Carassius auratus, with special reference to the
Mauthner cell. J. WHITE*; T. SZABO-MAAS. Delaware State
Univ.
4:00 VV39 501.08 Hippocampus-synthesized estrogen and
androgen rapidly modulate LTP and dendritic spines. S.
KAWATO*; Y. HOJO; Y. OOISHI; S. HIGO; H. MUKAI. Univ.
of Tokyo.
1:00 VV40 501.09 Aromatase availability in amygdala
is positively correlated with trait constraint in women. A.
BIEGON*; N. ALIA-KLEIN; S. KIM; J. LOGAN; F. TELANG;
G. WANG; C. WONG; J. FOWLER. Brookhaven Natl. Lab.
2:00 VV41 501.10 Mating can improve cognitive
performance of male rats concomitant with midbrain
androstane neurosteroidogenesis. J. J. PARIS*; A. S.
KOHTZ; D. DACOSTA; C. A. FRYE. Univ. Albany, Robert
Wood Johnson Med. Sch.
3:00 VV42 501.11 Localization of steroid 5α-reductase
type 2 isozyme in the adult rat brain. A. CASTI; A. CASU;
P. CASTI; R. FRAU; M. BORTOLATO; S. SPIGA; M.
CASTELLI*; M. ENNAS. Dept of Neuroscience, Univ. of
Cagliari, Univ. of Cagliari, USC, Univ. of Cagliari, Univ. of
Cagliari.
POSTER
502. Hypoxia and Obstructive Sleep Apnea
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 VV43 502.01 Dexmedetomidine depresses breathing
in a rat model of metabolic syndrome. A. SAULLES;
W. FILBEY, II; H. A. BAGHDOYAN*; L. G. KOCH; S. L.
BRITTON; R. LYDIC. Univ. of Michigan.
2:00 VV44 502.02 Brief intermittent neural apneas elicit
inactivity-induced phrenic motor facilitation in rats. N. A.
BAERTSCH*; K. A. STREY; T. BAKER-HERMAN. Univ. of
Wisconsin-Madison.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 VV45 502.03 Glial-neuronal interactions in chronic
intermittent hypoxia in mice: A nuclear magnetic resonance
spectroscopy study. M. NISHINA*; M. SUZUKI; K.
MATSUSHITA; Y. KAWAMURA; K. YOSHIMURA; M.
SUZUKI; S. MASTUSHITA. Saitama Med. Univ., Saitama
Med. Univ., Ins. Inotinomizu, Saitama Med. Univ., Nihon Inst.
of Med. Sience, Saitama Med. Univ.
4:00 VV46 502.04 Kölliker-Fuse neurons send collateral
projections to multiple respiratory- and nonrespiratory-related
structures in brainstem. C. POON; G. SONG*. MIT.
1:00 VV47 502.05 Pneumotaxic neurons as possible
neural correlates of respiratory STP, STD, hypoadditive
central-peripheral chemoreflex interaction, and classical
conditioning. C. TIN*; G. SONG; C. POON. M.I.T., M.I.T.
2:00 VV48 502.06 Pneumotaxic early-expiratory neurons
mediate post-inspiratory activity and post-hypoxia decline in
respiratory frequency. G. SONG; C. TIN; C. POON*. Mass
Inst. Tech.
3:00 VV49 502.07 Lumbar spinal cord 5HT1A receptors
knockdown by siRNA inhibits respiration in anesthetized rats.
L. YANG*; Y. NING; G. SONG; C. POON. MIT.
4:00 VV50 502.08 Apnea produces hyperactive synaptic
activities in the hippocampus in in vivo rats. S. J. FUNG; M.
XI; V. LIM; D. R. BRONSON; C. L. WILSON*; M. H. CHASE.
VA Greater Los Angeles Healthcare Syst., Websciences Intl.,
UNIV OF CALIFORNIA LOS ANGELES, UCLA Sch. of Med.
1:00 VV51 502.09 • Circulatory leptin increases the
activity of neurons in the nucleus of the solitary tract (NTS)
projecting to rostral ventrolateral medulla (RVLM). J.
CIRIELLO*; J. M. MOREAU; S. A. MESSENGER; W. IQBAL;
M. J. MIGCHELS. Univ. Western Ontario, Univ. Western
Ontario.
2:00 VV52 502.10 Intermittent hypoxia and circulating levels
of leptin induce fos and pSTAT3 immunoreactivity in carotid
body. S. A. MESSENGER*; J. M. MOREAU; W. IQBAL; M. J.
MIGCHELS; J. CIRIELLO. Univ. of Western Ontario.
3:00 VV53 502.11 Abnormal neural responses to the
Valsalva maneuver in heart failure. J. A. OGREN*; P. M.
MACEY; R. KUMAR; R. M. HARPER; M. A. WOO. UCLA,
David Geffen Sch. of Med., David Geffen Sch. of Med.
4:00 VV54 502.12 Cingulum bundle axonal integrity in
obstructive sleep apnea. H. L. RICHARDSON*; P. M.
MACEY; A. MOIYADI; R. KUMAR; M. A. WOO; F. L. YAN-
GO; R. M. HARPER. Univ. of California At Los Angeles,
Univ. of California At Los Angeles, Univ. of California At Los
Angeles.
1:00 VV55 502.13 Effects of chronic intermittent hypoxia
exposure on benzodiazepine-sensitive GABAergic
modulation of the chemoreceptor reflex in the NTS in rats. M.
SUZUKI*; M. NISHINA; K. YOSHIMURA; Y. KAWAMURA; S.
NAKAMURA; M. SUZUKI. Hlth. & Med. Care, Saitama Med.
Univ., Med. Res. Center, Saitama Med. Univ., Dept Rehabil,
Nihon Inst. Med. Sci., Div. biology, Saitama Med. Univ., Div.
Anesth, JA Kumagaya Gen Hosp, Div. Lab. Animal Med,
Saitama Med. Univ.
2:00 VV56 502.14 Severe acute intermittent hypoxia
induces adenosine (not serotonin) dependent phrenic longterm
facilitation. N. L. NICHOLS*; E. A. DALE-NAGLE; G. S.
MITCHELL. Univ. Wisconsin.
3:00 VV57 502.15 The effects of drugs of abuse on k atp
channel expression in oxygen-sensitive rat chromaffin
cells: Role of hypoxia-inducible factor-2α. S. SALMAN; J.
BUTTIGIEG; S. BROWN; C. A. NURSE*. McMaster Univ.,
Krembil Neurosci. Ctr., McMaster Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 VV58 502.16 Upregulated COX-2 expression in mouse
brain during re-oxygenation after chronic moderate hypoxia.
G. F. BENDERRO; J. C. LAMANNA*. Case Western
Reserve Univ. Sch. Med., Case Western Reserve Univ. Sch.
Med.
POSTER
503. Early Life Experience: Maternal Care and Neonatal
Stress
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 VV59 503.01 Postnatal treatment with the 5-HT2
receptor antagonist ketanserin prevents the neurogenic
changes observed in the early stress model of
maternal separation. D. SURI*; K. C. VADODARIA; M.
BENEKAREDDY; V. A. VAIDYA. Tata Inst. of Fundamental
Res.
2:00 VV60 503.02 Subtle changes in prefrontal cortex
acetylcholine signaling following early life stress. E.
PROULX*; N. M. GOODFELLOW; E. K. LAMBE. Univ.
Toronto.
3:00 VV61 503.03 Early life adversity and serotonin
transporter gene variation interact to shape the adult
hypothalamo-pituitary-adrenal axis. R. V. DOELEN*; W.
DESCHAMPS; E. W. ROUBOS; J. R. HOMBERG; T. L.
KOZICZ. Radboud Univ. Nijmegen.
4:00 VV62 503.04 Epigenetic modification of the Bdnf
gene in behavioral and emotional regulatory brain regions
associated with infant-caregiver experiences. T. L. ROTH*; J.
BLAZE; K. CHEN; T. DICHIARA; S. JONES; B. RIDER. Univ.
of Delaware.
1:00 VV63 503.05 Altered maternal care and offspring
development after mild gestational stress are associated
with epigenetic regulation of brain gene expression. F.
C. ZUCCHI*; Y. YAO; Y. ILNYTSKYY; D. J. OLIVEIRA;
C. ROBERTS; O. KOVALCHUK; I. KOVALCHUK; D. M.
OLSON; G. A. METZ. Univ. Lethbridge, Univ. Alberta.
2:00 VV64 503.06 Neonatal handling affects
acetylcholinesterase activity and total thiol content in a sex
specific manner in the hippocampus of juvenile rats. C.
NOSCHANG*; R. KROLOW; D. ARCEGO; A. A. DA CUNHA;
A. G. K. FERREIRA; F. R. MACHADO; A. T. S. WYSE; C.
DALMAZ. Univ. Federal Do Rio Grande Do Sul.
3:00 VV65 503.07 Sex and sex composition of litter affect
maternal behavior and DNA methylation of the Nr3c1 and
Egr1 genes in rat offspring. T. A. KOSTEN*; W. HUANG; D.
A. NIELSEN. Baylor Col. of Med.
4:00 VV66 503.08 Genome-wide analyses of the
transgenerational impact of early life stress in mice. J.
BOHACEK*; A. INIGUEZ; G. COIRET; O. MIRANTE;
G. STEINER; C. KASHUK; K. GAPP; F. MANUELLA; J.
MOREAU; I. M. MANSUY. Brain Res. Institute, Univ. Zurich |
ETH Zurich, Roche NimbleGen Inc, Hoffmann-La Roche.
1:00 VV67 503.09 Early maternal care deprivation induces
both ethanol intake and changes on the expression of cb1
receptor in male wistar rats. A. ROMANO*, SR; M. MÉNDEZ;
O. PROSPÉRO. Univ. Nacional Autonoma De Mexico.
Neuroscience 2011 | Monday PM | 145
Mon. PM

2:00 VV68 503.10 Maternal deprivation reduces growth and
food intake and increases anxiety-like behavior in adolescent
rats: The role of Neuropeptide Y. D. SUCHECKI*; G. S. O.
WERTHEIMER; C. N. GIRARDI; B. LONGO. Univ. Federal
Sao Paulo, Univ. Federal Sao Paulo.
3:00 VV69 503.11 Epigenetic mechanisms of life-long
hypothalamic CRH repression following augmented maternal
care involve NRSF-mediated transcriptional repression
and chromatin changes. J. L. COPE*; S. MCCLELLAND;
A. KOROSI; J. YANG; A. KOH; T. Z. BARAM. Univ. of
California, Irvine, Univ. of Amsterdam, Univ. of California,
Irvine.
4:00 VV70 503.12 Neonatal maternal separation alters
methamphetamine-induced locomotor activity in a dose- and
sex-dependent manner. E. HENSLEIGH; S. LYNCH; K.
ABUALI; M. SEMMEL; L. M. PRITCHARD*. Univ. Nevada
Las Vegas.
1:00 VV71 503.13 Hippocampal estrogen receptor β is a
sensitive factor affected by early-life stress and may play a
key role in information processing and memory consolidation
in hippocampus. H. WANG; K. MEYER; V. KORZ*. Leibniz
Inst. for Neurobio., Otto Von Guericke Univ. Magdeburg, Inst.
of Biol.
2:00 VV72 503.14 Epigenetic contributions to the
transgenerational effects of maternal stress: The role of
RNA editing. I. GAISLER-SALOMON*; H. ZAIDAN; Y.
GOLUMBIC; J. FEILER; N. AMARIGLIO; M. SAFRAN; J.
SCHULKIN; G. RECHAVI; M. LESHEM. Univ. of Haifa,
Sheba Med. Ctr., Georgetown Univ.
3:00 VV73 503.15 Maternal separation causes long-lasting
effects upon concentrations of pro-inflammatory cytokines in
hippocampus of rats. L. A. DIEHL*; D. P. LAUREANO; A. N.
D. BENITZ; T. P. HENRIQUES; C. DALMAZ. Federal Univ. of
Rio Grande Do Sul, Federal Univ. of Rio Grande do Sul.
4:00 VV74 503.16 Effects of social instigation of dams upon
maternal behavior and early social behaviors of the pups.
T. P. HENRIQUES*; M. A. SOUZA; C. N. CORRÊA; M. B.
ALVES; L. A. DIEHL; C. P. VEIGA; R. M. M. DE ALMEIDA;
A. B. LUCION. Univ. Federal Do Rio Grande Do Sul, Federal
Univ. of Rio Grande do Sul, Federal Univ. of Rio Grande do
Sul, Federal Univ. of Rio Grande do Sul.
1:00 VV75 503.17 Postnatal inhibition of aromatase leads
to widespread increases in c-fos expression in response to
acute restraint stress in adult male rats. B. I. BINGHAM*;
N. WANG; V. VIAU. Unive British Columbia, Univ. of British
Columbia.
2:00 VV76 503.18 The impact of neonatal inflammatory
injury on stress-related behavior and circuits in adult male
and female rats. N. C. VICTORIA; A. Z. MURPHY*. Georgia
State Univ.
3:00 VV77 503.19 � Changes in the endocannabinoid
system and in sleep after postnatal stress in rats. N. M.
REYES PRIETO*; L. ALVARADO-CAPULEÑO; S. CAYNAS
ROJAS; M. PÉREZ MORALES; L. MOSCOSA-ORTIZ; M.
MENDEZ-DÍAZ; O. PROSPÉRO-GARCÍA. Univ. Nacional
Autonoma De México.
4:00 VV78 503.20 Early life stress alters brain corticotropin
releasing factor and serotonergic systems and a leads to the
development of a drug-seeking phenotype in adolescence.
K. E. TSCHETTER; L. B. CALLAHAN; P. J. RONAN*. USD
Sch. of Medicine/VA Res., Avera Res. Inst., Univ. South
Dakota Sch. Med.
146 | Society for Neuroscience
1:00 VV79 503.21 Neonatal stress impairs affiliative
behavior and hippocampal BDNF levels and processing in
mature Balb/CByJ mice. K. SUBEDI*; L. NAIDU; M. KOBAN;
A. AZHAGIRI; C. F. HOHMANN; C. A. PARDO. Morgan State
Univ., Johns Hopkins Univ.
POSTER
504. Stress: Nutrient Intake, Metabolism, and Exercise
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 VV80 504.01 The protective effect of exercise against
learned helplessness persists after forced cessation of
exercise. A. B. LOUGHRIDGE*; B. N. GREENWOOD; N.
C. SADAOUI; E. R. WOODRUFF; M. FLESHNER. Univ. of
Colorado.
2:00 VV81 504.02 � The role of exercise controllability
in exercise-induced stress resistance. K. SPENCE*; B.
N. GREENWOOD; D. M. CREVLING; J. M. RIGALI; M.
FLESHNER. Fleshner Lab.
3:00 VV82 504.03 5-HT2C receptors in the dorsal striatum
are a novel target for exercise-induced stress resistance. P.
V. STRONG*; A. B. LOUGHRIDGE; M. FLESHNER; B. N.
GREENWOOD. Univ. Colorado Boul.
4:00 VV83 504.04 Complex stressor exposure disrupts
homeostatic physiology and leads to long-term elevations in
heart rate. R. S. THOMPSON*; P. STRONG; T. MASLANIK;
W. CRAIG; B. N. GREENWOOD; M. FLESHNER. Univ.
Colorado Boul, Univ. of Colorado.
1:00 VV84 504.05 The effects of wheel running on auditory
fear conditioning and extinction. J. HELLWINKEL*; P. V.
STRONG; M. FLESHNER; B. N. GREENWOOD. Univ. of
Colorado.
2:00 VV85 504.06 Glucocorticoid-mediated gene expression
in ADX-CVS animal model. R. ZHANG*; J. P. HERMAN.
Childrens Hospital, Harvard Med. Sch., Univ. of Cincinnati.
3:00 VV86 504.07 Social isolation, as well as treatment with
the CB1 receptor antagonist SR 141716, markedly reduced
the anticipatory and consummatory pleasure induced by
food presentation. L. DAZZI*; M. SERRA; G. BIGGIO. Univ.
Cagliari.
4:00 VV87 504.08 The role of social isolation on an
intermittent access protocol of binge eating in rats.
A. C. BORGES*; T. B. ALBERTI; V. A. MOTTA; M. A.
PASCHOALINI. Univ. of Brasilia, Federal Univ. of Santa
Catarina, Univ. of Brasilia, Federal Univ. of Santa Catarina.
1:00 VV88 504.09 Involvement of the dorsomedial
hypothalamus in the physiological responses evoked by air
jet stress in wistar rats fed a high fat diet. R. C. MENEZES*;
A. R. R. ABREU; A. R. R. DE ABREU; L. G. B. T. SANTOS.
Federal Univ. of Ouro Preto- UFOP.
2:00 VV89 504.10 Interaction of different neurotransmitters
in the lateral parabrachial nucleus in the control of sodium
intake. M. T. FAVERO; C. G. PAVAN; L. B. DE OLIVEIRA; S.
P. BARBOSA; L. A. DE LUCA JR; D. S. A. COLOMBARI; P.
M. DE PAULA; E. COLOMBARI; J. MENANI*. UNESP.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 VV90 504.11 Prazosin injected peripherally facilitates
the effect of noradrenaline into lateral parabrachial nucleus
on sodium intake. S. GASPARINI*; J. M. GOMIDE; G. M. F.
ANDRADE-FRANZÉ; D. S. A. COLOMBARI; L. A. DE LUCA
JR; P. M. DE PAULA; T. S. MOREIRA; J. V. MENANI. São
Paulo State Univ., Univ. of São Paulo.
4:00 VV91 504.12 Pituitary adenylate cyclase-activating
peptide (PACAP) infusion into the posterior, but not anterior,
bed nucleus of the stria terminalis (BNST) produces weight
loss 24 hours post infusion. M. KOCHO-SCHELLENBERG*;
K. R. LEZAK; C. W. ROMAN; M. J. HARTSOCK; R. KIEFER;
B. A. GRIMMIG; K. BRAAS; V. MAY; S. E. HAMMACK. Univ.
of Vermont.
1:00 VV92 504.13 Differential regulation of PACAP/PAC1R
expression by corticosterone and stress. K. R. LEZAK*;
C. W. ROMAN; M. KOCHO-SCHELLENBERG; H. L.
SCHOENBERG; K. C. SCHUTZ; K. M. BRAAS; V. MAY; S.
E. HAMMACK. Univ. Vermont, Univ. Vermont.
2:00 VV93 504.14 Stress induces metabolic syndrome that
persists after recovery. V. H. PEREIRA; F. G. PEREIRA;
C. MOTA; J. OLIVEIRA*; F. MARQUES; O. ALMEIDA; J. J.
CERQUEIRA; N. SOUSA. Life and Hlth. Sci. Res. Institute,
Sch. of Hlth. Sci., Life and Hlth. Sci. Res. Inst., Max Planck
Inst. of Psychiatry.
3:00 VV94 504.15 Does running prevent stress-induced
activation of anxiety circuitry by buffering the hpa axis? T. J.
SCHOENFELD*; E. GOULD. Princeton Univ.
4:00 VV95 504.16 Sex differences in the emotional
control over eating and weight gain in Syrian hamsters. B.
CLOSSEN*; J. SHANNONHOUSE; R. HAIRGROVE; L.
MERTESDORF; M. PATEL; L. FONG; C. MORGAN. Texas
A&M Inst. for Neurosci., Texas A&M, Texas A&M, Texas
A&M Inst. for Neurosci.
1:00 VV96 504.17 Frequency-dependent cholinergic
regulation of adrenal catecholamine production and
release by insulin-induced recurrent hypoglycemia. B.
B. NANKOVA*; N. KIRTOK; O. CHAN; E. F. LAGAMMA.
New York Med. Col., Maria Fareri Children’s Hospital,
Westchester Med. Ctr., Yale Univ.
2:00 WW1 504.18 Differential metabolic profiles between
wild-type and ghsr ko mice following chronic social defeat
stress. Z. R. PATTERSON*; R. KHAZALL; M. SLEEMAN;
H. ANISMAN; A. B. ABIZAID. Carleton Univ., Regeneron
Pharmaceuticals.
3:00 WW2 504.19 Coping strategy and brain energy levels:
Regional ATP changes in rats. J. SEO; Y. YIM; G. KIM; S.
SOHN; C. KIM; D. KIM*. Yonsei Univ. Coll Med.
4:00 WW3 504.20 • Inflammatory-metabolic crosstalk
through redox effects at the synapse. L. L. DUGAN*; E. G.
INUI; K. B. GREY; V. NAGARAJAN. UCSD.
1:00 WW4 504.21 � Sex dependent response differences
to chronic high-speed forced exercise in rotorod and fear
conditioning. C. A. DE SOLIS*; J. A. KENNARD; J. L.
GOOCH; E. C. EGAN; D. S. WOODRUFF-PAK. Temple
Univ.
2:00 WW5 504.22 � The effects of the estrous cycle on
behavior after chronic forced exercise in female C57BL/6
mice. E. EGAN*; J. L. GOOCH; C. A. DE SOLIS; J. A.
KENNARD; D. S. WOODRUFF-PAK. Temple Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
505. Cellular and Molecular Mechanisms Underlying Sleep
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 WW6 505.01 Activation of pedunculopontine tegmental
calcium/calmodulin kinase promotes wakefulness and
suppresses rapid eye movement sleep in the freely moving
rat. S. DATTA*; M. O’MALLEY; B. W. MACONE; E. H.
PATTERSON. Boston Univ. Sch. Med.
2:00 WW7 505.02 Astrocytic coverage of neurons in the rat
basal forebrain and lateral hypothalamus: Effects of sleep
deprivation. C. L. BRIGGS*; M. HIRASAWA; K. SEMBA.
Dalhousie Univ., Mem. Univ. of Newfoundland.
3:00 WW8 505.03 � Effect of total sleep deprivation on
the expression of neuroglobin in the adult rat brain. M. A.
MELGAREJO*; E. ACOSTA-PEÑA; A. VENEBRA-MUÑOZ;
F. GARCIA-GARCIA. Univ. Veracruzana.
4:00 WW9 505.04 Corticotropin releasing hormone inhibits
sleep-promoting neurons in the preoptic hypothalamus
in rats. I. GVILIA*; K. HSIEH; B. ANGARA; D. MCGINTY;
R. SZYMUSIAK. Veterans Affairs Greater Los Angeles
Healthcare Syst., Ilia State Univ.
1:00 WW10 505.05 Activation of hypoglossal (XII)
motoneurons from the perifornical region of the posterior
hypothalamus depends on orexinergic (ORX) activation
in both the hypothalamus and the XII nucleus. G. M.
STETTNER*; L. KUBIN. Univ. of Pennsylvania.
2:00 WW11 505.06 Sleep fragmentation-induced excessive
sleepiness is modulated by TNF-α mediated pathway. V.
RAMESH*; N. KAUSHAL; D. NAIR; F. HAKIM; D. GOZAL.
Univ. of Chicago.
3:00 WW12 505.07 WITHDRAWN
4:00 WW13 505.08 Glial-specific knockout of adenosine
kinase increases slow wave activity. T. E. BJORNESS*;
N. DALE; B. SAHIN; A. A. FIENBERG; A. SUZUKI; G.
METTLACH; J. A. BIBB; R. W. GREENE. Univ. of Texas,
Southwestern Med. Ctr., Univ. of Warwick, Intra-Cellular
Therapies, Inc., Veterans Affairs North Texas Hlth. Ctr.
1:00 WW14 505.09 Optogenetic targeting of the ventrolateral
preoptic area to explore its role in anesthetic state
transitions. H. S. MCCARREN*; J. T. MOORE; B. HAN;
S. G. BECK; M. B. KELZ. Univ. of Pennsylvania, Univ. of
Pennsylvania, Univ. of Pennsylvania, Univ. of Pennsylvania.
2:00 WW15 505.10 Na + -dependent release of adenosine in
the basal forebrain. R. E. SIMS*; N. DALE. Univ. of Warwick.
3:00 WW16 505.11 Physiological significance of
serotonergic inhibitory input to orexin/hypocretin neurons
on the regulation of sleep/wakefulness. S. TABUCHI*; T.
TSUNEMATSU; S. SUGIO; K. F. TANAKA; M. TOMINAGA;
A. YAMANAKA. NIPS.
4:00 WW17 505.12 On expression of certain proteins
in mesopontine cholinergic neurons at their soma, and
terminals in the pontine reticular formation. C. LIANG; G. A.
MARKS*. DVA, Univ. Texas Southwestern Med. Ctr. & Dallas
VA.
1:00 WW18 505.13 The role of astrocytic calcium in the
regulation of sleep and sleep homeostasis. T. BLUTSTEIN*;
S. LEE; P. G. HAYDON. Tufts Univ. Sch. of Med.
Neuroscience 2011 | Monday PM | 147
Mon. PM

2:00 WW19 505.14 REM sleep increases after selective
knockdown of orexin type 2 receptor in lateral pontine
tegmentum (LPT) and ventral subcoeruleus (vSubC). L.
CHEN*; M. Z. LEONARD; Y. BOLORTUYA; S. WINSTON;
J. T. MCKENNA; R. E. BROWN; R. W. MCCARLEY. VABHS
and Harvard Med. Sch., Stonehill Col.
3:00 WW20 505.15 • Chocolate increases cataplexy and
c-Fos expression in orexin knockout mice. Y. OISHI*; T.
MOCHIZUKI; C. B. SAPER; T. E. SCAMMELL. Beth Israel
Deaconess Med. Center, Harvard Med. Sch.
4:00 WW21 505.16 The amygdala is necessary for
triggering cataplexy in orexin KO mice. C. R. BURGESS*;
M. YAMAMOTO; T. MOCHIZUKI; J. H. PEEVER; T. E.
SCAMMELL. Univ. of Toronto, Harvard Med. Sch.
1:00 WW22 505.17 Hypocretin/orexin neurons in a Prader-
Willi syndrome animal model. G. GAN; Y. WENG; S.
SUYAMA; X. GAO*. Yale Univ. Sch. Med., Affiliated Hosp. of
Hainan Med. Col.
2:00 WW23 505.18 BiP/GRP78 reduction in neural areas
associated with sleep and wake of aged mice. K. G.
SINGLETARY*; N. NAIDOO. Univ. of Pennsylvania.
3:00 WW24 505.19 Effects of acute sleep deprivation and the
circadian clock on expression of fatty-acid binding proteins
in mouse brain. J. R. GERSTNER*; C. HUH; B. MILLER; A.
PIZARRO; G. PASCHOS; G. FITZGERALD; J. TAKAHASHI;
J. HOGENESCH; A. PACK. Univ. of Pennsylvania,
Scripps Res. Inst., Univ. of Pennsylvania, Univ. of Texas
Southwestern.
4:00 WW25 505.20 Basal forebrain Kv2.2-GABAergic
neurons are involved in promoting wakefulness in the
mouse. T. O. HERMANSTYNE; J. A. MONG; H. MISONOU*.
Univ. Maryland Baltimore, Univ. Maryland Baltimore.
1:00 WW26 505.21 Genetic analysis of sleep spindles. S. C.
WARBY*; H. E. MOORE; O. CARRILLO; M. KAWASHIMA;
J. FARACO; L. LIN; P. PEPPARD; T. YOUNG; E. MIGNOT.
Stanford Univ., Univ. of Wisconsin-Madison.
POSTER
506. Circadian Clock Mechanisms
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 WW27 506.01 Circadian pacemaking within
the suprachiasmatic nucleus analysed with a novel
mCry1::luciferase transgenic mouse. M. H. HASTINGS*; L.
F. DRYNAN; J. C. CHESHAM; J. FUSTIN; H. DARDENTE;
D. G. HAZLERIGG; E. S. MAYWOOD. Lab. Mol Biol, Univ. of
Aberdeen.
2:00 WW28 506.02 Circadian rhythm of redox state and
regulation of neuronal excitability in rodent SCN neurons.
T. A. WANG*; G. GOVINDAIAH; Y. YU; C. L. COX; M. U.
GILLETTE. Univ. of Illinois at Urbana-Champaign, Univ. of
Illinois at Urbana-Champaign, Univ. of Illinois at Urbana-
Champaign, Univ. of Illinois at Urbana-Champaign.
3:00 WW29 506.03 Altered circadian rhythms and SCN
organization in ephrin-A5 knockout mice. E. T. WEBER*; D.
MOORE; A. SON; R. ZHOU. Rider Univ., Rutgers Univ.
148 | Society for Neuroscience
4:00 WW30 506.04 Parameterization of periodicity and phase
in redox oscillations and PER2:luciferase expression in
suprachiasmatic nucleus and hippocampal glia. C. S. LIU*;
T. WANG; S. J. IRVING; T. P. COLEMAN; M. U. GILLETTE.
Univ. of Illinois, Univ. of Illinois, Univ. of Illinois.
1:00 WW31 506.05 Evidence that the transcription factor
runx2 plays a functional role in the control of circadian
rhythms in the suprachiasmatic nucleus. M. E. REALE*; I. C.
WEBB; L. M. COOLEN; M. N. LEHMAN. Univ. of Michigan,
Univ. of Western Ontario, Univ. of Michigan.
2:00 WW32 506.06 Lhx1 is required for differentiation
and function of the mouse suprachiasmatic nucleus. T.
A. LEGATES*; J. L. BEDONT; H. WANG; S. HATTAR; S.
BLACKSHAW. Johns Hopkins Univ., Johns Hopkins Univ.
Sch. of Med.
3:00 WW33 506.07 Characterization of a short, bioactive
form of vasoactive intestinal peptide (VIP) in the SCN. J. W.
MITCHELL*; N. ATKINS, Jr.; S. REN; J. V. SWEEDLER; M.
U. GILLETTE. Univ. of Illinois At Urbana-Champaign, Univ.
of Illinois At Urbana-Champaign, Univ. of Illinois At Urbana-
Champaign.
4:00 WW34 506.08 Temporal organization of circadian
gene expression in subpopulations of neurons in the
suprachiasmatic nucleus. J. L. LENSIE*; E. M. MINTZ. Kent
State Univ., Kent State Univ.
1:00 WW35 506.09 Characterization of the circadian clock in
Aplysia. G. R. RICHARD; M. MICHEL*; L. C. LYONS. Florida
State Univ.
2:00 WW36 506.10 Linking the gears to the hands: Clock
gene expression is linked to daily patterns in firing rate. J.
JONES*; D. G. MCMAHON. Vanderbilt Univ.
3:00 WW37 506.11 Chronic activation of glycogen synthase
kinase 3 (GSK3) modulates period and amplitude of the
mammalian circadian clock. J. R. PAUL*; R. L. JOHNSON;
R. C. BESING; R. S. JOPE; K. L. GAMBLE. Univ. of
Alabama At Birmingham.
4:00 WW38 506.12 Genomic identification of a circadian
signaling system in Daphnia pulex. A. TILDEN*; M. D.
MCCOOLE; S. M. HARMON; K. N. BAER; A. E. CHRISTIE.
Colby Col., Col. of Pharmacy, Univ. of Louisiana, Mount
Desert Island Biol. Lab.
POSTER
507. Brain Blood Flow and the Blood-Brain Barrier
Theme E: Homeostatic and Neuroendocrine Systems
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 WW39 507.01 A1 adenosine receptors (A1ARs) on
oligodendrocytes do not mediate hypoxia-induced white
matter injury. Y. ZHU*; C. C. WENDLER; R. S. AKUNDI; S.
A. RIVKEES. Yale Univ., Yale Univ.
2:00 WW40 507.02 Selective expression of the tight junction
protein claudin-3 in the epithelium of the choroid plexus and
the olfactory system of the developing and adult mouse. C.
NITSCH*; A. STEINEMANN-INAUEN; S. CHIP; I. MALY.
Dept. Biomedicine, Univ. Basel.
3:00 WW41 507.03 Cyclic AMP effects on the arachnoid
blood-csf-barrier. E. A. HANSEN*; C. LAM; A. HUBEL. VA
Med. Ctr., Univ. of Minnesota.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 WW42 507.04 GPR30 agonist improves the cerebral
penetrating arteriolar function after ischemia/reperfusion
injury. T. MURATA*; H. H. DIETRICH; C. XIANG; R. G.
DACEY, Jr. Washington Univ. Sch. of Med. In St.Louis.
1:00 WW43 507.05 Immunohistochemical alterations of
laminin and dystroglycan complex related to the blood-brain
barrier permeability in different vessels. K. PÓCSAI*; E.
FARAGÓ; S. SADEGHIAN; J. MAHALEK; M. KÁLMÁN.
Semmelweis Univ., Eötvös Lóránd Univ.
2:00 WW44 507.06 The scavenger receptor CD36 contributes
to cerebral amyloid angiopathy and to the attendant
neurovascular and behavioral dysfunction in tg2576 mice. L.
PARK*; J. ZHOU; P. ZHOU; R. PITSTICK; L. YOUNKIN; S.
YOUNKIN; G. A. CARLSON; J. P. PIERCE; S. E. JAMAL; C.
IADECOLA. Weill Cornell Med. Col., McLaughlin Res. Inst.,
Mayo Clin. Jacksonville.
3:00 WW45 507.07 Acute regulation of MCT1 function in
cerebrovascular endothelial cells by cAMP dependent
vesicular trafficking. J. P. SMITH*; A. L. UHERNIK; B. N.
NUANEZ; K. T. DARCY; M. SNEVE; Z. LIU; L. R. DREWES.
Colorado State Univ.-Pueblo, Colorado State University-
Pueblo, Univ. of Minnesota Med. Sch. Duluth.
4:00 WW46 507.08 The effects of calcium modulation on
the paracellular transport in arachnoid cells. C. H. LAM*; E.
HANSEN; A. HUBEL. Univ. of Minnesota, VA Med. Ctr., Univ.
of MInnesota.
1:00 WW47 507.09 An attempt to transfer protein molecules
as nanoparticles through the blood-brain barrier. I.
HEGEDűS; E. FARAGÓ; E. NAGY; K. MIHALY*. Univ. of
Pannonia, Eötvös Lóránd Univ., Semmelweis Univ.
2:00 WW48 507.10 Differential brain metabolism following
single vs. repeated ethanol exposure in adolescent rats:
A [ 18 F]fluorodeoxyglucose-PET study. R. SIRCAR*; S.
SCHERRER; W. SCHIFFER; S. DEWEY; D. EIDELBERG.
Albert Einstein Coll Med/FIMR, The Feinstein Inst. for Med.
Res.
3:00 WW49 507.11 � REM sleep deprivation and restriction
results in increased blood-brain barrier permeability to
Evans blue. G. HURTADO-ALVARADO; B. G. GOMEZ*; J.
VELÁZQUEZ-MOCTEZUMA. Neurosci. Area, CBS, Univ.
Autonoma Metropolitana, Unidad Iztapalapa.
4:00 WW50 507.12 Towards a mechanistic understanding
of brain delivery following intranasal administration. J. J.
LOCHHEAD; D. J. WOLAK; R. G. THORNE*. Univ. of
Wisconsin- Madison, Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison.
1:00 WW51 507.13 • New Leptin and GDNF derivatives
engineered by fusion with Angiopep-2 cross efficiently the
blood-brain barrier. M. DEMEULE*; D. BOIVIN; A. RÉGINA;
R. BÉLIVEAU; J. CASTAIGNE. Angiochem Inc., Lab. of Mol.
Medicine, Univ. du Québec à Montréal.
2:00 WW52 507.14 Mesenchymal stem cells transmigrate
across brain microvascular endothelial cell monolayers
through the transiently formed interendothelial gaps. T.
KATAYAMA*; T. MATSUSHITA; T. KIBAYASHI; O. HONMOU;
S. SHIMOHAMA; M. MINAMI. Dept Pharmacol, Grad Sch.
Pharm Sci, Hokkaido Univ., Dept. Neurol., Sch. Med.,
Sapporo Med. Univ., Dept. Neural Rep. and Ther., Sch.
Med., Sapporo Med. Univ.
3:00 WW53 507.15 A minimal two-stage model of energy
metabolism and energy control in the brain. F. A. DEHMELT*;
C. K. MACHENS. Ecole Normale Superieure.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 WW54 507.16 Simultaneous two-photon imaging of
oxygen and blood flow in deep cerebral vessels. J. LECOQ;
A. PARPALEIX; E. ROUSAKIS; M. DUCROS; Y. GOULAM
HOUSSEN; S. VINOGRADOV; S. CHARPAK*. Inserm, Univ.
of Pennsylvania.
1:00 WW55 507.17 • Two-photon microscopy study of
nitroglycerin effects on cerebral blood flow in rats. E.
PRYAZHNIKOV*; M. KISLIN; M. TIBEIKINA; D. TOPTUNOV;
S. KHIRUG; L. KHIROUG. Univ. of Helsinki, Neurotar Ltd.
2:00 WW56 507.18 WITHDRAWN
3:00 WW57 507.19 Persistent failure of neurovascular
coupling induced by prolonged moderate hypoxia in the
somatosensory cortex in mice. I. KANNO*; K. MASAMOTO;
H. TAKUWA; H. KAWAGUCHI; J. TANIGUCHI; Y. TOMITA;
N. SUZUKI; H. ITO. Natl. Inst. of Radiological Sci., Natl. Inst.
of Radiological Sci., Univ. of Electro-Communications, Chiba
Univ. Grad. Sch. of Med., Keio Univ. Sch. of Med.
4:00 WW58 507.20 State-dependent correlations between
spontaneous neocortical activity and cerebral blood flow.
P. HERMAN*; Y. YU; R. SACHDEV; B. SANGANAHALLI;
D. MCCORMICK; F. HYDER. Yale Univ. Sch. of Med., Yale
Univ. Sch. of Med., Yale Univ., Yale Univ., Yale Univ.
1:00 WW59 507.21 Do glial waves in vivo contribute to
neurovascular coupling? C. MATHIESEN*; A. BRAZHE;
M. LAURITZEN. Panum Inst., Ctr. for Healthy aging, Biol.
faculty, Dept. of Clin. Neurophysiol.
2:00 WW60 507.22 A multi-phase model of neurovascular
coupling. B. R. CHEN*; B. L’HEUREUX; M. B. BOUCHARD;
M. CASTELLI; E. M. C. HILLMAN. Columbia Univ., Columbia
Univ. Col. of Physicians and Surgeons.
3:00 WW61 507.23 Nonlinear relationships between mean
firing rates and simulated hemodynamic responses. D. J.
HERZFELD*; S. A. BEARDSLEY. Marquette Univ., Boston
Univ., Med. Col. of Wisconsin.
4:00 WW62 507.24 Changes in hemodynamic responses
after endomorphin-2 (EM2) injection into the rostral
ventrolateral medulla (RVLM) in spontaneously
hypertensive rats (SHR) submitted to swimming exercise.
R. L. ALMEIDA*; C. A. OGIHARA; I. H. SAVIOLLI; E.
COLOMBARI; M. A. SATO. FACULDADE DE MEDICINA
DO ABC, Adventist Universitary Ctr. of Sao Paulo-UNASP,
FACULDADE DE MEDICINA DO ABC.
1:00 WW63 507.25 Cerebral microvascular plasticity from
birth to death. R. HARB*; C. WHITEUS; C. FREITAS; J.
GRUTZENDLER. Yale Univ., Northwestern Univ.
2:00 WW64 507.26 • A vascular atlas of the mouse brain in
Waxholm reference space. A. BADEA*; K. B. GHAGHADA;
G. P. COFER; Y. QI; A. HESS; G. JOHNSON. Duke Univ.
Med. Ctr., The Univ. of Texas Hlth. Sci. Ctr., Friedrich
Alexander Univ., Duke Univ. Med. Ctr.
3:00 WW65 507.27 In-vivo 3D morphology of cerebral
vasculature during neonatal development. M. KOZBERG*;
B. R. CHEN; S. E. DELEO; E. M. C. HILLMAN. Lab. For
Functional Optical Imaging, Columbia Univ.
Neuroscience 2011 | Monday PM | 149
Mon. PM

POSTER
508. Memory Retrieval
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 WW66 508.01 Lateralization of successful retrieval
effects in posterior parietal cortex during recognition of
perceived compared to imagined events. D. R. KING*; M.
B. MILLER. Univ. of California, Santa Barbara, Univ. of
California, Santa Barbara.
2:00 WW67 508.02 Neural correlates of recollection and
familiarity: Differences between individual and group level
results in an fMRI study. A. FRITHSEN*; M. B. MILLER.
Univ. of California, Santa Barbara.
3:00 WW68 508.03 Recollection related ERP effects
unaffected by expectancy violations - parietal old/new
ERP effects in the presence of invalid memory cueing. E.
KNIGHT*; I. DOBBINS; L. TRUJILLO; A. JAEGER; D. M.
SCHNYER. Univ. of Texas at Austin, Washington Univ. in St.
Louis.
4:00 WW69 508.04 Temporal interplay of attention and
memory during associative retrieval. M. R. UNCAPHER*; S.
DUBROW; J. B. HUTCHINSON; A. D. WAGNER. Stanford
Univ., Dept Psychol, Stanford Univ.
1:00 WW70 508.05 Electrocorticography reveals selectivity
of human retrosplenial cortex to self-referential stimuli. B. L.
FOSTER*; M. DASTJERDI; J. PARVIZI. Stanford Univ.
2:00 WW71 508.06 � Route and survey-based learning
differentially affect human allocentric and egocentric spatial
representations. K. ZHERDEVA*; H. ZHANG; A. EKSTROM.
Univ. of California, Univ. of California.
3:00 WW72 508.07 Correlation between parietal-related fMRI
activation during allocentric spatial navigation and scalp-
EEG measured theta oscillatory activity. H. ZHANG*; C.
TANASE; C. CARTER; A. EKSTROM. UC Davis, UC Davis,
UC,Davis, UC,Davis.
4:00 XX1 508.08 Decoding human electrocorticography
using multivariate pattern classification during spatial and
temporal episodic retrieval. A. WATROUS*; N. TANDON;
T. PIETERS; T. ELLMORE; A. D. EKSTROM. Univ. of
California,Davis, Univ. of Texas Med. Sch., Univ. of Texas
Med. Sch., Univ. of California,Davis.
1:00 XX2 508.09 Binding of spatial layout and temporal
order information within the human hippocampal circuitry.
M. COPARA*; H. ZHANG; L. A. LIBBY; J. JACKSON; K.
ZHERDEVA; A. D. EKSTROM. Univ. of California, Davis,
Univ. of California, Davis, Univ. of California, Davis.
2:00 XX3 508.10 Same old.. same old: Reactivation
of relational information in the cortex is similar to initial
processing. J. A. WALKER*; K. A. LOW; N. J. COHEN;
M. FABIANI; G. GRATTON. Univ. of Illinois at Urbana-
Champaign, Beckman Inst.
3:00 XX4 508.11 Relational memory retrieval at short
delays under interference from recently encountered
associations. L. YEE*; C. J. BROZINSKY; M. D’ESPOSITO;
N. J. COHEN. Univ. of Illinois Urbana-Champaign, Univ. of
California Berkeley.
4:00 XX5 508.12 Brain activity in humans in medial
temporal lobe and neocortex as a function of the age of
memory (1 hour to 1 month). C. N. SMITH*; R. E. CLARK; L.
R. SQUIRE. UCSD, Veterans Affairs Med. Ctr., UCSD.
150 | Society for Neuroscience
1:00 XX6 508.13 Controlling conflict from interfering longterm
memory representations. P. H. KHADER*; K. JOST; F.
RÖSLER. Philipps-University, RWTH Aachen Univ., Univ. of
Potsdam.
2:00 XX7 508.14 Control processes engaged in
switching between long-term memory representations. J.
M. KIZILIRMAK*; F. RÖSLER; P. H. KHADER. Philipps-
University Marburg, Univ. Potsdam.
3:00 XX8 508.15 The neural correlates of cognitive control:
Successful remembering and intentional forgetting. A. A.
RIZIO*; N. A. DENNIS. The Pennsylvania State Univ.
4:00 XX9 508.16 Network dynamics supporting the
cognitive control of memory retrieval. J. L. BARREDO*; W.
R. AVERILL; I. OZTEKIN; D. BADRE. Brown Univ., Brown
Univ., Koc Univ.
1:00 XX10 508.17 Functional compensation in response to
increasing task difficulty: An fMRI investigation of episodic
and semantic memory in young adults. E. BAENA*; L. RYAN.
Univ. Arizona.
2:00 XX11 508.18 Diruption of prefrontal cortical function
improves memory performance without awareness. T. LEE*;
R. S. BLUMENFELD; M. D’ESPOSITO. UC Berkeley, UC
Berkeley.
3:00 XX12 508.19 Nonconscious memory for motion
activates MT+. P. P. THAKRAL*; S. D. SLOTNICK. Boston
Col.
4:00 XX13 508.20 Repeated labilization-reconsolidation
processes strengthen declarative memory in Humans. M. E.
PEDREIRA*; L. M. C. RODRIGUEZ; C. FORCATO. Univ. de
Buenos Aires.
1:00 XX14 508.21 • � Perseverative consolidation: A
paradox still searching for an explanation. A. F. SÁNCHEZ*;
V. M. SOLIS-MACIAS. Dept. Psychology Natl. Univ. of
Mexico, Natl. Univ. of Mexico.
2:00 XX15 508.22 • � Properties of distractors are critical
for recognition hypermnesia. E. ROSAS*; V. M. SOLÍS. Natl.
Autonomous Univ. of Mexico.
3:00 XX16 508.23 Long-term potentiation of visual
evoked potentials correlates with by familiarity-based
recognition memory in healthy older adults. L. J. TIPPETT*;
A. KOULIKOVA; J. S. HOLDSTOCK; A. R. MAYES; C.
THOMPSON; I. J. KIRK. The Univ. of Auckland, Univ. of
Liverpool, Univ. of Manchester.
4:00 XX17 508.24 Which one is heavier? Which one is
larger? Electrophysiological evidence of semantic size and
weight processes in the brain. H. CHIANG*; M. A. KRAUT;
R. ANAND; J. HART JR. Ctr. For Brainhealth, The Johns
Hopkins Sch. of Med., The Univ. of Texas at Dallas.
POSTER
509. Reading Studies
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 XX18 509.01 EEG correlates of visual word processing
efficiency in dyslexia. B. L. SUSSMAN*; J. W. HOUPT; J. T.
TOWNSEND; S. D. NEWMAN. Indiana Univ.
2:00 XX19 509.02 Neural correlates of reading in first and
second language. O. BOUKRINA*; S. J. HANSON; C.
HANSON. Rutgers, The State Univ. of New Jersey.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 XX20 509.03 A horse or an equine? How the age of
acquisition and frequency of use affect visual processing
of words: An ERP study. A. M. PROVERBIO*; R. ADORNI;
M. MANFREDI; A. ZANI. Univ. Milano-Bicocca, Inst. of
Cognitive Sci. and Technologies.
4:00 XX21 509.04 Reading ability mediates neural activation
in adolescent readers on word and sentence comprehension
tasks. R. A. STEWART*; A. P. SIVAPURAPU; A.
VENKATADRI; M. RYAN; L. ROSENBERG; S. L. RIMRODT;
L. E. CUTTING. Kennedy Krieger Inst., Vanderbilt Univ.
1:00 XX22 509.05 • Investigation between speechreading
and alphabetic reading, auditory vocabulary and
phonological awareness in Brazilian children at age of
literacy acquisition. L. E. GRATON SANTOS*; L. M. D. M.
THOMAZETTE; F. C. CAPOVILLA. Univ. De São Paulo
(university of São Paulo).
2:00 XX23 509.06 Cognitive and language proficiencies
predict variability in neural activity mediating semantic and
syntactic processing in children. A. HAMPTON WRAY*; C.
WEBER-FOX. Purdue Univ.
3:00 XX24 509.07 Functional changes during reading skill
development: An fMRI study. A. SEKI*; H. UCHIYAMA; D.
TANAKA; T. KOEDA. Tottori Univ., Natl. Hosp. Organization,
Tottori Med. Ctr.
4:00 XX25 509.08 Developmental changes in the inferior
parietal lobule for integrating meanings with orthographic
similarity. S. LEE*; T. CHOU. Dept. of Psychology, Natl.
Taiwan Univ., Neurobio. and Cognitive Sci. Center, Natl.
Taiwan Univ.
1:00 XX26 509.09 Brain representations for syntactic and
semantic processing in 9- to 10-year old children. M. A.
SKEIDE*; A. D. FRIEDERICI; J. BRAUER. Max-Planck-
Institute For Human Cognitive and Brain Sci.
2:00 XX27 509.10 Structural correlates of auditory and
phonological skill in schoolchildren. M. GRUBE*; S. KUMAR;
F. COOPER; S. WOODS; T. D. GRIFFITHS. Newcastle Univ.
3:00 XX28 509.11 Age-related differences in the posterioranterior
gradient of word-specificity in the visual word
form system. O. A. OLULADE*; L. FLOWERS; E. M.
NAPOLIELLO; G. F. EDEN. Ctr. For the Study of Learning -
Georgetown Univ. Med. Ctr.
4:00 XX29 509.12 Task demands and stimulus properties
interact to modulate BOLD activity in reading- and control-
related regions. S. K. Z. IHNEN*; S. E. PETERSEN; B.
L. SCHLAGGAR. Washington Univ., Washington Univ.,
Washington Univ. Sch. of Med., Washington Univ. Sch. of
Med., Washington Univ. Sch. of Med.
1:00 XX30 509.13 Neural correlates of text inversion. C.
DURISKO*; G. BEN-YEHUDAH; J. A. FIEZ. Univ. Pittsburgh,
The Open Univ. of Israel, Univ. Pittsburgh.
2:00 XX31 509.14 Reading faces: Examining the effects of a
novel face-based orthography. M. W. MOORE; C. DURISKO;
C. A. PERFETTI; J. A. FIEZ*. Univ. of Pittsburgh, Univ.
Pittsburgh.
3:00 XX32 509.15 Robust visual word form area (VWFA)
activation during encoding of abstract shapes. L. MOO*;
S. D. SLOTNICK. Mass Gen. Hosp, Bedford VA Med. Ctr.,
Boston Col.
4:00 XX33 509.16 Evidence for a relationship between
the heterogeneity of local regional correlations within the
VWFA and reading ability. G. F. EDEN*; D. FLOWERS; E.
M. NAPOLIELLO; M. LUETJE; X. JIANG. Georgetown Univ.,
Georgetown Univ.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 XX34 509.17 Seeing the meaning: Higher-order
neuroplastic changes in the time scale of processing within
early visual areas in the congenitally blind. A. D’ALFONSO*;
Y. LERNER; P. PLAZA; C. HONEY; L. RENIER; J.
RAUSCHECKER; U. HASSON. Dept. of Psychology
Princeton Univ., Princeton Neurosci. Institute, Princeton
Univ., Dept. of Neuroscience, Georgetown Univ. Med. Ctr.
2:00 XX35 509.18 The first 250 ms in visual word
recognition: Who is talking to whom? M. LOBIER; P. C.
HANSEN*; K. WHEAT; S. VALDOIS; P. L. CORNELISSEN.
CNRS UMR 5105, Univ. of Birmingham, Univ. of York.
3:00 XX36 509.19 Individual differences in reading speed
and cortical activation while reading Japanese novels:
Simultaneous recording of NIRS and Tobii Eye Tracker. H.
MIYATA*; S. WATANABE; Y. MINAGAWA-KAWAI; K. UEDA;
T. SASAKI. Dept. of Psychology, Keio Univ., Japan Society
for the Promotion of Sci., Keio Univ., Keio Univ., The Univ. of
Tokyo, NBS Japan Society of Speed Reading Educ.
4:00 XX37 509.20 An investigation of twenty/20 vision in
reading. P. J. HELLYER*; Z. V. J. WOODHEAD; R. LEECH;
R. J. S. WISE. Imperial Col. London.
1:00 XX38 509.21 Stress and phonemes are processed
independently in neuronal word form recognition. U.
SCHILD*; A. B. C. BECKER; C. K. FRIEDRICH. Univ. of
Hamburg.
2:00 XX39 509.22 The relative benefits of covert and overt
fMRI language paradigms with respect to face motor cortex
activation. S. E. STREAM; S. JAIN; S. BICKEL*; L. ENTZ;
G. KLEIN; P. KINGSLEY; J. CORINES; S. VAKILI; A. D.
MEHTA. North Shore / LIJMC, Natl. Inst. of Neurosci., North
Shore / LIJMC.
3:00 XX40 509.23 � Lateralised visual attention is unrelated
to language lateralisation, and not influenced by task
difficulty - A functional transcranial Doppler study. R. E.
ROSCH*; N. A. BADCOCK; D. V. M. BISHOP. Magdalen
College, Univ. of Oxford, Univ. of Oxford.
4:00 XX41 509.24 Multivariate analysis of fMRI response
and semantic properties in right fusiform gyrus. R.
BRUFFAERTS*; P. DUPONT; R. PEETERS; S. DE DEYNE;
G. STORMS; R. VANDENBERGHE. Kuleuven, UZLeuven,
UZLeuven, Kuleuven.
POSTER
510. Human Cognition and Behavior: Individual Differences
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 XX42 510.01 Post-malaria cognitive impairment
remediated by computer-based training: A case report. A. A.
OVERMAN*. Elon Univ.
2:00 XX43 510.02 A general factor of cognitive pathology
is associated to increased functional connectivity in Multiple
Sclerosis. D. J. HAWELLEK*; J. F. HIPP; C. M. LEWIS;
M. CORBETTA; A. K. ENGEL. Dept. For Neurophysiol. &
Pathophysiology, Univ. Med. Ctr. Hamb, Ctr. for Integrative
Neurosci., Ernst Stüngmann Inst. in Cooperation with Max
Planck Society, Inst. for Advanced Biomed. Technologies,
Washington Univ. Sch. of Med.
3:00 XX44 510.03 Relationship between individual
differences in navigation strategies and addiction
vulnerability. N. C. SCHMITZER-TORBERT*; A.
MACDONALD, III. Wabash Col., Univ. of Minnesota.
Neuroscience 2011 | Monday PM | 151
Mon. PM

4:00 XX45 510.04 Sex differences in resting default
mode network. A. DUCHESNE*; C. COOPERMAN; J.
C. PRUESSNER. Douglas Res. Inst., Douglas research
institute, Douglas research institute.
1:00 XX46 510.05 � Spatial perspective taking, agency and
social skill interactions. A. J. MURRAY; A. L. SHELTON*; A.
M. CLEMENTS-STEPHENS. Johns Hopkins Univ.
2:00 XX47 510.06 � Correlation of resting state functional
connectivity with Raven’s Advanced Progressive Matrices
performance. M. S. PETERSON*; T. B. MEIER; J. C.
MOTZKIN; R. D. RAY; V. A. NAIR; B. B. BISWAL; R. M.
BIRN; M. E. MEYERAND; V. PRABHAKARAN. Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison, Univ. of
Med. and Dent. of New Jersey, Univ. of Wisconsin-Madison,
Univ. of Wisconsin-Madison, Univ. of Wisconsin-Madison.
3:00 XX48 510.07 Variation in human brains may facilitate
evolutionary change toward a limited range of phenotypes.
C. J. CHARVET*; R. B. DARLINGTON; B. L. FINLAY. Cornell
Univ.
4:00 XX49 510.08 Masculinity/femininity predicts brain
volumes in normal healthy children. A. M. BELFI*; A. L.
CONRAD; J. D. DAWSON; P. C. NOPOULOS. Univ. of Iowa.
1:00 XX50 510.09 Neural correlates of creative drawing by
artists and non-artists. J. P. WAGEMANS*; K. VANCLEEF;
M. KOOLE; S. VAN DE CRUYS; K. PORTERS; K. VAN
LAERE. Univ. of Leuven (K.U. Leuven), Univ. of Leuven
(K.U. Leuven).
2:00 XX51 510.10 Novel evidence for a domain-general
attentional control mechanism predicting individual
differences in working memory capacity. R. J. GIULIANO*;
H. J. NEVILLE. Univ. of Oregon.
3:00 XX52 510.11 Parallel independent component analysis
detects correlations between resting state sub-networks
and behavioral data. J. C. WILDENBERG*; T. B. MEIER;
V. A. NAIR; J. C. MOTZKIN; R. D. RAY; R. M. BIRN; V.
PRABHAKARAN; M. E. MEYERAND. Univ. Wisconsin.
4:00 XX53 510.12 Effects of COMT haplotype on cortical
thickness and surface area in human brain. M. LIN*; P.
M. GREENWOOD; W. R. MCGARRY; K. J. FRYXELL; J.
THOMPSON; R. PARASURAMAN. George Mason Univ.,
George Mason Univ.
1:00 XX54 510.13 Linkage between heritable
neuropsychiatric disorders and academic interests. S. S.
WANG*; B. C. CAMPBELL. Princeton Univ., Princeton Univ.,
Rockefeller Univ.
2:00 XX55 510.14 Neuroimaging analysis of anatomical
abnormalities in patients with post-traumatic stress disorder,
obsessive-compulsive disorder, and schizophrenia. P.
S. KUNWAR*; S. C. FURTAK; J. L. GREENBERG; G.
COOMBS; J. J. Y. IM; M. ZEIDAN; M. FALKENSTEIN; D.
J. HOLT; R. K. PITMAN; S. WILHELM; S. L. RAUCH; M.
MILAD. Dept. of Psychiatry, Massachusetts Gen. Hosp. and
Harvard Med. Sch., Massachusetts Gen. Hosp., Dept. of
Psychiatry, McLean Hosp.
3:00 XX56 510.15 The brain genomics superstruct project.
R. L. BUCKNER*; M. HOLLINSHEAD; A. J. HOLMES; D. G.
BROHAWN; J. A. FAGERNESS; T. O’KEEFE; V. PETROV;
G. FARIELLO; L. BAKST; S. RUBENSTEIN; T. BENNER;
G. SORENSEN; B. R. ROSEN; J. L. ROFFMAN; J. W.
SMOLLER. HHMI at Harvard Univ., Ctr. for Brain Science,
Harvard Univ., Athinoula A. Martinos Ctr. for Biomed.
Imaging, Massachusetts Gen. Hosp., Harvard Med. Sch.,
Psychiatric and Neurodevelopmental Genet. Unit, Ctr. for
Human Genet. Research, Massachusetts Gen. Hosp.
152 | Society for Neuroscience
4:00 XX57 510.16 � Use of over the counter stimulant
products amongst college students. S. POPE*; M. BIRKETT.
Northern Arizona Univ.
1:00 XX58 510.17 � Sex differences in the corpus callosum:
Comparing two partitioning schemes. R. DHALIWAL; W. E.
GRISHAM*. UCLA, UCLA.
2:00 XX59 510.18 • A naturalistic preferential reaching task:
Examination of right and left handed adults. P. J. BRYDEN*;
R. DELITALA. Wilfrid Laurier Univ.
3:00 XX60 510.19 Common and distinct neural substrates
associated with semantic judgment across cultures. C.
HUANG*; D. C. PARK. Dept. of Psychology, Univ. of Illinois
at Urbana-Champaign, Ctr. for Vital Longevity, Univ. of Texas
at Dallas.
4:00 XX61 510.20 Heritability of structural brain connectivity
network measures in 188 twins. E. L. DENNIS*; N.
JAHANSHAD; A. TOGA; J. BROWN; J. RUDIE; S.
BOOKHEIMER; M. DAPRETTO; K. JOHNSON; K.
MCMAHON; G. DE ZUBICARAY; N. MARTIN; M. WRIGHT;
P. THOMPSON. Lab. of Neuroimaging, UCLA, Ctr. for
Cognitive Neuroscience, UCLA, Ahmanson Lovelace Brain
Mapping Center, UCLA, Ctr. for Advanced Imaging, Univ.
of Queensland, Queensland Inst. of Med. Res., Sch. of
Psychology, Univ. of Queensland.
1:00 XX62 510.21 Individual differences in trait emotional
responding on neural activation during rest: An ICA
approach. R. D. RAY*; T. B. MEIER; J. C. MOTZIN; V.
A. NAIR; B. B. BISWAL; R. BIRN; E. E. MEYERAND; V.
PRABHAKARAN. Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of New Jersey, Univ. of Wisconsin-
Madison, Univ. of Wisconsin-Madison.
2:00 XX63 510.22 • Smoking addiction moderates the
effects of emotional distractors on fronto-parietal BOLD
activation during the affective Stroop task. B. FROELIGER*.
Duke Univ. Med. Ctr.
3:00 XX64 510.23 � Interaction between mindfulness and
reward-related ventral striatum reactivity predicts trait anger.
C. LI; Y. S. NIKOLOVA; V. SOCHAT; B. D. BRIGIDI; A. R.
HARIRI*. Duke Univ., Duke Univ.
4:00 XX65 510.24 Individual variation in strategic inhibitory
control is linked to the presence of a 4-repeat allele on the
DRD4 gene. C. M. TIPPER*; S. JANUSONIS; E. AMINOFF;
A. FRITHSEN; A. JOHNSON; M. DATKO; M. MILLER; S. T.
GRAFTON. Univ. California, SB, UCSD.
1:00 XX66 510.25 BDNF polymorphism predicts general
intelligence after penetrating TBI. E. ROSTAMI*; F.
KRUEGER; S. ZOUBAK; O. DAL MONTE; M. PARDINI; C.
HODGKINSON; D. GOLDMAN; M. RISLING; J. GRAFMAN.
Karolinska Inst., NIH, NIH, Natl. Inst. of Neurolog. Disorders
and Stroke, Univ. of Genoa, Natl. Inst. of Alcohol Abuse and
Alcoholism, NIH, Karolinska Institutet, Kessler Fndn. Res.
Ctr.
2:00 XX67 510.26 Stability of resting-state functional
connectivity predicts behavioral inattention and impulsivity.
E. M. GORDON*; S. E. BEAN; M. STOLLSTORFF; C. J.
VAIDYA. Georgetown.
3:00 XX68 510.27 Do you think it or feel it? Language
and neural activity reflect individual differences in emotion
processing. X. YANG*; D. E. SAXBE; L. A. BOROFSKY; M.
C. MURPHY; M. H. IMMORDINO-YANG. USC, USC, USC,
USC.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

4:00 XX69 510.28 � Studies on altered DNA integrity in the
brain regions of suicidal victims of bipolar depression. J.
THUGANTI*; R. TSS; R. KSJ. JSS Med. Col. and Hosp.,
INDICASAT-AIP.
POSTER
511. Executive Function: Decision Making, Impulsivity, and
Risk
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 XX70 511.01 Social isolation during adolescence
alters dopamine modulation in the adult medial prefrontal
cortex. D. S. COUNOTTE*; P. J. J. BAARENDSE; L. J. M.
J. VANDERSCHUREN; P. O’DONNELL. Univ. of Maryland
Baltimore, Rudolf Magnus Inst. of Neuroscience, Univ. Med.
Ctr. Utrecht, Fac. of Vet. Medicine, Utrecht Univ.
2:00 XX71 511.02 The role of adolescent social behavior
in the development of impulse control in rats. P. J. J.
BAARENDSE; D. S. COUNOTTE; P. O’DONNELL; L. J.
VANDERSCHUREN*. Rudolf Magnus Inst. of Neurosci,
Univ. of Maryland Sch. of Med., Dept. of Animals in Sci.
and Society, Div. of Behavioural Neuroscience, Fac. of Vet.
Medicine, Utrecht Univ.
3:00 XX72 511.03 Increased impulsive action in adolescent
compared to adult rats: Possible role for the NMDA receptor
NR2B subunit. C. L. BURTON*; P. J. FLETCHER. Univ.
Toronto, Ctr. of Addiction and Mental Hlth., Univ. of Toronto,
Univ. of Toronto.
4:00 XX73 511.04 Adolescent risk-taking and cocaine selfadministration.
M. R. MITCHELL*; V. G. WEISS; K. VERA;
B. SETLOW. Univ. of Florida, Col. of Med., Univ. of Florida.
1:00 XX74 511.05 Pharmacological inhibition of
noradrenergic system impairs a spatial decision-making task
via prefrontal cortex. S. AMEMIYA*; T. NOJI; N. KUBOTA; T.
NISHIJIMA; I. KITA. Tokyo Metropolitan Univ.
2:00 XX75 511.06 Endocannabinoids facilitate cocaineinduced
impulsivity. G. A. HERNANDEZ*; Z. ABBAS; R.
GENTRY; A. ARVANITOGIANNIS; J. F. CHEER. Univ. of
Maryland, Concordia Univ.
3:00 XX76 511.07 Dissociations between impulsive
choice and impulsive action in a mouse model of FTDP-
17. T. HUMBY*; J. EDDY; J. TANNER; J. BOUSFIELD; J.
SELLARS; L. WILKINSON. Cardiff Univ.
4:00 XX77 511.08 Risk sensitivity as a test of impulsive
choice in rats. J. MCCLURE*; P. PO; J. PODOS; H.
RICHARDSON. Univ. of Massachusetts Amherst, Univ. of
Massachusetts Amherst.
1:00 XX78 511.09 Interconnected pathway between
rat ventral prefrontal cortex, thalamic reuniens and
ventral hippocampus revealed by retrograde transport of
pseudorabies virus. J. A. PRASAD*; P. ANTKOWIAK; Y.
CHUDASAMA. McGill Univ.
2:00 XX79 511.10 Ventral hippocampal lesions induce
impulsive choice behaviour. A. R. ABELA*; L. Q. YU; Y.
CHUDASAMA. McGill Univ.
3:00 XX80 511.11 Dynamic and dissociable fluctuations in
prefrontal and ventral striatal dopamine efflux during riskbased
decision making. J. R. ST.ONGE*; S. AHN; K. SO;
A. G. PHILLIPS; S. B. FLORESCO. Univ. British Columbia,
Univ. of British Columbia, Univ. of British Columbia.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
4:00 XX81 511.12 Lesions in the nucleus accumbens, but
not dorsolateral striatum, affect risky choice behavior in
the rat. R. LIAO*; J. YANG. Natl. Cheng-Chi Univ., Insti.
Neurosci., Res. Ctr. Mind Brain Learning.
1:00 XX82 511.13 Representation of action timing and
feedback in substantia nigra GABAergic and dopaminergic
neurons. H. H. YIN*; M. ROSSI; D. FAN. Duke Univ., Duke
Univ., Duke Univ.
2:00 XX83 511.14 Selective perturbations in effort, but not
delay-based decision making induced by acute stress. N.
SHAFIEI*; S. B. FLORESCO. Univ. of British Columbia.
3:00 XX84 511.15 Fooling dopamine: The effects of
stimulation of the lateral habenula on risk-based decision
making. C. M. STOPPER*; S. B. FLORESCO. Univ. British
Columbia, Univ. British Columbia.
4:00 XX85 511.16 � The effects of reducing prefrontal
cortical GABA activity on delay and risk-based decision
making. S. KHAYAMBASHI; S. B. FLORESCO*. Univ. British
Columbia, Univ. British Columbia.
1:00 XX86 511.17 Decision-making under risk in mice:
The effect of motivational state, reward identity, and
dopaminergic modulation. M. LEBLOND*; C. YU; J. K.
BRYNILDSEN; H. YIN*. Duke Univ.
2:00 XX87 511.18 Decision-making in a rat gambling task is
modulated by D2/D3 receptors. P. MORGADO; B. RIBEIRO;
A. A. ALMEIDA*; N. SOUSA; J. J. CERQUEIRA. Univ. of
Minho, Univ. Minho.
3:00 XX88 511.19 Evaluation of risky decision making
using the rat gambling task and attentional set-shifting. S. J.
ECKRICH*; S. K. SALAND; J. S. RODEFER. Florida State
Univ.
4:00 XX89 511.20 • Improved cognitive impulsivity and
increased emotional reactivity in mice overexpressing
erythropoietin in the brain. M. ALVAREZ-SANCHEZ; E.
VANNONI; V. DIAZ; H. LIPP*; M. GASSMANN; D. P.
WOLFER. Univ. of Zurich, Vetsuisse Fac., Ctr. for Integrative
Human Physiol. (ZIHP), Univ. Zurich, Inst. of Anat., Univ.
Zurich, Swiss Federal Inst. of Technol., Univ. of Zurich, Inst.
of Anat.
1:00 XX90 511.21 Stress and decision-making in rats:
Effects of corticosterone. S. KOOT*; A. BAARS; P.
HESSELING; R. VAN DEN BOS; M. JOËLS. Rudolf Magnus
Inst. of Neurosci., Fac. of Vet. Medicine, Utrecht Univ.
2:00 XX91 511.22 Competitive effort registers in the rat
anterior cingulate cortex as a cost-benefit decision variable.
K. HILLMAN*; D. BILKEY. Univ. of Otago.
3:00 XX92 511.23 Reinforcer devaluation is impaired by
either excitotoxic or serotonin specific orbitofrontal cortex
lesions in rats. E. WEST*; P. A. FORCELLI; D. MCCUE; K.
GALE; L. MALKOVA. Georgetown Univ., Georgetown Univ.
4:00 YY1 511.24 Neural activity in the orbitofrontal cortex
in response to changes in value versus identity of expected
rewards. T. LIU*; T. STALNAKER; G. SCHOENBAUM. Natl.
Taiwan Univ., Univ. of Maryland Sch. of Med.
Neuroscience 2011 | Monday PM | 153
Mon. PM

POSTER
512. Prefrontal and Striatal Molecular and Physiology
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 YY2 512.01 Signaling pathways of the D3 agonist
pramipexole in the rat ventral forebrain. W. CHANG*; R. L.
SAINT MARIE; M. R. BREIER; A. YANG; M. MIZERA; R. P.
HAMMER, Jr.; N. R. SWERDLOW. Univ. of California San
Diego, Univ. of Arizona Col. of Med.
2:00 YY3 512.02 Chronic treatment with a typical, but not
with an atypical, antipsychotic drug enhances the pursuit of
reward cues. A. BÉDARD; J. MAHEUX; D. LÉVESQUE; A.
SAMAHA*. Univ. Montreal.
3:00 YY4 512.03 NK1R-/- mice, a model of attention deficit
hyperactivity disorder, display perseverative behaviour
in the 5-choice serial reaction time task but not in the
marble-burying paradigm. R. K. WEIR*; J. A. DUDLEY; S.
C. STANFORD; S. P. HUNT. Univ. Col. London, Univ. Col.
London.
4:00 YY5 512.04 The neurokinin-1 receptor knock-out
mouse as a model of Attention Deficit Hyperactivity Disorder:
Linking the neurokinin-1 receptor and impulsivity. J. A.
DUDLEY*; R. K. WEIR; T. C. YAN; E. M. GRABOWSKA;
Y. P. OLIVER; T. L. RIPLEY; D. N. STEPHENS; S. C.
STANFORD; S. P. HUNT. UCL, Univ. of Sussex.
1:00 YY6 512.05 Reward inference by primate prefrontal
and striatal neurons. X. PAN, male; H. FAN, male; M.
SAKAGAMI*. Tamagawa Univ. Res. Inst.
2:00 YY7 512.06 Cocaine experience dynamically alters
DNA methylation at plasticity genes within the nucleus
accumbens. J. J. DAY*; M. KIBE; K. ENGEL; J. SWEATT.
UAB.
3:00 YY8 512.07 BDNF signaling modulates striatal
glutmatergic transmission and facilitates cognitive flexibility.
D. E. D’AMORE*; K. N. PARIKH; B. A. TRACY; V. PARIKH.
Temple Univ.
4:00 YY9 512.08 Dynamic formation of cell assemblies in
the striatal network of the behaving primate. A. ADLER; S.
KATABI; I. FINKES; Z. ISRAEL; Y. PRUT; H. BERGMAN*.
Hebrew Univ., Hadassah university hospital.
1:00 YY10 512.09 Thalamic matrix projections drive layer 1
inhibitory cells in prefrontal cortex. S. J. CRUIKSHANK*; O.
J. AHMED; T. R. STEVENS; S. L. PATRICK; M. ELMALEH;
B. W. CONNORS. Brown Univ.
2:00 YY11 512.10 Layer 1 inhibitory interneurons of the
prefrontal cortex are physiologically diverse, spatially
stratified, and densely interconnected. O. J. AHMED*;
S. J. CRUIKSHANK; T. R. STEVENS; S. L. PATRICK; A.
GONZALEZ; E. HUR; B. W. CONNORS. Brown Univ.
3:00 YY12 512.11 Role of prefrontal cortical GABAergic
interneurons in the control of dopamine-dependent working
memory. S. E. LEW*; K. Y. TSENG. Univ. de Buenos Aires,
The Chicago Med. Sch.
4:00 YY13 512.12 Signaling of reward prediction errors by
fast-spiking interneurons in dorsomedial striatum is specific
for the action that produced them. T. A. STALNAKER*;
G. G. CALHOON; M. OGAWA; M. R. ROESCH; G.
SCHOENBAUM. Univ. of Maryland Sch. of Med., Univ. of
Maryland Sch. of Med., MIT, Univ. of Maryland Col. Park,
Univ. of Maryland Sch. of Med.
154 | Society for Neuroscience
1:00 YY14 512.13 Activation of 5-HT2 receptors decreases
prefrontal cortex activity and the power of gamma band
oscillations in freely-moving rats. J. WOOD*; Y. KIM; B.
MOGHADDAM. Univ. of Pittsburgh.
2:00 YY15 512.14 Roles of NMDA and AMPA receptor
stimulation in persistent firing in dorsolateral prefrontal
cortical networks during a working memory task. M. WANG*;
Y. YANG; N. J. GAMO; L. E. JIN; J. A. MAZER; X. WANG; A.
F. T. ARNSTEN. Yale Univ. Sch. of Med.
3:00 YY16 512.15 Dopaminergic regulation of firing behavior
in a population of layer V prefrontal cortex pyramidal cells. I.
T. ELLWOOD*; S. M. GEE; V. S. SOHAL. UCSF, UCSF.
4:00 YY17 512.16 Distinct subpopulations of layer v
pyramidal neurons persistently fire following d2 activation in
prefrontal cortex. S. GEE*; I. ELLWOOD; V. SOHAL. UCSF.
1:00 YY18 512.17 • Effect of PDE2 inhibition on
striatal dopamine in a microdialysis study reflects its
prodopaminergic activity in animal models. B. LANGEN;
R. DOST; H. LANKAU; N. HOEFGEN; T. HAGE*. biocrea
GmbH, biocrea Gmbh, Biocrea Gmbh.
2:00 YY19 512.18 Behavioral characterization of CamKIIcre-
GSK3βFlox mice. C. LATAPY*; V. RIOUX; J. BEAULIEU.
Laval Univ.
3:00 YY20 512.19 Neuronal activity in prefrontal cortex of
monkeys performing a multi-item working memory task. R.
O. KONECKY*; C. R. OLSON. Ctr. For the Neural Basis of
Cognition (CNBC), Univ. of Pittsburgh.
4:00 YY21 512.20 Role of hyperpolarization-activated cyclic
nucleotide gated (HCN) cation channels in stress-induced
prefrontal cognitive dysfunction. N. J. GAMO*; B. P. RAMOS;
C. D. PASPALAS; A. F. T. ARNSTEN. Yale Univ.
1:00 YY22 512.21 The neurons of the prefrontal cortex
are able to discriminate the value of food reinforcement in
the choice behavior task in cats. E. KULESHOVA*; V. V.
SIDORINA; A. V. ZALESHIN; G. K. MERZHANOVA. Inst. of
Higher Nervous Activity and Neurophysiol. of the Russian
Acad., IVND RAS.
2:00 YY23 512.22 Neural correlates of a spatial decision
before and after training. X. QI*; T. MEYER; T. R.
STANFORD; C. CONSTANTINIDIS. Carnegie Mellon Univ.,
Wake Forest Univ. Sch. of Med.
3:00 YY24 512.23 Oral administration of methylphenidate
increases dopamine release in the prefrontal cortex and
striatum in the monkey - a microdialysis study. T. KOJIMA; T.
KODAMA; Y. HONDA; M. WATANABE*. Tokyo Metropol Inst.
Med. Sci.
4:00 YY25 512.24 • Controllable stress produces resistance
to the effects of chronic unpredictable stress. J. G. N.
FLYER*; B. M. THOMPSON; L. R. WATKINS; S. F. MAIER.
Univ. of Colorado.
1:00 YY26 512.25 Acute and long-term stress-protective
effects of a controllable stressor are blocked by NMDA
receptor antagonist in the posterior dorsal medial striatum.
R. M. ALEKSEJEV; J. AMAT*; J. P. CHRISTIANSON; K. M.
SEATON; L. R. WATKINS; S. F. MAIER. Univ. Colorado.
2:00 YY27 512.26 • The long-lasting stress-protective
effects of controllable stress depend on plasticity in the
prelimbic medial prefrontal cortex. J. P. CHRISTIANSON*; R.
C. DRUGAN; J. AMAT; R. R. ROZESKE; R. ALEKSEJEV; L.
R. WATKINS; S. F. MAIER. Univ. of Colorado, Univ. of New
Hampshire.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 YY28 512.27 Dopaminergic and gabaergic modulation
of dendritic calcium transients in the rat prefrontal cortex. S.
D. ANTIC*; W. L. ZHOU. UConn Hlth. Ctr.
POSTER
513. Medial Temporal Lobe Systems: Molecular and Cellular
Mechanisms
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 YY29 513.01 Alterations in the neurochemical
pathways contribute to the enhanced memory in long
living ames dwarf mice. M. AHUJA; K. THIRUCHELVAM;
S. UTHAYATHAS; M. BUABIED; E. ABDEL RAHMAN;
V. SUPPIRAMANIAM; H. BROWN-BORG; M.
DHANASEKARAN*. Harrison Sch. of Pharmacy, Auburn
Univ., Univ. of North Dakota Sch. of Med. and Hlth. Sci.
2:00 YY30 513.02 Reduced cortactin phosphorylation in the
hippocampus is observed following spatial working memory
formation. M. L. OLSON*; B. J. CONRAD; J. S. WATSON.
Concordia Col., Concordia Col.
3:00 YY31 513.03 Quantitative mapping of monosynaptic
inputs to entorhinal layer II neurons via transgenicallytargeted
rabies virus suggests a strong direct projection from
hippocampal area CA2. D. C. ROWLAND*; A. WEIBLE; I.
WICKERSHAM; H. WU; H. SEUNG; M. R. MAYFORD; M. P.
WITTER; C. G. KENTROS. Univ. Oregon, Univ. of Oregon,
MIT, The Scripps Res. Inst., Norwegian Univ. of Sci. and
Technol.
4:00 YY32 513.04 Entorhinal cortex afferents to the
upper bank of the polysensory area of the superior
temporal sulcus in the nonhuman primate (Macaca
fascicularis). M. LEGIDOS GARCIA*; M. M. ARROYO-
JIMENEZ; A. MOHEDANO-MORIANO; P. MARCOS; E.
ARTACHO-PERULA; M. UBERO; M. MUÑOZ-LOPEZ; D.
HERNANDEZ; J. GONZALEZ-FUENTES; M. LAGARTOS-
DONATE; S. CEBADA-SANCHEZ; A. GALVEZ; M. IÑIGUEZ-
DE ONZOÑO; M. RAMOS; C. RUIZ-LOPEZ; D. AMARAL; R.
INSAUSTI. Sch. of Med., Dept. Psychiatry.
1:00 YY33 513.05 Postnatal development of the
hippocampal formation: A stereological study in macaque
monkeys. A. JABÈS; P. BANTA LAVENEX; D. G. AMARAL;
P. LAVENEX*. Univ. Fribourg, The M.I.N.D. Inst.
2:00 YY34 513.06 Axonal branching patterns of central
amygdala efferents in the rat: Single neurons reconstructions
and morphometric analysis. P. VEINANTE*. INCI CNRS
Upr3212.
3:00 YY35 513.07 Don’t overthink it: Cognitive benefits of
Premarin treatment depend on task complexity in a rodent
model of surgical-menopause. E. B. ENGLER-CHIURAZZI*;
J. CASELLI; K. SCHAEFER; C. GAMMAGE; H. BIMONTE-
NELSON. Arizona State Univ., Arizona Alzheimer’s
Consortium.
4:00 YY36 513.08 � Analysis of conditioning-induced
neocortical synapsin I expression. A. S. DAVIS*; L. S. CHAU;
R. GALVEZ. Univ. of Illinois.
1:00 YY37 513.09 Role of the medial septal-diagonal
band nucleus in working memory: Effects of cholinergic or
GABAergic lesions on memory demand and interference. A.
L. STEWART*; J. J. ROLAND; R. J. SERVATIUS; K. PANG.
New Jersey Med. Sch., New Jersey Hlth. Care Syst.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 YY38 513.10 • Reduced hippocampal acetylcholine
efflux after medial septal-diagonal band (MSDB) GABAergic
lesion is associated with impaired working memory:
behavioral and neurochemical effects of physostigmine.
J. J. ROLAND*; A. L. STEWART; L. M. SAVAGE; R. J.
SERVATIUS; K. C. H. PANG. NJMS-UMDNJ, Binghamton
University-SUNY, Dept. of Veteran Affairs Med. Ctr.
3:00 YY39 513.11 AMPA receptor-mediated currents
onto hippocampal GABAergic interneurons are required
for spatial working memory and normal spatial coding. K.
ALLEN*; A. CAPUTI; E. C. FUCHS; C. LE MAGUERESSE;
H. MONYER. Med. Fac. of Heidelberg Univ. and DKFZ.
4:00 YY40 513.12 Similarity of spontaneous and sensory
evoked activity does not imply Bayesian inference in cortex.
M. OKUN*; P. YGER; S. SAKATA; S. L. MARGUET; S. B.
HOFER; T. D. MRSIC-FLOGEL; K. D. HARRIS. Imperial
Col. London, Univ. of Strathclyde, Rutgers Univ., Exptl.
Neuropediatrics, Ctr. for Mol. Neurobio., Univ. Col. London.
1:00 YY41 513.13 Neocortical arc expression following
associative learning. L. S. CHAU*; S. KHAN; K. SIRAJ; M.
KHAN; A. PRAKAPENKA; R. GALVEZ. Univ. of Illinois, Univ.
of Illinois.
2:00 YY42 513.14 Cortical mitochondrial dysfunction after
traumatic brain injury precedes loss of memory. J. J. LUCKY;
J. E. BUONORA; M. A. SELAK; W. S. KEAN; A. YARNELL;
D. C. MCMULLEN; N. E. GRUNBERG; W. D. WATSON*;
J. T. COLE. Uniformed Services Univ., Uniformed Services
Univ.
3:00 YY43 513.15 The intracerebral signaling in diabetic rats
in relation with cognition -immunohistochemical studies-. A.
S. SHINGO*; S. KITO. Okinaka Mem. Inst. For Med. Res.,
Seisho Hosp.
POSTER
514. Dopamine Mechanisms and Physiology
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 YY44 514.01 Pedunculopontine tegmental nucleus
neurons provide reward-related signals to midbrain
dopamine neurons. S. HONG*; O. HIKOSAKA. NEI, NIH.
2:00 YY45 514.02 Endocannabinoids shape cue-evoked
dopamine signaling during reward seeking. E. B. OLESON*;
R. N. GENTRY; D. L. BERNSTEIN; R. CACHOPE; J. F.
CHEER. Univ. of Maryland Sch. Med.
3:00 YY46 514.03 Unilateral inactivation of the rostromedial
tegmental nucleus promotes contralateral turning and
increased ipsilateral phasic dopamine release in the nucleus
accumbens. S. R. EBNER*; M. F. ROITMAN. Univ. of Illinois
At Chicago.
4:00 YY47 514.04 Sugar reward and dopaminergic activity
during recurrent glucoprivation. L. A. TELLEZ*; X. REN; J.
G. P. FERREIRA; C. YECKEL; I. E. DE ARAUJO. The Jonh
B Pierce Lab. & Yale Univ. Sch. of Med., The Jonh B Pierce
Lab. & Yale Univ. Sch. of Publ. Hlth.
1:00 YY48 514.05 High frequency MFB stimulation boosts
reward but fails to increase the amplitude of stimulationinduced
dopamine transients in the nucleus accumbens. P.
SHIZGAL*; M. COSSETTE. Concordia Univ.
Neuroscience 2011 | Monday PM | 155
Mon. PM

2:00 YY49 514.06 Rewarding unilateral stimulation of the
medial forebrain bundle triggers dopamine transients in
both the ipsilateral and contralateral nucleus accumbens. M.
COSSETTE*; P. SHIZGAL. Concordia Univ.
3:00 YY50 514.07 Burst excitation of the VTA dopamine
neuron in both reward and escape motivated jumping
behaviors. D. V. WANG*; J. Z. TSIEN. Georgia Hlth. Sci.
Univ.
4:00 YY51 514.08 Ghrelin modulates phasic dopamine
signals evoked by food reward. J. J. CONE*; M. F.
ROITMAN. Univ. of Illinois at Chicago, Univ. of Illinois at
Chicago.
1:00 YY52 514.09 Molecular profiles and evolution of
dopaminergic cell populations in the vertebrate brain. H. A.
HOFMANN*; M. R. FONTENOT; L. A. O’CONNELL. Univ.
Texas at Austin.
2:00 YY53 514.10 Optogenetic stimulation of cholinergic
internuerons in the nucleus accumbens causes dopamine
release. J. M. IRVING*; Y. MATEO; J. F. CHEER. Univ. of
Maryland, Baltimore, NIAAA.
3:00 YY54 514.11 Distinct sources of direct inputs to VTA
and SNc dopamine neurons. M. WATABE-UCHIDA*; L. ZHU;
N. UCHIDA. Harvard Univ.
4:00 YY55 514.12 Dopamine uptake differentially regulates
tonic and phasic dopamine Dopamine signaling. J. K.
DREYER*; J. D. HOUNSGAARD. Univ. of Copenhagen.
1:00 YY56 514.13 Dopamine neuron NMDARs are required
for dynamic updating of a choice strategy depending on
decision difficulty. E. A. HUESKE*; S. TONEGAWA; N.
UCHIDA. MIT, Harvard Univ.
2:00 YY57 514.14 Footshock induced cFos in dopamine
innervated portion of the lateral habenula diminished
following lesion of the fasciculus retroflexus. P. L. BROWN*;
P. SHEPARD. Univ. of Maryland Baltimore.
3:00 YY58 514.15 Dorsal raphe nucleus modulates in vivo
dopamine release in the mouse nucleus accumbens core
through 5-HT3 receptors. H. WANG*; M. MORALES; R.
CACHOPE; J. CHEER. IRP/NIDA/NIH, Univ. of Maryland
Sch. of Med.
4:00 YY59 514.16 Reward and reward-predictive
cues are correlated with regionally selective phasic
dopamine signaling in the striatum. H. D. BROWN*; J. E.
MCCUTCHEON; M. E. RAGOZZINO; M. F. ROITMAN;
J. J. CONE. Univ. of Illinois At Chicago, Univ. of Illinois at
Chicago.
1:00 YY60 514.17 Exploring the synergy between dopamine
and glutamate in basal forebrain reward processes. M. A.
WARACZYNSKI*; L. W. KUEHN; W. ZWIFELHOFER. Univ.
Wisconsin Whitewater.
2:00 YY61 514.18 Foraging decision-making and fitness
in Drosophila models. X. ZHUANG*; W. CHI; L. XU; C.
FRAZIER. Univ. Chicago, Univ. of Chicago, Univ. of Chicago.
3:00 YY62 514.19 Phasic dopamine is selectively evoked in
nucleus accumbens core for a caloric vs. non-caloric reward.
J. E. MCCUTCHEON; J. A. BEELER; M. F. ROITMAN*. Univ.
Illinois At Chicago, The Univ. of Chicago.
4:00 YY63 514.20 Dopaminergic enhancement of local food
seeking is under global homeostatic control. J. A. BEELER*;
C. R. M. FRAZIER; X. ZHUANG. The Univ. of Chicago.
1:00 YY64 514.21 Elevated tonic dopamine reduces obesity
in leptin-deficient mice. C. R. FRAZIER*; J. BEELER; P.
VEZINA; X. ZHUANG. Univ. of Chicago, Univ. of Chicago,
Univ. of Chicago.
156 | Society for Neuroscience
POSTER
515. Reward, Attention, and Decision Making: Physiological
Mechanisms
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 YY65 515.01 Prefrontal projections to the subthalamic
nucleus: A study of the non-motor hyperdirect pathway
in the macaque monkey. W. I. HAYNES*; J. LEHMAN; J.
FEEKES; S. N. HABER. Univ. Pierre et Marie Curie, Univ. of
Rochester.
2:00 YY66 515.02 Structural connectivity of a reward-based
decision making network. A. BAKKOUR*; T. SCHONBERG;
E. BARKLEY-LEVENSON; R. A. POLDRACK. Univ. of Texas
at Austin, UCLA.
3:00 YY67 515.03 Representational connectivity analysis
between regions of the reward-based decision-making
network. T. SCHONBERG*; J. MUMFORD; A. BAKKOUR;
E. BARKLEY-LEVENSON; R. A. POLDRACK. Univ. of Texas
at Austin, Univ. of Texas at Austin, Univ. of California Los
Angeles.
4:00 YY68 515.04 The temporal derivative of expected
utility, a neural mechanism for dynamic decision-making.
X. ZHANG*; J. HRISCH. Columbia Univ., Columbia Univ.,
Columbia Univ.
1:00 YY69 515.05 Modeling adaptive decision making
with metaplastic synapses in environments that change on
multiple timescales. K. IIGAYA*; S. FUSI. Columbia Univ.,
Kavli Inst. for Brain Sci.
2:00 YY70 515.06 Effects of reward on memory and choice.
G. WIMMER*; E. K. BRAUN; D. SHOHAMY. Columbia Univ.
3:00 YY71 515.07 Bayesian integration of reward
predictions based on experienced value and decision
uncertainty. J. HIROKAWA*; A. LAK; A. KEPECS. Cold
Spring Harbor Lab.
4:00 YY72 515.08 The role of orbitofrontal and lateral
prefrontal cortex in economic choice and choice-guided
behavior. X. CAI*; C. PADOA-SCHIOPPA. Washington Univ.
Sch. of Med.
1:00 YY73 515.09 Neuronal activity in dorsal and ventral
anterior cingulate cortex during economic choice. C.
PADOA-SCHIOPPA*; X. CAI; J. MCCALL. Washington Univ.
2:00 YY74 515.10 Prefrontal and parietal contributions to
decision-making under risk. B. STUDER*; F. MANES; L.
CLARK. Univ. of Cambridge, Univ. of Cambridge, Favaloro
Univ., Inst. of Cognitive Neurol. (INECO).
3:00 YY75 515.11 Cortical normalization predicts stochastic
choice behavior in value-guided decision-making. K. LOUIE*;
P. W. GLIMCHER. New York Univ., New York Univ.
4:00 YY76 515.12 The role of the primate amygdala in visual
spatial attention. C. J. PECK*; B. LAU; C. D. SALZMAN.
Columbia Univ., Columbia Univ., New York State Psychiatric
Inst.
1:00 YY77 515.13 Attentional selection is modulated
by reward structure in patients with visual neglect. L.
DRUMMOND*; S. SHOMSTEIN. The George Washington
Univ.
2:00 YY78 515.14 Using electrical stimulation and fMRI
to map connections of the amygdala in monkey. A.
MESSINGER*; C. C. WINKLE; R. B. TOOTELL; L. G.
UNGERLEIDER. NIMH, NIMH.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 YY79 515.15 Neural activity in prefrontal cortex and the
amygdala during a context-switching task. A. SAEZ*; C. D.
SALZMAN. Columbia Univ., Columbia Univ.
4:00 YY80 515.16 Amygdala neurons adaptively encode the
motivational significance of conditioned stimuli in a relative
manner. R. SCHOER*; A. SAEZ; C. SALZMAN. Columbia
Univ., Columbia Univ., New York State Psychiatric Inst.,
W.M. Keck Ctr. on Brain Plasticity and Cognition, Kavli Inst.
for Brain Sci.
1:00 YY81 515.17 Role of posterior cingulate cortex (CGp)
in signaling rapid environmental changes for policy selection.
D. L. BARACK*; J. M. PEARSON; S. W. C. CHANG; M. L.
PLATT. Duke Univ., Duke Univ., Duke Univ.
2:00 YY82 515.18 Midbrain dopamine neurons represent
behavioral relevance in a working memory task. M.
MATSUMOTO*; M. TAKADA. Primate Res. Institute, Kyoto
Univ.
3:00 YY83 515.19 Neurons preferring positive states are
localized in area 14c in the monkey ventromedial prefrontal
cortex. I. E. MONOSOV*; O. HIKOSAKA. NEI/NIH.
4:00 YY84 515.20 Distinct involvement of direct and indirect
pathways in the dorsal striatum in goal-directed decision
making. H. MATSUMOTO*; M. UCHIDA; N. UCHIDA.
Harvard Univ.
1:00 YY85 515.21 Locus coeruleus neurons in monkeys:
Cost and benefits, or effort? S. BOURET*; B. J. RICHMOND.
Inst. du Cerveau et de la Moelle Epiniere, NIMH/NIH.
2:00 YY86 515.22 Comparison of monkeys’ behavioral
performances in reward schedule task with and without
decision-making by temporal discounting model of reward
value. T. SETOGAWA; T. MIZUHIKI*; K. INABA; M.
SHIDARA. Univ. Tsukuba.
3:00 YY87 515.23 Motivational saliency signal in ventral
striatum is modulated by genetic variation in the ARC gene
region. S. A. COLALILLO*; D. N. BLITZER; J. W. BARTER;
M. R. HAYNES; K. H. WANG; D. R. WEINBERGER; C. F.
ZINK. NIMH/NIH.
4:00 YY88 515.24 Reliability and validity of incentive
processing neural signals. C. C. WU*; A. J. TRUJILLO;
G. R. SAMANEZ-LARKIN; B. KNUTSON. Stanford Univ.,
Vanderbilt Univ.
1:00 YY89 515.25 Current source density analysis of error
and feedback signals in macaque supplementary eye field
during saccade countermanding. D. C. GODLOVE*; N. KIM;
G. F. WOODMAN; J. D. SCHALL. Vanderbilt Univ.
POSTER
516. Animal Models of PTSD
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 YY90 516.01 The effect of exposure to novel or shock
context on the activation of orexin neuron in a rat model of
shock-induced fear sensitization. X. CHEN; Y. LI; S. LI; G. J.
KIROUAC*. Univ. of Manitoba, Univ. of Manitoba.
2:00 YY91 516.02 Elevated prepro-orexin mRNA expression
in a rat model of post-traumatic stress disorder. X. CHEN*;
Y. LI; S. LI; H. BERGEN; G. J. KIROUAC. Univ. of Manitoba,
Univ. of Manitoba, Univ. of Manitoba.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
3:00 YY92 516.03 A computational model of fear
conditioning in rats: Implications for PTSD. A. A.
MOUSTAFA*; M. W. GILBERTSON; S. P. ORR; R. J.
SERVATIUS; C. E. MYERS. Rutgers, Manchester VA Med.
Ctr., Massachusetts Gen. Hosp. - East, Stress & Motivated
Behavior Institute, New Jersey Med. Sch., Grad. Sch. of
Biomed. Sciences, Univ. of Med. and Dent. of New Jersey,
Dept. of Veterans Affairs, New Jersey Hlth. Care Syst.,
Rutgers University-Newark.
4:00 ZZ1 516.04 � Anxiety and dendritic spine density
in the granule cells of the rat hippocampal dentate gyrus:
Implications for PTSD. N. SHAKFEH; N. MEYLAN;
R. F. MERVIS*; R. ADAMEC. Univ. of South Florida,
Neurostructural Res. Labs, Univ. South Florida Coll Med.,
Mem. Univ.
1:00 ZZ2 516.05 • Fear circuit revisited: The basal
nuclei of the amygdala are crucial for conditioned fear
expression. S. DUVARCI*; T. AMANO; D. POPA; D. PARE.
Rutgers Univ., Rutgers Univ., Inst. Natl. de la Sante et de la
Recherche Medicale.
2:00 ZZ3 516.06 A rat model of post-traumatic stress
disorder (PTSD) reproduces the hippocampal deficits seen
in humans. S. GOSWAMI*; S. SAMUEL; D. PARE. Rutgers,
The State Univ. of New Jersey.
3:00 ZZ4 516.07 Acute exposure to footshock stress prior
to acquisition and especially during consolidation of predator
odor auditory fear conditioning induces an extinction
resistant fear memory. M. J. CORLEY*; L. K. TAKAHASHI.
Univ. of Hawaii at Manoa.
4:00 ZZ5 516.08 Role of serum- and glucocorticoid-
induced kinase-1 (SGK1) in post-traumatic stress disorder
and depression. P. LICZNERSKI*; V. DURIC; M. BANASR;
K. N. ALAVIAN; N. M. FOURNIER; E. A. JONAS; R. S.
DUMAN. Yale Univ. Sch. of Med., Yale Univ. Sch. of Med.
1:00 ZZ6 516.09 Reelin mediates the neurosteroid-induced
long-lasting improvement of aggression and anxiety-like
behavior in a mouse model of PTSD. M. S. NIN*; L. A.
MARTINEZ; F. PIBIRI; M. NELSON; G. PINNA. Univ. of
Illinois At Chicago.
2:00 ZZ7 516.10 Glucocorticoids are required for extinction
of predator stress-induced hyperarousal. J. J. BLUNDELL*;
R. CLAY; M. HEBERT; G. GILL; L. STAPLETON; A.
PRIDHAM; M. COADY; J. BISHOP; R. ADAMEC. Mem.
Univ., Mem. Univ., Mem. Univ. of Newfoundland.
POSTER
517. Neuroethology: Comparative Sensory Physiology
Theme F: Cognition and Behavior
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 ZZ8 517.01 Differential lateralization in the NCM and
HVC of juvenile zebra finch males during song learning.
S. MOORMAN*; S. M. H. GOBES; M. KUIJPERS; M. A.
ZANDBERGEN; J. J. BOLHUIS. Utrecht Univ., Harvard
Univ., Neurosci. Program.
2:00 ZZ9 517.02 Associating RA activity with vocal
communication in the members of a social group of
zebra finches. A. TER MAAT; L. TROST; R. F. JANSEN;
M. L. GAHR*. Max Planck Inst. of Ornithology, VU Univ.
Amsterdam.
Neuroscience 2011 | Monday PM | 157
Mon. PM

3:00 ZZ10 517.03 Testosterone modulates genomic
responses to song and serotonergic innervation of
auditory areas in a seasonally breeding songbird. L. L.
MATRAGRANO*; M. M. LEBLANC; A. CHITRAPU; D. L.
MANEY. Emory Univ.
4:00 ZZ11 517.04 Using a song production model to
study tuning properties of selective neurons in zebra
finches. A. AMADOR*; Y. SANZ PERL; G. B. MINDLIN; D.
MARGOLIASH. Univ. of Chicago, Univ. of Buenos Aires.
1:00 ZZ12 517.05 • Discrimination of acoustic sequences in
songbird auditory forebrain. K. LU*; T. ZIV; D. S. VICARIO.
Rutgers State Univ.
2:00 ZZ13 517.06 Stimulus-specific adaptation in auditory
forebrain of freely moving zebra finches. J. XIAO; M. L.
PHAN; D. S. VICARIO*. Rutgers Univ., Rutgers Univ.
3:00 ZZ14 517.07 Using temporary inactivation to study
auditory processing and interactions in the songbird
forebrain. U. V. AIYA; P. A. SHUKLA; M. L. PIERCE; D. S.
VICARIO; M. L. PHAN*. Rutgers, State Univ. NJ, Rutgers,
State Univ. NJ.
4:00 ZZ15 517.08 Exposure to an unfamiliar acoustic
environment in adulthood alters lateralized processing. L.
YANG*; D. S. VICARIO. Rutgers Univ.
1:00 ZZ16 517.09 Fish geometry and electric organ
discharge determine differential functions of the
electrosensory epithelium. J. I. SANGUINETTI SCHECK*;
F. E. PEDRAJA; E. CILLERUELO; A. MIGLIARO; P.
AGUILERA; A. CAPUTI; R. BUDELLI. Universisdad De
La Republica, IIBCE - Inst. de Investigaciones Biologicas
Clemente Estable.
2:00 ZZ17 517.10 Multisensory cues for an image
stabilization task. S. A. STAMPER*; E. ROTH; N. J. COWAN;
E. S. FORTUNE. Johns Hopkins Univ., Johns Hopkins Univ.
3:00 ZZ18 517.11 Role of direction selective responses in
locomotor control. E. S. FORTUNE*; S. A. STAMPER; E.
TYTELL; E. ROTH; N. J. COWAN. Johns Hopkins Univ.,
Johns Hopkins Univ.
4:00 ZZ19 517.12 Dynamics of the natural electrosensory
input in a freely swimming weakly electric fish. H.
FOTOWAT*; R. R. HARRISON; R. KRAHE. McGill Univ.,
Intan Technologies, LLC, McGill Univ.
1:00 ZZ20 517.13 Tactile discrimination abilities in shorttailed
opossums (Monodelphis domestica). J. C. DOOLEY*;
J. LUU; B. GRUNEWALD; L. KRUBITZER. UC Davis, UC
Davis.
2:00 ZZ21 517.14 Implementation of exteroceptive reflexes
in the lamprey robot. A. WESTPHAL*; J. AYERS. Marine Sci.
Center, Northeastern Univ.
3:00 ZZ22 517.15 Central and behavioral consequences
of ototoxin -induced hair cell death in larval tadpoles. E. E.
ALEXANDER; A. MEGELA SIMMONS*. Brown Univ.
4:00 ZZ23 517.16 EEG beta and theta bands in an
anuran species change in response to biologically relevant
communication sounds. G. FANG; P. YANG; Y. TANG*.
Chengdu Inst. of Biol.
1:00 ZZ24 517.17 • Does sturgeon do use electrosense in
predating? J. SONG*; X. G. ZHANG; H. BLECKMANN; C. X.
FAN; H. Y. GUO; X. J. WANG. Shanghai Occean Univ., Bonn
Univ.
158 | Society for Neuroscience
2:00 ZZ25 517.18 Visual orientation behavior of two larval
insects to emissive colors. K. BEATTIE; V. D. SHIELDS*; J.
SANFORD; S. NGOSSO; F. OTALORA-LUNA; J. DICKENS.
Towson Univ, Biol. Sci., Inst. Venezolano de Investigaciones
Científicas, Henry A. Wallace Beltsville Agr. Res. Ctr. Plant
Sci. Inst.
POSTER
518. Genomics, Proteomics, and Systems Biology
Theme G: Novel Methods and Technology Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 ZZ26 518.01 miRNA profiling of bilateral rat
hippocampal CA3 by deep sequencing. H. HIRASE*; Y.
SHINOHARA; K. YAHAGI; M. KAWANO; H. NISHIYORI; C.
KAWAZU; N. SUZUKI; R. MANABE. RIKEN, Saitama Univ.,
RIKEN.
2:00 ZZ27 518.02 5-Hydroxymethylcytosine and
transcriptional profiles in specific cerebellar cell lines. M.
MELLEN*; S. KRIAUCIONIS; N. HEINTZ. The Rockefeller
Univ., The Ludwig Inst. for Cancer Res.
3:00 ZZ28 518.03 Profiling protein expression pattern in
BACE1 and BACE2 overexpression cell model using iTRAQ
technology. X. ZHANG*; W. CHEN; W. SONG. Univ. of
British Columbia.
4:00 ZZ29 518.04 � Comparative proteomic analysis of
primary schwann cells and the derived cell line RSC96
reveals three novel proteins involved in schwann cell
migration. F. DING*; Y. JI; M. SHEN; Q. CHEN; Q. HE.
Nantong University, China.
1:00 ZZ30 518.05 Micorarray analysis of transcription factor
expression during Xenopus inner ear development reveals
candidates for differential expression. S. M. VIRK*; C.
TRUJILLO-PROVENCIO; E. E. SERRANO. New Mexico St
Univ.
2:00 ZZ31 518.06 • Tools for the quantification of total and
phosphorylated Tau using ELISA and Luminex assays. J.
FEIN; J. KILHEENEY; T. SEBATA; J. HUUSKONEN*; M.
BLANKFARD. Life Technologies.
3:00 ZZ32 518.07 • A new approach to aid the discovery
of novel neuropeptides. K. SKOLD*; M. SÖDERQUIST;
M. BORÉN; H. WADENSTEN; P. E. ANDRÉN. Denator,
Uppsala Univ.
4:00 ZZ33 518.08 The challenge of neuron classification.
From Petilla to practice. S. D. LARSON; A. E.
BANDROWSKI; J. S. GRETHE; M. E. MARTONE; G. A.
ASCOLI; G. M. SHEPHERD*. UCSD, George Mason Univ.,
Yale Univ. Sch. of Med.
1:00 ZZ34 518.09 Alterations in epigenetic modifications
triggered by tungsten-alloy toxicity. R. VERMA*; X. XU;
M. K. JAISWAL; C. OLSEN; D. MEARS; G. CARETTI; Z.
GALDZICKI. Uniformed Services Univ. of the Hlth. Sci.,
Uniformed Services Univ. of the Hlth. Sci., Uniformed
Services Univ. of the Hlth. Sci., Dept. of Biomolecular Sci.
and Biotechnology, Univ. of Milan.
2:00 ZZ35 518.10 The protease substrate degradomes of
long-term depression and apoptosis in neurons. M. HAN; S.
JIAO; Z. LI; S. P. MARKEY*. NIMH, NIH, NIMH, NIH.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 ZZ36 518.11 Analysis the effect of small heat shock
protein 90 inhibitor on the glucose-stressed sensory neuron
proteome. L. ZHANG*; B. BLAGG; R. DOBROWSKY. Univ.
of Kansas, Univ. of Kansas.
4:00 ZZ37 518.12 Comparative analysis of transcriptional
phenotypes elicited by individual drugs of abuse. E.
LEHRMANN*; S. DE; Y. ZHANG; K. G. BECKER. Gene
Expression & Genomics Unit, NIA IRP, NIH.
1:00 ZZ38 518.13 High resolution genetic mapping of
multiple neuronal traits using an outbred population of mice
and low coverage next generation sequencing. J. NICOD*;
C. HASSETT; L. GOODSTADT; M. GOODSON; X. GAN;
B. NELL; R. JOYNSON; H. PAGE; C. ROWE; J. CLEAK; P.
HERNANDEZ-PLIEGO; R. MOTT; P. POTTER; T. WEAVER;
J. FLINT. Oxford Univ., Oxford Univ., MRC Harwell, MRC
Harwell.
2:00 ZZ39 518.14 Label-free quantitative proteomic
comparison of detergent-free and detergent-resistant lipid
rafts from neonatal mouse brain. M. LI; F. FAN; B. WAKIM;
B. HALLIGAN; H. YU*. Qilu Hospital, Shandong Univ., Univ.
of Mississippi Med. Ctr., Med. Col. of Wisconsin, Med. Col.
of Wisconsin, Med. Col. of Wisconsin.
3:00 ZZ40 518.15 A comprehensive and reproducible ioncurrent-based
proteomic expression profiling strategy to
characterize the changes in striatal proteins in response
to chronic cocaine exposure. J. QU; X. JIANG; J. LI; M.
SUAREZ; R. M. STRAUBINGER; A. C. THOMPSON*. Univ.
at Buffalo, Univ. at Buffalo, Univ. Buffalo.
4:00 ZZ41 518.16 Affinity purification of ubiquitinated
proteins and peptides from rat brain extracts. G. E. CRAFT*;
M. BANASR; T. LAM; K. STONE; A. C. NAIRN. Yale Univ.,
Yale Univ.
1:00 ZZ42 518.17 Proteomic analysis of metastable proteins
in culture cell models. G. XU*; J. GUINGAB; F. KOBEISSY;
M. S. GOLD; D. R. BORCHELT. Univ. Florida, Univ. Florida.
2:00 ZZ43 518.18 Neuronal subtype-specific proteomic
analysis of sub-cellular organelles. A. CHEN*; G. CRAFT; A.
C. NAIRN. Yale Univ.
3:00 ZZ44 518.19 Monogenic control of gene expression in
the murine hippocampus. R. S. NOWAKOWSKI*. FSU Col.
of Med.
4:00 ZZ45 518.20 The role of secondary and tertiary
structure prediction in determining the function of novel
genes found in Xenopus laevis. M. R. BEST*; F. FIORETTO;
A. DAL PALU; E. PONTELLI; T. SON; T. R. POWERS; E.
E. SERRANO. New Mexico State Univ., New Mexico State
Univ., New Mexico State Univ., New Mexico State Univ.
1:00 ZZ46 518.21 Drug delivery to the inner ear of rats
using magnetically steered nanoparticles. D. A. DEPIREUX*;
R. LEE; A. SARWAR; B. SHAPIRO. Univ. of Maryland At Col.
Park, Univ. of Maryland At Col. Park, Univ. of Maryland At
Col. Park.
2:00 ZZ47 518.22 • Dynamic proteomics approach using
heavy water ( 2 H 2 O) labeling to measure turnover rates of
proteins secreted by adult rat hippocampal stem / progenitor
cells. M. SHANKARAN*; C. KING; J. PRICE; W. HOLMES;
C. FESSLER; J. PROTASIO; M. HELLERSTEIN. Kinemed
Inc, Kinemed Inc, Kinemed Inc, Univ. of California.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
POSTER
519. Staining, Tracing, and Imaging Techniques II
Theme G: Novel Methods and Technology Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 ZZ48 519.01 • In-vivo assessment of human retinal
neuronal layers with optical coherence tomography. M.
A. SEIGO; S. B. SYC; A. STANKIEWICZ; E. FORD; C.
ECKSTEIN; S. D. NEWSOME; J. N. RATCHFORD; E. M.
FROHMAN; P. A. CALABRESI*; S. SAIDHA. Johns Hopkins
Univ., Univ. of Texas Southwestern.
2:00 ZZ49 519.02 Functional and stable expression of
the calcium indicating protein GCaMP3 in astrocytes
and neurons in adult rat hippocampus following in utero
electroporation with piggyBac transposase. J. M. GEE*; K. P.
FLOOD; R. M. SMEAL; M. N. ECONOMO; S. C. MORRIS;
M. R. CAPECCHI; K. S. WILCOX; J. A. WHITE; P. TVRDIK.
Univ. of Utah, Univ. of Utah, Boston Univ., Univ. of Utah.
3:00 ZZ50 519.03 Fluorophore-conjugated muscimol
inhibits behaviorally-induced activity-regulated cytoskeletonassociated
protein in the hippocampus. N. JACOBS; T.
A. ALLEN*; A. A. TURK; N. J. FORTIN. Univ. of California
Irvine, Univ. of California Irvine.
4:00 ZZ51 519.04 Creation of a 3D mouse brain map of
projectional space: Developing a methodological pipeline
for multiresolution automated image acquisition and online
data presentation. A. BERNARD*; B. WINSLOW; C.
SLAUGHTERBECK; C. LAU; S. HUANG; W. WAKEMAN;
B. YOUNGSTROM; L. NG; A. SODT; S. W. OH; P.
WOHNOUTKA; A. R. JONES; H. ZENG. Allen Inst. Brain
Sci.
1:00 ZZ52 519.05 A hemi-perfusion method for collecting
fresh frozen and perfusion-fixed tissue from the same
animal. A. C. CUMMINS*; J. L. FUDGE; H. A. CAMERON;
P. NOBLE. Nonhuman Primate Neurobio. Core, NIMH NIH,
Univ. of Rochester Med. Ctr., NIMH NIH.
2:00 ZZ53 519.06 Localization of presynaptic inputs
on dendrites of individually labeled neurons in three
dimensional space using a center distance algorithm. B. D.
AUSDENMOORE; D. R. LADLE*. Wright State Univ.
3:00 ZZ54 519.07 Mapping circuit development of
anatomically- and genetically-defined neuronal populations
in the mouse brain. S. A. SORENSEN*; S. W. OH; L.
MADISEN; T. N. NGUYEN; A. R. JONES; H. ZENG. Allen
Inst.
4:00 ZZ55 519.08 Allen mouse brain connectivity atlas
project. S. W. OH*; J. A. HARRIS; L. L. NG; A. BERNARD;
Q. WANG; B. WINSLOW; S. A. SORENSEN; L. MADISEN;
C. LAU; W. WAKEMAN; J. KIDNEY; M. J. HAWRYLYCZ;
J. G. HOHMANN; J. W. PHILLIPS; C. DANG; P.
WOHNOUTKA; A. R. JONES; H. ZENG. Allen Inst. for Brain
Sci.
1:00 ZZ56 519.09 Toward a mouse connectome: A highthroughput
approach for the characterization of long-range
connectivity in the mouse brain. B. ZINGG; H. HINTIRYAN;
L. GOU; D. LEE*; Q. NG; A. JOSHI; S. YAMASHITA; M.
BOTA; L. SWANSON; A. TOGA; H. DONG. UCLA Lab. of
Neuroimaging, USC.
2:00 ZZ57 519.10 Cortical double co-injections of neuronal
tracers reveal subdivisions of the dorsal anteromedial
thalamic nucleus (AMd). H. HINTIRYAN; B. ZINGG; L. GOU;
L. W. SWANSON*; A. W. TOGA; H. DONG. UCLA, USC.
Neuroscience 2011 | Monday PM | 159
Mon. PM

3:00 ZZ58 519.11 Cortical connection in the inferotemporal
cortex of marmoset monkey identified by in vivo connection
imaging. W. SUZUKI*; T. BANNO; T. TANI; N. ICHINOHE.
Natl. Inst. of Neurosci., Hirosaki Unversity, Sch. of Med.
4:00 ZZ59 519.12 Uncoupling illumination duration from
acquisition during single-molecule tracking increases
localization precision of rapidly moving molecules:
Application to super-resolution imaging of spine morphology.
N. A. FROST; T. A. BLANPIED*. Univ. of Maryland Sch. of
Med., Univ. of Maryland Sch. of Med.
1:00 ZZ60 519.13 Dendritic spines of olfactory bulb granule
cells are dynamic throughout life. K. A. SAILOR*; G. SUN; E.
HUANG; H. SONG; G. MING. Johns Hopkins Univ.
2:00 ZZ61 519.14 • Assessing pharmacokinetics of
intrathecally injected 111In-DTPA and 18F-FDG via in
vivo imaging in rats. J. HOPPIN; J. Y. HESTERMAN; K.
D. ORCUTT; W. CUPELO; M. GERMINO; E. WHITE; C.
LACKAS; M. LANE; D. KENTALA; T. REINDFIELD; K.
PICKEL; A. VERMA*. inviCRO, MPI Res., Biogen Idec.
3:00 ZZ62 519.15 • Imaging brain infarct with a novel
fluorescent probe PSVue794 in a rat middle cerebral artery
occlusion-reperfusion model. C. CHU; X. HUANG; J. J. LUO;
B. D. GRAY; K. Y. PAK; N. J. DUN*. Temple Univ. Sch. Med.,
Temple Univ. Sch. Med., Mol. Targeting Technologies, Inc.,
Temple Univ. Sch. Med.
4:00 ZZ63 519.16 • Comparison of an atlas-based method
with results from manual tractography for detecting age
effects on fiber tract FA in a pediatric population. Y. CHUNG*;
V. VENKATRAMAN; D. J. HAGLER JR; C. PUNG; T.
JERNIGAN; A. DALE. UCSD, UCSD, UCSD, UCSD, UCSD.
1:00 ZZ64 519.17 Solvatochromic probes as powerful tools
for studying the physico-chemical composition of myelin. P.
K. STYS*; Y. ZHAO; W. TEO. Univ. Calgary.
2:00 ZZ65 519.18 Comprehensive anatomical and genetic
mapping of axonal projections in the mouse brain - labeling
approaches and data analysis. J. A. HARRIS*; S. W. OH;
Q. WANG; M. MORTRUD; T. NGUYEN; B. OUELLETTE; B.
WINSLOW; A. BERNARD; H. ZENG. Allen Inst. For Brain
Sci.
3:00 ZZ66 519.19 � High-speed voltage-sensitive dye
imaging of neuronal activity propagation through limbic brain
networks in vitro. J. STEPAN; J. DINE; C. AVRABOS; G.
VON WOLFF; W. ZIEGLGANSBERGER*; F. HOLSBOER;
M. EDER. Max-Planck-Inst Psychiatry.
4:00 ZZ67 519.20 Optical Imaging of the visual cortex on
both hemispheres through intact skull. K. YANG*; J. M.
LEDUE; M. CYNADER. Brain Res. Ctr.
1:00 ZZ68 519.21 Comparison between adeno-associated
virus and biotinylated dextran amine tracers for highthroughput
analysis of connectivity of the mouse brain. Q.
WANG*; J. A. HARRIS; A. BERNARD; M. MORTRUD; A.
HENRY; S. W. OH; H. ZENG; J. G. HOHMANN. The Allen
Inst. For Brain Sci., The Allen Inst. for Brain Sci.
2:00 ZZ69 519.22 PCR fragments as probes for detection
of double-strand dna breaks in tissue sections. V. V.
DIDENKO*. Baylor Col. of Med.
3:00 ZZ70 519.23 Branch merging algorithm for automated
tracing of neurites from light microscopy stacks of images.
A. B. STEPANYANTS*; V. MEHTA; P. CHOTHANI.
Northeastern Univ.
4:00 ZZ71 519.24 In vivo optical imaging of individual cells
in deep brain regions of mouse brain. J. PASCUAL BRAZO*;
S. AELVOET; Z. DEBYSER; V. BAEKELANDT. Fac. of
Medicine, K.U. Leuven.
160 | Society for Neuroscience
1:00 ZZ72 519.25 Simultaneous chemical activation
and image scanning on single scanner laser scanning
microscope systems. P. J. HELM*; S. AUGUSTINAITE; P.
HEGGELUND; T. REPPEN. Univ. of Oslo, Ctr. for Mol. Biol.
and Neurosci. (CMBN), Univ. of Oslo, Univ. of Oslo.
2:00 ZZ73 519.26 Scratching the surface: A high-throughput
platform for traumatic brain injury research. C. JOWERS; A.
TABERNER; M. DRAGUNOW*; I. ANDERSON. Auckland
Bioengineering Institute, Univ. of Auckland, Engin. Science,
Univ. of Auckland, Univ. of Auckland.
3:00 ZZ74 519.27 • Optically measured propagation speed
of action potentials in dendrites. G. SZALAY; G. KATONA; P.
MAÁK; M. VERESS; A. KASZÁS; B. CHIOVINI; B. ROZSA*.
Inst.of Exptl. Med., Budapest Univ. of Technol., Pázmány
Péter Catholic Univ.
4:00 ZZ75 519.28 Axonal projection roadmap of the main
olfactory bulb (MOB): A connectome approach in c57bl/6
mice. H. DONG*; H. HINTIRYAN; L. GOU; B. ZINGG. UCLA
Sch. Med.
1:00 ZZ76 519.29 High resolution stereotaxy using
structured light imaging. B. J. GRAHAM*; S. CAROUSO; D.
D. COX. The Rowland Inst. At Harvard.
2:00 ZZ77 519.30 Ca 2+ imaging of live myelinated axons
using FRET spectral microscopy. P. C. CHRISTENSEN*; O.
GRIESBECK; P. K. STYS. Univ. of Calgary, Hotchkiss Brain
Inst., Max Planck Inst. of Neurobio., Univ. of Calgary.
POSTER
520. New Techniques: Microelectrode-Based Approaches
Theme G: Novel Methods and Technology Development
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 ZZ78 520.01 New flexible neuronal probes for longterm
experiments. T. M. DOUBLET*; D. KHODAGHOLY; E.
ISMAILOVA; P. QUILICHINI; P. LELEUX; A. GHESTEM; T.
HERVE; G. MALLIARAS; C. BERNARD. INSERM U 751,
Ctr. Microélectronique de Provence, Microvitae, INSERM U
751.
2:00 ZZ79 520.02 Long-term time lapse recordings from
single neurons in the mouse neocortex. L. COHEN*; H.
MEIRI; Y. YAROM; A. MIZRAHI. The Hebrew Univ. of
Jerusalem.
3:00 ZZ80 520.03 Whole cell K+ currents in PC12 cells
grown on carboxylated-multiwalled carbon nanotube coated
substrates. S. MINNIKANTI; S. CHOI; J. J. PANCRAZIO; N.
PEIXOTO*. George Mason Univ.
4:00 ZZ81 520.04 Recording from neurons in brain tissue
with solid-conductor, intracellular nanoelectrodes. M. R.
ANGLE*; A. T. SCHAEFER. Max Planck Inst. for Med. Res.
1:00 ZZ82 520.05 • Characterization of embryonic stem
cell-derived neurons on an high-throughput automated
patch clamp system. X. JIANG*; K. COOK; J. HESLEY; J.
COSTANTIN; A. POWE; S. L. STICE; O. SIRENKO. Mol.
Devices, Inc., ArunA Biomedical, Inc.
2:00 ZZ83 520.06 Implantable hybrid arrays with silicon and
bi-morphic probes and their tissue response. M. HAN*; D.
B. MCCREERY; P. S. MANOONKITIWONGSA,. Huntington
Med. Res. Inst., Huntington Med. Res. Inst., Huntington Med.
Res. Inst.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.

3:00 ZZ84 520.07 Development of hybrid arrays for brainmachine
interface using commercial microelectrodes. D. B.
MCCREERY*; A. KOUPRINE; V. PIKOV; H. DUONG; M.
HAN. Huntington Med. Res. Inst., Huntington Med. Res.
Inst.,, Huntington Med. Res. Inst.
4:00 ZZ85 520.08 Lab-bench perfusion setup for combined
long-term multielectrode in vitro electrophysiology and timelapse
microscopy. A. V. MARTINIUC; F. DIFATO; M. NANNI;
F. SUCCOL; A. KNOLL; F. BENFENATI; A. BLAU*. Tech.
Univ. Munich (TUM), The Italian Inst. of Technol. (IIT).
1:00 ZZ86 520.09 The array drive: Optimizing the yield
and flexibility of chronic, multielectrode array recordings. B.
ENGLITZ*; S. V. DAVID; D. A. DEPIREUX; S. A. SHAMMA.
Univ. of Maryland, Col. Park.
2:00 ZZ87 520.10 Validation of a high-density
microelectrode array for acute brain slice recordings. E.
FERREA; L. MEDRIHAN; A. MACCIONE; D. GHEZZI; P.
BALDELLI; F. BENFENATI; L. BERDONDINI*. Inst. Italiano
di Tecnologia, Univ. di Genova, Italian Inst. of Technol.
3:00 ZZ88 520.11 Intracellular recording using vertically
aligned nanowire electrode arrays in hippocampal neurons
and GH3 cells. K. LEE; S. KIM; I. KIM; H. RHIM; S. PARK;
H. CHOI*. Yonsei Univ., Korea Inst. of Sci. and Technol.,
Yonsei Univ.
4:00 AAA1 520.12 • A large-scale, distributed recording
system for semi-chronic monitoring of cortical and subcortical
neuronal activity in alert monkeys-VI. C. M. GRAY*;
B. GOODELL; N. DOTSON; R. SALAZAR. Montana State
Univ.
1:00 AAA2 520.13 A multi-tiered tetrode with an integrated
optical channel for neuronal unit recording with localized light
delivery. M. GHEEWALA; S. LIN; W. SHIH; J. A. DANI; J. C.
WOLFE*. Univ. of Houston, Baylor Col. of Med.
2:00 AAA3 520.14 Extensive characterization of pro- and
anti-convulsive compounds in acute hippocampal slices
recorded with Multi-Electrode Arrays (MEA). E. STEIDL*; M.
GLEYZES; F. MADDALENA; B. QUENTIN; H. SAVINEL; R.
TEYSSIE; B. BUISSON. Neuroservice, NEUROSERVICE.
3:00 AAA4 520.15 Dissecting the orchestrated electrical
activity in neuronal networks: A multimodal approach
combining high density MEAs with fluorescence imaging. A.
MACCIONE*; S. ULLO; A. SIMI; A. DEL BUE; E. PETRINI;
A. BARBERIS; V. MURINO; L. BERDONDINI. Inst. Italiano
Di Tecnologia, Inst. Italiano Di Tecnologia.
4:00 AAA5 520.16 High density utah microelectrode array for
neural interface applications. P. TATHIREDDY; R. SHARMA;
L. RIETH*; H. WARK; R. NORMANN; F. SOLZBACHER.
Univ. of Utah, Univ. of Utah, Univ. of Utah.
1:00 AAA6 520.17 Flexible substrate temperature sensor
array for brain interfaces. I. KIM*; R. FOK; Y. LI; T. N.
JACKSON; B. J. GLUCKMAN. Penn State Univ., Penn State
Univ., Penn State Univ., Penn State Univ., Penn State Univ.
2:00 AAA7 520.18 • A perfusion-integrated MEA for
fluidic control in acute and long-term studies of network
electrophysiology. M. A. MCCLAIN*; E. BROWN; S.
RAJARAMAN; T. O’BRIEN; J. ROSS. Axion Biosystems.
3:00 AAA8 520.19 • Multiwell microelectrodes arrays
(mwmeas) for network electrophysiology. S. RAJARAMAN*;
M. A. MCCLAIN; C. KARNATI; R. D. GRIER; I. C. HENRICH;
J. D. ROSS. Axion Biosystems, Inc.
4:00 AAA9 520.20 3D neuron localization with silicon
electrode arrays. T. BLANCHE*. Univ. of California, Berkeley.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
1:00 AAA10 520.21 • Interfacing silicon neural probes
with CMOS electronics: Toward very large scale
electrophysiology in awake behaving mice. R. R.
HARRISON*; J. DU; T. J. BLANCHE; H. A. LESTER; S.
C. MASMANIDIS. Intan Technologies, Caltech, Univ. of
California, Berkeley, Caltech.
2:00 AAA11 520.22 Modified carbon-fiber microelectrodes for
measuring adenosine clearance rates and stimulated efflux.
A. E. ROSS*; B. J. VENTON. Univ. of Virginia.
3:00 AAA12 520.23 Carbon nanotube-modified
microelectrodes for measurements of neurotransmitters in
Drosophila. N. XIAO*; B. J. VENTON. Univ. of Virginia.
4:00 AAA13 520.24 • A turn key fast scan system for
detection of in vivo dopamine release. E. NAYLOR; D.
A. JOHNSON; M. JANKE; D. AILLON; S. GABBERT;
H. HARMON; J. TOLEDO SALAS; G. WILSON; D. A.
JOHNSON*; P. PETILLO. Pinnacle Technology, Inc., Univ. of
Kansas.
1:00 AAA14 520.25 • Modeling wireless control of a singlediode
stimulator. D. W. GULICK*; B. C. TOWE. Arizona State
Univ.
2:00 AAA15 520.26 • Microfluidic pipette for localized
perfusion in tissue slices. A. AINLA; E. T. JANSSON; C.
BOSTRÖM; G. D. M. JEFFRIES; K. E. JARDEMARK*;
A. JESORKA; O. ORWAR. Chalmers Univ. of Technol.,
Karolinska Inst.
3:00 AAA16 520.27 Morphological and electrophysiological
parameters of spatially complex networks of peripheral
sensory neurons formed in microfluidic devices. A.
MADURAM; E. JOHNSON; M. CATANHO; S. RUBAKHIN; D.
JONES; R. GILLETTE*; J. SWEEDLER. Univ. Illinois, Univ.
Illinois, Univ. Illinois, Univ. Illinois.
4:00 AAA17 520.28 Unidirectional burst propagation is
controlled by strength of connectivity in a predefined
neural network. L. PAN; S. ALAGAPAN; E. FRANCA; T. B.
DEMARSE; G. J. BREWER; B. C. WHEELER*. Univ. of
Florida, Southern Illinois Univ. Sch. of Med., Univ. of Florida.
1:00 AAA18 520.29 Improved methods for acute brain slice
preparation from adult and aging brain. J. T. TING*; G.
FENG. McGovern Inst. for Brain Res. at MIT, Duke Univ.
Med. Ctr.
Neuroscience 2011 | Monday PM | 161
Mon. PM

ABSTRACT
NUMBER STATEMENT
Conflict of Interest Statements
The following presenters, signified by a dot (•) in the program, indicated a real or perceived conflict of interest.
Presenters listed without a dot in the program had no financial relationships to disclose.
309 Y. Smith: Research Grant; Oxford Biomedica, Oxford, UK.
317.01 D.A. Lewis: Other Research Support; Currently receives
investigator-initiated research support from the BMS
Foundation, Bristol-Myers Squibb, Curridium Ltd and Pfizer.
Consultant/Advisory Board; 2008-2010 served as a consultant
in the areas of target identification and validation and new
compound development to AstraZeneca, BioLine RX, Bristol-
Myers Squibb, Merck, Neurogen and SK Life Science.
319.02 C. Volbracht: Employment; H. Lundbeck A/S.
319.07 E.J. Davidowitz: Employment; Oligomerix, Inc. P. Lopez:
Employment; Oligomerix, Inc. J.G. Moe: Employment;
Oligomerix, Inc..
319.11 A.M. Goate: Research Grant; AstraZeneca.
320.01 C.G. Habeck: Employment; Columbia University.
Research Grant; NIH/NIB 5R01EB006204-03, NIH/NIA
5R01AG026114-02.
320.02 P.A. Cook: Research Grant; This work is supported by
Pfizer Inc. under the Penn-Pfizer Alliance. M. Grossman:
Consultant/Advisory Board; Pfizer, Inc. F.J. Swenson:
Employment; Pfizer Inc
320.05 M. Grossman: Consultant/Advisory Board; Forest Labs, Allon
Therapeutics, Pfizer Pharmaceuticals.
320.07 S. Das: Research Grant; Penn-Pfizer Alliance Grant 10295.
P. Yushkevich: Research Grant; Penn-Pfizer Alliance Grant
10295. D. Wolk: Research Grant; Penn-Pfizer Alliance Grant
10295.
321.09 G.P. Dietz: Employment; H. Lundbeck A/S. K. Bayer
Andersen: Employment; H. Lundbeck A/S. J. Leander
Johansen: Employment; Millipore. K. Fog: Employment; H.
Lundbeck A/S. G.P. Smith: Employment; H. Lundbeck A/S.
322.05 S.A. Busch: Employment; Athersys, Inc. J.A. Hamilton:
Employment; Athersys, IncA. DeChant:. A.E. Ting:
Employment; Athersys, Inc. R.J. Deans: Employment;
Athersys, Inc.. R.W. Mays: Employment; Athersys, Inc..
322.12 V.A. Lennon: Other; US patent issued to Mayo Foundation
pertaining to AQP4-IgG as diagnostic test.
322.14 A.I. Kaplin: Ownership Interest; Adam Kaplin is the Inventor
of ROI JHU Ref.: C10587 “Psychometric Assessment Gained
by Electronic Sampling (PAGES), a Technology, to Ascertain,
Organize and Monitor Patient’s Self- assessment of Vario.
324.07 S. Mysore Gopalrao: Other Research Support; FWO-
Vlaanderen, EFV/10/008, GOA, IUAP324.08 N. Miyakawa:
Research Grant; Kakenhi 21700442. K. Majima: Research
Grant; JSPS. T. Suzuki: Research Grant; SRPBS from
MEXT. Y. Kamitani: Research Grant; SRPBS from MEXT.
Other Research Support; Nissan foundation. I. Hasegawa:
Research Grant; SRPBS from MEXT.
324.08 N. Miyakawa: Research Grant; Kakenhi 21700442. K.
Majima: Research Grant; JSPS. T. Suzuki: Research Grant;
SRPBS from MEXT. Y. Kamitani: Research Grant; SRPBS
from MEXT. Other Research Support; Nissan foundation. I.
Hasegawa: Research Grant; SRPBS from MEXT.
330.17 O. Gonzalez-Perez: Research Grant; CONACyT (C.B.2008:
101476
331.13 A. Boscolo: Employment; NIH/NICHD HD 44517 (to V.J-T.),
Harold Carron endowment (to V.J-T). Research Grant; John
E. Fogarty Award TW007423-128322 (to P.I. V.J-T.), NIH/
NICHD HD 44517 (to V. J-T.). Other Research Support;
V.J-T. is an Established Investigator of the American Heart
Association. V. Jevtovic-Todorovic: Research Grant;
NIH/NICHD HD 44517 (to V.J-T.), John E. Fogarty Award
TW007423-128322 (to P.I. V.J-T.), NIH/NICHD HD 44517 (to
V. J-T.), Harold Carron endowment (to V.J-T).
331.14 J.A. Starr: Employment; University of Virginia, Department
of Anesthesiology. V. Jevtovic-Todorovic: Research
Grant; NIH/NICHD HD 44517, NIH/NICHD HD 44517. Other
Research Support; John E. Fogarty Award TW007423-
162 | Society for Neuroscience
ABSTRACT
NUMBER STATEMENT
128322, Harold Carron endowment.
332.04 J.B. Carmel: Research Grant; NIH NS064004. Other
Research Support; Burke-Cornell Medical Research Institute.
Consultant/Advisory Board; Acorda Therapeutics J.H. Martin:
Research Grant; NIH NS064004.
333.01 Y.S. Zhao: Research Grant; Hong Kong RGC GRF grant
662108.
333.07 P.P. Li: Employment; HKUST. Research Grant; Hong Kong
RGC GRF grant 662108.
334.09 A.M. Taylor: Ownership Interest; Xona Microfluidics, LLC
335.15 A.E. Garrison: Employment; DSM-Martek. M.J. Weiser:
Employment; DSM-Martek. C.M. Butt: Employment; DSM-
Martek.
335.19 S.H. Scott: Ownership Interest; Co-founder and CSO, BKin
Technologies Ltd..
336.05 D.B. Timmermann: Employment; NeuroSearch. M. Grunnet:
Employment; NeuroSearch. D. Peters: Employment;
NeuroSearch. P.K. Ahring: Employment; NeuroSearch.
336.11 G. von Euler: Employment; AstraZeneca. D. Bertrand:
Employment; HiQScreen Sàrl. E.C. Johnson: Employment;
AstraZeneca.
336.16 I. Bermudez: Research Grant; Brookes QR grants. Other
Research Support; The Royal Society.
336.18 S. Valera: Other Research Support; Pfizer Global Research
& Development. R.S. Hurst: Employment; Pfizer Global
Research & Development. H. Rollema: Consultant/Advisory
Board; Pfizer Research & Development. D. Bertrand: Other
Research Support; Pfizer Research & Development.
336.19 M. Grupe: Employment; NeuroSearch. M. Grunnet:
Employment; NeuroSearch. J.K. Christensen: Employment;
NeuroSearch. P.K. Ahring: Employment; NeuroSearch.
337.02 B. Patel: Research Grant; MRC.
338.05 J.F. Liu: Employment; CoNCERT Pharmaceuticals, Inc. S.
Harbeson: Employment; CoNCERT Pharmaceuticals, Inc. V.
Uttamsingh: Employment; CoNCERT Pharmaceuticals,
Inc. A.J. Morales: Employment; Novartis Institutes for
BioMedical Research. S. Nguyen: Employment; CoNCERT
Pharmaceuticals, Inc. G. Bridson: Employment; CoNCERT
Pharmaceuticals, Inc. C. Cheng: Employment; CoNCERT
Pharmaceuticals, Inc. L. Bradley: Employment; CoNCERT
Pharmaceuticals, Inc. A. Aslanian: Employment; CoNCERT
Pharmaceuticals, Inc. L. Wu: Employment; CoNCERT
Pharmaceuticals, Inc. R. Tung: Employment; CoNCERT
Pharmaceuticals, Inc..
338.06 S.L. Harbeson: Employment; CoNCERT Pharmaqceuticals,
Inc. J.F. Liu: Employment; CoNCERT Pharmaqceuticals,
Inc. V. Uttamsingh: Employment; CoNCERT
Pharmaqceuticals, Inc. S. Nguyen: Employment; CoNCERT
Pharmaceuticals, Inc. G. Bridson: Employment; CoNCERT
Pharmaceuticals, Inc. L. Wu: Employment; CoNCERT
Pharmaceuticals, Inc..
339.03 A.M. Basso: Employment; Abbott. C. Klein: Employment;
Abbott. M. Zhang: Employment; Abbott. A.L. Relo:
Employment; Abbott. E.A. Cronin: Employment; Abbott. V.A.
Roderwald: Employment; Abbott. L.E. Rueter: Employment;
Abbott. K.M. Wicke: Employment; Abbott. W. Amberg:
Employment; Abbott. M. Schmidt: Employment; Abbott.
339.09 W.S. Messer: Research Grant; NS 35127. Ownership Interest;
Mithridion, Inc.. Consultant/Advisory Board; Mithridion, Inc..
339.11 Y.G. Shanker: Employment; Amgen. S. Altmann:
Employment; Amgen. D. Ortuno: Employment; Amgen. A.
Munzli: Employment; Amgen. R. Schwandner: Employment;
Amgen. L. Schenkel: Employment; Amgen.
340.02 I.M. Newington: Employment; General Electric Healthcare
Unlimited. R. Ahmad: Employment; General Electric
Healthcare Unlimited. H. Betts: Employment; General Electric

ABSTRACT
NUMBER STATEMENT
Healthcare Unlimited. R. Davis: Employment; General
Electric Healthcare Unlimited. D. Hiscock: Employment;
General Electric Healthcare Unlimited. J.S.D. Kumar:. J.J.
Mann:. R.V. Parsey: S. Plant: Employment; General Electric
Healthcare Unlimited. E. Robins: Employment; General
Electric Healthcare Unlimited. G. Smith: Employment;
General Electric Healthcare Unlimited. D. Wynn:
Employment; General Electric Healthcare Unlimited.
340.05 A. Jucaite: Other Research Support; Astrazeneca. D.J.
McCarthy: Other Research Support; AstraZeneca, Karolinska
Institutet. C. Halldin:. L. Farde: Other Research Support;
AstraZeneca Pharmaceuticals. S. Kanes: Other Research
Support; AstraZeneca.
340.11 T. Shiga: Research Grant; LRI by JCIA, a grant by MEXT.
341.02 C. Rojas: Other Research Support; Helsinn Healthcare SA.
M. Stathis: Other Research Support; Helsinn Healthcare
SA. S. Cantoreggi: Employment; Helsinn Healthcare SA.
C. Pietra: Employment; Helsinn Healthcare SA. B. Slusher:
Other Research Support; Helsinn Healthcare SA.
341.22 Y. Guo: Employment; Cleveland VA Medical Research.
Research Grant; VA Merit Award Grant. P. Feng: Employment;
Cleveland VA Medical Research Foundation. Research Grant;
VA Merit Award Grant.
341.25 V.N. Barth: Employment; Eli Lilly & Co. N.A. Goebl:
Employment; Eli Lilly & Co. J. Tauscher: Employment; Eli
Lilly & Co
343.21 J.P. jacobsen: Research Grant; Lundbeck A/S. P. Plenge:. W.
Roberts:. A. Pherson: Employment; Lundbeck A/S. C.M.
Sanchez: Employment; Lundbeck A/S. M.G. Caron:
Research Grant; Lundbeck A/S.
344.04 P. Chang: Research Grant; CMRPD170423.
344.08 H. Chen: Employment; Caliper Life Sciences.
344.11 K.D. Niswender: Research Grant; Novo Nordisk. Consultant/
Advisory Board; Novo Nordisk.
344.15 B. Sharma: Research Grant; NIH Grant DA027845. P.
Akula Bala: Research Grant; NIH Grant DA027845. R.
Acharya: Research Grant; NIH Grant DA027845. J.D.
Foster: Research Grant; NIH Grant DA027845. S. Noskov:.
A.H. Newman: Employment; NIH-NIDA-IRP. R. Vaughan:
Research Grant; NIH Grant DA027845. L.K. Henry: Research
Grant; NIH Grant DA027845.
345.14 F. Hu: Research Grant; China MOST 973 2010CB8339002. J.
Ren:. M. Luo: Research Grant; China MOST 973
2010CB8339002.
345.17 K.K. Walder: Research Grant; NIH NS072735. Other
Research Support; Grinnell College. S. Ryan: Employment;
Grinnell College. Research Grant; NIH NS072735. Other
Research Support; Grinnell College. T. Bzdega: Employment;
Georgetown University. Research Grant; NIH NS38080. R.
Olszewski: Employment; Georgetown University. Research
Grant; NIH NS38080. J.H. Neale: Employment; Georgetown
University. Research Grant; NIH NS38080. C.A. Lindgren:
Employment; Grinnell College. Research Grant; NIH
NS072735. Other Research Support; Grinnell College.
345.21 W.F. Colmers: Research Grant; CIHR MT10520. J.H. Urban:
Research Grant; NIH R01-MH090297.
346.01 S.B. Kombian: Research Grant; Kuwait University Research
Administration. O.A. Phillips: Research Grant; Kuwait
University Research Adminstration.
346.06 T. Aoki: Employment; Taisho Pharmaceutical Co., Ltd. M.
Kotani: Employment; Taisho Pharmaceutical Co., Ltd. J.
Karasawa: Employment; Taisho Pharmaceutical Co., Ltd. S.
Chaki: Employment; Taisho Pharmaceutical Co., Ltd..
346.09 K. Tseng: Research Grant; National Institute of Health Grant
R01-MH086507 (KYT). Other Research Support; Rosalind
Franklin University (KYT)
346.10 G.A. Gerhardt: Ownership Interest; Quanteon, LLC.
347.01 J. Zhang: Employment; Institute for Cell Engineering, Johns
Hopkins University School of Medicine. Research Grant;
American Heart Association Postdoctoral Fellowship to JZ
(0725470U), USPHS AG029368, DA00266, the Simon’s
Foundation Autism Research Initiative.
ABSTRACT
NUMBER STATEMENT
347.04 H. Li: Employment; USUHS. Research Grant; CDMRP. Other
Research Support; CSTS.
348.01 O.M. Fitch: Employment; Baylor College of Medicine.
Research Grant; NIH grant EY-12782. Other; Virginia Tech
Carilion Research Institute. M.J. Friedlander: Employment;
Virginia Tech Carilion Research Institute. Research Grant;
NIH grant EY-12782.
348.02 D. Kalikulov: Employment; Virginia Tech Carilion Research
Institute. Research Grant; NIH grant EY-12782. M.J.
Friedlander: Employment; Virginia Tech Carilion Research
Institute. Research Grant; NIH grant EY-12782.
351.04 C. Booth: Research Grant; Pfizer. J.T. Brown: Research
Grant; Pfizer. A. Randall: Employment; Pfizer. Research
Grant; Pfizer.
351.05 S.M. Lotarski: Employment; Pfizer Global R & D. P. Stolyar:
Employment; Pfizer Global R & D. K.A. Serpa: Employment;
Pfizer Global R & D. M.M. Zaleska: Employment; Pfizer
Global R & D.
351.11 M. Kurihara: Research Grant; Pfizer. A. Randall:
Employment; Pfizer. Research Grant; Pfizer. J.T. Brown:
Research Grant; Pfizer.
351.15 K.J. Tsai: Research Grant; National Science Council.
351.16 J. Castro-Alvarez: Other; Doctoral student. K.S. Kosik:
Research Grant; NIH. G.P. Cardona Gomez: Research
Grant; NIH. Other Research Support; Colciencias.
351.17 F. Striggow: Employment; KeyNeurotek Pharmaceuticals
(until June 30, 2010). T.G.A. Mack: Employment;
KeyNeurotek Pharmaceuticals (until June 30, 2010). W.
Schmidt: Employment; eyNeurotek Pharmaceuticals (until
June 30, 2010).
351.18 C.C. Hsu: Employment; Pfizer Global Research &
Development. C. Gonzales: Employment; Pfizer Global
Research & Development. R. Roof: Employment; Pfizer
Global Research & Development. Y. Chen: Employment;
Pfizer Global Research & Development. S. Liang:
Employment; Pfizer Global Research & Development.
K. Paumier: Employment; Pfizer Global Research &
Development. M. Zaleska: Employment; Pfizer Global
Research & Development.
351.19 D.M. Barten: Employment; Bristol-Myers Squibb. L. Yang:
Employment; Bristol-Myers Squibb. G.W. Cadelina:
Employment; Bristol-Myers Squibb. L.B. DeCarr:
Employment; Bristol-Myers Squibb. S. Sankaranarayanan:
Employment; Bristol-Myers Squibb. C.M. Conway:
Employment; Bristol-Myers Squibb. M.K. Ahlijanian:
Employment; Bristol-Myers Squibb. C.F. Albright:
Employment; Bristol-Myers Squibb.
351.22 L. Scott: Employment; Pfizer Global Research. T. Kiss:
Employment; Pfizer Global Research. T.T. Kawabe:
Employment; Pfizer Global Research. B. Harvey:
Employment; Pfizer Global Research. M. Hajos: Employment;
Pfizer Global Research.
351.26 I.E. de Jong: Employment; H. Lundbeck A/S. P. Jul:
Employment; H. Lundbeck A/S. A.I. Parachikova:
Employment; H. Lundbeck A/S. L. Helboe: Employment; H.
Lundbeck A/S. A.B. Elvang: Employment; H. Lundbeck A/S.
C. Volbracht: Employment; H. Lundbeck A/S.
352.03 K.S. Montgomery: Research Grant; NIA-R01-AG029421,
F31 AG037286-01. J.L. Bizon: Research Grant; NIA-R01-
AG029421.
352.17 V. Lahmy: Employment; AMYLGEN. J. Meunier:
Employment; AMYLGEN. S. Malmström: Employment;
AMYLGEN. V. Villard: Employment; AMYLGEN. A.
Vamvakides: Employment; ANAVEX. T. Maurice: Consultant/
Advisory Board; AMYLGEN, ANAVEX.
352.18 J. Meunier: Employment; Amylgen. S. Malmström:
Employment; Amylgen. V. Villard: Employment; Amylgen. L.
Givalois: Consultant/Advisory Board; Amylgen. T. Maurice:
Consultant/Advisory Board; Amylgen, Anavex.
353.10 H. Tian:. J.G. Moe: Employment; Oligomerix, Inc. E.
Davidowitz: Employment; Oligomerix, Inc. P. Lopez:
Employment; Oligomerix, Inc..
Neuroscience 2011 | Monday Conflict of Interest Statements | 163

ABSTRACT
NUMBER STATEMENT
353.20 S.P. Braithwaite: Employment; Signum Biosciences Inc M.
Voronkov: Employment; Signum Biosciences Inc J.B. Stock:
Ownership Interest; Signum Biosciences Inc.
354.06 J. Shi: Employment; University of Tennessee.
354.09 K.Q. Tanis: Employment; Merck. A.A. Podtelezhnikov:
Employment; Merck. J.K. Lunceford: Employment; Merck.
J. Hing: Employment; Merck. J. Clements: Employment;
Merck. E.M. Finney: Employment; Merck. A. Albright:
Employment; Merck. A. Loboda: Employment; Merck. S.S.
Blackman: Employment; Merck. R. Ian: Employment; Merck.
R. Margolin: Employment; Merck.
354.12 L. Zhang: Employment; Merck Research Laboratories. L.A.
Hyde: Employment; Merck Research Laboratories. W. Wu:
Employment; Merck Research Laboratories. D. Burnett:
Employment; Merck Research Laboratories. M. Cohen-
Williams: Employment; Merck Research Laboratories. R.
Del Vecchio: Employment; Merck Research Laboratories.
N. Jones: Employment; Merck Research Laboratories. J.
Lee: Employment; Merck Research Laboratories. L. Song:
Employment; Merck Research Laboratories. G. Terracina:
Employment; Merck Research Laboratories. Q. Zhang:
Employment; Merck Research Laboratories. J. Clader:
Employment; Merck Research Laboratories. W. Greenlee:
Employment; Merck Research Laboratories. A. Nomeir:
Employment; Merck Research Laboratories. M. Beradi:
Employment; Merck Research Laboratories. C. Mahon:
Employment; Merck Research Laboratories. R. Margolin:
Employment; Merck Research Laboratories. M. Hu:
Employment; Merck Research Laboratories. E.M. Parker:
Employment; Merck Research Laboratories.
354.13 J. Janson: Employment; AstraZeneca. S. Eketjäll:
Employment; AstraZeneca. K. Tunblad: Employment;
AstraZeneca. F. Jeppsson: Employment; AstraZeneca.
S. Briem: Employment; AstraZeneca. A. Radesäter:
Employment; AstraZeneca. K. Eliason: Employment;
AstraZeneca. J. Fälting: Employment; AstraZeneca. S.
Visser: Employment; AstraZeneca.
354.19 S. Yang: Employment; student.
354.20 S. Kim: Employment; student
354.23 Y. Yun: Other; hidl qkdrkqkdrk.
354.27 M.S. Kindy: Ownership Interest; Applied Neurotechnology,
IncG.R. Hook: Ownership Interest; ALSP, Inc. V. Hook:
Consultant/Advisory Board; ALSP, Inc..
355.27 D.V. Vasilyev: Employment; Pfizer. K.L. Paumier:
Employment; Pfizer. C. Gonzales: Employment; Pfizer. J.
Dunlop: Employment; Pfizer, Inc. E.J. Kaftan: Employment;
Pfizer.
356.12 S. Chiou: Employment; Elan Pharmaceuticals. R. Brendza:
Employment; Elan Pharmaceuticals. K. Callaway:
Employment; Elan Pharmaceuticals. S. Nelson:. M.
Yu: Employment; Gilead. K. Makayed: Employment;
Elan Pharmaceuticals. H. Ni:. K. Hu: Employment;
Elan Pharmaceuticals. M. Lee: Employment; Gilead.
D. Fauss: Employment; Elan Pharmaceuticals. R.
Motter: Employment; Elan Pharmaceuticals. G. Kinney:
Employment; Elan Pharmaceuticals. D. Games: Employment;
Elan Pharmaceuticals. T. Yednock: Employment; Elan
Pharmaceuticals. L. McConlogue: Employment; Elan
Pharmaceuticals.
357.01 I. Lastres-Becker: Other Research Support; L’oreal-UNESCO
support for women in science.
357.03 J.T. Greenamyre: Research Grant; Michael J. Fox
Foundation, National Institutes of Health.
357.07 M. Chesselet: Consultant/Advisory Board; Honoraria and
travel reimbursement for serving as a reviewer for the MJFF.
357.24 P.J. McLean: Research Grant; NIH/NINDS NS063963.
357.25 D.L. Price: Employment; Neuropore Therapies, Inc. A.D.
Paulino: Employment; Neuropore Therapies, Inc. E.
Rockenstein: Consultant/Advisory Board; Neuropore
Therapies, Inc. I. Tsigelny: Consultant/Advisory Board;
Neuropore Therapies, Inc. W. Wrasidlo: Consultant/Advisory
Board; Neuropore Therapies, Inc. H. Moessler: Employment;
Neuropore Therapies, Inc. E. Masliah: Consultant/Advisory
164 | Society for Neuroscience
ABSTRACT
NUMBER STATEMENT
Board; Neuropore Therapies, Inc..
358.11 P. Samadi: Employment; McGill University. Research Grant;
Grants from the CIHR and NSERC to AFS. Other Research
Support; PS holds the Tomlinson Postdoctoral Fellowship from
McGill University, and Jeanne Timmins Costello Fellowship
from MNI
358.16 J. Kim: Research Grant; National Research Foundation of
Korea (NRF). J. Han: Research Grant; National Research
Foundation of Korea (NRF).
358.23 C. Scali: Employment; Siena Biotech SpA. I. Ceccarelli:
Employment; Siena Biotech SpA. R. Remelli: Employment;
Siena Biotech SpA. D. Franceschini: Employment; Siena
Biotech SpA. L. Rossini: Employment; Siena Biotech Spa.
G. Pollio: Employment; Siena Biotech SpA. M. Camarri:
Employment; Siena Biotech SpA. I. Biotti: Other Research
Support; Siena Biotech SpA. A. Cappelli: Employment; Siena
Biotech SpA. V. Miragliotta: Employment; Siena Biotech SpA.
P. Fiengo: Employment; Siena Biotech SpA. A. Caricasole:
Employment; Siena Biotech SpA. G. Gaviraghi: Employment;
Siena Biotech SpA.
359.02 S. Lee: Research Grant; VA Merit. Other Research Support;
William Webster Endowment Award.
359.05 M. Hendrickson: Employment; Kent State University/
Cleveland Clinic. A. Chang: Employment; Cleveland Clinic.
S. Staugaitis: Employment; Cleveland Clinic. K. Easley:
Employment; Cleveland Clinic. B.D. Trapp: Employment;
Cleveland Clinic. Other; Kent State University.
359.14 S. Mozafari: Employment; Tarbiat Modares university,
Department of Physiology. F. Pourabdolhossein:
Employment; Tarbiat Modares university, Department of
Physiology.
360.06 C.A. Schevon: Research Grant; NIH K08 NS48871.
360.07 A.J. Trevelyan: Research Grant; Epilepsy Research UK.
361.09 D. Smith: Employment; Angion Biomedica Corp. Research
Grant; NIH 2R44NS045373-02A2. D.S. Warner: Research
Grant; NIH 2R44NS045373-02A2.
361.22 M. Ryou: Employment; University of North Texas Health
Science Center. Research Grant; NIA Training grant
T32 AG020494, NIH grants R01NS054687, NIH grants
R01NS054651
361.23 A.E. Yu: Research Grant; T32 AG020494, R01NS054687,
R01NS054651.
362.10 X. Liu: Research Grant; NINDS grants PO1 NS23393, RO1
HL064766 and AHA 10SDG2790012..
362.20 K. Sawamoto: Research Grant; The Project for Realization
of Regenerative Medicine of Ministry of Education, Culture,
Sports, Science & Technology. K. Asai: Research Grant; The
Project for Realization of Regenerative Medicine of Ministry of
Education, Culture, Sports, Science & Technology. H. Hida:
Research Grant; The Project for Realization of Regenerative
Medicine of Ministry of Education, Culture, Sports, Science &
Technology.
362.22 H. Lee: Research Grant; This research was supported by a
grant from KRIBB Research Initiative Program (KGM0321112
363.02 Y. Tanaka: Research Grant; Grant-in-Aid for Scientific
Research from the Japan Society for the Promotion of
Science 20248030
363.03 S. Dai: Research Grant; National Natural Science Foundation
of China (No.30900587), Natural Science Foundation
of Chongqing, China (NO.CSTC2009BB5317), Science
Foundation of Third Military Medical University to Dai SS.
363.05 H. Wu: Research Grant; NIH RO-1.
363.13 P.K. Bose: Research Grant; Department of Veterans Affairs
Merit Review B6570R. Other Research Support; Medtronic
Inc.. 363.26 N.A. Terpolilli: Research Grant; Munich
University FöFoLe Grant.
363.26 N.A. Terpolilli: Research Grant; Munich University FöFoLe
Grant.
364.03 D.W. Beacham: Employment; Life Technologies. B.S.
Mandavilli: Employment; Life Technologies. L. Pignataro:.
M. Yan: Employment; Life Technologies. M.S. Janes:

ABSTRACT
NUMBER STATEMENT
Employment; Life Technologies.
364.15 T. Summavielle: Research Grant; Sigma-tau S.p.A., Pomezia,
Italy. A. Virmani: Employment; Sigma-tau S.p.A., Pomezia,
Italy.
365.07 L. Wei: Employment; University of Minnesota Medical School.
Research Grant; DA11190, DA11806, DK54733, DK60521
and K02-DA13926.
365.10 B. Shukitt-Hale: Other Research Support; California
Strawberry Commission, US Highbush Blueberry Council,
Wild Blueberry Association of North America
365.11 B. Shukitt-Hale: Other Research Support; California Walnut
Commission.
365.12 B. Shukitt-Hale: Other Research Support; California
Strawberry Commission, US Highbush Blueberry Council,
Wild Blueberry Association of North America.
365.17 P.J. Gannon: Research Grant; T32-GM008076. K. Jordan-
Sciutto: Research Grant; MH083517.
365.18 B. Shukitt-Hale: Other Research Support; AIBMR Life
Sciences.
366.09 P. Ferchmin: Employment; Universidad Central Del Caribe,,
University of Puerto Rico-Medical Sciences Campus.
Research Grant; CounterACT UO1NS063555, Infrastructure
and core facilities were made possible by NIH Grant Number
G12RR-03035 from the National Center for Research
Resources. Ownership Interest; Patent pending. V.A.
Eterovic: Other; Patent pending.
367.01 N.E. LaPointe: Research Grant; Eisai Inc. L. Wilson:
Research Grant; Eisai Inc. S.C. Feinstein: Research Grant;
Eisai Inc. M. Jordan: Research Grant; Eisai Inc..
367.05 S.D. Croll: Employment; Regeneron Pharmaceuticals.
Ownership Interest; Regeneron Pharmaceuticals.
367.09 C. Huang: Employment; Biogen Idec. R.H. Scannevin:
Employment; Biogen Idec. R. Huang: Employment; Biogen
Idec. T.M. Engber: Employment; Biogen Idec. K.J. Rhodes:
Employment; Biogen Idec. H.M. Arnold: Employment; Biogen
Idec.
367.24 W.H. Frey II: Ownership Interest; WHF is a co-inventor on
a patent owned by HealthPartners Research foundation
regarding the intranasal delivery of deferoxamine for the
treatment of neurodegenerative diseases. L.R. Hanson:
Ownership Interest; LRH is a co-inventor on a patent
owned by HealthPartners Research foundation regarding
the intranasal delivery of deferoxamine for the treatment of
neurodegenerative diseases.
368.13 L. Ver Donck: Employment; Janssen Pharmaceutica NV,
Johnson & Johnson. Ownership Interest; Johnson & Johnson.
H. Duytschaever: Employment; Janssen Pharmaceutica
NV, Johnson & Johnson. R. Willems: Employment; Janssen
Pharmaceutica NV, Johnson & Johnson.
368.20 M. Caron: Other Research Support; Lundbeck. Consultant/
Advisory Board; Lundbeck, Roche, Merck.
368.23 E. Grunewald: Research Grant; Pfizer. C. Claxton: Research
Grant; Pfizer. Q. Wang: Employment; Pfizer. N.J. Brandon:
Employment; Pfizer. D.J. Porteous: Research Grant; Pfizer.
J.K. Millar: Research Grant; Pfizer.
368.25 C.M. O’Carroll: Employment; Dart Neuroscience R. Hen:
Consultant/Advisory Board; Brain Cells Inc. and Astra Zeneca.
368.26 D.J. Heal: Other Research Support; Abbott Healthcare
Products BV. A.C. McCreary: Other Research Support;
Abbott Healthcare Products BV. K.B. Freeman: Other
Research Support; Abbott Healthcare Products BV. W.L.
Woolverton: Other Research Support; Abbott Healthcare
Products BV.
369.03 M. Nakamura: Research Grant; Grant-in-Aid for Young
Scientists, KAKENHI (08105875), the Ministry of Education,
Culture, Sports, Science and Technology (MEXT).
369.05 G. Chen: Employment; Johnson and Johnson. C.A. Zarate:
Other; Dr. Zarate is listed as a co-inventor on a patent for the
use of ketamine in major depression. Dr. Zarate has assigned
his patent rights on ketamine to the U.S. government..
369.06 C.R. Butson: Consultant/Advisory Board; St. Jude Medical.
ABSTRACT
NUMBER STATEMENT
369.08 W.C. Drevets: Other; Pending Use Patent. M. Furey: Other;
Pending Use Patent.
369.11 C.R. Conway: Speakers Bureau/Honoraria; Pfizer, Bristol
-Myers, Squibb, Merck, Sunovion.
371.19 K. Coffey: Employment; Rutgers University.
371.28 W. Wong: Employment; Department of Cellular and Molecular
Pharmacology, Rosalind Franklin University of Medicine and
Science. J.E. McCutcheon: Employment; University of Illinois
at Chicago. K.A. Ford: Employment; Department of Cellular
and Molecular Pharmacology, Rosalind Franklin University
of Medicine and Science. N.E. Pagels: Employment;
Department of Cellular and Molecular Pharmacology,
Rosalind Franklin University of Medicine and Science. M.
Marinelli: Employment; Department of Cellular and Molecular
Pharmacology, Rosalind Franklin University of Medicine and
Science. Research Grant; NIDA DA020654 and DA020654-
04-S1.
372.10 C.M. Quintero: Employment; NIDA/NIH/DHHS. I.N.
Krasnova: Employment; NIDA/NIH/DHHS. S. Pontis:
Employment; NIDA/NIH/DHHS. E. Ivanova: Employment;
NIDA/NIH/DHHS. T.S. Shippenberg: Employment; NIDA/NIH/
DHHS. J.L. Cadet: Employment; NIDA/NIH/DHHS.
373.04 J. Ye: Research Grant; NIH, NIAAA.
373.12 S.C. Steffensen: Research Grant; NIH R01.
374.05 T.A. Cleland: Research Grant; NIH grant DC009948.
375.06 J. Chapuis: Other Research Support; Fyssen Fundation postdoctoral
fellowship to J.C. D.A. Wilson: Research Grant; NIH
grants DC003906 and DC 008982.
376.04 Y. Sawahata: Employment; NHK (Japan Broadcasting
Corporation). K. Komine: Employment; NHK (Japan
Broadcasting Corporation). T. Morita: Employment; NHK
(Japan Broadcasting Corporation). N. Hiruma: Employment;
NHK (Japan Broadcasting Corporation).
376.13 T.D. Ard: Employment; National Institutes of Health.
377.08 S. Lee: Employment; HHMI, UC Berkeley. Y. Dan:
Employment; HHMI.
377.13 J. Cang: Research Grant; NIH Grants EY018621 and
EY020950, Sloan Research Fellowship, Klingenstein
Fellowship Award in Neurosciences.
380.08 S.P. McGaraughty: Employment; Abbott Labs. J. Xu:
Employment; Abbott Labs. K.L. Chu: Employment; Abbott
Labs. J. Mikusa: Employment; Abbott Labs.
380.09 F. Zhao: Employment; NeuroSolutions Ltd. H. Wei:
Employment; NeuroSolutions Ltd. R.D. Jeggo: Employment;
NeuroSolutions Ltd. D. Spanswick: Employment;
NeuroSolutions Ltd..
380.12 R.S. Bitner: Employment; Abbott Laboratories. Y. Lee:
Employment; Abbott Laboratories. J. Brederson:
Employment; Abbott Laboratories. S. Markosyan:
Employment; Abbott Laboratories. A. Nikkel: Employment;
Abbott Laboratories. J. Mikusa: Employment; Abbott
Laboratories. M.F. Jarvis: Employment; Abbott Laboratories.
380.14 T. Zhang: Research Grant; Stryker Corporation. J.J. Janik:
Employment; Stryker Corporation. W.M. Grill: Research
Grant; Stryker Corporation.
380.15 T.A. Fey: Employment; Abbott Laboratories. J.B. Wetter:
Employment; Abbott Laboratories. H. Xu: Employment; Abbott
Laboratories. D.F. Stolarik: Employment; Abbott Laboratories.
M.J. Rieser: Employment; Abbott Laboratories. M.F. Jarvis:
Employment; Abbott Laboratories. R.S. Bitner: Employment;
Abbott Laboratories.
381.04 M. Miyamoto: Employment; Nihon University. Research
Grant; Sato and Uemura Funds from Nihon University
School of Dentistry. Other Research Support; the Ministry
of Education, Culture, Sports, Science, and Technology
to promote multidisciplinary research project. Y. Tsuboi:
Employment; Nihon University. Research Grant; Sato and
Uemura Funds from Nihon University School of Dentistry.
Other Research Support; the Ministry of Education, Culture,
Sports, Science, and Technology to promote multidisciplinary
research project. M. Shinoda: Employment; Nihon University.
Research Grant; Sato and Uemura Funds from Nihon
Neuroscience 2011 | Monday Conflict of Interest Statements | 165

ABSTRACT
NUMBER STATEMENT
University School of Dentistry. Other Research Support;
the Ministry of Education, Culture, Sports, Science, and
Technology to promote multidisciplinary research project. K.
Iwata: Employment; Nihon University. Research Grant; Sato
and Uemura Funds from Nihon University School of Dentistry.
Other Research Support; the Ministry of Education, Culture,
Sports, Science, and Technology to promote multidisciplinary
research project.
381.07 K.N. Westlund: Other Research Support; University of
Kentucky President’s Research Funds.
381.13 G.S. Firestein: Research Grant; Intellikine.
382.10 M.I. Nemenov: Ownership Interest; Lasmed, LLC.
382.15 S. Biswal: Other; Co-Founder, SiteOne Therapeutics, Inc..
J. Mulcahy: Other; Co-Founder, SiteOne Therapeutics,
Inc. G.P. Miljanich: Employment; Airmid Inc.. Ownership
Interest; SiteOne Therapeutics, Inc., Airmid Inc.. Consultant/
Advisory Board; Naurex Inc., Adynxx Inc. D. Yeomans: Other;
Co-Founder, SiteOne Therapeutics. J. Du Bois: Other; Co-
Founder, SiteOne Therapeutics, Inc..
382.17 K.L. Kerr: Research Grant; University of Tulsa research grant.
383.10 J.E. Zadina: Ownership Interest; JEZ has patents filed on the
subject compounds.
383.16 G.W. Maguire: Ownership Interest; BioRegenerative
Sciences, Inc. P. Friedman: Ownership Interest;
BioRegenerative Sciences, Inc..
384.11 J.C. Brumberg: Employment; Quens College, CUNY.
Research Grant; NINDS, NIH.
384.19 P. Chu: Employment; CUNY Graduate Center. J.C.
Brumberg: Employment; Queens College, CUNY. Research
Grant; NINDS, NIH.
385.07 J. Isaac: Employment; Lilly UK.
385.19 F.P. McGlone: Employment; Liverpool John Moores
University.
385.21 S.M. Barlow: Research Grant; NIH DC003311. Ownership
Interest; KC BioMedix, Inc
386.11 E. Buhl: Research Grant; BBSRC.
388.12 R. Predel: Research Grant; Predel 595/6-1,2 766/9-1. J.
Schachtner:. P. Kloppenburg: Research Grant; KL 762/2-
2, 762/4-1. S. Neupert: Research Grant; Predel 595/6-1,2
766/9-1, KL 762/2-2, 762/4-1.
390.02 J. Lieblein: Employment; Abbott Nutrition J.P. Godbout:
Research Grant; Abbott Nutrition.
392.05 M. Furuta: Research Grant; KAKENHI20790198, 22790232.
393.01 G. Herrera: Employment; Catamount Research and
Development.
393.03 M.A. Vizzard: Research Grant; DK051369, DK060481,
DK065989, P20 RR16435.
393.05 M.A. Vizzard: Research Grant; DK051369, DK060481,
DK065989, P20 RR16435, NIH/NIDDK.
393.08 S. Yoshida: Employment; Taiho Pharmaceutical Co., Ltd. Y.
Hayashi: Employment; Taiho Pharmaceutical Co., Ltd. F.
Mori: Employment; Taiho Pharmaceutical Co., Ltd. T.
Nishihashi: Employment; Taiho Pharmaceutical Co., Ltd. N.
Orimoto: Employment; Taiho Pharmaceutical Co., Ltd. K.
Miyoshi: Employment; Taiho Pharmaceutical Co., Ltd. K.
Matsuo: Employment; Taiho Pharmaceutical Co., Ltd. N.
Yoshimura: Employment; Taiho Pharmaceutical Co., Ltd..
393.09 Y. Hayashi: Employment; Taiho Pharmaceutical Co., Ltd..
393.10 A. Hakozaki: Employment; Taiho Pharmaceutical Co., Ltd. Y.
Hayashi: Employment; Taiho Pharmaceutical Co., Ltd. S.
Yoshida: Employment; Taiho Pharmaceutical Co., Ltd. N.
Orimoto: Employment; Taiho Pharmaceutical Co., Ltd. K.
Miyoshi: Employment; Taiho Pharmaceutical Co., Ltd. K.
Matsuo: Employment; Taiho Pharmaceutical Co., Ltd..
393.11 Y. Hayashi: Employment; Taiho Pharmaceutical Co., Ltd. S.
Yoshida: Employment; Taiho Pharmaceutical Co., Ltd
393.15 M.O. Fraser: Consultant/Advisory Board; Pfizer, Astellas,
POC.
394.19 G. Das: Employment; Laboratory of Information Biology,
Graduate School of Information sciences K. Itoi: Employment;
166 | Society for Neuroscience
ABSTRACT
NUMBER STATEMENT
Department of Neuroendocrinology, Graduate School of
Medicine.
394.20 L. Verdugo-Díaz: Research Grant; PAPIIT IN207210, UNAM.
M.A. Juárez-Oropeza: Research Grant; PAPIIT IN205410,
UNAM. P.V. Torres-Durán: Research Grant; PAPIIT
IN205410, UNAM.
395.02 T.W. Castonguay: Other Research Support; Maryland
Agricultural Experiment Station. B. Jiang: Other Research
Support; Support for this research was provided by a grant to
the University of Maryland from the Howard Hughes Medical
Institute Undergraduate Science Education Program. J.
Khural: Other Research Support; Support for this research
was provided by a grant to the University of Maryland from
the Howard Hughes Medical Institute Undergraduate Science
Education Program..
395.03 T. Sartorius: Research Grant; Deutsche
Forschungsgemeinschaft (DFG), German Federal Ministry of
Education and Research (BMBF) to the German Center for
Diabetes Research (DZD e.V.). H. Haering: Research Grant;
Deutsche Forschungsgemeinschaft (DFG), German Federal
Ministry of Education and Research (BMBF) to the German
Center for Diabetes Research (DZD e.V.). A.M. Hennige:
Research Grant; Deutsche Forschungsgemeinschaft (DFG),
German Federal Ministry of Education and Research (BMBF)
to the German Center for Diabetes Research (DZD e.V.).
395.19 M. Huerta-Viera: Research Grant; FRABA-2010 to MH/
CONACyT-83113 to MH.
396.02 M. Marconi: Employment; Pfizer. E.K. Sylvain: Employment;
Pfizer. K.R. Bales: Employment; Pfizer.
397.10 S. Beeské: Employment; Sanofi-Aventis. D. Françon:
Employment; Sanofi-Aventis. W. Hurst: Employment; Sanofi-
Aventis. Z. Gao: Employment; Sanofi-Aventis. P. Avenet:
Employment; Sanofi-Aventis. G. Griebel: Employment;
Sanofi-Aventis.
397.19 A. Jimenez-Anguiano: Research Grant; CONACyT # 50633.
398.14 E.C. Leuthardt: Ownership Interest; Neurolutions.
399.17 W. Zhu: Employment; School of Information Science,
Yunnan University. Research Grant; National Nature
Science Foundation of China (61005087), Yunnan Science
and Technology Project (2009CD018), Yunnan Education
Department Key Project (2010Z067), Research Fund of
Yunnan University (KL080012, 030-WX069051). J. Zhang:
Research Grant; National Nature Science Foundation of
(60975076), Fujian Social Science and Planning Project
(No.2008C010), The Ministry of Science and Technology of
China Grant (2005CB522800).
399.26 F. Broccard: Employment; University of California San Diego.
Research Grant; Neovision2 Program, DARPA and Evolved
Machines. S. Joshi: Employment; University of California
San Diego. Research Grant; Neovision2 Program, DARPA
and Evolved Machines. T. Yu: Employment; University of
California San Diego. Research Grant; Neovision2 Program,
DARPA and Evolved Machines. J. Park: Employment;
University of California San Diego. Research Grant;
Neovision2 Program, DARPA and Evolved Machines. C.
Maier: Employment; University of California San Diego.
Research Grant; Neovision2 Program, DARPA and Evolved
Machines. M. Arnold: Employment; Salk Institute for
Biological Studies. Research Grant; Neovision2 Program,
DARPA and Evolved Machines. T. Sejnowski: Employment;
Salk Institute for Biological Studies. Research Grant;
Neovision2 Program, DARPA and Evolved Machines. G.
Cauwenberghs: Employment; University of California San
Diego. Research Grant; Neovision2 Program, DARPA and
Evolved Machines.
400.01 M. Dastjerdi: Employment; Laboratory of Behavioral
and Cognitive Neurology Department of Neurology and
Neurological Sciences Stanford University School of
Medicine. Research Grant; Stanford University NeuroVentures
Program, Stanford University - SINTN. B.L. Foster:
Employment; Neurology and Neurological Sciences Stanford
University School of Medicine. Research Grant; Stanford
University NeuroVentures Program, Stanford University
- SINTN. J. Parvizi: Employment; Stanford University.

ABSTRACT
NUMBER STATEMENT
Research Grant; Stanford University NeuroVentures Program,
Stanford University - SINTN.
400.04 K. Detyniecki: Research Grant; National Epi-fellows
Foundation. H. Blumenfeld: Research Grant; National Epifellows
Foundation.
401.10 S.M. Garnsey: Employment; Neuroscience Program.
401.17 G. Liuzzi: Research Grant; German Research Foundation.
402.11 E. Ramirez: Research Grant; MBRS-RISE.
402.13 D.A. Yurgelun-Todd: Consultant/Advisory Board; Kyowa
Hakko, Eli Lilly, Janssen.
403.01 Y. Jung: Research Grant; AA010723, AA017168, AA017923,
AA012388.
404.19 G. Zhang: Research Grant; NIH. R.G. Cook: Research
Grant; NSF. A.I. Geller: Research Grant; NIH. Ownership
Interest; Alkermes Inc, AIG.
405.03 A.F.T. Arnsten: Other Research Support; Shire
Pharmaceuticals. Consultant/Advisory Board; Shire
Pharmaceuticals.
405.16 R.J. Gilbert: Employment; University of Florida. Research
Grant; NIH AG029421.
405.17 P.L. Croxson: Research Grant; Wellcome Trust UK. J.X.
O’Reilly: Research Grant; Medical Research Council UK.
M.P. Noonan: Other Research Support; Wellcome Trust
Studentship. R.B. Mars: Other Research Support; Marie Curie
Fellowship. K.L. Miller: Research Grant; Wellcome Trust UK.
M.F. Rushworth: Research Grant; Medical Research Council
UK. M.G. Baxter: Research Grant; Wellcome Trust UK.
407.16 A. Kumar: Research Grant; AG014979, AG037984,
AG036800, the Evelyn F. McKnight Brain Research
Foundation.
408.10 B.D. Waterhouse: Research Grant; MH087921409.03
T.A. Otto: Research Grant; NSF-IOS0919159.
409.03 T.A. Otto: Research Grant; NSF-IOS0919159.
413.08 S. Hase: Employment; Keio University. K. Hotta:
Employment; Keio University. K. Oka: Employment; Keio
University.
421.10 G.A. Spirou: Research Grant; NIDCD DC007695, NCRR
RR031155. M.H. Ellisman: Research Grant; NCRR
RR004050.
422.08 M. Han: Other Research Support; This study is supported by
Foundation Venture Capital Group.. Ownership Interest; Dr.
Robert Nagele is one of the founders of Durin Technologies,
Inc.. Consultant/Advisory Board; Eric Nagele is a scientific
consultant for Durin Technologies, Inc. E. Nagele: Consultant/
Advisory Board; Eric Nagele is a scientific consultant of Durin
Technologies, Inc.. R. Nagele: Ownership Interest; Dr. Robert
Nagele is one of the founders of Durin Technologies, Inc..
422.10 R.S. Turner: Research Grant; Pfizer, Baxter, Elan, Lilly,
Ceregene..
423.04 X. Zhu: Consultant/Advisory Board; Arial Neuroscience.
424.02 R. Hagerman: Other Research Support; Neuropharm,
Seaside therapeutics, Forest, Johnson and Johnson and
Roche. Consultant/Advisory Board; Novartis
424.03 M.C. Levin: Ownership Interest; Patent Pending for
“Biomarker for Neurodegeneration in Neurological Disease” in
collaboration with UTHSC.
424.06 S. Guo: Employment; Isis Pharmaceuticals. S. Booten:
Employment; Isis Phar,aceuticals. L. Alvarado: Employment;
Isis Pharmaceuticals. A. Siwkowski: Employment; Isis
Pharmaceuticals. M. Benson: Employment; Indiana
University School of Medicine. B. Monia: Employment; Isis
Pharmaceuticals.
424.09 M.M. Walsh: Research Grant; merck. Consultant/Advisory
Board; o’connor frederick consultants. A. Saha: Research
Grant; merck. Consultant/Advisory Board; frederick o’connor
consultants.
424.10 N.J. Dolman: Employment; Life Technologies. D. Beacham:
Employment; Life Technologies. K. Chambers: Employment;
Life Technologies. B. mandavilli: Employment; Life
Technologies. R. Batchelor: Employment; Life Technologies.
ABSTRACT
NUMBER STATEMENT
M. Janes: Employment; Life Technologies.
431.03 A. Thiele: Employment; Newcastle University. Research
Grant; BBSRC and Wellcome Trust. J. Herrero: Employment;
Newcastle University. Research Grant; BBSRC and Wellcome
Trust.
432.02 J.W.M. Bulte: Research Grant; Q Therapeutics.
432.03 M.M. Modo: Employment; University of Pittsburgh. Research
Grant; NIBIB 1 P20 EB007076-01.
433.05 N.M. Walton: Employment; Astellas Pharmaceuticals.
K. Tajinda: Employment; Astellas Pharmaceuticals.
R. Shin: Employment; Astellas Pharmaceuticals. S.
Miyake: Employment; Astellas Pharmaceuticals. C.L.
Heusner: Employment; Astellas Pharmaceuticals. J.H.
Kogan: Employment; Astellas Pharmaceuticals. Q. Chen:
Employment; Astellas Pharmaceuticals. K. Tamura:
Employment; Astellas Pharmaceuticals. M. Matsumoto:
Employment; Astellas Pharmaceuticals.
434.06 S. Li: Employment; University of Calgary, Hotchkiss Brain
Institute. Research Grant; CIHR IRSC. Other Research
Support; CIHR Strategic Training Program, Children
Hospital’s Foundation. P. Mattar: Employment; Cellular
Neurobiology Research Unit, Institut de recherches cliniques
de Montréal. C. Schuurmans: Research Grant; CIHR IRSC.
434.17 C. Grothe: Research Grant; This work is supported by
NYSTEM N09G-271 and German Research Foundation
(DFG) grant to C. Grothe..
434.19 H. Gu: Employment; Emory University. Research Grant;
National Institute of Health, American Heart Association and
Bugher. S. Yu: Employment; Emory University. Research
Grant; National Institute of Health, American Heart Association
and Bugher. L. Wei: Employment; Emory University.
Research Grant; National Institute of Health, American Heart
Association and Bugher.
434.23 M.J. Donoghue: Employment; Georgetown University.
Research Grant; IOS-0923642.
434.24 M. Fennell: Employment; GigaCyte. Research Grant; Bristol-
Myers Squibb. R. Malavarca: Employment; GigaCyte.
Research Grant; Bristol-Myers Squibb. A. Cacace:
Employment; Bristol-Myers Squibb. M. Roach: Employment;
GigaCyte.
435.08 T.A. Lanz: Employment; Pfizer. L.H. Kimmel: Employment;
Pfizer. S.J. Engle: Employment; Pfizer. A.M. Friedrich:
Employment; Pfizer. M.L. Weber: Employment; Pfizer. F.M.
Prior: Employment; Pfizer. J.T. Lazzaro: Employment;
Pfizer. I.V. Efremov: Employment; Pfizer. R.J. Kleiman:
Employment; Pfizer.
437.03 A. Sholl-Franco: Research Grant; CNPq, FAPERJ.
439.10 K.L. Lankford: Research Grant; German Research
Foundation (Ra 1901/1-1); Hochschulinterne
Leistungsföderung (HiLF) of the Hannover Medical School.
439.14 S.A. Busch: Employment; Athersys, Inc. J.A. Hamilton:
Employment; Athersys, Inc N. Lehman: Employment;
Athersys, Inc. R. Cutrone: Employment; Athersys, Inc. R.J.
Deans: Employment; Athersys, Inc. A.E. Ting: Employment;
Athersys, Inc. R.W. Mays: Employment; Athersys, Inc
440.03 T.L. Dickendesher: Other; Pfizer Global Research and
Development. K.L. Askew: Other; Pfizer Global Research
and Development. B. Bates: Other; Pfizer Global Research
and Development. M.M. Zaleska: Other; Pfizer Global
Research and Development. A. Wood: Other; Pfizer Global
Research and Development. R.J. Giger: Other; Pfizer Global
Research and Development.
440.09 D. Wu: Research Grant; Wellcome Trust (Ref.
084688/Z/08/Z). Y. Zhang: Research Grant; Wellcome Trust
(Ref. 084688/Z/08/Z). X. Bo: Research Grant; Wellcome Trust
(Ref. 084688/Z/08/Z).
440.15 S.M. Strittmatter: Ownership Interest; Axerion Therapuetics.
440.19 Q. Li: Employment; 1The International Center for Spinal Cord
Injury, Hugo Moser Research Institute at Kennedy Krieger
Institute, Baltimore, MD 21205.
441.09 H. Kawasaki: Research Grant; Smoking Research
Foundation.
Neuroscience 2011 | Monday Conflict of Interest Statements | 167

ABSTRACT
NUMBER STATEMENT
442.01 H.H. Hansen: Employment; Full time employee at
NeuroSearch A/S.
442.04 R.L. Parker: Research Grant; T32 GM07616 J.M. Miwa:
Employment; California Institute of Technology. Research
Grant; AG-33954, TRDRP 19KT-0032. Ownership Interest;
Ophidion, Inc.. Consultant/Advisory Board; Ophidion, Inc..
442.11 J. Colon-Saez: Employment; National Institute Environmental
Health Sciences. Other Research Support; Intramural
Research program
443.07 E.C. Park: Research Grant; State of New Jersey Spinal Cord
Postdoctoral Research Fellowship(10-2950-SCR-E-0).
444.08 M. Hossain: Other Research Support; NIH GRANT
DA024797. B.D. Safratowich: Other Research Support; NIH
GRANT DA024797. L. Carvelli: Other Research Support; NIH
GRANT DA024797.
445.22 Y. Shinoda: Employment; Universitätsmedizin Göttingen.
S. Ahmed: Employment; Universitätsmedizin Göttingen. J.
Schrader: Employment; Universitätsmedizin Göttingen C.
Dean: Employment; Universitätsmedizin Göttingen.
446.08 P. Pan: Employment; Weill Cornell Medical College
446.28 Z. Xie: Employment; Department of Anesthesia and Critical
Care, University of Chicago. Research Grant; FAER
Grant, BRF Grant B.E. Herring: Research Grant; NIH
Grant NS060342. A.P. Fox: Employment; Department of
Neurobiology, Pharmacol. & Physiol., University of Chicago.
Research Grant; NIH Grant GM081809.
447.05 J. Ratnayaka: Research Grant; Wellcome Trust
WT084357MF, BBSRC BB/F01871
448.01 S. Clemens: Research Grant; II-R, Pfizer.
448.07 P.A. Feliciano: Research Grant; NIH grants R01 MH061059,
U54 NS 039408.
449.08 J.T. Brown: Consultant/Advisory Board; pfizer. A.D. Randall:
Employment; pfizer. Research Grant; pfizer.
449.09 K.M. Harris: Research Grant; NS021184, NS074644.
450.03 L. Kiedrowski: Research Grant; NIH, AHA.
450.14 H. Wu: Other Research Support; University of Calgary.
451.12 A. Compte: Research Grant; MICINN BFU2009-09537. J. de
la Rocha: Research Grant; NIH DC-005787-01A1, MICCIN
SAF2010-15730, Marie Curie IRG PIRG07-GA-2010-268382.
451.20 L. Lin: Research Grant; National Natural Science Foundation
of China (No.30990262).
452.02 J.J. Renger: Employment; Merck Research Laboratories.
Ownership Interest; Merck Research Laboratories. V.N.
Uebele: Employment; Merck Research Laboratories.
Ownership Interest; Merck Research Laboratories.
452.07 S. Yang: Research Grant; VA Merit Review. C. Tang:
Research Grant; VA Merit Review.
453.12 J.A. Dobrowolska: Employment; Washington University
in St. Louis. Other Research Support; Eli Lilly. Y. Huang:
Employment; Washington University in St. Louis. T. Kasten:
Employment; Washington University in St. Louis. W.
Sigurdson: Employment; Washington University in St. Louis.
R.J. Bateman: Employment; Washington University in St.
Louis. Research Grant; Eli Lilly, Hope Center Translational
Research Grant, ADRC (NIH grant AG05681), The Knight
Initiative for Alzheimer Research, The James and Elizabeth
McDonnell Fund for Alzheimer Research, Roschmann Fund
for Alzheimer Research, NIH 3P01-AG02627603S1, NIH K23-
AG03094601, NIH R-01-NS065667, Barnes Jewish Hospital
Foundation Grant, GCRC (MO1 RR00036), NIH RR000954,
The Ellen Langsdorf Alzheimer Biomarker Research Fund,
Merck. Other Research Support; BMS. Speakers Bureau/
Honoraria; FDA, Merck, Pfizer, BMS, Elan. Ownership
Interest; C2N Diagnostics. Consultant/Advisory Board; Cofounder
C2N Diagnostics, Pfizer, C2N Diagnostics. Other; ad
hoc reviewer.
455.14 J.H. Prehn: Other; J.H.M.P. is a beneficiary of Intellectual
Property relating to the use of Angiogenin for the diagnosis
and treatment of ALS and other neurodegenerative disorders.
456.08 J. Viventi: Research Grant; National Institutes of Health
under Ruth L. Kirschstein National Research Service Award
168 | Society for Neuroscience
ABSTRACT
NUMBER STATEMENT
2T32HL007954 from the NIH-NHLBI. B. Litt: Research Grant;
National Institutes of Health Grants (NINDS RO1-NS041811,
NINDS R01 NS 48598). Other Research Support; Dr.
Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy
Research.
456.10 L.B. Grand: Research Grant; NIH, CHIR, NSERC, FRSQ.
M. Blais-D’Amours: Research Grant; NIH, CHIR, NSERC,
FRSQ. I. Timofeev: Research Grant; NIH, CHIR, NSERC,
FRSQ.
457.03 X. Xu: Employment; University of Southern California.
459.05 S.K. Nordquist: Employment; University of Texas. Other
Research Support; NOW Foods. T.A. Jones: Research
Grant; NS056839. Other Research Support; NOW Foods.
459.10 A.G. Machado: Employment; Cleveland Clinic. Research
Grant; 5R01HD061363, 1DP2OD006469. Ownership
Interest; IntElect Medical, Cardionomics, ATI. Consultant/
Advisory Board; Monteris. Other; Boston Scientific K. Baker:
Employment; University of Minnesota. Ownership Interest;
IntElect Medical, Cardionomics, ATI. Other; Boston Scientific.
460.09 J. Choi: Research Grant; A grant of the Korea Health
technology R&D Project, Ministry of Health & Welfare,
Republic of Korea (A101565), Korea Research Foundation
Grant, MEST 2009-0081466. B. Kim: Research Grant; Korea
Research Foundation Grant, MEST 2009-0081466.
460.12 M. Hokari:. X. Tang: Employment; UCSF and SF VAMC.
Research Grant; NIH.
460.18 J.L. Cheatwood: Other Research Support; Solae, LLC. D.N.
Butteiger: Employment; Solae, LLC.. W.J. Banz: Other
Research Support; Solae, LLC.
461.02 F. Pourabdolhossein: Other Research Support; Some part of
this work supported by MSIF (multiple Sclerosis international
federation) which support me to live in Paris for near 10 month
and do the most important part of the thesis project..
461.05 Z. Zhang: Research Grant; RO1 NS 062832. M. Chopp:
Research Grant; PO1 NS23393; RO1 HL64766.
462.02 Y. Xiong: Research Grant; NIH Grant RO1 NS62002, NIH
Grant PO1 NS42345. A. Mahmood: Research Grant; NIH
Grant PO1 NS42345. M. Chopp: Research Grant; NIH Grant
RO1 NS62002.
462.03 Y. Xiong: Research Grant; NIH Grant RO1 NS62002. Other
Research Support; NIH Grant PO1 NS42345. A. Mahmood:
Research Grant; NIH Grant PO1 NS 42345. M. Chopp:
Research Grant; NIH Grant PO1 NS42345.
465.04 G.A. Gerhardt: Ownership Interest; Greg A. Gerhardt is the
sole proprietor of Quanteon, LCC.
466.19 N.M. Midde: Research Grant; NIH-DA026721.
467.05 D.A. Lewis: Research Grant; BMS Foundation, Bristol-Myers
Squibb, Curridium Ltd, Pfizer. Consultant/Advisory Board;
Neurogen, SK Life Science, AstraZeneca, BioLine RX, Bristol-
Myers Squibb, Hoffman-Roche, Lilly, Merck
467.10 M. Wang: Research Grant; NIH R01 grant.
467.12 A.J. Deo: Other Research Support; Doris Duke Charitable
Foundation. M. Cahill: Research Grant; NIH1F31AG031621-
01A2. J. VanLeeuwen: Research Grant; NIH1F31MH087043.
A. Sampson: Consultant/Advisory Board; Johnson & Johnson
Pharmaceutical Research and Development. P. Penzes:
Research Grant; R01MH071316. D.A. Lewis: Research
Grant; BMS Foundation, Bristol-Myers Squibb, Curridium Ltd
and Pfizer. Consultant/Advisory Board; AstraZeneca, BioLine
RX, Bristol-Myers Squibb, Hoffman-Roche, Lilly, Merck,
Neurogen, and SK Life Science (2077-2010). R.A. Sweet:
Research Grant; MH071533, MH084053.
467.15 D.D. Georgiev: Research Grant; JSPS Postdoctoral
Fellowship.. D.A. Lewis: Research Grant; NIH Grant
MH043784, NIH Grant MH084053. Other Research Support;
BMS Foundation, Bristol-Myers Squibb, Curridium Ltd, Pfizer.
Consultant/Advisory Board; AstraZeneca, BioLine RX, Bristol-
Myers Squibb, Hoffman-Roche, Lilly, Merck, Neurogen, SK
Life Science. T. Hashimoto: Research Grant; JSPS Grant
KAKENHI 21390332, JSPS Grant KAKENHI 21.09141.
467.16 D.A. Lewis: Research Grant; BMS Foundation, Bristol-Meyers
Squibb, Curridium Ltd, Pfizer. Consultant/Advisory Board;

ABSTRACT
NUMBER STATEMENT
AstraZeneca, Bioline RX, Bristol-Meyers Squibb, Hoffman-
Roche, Lilly, Merck, Neurogen, SK Life Science.
467.23 D. Datta: Research Grant; MH051234. D.A. Lewis: Research
Grant; Investigator-initiated research support from the BMS
Foundation, Bristol-Myers Squibb, Curridium Ltd and Pfizer.
Consultant/Advisory Board; Consultant in the areas of target
identification and validation and new compound development
to AstraZeneca, BioLine RX, Bristol-Myers Squibb, Hoffman-
Roche, Lilly, Merck, Neurogen and SK Life Science.
467.24 D.A. Lewis: Other Research Support; BMS Foundation,
Bristol-Meyers Squibb, Curridium Ltd, Pfizer. Consultant/
Advisory Board; AstraZeneca, Bioline RX, Bristol-Meyers
Squibb, Merck, Neurogen, SK Life Science.
468.04 N.M. Richtand: Research Grant; MH083192, Dept. of
Veterans Affairs Medical Research Service, Ortho-McNeil
Janssen, AstraZeneca Pharmaceuticals (study drugonly).
Speakers Bureau/Honoraria; Bristol-Meyers Squibb,
Merck, Novartis, Sunovion Pharmaceuticals Inc, Sepracor.
Consultant/Advisory Board; Bristol-Meyers Squibb, Sunovion
Pharmaceuticals Inc., Sepracor, Gerson Lehrman Group. N.R.
Swerdlow: Research Grant; MH059803, MH068366,
MH042228.
468.09 G.S. Dawe: Other Research Support; Cerca Insights Sdn
Bhd. Consultant/Advisory Board; Cerca Insights Sdn Bhd.
R. Albert: Employment; Cerca Insights Sdn Bhd. H. Soo:
Employment; Cerca Insights Sdn Bhd. C. Lai: Employment;
Cerca Insights Sdn Bhd. A.K. Ratty: Employment; Chakra
Biotech Pte Ltd. Consultant/Advisory Board; Cerca Insights
Sdn Bhd, Chakra Biotech Pte Ltd.
468.11 C.B. Nemeroff: Research Grant; NIH, Agency for Healthcare
Research and Quality (AHRQ). Ownership Interest;
Method and devices for transdermal delivery of lithium
(US 6,375,990B1), Method of assessing antidepressant
drug therapy via transport inhibition of monoamine
neurotransmitters by ex vivo assay (US 7,148,027B2),
Xhale, Revaax Pharma stock owner, NovaDel Pharma
Inc stock owner, CeNeRx Biopharma stock owner,
PharmaNeuroBoost stock owner. Consultant/Advisory Board;
NARSAD, AFSP, CeNeRx BioPharma, Anxiety Disorders
Association of America (ADAA), PharmaNeuroboost, Takeda,
PharmaNeuroBoost, NovaDel Pharma Inc, Xhale. Other;
financial interest -- CeNeRx BioPharma, financial interest
-- PharmaNeuroBoost. B. Kinkead: Research Grant; NIMH
grant support.
469.04 A.L. Andrade: Employment; Universidade Federal de São
Paulo. Research Grant; Associação Fundo de Incentivo à
Psicofarmacologia, CNPq, CAPES, Fundação de Amparo à
Pesquisado Estado de São Paulo-FAPESP.
471.06 V.I. Chefer: Employment; NIDA IRP. R. Henriksson:
Employment; NIDA IRP. T. Shippenberg: Employment; NIDA
IRP.
471.24 G. Yadid: Research Grant; NIH (grant R21DA027776).
474.15 M.J. Owens: Research Grant; NIH, SK Life Sciences,
Lundbeck, Sunovion, Eli Lilly, Cyberonics. Consultant/
Advisory Board; Lundbeck, RJ Reynolds.
476.01 B. Ding: Research Grant; NIH Grant. R.D. Frisina: Research
Grant; NIH Grant. X. Zhu: Research Grant; NIH Grant. Y.
Sakai: Research Grant; NIH Grant. M. Harvey: Research
Grant; NIH Grant. D. Frisina: Research Grant; NIH Grant.
B. Sokolowski: Research Grant; NIH Grant. J.P. Walton:
Research Grant; NIH Grant.
476.03 X. Zhu: Research Grant; NIH Grant. J.P. Walton: Research
Grant; NIH Grant. B. Ding: Research Grant; NIH Grant. R.D.
Frisina: Research Grant; NIH Grant.
476.07 T.E. Cope: Employment; NHS. T.D. Griffiths: Employment;
NHS. Research Grant; Wellcome Trust.
476.14 R. Bibi: Research Grant; CCNY-MSKCC U54 Partnership.
478.01 S. Sharma: Employment; All India Institute of Medical
Sciences. T.C. Nag: Employment; All India Institute of Medical
Sciences. D. Bhardwaj: Employment; All India Institute of
Medical Sciences. A. Thakar: Employment; All India Institute
of Medical Sciences. T. Roy: Employment; All India Institute of
Medical Sciences. Research Grant; Indian Council of Medical
ABSTRACT
NUMBER STATEMENT
Research (ICMR).
478.17 M.J. Fischl: Research Grant; NIH DC 008989.
481.02 H.R. Clemo: Research Grant; NIH NS 039460, NIH NS
064675.
481.12 J.S. Nasse: Research Grant; T32 DE014320. S.P. Travers:
Research Grant; NIH DC00417. J.B. Travers: Research
Grant; NIH DC00416.
482.09 D.A. Protti: Research Grant; ARC DP0988227.
484.06 R. Srinivasan: Research Grant; R01 MH6800.
484.17 B. Ahmed: Research Grant; BBSRC (UK). P.M. Cordery:
Research Grant; BBSRC(UK). D. McLelland: Research
Grant; Wellcome Trust (UK). W. Bair: Other Research
Support; Wellcome Trust (UK). K. Krug: Research Grant;
BBSRC (UK). Other Research Support; The Royal Society
(UK).
488.22 Y. Wang: Employment; University of Texas-Houston Medical
School. Research Grant; James S. McDonnell Foundation,
Pew Scholars Program
490.05 J. Huesers: Research Grant; DFG GRK-885-NeuroAct, FOR-
560
491.09 M.J. McKeown: Research Grant; National Parkinson’s
Foundation, Pactific Alzheimer’s Research Foundation,
Parkinson’s Society of Canada. Speakers Bureau/Honoraria;
Teva Innovation, Novartis. Consultant/Advisory Board; Teva
Innovation, Novartis.
494.04 R.J. Traub: Research Grant; NIH R01 NS37424.
494.05 S. Bradesi: Research Grant; NIDA. E. Mayer: Research
Grant; NIDDK.
494.11 L. Yang: Employment; Eli Lilly and company. J. Kennedy:
Employment; Eli Lilly and company. D. Morrow: Employment;
Eli Lilly and company.
494.15 C. Lin: Research Grant; Fund of Natural science Fujian
Province(C0910595). Other Research Support; Fund of Fujian
Mudical University 09ZD009
495.10 P. Stroman: Ownership Interest; SpinalMap Inc..
498.12 R.B. Parreira: Other Research Support; National
Foundation for the Development of Private Higher Education
(FUNADESP); PIBIC/CNPQ; PROSUP/CAPES, Brazil.. R.A.
da Silva Jr: Other Research Support; National Foundation for
the Development of Private Higher Education (FUNADESP);
PIBIC/CNPQ; PROSUP/CAPES, Brazil..
498.13 M. Bilodeau: Research Grant; Natural Sciences and
Engineering Research Council of Canada, Canada
Foundation for Innovation.
498.14 F.B. Horak: Consultant/Advisory Board; APDM, Inc, 2828
Southwest Corbett Avenue Portland, OR 97201.
500.01 M.E. Wierman: Research Grant; HD32119.
500.09 J. Parkash: Employment; JPARc INSERM. Research Grant;
ANR France
502.09 J. Ciriello: Research Grant; Heart and Stroke Fdn. of Ontario.
504.20 L.L. Dugan: Employment; UCSD. Research Grant; NIH,
Larry L Hillblom Foundation. E.G. Inui: Employment; UCSD.
K.B. Grey: Employment; UCSD. V. Nagarajan: Employment;
UCSD.
505.15 Y. Oishi: Other Research Support; Japan Society for the
Promotion of Science507.13 M. Demeule: Employment;
Angiochem. Ownership Interest; Angiochem. A. Régina:
Employment; Angiochement. Ownership Interest; Angiochem.
R. Béliveau: Research Grant; Angiochem. Ownership
Interest; Angiochem. Consultant/Advisory Board; Angiochem.
J. Castaigne: Employment; Angiochem. Ownership Interest;
Anigochem.
507.13 M. Demeule: Employment; Angiochem. Ownership Interest;
Angiochem. A. Régina: Employment; Angiochement.
Ownership Interest; Angiochem. R. Béliveau: Research
Grant; Angiochem. Ownership Interest; Angiochem.
Consultant/Advisory Board; Angiochem. J. Castaigne:
Employment; Angiochem. Ownership Interest; Anigochem.
507.17 E. Pryazhnikov: Employment; Neurotar Ltd. . S. Khirug:
Employment; Neurotra Ltd.
Neuroscience 2011 | Monday Conflict of Interest Statements | 169

ABSTRACT
NUMBER STATEMENT
507.26 A. Badea: Research Grant; P41 RR005959, U24 CA092656.
G.P. Cofer: Research Grant; P41 RR005959, U24 CA092656.
Y. Qi: Research Grant; P41 RR005959, U24 CA092656. A.
Hess:. G. Johnson: Research Grant; P41 RR005959, U24
CA092656.
508.21 A.F. Sánchez: Employment; National University of
Mexico. Research Grant; IN304809-3. V.M. Solis-Macias:
Employment; National University of Mexico. Research Grant;
IN304809-3.
508.22 E. Rosas: Research Grant; PAPIIT No. IN304809-3. V.M.
Solís: Research Grant; PAPIIT No. IN304809-3.
509.05 L.E. Graton Santos: Research Grant; CNPq. L.M.D.M.
Thomazette: Research Grant; CNPq. F.C. Capovilla:
Employment; Universidade de São Paulo (university of Sao
Paulo). Research Grant; CNPq - Bolsista por produtividade
em pesquisa.
510.18 P.J. Bryden: Employment; Wilfrid Laurier University. Research
Grant; NSERC.
510.22 B. Froeliger: Employment; Duke University Medical Center.
Research Grant; NIDA.
511.20 H. Lipp: Consultant/Advisory Board; NewBehavior AG.
512.17 B. Langen: Employment; biocrea GmbH. R. Dost:
Employment; biocrea GmbH. H. Lankau: Employment;
biocrea GmbH. N. Hoefgen: Employment; biocrea GmbH. T.
Hage: Employment; biocea GmbH.
512.24 J.G.N. Flyer: Employment; University of Colorado.
512.26 J.P. Christianson: Research Grant; MH050479.
513.10 K.C.H. Pang: Research Grant; NIH RO1-NS44373.
516.05 D. Pare: Research Grant; NIMH R01 083710.
517.05 K. Lu: Employment; Rutgers, The State University of
New Jersey. Research Grant; NIDCD DC008854. T.
Ziv: Employment; Rutgers, The State University of New
Jersey. Research Grant; NIDCD DC008854. D.S. Vicario:
Employment; Rutgers, The State University of New Jersey.
Research Grant; NIDCD DC008854.
517.17 J. Song: Research Grant; National Natural Science
Foundation of China 30970365, Hydrobiology funding
S30701.
518.06 J. Fein: Employment; Life Technologies. J. Kilheeney:
Employment; Life Technologies. T. Sebata: Employment;
Life Technologies. J. Huuskonen: Employment; Life
Technologies. M. Blankfard: Employment; Life Technologies.
518.07 K. Skold: Employment; Denator AB. M. Söderquist:
Employment; Denator AB. M. Borén: Employment; Denator
AB.
518.22 M. Shankaran: Employment; KineMed, Inc. C. King:
Employment; KineMed, Inc. J. Price: Employment; KineMed,
Inc. W. Holmes: Employment; KineMed, Inc. C. Fessler:
Employment; Kinemed, Inc. J. Protasio: Employment;
KineMed, Inc. M. Hellerstein: Consultant/Advisory Board;
KineMed, Inc.
519.01 S.D. Newsome: Speakers Bureau/Honoraria; Biogen
IDEC. J.N. Ratchford: Research Grant; Novartis,
Biogen IDEC, University of California-Los Angeles. E.M.
Frohman: Speakers Bureau/Honoraria; Biogen IDEC, TEVA
Neuroscience, Acorda, Bayer, Novartis. Consultant/Advisory
Board; Biogen IDEC, TEVA Neuroscience, Acorda, Bayer,
Novartis, Abbott Laboratories. P.A. Calabresi: Research
Grant; EMD-Serono, Teva, Biogen-IDEC, Genentech, Bayer,
Abbott, Vertex. Consultant/Advisory Board; Novartis, EMD-
Serono, Teva, Biogen-IDEC. S. Saidha: Consultant/Advisory
Board; MedicalLogix.
519.14 J. Hoppin: Employment; inviCRO. Ownership Interest;
inviCRO. J.Y. Hesterman: Employment; inviCRO. Ownership
Interest; inviCRO. K.D. Orcutt: Employment; inviCRO. W.
Cupelo: Employment; inviCRO. M. Germino: Employment;
inviCRO. E. White: Employment; inviCRO. C. Lackas:
Employment; inviCRO. M. Lane: Employment; MPI Research.
D. Kentala: Employment; MPI Research. T. Reindfield:
Employment; MPI Research. K. Pickel: Employment; MPI
Research. A. Verma: Employment; Biogen Idec.
519.15 B.D. Gray: Employment; BDG is an employee of Molecular
170 | Society for Neuroscience
ABSTRACT
NUMBER STATEMENT
Targeting Technologies, Inc. K.Y. Pak: Employment; KYP is
an employee of Molecular Targeting Technologies, Inc..
519.16 Y. Chung: Employment; UCSD.
519.27 G. Katona: Ownership Interest; Femtonics Ltd.. B. Rozsa:
Ownership Interest; Femtonics Ltd..
520.05 X. Jiang: Employment; Molecular Devices, Inc, ArunA
Biomedical, Inc. K. Cook: Employment; Molecular Devices,
Inc. J. Hesley: Employment; Molecular Devices, Inc. J.
Costantin: Employment; Molecular Devices, Inc. A. Powe:
Employment; ArunA Biomedical, Inc., University of Georgia.
S.L. Stice: Employment; ArunA Biomedical, Inc., University of
Georgia. O. Sirenko: Employment; Molecular Devices, Inc..
520.12 C.M. Gray: Ownership Interest; Gray Matter Research. B.
Goodell: Ownership Interest; Gray Matter Research
520.18 M.A. McClain: Employment; Axion Biosystems Inc. E.
Brown: Employment; Axion Biosystems Inc. S. Rajaraman:
Employment; Axion Biosystems Inc. T. O’Brien: Employment;
Axion Biosystems Inc. J. Ross: Employment; Axion
Biosystems Inc..
520.19 S. Rajaraman: Employment; Axion BioSystems. M.A.
McClain: Employment; Axion BioSystems. C. Karnati:
Employment; Axion BioSystems. R.D. Grier: Employment;
Axion BioSystems. I.C. Henrich: Employment; Axion
BioSystems. J.D. Ross: Employment; Axion BioSystems.
520.21 R.R. Harrison: Ownership Interest; RRH is part owner of
Intan Technologies.
520.24 E. Naylor: Employment; Pinnacle Technology Inc. D.A.
Johnson: Employment; Pinnacle Technology Inc.. Ownership
Interest; Pinnacle Technology Inc. M. Janke: Employment;
Pinnacle Technology Inc. D. Aillon: Employment; Pinnacle
Technology Inc. S. Gabbert: Employment; Pinnacle
Technology Inc. H. Harmon: Employment; Pinnacle
Technology Inc. D.A. Johnson: Employment; Pinnacle
Technology Inc.. Ownership Interest; Pinnacle Technology
Inc. P. Petillo: Employment; Pinnacle Technology Inc..
520.25 B.C. Towe: Other; US Patent 7,702,395.
520.26 E.T. Jansson: Other Research Support; AstraZeneca. C.
Boström: Other Research Support; AstraZeneca.. K.E.
Jardemark: Other Research Support; AstraZeneca. O.
Orwar: Other Research Support; AstraZeneca.

Hotel Floor Plans
Renaissance Washington, DC Hotel
CONGRESSIONAL
EXHIBIT HALL
C A
B
MEETING ROOM
LEVEL
EXEC.
BUS. CTR.
MOUNT VERNON
A B
BALLROOM LEVEL
GRAND BALLROOM
SOUTH SALON
CENTRAL SALON
NORTH SALON
B A
RENAISSANCE BALLROOM
EAST
SALON
B
WEST
SALON
A

Grand Hyatt Washington, DC Hotel
CONSTITUTION LEVEL (3B)
INDEPENDENCE LEVEL (5B)
MEN
WOMEN
COAT
CHECK
RENWICK
BULFINCH
ELEVATOR
TO ATRIUM,
1B AND 5B
LATROBE BURNHAM
FRANKLIN
SQUARE
LAFAYETTE
PARK
FARRAGUT
SQUARE
REGISTRATION
DESK
WASHINGTON
BOARDROOM
POTOMAC
MCPHERSON
SQUARE
UP TO CONSTITUTION
CONCOURSE (3B)
REGISTRATION
DESK
INDEPENDENCE
FOYER
ELEVATOR
TO ATRIUM,
1B AND 3B
MEN WOMEN
CHERRY
BLOSSOM
WILSON ROOSEVELT
E
D
C
CONSTITUTION FOYER
CONSTITUTION BALLROOM
CORRIDOR C
CORRIDOR B
CABIN
JOHN
ARLINGTON
B A
I H G F
CORRIDOR B
INDEPENDENCE BALLROOM
A
CORRIDOR A
E D C B

Convention Center Floor Plans
Concourse Level
Access to Exhibit Halls A – C
Show Offices A – C
E
&

EXHIBITOR REGISTRATION
& SERVICE CENTER
EXHIBIT
MANAGEMENT
OFFICE
EXHIBITOR
LOUNGE
MESSAGE
CENTER

Lobby Level/Level 1 & Meeting Rooms 101-103 & 140-160
COAT AND LUGGAGE CHECK
TUESDAY, NOV. 15 —
WEDNESDAY NOV. 16 ONLY
COAT AND LUGGAGE CHECK
FRIDAY, NOV. 11 —
MONDAY NOV. 14 ONLY
MESSAGE
CENTER
INFANT
CARE
CHILD
CARE
EXPRESS
BADGE
PICK-UP
SPEAKER READY ROOM
RECYCLE CENTER
CONCOURSE
SFN
INFO
BOOTH
SHUTTLE
INFO
DESK
DOWN TO POSTERS & EXHIBITS

N
FO
TH
TLE
O
K
DOWN TO POSTERS & EXHIBITS
HEADQUARTERS/
LOGISTICS &
PROGRAM OFFICE
EXPRESS
BADGE
PICK-UP
RETAIL
REGISTRATION
EXPRESS BADGE PICK-UP
HOUSING DESK
MEMBERSHIP
SfN INFO BOOTH
CME REGISTRATION/
CERTIFICATES OF ATTENDANCE
LOST & FOUND
WIRELESS SUPPORT
EAST SALON
WEST SALON
PROGRAM & EXHIBIT PICK-UP
NEUROSCIENCE MEETING PLANNER
VIEWING AREA
NEUROJOBS
SOCIETY EXECUTIVE LOUNGE
EXPRESS
BADGE
PICK-UP
DOWN TO
POSTERS & EXHIBITS
TO RENAISSANCE
WASHINGTON, DC HOTEL

Level Two
Exhibit Halls D & E
Meeting Rooms 201-210
north building
DOWN TO POSTERS AND EXHIBITS (HALL C)
FOOD COURT
FEA

middle building south building
FIRST AID
FEATURED AND SPECIAL LECTURES
SFN
INFO
BOOTH
NEURONLINE BOOTH
PRESS ROOM PRESS INTERVIEW ROOM
MESSAGE
CENTER
GRAND LOBBY BRIDGE

Level Three
Ballrooms A-C
Meeting Rooms 301-306
south building
DOWN ESCALATOR
TO GRAND LOBBY
DOWN ESCALATOR
TO GRAND LOBBY

Neuroscience 2011 – Exhibits and Poster Sessions
Walter E. Washington Convention Center: Halls A–C
Meeting Dates: Nov. 12–16
Exhibit Dates: Nov. 13–16
Hall entrances open at noon on Saturday, Nov. 12 and at 7 a.m. on Sunday, Nov.13 to Wednesday, Nov. 16 for poster presenter setup.
Poster sessions are open for all attendees at 1 p.m. on Saturday, Nov. 12 and 8 a.m. Sunday, Nov. 13 to Wednesday, Nov. 16.
NOTE: Floor plan subject to change, for current floor plan please visit www.sfn.org/exhibits.
N ST., ABOVE
ABSTRACT
LOCATOR
E XIT
E XIT
E XIT
E XIT
Abstract Locators
Concession Areas
First Aid
Publishers Row
A34 A35 B32 B33 C25 C26 D36 D37 E32 E33
A33 A36 B31 B34 C24 C27 D35 D38 E31 E34
A32 A37 B30 B35
D34 D39 E30 E35
A31 A38 B29 B36
D33 D40 E29 E36
A30 A39 B28 B37
D32 D41 E28 E37
A29 A40 B27 B38 C23 C28 D31 D42 E27 E38
A28 A41 B26 B39 C22 C29 D30 D43
A27 A42 B25 B40 C21 C30 D29 D44 E26 140
A26 A43
A25 A44
B24 B41
B23 B42
C20 C31 D28 D45
D27 D46
E25
E24
138
A24 A45 B22 B43
D26 D47 E23 136
A23 A46 B21 B44
D25 D48 E22
A22 A47 B20 B45
D24 D49 E21
A21 A48
A20 A49
B19 B46
B18 B47
C19 C32
C18 C33
D23 D50
D22 D51
E20
E19
132
A19 A50 B17 B48 C17 C34 D21 D52 E18 130
A18 A51 B16 B49 C16 C35 D20 D53 E17
A17 A52 B15 B50 C15 C36 D19 D54 E16
A16 A53 B14 B51 C14 C37 D18 D55 E15
A15 A54 B13 B52 C13 C38
C12 C39
D17 D56
D16 D57
E14
124
A14 A55
D15 D58
D14 D59
A13 A56
D13 D60
A12 A57 B12 B53
D12 D61
A11 A58 B11 B54 C11 C40 D11 D62
A10 A59 B10 B55 C10 C41 D10 D63
A9 A60 B9 B56 C9 C42 D9 D64
A8 A61 B8 B57 C8 C43 D8 D65
A7 A62 B7 B58 C7 C44 D7 D66
A6 A63 B6 B59 C6 C45 D6 D67
A5 A64 B5 B60 C5 C46 D5 D68
A4 A65 B4 B61 C4 C47 D4 D69
A3 A66 B3 B62 C3 C48 D3 D70
A2 A67 B2 B63 C2 C49 D2 D71
A1 A68 B1 B64 C1 C50 D1 D72
KEY
E
E
Institutions
Nonprofits
ABSTRACT LOCATOR
E13
E12
E11
E10
E9
E8
E7
E6
E5
E4
E3
E2
E1
116
114
100 AISLE
131
125
112 113
110 111
104
Carestream
Molecular
Imaging
139
109
105
Sustaining Associate Members
G6 G7
G5 G8
G4 G9
G3 G10
G2 G11
F1 F2 G1 G12
230 231
228 229
226 227
224 225
212
210
208
206
204
200 AISLE
241
239
237
235
233
219
217
215
209
205
H6 H7 I6 I7
K6 K7 L6 L7 M6 M7 N6 N7 O6 O7 P6 P7
R6 R7 S6
H5 H8 I5 I8
K5 K8 L5 L8 M5 M8 N5 N8 O5 O8 P5 P8
R5 R8 S5
H4 H9 I4 I9
K4 K9 L4 L9 M4 M9 N4 N9 O4 O9 P4 P9
R4 R9 S4
H3 H10 I3 I10
K3 K10 L3 L10 M3 M10 N3 N10 O3 O10 P3 P10
R3 R10 S3
H2 H11 I2 I11
K2 K11 L2 L11 M2 M11 N2 N11 O2 O11 P2 P11
R2 R11 S2
H1 H12 I1 I12 J1 J2 K1 K12 L1 L12 M1 M12 N1 N12 O1 O12 P1 P12 Q1 Q2 R1 R12 S1
340 341
338
336
334
332
330
328
326
324
312
310 311
308 309
306
300 AISLE
335
319
317
315
313
304 305
302 303
300 301
E XIT
440
438
436
434
Neuralynx
325
418
416
414
408
404
400
400 AISLE
Clever
Sys
439
431
429
427
425
413
411
409
403
E XIT
530 531
528 529
526 527
524 525
508
502
E XIT
500 AISLE
541
539
537
535
519
517
515
513
511
509
505
640
638
636 637
634 635
630 631
628
626
624 625
618
616
614 615
612 613
610 611
608 609
501 600 601
E XIT
600 AISLE
639
627
617
605
602 702 703
HALL C ENTRANCE
E XIT
738 739
736
734
730
728
724
718
716
714
712
710
708 709
704
700
700 AISLE
711
E XIT
840
838
824
Hamamatsu
800 AISLE
835
Thorlabs
819
817
815
812 813
810 811
808 809
805
801
TSE
918
916
914 915
912
908
900 AISLE
941
939
937
935
931
925
917
911
909
904 905
902 903
900 901
1040 1041
1038 1039 1138
1036
1034
1030
1028
1016
1014
1012
1004
1000
1000 AISLE
1024 1025
1008
EMD
Millipore
E
1011
111 2
1100 AISLE
1139 1238
1127
1230
1125 1224
111 7 1216
111 5 1214
111 3 1212
1210
1009 1108 1109 1208
1005 1104
1003 1102
1135 1234
1129
1105 1204
1101 1200

1000 AISLE
1041
1039 1138
1025
111 2
1100 AISLE
1139 1238
1127
1125 1224
111 5 1214 1215 1314
111 3 1212
1210
1009 1108 1109 1208
1230 1231 1330 1331
1105 1204
1200 AISLE
1235 1334
1233 1332
1229
1227
1225 1324 1325
111 7 1216 1217 1316
1101 1200
1237
1201 1300
E XIT
1338 1339
1304
1300 AISLE
Charles
River
1303
E HALL B ENTRANCE
E
E XIT
1400 AISLE
1437
1435 1534
1433
1532
1424
1415
1500 / 1600 AISLE
1639 1738
1625
1607
Nikon
Inst
1700 AISLE
1737
1832
1731 1830
1800 AISLE
1835 1934
1831 1930
1825
1918
1717 1816 1817 1916
1814 1815 1914
1812 1813 1912
1810 1811 1910
1808 1809 1908
1806 1807 1906
1804 1805 1904 1905
1603 1702 1703 1802 1803 1902 1903 2002
1701 1800 1801 1900
1900 AISLE
1931
1925 2024
E XIT
E XIT
E XIT E XIT
E XI
T
E XI
T E XI
T
E XI
T
Y10 Y27
Y9 Y28
Y8 Y29
Z10 Z27
Z9 Z28
Z8 Z29
AA10 AA27
AA9 AA28
AA8 AA29
CC10 CC23 DD10 DD27
CC9 CC24 DD9 DD28
CC8 CC25 DD8 DD29
FF9 FF26
FF8 FF27
GG10 GG27 HH10 HH23
GG9 GG28 HH9 HH24
GG8 GG29 HH8 HH25
JJ10 JJ27
JJ9 JJ28
JJ8 JJ29
KK10 KK27
KK9 KK28
KK8 KK29
R6 R7 S6 S7
ABSTRACT LOCATOR
T4 T5
V6 V7 W6 W7 X6 X7
Y7 Y30
Y6 Y31
Z7 Z30
Z6 Z31
AA7 AA30
AA6 AA31 BB6 BB19
CC7 CC26
CC6 CC27
DD7 DD30
DD6 DD31 EE6 EE23
FF7 FF28
FF6 FF29
GG7 GG30
GG6 GG31
HH7 HH26
HH6 HH27 II6 II23
JJ7
JJ6
JJ30
JJ31
KK7 KK30
KK6 KK31
R5 R8 S5 S8
V5 V8 W5 W8 X5 X8 Y5 Y32 Z5 Z32 AA5 AA32 BB5 BB20 CC5 CC28 DD5 DD32 EE5 EE24 FF5 FF30 GG5 GG32 HH5 HH28 II5 II24 JJ5 JJ32 KK5 KK32
R4 R9 S4 S9
V4 V9 W4 W9 X4 X9 Y4 Y33 Z4 Z33 AA4 AA33 BB4 BB21 CC4 CC29 DD4 DD33 EE4 EE25 FF4 FF31 GG4 GG33 HH4 HH29 II4 II25 JJ4 JJ33 KK4 KK33
R3 R10 S3 S10 T3 T6
V3 V10 W3 W10 X3 X10 Y3 Y34 Z3 Z34 AA3 AA34 BB3 BB22 CC3 CC30 DD3 DD34 EE3 EE26 FF3 FF32 GG3 GG34 HH3 HH30 II3 II26 JJ3 JJ34 KK3 KK34
Q1 Q2
R2 R11
R1 R12
S2 S11
S1 S12
T2 T7
T1 T8 U1 U2
V2 V11
V1 V12
W2 W11
W1 W12
X2 X11
X1 X12
Y2 Y35
Y1 Y36
Z2 Z35
Z1 Z36
AA2 AA35
AA1 AA36
BB2 BB23
BB1 BB24
CC2 CC31
CC1 CC32
DD2 DD35
DD1 DD36
EE2 EE27
EE1 EE28
FF2 FF33
FF1 FF34
GG2 GG35
GG1 GG36
HH2 HH31
HH1 HH32
II2
II1
II27
II28
JJ2
JJ1
JJ35
JJ36
KK2 KK35
KK1 KK36
EMD
Millipore
1011
1005 1104
1003 1102
1135 1234
1129
Abstract Locators
Concession Areas
First Aid
Publishers Row
1211 1310
1207
Stoelting
KEY
Elsevier
Molecular
Devices
Society for
Neuroscience
(SfN)
Institutions
Nonprofits
Sustaining Associate Members
7TH ST., ABOVE
Y18 Y19 Z18 Z19 AA18 AA19
DD18 DD19 EE14 EE15 FF17 FF18 GG18 GG19
II14 II15 JJ18 KK18
JJ19 KK19 LL16 LL17 MM15 MM16
Y17 Y20 Z17 Z20 AA17 AA20
DD17 DD20 EE13 EE16 FF16 FF19 GG17 GG20
II13 II16 JJ17 JJ20 KK17 KK20 LL15 LL18 MM14 MM17
Y16 Y21 Z16 Z21 AA16 AA21 BB12 BB13 CC16 CC17 DD16 DD21 EE12 EE17 FF15 FF20 GG16 GG21 HH16 HH17 II12 II17 JJ16 JJ21 KK16 KK21 LL14 LL19 MM13 MM18
Y15 Y22 Z15 Z22 AA15 AA22 BB11 BB14 CC15 CC18 DD15 DD22 EE11 EE18 FF14 FF21 GG15 GG22 HH15 HH18 II11 II18 JJ15 JJ22 KK15 KK22 LL13 LL20 MM12 MM19
Y14 Y23 Z14 Z23 AA14 AA23 BB10 BB15 CC14 CC19 DD14 DD23 EE10 EE19 FF13 FF22 GG14 GG23 HH14 HH19 II10 II19 JJ14 JJ23 KK14 KK23 LL12 LL21 MM11 MM20
Y13 Y24 Z13 Z24 AA13 AA24 BB9 BB16 CC13 CC20 DD13 DD24 EE9 EE20 FF12 FF23 GG13 GG24 HH13 HH20 II9 II20 JJ13 JJ24 KK13 KK24 LL11 LL22 MM10 MM21
Y12 Y25 Z12 Z25 AA12 AA25 BB8 BB17 CC12 CC21 DD12 DD25 EE8 EE21 FF11 FF24 GG12 GG25 HH12 HH21 II8 II21 JJ12 JJ25 KK12 KK25 LL10 LL23 MM9 MM22
Y11 Y26 Z11 Z26 AA11 AA26 BB7 BB18 CC11 CC22 DD11 DD26 EE7 EE22 FF10 FF25 GG11 GG26 HH11 HH22 II7 II22 JJ11 JJ26 KK11 KK26 LL9 LL24 MM8 MM23
Kopf
Inst
Sigma Life
Science
1826
1725 1824
1839 1938
1837 1936
1833
BIOPAC 2140 2141
2241 2340
2440
Corning Andor Tech
1939
1927
1907
2028
2010
2008 2009 2108 2109 2208 2209 2308 2309
E XIT
2000 AISLE
2138 2139 2238
2037 2136 2137
2134 2135 2234
2033 2132
2031 2130
2027
2025 2124 2125
2017
2015 2114 2115 2214
2013 2112 2113 2212
2011 2110 2111
2005 2104
2001 2100
E XIT
2100 AISLE
2131 2230
2119 2218
2117 2216
2101 2200
E XIT
Bio-Rad
2103
2200 AISLE
2231
2204 2205
2239 2338
2227
2225 2324
2203 2302
E XIT
2328
2211 2310
2300 AISLE
2337 2436 2437
2333 2432 2433 2532
2331 2430 2431
2329 2428 2429 2528
2327
2434 2435 2534
2325 2424
2315
Plexon
2400 AISLE
2427
Eppendorf
North USA
2425 2524
2405 2504 2505
2301 2400 2401 2500
2409 2508 2509 2608
E XIT
2538 2539
2510
2500 AISLE
2513
2502 2503 2602
E XIT
ABSTRACT LOCATOR
2525
2610
FE
2635 2734 2735
Olympus
USA
2600 AISLE
2617 2716
2615 2714 2715 2814
2613 2712 2713 2812
2605
2736 2737 2836
2718
2700 AISLE
2731
2717
2603 2702 2703
LL7
LL6
LL3
LL2
LL1
2832
2804
LL8
LL5
LL4
2609 2708 2709 2808
2601 2700 2701 2800
2838 2839
2828
2800 AISLE
LL25
LL26
LL27
LL28
LL29
LL30
LL31
LL32
2725 2824 2825
Leica
Microsystem
2809
MM7
MM6
MM5
MM4
MM3
MM2
MM1
2803 2902
MM24
MM25
MM26
MM27
MM28
MM29
MM30
MM
2900 AISLE
Carl Zeis
2
2
2
2

lympus
USA
Leica
Microsystems
E XIT
E XIT
E XIT
E XIT
T
I
X
E
T
I
X
E T
I
X
E
T
I
X
E
T
I
X
E
T
I
X
E
E XIT
E XIT
100 150
SCALE IN FEET
10
0 50
30
20 40
E
FE FE
FE
2601
2603
2605
2613
2615
2700 2701
2712 2713
2714 2715
2716
2718
2734 2735
2804
2812
2814
2836
2905 3004 3005
3007
3009
3029
3031
3034
3037
3104
3106 3107
3108 3109
3110 3111
3112 3113
3128 3129
3130 3131
3132
3139
3141
3201
3202 3203
3205
3207
3209
3217
3219
3224 3225
3227
3229
3230 3231
3233
3235
3237
3238 3239
3240 3241
3300
3302
3304
3306
3308
3310
3315
3316 3317
3318 3319
3324 3325
3327
3330
3332 3333
3418
3428
3430 3431
3432
3505
3507
3509
3511
3530
3538
3540 3541
2600 AISLE
2700 AISLE
2800 AISLE
2900 AISLE
3000 AISLE
3100 AISLE
3200 AISLE
3300 AISLE
3400 AISLE
3500 AISLE
2617
2635
2717
2725
2736 2737
2800
2803
2809
2824 2825
2832
2838 2839
2901
2902
2917
2935
3000 3001
3011
3016 3017
3025
3039
3100
3103
3124 3125
3138
JJ1
JJ2
JJ3
JJ4
JJ5
JJ6
JJ7
JJ8
JJ9
JJ10
JJ11
JJ12
JJ13
JJ14
JJ15
JJ16
JJ17
JJ18 JJ19
JJ20
JJ21
JJ22
JJ23
JJ24
JJ25
JJ26
JJ27
JJ28
JJ29
JJ33
JJ34
JJ35
JJ36
JJ30
JJ31
JJ32
KK1
KK2
KK3
KK4
KK5
KK6
KK7
KK8
KK9
KK10
KK11
KK12
KK13
KK14
KK15
KK16
KK17
KK18 KK19
KK20
KK21
KK22
KK23
KK24
KK25
KK26
LL27
LL28
LL29
KK33
KK34
KK35
KK36
LL30
LL31
LL32
LL1
LL2
LL3
LL4
LL5
LL6
LL7
LL8
LL9
LL10
LL11
LL12
LL13
LL14
LL15
LL16 LL17
LL18
LL19
LL20
LL21
LL22
LL23
LL24
LL25
LL26
MM NN OO PP QQ RR SS TT UU VV WW XX YY ZZ AAA
MM1
MM2
MM3
MM4
MM5
MM6
MM7
MM8
MM9
MM10
MM11
MM12
MM13
MM14
MM15 MM16
MM17
MM18
MM19
MM20
MM21
MM22
MM23
KK27
KK28
KK29
KK30
KK31
KK32
MM24
MM25
MM26
MM27
MM28
MM29
MM30 NN1
NN2
NN3
NN4
NN5
NN6
NN7
NN8
NN9
NN10
NN11
NN12
NN13
NN14
NN15
NN16
NN17
NN18 NN19
NN20
NN21
NN22
NN23
NN24
NN25
NN26
NN33
NN34
NN35
NN36
NN27
NN28
NN29
NN30
NN31
NN32
OO1
OO2
OO3
OO4
OO5
OO6
OO7
OO8
OO9
OO10
OO11
OO12
OO13
OO14
OO15
OO16
OO17
OO18 OO19
OO20
OO21
OO22
OO23
PP24
PP25
PP26
OO33
OO34
OO35
OO36
OO27
OO28
OO29
OO30
OO31
OO32
PP1
PP2
PP3
PP4
PP5
PP6
PP7
PP8
PP9
PP10
PP11
PP12
PP13
PP14 PP15
PP16
PP17
PP18
PP19
PP20
PP21
PP22
PP23
OO24
OO25
OO26
PP27
PP28 QQ1
QQ2
QQ3
QQ4
QQ5
QQ6
QQ7
QQ8
QQ9
QQ10
QQ11
QQ12
QQ13
QQ14
QQ15
QQ16
QQ17
QQ18 QQ19
QQ20
QQ21
QQ22
QQ23
QQ24
QQ25
QQ26
QQ33
QQ34
QQ35
QQ36
QQ27
QQ28
QQ29
QQ30
QQ31
QQ32
RR1
RR2
RR3
RR4
RR5
RR6
RR7
RR8
RR9
RR10
RR11
RR12
RR13
RR14
RR15
RR16
RR17
RR18 RR19
RR20
RR21
RR22
RR23
TT24
TT25
TT26
RR33
RR34
RR35
RR36
TT27
TT28
RR30
RR31
RR32
UU1
UU2
UU3
UU4
UU5
UU6
UU7
UU8
UU9
UU10
UU11
UU12
UU13
UU14
UU15
UU16
UU17
UU18 UU19
UU20
UU21
UU22
UU23
UU24
UU25
UU26
UU33
UU34
UU35
UU36
UU27
UU28
UU29
UU30
UU31
UU32
SS1
SS2
SS3
SS4
SS5
SS6
SS7
SS8
SS9
SS10
SS11
SS12
SS13
SS14
SS15
SS16 SS17
SS18
SS19
SS20
SS21
SS22
SS23
SS24
SS25
SS26
SS27
SS28
SS29
SS30
SS31
SS32 TT1
TT2
TT3
TT4
TT5
TT6
TT7
TT8
TT9
TT10
TT11
TT12
TT13
TT14 TT15
TT16
TT17
TT18
TT19
TT20
TT21
TT22
TT23
RR27
RR28
RR29
RR24
RR25
RR26
VV1
VV2
VV3
VV4
VV5
VV6
VV7
VV8
VV9
VV10
VV11
VV12
VV13
VV14
VV15
VV16
VV17
VV18
VV19
VV20
VV21
VV22
VV23
VV24
VV25
VV26
VV27
VV28
VV29
VV30
VV31
VV32
VV33
VV34
VV68
VV67
VV66
VV65
VV64
VV63
VV62
VV61
VV60
VV59
VV58
VV57
VV56
VV55
VV54
VV53
VV52
VV51
VV50
VV49
VV48
VV47
VV46
VV45
VV44
VV43
VV42
VV41
VV40
VV39
VV38
VV37
VV36
VV35
VV69
VV70
VV71
VV72
VV73
VV74
VV75
VV76
VV77
VV78
VV79
VV80
VV81
VV82
VV83
VV84
VV85
VV86
VV87
VV88
VV89
VV90
VV91
VV92
VV93
VV94
VV95
VV96
WW1
WW2
WW3
WW4
WW5
WW6
WW7
WW8
WW9
WW10
WW11
WW12
WW13
WW14
WW15
WW16
WW17
WW18
WW19
WW20
WW21
WW22
WW23
WW24
WW25
WW26
WW27
WW28
WW29
WW30
WW31
WW32
WW33
WW34
WW68
WW67
WW66
WW65
WW64
WW63
WW62
WW61
WW60
WW59
WW58
WW57
WW56
WW55
WW54
WW53
WW52
WW51
WW50
WW49
WW48
WW47
WW46
WW45
WW44
WW43
WW42
WW41
WW40
WW39
WW38
WW37
WW36
WW35
WW69
WW70
WW71
WW72 XX1
XX2
XX3
XX4
XX5
XX6
XX7
XX8
XX9
XX10
XX11
XX12
XX13
XX14
XX15
XX16
XX17
XX18
XX19
XX20
XX21
XX22
XX23
XX24
XX25
XX26
XX27
XX28
XX29
XX30
XX31
XX32
XX33
XX34
XX40
XX39
XX38
XX37
XX36
XX35
XX48
XX47
XX46
XX45
XX44
XX43
XX42
XX41
XX56
XX55
XX54
XX53
XX52
XX51
XX50
XX49
XX58
XX57
XX59
XX60
XX61
XX62
XX63
XX64
XX65
XX66
XX67
XX68
XX69
XX70
XX71
XX72
XX73
XX74
XX75
XX76
XX77
XX78
XX79
XX80
XX81
XX82
XX83
XX84
XX85
XX86
XX87
XX88
XX89
XX90
XX91
XX92 YY1
YY2
YY3
YY4
YY5
YY6
YY7
YY8
YY9
YY10
YY11
YY12
YY13
YY14
YY15
YY16
YY17
YY18
YY19
YY20
YY21
YY22
YY23
YY24
YY25
YY26
YY27
YY28
YY29
YY30
YY31
YY32
YY33
YY34
YY40
YY39
YY38
YY37
YY36
YY35
YY48
YY47
YY46
YY45
YY44
YY43
YY42
YY41
YY56
YY55
YY54
YY53
YY52
YY51
YY50
YY49
YY58
YY57
YY59
YY60
YY61
YY62
YY63
YY64
YY65
YY66
YY67
YY68
YY69
YY70
YY71
YY72
YY73
YY74
YY75
YY76
YY77
YY78
YY79
YY80
YY81
YY82
YY83
YY84
YY85
YY86
YY87
YY88
YY89
YY90
YY91
YY92
ZZ1
ZZ2
ZZ3
ZZ4
ZZ5
ZZ6
ZZ7
ZZ8
ZZ9
ZZ10
ZZ11
ZZ12
ZZ13
ZZ14
ZZ15
ZZ16
ZZ17
ZZ18
ZZ19
ZZ20
ZZ21
ZZ22
ZZ23
ZZ24
ZZ25
ZZ26
ZZ27
ZZ28
ZZ29
ZZ30
ZZ31
ZZ32
ZZ33
ZZ34
ZZ40
ZZ39
ZZ38
ZZ37
ZZ36
ZZ35
ZZ48
ZZ47
ZZ46
ZZ45
ZZ44
ZZ43
ZZ42
ZZ41
ZZ56
ZZ55
ZZ54
ZZ53
ZZ52
ZZ51
ZZ50
ZZ49
ZZ58
ZZ57
ZZ59
ZZ60
ZZ61
ZZ62
ZZ63
ZZ64
ZZ65
ZZ66
ZZ67
ZZ68
ZZ69
ZZ70
ZZ71
ZZ72
ZZ73
ZZ74
ZZ75
ZZ76
ZZ77
ZZ78
ZZ79
ZZ80
ZZ81
ZZ82
ZZ83
ZZ84
ZZ85
ZZ86
ZZ87
ZZ88
AAA1
AAA2
AAA3
AAA4
AAA5
AAA6
AAA7
AAA8
AAA9
AAA10
AAA11
AAA12
AAA13
AAA14
AAA15
AAA16
AAA17
AAA18
AAA19
AAA20
AAA21
AAA22 AAA23
AAA24
AAA25
AAA26
AAA27
AAA28
AAA29
AAA33
AAA34
AAA35
AAA36
AAA30
AAA31
AAA32
AAA37
AAA38
AAA39
AAA40
AAA41
AAA42
AAA43
AAA44
2609
2702 2703
2708 2709
2731
2808
2828
3033
3036
3038
3134
3204
3210 3211
3226
3305
3312
3326
3329
3334
3337
3338
3405
3414
3424 3425
3439
3513
3517
3525
3531
3537
MOUNT VERNON PLACE, ABOVE
HALL A ENTRANCE
KITCHEN
RACT LOCATOR
ABSTRACT LOCATOR
ABSTRACT LOCATOR
Carl Zeiss
NIDA NIMH
NIH,
Central
Booth
NDP
NSF
TILL
Photonics
GmbH
Andor Tech
Sutter Instrument
Company

Notes

NEUROSCIENCE 2012
NEUROSCIENCE 2012
See You in new orleans
october 13 – 17, 2012

sociEtY FoR NEURosciENcE
Program
Monday
November 14, 2011
washiNgtoN, dc